Substance_id	Substance_name	Substance_category	Substance_subcategory	cas_no	id_drugbank	id_pharmgkb	id_kegg	id_ttd	id_pubchem	id_chemspider	id_npass	synonyms	Molecular_formula	inchikey	iupacname	Product_company	Therapeutic_class
PMDBD16	Acetaminophen	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	103-90-2	DB00316	PA448015	D00217	DAP001436	1983	1906	NPC76327	acetaminophen; Paracetamol; 4-Acetamidophenol; 103-90-2; N-(4-Hydroxyphenyl)acetamide; Tylenol; APAP; Panadol; Acetaminofen; Datril; N-Acetyl-p-aminophenol; p-Hydroxyacetanilide; 4'-Hydroxyacetanilide; p-Acetamidophenol; Naprinol; Lonarid; Algotropyl; Anelix; Multin; Acenol; Acamol; p-Acetaminophenol; Pyrinazine; Injectapap; Clixodyne; Liquagesic; Acetagesic; Gelocatil; Servigesic; Acetalgin; Abensanil; Valadol; Tralgon; Tabalgin; Lestemp; Alvedon; Valgesic; Tussapap; Finimal; Paracet; Homoolan; Febrolin; Febrilix; Febridol; Dymadon; Anaflon; Apamide	C8H9NO2	RZVAJINKPMORJF-UHFFFAOYSA-N	N-(4-hydroxyphenyl)acetamide	Beximco Pharma	Analgesics
PMDBD135	Butyric Acid	Therapeutic Substance	Investigational Drug	107-92-6	DB03568	n.a.	n.a.	n.a.	264	259	n.a.	butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; Butanic acid; 1-propanecarboxylic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; HSDB 940; CCRIS 6552; butoic acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; MFCD00002814; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H; CHEBI:30772	C4H8O2	FERIUCNNQQJTOY-UHFFFAOYSA-N	butanoic acid	n.a.	n.a.
PMDBD189	Choline	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	62-49-7	DB00122	PA448976	D07690	n.a.	305	299	NPC136014	choline; Choline ion; Bilineurine; Choline cation; Cholinum; 2-Hydroxy-N,N,N-trimethylethanaminium; 62-49-7; (2-Hydroxyethyl)trimethylammonium; trimethylethanolamine; N-trimethylethanolamine; CCRIS 5847; AI3-24208; UNII-N91BDP6H0X; BRN 1736748; N,N,N-trimethylethanol-ammonium; CHEBI:15354; (beta-hydroxyethyl)trimethylammonium; EINECS 200-535-1; CHEMBL920; N91BDP6H0X; (2-hydroxyethyl)trimethylazanium; 2-hydroxy-N,N,N-trimethyl-ethanaminium; vitamin J; CHT; NSC402838; NCGC00015219-03; C5H14NO	C5H14NO+	OEYIOHPDSNJKLS-UHFFFAOYSA-N	2-hydroxyethyl(trimethyl)azanium	n.a.	n.a.
PMDBD378	Gallic acid	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	370	n.a.	NPC225710	Gallic acid; 3,4,5-Trihydroxybenzoic acid; 149-91-7; gallate; Gallic acid, tech.; GALOP; Pyrogallol-5-carboxylic acid; Kyselina gallova; HSDB 2117; 3,4,5-Trihydroxybenzoate; CCRIS 5523; Kyselina gallova [Czech]; Gallic acid polymer; UNII-632XD903SP; NSC 674319; Gallicum acidum; CHEBI:30778; AI3-16412; Kyselina 3,4,5-trihydroxybenzoova; EINECS 205-749-9; NSC 20103; MFCD00002510; BRN 2050274; Kyselina 3,4,5-trihydroxybenzoova [Czech]; CHEMBL288114; 3,4,5-trihydroxy-Benzoic acid; 632XD903SP; NSC20103; NSC6	C7H6O5	LNTHITQWFMADLM-UHFFFAOYSA-N	3,4,5-trihydroxybenzoic acid	n.a.	n.a.
PMDBD130	Bupropion	Therapeutic Substance	Approved Drug	34911-55-2	DB01156	PA448687	D07591	DAP000052	444	431	n.a.	bupropion; Amfebutamone; 34911-55-2; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; Amfebutamon; Wellbutrin; (+-)-Bupropion; amfebutamonum; Amfebutamona; 34841-39-9; Bupropion [INN:BAN]; Wellbatrin; Elontril; Amfebutamonum [INN-Latin]; Zyban; Amfebutamona [INN-Spanish]; Bupropion SR; Bupropion hydrocloride; AMFEBUTAMONE HCl; alpha-(tert-butylamino)-m-chloropropiophenone; CHEMBL894; BRN 2101062; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; CHEBI:3219; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1	C13H18ClNO	SNPPWIUOZRMYNY-UHFFFAOYSA-N	2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one	GlaxoSmithKline plc	n.a.
PMDBD430	Hippuric acid	Environmental Chemicals	Industrial Chemicals and Pollutants; Toxic Agents	n.a.	n.a.	n.a.	n.a.	n.a.	464	n.a.	NPC3371	Hippuric acid; 2-Benzamidoacetic acid; 495-69-2; N-Benzoylglycine; Benzoylglycine; Benzamidoacetic acid; hippurate; Benzoylaminoacetic acid; Hippursaeure; Phenylcarbonylaminoacetic acid; Benzamidoessigsaeure; Benzoylaminoessigsaeure; N-Benzoyl-glycin; (benzoylamino)acetic acid; Bz-Gly-OH; Acido ippurico; Acido ippurico [Italian]; 2-(Phenylformamido)Acetic Acid; NSC 9982; UNII-TE0865N2ET; 66407-11-2; Hippuric acid, 98%; N-(phenylcarbonyl)glycine; EINECS 207-806-3; MFCD00002692; CHEMBL	C9H9NO3	QIAFMBKCNZACKA-UHFFFAOYSA-N	2-benzamidoacetic acid	n.a.	n.a.
PMDBD445	Indole	Therapeutic Substance; Herbal Substance	Investigational Drug	120-72-9	DB04532	n.a.	n.a.	n.a.	798	776	NPC82295	indole; 1H-Indole; 120-72-9; Indol; 2,3-Benzopyrrole; 1-Benzazole; Ketole; 1-Azaindene; Benzopyrrole; 2,3-Benzopyrole; Caswell No. 498B; Indole (natural); Indol [German]; 1-Benzo(b)pyrrole; 1H-Benzo[b]pyrrole; FEMA No. 2593; CCRIS 4421; HSDB 599; EPA Pesticide Chemical Code 025000; Benzo[b]pyrrole; UNII-8724FJW4M5; AI3-01540; NSC 1964; EINECS 204-420-7; CHEMBL15844; CHEBI:16881; 8724FJW4M5; MFCD00005607; NCGC00167539-01; Indole, 99+%; DSSTox_CID_737; DSSTox_RID_75761; DSSTox_GSID_20737; IND; CAS-120-72-9; benzazole; mono-indole; Indole.; 1-H-in	C8H7N	SIKJAQJRHWYJAI-UHFFFAOYSA-N	1H-indole	n.a.	n.a.
PMDBD1392	Pyrazinamide	Therapeutic substance	Drug	98-96-4	DB00339	PA451182	D00144	DAP000660	1046	1017	n.a.	pyrazinamide; pyrazinecarboxamide; 98-96-4; pyrazine-2-carboxamide; pyrazinoic acid amide; Zinamide; 2-Pyrazinecarboxamide; Aldinamide; Aldinamid; Pirazinamid; Pyrazineamide; Tebrazid; Pyrafat; Unipyranamide; pyrazine carboxylamide; Pirazimida; Farmizina; Eprazin; Novamid; 2-Carbamylpyrazine; Pyrazinecarboxylic acid amide; Pirazinamida; Pyrazinamidum; Tisamid; Isopas; Pirazinamide; Pyrazine carboxamide; Pezetamid; Piraldina; D-50; Pirazinamide [DCIT]; MK 56; PZA; Pyrazinamidum [INN-Latin]; NCI-C01785; Pirazinamida [INN-Spanish]; C5H5N3O; D-50 	C5H5N3O	IPEHBUMCGVEMRF-UHFFFAOYSA-N	pyrazine-2-carboxamide	n.a.	n.a.
PMDBD1363	Phenytoin	Therapeutic substance	Drug	57-41-0	DB00252	PA450947	D00512	DAP000130	1775	1710	n.a.	phenytoin; 5,5-DIPHENYLHYDANTOIN; 57-41-0; Diphenylhydantoin; Dilantin; 5,5-diphenylimidazolidine-2,4-dione; Phenytoine; Dihydantoin; Zentropil; Diphenylan; Diphantoin; Dilabid; Aleviatin; Epamin; Lepitoin; Fenylepsin; Diphedan; Sodanton; Phentytoin; Lehydan; Dihycon; Difenin; Diphenylhydatanoin; Sylantoic; Hidantomin; Hidantilo; Diphenine; Thilophenyl; Fenytoine; Elepsindon; Dantoinal; Zentronal; Phenatoine; Hidantina; Diphentyn; Dillantin; Dilantine; Sodantoin; Phanatine; Phanantin; Kessodanten; Hydantoinal; Fenitoina; Epilantin; Ditoinate; Di-Hydan	C15H12N2O2	CXOFVDLJLONNDW-UHFFFAOYSA-N	5,5-diphenylimidazolidine-2,4-dione	n.a.	n.a.
PMDBD1432	Tacrine	Therapeutic substance	Drug	321-64-2	DB00382	PA451576	D08555	DAP000558	1935	1859	n.a.	Tacrine; 1,2,3,4-tetrahydroacridin-9-amine; 321-64-2; Tetrahydroaminacrine; 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE; Tetrahydroaminoacridine; Cognex; Tetrahydroaminocrin; Tetrahydroaminocrine; 9-amino-1,2,3,4-tetrahydroacridine; Tacrine [INN:BAN]; Tacrinum [INN-Latin]; Tacrina [INN-Spanish]; CS 12602; UNII-4VX7YNB537; 1,2,3,4-Tetrahydro-9-aminoacridine; CHEMBL95; EINECS 206-291-2; 5-Amino-6,7,8,9-tetrahydroacridine (European); 5-Amino-6,7,8,9-tetrahydroacridi	C13H14N2	YLJREFDVOIBQDA-UHFFFAOYSA-N	1,2,3,4-tetrahydroacridin-9-amine	n.a.	n.a.
PMDBD1010	Acebutolol	Therapeutic substance	Drug	37517-30-9	DB01193	PA448011	D02338	DAP000484	1978	1901	n.a.	acebutolol; Acetobutolol; 37517-30-9; Neptal; dl-Acebutolol; Acebutololo; Prent; Acebutololum; Sectral; (+-)-Acebutolol; N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)butyramide; Acebutololum [INN-Latin]; Acebrutololum [INN-Latin]; Acetobutolol [INN-Spanish]; Acebutolol [USAN:INN:BAN]; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; CHEBI:2379; CCRIS 9214; RP 21823; EINECS 253-539-0; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; BRN 2162244; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hyd	C18H28N2O4	GOEMGAFJFRBGGG-UHFFFAOYSA-N	N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide	n.a.	n.a.
PMDBD1012	Acetohexamide	Therapeutic substance	Drug	968-81-0	DB00414	PA164777011	D00219	DAP000922	1989	1912	n.a.	acetohexamide; 968-81-0; Dymelor; Acetohexamid; Gamadiabet; Dimelor; Metaglucina; Tsiklamid; Hypoglicil; Dimelin; Ordimel; Minoral; Acetohexamida; Acetohexamidum; 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea; N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea; Acetohexamidum [INN-Latin]; Acetohexamida [INN-Spanish]; 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea; CCRIS 4; NCI-C03247; UNII-QGC8W08I6I; 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea; 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide; Benzenesulfonamide, 4-acetyl-N-[(cyc	C15H20N2O4S	VGZSUPCWNCWDAN-UHFFFAOYSA-N	1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea	n.a.	n.a.
PMDBD22	Albendazole	Therapeutic Substance	Approved Drug	54965-21-8	DB00518	PA164746058	D00134	DAP000951	2082	1998	n.a.	albendazole; 54965-21-8; Albenza; Eskazole; Valbazen; Zentel; Proftril; Albendazol; Bilutac; Albendazolum; Zental; SK&amp;F 62979; SKF 62979; Methyl 5-(propylthio)-2-benzimidazolecarbamate; SK&amp;F-62979; Albendazolum [INN-Latin]; Albendazol [INN-Spanish]; 5-(Propylthio)-2-carbomethoxyaminobenzimidazole; Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate; SKF-62979; methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate; (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; methyl N-(6-propylsulfanyl-1H-benzim	C12H15N3O2S	HXHWSAZORRCQMX-UHFFFAOYSA-N	methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate	GlaxoSmithKline	Antiprotozoal Agents
PMDBD26	Alfuzosin	Therapeutic Substance	Approved Drug	81403-80-7	DB00346	PA164774795	D07124	DCL000664	2092	2008	n.a.	alfuzosin; 81403-80-7; Alfuzosinum; Alfuzosina; Alfuzosine; Alfuzosinum [Latin]; Alfuzosine [French]; Alfuzosina [Spanish]; Alfuzosin [INN:BAN]; Uroxatral; ALFLUZOCIN; SL 77499; SL 77-499; HSDB 7290; CHEMBL709; N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide; CHEBI:51141; N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide; Alfusosine; C19H27N5O4; alphuzos	C19H27N5O4	WNMJYKCGWZFFKR-UHFFFAOYSA-N	N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide	Sanofi-Aventis	Antihypertensive Agents
PMDBD1021	Allopurinol	Therapeutic substance	Drug	315-30-0	DB00437	PA448320	D00224	DAP000773	135401907	2010	n.a.	allopurinol; 315-30-0; 1H-Pyrazolo[3,4-d]pyrimidin-4-ol; Zyloprim; Zyloric; Lopurin; Caplenal; Bleminol; Atisuril; Uripurinol; Milurit; Embarin; Progout; Foligan; Urosin; Suspendol; Epidropal; Cellidrin; Anoprolin; Uriprim; Hamarin; Allural; Ailural; Bloxanth; Allopur; Lysuron; Alositol; Xanturat; Uricemil; Ledopur; Cosuric; Urtias; Apurin; Remid; Apurol; Urolit; Gotax; Geapur; Urbol; Anzief; Aloral; Ketobun-A; Urobenyl; Apulonga; Takanarumin; Miniplanor; Ketanrift; Dabrosin; Dabroson; Nektrohan; Riball; Aluline; Adenock; Monarch; Gichtex; Allozym; Hexanuret; Epu	C5H4N4O	OFCNXPDARWKPPY-UHFFFAOYSA-N	1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one	n.a.	n.a.
PMDBD1022	Alosetron	Therapeutic substance	Drug	122852-42-0	DB00969	PA164745502	D07129	DAP000369	2099	2015	n.a.	alosetron; 122852-42-0; Lotronex; UNII-13Z9HTH115; Alosetron [INN:BAN]; GR68755; CHEBI:253342; 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one; 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one; 13Z9HTH115; Q-200612; C17H18N4O; MLS001401464; Alosetron (INN); 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one; 5-Methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one	C17H18N4O	JSWZEAMFRNKZNL-UHFFFAOYSA-N	5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one	n.a.	n.a.
PMDBD29	Alprenolol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	13655-52-2	DB00866	PA164750541	D07156	DAP000941	2119	2035	NPC141739	alprenolol; Alpheprol; Alfeprol; 13655-52-2; Alprenololum; Alfeprol [Russian]; Alprenololum [INN-Latin]; Alprenolol [INN:BAN]; 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol; 1-(2-Allylphenoxy)-3-isopropylamino-2-propanol; EINECS 237-140-9; CHEMBL266195; (RS)-Alprenolol;dl-Alprenolol; CHEBI:51211; NCGC00015099-05; DSSTox_CID_25127; DSSTox_RID_80	C15H23NO2	PAZJSJFMUHDSTF-UHFFFAOYSA-N	1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol	AstraZeneca	Antiarrhythmic Agents
PMDBD30	Altretamine	Therapeutic Substance	Approved Drug	645-05-6	DB00488	PA164743136	n.a.	DAP000989	2123	2038	n.a.	altretamine; 645-05-6; HEXAMETHYLMELAMINE; Hexalen; Hexastat; Hemel; 2,4,6-Tris(dimethylamino)-1,3,5-triazine; Altretaminum; Altretamina; Altretaminum [INN-Latin]; ENT 50852; NC 195; 2,4,6-Tris(dimethylamino)-s-triazine; NCI-C50259; HMM; Altretamina [INN-Spanish]; N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine; Altretamine (Hexalen); NSC 13875; HTM; HXM; UNII-Q8BIH59O7H; CCRIS 5492; MLS000069621	C9H18N6	UUVWYPNAQBNQJQ-UHFFFAOYSA-N	2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine	n.a.	Anticancer Agents
PMDBD32	Amantadine	Therapeutic Substance	Approved Drug	768-94-5	DB00915	PA448360	n.a.	DAP000781	2130	2045	n.a.	amantadine; 1-Adamantanamine; 768-94-5; adamantan-1-amine; 1-Adamantylamine; 1-Aminoadamantane; Adamantylamine; Adamantanamine; Aminoadamantane; Symmetrel; Amantidine; Pk-merz; Adamantamine; Symadine; 1-Adamantamine; Amantadinum; Amantadina; Amantadine [INN:BAN]; Amantadinum [INN-Latin]; Amantadina [INN-Spanish]; adamantan-1-ylamine; Gocovri; TCMDC-125869; 1-adamantaneamine; UNII-BF4C9Z1J53; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; NSC 341865; Tricyclo(3.3.1.13,7)decan-1-amine; tricyclo[3.3.1.1~3,7~]decan-1-amine; HSDB 3202; Tricyclo[3.	C10H17N	DKNWSYNQZKUICI-UHFFFAOYSA-N	adamantan-1-amine	n.a.	Antiviral Agents
PMDBD1448	Theophylline	Therapeutic substance	Drug	58-55-9	DB00277	PA451647	D00371	DAP000002	2153	2068	n.a.	theophylline; 58-55-9; 1,3-Dimethylxanthine; Theophyllin; Elixophyllin; Theolair; Nuelin; Theophylline anhydrous; Theocin; Respbid; Theo-dur; Elixophylline; Pseudotheophylline; Lanophyllin; Theovent; Uniphyl; Slo-phyllin; Teofyllamin; Parkophyllin; Bronkodyl; Xantivent; Theocontin; Uniphyllin; Optiphyllin; Maphylline; Liquophylline; Doraphyllin; Armophylline; Accurbron; Theacitin; Synophylate; Medaphyllin; Theofol; Theobid; Teolair; Solosin; Aerolate; Theolix; Theograd; Elixicon; Elixex; Acet-theocin; Theophyl-225; Slo-bid; Aerolate III; Xanthium; Sust	C7H8N4O2	ZFXYFBGIUFBOJW-UHFFFAOYSA-N	1,3-dimethyl-7H-purine-2,6-dione	n.a.	n.a.
PMDBD36	Amiodarone	Therapeutic Substance	Approved Drug	1951-25-3	DB01118	PA448383	D02910	DAP000496	2157	2072	n.a.	amiodarone; 1951-25-3; Cordarone; Amiodarona; Amiodaronum; Amjodaronum; Amiodaronum [INN-Latin]; Amiodarona [INN-Spanish]; Pacerone; L 3428; L-3428; UNII-N3RQ532IUT; 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran; (2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone; C25H29I2NO3; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; SKF 33134-A; EINECS 217-772-1; CHEMBL633; BRN 1271711; N3RQ532	C25H29I2NO3	IYIKLHRQXLHMJQ-UHFFFAOYSA-N	(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone	Wyeth-Ayerst Laboratories	Antiarrhythmic Agents
PMDBD1028	Amitriptyline	Therapeutic substance	Drug	50-48-6	DB00321	PA448385	D07448	DNC001466	2160	2075	n.a.	amitriptyline; Amitriptylin; Elavil; 50-48-6; Triptanol; Damitriptyline; Lantron; Seroten; Damilen; Flavyl; Proheptadiene; Amitryptiline; Triptisol; Adepress; Tryptanol; Adepril; Amitriprolidine; Triptilin; Redomex; Amytriptylin; Damilan; Ro 4-1575; Amitriptylin [German]; Amitriptilina [Italian]; Amitriptyline [INN:BAN]; Amitril; Sarotex; Amitriptylinum [INN-Latin]; Amitriptilina [INN-Spanish]; MK 230; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimet	C20H23N	KRMDCWKBEZIMAB-UHFFFAOYSA-N	N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine	n.a.	n.a.
PMDBD39	Amlodipine	Therapeutic Substance	Approved Drug	88150-42-9	DB00381	PA448388	D07450	DAP000139	2162	2077	n.a.	amlodipine; 88150-42-9; Norvasc; Amlodis; Coroval; Amlocard; Lipinox; AMLODIPINE BASE; Amlodipinum; Amlodipino; Caduet; Istin; Amlodipine Free Base; Amlodipinum [Latin]; Amlodipino [Spanish]; Amlodipine [INN:BAN]; Amlodipine besilate; CHEBI:2668; Norvasc (TN); 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; UK-4834011; Amlor; 3-O-ethyl 5-O-methyl 2-(2-aminoetho	C20H25ClN2O5	HTIQEAQVCYTUBX-UHFFFAOYSA-N	3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	Dainippon Sumitomo	Antihypertensive Agents
PMDBD41	Amoxapine	Therapeutic Substance	Approved Drug	14028-44-5	DB00543	PA448405	D00228	DAP001149	2170	2085	n.a.	amoxapine; 14028-44-5; Asendin; Demolox; Moxadil; Amoxan; Desmethylloxapin; Asendis; Amoxapina; Amoxepine; Amoxapinum; Amoxapinum [INN-Latin]; Amoxapina [INN-Spanish]; 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine; CL 67772; CL-67772; UNII-R63VQ857OT; 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine; EINECS 237-867-1; C17H16ClN3O; BRN 0832057; CHEMBL1113; 2-Chlor-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepin; 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine; 2-Ch	C17H16ClN3O	QWGDMFLQWFTERH-UHFFFAOYSA-N	8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine	n.a.	Antidepressants
PMDBD45	Anagrelide	Therapeutic Substance	Approved Drug	68475-42-3	DB00261	PA164742986	D07455	DAP000612	135409400	2097	n.a.	anagrelide; 68475-42-3; Anagrelida; Anagrelidum; Xagrid; 6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one; Anagrelide [INN:BAN]; Anagrelidum [INN-Latin]; Anagrelida [INN-Spanish]; C10H7Cl2N3O; UNII-K9X45X0051; BL 416201; HSDB 7325; CHEMBL760; BRN 0619582; 6,7-Dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one; 6,7-Dichlor-1,5-dihydroimidazo(2,1-b)chinazolin-2(3H)-on; CHEBI:142290; K9X45X0051; 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one	C10H7Cl2N3O	OTBXOEAOVRKTNQ-UHFFFAOYSA-N	6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one	Shire Phamaceuticals	Antithrombotic Agents
PMDBD46	Anastrozole	Therapeutic Substance	Approved Drug	120511-73-1	DB01217	PA448432	D00960	DAP000627	2187	2102	n.a.	anastrozole; 120511-73-1; Arimidex; anastrazole; Anastrozol; 2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile); ZD-1033; ZD1033; ZD 1033; ICI D1033; UNII-2Z07MYW1AZ; 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile; ICI-D1033; HSDB 7462; ICI-D 1033; alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; 2Z07MYW1AZ; CHEMBL1399; 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile); CHEBI:2704	C17H19N5	YBBLVLTVTVSKRW-UHFFFAOYSA-N	2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile	AstraZeneca	Anticancer Agents
PMDBD49	Anthralin	Therapeutic Substance	Approved Drug	1143-38-0	DB11157	n.a.	n.a.	n.a.	2202	2117	n.a.	anthralin; Dithranol; 1143-38-0; 1,8-Dihydroxyanthrone; 1,8-Dihydroxy-9-anthrone; Cignolin; Chrysodermol; Cigthranol; 1,8-Dihydroxyanthracen-9(10H)-one; Batridol; Psoriacid-Stift; Anthra-Derm; 1,8-dihydroxy-10H-anthracen-9-one; Drithoscalp; DrithoCreme; 1,8-DIHYDROXY-9(10H)-ANTHRACENONE; NSC 43970; Anthraline; NSC 629313; UNII-U8CJK0JH5M; Dithranolum [INN-Latin]; Anthralin [USP]; CCRIS 628; CHEBI:37510; EINECS 214-538-0; U8CJK0JH5M; BRN 2054360; CHEMBL46469; Dithranol [INN]	C14H10O3	NUZWLKWWNNJHPT-UHFFFAOYSA-N	1,8-dihydroxy-10H-anthracen-9-one	n.a.	n.a.
PMDBD18	Acetylsalicylic acid	Therapeutic Substance	Approved Drug	50-78-2	DB00945	PA448497	D00109	DAP000843	2244	2157	n.a.	aspirin; ACETYLSALICYLIC ACID; 50-78-2; 2-Acetoxybenzoic acid; 2-(Acetyloxy)benzoic acid; o-Acetoxybenzoic acid; Acylpyrin; O-Acetylsalicylic acid; Ecotrin; Easprin; Acetophen; Acenterine; Polopiryna; Acetosal; Acetylsalicylate; Colfarit; Salicylic acid acetate; o-Carboxyphenyl acetate; Enterosarein; Temperal; Acetylin; Aspergum; Salcetogen; Pharmacin; Acetosalin; Premaspin; Micristin; Benaspir; Aspirdrops; Acetonyl; Aceticyl; Empirin; Ecolen; Rhodine; Endydol; Saletin; Rheumintabletten; Solprin acid; Enterosarine; Bialpirinia; Globentyl; Enterici	C9H8O4	BSYNRYMUTXBXSQ-UHFFFAOYSA-N	2-acetyloxybenzoic acid	Bayer Pharmaceuticals Corporation	Analgesics
PMDBD76	Astemizole	Therapeutic Substance	Approved Drug	68844-77-9	DB00637	PA448498	D00234	DAP000326	2247	2160	n.a.	astemizole; 68844-77-9; Hismanal; Histaminos; Paralergin; Laridal; Retolen; Alermizol; Histamen; Astemison; Kelp; Astemizol; Wareezol; Hestazol; Astemizolum; Metodih; Novo-mastizol A; Astemizol [German]; Astemizol [INN-Spanish]; Astemizolum [INN-Latin]; C28H31FN4O; CCRIS 7595; R 42512; 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine; GNF-PF-2461; HSDB 6799; UNII-7HU6337315; 1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole	C28H31FN4O	GXDALQBWZGODGZ-UHFFFAOYSA-N	1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine	Janssen Pharmaceutica	Antiallergic Agents
PMDBD1047	Atrazine	Environmental Chemicals	Pesticides	1912-24-9	DB07392	n.a.	n.a.	n.a.	2256	2169	n.a.	atrazine; 1912-24-9; Gesaprim; Atrazin; Oleogesaprim; Chromozin; Primaze; Gesoprim; Fenatrol; Radazin; Fenamin; Atrasine; Zeazine; Strazine; Pitezin; Hungazin; Atranex; Argezin; Primatol; Atazinax; Aktikon; Zeazin; Wonuk; Cyazin; Candex; Vectal; Inakor; Aatrex; Cekuzina-T; Aktinit A; Actinite PK; Atratol A; Aktinit PK; Aktikon PK; Weedex A; Crisazine; Fenamine; Crisatrina; Radizin; Atrataf; Akticon; Aatram; Zeapos; Griffex; Atratol; Atrex; Atred; Primatol A; Hungazin PK; Aatrex nine-O; Vectal SC; Herbatoxol; Zeopos; Triazine A 1294; Gesaprim 50; Farmco atrazine	C8H14ClN5	MXWJVTOOROXGIU-UHFFFAOYSA-N	6-chloro-4-N-ethyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine	n.a.	n.a.
PMDBD85	Azathioprine	Therapeutic Substance	Approved Drug	446-86-6	DB00993	PA448515	D00238	DAP000782	2265	2178	n.a.	azathioprine; 446-86-6; Imuran; Azothioprine; Azathioprin; Azatioprin; Azamun; Imurel; Azanin; Azathiopurine; Ccucol; Muran; Imurek; Azasan; Rorasul; Azamun [Czech]; BW 57-322; NSC-39084; BW-57-322; NCI-C03474; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine; 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine; Azatioprina [INN-Spanish]; Azathioprinum [INN-Latin]; Imuran (TN); NSC 39084; 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine; Methylnitroimidazolylmercaptopurine; 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; UNII-MRK24	C9H7N7O2S	LMEKQMALGUDUQG-UHFFFAOYSA-N	6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine	GlaxoSmithKline	Immunosuppressive Agents
PMDBD101	Benzbromarone	Therapeutic Substance	Approved Drug	3562-84-3	DB12319	n.a.	D01056	n.a.	2333	2243	n.a.	benzbromarone; 3562-84-3; Benzbromaron; Desuric; Urinorm; Normurat; Uricovac; Minuric; Exurate; Hipurik; Narcaricin; Azubromaron; L 2214-Labaz; Uroleap (TN); Harolan; MJ 10061; 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran; L 2214; Benzbromaronum [INN-Latin]; (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone; Benzobromarona [INN-Spanish]; NSC 85433; Benzbromarone [USAN:INN:BAN]; L2214-Lab	C17H12Br2O3	WHQCHUCQKNIQEC-UHFFFAOYSA-N	(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone	Labaz Laboratories	n.a.
PMDBD103	Benzthiazide	Therapeutic Substance	Approved Drug	91-33-8	DB00562	PA164776841	D00651	DAP000603	2343	2253	n.a.	benzthiazide; Benzothiazide; 91-33-8; Aquatag; Lemazide; Dihydrex; Fovane; Freeuril; Exosalt; Edemex; Proaqua; Diucen; Urese; Exna; Regulon; Diucene; Pfizer 1393; Benzthiazidum; Benzotiazida; Aquapres; Urazide; Aquasec; Fouane; Hy-drine; Pro-aqua; Aqua-Scrip; Rid-ema; S-Aqua; Benztiazide [DCIT]; Benzthiazidum [INN-Latin]; Benzotiazida [INN-Spanish]; C15H14ClN3O4S3; 3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide; P 1393; UNII-1TD8J48L61; HSDB 3296	C15H14ClN3O4S3	NDTSRXAMMQDVSW-UHFFFAOYSA-N	3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	n.a.	Antihypertensive Agents
PMDBD107	Berberine	Herbal Substance	Medicinal Herbal Compounds	2086-83-1	DB04115	PA165860812	D00092	DNC000385	2353	2263	NPC53069	berberine; 2086-83-1; Umbellatine; Berberin; UNII-0I8Y3P32UF; 0I8Y3P32UF; C20H18NO4; CHEBI:16118; Berberal; EINECS 218-229-1; BRN 3570374; ST055798; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; Berbamine sulphate acid; CHEMBL12089; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(	C20H18NO4+	YBHILYKTIRIUTE-UHFFFAOYSA-N	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	n.a.	n.a.
PMDBD112	Bicalutamide	Therapeutic Substance	Approved Drug	90357-06-5	DB01128	PA164746255	D00961	DAP000092	2375	2284	n.a.	bicalutamide; 90357-06-5; Casodex; Cosudex; Calutide; ICI-176334; ICI 176334; Bicalutamide (CDX); N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide; Bicalutamide (Casodex); CHEMBL409; BRN 5364666; N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; (+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide; C18H14F4N2O4S; ICI 176,334; Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluor	C18H14F4N2O4S	LKJPYSCBVHEWIU-UHFFFAOYSA-N	N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide	AstraZeneca plc	Anticancer Agents
PMDBD113	Bifonazole	Therapeutic Substance	Approved Drug	60628-96-8	DB04794	PA164746464	n.a.	DAP000877	2378	2287	n.a.	bifonazole; 60628-96-8; Mycospor; Bifonazol; Trifonazole; BAY H 4502; Amycor; Azolmen; Bifonazolum [INN-Latin]; Bifonazol [INN-Spanish]; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; 1-[phenyl-(4-phenylphenyl)methyl]imidazole; (+-)-1-(p,alpha-Diphenylbenzyl)imidazole; Bay H-4502; 1-(p,alpha-Diphenylbenzyl)imidazole; Bay-h-4502; EINECS 262-336-6; BRN 0618427; MLS000028576; CHEMBL277535; Bifonazolum; CHEBI:78692; 1-[biphenyl-4-yl(phenyl)meth	C22H18N2	OCAPBUJLXMYKEJ-UHFFFAOYSA-N	1-[phenyl-(4-phenylphenyl)methyl]imidazole	Bayer Pharmaceuticals Corporation	Antifungal Agents
PMDBD115	Biperiden	Therapeutic Substance	Approved Drug	514-65-8	DB00810	PA448626	D00779	DAP001125	2381	2289	n.a.	biperiden; 514-65-8; Biperidene; Akineton; Biperidine; Beperiden; Bipariden; Biperideno; Biperidenum; Biperidenum [INN-Latin]; Biperidene [INN-French]; Biperideno [INN-Spanish]; KL 373; alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol; UNII-0FRP6G56LD; Biperiden HCl; 3-Piperidino-1-phenyl-1-bicycloheptenyl-1-propanol; 1-Bicycloheptenyl-1-phenyl-3-piperidino-propanol-1; EINECS 208-184-6; BRN 0290038; alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol; CHEMBL1101; 0FRP6G56LD; CHEBI:3112; 3-Piperidino-1-phen	C21H29NO	YSXKPIUOCJLQIE-UHFFFAOYSA-N	1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol	Knoll Pharma	Antiparkinson Agents
PMDBD116	Bisacodyl	Therapeutic Substance	Approved Drug	603-50-9	DB09020	n.a.	D00245	n.a.	2391	2299	n.a.	bisacodyl; 603-50-9; Dulcolax; Brocalax; Bicol; Sanvacual; Durolax; Fenilaxan; Stadalax; Hillcolax; Endokolat; Theralax; Dulcolan; Ulcolax; Telemin; Laxans; Godalax; Neolax; Laxine; Ivilax; Eulaxan; Nigalax; Laxorex; Laxadin; Zetrax; Pyrilax; Sk-bisacodyl; Laxanin N; Deficol; LACO; Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester); LA96a; HalfLytely; Bisacodylum [INN-Latin]; Bisacodilo [INN-Spanish]; Bis(p-acetoxyphenyl)-2-pyridylmethane; Di-(p-acetoxyphenyl)-2-pyridylmethane; Di-(4-acetoxyphenyl)-2-pyridylmethane; MLS000069729; UNII-10	C22H19NO4	KHOITXIGCFIULA-UHFFFAOYSA-N	[4-[(4-acetyloxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate	n.a.	n.a.
PMDBD124	Bromazepam	Therapeutic Substance	Approved Drug	1812-30-2	DB01558	PA10035	D01245	DAP001035	2441	2347	n.a.	bromazepam; Lexotanil; Durazanil; Compedium; Lexilium; Creosedin; Lexaurin; Lectopam; Lexotan; Lekotam; Lexomil; Compendium; Calmepam; Normoc; 1812-30-2; Ultramidol; LA Xvii; Bromazepamum [INN-Latin]; Bromazepamum [Latin]; Ro 5-3350; 7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H)-one; KL-001; KL 001; Bromazepam [USAN:INN:BAN:JAN]; 7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one; UNII-X015L14V0O; NSC 140669; EINECS 217-322-4; 7-bromo-5-pyridin-2-y	C14H10BrN3O	VMIYHDSEFNYJSL-UHFFFAOYSA-N	7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one	Hoffmann-La Roche pharmaceutical company	Hypnotics and Sedatives
PMDBD126	Bromperidol	Therapeutic Substance	Approved Drug	10457-90-6	DB12401	n.a.	n.a.	n.a.	2448	2354	n.a.	bromperidol; 10457-90-6; Impromen; Bromoperidol; 4-(4-(4-bromophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one; UNII-LYH6F7I22E; Bromperidolum [INN-Latin]; R 11333; EINECS 233-943-3; 4-(4-(4-Bromophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone; CC 2489; BRN 1552256; LYH6F7I22E; 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one; Tesoprel; 4-(4-(p-Bromophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone; 4-(4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone	C21H23BrFNO2	RKLNONIVDFXQRX-UHFFFAOYSA-N	4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	n.a.	n.a.
PMDBD129	Bufexamac	Therapeutic Substance	Approved Drug	2438-72-4	DB13346	n.a.	D01271	n.a.	2466	2372	n.a.	bufexamac; 2438-72-4; Bufexamic acid; 2-(4-Butoxyphenyl)-N-hydroxyacetamide; Parfenac; Malipuran; Droxaryl; Parfenal; Feximac; Mofenar; 4-Butoxy-N-hydroxybenzeneacetamide; Paraderm; Norfemac; Bufexamacum; Flogicid; p-Butoxyphenylacetohydroxamic acid; Bufexamaco; 4-Butoxyphenylacetohydroxamic acid; Anderm; Flogocid N plastigel; 2-(p-Butoxyphenyl)-acetohydroxamic acid; Acide p-butoxyphenylacethydroxamique; Bufessamac [DCIT]; Bufexamacum [INN-Latin]; Bufexamaco [INN-Spanish]; CP 1044 J3; UNII-4T3C38J78L; Benzeneacetamide, 4-butoxy-N-hyd	C12H17NO3	MXJWRABVEGLYDG-UHFFFAOYSA-N	2-(4-butoxyphenyl)-N-hydroxyacetamide	n.a.	n.a.
PMDBD1064	Bumetanide	Therapeutic substance	Drug	28395-03-1	DB00887	PA448682	D00247	DAP000361	2471	2377	n.a.	bumetanide; 28395-03-1; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Bumex; Burinex; Fordiuran; Lunetoron; Segurex; Fontego; Ro 10-6338; Bumetanida; Aquazone; Bumetanidum; Diurama; Butinat; Yurinex; Cambiex; Bumetanidum [INN-Latin]; Bumetanida [INN-Spanish]; Lixil-Leo; PF 1593; 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; UNII-0Y2S3XUQ5H; EINECS 249-004-6; BRN 2185351; 0Y2S3XUQ5H; MLS000028457; CHEBI:3213; Bumethanide; C17H20N2O5S; Burine; BENZOIC ACID, 3-(BUTYLAMI	C17H20N2O5S	MAEIEVLCKWDQJH-UHFFFAOYSA-N	3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid	n.a.	n.a.
PMDBD1065	Buspirone	Therapeutic substance	Drug	36505-84-7	DB00490	PA448689	D07593	DAP000031	2477	2383	n.a.	buspirone; 36505-84-7; Ansial; Buspironum; Buspirona; Buspironum [INN-Latin]; Buspirona [INN-Spanish]; Buspirone [INN:BAN]; UNII-TK65WKS8HL; MJ-9022-1; 8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione; 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione; CHEMBL49; EINECS 253-072-2; TK65WKS8HL; BRN 0964904; CHEBI:3223; C21H31N5O2; 8-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione	C21H31N5O2	QWCRAEMEVRGPNT-UHFFFAOYSA-N	8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione	n.a.	n.a.
PMDBD131	Butamben	Therapeutic Substance	Approved Drug	94-25-7	DB11148	n.a.	n.a.	n.a.	2482	2388	n.a.	Butyl 4-aminobenzoate; butamben; 94-25-7; Butesin; Butylcaine; Butyl aminobenzoate; Butoform; Butesine; Scuroform; Planoform; Scuroforme; Butyl keloform; BUTYL P-AMINOBENZOATE; 4-(Butoxycarbonyl)aniline; Benzoic acid, 4-amino-, butyl ester; N-Butyl p-aminobenzoate; n-Butyl-p-aminobenzoate; 4-Aminobenzoic Acid n-Butyl Ester; 4-Aminobenzoic acid butyl ester; Benzoic acid, p-amino-, butyl ester; p-Aminobenzoic acid butyl ester; Butyl PABA; NSC 128464; UNII-EFW857872Q; CCRIS 5891; 4-amino butylbenzoate; p-Aminobenzoic acid, butyl ester	C11H15NO2	IUWVALYLNVXWKX-UHFFFAOYSA-N	butyl 4-aminobenzoate	n.a.	n.a.
PMDBD1069	Caffeine	Therapeutic substance	Drug	1958/8/2	DB00201	PA448710	D00528	DAP000099	2519	2424	n.a.	caffeine; 58-08-2; 1,3,7-Trimethylxanthine; Guaranine; Thein; Methyltheobromine; Cafeina; Theine; Koffein; Mateina; Alert-pep; Coffeine; Caffein; Cafipel; Refresh'n; Caffedrine; Stim; Nodaca; Dexitac; Caffine; Cafecon; Cafamil; Anhydrous caffeine; No-Doz; Eldiatric C; 7-Methyltheophylline; Vivarin; Organex; Hycomine; Nix Nap; Methyltheobromide; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Phensal; Coffein; Caffeine, synthetic; Quick-Pep; Coffeinum; Tirend; 1,3,7-Trimethyl-2,6-dioxopurine; 1,3,7-Trimethylpurine-2,6-dione; Theophylline, 7-methy	C8H10N4O2	RYYVLZVUVIJVGH-UHFFFAOYSA-N	1,3,7-trimethylpurine-2,6-dione	n.a.	n.a.
PMDBD893	Verapamil	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	52-53-9	DB00661	PA451868	D02356	DAP000040	2520	2425	NPC42793	VERAPAMIL; Iproveratril; 52-53-9; Vasolan; Dilacoran; Isoptin; Isoptine; Falicard; Finoptin; Isoptimo; Calan; Verapamilum; Verapamilo; Verapamilum [INN-Latin]; Lekoptin; Verapamilo [INN-Spanish]; Isotopin; Calcan; Tarka; D-365; Verelan; Izoptin; Securon; Verapamil [USAN:INN:BAN]; CP-16533-1; Covera-HS; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; Verpamil; CCRIS 6749; Verelan PM; Isoptin SR	C27H38N2O4	SGTNSNPWRIOYBX-UHFFFAOYSA-N	2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile	Pfizer Inc	Analgesics
PMDBD1073	Candesartan	Therapeutic substance	Drug	139481-59-7	DB13919	PA448765	D00522	n.a.	2541	2445	n.a.	candesartan; 139481-59-7; Blopress; CV-11974; 1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid; CV 11974; UNII-S8Q36MD2XX; 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid; CHEMBL1016; S8Q36MD2XX; 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid; CHEBI:3347; C24H20N6O3; 2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid; NCGC00167474-01; AK-57139; DSSTox_CID_	C24H20N6O3	HTQMVQVXFRQIKW-UHFFFAOYSA-N	2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid	n.a.	n.a.
PMDBD1075	Carbamazepine	Therapeutic substance	Drug	298-46-4	DB00564	PA448785	D00252	DAP000129	2554	2457	n.a.	carbamazepine; 298-46-4; Tegretol; Carbamazepen; 5H-Dibenzo[b,f]azepine-5-carboxamide; Finlepsin; Carbazepine; Biston; Equetro; 5H-Dibenz[b,f]azepine-5-carboxamide; Carbamezepine; Tegretal; Epitol; Karbamazepin; Neurotol; Carbatrol; Timonil; Telesmin; Stazepine; Carbamazepin; Lexin; Tegretol-Xr; benzo[b][1]benzazepine-11-carboxamide; Carbamazepinum; Carbamazepina; Bipotrol; Amizepin; Teril; Geigy 32883; 5-Carbamyl-5H-dibenzo(b,f)azepine; 5-Carbamoyl-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine-5-carboxamide; Carnexiv; Calepsin; 5-Carbamoyl	C15H12N2O	FFGPTBGBLSHEPO-UHFFFAOYSA-N	benzo[b][1]benzazepine-11-carboxamide	n.a.	n.a.
PMDBD148	Carisoprodol	Therapeutic Substance	Approved Drug	78-44-4	DB00395	PA448809	D00768	n.a.	2576	2478	n.a.	carisoprodol; 78-44-4; Isomeprobamate; Carisoprodate; Carisoprodatum; SOMA; Isoprotane; Isoprothane; Carisoma; Isobamate; Sanoma; Isopropyl meprobamate; Skutamil; Miolisodal; Somalgit; Atonalyt; Flexartal; Mioratrina; Somanil; Mioril; Relasom; Nospasm; Flexal; Arusal; Apesan; Carlsoprol; Diolene; Carlsoma; Carlsodol; Brianil; Domarax; Mioriodol; Mediquil; Izoprotan; Isoprotan; Carisol; Caprodat; Calenfa; Stialgin; Somadril; Carsodal; Carisoprodolum; Meprodat; Listaflex; Flexagit; Fibrosona; Chinchen; Carsodol; Flexidon; Flexagilt; Caridolin; Neotica; Artifar	C12H24N2O4	OFZCIYFFPZCNJE-UHFFFAOYSA-N	[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate	n.a.	n.a.
PMDBD1080	carmustine	Therapeutic substance	Drug	154-93-8	DB00262	PA448810	D00254	DAP000041	2578	2480	n.a.	carmustine; 154-93-8; 1,3-Bis(2-chloroethyl)-1-nitrosourea; BCNU; Carmustin; Nitrumon; Carmubris; Gliadel; BiCNU; Bi CNU; Carmustinum; Bischloroethyl nitrosourea; Bischlorethylnitrosurea; Bischlorethylnitrosourea; Carmustina; Becenum; N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA; 1,3-Bis(2-chloroethyl)nitrosourea; Bis(2-chloroethyl)nitrosourea; NSC-409962; SRI 1720; FDA 0345; Bischloroethylnitrosourea; BiCNU (TN); Carmustinum [INN-Latin]; Carmustina [INN-Spanish]; DTI 015; NCI-C04773; SK 27702; Bis(2-c	C5H9Cl2N3O2	DLGOEMSEDOSKAD-UHFFFAOYSA-N	1,3-bis(2-chloroethyl)-1-nitrosourea	n.a.	n.a.
PMDBD150	Carvedilol	Therapeutic Substance	Approved Drug	72956-09-3	DB01136	PA448817	D00255	DAP000135	2585	2487	n.a.	carvedilol; 72956-09-3; Coreg; Dilatrend; Eucardic; Carvedilolum [Latin]; BM 14190; Carvedilolum; 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; SKF 105517; BM-14190; 1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol; Coreg CR; DQ 2466; HSDB 7044; 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; Carvedilol phosphate; CHEMBL723; DQ-2466; CHEBI:3441; C24H26N2O4	C24H26N2O4	OGHNVEJMJSYVRP-UHFFFAOYSA-N	1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol	GlaxoSmithKline plc	Vasodilator Agents
PMDBD170	Celecoxib	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	169590-42-5	DB00482	PA448871	D00567	DAP000737	2662	2562	NPC316910	celecoxib; 169590-42-5; Celebrex; Celebra; Onsenal; Celocoxib; Celecox; SC 58635; SC-58635; 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE; YM177; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; YM 177; 184007-95-2; HSDB 7038; UNII-JCX84Q7J1L; p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide; SC58635; C17H14F3N3O2S; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide; 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benz	C17H14F3N3O2S	RZEKVGVHFLEQIL-UHFFFAOYSA-N	4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide	Pfizer	Analgesics
PMDBD175	Cetirizine	Therapeutic Substance	Approved Drug	83881-51-0	DB00341	PA448905	n.a.	DAP000323	2678	2577	n.a.	cetirizine; 83881-51-0; Virlix; Cetirizina; Cetirizin; Setir; Cetryn; Ziptek; Cetirizinum; Zirtek; Cetirizinum [Latin]; Hitrizin Film Tablet; Cetirizina [Spanish]; 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; Cetirizine [INN:BAN]; CETIRIZINE HYDROCHLORIDE; CHEMBL1000; C21H25ClN2O3; CHEBI:3561; AC-170; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid; (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}eth	C21H25ClN2O3	ZKLPARSLTMPFCP-UHFFFAOYSA-N	2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid	Pfizer Pharmaceuticals	Antiallergic Agents
PMDBD181	Chlormezanone	Therapeutic Substance	Approved Drug	80-77-3	DB01178	PA448939	D00268	DAP001252	2717	2616	n.a.	chlormezanone; 80-77-3; Chlormethazanone; Trancopal; Chlormethazone; Clormetazon; Chlormezanon; Clormetazanone; Phenarol; dl-Chlormezanone; Trancote; Supotran; Miorilax; Rilaquil; Rilansyl; Clorilax; Rilassol; Myolespen; Tanafol; Bisina; Banabin; Alinam; Rilax; Rexan; Banabin-sintyal; Muskel-Trancopal; Mio-sed; Banabil-sintyal; 2-(4-Chlorophenyl)-3-methyl-1,3-thiazinan-4-one 1,1-dioxide; Chlormezanonum; Tranrilax; Dichloromezanone; Clormezanone [DCIT]; Suprotan; Chlomedinon; Rillasol; Muskel; Lobak; (+-)-Chlormezanone; Clormezanona [INN-Spanish]	C11H12ClNO3S	WEQAYVWKMWHEJO-UHFFFAOYSA-N	2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one	n.a.	Analgesics
PMDBD1108	Chlorothiazide	Therapeutic substance	Drug	58-94-6	DB00880	PA448953	D00519	DAP000605	2720	2619	n.a.	chlorothiazide; 58-94-6; Chlorthiazide; Diuril; Chlorothiazid; Chlotride; Chlortiazid; Thiazide; Saluretil; Chlorurit; Warduzide; Chlorosal; Yadalan; Salunil; Alurene; Diutrid; Diurilix; Clotride; Salisan; Diuresal; Saluric; Diurite; Urinex; Flumen; Minzil; Neo-Dema; Sk-chlorothiazide; Chlorothiazidum; Chlorthiazidum; Clorotiazida; Chlorthiazid; Aldoclor; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Clorotiazide [DCIT]; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; Diuril Boluses, Veterinary; Clorotiazida [	C7H6ClN3O4S2	JBMKAUGHUNFTOL-UHFFFAOYSA-N	6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	n.a.	n.a.
PMDBD183	Chloroxine	Therapeutic Substance	Approved Drug	773-76-2	DB01243	PA164754879	D03472	n.a.	2722	2621	n.a.	chloroxine; 5,7-Dichloroquinolin-8-ol; 773-76-2; 5,7-Dichloro-8-hydroxyquinoline; Chlorquinol; Capitrol; 5,7-Dichloro-8-quinolinol; Dichloroxin; Quixalin; Chloroxyquinoline; Dichloroquinolinol; Dikhloroskin; Quinolor; Endiaron; Clofuzid; Dichlorohydroxyquinoline; Chlofucid; Quesyl; 5,7-Dichlorooxine; 5,7-Dichloroxine; Chlorohydroxyquinoline; 5,7-Dichloro-8-oxyquinoline; Chloroxine [USAN]; 5,7-Dichlor-8-hydroxychinolin; C9H5Cl2NO; NSC 3904; CHQ; UNII-2I8BD50I8B; CCRIS 5751; Capitrol Cream Shampoo; EINECS 212-2	C9H5Cl2NO	WDFKMLRRRCGAKS-UHFFFAOYSA-N	5,7-dichloroquinolin-8-ol	n.a.	n.a.
PMDBD1110	Chlorpropamide	Therapeutic substance	Drug	94-20-2	DB00672	PA448966	D00271	DAP000923	2727	2626	n.a.	chlorpropamide; 94-20-2; Chloropropamide; Diabinese; Chlorpropamid; Diabenese; Glucamide; Meldian; Diabetoral; Chlorodiabina; Diabeneza; Chloronase; Adiaben; Diabaril; Melitase; Insulase; Dynalase; Catanil; Millinese; Mellinese; Diabenal; Diabechlor; Glisema; Oradian; Asucrol; Diabet-Pages; Diamel Ex; Clorpropamide; Clorpropamid; Prodiaben; Diabexan; 4-chloro-N-(propylcarbamoyl)benzenesulfonamide; 1-(4-Chlorophenylsulfonyl)-3-propylurea; Chlorpropamidum; Clorpropamida; Bioglumin; 1-(p-Chlorobenzenesulfonyl)-3-propylurea; 1-Propyl-3-(p-chlorobe	C10H13ClN2O3S	RKWGIWYCVPQPMF-UHFFFAOYSA-N	1-(4-chlorophenyl)sulfonyl-3-propylurea	n.a.	n.a.
PMDBD1112	Chlorthalidone	Therapeutic substance	Drug	77-36-1	DB00310	PA448970	D00272	DAP000521	2732	2631	n.a.	chlorthalidone; Chlortalidone; 77-36-1; Phthalamudine; Chlorphthalidolone; Chlorthalidon; Hygroton; Phthalamodine; Chlorothalidone; Chlorphthalidone; Zambesil; Thalitone; Saluretin; Natriuran; Oradil; Isoren; Igroton; Renon; Hydro-Long; Oxodolin; Chlortalidonum; Famolin; Urolin; Oksodolin (oxodolin); Racemic chlorthalidone; 2-Chloro-5-(1-hydroxy-3-oxoisoindolin-1-yl)benzenesulfonamide; (+-)-Hygroton; Clortalidone [DCIT]; (+-)-Chlorthalidone; Demi-Regroton; Clortalidona [INN-Spanish]; Chlortalidonum [INN-Latin]; G-33182; 1-Keto-3-(3'-sulfam	C14H11ClN2O4S	JIVPVXMEBJLZRO-UHFFFAOYSA-N	2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide	n.a.	n.a.
PMDBD1113	Chlorzoxazone	Therapeutic substance	Drug	95-25-0	DB00356	PA448971	D00771	DAP000952	2733	2632	n.a.	chlorzoxazone; 95-25-0; Paraflex; Chlorzoxazon; Chloroxazone; 5-Chloro-2-benzoxazolone; 5-Chloro-2-benzoxazolinone; Biomioran; Myoflexine; Myoflexin; Escoflex; Pathorysin; Solaxin; Miotran; Neoflex; Mioran; 5-Chloro-2-hydroxybenzoxazole; Parafon Forte DSC; 5-Chlorobenzoxazolidone; Chlorzoxane; 5-Chloro-2(3H)-benzoxazolone; 5-Chloro-2-benzoxazolol; Usaf ma-10; 5-Chlorobenzoxazol-2-one; Strifon Forte Dsc; 5-Chloro-1,3-benzoxazol-2(3H)-one; 5-Chlorobenzoxazolone; 2-Hydroxy-5-chlorobenzoxazole; 5-Chlorobenzo	C7H4ClNO2	TZFWDZFKRBELIQ-UHFFFAOYSA-N	5-chloro-3H-1,3-benzoxazol-2-one	n.a.	n.a.
PMDBD1116	Cilostazol	Therapeutic substance	Drug	73963-72-1	DB01166	PA164746334	D01896	DAP000191	2754	2652	n.a.	cilostazol; 73963-72-1; Pletal; Cilostazole; Pletaal; OPC-13013; Cilostazolum; Cilostazolum [INN-Latin]; OPC 13013; OPC 21; OPC-21; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; UNII-N7Z035406B; CHEBI:31401; C20H27N5O2; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbo	C20H27N5O2	RRGUKTPIGVIEKM-UHFFFAOYSA-N	6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one	n.a.	n.a.
PMDBD194	Cimetidine	Therapeutic Substance	Approved Drug	51481-61-9	DB00501	PA449001	D00295	DAP000338	2756	2654	n.a.	cimetidine; 51481-61-9; Tagamet; Eureceptor; Tametin; Ulcedine; Dyspamet; Cimetag; Acinil; Ulcedin; Tratul; Gastromet; Acibilin; Edalene; Cimetum; Ulcomet; Ulcimet; Cimal; Ulhys; Tagamet Hb; Tagamet Hb 200; Cimetidine Hcl; Ulcomedina; Cimetidina; Valmagen; Metracin; SKF-92334; Ulcofalk; Ulcestop; Cimetidinum; Gastrobitan; Evicer; Peptol; SKF 92334; Cimetidinum [INN-Latin]; Cimetidina [INN-Spanish]; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl	C10H16N6S	AQIXAKUUQRKLND-UHFFFAOYSA-N	1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine	GlaxoSmithKline	Antiulcer Agents
PMDBD196	Cinnarizine	Therapeutic Substance	Approved Drug	298-57-7	DB00568	PA164749342	D01295	DAP000325	2761	1264793	n.a.	1-(diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine; 1-Cinnamyl-4-diphenylmethylpiperazine; Prestwick1_000278; Prestwick0_000278; 1-(Diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine; Oprea1_696883; SPBio_002375; CTK4D2521; HMS3372L16; KS-000048IA; DB00568; MCULE-5586055809; DB-047662; C3459; FT-0665055; FT-0623849; FT-0665054; Q27224950; 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl) piperazine	C26H28N2	DERZBLKQOCDDDZ-UHFFFAOYSA-N	1-benzhydryl-4-(3-phenylprop-2-enyl)piperazine	n.a.	n.a.
PMDBD197	Cinoxacin	Therapeutic Substance	Approved Drug	28657-80-9	DB00827	PA449007	D00872	DAP000999	2762	2660	n.a.	cinoxacin; 28657-80-9; Cinobac; Compound 64716; Cinoxacino; Cinoxacine; Cinoxacinum; Cinobactin; Uronorm; Cinx; Cinoxacine [INN-French]; Cinoxacinum [INN-Latin]; Cinoxacino [INN-Spanish]; UNII-LMK22VUH23; 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid; NSC 304467; MLS000069630; EINECS 249-133-8; 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; BRN 1084304; LMK22VUH23; SMR000058232; 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid; CHEBI:3716; C12H10N2O5; [1,3]Dioxolo[4,5-g]cinnol	C12H10N2O5	VDUWPHTZYNWKRN-UHFFFAOYSA-N	1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid	n.a.	Antiinfective Agents
PMDBD1118	Ciprofloxacin	Therapeutic substance	Antibiotics	85721-33-1	DB00537	PA449009	D00186	DAP001360	2764	2662	n.a.	ciprofloxacin; 85721-33-1; Ciprofloxacine; Ciprobay; Ciproxan; Cipro; Ciprofloxacina; Cipro IV; Ciprofloxacinum; Ciprofloxacino; Ciproquinol; Cipromycin; Ciproflox; Ciprocinol; Ciprodar; Cifloxin; Ciproxina; Ciprinol; Bernoflox; Septicide; Bacquinor; Cipro XR; Ciloxan; 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Cetraxal; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; Spitacin; Quintor; Quinolid; Proflaxin; Probiox; Ipiflox; Roxytal; Italnik; Fimoflox; Corsac	C17H18FN3O3	MYSWGUAQZAJSOK-UHFFFAOYSA-N	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD1120	Citalopram	Therapeutic substance	Drug	59729-33-8	DB00215	PA449015	D07704	DAP000118	2771	2669	n.a.	citalopram; 59729-33-8; Nitalapram; Celexa; Cipram; Citalopramum [INN-Latin]; Bonitrile; [3H]Citalopram; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; Lu-10-171; Lu 10-171; C20H21FN2O; EINECS 261-891-1; CHEMBL549; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; CHEBI:77397; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1,3-Dihydro-1-(3-(dimet	C20H21FN2O	WSEQXVZVJXJVFP-UHFFFAOYSA-N	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile	n.a.	n.a.
PMDBD209	Clioquinol	Therapeutic Substance	Approved Drug	130-26-7	DB04815	PA449039	n.a.	n.a.	2788	2686	n.a.	clioquinol; 130-26-7; 5-Chloro-7-iodoquinolin-8-ol; Iodochlorhydroxyquin; Chinoform; Chloroiodoquin; Chloroiodoquine; 5-Chloro-8-hydroxy-7-iodoquinoline; Iodochloroxyquinoline; Cliquinol; Vioform; Iodochlorohydroxyquinoline; Chlorojodochin; Iodochloroxine; Iodochloroquine; Enteroquinol; Iodoenterol; 7-Iodo-5-chloroxine; Entero-Vioform; 5-Chloro-7-iodo-8-quinolinol; Iodochlorhydroxyquinoline; Iodoxyquinoline; Iodenterol; Entrokin; Enteroseptol; Domeform; Barquinol; Rheaform; Quinoform; Quinambicide; Lekosept; Dioquinol; Dermaform; Entersept	C9H5ClINO	QCDFBFJGMNKBDO-UHFFFAOYSA-N	5-chloro-7-iodoquinolin-8-ol	n.a.	n.a.
PMDBD1123	Clobazam	Therapeutic substance	Drug	22316-47-8	DB00349	PA10888	D01253	DAP000672	2789	2687	n.a.	Clobazam; Urbanyl; Frisium; Chlorepin; Clorepin; 22316-47-8; Urbadan; Onfi; LM-2717; Clobazamum; HR 376; RU-4723; H-4723; Clobazamum [INN-Latin]; LM 2717; 7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione; H 4723; UNII-2MRO291B4U; 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione; NSC 336279; 1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; CCRIS 7506; CHEBI:31413; EINECS 244-908-7; HR-376; BRN 0758410	C16H13ClN2O2	CXOXHMZGEKVPMT-UHFFFAOYSA-N	7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione	n.a.	n.a.
PMDBD210	Clofazimine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	2030-63-9	DB00845	PA164748759	D00278	DAP000789	2794	2692	NPC469949	clofazimine; 2030-63-9; Lamprene; Lampren; Chlofazimine; Clofazimina; Clofaziminum; Clofaziminum [INN-Latin]; B 663 (Pharmaceutical); Clofazimina [INN-Spanish]; NSC-141046; B-663; G 30320; N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine; UNII-D959AE5USF; B 663 (VAN); C27H22Cl2N4; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin; B 663; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine	C27H22Cl2N4	WDQPAMHFFCXSNU-UHFFFAOYSA-N	N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine	Norvatis Phamaceuticals Corporation	Antiinflammatory Agents
PMDBD1126	Clomipramine	Therapeutic substance	Drug	303-49-1	DB01242	PA449048	D00811	DAP000742	2801	2699	n.a.	clomipramine; Chlorimipramine; 303-49-1; Monochlorimipramine; 3-Chloroimipramine; Hydiphen; Anafranil base; Anafranil (free base); 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; Clomipraminum [INN-Latin]; Clomipramina [INN-Spanish]; Clomipramine [INN:BAN]; Clomicalm; NSC 169865; UNII-NUV44L116D; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; Anafranil (TN); EINECS 206-144-2; G 34586; BRN 1323	C19H23ClN2	GDLIGKIOYRNHDA-UHFFFAOYSA-N	3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine	n.a.	n.a.
PMDBD214	Clonazepam	Therapeutic Substance	Approved Drug	1622-61-3	DB01068	PA449050	D00280	DAP000259	2802	2700	n.a.	clonazepam; Klonopin; Rivotril; Chlonazepam; Iktorivil; Cloazepam; Antelepsin; 1622-61-3; Clonazepamum; Clonopin; Landsen; Antilepsin; Lonazep; Kenoket; Paxam; Clonex; Solfidin; Lktorivil; Alti-Clonazepam; Ro 4-8180; Ro 5-4023; Klonopin Rapidly Disintegrating; Clonazepamum [INN-Latin]; 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one; 1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one; UNII-5PE9FDE8GB; 5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one; 2H-1,4-Benzodiazepin-2-one, 5-(2-chlo	C15H10ClN3O3	DGBIGWXXNGSACT-UHFFFAOYSA-N	5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one	Roche Pharmaceuticals	Anticonvulsants
PMDBD215	Clonidine	Therapeutic Substance	Approved Drug	4205-90-7	DB00575	PA449051	D00281	DAP000231	2803	2701	n.a.	clonidine; 4205-90-7; Clonidin; Catapres; Duraclon; Chlornidinum; Catapres-TTS; Catarpresan; Catarpres; Adesipress; Catapressan; ST 155BS; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; ST-155-BS; Catapresan; Clonidinum [INN-Latin]; Clonidinhydrochlorid; CATAPRES-TTS-3; CATAPRES-TTS-1; CATAPRES-TTS-2; 2-(2,6-Dichloroanilino)-2-imidazoline; SKF 34427; Catapres- TTS; Clonidina [INN-Spanish]; M-5041T; Hemiton; CLORPRES; 2-((2,6-Dichlorophenyl)imino)imidazolidine; clonidine (amino form); 2-(2,6-Dichloroanilino)-1,3-diazacyclopente	C9H9Cl2N3	GJSURZIOUXUGAL-UHFFFAOYSA-N	N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine	Intas Pharmaceuticals	Antihypertensive Agents
PMDBD218	Clotrimazole	Therapeutic Substance	Approved Drug	23593-75-1	DB00257	PA449057	D00282	DAP000138	2812	2710	n.a.	clotrimazole; 23593-75-1; Lotrimin; Canesten; Mycelex; Mycosporin; Clotrimazol; Empecid; Mykosporin; Gyne lotrimin; Trimysten; Chlotrimazole; 1-(o-Chlorotrityl)imidazole; Mycelex G; Rimazole; Tibatin; Mycelex 7; Mono-baycuten; Mycelex Troches; Lotrimin AF Cream; Gyne-Lotrimin; Mycelex OTC; Lotrimin AF Solution; Pedisafe; Canestine; Veltrim; Gynix; Lotrimin Af; Trivagizole 3; Desamix F; Mycelex-G; Fem Care; Gyne-Lotrimin 3; Mycelex-7; Monobaycuten; Clotrimazolum; Canifug; 1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole; (Chlorotrityl)imidazole	C22H17ClN2	VNFPBHJOKIVQEB-UHFFFAOYSA-N	1-[(2-chlorophenyl)-diphenylmethyl]imidazole	Bayer Pharmaceuticals Corporation	Antifungal Agents
PMDBD1128	Clozapine	Therapeutic substance	Drug	5786-21-0	DB00363	PA449061	D00283	DAP000029	135398737	10442628	n.a.	clozapine; 5786-21-0; Leponex; Clozapin; Fazaclo; CLOZARIL; Clorazil; Iprox; Clozapina; Clozapinum; HF-1854; Clozapinum [INN-Latin]; W-801; Clozapina [INN-Spanish]; HF 1854; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; UNII-J60AR2IKIC; CCRIS 9171; HSDB 6478; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine; CHEMBL42; EINECS 227-313-7; J60AR2IKIC; BRN 07649	C18H19ClN4	QZUDBNBUXVUHMW-UHFFFAOYSA-N	3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine	n.a.	n.a.
PMDBD223	Colchicine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	64-86-8	DB01394	PA449092	D00570	DAP001254	2833	2731	NPC226941	Colchine; 64-86-8; (R/S)-Colchicine; 209810-38-8; CHEBI:23359; (S)-(-)-colchicine; 54192-66-4; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide; (+)-Colchicine; MFCD00078484; Colchicine;colchicine; CHEMBL87; (S)-Colchicine &gt;95%; Epitope ID:141498; (+-)-COLCHICINE; Neuro_000002; KSC621O9T; MLS001181527; SCHEMBL675246; CTK5C1799; DTXSID20274387; HMS3414L21; HMS3678L19; HMS3267B14; HMS2875H17; BCP09065; CC0177; AC-2	C22H25NO6	IAKHMKGGTNLKSZ-UHFFFAOYSA-N	N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide	n.a.	n.a.
PMDBD234	Cyclobenzaprine	Therapeutic Substance	Approved Drug	303-53-7	DB00924	PA449160	D07758	DAP000891	2895	2792	n.a.	cyclobenzaprine; Proheptatriene; 303-53-7; Proheptatrien; Proeptatriene; Lisseril; Ciclobenzaprina; Fexmid; Cyclobenzaprinum; 10,11-Dehydroamitriptyline; Cyclobenzaprine [INN]; Proeptatriene [Italian]; Yurelax; Cyclobenzaprinum [INN-Latin]; MK 130; Ciclobenzaprina [INN-Spanish]; Ro 4-1577; UNII-69O5WQQ5TI; Cyclobenzaprine (INN); EINECS 206-145-8; Flexeril hydrochloride; 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine; 69O5WQQ5TI; 9715 R.P; CHEBI:3996; 5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene	C20H21N	JURKNVYFZMSNLP-UHFFFAOYSA-N	N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine	Janssen Research And Development Llc	Antidepressants
PMDBD236	Cyclopenthiazide	Therapeutic Substance	Approved Drug	742-20-1	DB13532	n.a.	n.a.	n.a.	2904	2801	n.a.	cyclopenthiazide; Cyclomethiazide; 742-20-1; Benesal; Cyclopentiazid; Cyclometiazid; Navidreks; Navidrex; Salimid; Salimed; Ultra-Minzil; Salurilo-C; Navidrix; Tsiklometiazid; Ciba 8341-Su; SU 8341; Su-8341; 3-Cyclopentylmethyl hydrochlorothiazide deriv; UNII-866GEV195O; UNII-T7817XC41U; MLS000737270; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(cyclopentylmethyl)-3,4-dihydro-, 1,1-dioxide; 6-Chloro-3-(cyclopentylmethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; T7817XC41U; 866GEV195O; NSC107679; NSC-1	C13H18ClN3O4S2	BKYKPTRYDKTTJY-UHFFFAOYSA-N	6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	n.a.	n.a.
PMDBD237	Cyclophosphamide	Therapeutic Substance	Approved Drug	50-18-0	DB00531	PA449165	D07760	DAP000532	2907	2804	n.a.	cyclophosphamide; 50-18-0; Cyclophosphamid; Cyclophosphane; Neosar; Cytoxan; Cytophosphan; Procytox; Clafen; Endoxan; Cyclophosphan; Cyclostin; Sendoxan; Cyclophosphamidum; Cytophosphane; Endoxana; Endoxanal; Claphene; Genoxal; Endoxan-Asta; Endoxan R; Zyklophosphamid; Mitoxan; (RS)-Cyclophosphamide; (+-)-Cyclophosphamide; Cyclophosphoramide; Cyklofosfamid; Cyclofosphamide; Senduxan; Enduxan; Endoxane; Semdoxan; Cyclophosphanum; Ciclophosphamide; Cyclophosphamide anhydrous; Rcra waste number U058; Asta B 518; D,L-Cyclophosphamide; Cycloblastin	C7H15Cl2N2O2P	CMSMOCZEIVJLDB-UHFFFAOYSA-N	N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine	Baxter International Inc	Anticancer Agents
PMDBD1135	Cyproheptadine	Therapeutic substance	Drug	129-03-3	DB00434	PA164749366	n.a.	DAP000103	2913	2810	n.a.	CYPROHEPTADINE; Periactin; 129-03-3; Eiproheptadine; Periactinol; Dronactin; 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine; Cyproheptadinum; Ciproheptadina; MK 141; Cyproheptadine [INN:BAN]; Cyproheptadinum [INN-Latin]; Ciproheptadina [INN-Spanish]; 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine; 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine; 5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene; 1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine; 4-(5-Dibenzo(a,d)cyclohepte	C21H21N	JJCFRYNCJDLXIK-UHFFFAOYSA-N	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine	n.a.	n.a.
PMDBD1139	Dapsone	Therapeutic substance	Drug	80-08-0	DB00250	PA449211	D00592	DAP000637	2955	2849	n.a.	dapsone; 80-08-0; Diaphenylsulfone; 4,4'-Sulfonyldianiline; Dapson; 4-Aminophenyl sulfone; 4,4'-Diaminodiphenyl sulfone; 4,4'-Diaminodiphenylsulfone; Diaphenylsulfon; Sulfona; DADPS; Sulphadione; Avlosulfone; Sulfadione; Diphenasone; Disulone; Udolac; p-Aminophenyl sulfone; Bis(4-aminophenyl) sulfone; Croysulfone; Novophone; Dapsonum; Dumitone; Avlosulfon; Aczone; Eporal; Diphone; Diaphenylsulphon; Metabolite C; Diaphenylsulphone; Sulfonyldianiline; Sumicure S; Sulphonyldianiline; Bis(p-aminophenyl) sulfone; p,p-Sulphonylbisbenzamine; Sulfon	C12H12N2O2S	MQJKPEGWNLWLTK-UHFFFAOYSA-N	4-(4-aminophenyl)sulfonylaniline	n.a.	n.a.
PMDBD1148	Desipramine	Therapeutic substance	Drug	50-47-5	DB01151	PA449233	D07791	DAP001151	2995	2888	n.a.	desipramine; Norimipramine; Desmethylimipramine; Desipramin; 50-47-5; Demethylimipramine; Monodemethylimipramine; Desimipramine; Dimethylimipramine; Dezipramine; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; Methylaminopropyliminodibenzyl; desipraminum; Desimpramine; Sertofran; Norpramine; Desipramina; DMI (pharmaceutical); N-(3-Methylaminopropyl)iminobibenzyl; 5-(gamma-Methylaminopropyl)iminodibenzyl; Desipramine (D4); DMI 50475; Desipramine [INN:BAN]; Desipraminum [INN-Latin]; Desipra	C18H22N2	HCYAFALTSJYZDH-UHFFFAOYSA-N	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine	n.a.	n.a.
PMDBD1154	Diazepam	Therapeutic substance	Drug	439-14-5	DB00829	PA449283	D00293	DNC000549	3016	2908	n.a.	diazepam; Valium; 439-14-5; Diazemuls; Ansiolisina; Stesolid; Seduxen; Sibazon; Relanium; Faustan; Apaurin; Methyldiazepinone; Unisedil; Stesolin; Serenamin; Ruhsitus; Renborin; Quievita; Valitran; Tranqdyn; Seduksen; Relaminal; Quiatril; Quetinil; Dipezona; Diazetard; Diazepan; Calmpose; Tranimul; Tensopam; Serenack; Paranten; Kiatrium; Domalium; Condition; Bialzepam; Ansiolin; Tranquirit; Serenzin; Neurolytril; Liberetas; Diacepan; Ceregulart; Calmocitene; Bensedin; Atensine; Apozepam; Velium; Plidan; Paxate; Morosan; Umbrium; Sonacon; Sedipam; Levium; Diapam	C16H13ClN2O	AAOVKJBEBIDNHE-UHFFFAOYSA-N	7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	n.a.	n.a.
PMDBD1156	Diazoxide	Therapeutic substance	Drug	364-98-7	DB01119	PA449285	D00294	DAP000956	3019	2911	n.a.	diazoxide; 364-98-7; Proglycem; Hyperstat; Eudemine; Hypertonalum; Proglicem; Dizoxide; Mutabase; 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Diazossido; Sch-6783; Diazoxidum; Diazoxido; Sch 6783; Diazossido [Italian]; SRG-95213; Diazossido [DCIT]; SRG 95213; 2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide; Diazoxidum [INN-Latin]; Diazoxido [INN-Spanish]; C8H7ClN2O2S; UNII-O5CB12L4FN; NSC-64198; NSC 76130; CHEBI:4495; EINECS 206-668-1; NSC 64198; O5CB12L4FN; MLS000028459; 7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1	C8H7ClN2O2S	GDLBFKVLRPITMI-UHFFFAOYSA-N	7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide	n.a.	n.a.
PMDBD263	Diclofenac	Therapeutic Substance	Approved Drug	15307-86-5	DB00586	PA449293	D07816	DAP000620	3033	2925	n.a.	diclofenac; 15307-86-5; Diclofenac acid; dichlofenac; Voltaren; Diclofenacum; Diclophenac; 2-(2-((2,6-Dichlorophenyl)amino)phenyl)acetic acid; Diclofenaco; ProSorb-D; Voltarol; Diclofenac resinate; Pennsaid; 2-((2,6-Dichlorophenyl)amino)benzeneacetic acid; 2-(2,6-Dichloroanilino)phenylacetic Acid; Diclofenacum [INN-Latin]; Diclofenaco [INN-Spanish]; Solaraze; 2-[2-(2,6-dichloroanilino)phenyl]acetic acid; UNII-144O8QL0L1; {2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid; CHEBI:4	C14H11Cl2NO2	DCOPUUMXTXDBNB-UHFFFAOYSA-N	2-[2-(2,6-dichloroanilino)phenyl]acetic acid	Novartis Pharmaceuticals Corp	Neurology Agents
PMDBD266	Dicyclomine	Therapeutic Substance	Approved Drug	77-19-0	DB00804	PA164744928	n.a.	DAP001118	3042	2934	n.a.	dicyclomine; Dicycloverin; Dicycloverine; Bentyl; Bentylol; Wyovin; Diocyl; Di-syntramine; Dicicloverina; 77-19-0; Dicycloverinum; Merbentyl; Dicycloverinum [INN-Latin]; Dicicloverina [INN-Spanish]; Bentyl hydrochloride; Dicycloverine [INN:BAN]; UNII-4KV4X8IF6V; Bentylol hydrochloride; Dicycloverin hydrochloride; HSDB 3058; [1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester; EINECS 201-009-4; Bicyclohexyl-1-carbonsaeure-2'diethylaminoethylester; (1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester; 4K	C19H35NO2	CURUTKGFNZGFSE-UHFFFAOYSA-N	2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate	Peckforton Pharmaceuticals	Anticholinergic Agents
PMDBD273	Diethylstilbestrol	Therapeutic Substance	Approved Drug	56-53-1	DB00255	PA449307	D00577	DAP001011	3054	395306	n.a.	cis-Diethyl Stilbestrol; 6898-97-1; 4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol; (Z,E)-Diethylstilbestrol; 4,4'-hex-3-ene-3,4-diyldiphenol; cis-Diethylstilbestrol; DSSTox_RID_79594; DSSTox_CID_20770; DSSTox_GSID_40770; CCRIS 9140; 22610-99-7; CAS-6898-97-1; AI3-17297; C18H20O2; Stilbestrol;DES; NCGC00090749-04; Diethylstilbestrol BP; Spectrum_000940; Diethylstilbestrol,(S); Spectrum3_000391; Spectrum2_000148; Spectrum4_000512; Prestwick0_000756; Prestwick1_000756; ACMC-209o5h; Oprea1_042	C18H20O2	RGLYKWWBQGJZGM-UHFFFAOYSA-N	4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol	n.a.	n.a.
PMDBD1160	Diflunisal	Therapeutic substance	Drug	22494-42-4	DB00861	PA449313	D00130	DAP000152	3059	2951	n.a.	diflunisal; 22494-42-4; Dolobid; Fluniget; Dolobis; Flovacil; Fluodonil; Flustar; Adomal; 5-(2,4-Difluorophenyl)salicylic acid; Citidol; Noaldol; Algobid; Unisal; Reuflos; 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid; MK-647; Diflusinal; MK 647; Diflunisalum [INN-Latin]; 2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid; 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid; 5-[2,4-Difluorophenyl]salicylic acid; UNII-7C546U4DEN; 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID; 2'	C13H8F2O3	HUPFGZXOMWLGNK-UHFFFAOYSA-N	5-(2,4-difluorophenyl)-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD1162	Diphenhydramine	Therapeutic substance	Drug	58-73-1	DB01075	PA449349	D00300	DAP000490	3100	2989	n.a.	diphenhydramine; 58-73-1; Benadryl; Benzhydramine; Probedryl; Alledryl; Dihidral; 2-(Benzhydryloxy)-N,N-dimethylethanamine; Antistominum; Benzhydroamina; Benzhydraminum; Diphantine; Difenhydramin; Ibiodral; Difedryl; Dibondrin; Debendrin; Benadrin; Syntedril; Novamina; Medidryl; Hyadrine; Histaxin; Drylistan; Diabylen; Diabenyl; Dermodrin; Benodine; Baramine; Allergical; Mephadryl; Desentol; Dermistina; Betramin; Benzhydril; Benzantine; Benachlor; Bagodryl; Dabylen; Antomin; Dylamon; Benylin; Benylan; Benodin; Amidryl; Benapon; Nausen; Diphenylhydramine	C17H21NO	ZZVUWRFHKOJYTH-UHFFFAOYSA-N	2-benzhydryloxy-N,N-dimethylethanamine	n.a.	n.a.
PMDBD285	Diphenylpyraline	Therapeutic Substance	Approved Drug	147-20-6	DB01146	PA164746377	D07862	DAP001071	3103	2992	n.a.	diphenylpyraline; Hispril; Diphenylpyrilene; Allergen; Diphenylpyralamine; 147-20-6; Lyssipoll; Histyn; Mepiben; Histryl; Dayfen; Neargal; Belfene; 4-(Diphenylmethoxy)-1-methylpiperidine; Difenilpiralina; Diphenylpyralinum; 4-(Benzhydryloxy)-1-methylpiperidine; 1-Methyl-4-piperidyl benzhydryl ether; AN 1041; Diphenylpyraline [INN:BAN]; Difenilpiralina [INN-Spanish]; Diphenylpyralinum [INN-Latin]; 4-benzhydryloxy-1-methylpiperidine; UNII-33361OE3AV; EINECS 205-686-7; 4-(benzhydryloxy)-N-methylpiperidine; PIPERIDINE, 4-(DIPHENYLMETHOX	C19H23NO	OWQUZNMMYNAXSL-UHFFFAOYSA-N	4-benzhydryloxy-1-methylpiperidine	n.a.	Antihistamines
PMDBD286	Dipyridamole	Therapeutic Substance	Approved Drug	58-32-2	DB00975	PA449367	D00302	DNC001625	3108	2997	n.a.	dipyridamole; 58-32-2; Dipyridamol; Persantin; Dipyridamine; Dipyudamine; Persantine; Curantyl; Stimolcardio; Kurantil; Stenocardil; Cardoxin; Dipyridan; Dipiridamol; Cardioflux; Peridamol; Coroxin; Apricor; Anginal; Corosan; Coribon; Stenocardiol; Permiltin; Justpertin; Chilcolan; Agilease; Piroan; Cleridium 150; Prandiol; Gulliostin; Coronarine; Natyl; Prandiol 75; Usaf Ge-12; Dypyridamol; Iv Persantine; Dipyridamolum; RA 8; 2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol; RA-8; Dipiridamol 	C24H40N8O4	IZEKFCXSFNUWAM-UHFFFAOYSA-N	2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol	FISCHER and ROCH	Vasodilator Agents
PMDBD1163	Disopyramide	Therapeutic substance	Drug	3737/9/5	DB00280	PA449373	D00303	DAP000504	3114	3002	n.a.	disopyramide; 3737-09-5; Dicorantil; Rythmodan; Ritmodan; Disopiramida; Searle 703; Disopyramidum; Disopyramidum [INN-Latin]; Disopiramida [INN-Spanish]; SC 7031; alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide; SC-7031; gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide; H 3292; CHEMBL517; alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide; CHEBI:4657; EINECS 223-110-2; 4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide; NCGC00015358-18; Lispine	C21H29N3O	UVTNFZQICZKOEM-UHFFFAOYSA-N	4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide	n.a.	n.a.
PMDBD288	Disulfiram	Therapeutic Substance	Approved Drug	97-77-8	DB00822	PA449376	D00131	DAP000012	3117	3005	n.a.	disulfiram; Tetraethylthiuram disulfide; 97-77-8; Antabuse; Antabus; Bis(diethylthiocarbamoyl) disulfide; Esperal; Anticol; Alcophobin; Teturam; TETD; Exhorran; Dicupral; Hoca; Ethyldithiurame; Antietanol; Antaethyl; Tetradine; Antivitium; Abstensil; Teturamin; Tetraetil; Contralin; Antalcol; Antadix; Cronetal; Antikol; Antietil; Refusal; Krotenal; Averzan; Antetil; Antetan; Abstinyl; Aversan; Abstinil; Etabus; Ethyl tuads; Ethyl Thiram; Ethyl Thiurad; Ethyl Tuex; Thiuranide; Ephorran; Antaetil; Disulfan; Antaenyl; Stopetyl; Disulfuram; Contrapot; Antiaet	C10H20N2S4	AUZONCFQVSMFAP-UHFFFAOYSA-N	diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate	Odyssey Pharmaceuticals	Alcohol Deterrents
PMDBD1167	Donepezil	Therapeutic substance	Drug	120014-06-4	DB00843	PA449394	D00670	DAP000560	3152	3040	n.a.	donepezil; 120014-06-4; Aricept; 2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; Donepezil [INN:BAN]; 2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one; HSDB 7743; 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one; CHEMBL502; CHEBI:53289; C24H29NO3; donepezilo; 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one; 1H-Inden-1-one, 2,3-dihydro-5	C24H29NO3	ADEBPBSSDYVVLD-UHFFFAOYSA-N	2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one	n.a.	n.a.
PMDBD295	Ebselen	Therapeutic Substance	Investigational Drug	60940-34-3	DB12610	n.a.	n.a.	n.a.	3194	3082	n.a.	ebselen; 60940-34-3; 2-Phenyl-1,2-benzisoselenazol-3(2H)-one; 2-phenyl-1,2-benzoselenazol-3-one; Ebseleno; Ebselenum; Ebselene; SPI-1005; Ebselene [French]; Ebselenum [Latin]; Ebseleno [Spanish]; Ebselen [INN]; 2-phenylbenzo[d][1,2]selenazol-3(2H)-one; PZ 51; Harmokisane; PZ-51; C13H9NOSe; DR-3305; UNII-40X2P7DPGH; MLS000028488; CCRIS 3714; PZ51; 2-Phenyl-1,2-benzisoselenazolin-3-one; SMR000058445; 2-phenyl-1,2-benzoisoselenazol-3(2H)-one; CHEMBL51085; NSC 639762; DR 3305; Prestwick_1057; RP 60	C13H9NOSe	DYEFUKCXAQOFHX-UHFFFAOYSA-N	2-phenyl-1,2-benzoselenazol-3-one	n.a.	Fibrinolytic Agents
PMDBD304	Enoxacin	Therapeutic Substance	Approved Drug	74011-58-8	DB00467	PA449462	D00310	DAP001000	3229	3116	n.a.	enoxacin; 74011-58-8; Penetrex; Enoxacine; Comprecin; Flumark; AT-2266; Enoxacino; Enoxacinum; Bactidan; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; Enoxor; Almitil; Enoram; CI-919; Enoxacine [French]; Enoxacinum [Latin]; enofloxacin; CI 919; Enoxacino [Spanish]; Enoxacin (Penetrex); PD 107779; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; PD-107779; UNII-325OGW249P; NSC 629661; CCRIS 5242; C15H17FN4O3; CHEBI:157175; 1-ethyl-6-fluoro-4-oxo-7-pipe	C15H17FN4O3	IDYZIJYBMGIQMJ-UHFFFAOYSA-N	1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid	n.a.	Antiinfective Agents
PMDBD310	Epirizole	Therapeutic Substance	Approved Drug	18694-40-1	DB08991	n.a.	D01394	n.a.	3242	3129	n.a.	epirizole; Mepirizole; 18694-40-1; Methopyrimazole; Mebron; Mepirizol; 4-Methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine; Epirizolum [INN-Latin]; DA-398; Mepirizol [German]; 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine; Epirizol [INN-Spanish]; UNII-3B46O2FH8I; Epirizole [USAN:INN:JAN]; EINECS 242-507-1; BRN 0751084; MLS000028844; 3B46O2FH8I; 1-(4-Methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxypyrazole; 2-(3-Methyl-5-methoxy-1-pyrazolyl)-4-methoxy-6-methylpyrimidine; 2-(3-Methoxy-5-methyl	C11H14N4O2	RHAXSHUQNIEUEY-UHFFFAOYSA-N	4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine	n.a.	n.a.
PMDBD319	Ethacrynic acid	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	3278	n.a.	NPC282294	ETHACRYNIC ACID; Etacrynic Acid; 58-54-8; ethacrynate; Etacrinic acid; Hydromedin; Edecrin; Taladren; Otacril; Hidromedin; Edecrina; Endecril; Edecril; Crinuryl; Uregit; Reomax; Mingit; Etakrinic acid; Methylenebutyrylphenoxyacetic acid; MK-595; Ethacrinique (acide); Acido etacrinico; Acide etacrynique; Acidum etacrynicum; Kyselina ethakrynova; Kyselina ethakrynova [Czech]; Acidum etacrynicum [INN-Latin]; Acide etacrynique [INN-French]; Acido etacrinico [INN-Spanish]; (2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid; Methylen	C13H12Cl2O4	AVOLMBLBETYQHX-UHFFFAOYSA-N	2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid	n.a.	Diuretics
PMDBD323	Ethoxzolamide	Therapeutic Substance	Approved Drug	452-35-7	DB00311	PA164754743	D02441	DAP000598	3295	3179	n.a.	ethoxzolamide; Ethoxyzolamide; Ethoxazolamide; 452-35-7; Ethamide; 6-Ethoxy-2-benzothiazolesulfonamide; Etoxzolamide; Cardrase; Glaucotensil; Diuretic C; 6-Ethoxy-1,3-benzothiazole-2-sulfonamide; Mingoral; 6-Ethoxybenzo[d]thiazole-2-sulfonamide; 6-Ethoxyzolamide; 6-Ethoxybenzothiazole-2-sulfonamide; 6-Ethoxybenzothiazole-2-sulphonamide; U-4191; NSC 10679; UNII-Z52H4811WX; C9H10N2O3S2; HSDB 3268; CHEMBL18; EINECS 207-199-5; BRN 0212240; MLS000028637; AI3-50805; Redupresin; 6-Ethoxy-benzothiazole-2	C9H10N2O3S2	OUZWUKMCLIBBOG-UHFFFAOYSA-N	6-ethoxy-1,3-benzothiazole-2-sulfonamide	n.a.	Diuretics
PMDBD324	Etodolac	Therapeutic Substance	Approved Drug	41340-25-4	DB00749	PA449550	D00315	DAP000778	3308	3192	n.a.	etodolac; 41340-25-4; Etodolic acid; Lodine; Ultradol; Lodine XL; Ramodar; Etodolaco; Etodolacum; AY 24236; AY-24236; Etodolacum [INN-Latin]; Etodolaco [INN-Spanish]; AY-24,236; Edolan; CCRIS 3923; 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid; 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid; 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid; 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid	C17H21NO3	NNYBQONXHNTVIJ-UHFFFAOYSA-N	2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid	Meda Pharmaceuticals 	Analgesics
PMDBD328	Etretinate	Therapeutic Substance	Approved Drug	54350-48-0	DB00926	PA449554	D00316	n.a.	3312	4445538	n.a.	9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid ethyl ester; CTK8F9698; BCP31125; AKOS030228516; VZ20178; DB00926; KS-0000017G; FT-0653621; Q27166420; ethyl 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate; 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid ethyl ester; 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid ethyl ester	C23H30O3	HQMNCQVAMBCHCO-UHFFFAOYSA-N	ethyl 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate	n.a.	n.a.
PMDBD331	Famciclovir	Therapeutic Substance	Approved Drug	104227-87-4	DB00426	PA449585	D00317	DAP000489	3324	3207	n.a.	famciclovir; 104227-87-4; Famvir; BRL-42810; Famciclovirum; 2-(2-(2-Amino-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate; Famciclovirum [INN-Latin]; BRL 42810; Famciclovir (Famvir); UNII-QIC03ANI02; [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate; CHEBI:4974; FCV; 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine; 2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate; QIC03ANI02; C14H19N5O4; 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester); 1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)	C14H19N5O4	GGXKWVWZWMLJEH-UHFFFAOYSA-N	[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate	Schering-Plough	Antiviral Agents
PMDBD332	Famotidine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	76824-35-6	DB00927	PA449586	D00318	DAP000341	3325	3208	NPC323937	famotidine; 76824-35-6; Famotidinum; Famotidina; PEPCID; Brolin; Gastro; Gastrosidin; Apogastine; Gastrodomina; Ulceprax; Ulcatif; Rubacina; Purifam; Nevofam; Neocidine; Invigan; Ingastri; Gastrofam; Vagostal; Ulcofam; Rogasti; Renapepsa; Quamtel; Peptidin; Nulcerin; Nulceran; Notidin; Huberdina; Famowal; Famotin; Famonit; Famodar; Famocid; Cuantin; Blocacid; Ulgarine; Tipodex; Pepfamin; Panalba; Mensoma; Lecedil; Gastridan; Famotal; Famodin; Confobos; Bestidine; Ulfinol; Ulfamid; Ulfagel; Restadin; Quamatel; Pepdine; Pepcidin; Midefam; Gastropen; Gastrion; Gastr	C8H15N7O2S3	XUFQPHANEAPEMJ-UHFFFAOYSA-N	3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide	n.a.	n.a.
PMDBD1190	Felbamate	Therapeutic substance	Drug	25451-15-4	DB00949	PA449590	D00536	DAP000093	3331	3214	n.a.	felbamate; 25451-15-4; Felbatol; 2-Phenylpropane-1,3-diyl dicarbamate; 2-Phenyl-1,3-propanediol dicarbamate; Felbamyl; Taloxa; Felbamato; Felbamatum; W-554; Felbamatum [Latin]; Felbamato [Spanish]; 1,3-Propanediol, 2-phenyl-, dicarbamate; ADD-03055; Felbamate [USAN:INN]; W 554; UNII-X72RBB02N8; carbamic acid 2-phenyltrimethylene ester; CHEBI:4995; Carbamic acid, 2-phenyltrimethylene ester; EINECS 247-001-4; BRN 3345236; 3-(carbamoyloxy)-2-phenylpropyl carbamate; MLS000028465; X72RBB02N8; NCGC00015429-08; SMR000058448; (3-carbamoyloxy	C11H14N2O4	WKGXYQFOCVYPAC-UHFFFAOYSA-N	(3-carbamoyloxy-2-phenylpropyl) carbamate	n.a.	n.a.
PMDBD335	Felodipine	Therapeutic Substance	Approved Drug	72509-76-3	DB01023	PA449591	D00319	DAP000487	3333	3216	n.a.	felodipine; 72509-76-3; Plendil; Renedil; Flodil; Munobal; Splendil; Feloday; dl-Felodipine; Perfudal; Prevex; Modip; Hydac; Agon; Plendil ER; Felodipina; Penedil; Preslow; Felogard; Plendil Retard; Munobal Retard; Plendil Depottab; Felodipinum; Felodipinum [INN-Latin]; Felodipina [INN-Spanish]; Felodur ER; AGON SR; 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; C18H19Cl2NO4; Felodipine (Plendil); H 154/82; 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl met	C18H19Cl2NO4	RZTAMFZIAATZDJ-UHFFFAOYSA-N	5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate	AstraZeneca	Antihypertensive Agents
PMDBD337	Fenbufen	Therapeutic Substance	Approved Drug	36330-85-5	DB08981	PA166049176	D01344	n.a.	3335	3218	n.a.	fenbufen; 36330-85-5; Lederfen; Cinopal; Napanol; Bufemid; 4-(4-Biphenylyl)-4-oxobutyric acid; 3-(4-Phenylbenzoyl)propionic acid; 3-(4-Biphenylylcarbonyl)propionic acid; 4-(biphenyl-4-yl)-4-oxobutanoic acid; gamma-Oxo(1,1'-biphenyl)-4-butanoic acid; CL-82204; 4-([1,1'-biphenyl]-4-yl)-4-oxobutanoic acid; 3-(4-Biphenylcarbonyl)propionic acid; Fenbufenum [INN-Latin]; Fenbufene [INN-French]; CL 82204; 4-biphenyl-4-yl-4-oxobutanoic acid; UNII-9815R1WR9B; 4-oxo-4-(4-phenylphenyl)butanoic acid; MLS0	C16H14O3	ZPAKPRAICRBAOD-UHFFFAOYSA-N	4-oxo-4-(4-phenylphenyl)butanoic acid	n.a.	n.a.
PMDBD339	Fenfluramine	Therapeutic Substance	Approved Drug	458-24-2	DB00574	PA449592	n.a.	DAP001478	3337	3220	n.a.	fenfluramine; Obedrex; Rotondin; Pesos; Ponderax PA; Fenfluraminum; Fenfluramina; Adifax; (+-)-Fenfluramine; DL-Fenfluramine; Fenfluramina [DCIT]; 458-24-2; Fenfluraminum [INN-Latin]; Fenfluramine [INN:BAN]; N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; 2-Ethylamino-1-(3-trifluoromethylphenyl)propane; 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane; N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine; HSDB 3080; 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine; S 768; EINECS 207-276-3; DEA No. 1670; BRN 4783711	C12H16F3N	DBGIVFWFUFKIQN-UHFFFAOYSA-N	N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine	n.a.	n.a.
PMDBD340	Fenofibrate	Therapeutic Substance	Approved Drug	49562-28-9	DB01039	PA449594	D00565	DAP000270	3339	3222	n.a.	fenofibrate; 49562-28-9; Procetofen; Lipantil; Lipanthyl; Tricor; Fenobrate; Secalip; Lipidil; Antara; Proctofene; Triglide; Lipoclar; Finofibrate; Lipofene; Sedufen; Lipirex; Fenogal; Fenoglide; Elasterin; Protolipan; Fenotard; Lipsin; Liposit; Lipofen; Lipidex; Nolipax; Ankebin; Lipifen; Elasterate; Procetofene; Luxacor; Fenofibratum [INN-Latin]; Fenofibrato [INN-Spanish]; Lipantil (TN); Tricor (TN); propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate; LF-178; TRICOR (MICRONIZED); Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylprop	C20H21ClO4	YMTINGFKWWXKFG-UHFFFAOYSA-N	propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate	Abbott Laboratories	Antilipemic Agents
PMDBD341	Fenspiride	Therapeutic Substance	Approved Drug	n.a.	DB08979	n.a.	n.a.	n.a.	3344	3227	n.a.	fenspiride; 5053-06-5; Respiride; Fenspirid; Viarespan; Fenspiride [INN]; 8-Phenethyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one; 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one; Fenspiridum [INN-Latin]; Fenspirida [INN-Spanish]; UNII-S983QC7HKM; S983QC7HKM; 8-Phenethyl-1-oxa-3,8-diaza-spiro[4.5]decan-2-one; C15H20N2O2; Fenspiride (INN); EINECS 225-751-3; BRN 0533332; Fenspiridum; Fenspirida; 1-Oxa-3,8-diazaspiro	C15H20N2O2	FVNFBBAOMBJTST-UHFFFAOYSA-N	8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one	n.a.	n.a.
PMDBD1192	Fexofenadine	Therapeutic substance	Drug	83799-24-0	DB00950	PA449621	D07958	DAP000330	3348	3231	n.a.	fexofenadine; 83799-24-0; Carboxyterfenadine; Terfenadine carboxylate; Terfenadine-COOH; Terfenadine acid metabolite; Allegra; Fexofenadine [INN:BAN]; HSDB 7486; MDL 16455; 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; CHEMBL914; CHEBI:5050; 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; Fexofendine; AK-75768; 139965-10-9	C32H39NO4	RWTNPBWLLIMQHL-UHFFFAOYSA-N	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid	n.a.	n.a.
PMDBD1195	Flavoxate	Therapeutic substance	Drug	15301-69-6	DB01148	PA164781386	n.a.	DAP001114	3354	3237	n.a.	flavoxate; 15301-69-6; Flavoxatum; Flavoxato; 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate; Flavossato [DCIT]; Flavoxate [INN:BAN]; Flavoxatum [INN-Latin]; Flavoxato [INN-Spanish]; UNII-3E74Y80MEY; 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester; EINECS 239-337-5; 2-piperidinoethyl 3-methylflavone-8-carboxylate; Spasuret hydrochloride; CHEBI:5088; 3E74Y80MEY; 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate; beta-piperidinoethyl 3-meth	C24H25NO4	SPIUTQOUKAMGCX-UHFFFAOYSA-N	2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate	n.a.	n.a.
PMDBD353	Fleroxacin	Therapeutic Substance	Approved Drug	79660-72-3	DB04576	PA164774762	D01716	DAP000928	3357	3240	n.a.	fleroxacin; 79660-72-3; Megalone; Fleroxicin; Quinodis; Megalocin; Fleroxacinum; Fleroxacino; 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; Fleroxacine; AM-833; Fleroxacinum [Latin]; Fleroxacine [French]; Fleroxacino [Spanish]; Ro 23-6240; AM 833; FLRX; Fleroxacin (Quinodis); Ro 23-6240/000; UNII-N804LDH51K; Ro-236240; CCRIS 3972; CHEBI:31810; C17H18F3N3O3; BRN 4300996; 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; N804LDH51K	C17H18F3N3O3	XBJBPGROQZJDOJ-UHFFFAOYSA-N	6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	n.a.	Antiinfective Agents
PMDBD357	Fluconazole	Therapeutic Substance	Approved Drug	86386-73-4	DB00196	PA449653	D00322	DAP000628	3365	3248	n.a.	fluconazole; 86386-73-4; Diflucan; Triflucan; Biozolene; Elazor; Biocanol; Fluconazol; Fungata; Fluconazolum; Pritenzol; Flucazol; Flunizol; Flukezol; Flucostat; Zonal; UK 49858; Alflucoz; Oxifugol; Syscan; 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL; Forcan; Flusol; Cryptal; Canzol; Zoltec; Dimycon; Zemyc; Baten; Mutum; 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol; Fluconazol [Spanish]; Fluconazolum [Latin]; UK-49858; DRG-0005; UNII-8VZV102JFY; 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2	C13H12F2N6O	RFHAOTPXVQNOHP-UHFFFAOYSA-N	2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol	Pfizer	Antifungal Agents
PMDBD358	Flucytosine	Therapeutic Substance	Approved Drug	2022-85-7	DB01099	PA449654	D00323	DAP001542	3366	3249	n.a.	5-Fluorocytosine; flucytosine; 2022-85-7; Ancotil; Ancobon; 5-Fluorocystosine; Fluocytosine; 5-FC; Flucytosin; 5-Fluorocytosin; Fluorcytosine; Alcobon; 4-Amino-5-fluoropyrimidin-2(1H)-one; Flucytosinum; Ro 2-9915; 4-Amino-5-fluoro-2(1H)-pyrimidinone; 5-Flurocytosine; 5-Flucytosine; 2-Hydroxy-4-amino-5-fluoropyrimidine; 5-fluoro cytosine; Ancobon (TN); Flucitosina [DCIT]; Ro 29915 E/265601; NSC 103805; Flucytosinum [INN-Latin]; 117969-88-7; Flucytosine (Ancobon); Flucytosine (5	C4H4FN3O	XRECTZIEBJDKEO-UHFFFAOYSA-N	6-amino-5-fluoro-1H-pyrimidin-2-one	n.a.	Antifungal Agents
PMDBD360	Flufenamic acid	Therapeutic Substance	Approved Drug	530-78-9	DB02266	PA166049190	D01581	n.a.	3371	3254	n.a.	flufenamic acid; 530-78-9; Arlef; Fluphenamic acid; Nichisedan; Achless; Tecramine; Paraflu; Lanceat; Flufacid; Plostene; Fullsafe; Parlef; Surika; Parlif; Flufenaminsaeure; N-(3-Trifluoromethylphenyl)anthranilic acid; Reumajust A; Acido flufenamico; 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid; Ristogen; Sastridex; Meralen; Ansatin; 2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid; Fluore-200; ANT-1; NSC-82699; Acide flufenamique; Acidum flufenamicum; TVX 916; INF 1837; 3'-Trifluoro	C14H10F3NO2	LPEPZBJOKDYZAD-UHFFFAOYSA-N	2-[3-(trifluoromethyl)anilino]benzoic acid	n.a.	n.a.
PMDBD367	Fluphenazine	Therapeutic Substance	Approved Drug	69-23-8	DB00623	PA449676	D07977	DCL000806	3372	3255	n.a.	FLUPHENAZINE; Triflumethazine; Fluorophenazine; Fluorphenazine; Fluorfenazine; 69-23-8; Siqualon; Elinol; Phthorphenazine; Vespazine; Ftorphenazine; Siqualine; Sevinol; Pacinol; Prolixin; Fluphenazinum; Flufenazina; Flufenazin; Valamina; Dapotum; Flufenazina [DCIT]; SQ 4918; 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol; Fluphenazine [INN:BAN]; Moditen (Tabl or elixir); Fluphenazinum [INN-Latin]; 10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; 4-(3-(2-Trifluoromethyl-10-ph	C22H26F3N3OS	PLDUPXSUYLZYBN-UHFFFAOYSA-N	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol	Bristol-Myers Squibb	Antipsychotic Agents
PMDBD361	Flumequine	Therapeutic Substance	Approved Drug	42835-25-6	DB08972	n.a.	n.a.	n.a.	3374	3257	n.a.	flumequine; 42835-25-6; Flumigal; Apurone; Imequyl; Flumisol; Flumiquil; Flumix; 9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid; R 802 (bactericide); Flumequinum [INN-Latin]; Flumequino [INN-Spanish]; HSDB 7034; R 802; EINECS 255-962-6; MLS000069546; R-802; CHEBI:85269; 9-fluoro-6,7-dihydro-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic acid; NCGC00018211-03; Flumequinum; SMR000058826; AK-27078; Flumequino; DSSTox_CID_25623; DSSTox_RID_81008; 9-Fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-py	C14H12FNO3	DPSPPJIUMHPXMA-UHFFFAOYSA-N	7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid	n.a.	n.a.
PMDBD1200	Fluorouracil	Therapeutic substance	Drug	51-21-8	DB00544	PA128406956	D00584	DAP000829	3385	3268	n.a.	5-Fluorouracil; fluorouracil; 51-21-8; 5-FU; Fluoroplex; Efudex; Adrucil; Carac; Fluracil; 5-fluoropyrimidine-2,4(1H,3H)-dione; Fluoroblastin; Kecimeton; Carzonal; Timazin; Efudix; Arumel; Fluril; 5-Fluoracil; Queroplex; Fluracilum; Ulup; Phthoruracil; Fluro Uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Fluorouracilum; Ftoruracil; Efurix; Fluri; 5 Fluorouracil; 5-Fluoropyrimidine-2,4-dione; Effluderm (free base); Fluorouracilo; Fluroblastin; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4(1H,3H)-Pyrimidinedione, 5-fluo	C4H3FN2O2	GHASVSINZRGABV-UHFFFAOYSA-N	5-fluoro-1H-pyrimidine-2,4-dione	n.a.	n.a.
PMDBD366	Fluoxetine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	54910-89-3	DB00472	PA449673	D00823	DAP000186	3386	3269	NPC328267	fluoxetine; 54910-89-3; Prozac; Pulvules; Fluoxetin; Portal; Eufor; Animex-On; Fluoxetina; Fluoxetina [Spanish]; Fluoxetinum; Fluoxetinum [INN-Latin]; Fluoxetina [INN-Spanish]; Reconcile; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine; Fluoxetine [USAN:INN:BAN]; (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine; CHEMBL41; dl-3-(p-Trifluoromethylphenoxy)-N-me	C17H18F3NO	RTHCYVBBDHJXIQ-UHFFFAOYSA-N	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	Eli Lilly	Antidepressants
PMDBD1201	Flurbiprofen	Therapeutic substance	Drug	5104-49-4	DB00712	PA449683	D00330	DAP000621	3394	3277	n.a.	flurbiprofen; 5104-49-4; Ansaid; Froben; Antadys; Flurofen; Cebutid; Anside; 2-(2-fluorobiphenyl-4-yl)propanoic acid; 3-Fluoro-4-phenylhydratropic acid; Flugalin; Flubiprofen; Ocufen; Flurbiprofene [INN-French]; Flurbiprofenum [INN-Latin]; Flurbiprofeno [INN-Spanish]; BTS 18322; 2-(3-fluoro-4-phenylphenyl)propanoic acid; FP 70; BTS-18322; 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid; C15H13FO2; U-27182; (+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; Stayban; Zepolas; Adfeed; FLURBIPROPHEN; CCRIS 3708; U 27182; 2-(2-Fluorobiphe	C15H13FO2	SYTBZMRGLBWNTM-UHFFFAOYSA-N	2-(3-fluoro-4-phenylphenyl)propanoic acid	n.a.	n.a.
PMDBD1202	Flutamide	Therapeutic substance	Drug	13311-84-7	DB00499	PA449685	D00586	DAP000301	3397	3280	n.a.	flutamide; 13311-84-7; Niftolide; Eulexin; Niftholide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; NFBA; niftolid; Drogenil; Flutamin; Sch 13521; Cebatrol, veterinary; Flutamida; Flutamidum; Sch-13521; 4'-Nitro-3'-trifluoromethylisobutyranilide; Ham's F-12 medium; Flutamidum [INN-Latin]; Flutamida [INN-Spanish]; 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide; NSC 215876; Flutamide (Eulexin); CCRIS 7246; UNII-76W6J0943E; alpha,alpha,alpha-Trifluo	C11H11F3N2O3	MKXKFYHWDHIYRV-UHFFFAOYSA-N	2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide	n.a.	n.a.
PMDBD1205	Formoterol	Therapeutic substance	Drug	73573-87-2	DB00983	PA134687907	D07990	DAP000247	3410	3292	n.a.	formoterol; 73573-87-2; Foradil; Formoterolum [INN-Latin]; n-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide; FORMOTEROL FUMARATE; CHEBI:63082; 2'-hydroxy-5'-(1-hydroxy-2-((p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide; N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide; 2'-hydroxy-5'-{1-hydroxy-2-[(p-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide; Formoterol (INN); Oxis (TN); Oxeze/Oxis; BD-40A; CGP-25827A; NCGC00181126-01	C19H24N2O4	BPZSYCZIITTYBL-UHFFFAOYSA-N	N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide	n.a.	n.a.
PMDBD375	Furazolidone	Therapeutic Substance	Approved Drug	67-45-8	DB00614	PA164746760	D00830	DAP000993	3435	3317	n.a.	furazolidone; 67-45-8; Furazolidona; Furazolidonum; Nifurazolidonum; Furazolum; UNII-5J9CPU3RE0; Furazolidonum [INN-Latin]; Furazolidona [INN-Spanish]; 5J9CPU3RE0; CHEBI:5195; CCRIS 1540; HSDB 7036; Furox Aerosol Powder (Veterinary); NSC 6469; EINECS 200-653-3; NF-180; Prestwick_1067; AI3-50103; Spectrum_001098; Spectrum3_000436; Prestwick0_000808; Prestwick1_000808; Spectrum4_000559; Spectrum2_001015; Oprea1_494195; SCHEMBL64995; KBioGR_001257; KBioSS_001578; 2-Oxazolidinone, 3	C8H7N3O5	PLHJDBGFXBMTGZ-UHFFFAOYSA-N	3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one	n.a.	n.a.
PMDBD1209	Furosemide	Therapeutic substance	Drug	54-31-9	DB00695	PA449719	D00331	DAP000043	3440	3322	n.a.	furosemide; 54-31-9; Frusemide; Lasix; Furosemid; Furanthril; Errolon; Fusid; Frusemin; Macasirool; Fursemide; Furantril; Furanthryl; Beronald; Prefemin; Lowpstron; Aisemide; Trofurit; Rosemide; Fuluvamide; Desdemin; Radonna; Fulsix; Seguril; Furesis; Lasilix; Transit; Katlex; Lasex; Salix; Urex; Frusetic; Promedes; Fursemid; Eutensin; Lazix; Frusid; Urosemide; Profemin; Furosedon; Furanturil; Frusemid; Frusenex; Rusyde; Dryptal; Impugan; Uresix; Aluzine; Yidoli; Uremide; Nicorol; Diural; Laxur; Disal; Urian; Hydro-rapid; Apo-Frusemide; Synephron; Spirofur; Selecto	C12H11ClN2O5S	ZZUFCTLCJUWOSV-UHFFFAOYSA-N	4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid	n.a.	n.a.
PMDBD1210	Gabapentin	Therapeutic substance	Drug	60142-96-3	DB00996	PA449720	D00332	DNC000670	3446	3328	n.a.	gabapentin; 60142-96-3; Neurontin; 1-(Aminomethyl)cyclohexaneacetic acid; Gabapentine; Aclonium; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Gabapetin; Gabapentinum; Fanatrex; Gabapentino; Serada; Gabapentino [Spanish]; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID; gabapentina; Gabapentinum [INN-Latin]; Gabapentine [INN-French]; Gralise; Gabapentino [INN-Spanish]; Go 3450; Goe-3450; 2-(1-(aminomethyl)cyclohexyl)acetic acid; GOE 2450; CI-945; CI 945; gabapentin (Neurontin); DM-1796; (1-Aminomethyl-cycl	C9H17NO2	UGJMXCAKCUNAIE-UHFFFAOYSA-N	2-[1-(aminomethyl)cyclohexyl]acetic acid	n.a.	n.a.
PMDBD1212	Gemfibrozil	Therapeutic substance	Drug	25812-30-0	DB01241	PA449750	D00334	DAP000210	3463	3345	n.a.	gemfibrozil; 25812-30-0; 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid; Lopid; Decrelip; Jezil; Lipur; Bolutol; Apo-Gemfibrozil; Gemfibromax; Lipazil; Fibratol; Gemlipid; Gemfibril; Trialmin; Litarek; Hipolixan; Fibrocit; Cholespid; Ausgem; Pilder; CI-719; Gemfibrozilo; Gemfibrozilum; Renabrazin; Progemzal; Synbrozil; Lifibron; Ipolipid; Taborcil; Normolip; Lanaterom; Regulip; Reducel; Polyxit; Micolip; Tentroc; Lipira; Gemnpid; Elmogan; Clearol; Sinelip; Lipizyl; Lipigem; Innogen; Fetinor; Brozil; Gozid; Hidil; Gemd; WL-Gemfibrozil; Gevilon Uno; Gen-Fi	C15H22O3	HEMJJKBWTPKOJG-UHFFFAOYSA-N	5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid	n.a.	n.a.
PMDBD399	Gliclazide	Therapeutic Substance	Approved Drug	21187-98-4	DB01120	PA10892	D01599	DAP000522	3475	3356	n.a.	gliclazide; 21187-98-4; Glimicron; Gliclazidum [INN-Latin]; Gliclazida [INN-Spanish]; Diamicron; Nordialex; 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; CHEBI:31654; C15H21N3O3S; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; S-852; S-1702; Gliclazida; 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea; N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Gliclazide-d4; N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonami	C15H21N3O3S	BOVGTQGAOIONJV-UHFFFAOYSA-N	1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea	n.a.	Hypoglycemic Agents
PMDBD1215	Glimepiride	Therapeutic substance	Drug	93479-97-1	DB00222	PA449761	D00593	DAP000132	3476	16740595	n.a.	glimepiride; 93479-97-1; Amaryl; Glimepirid; Amarel; Glimepirida; Glimepiridum; Endial; Hoe-490; Glimepride; cis-Glimepiride; Glimepiridum [Latin]; HOE 490; Glimepirida [Spanish]; UNII-24T6XIR2MZ; CCRIS 7083; CHEBI:5383; UNII-6KY687524K; 684286-46-2; 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea; 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide; BRN 5365754; 24T6XIR2MZ; 6KY687524K; NCGC00016960-03; Ronam	C24H34N4O5S	WIGIZIANZCJQQY-UHFFFAOYSA-N	4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide	n.a.	n.a.
PMDBD400	Glipizide	Therapeutic Substance	Approved Drug	29094-61-9	DB01067	PA449762	D00335	DAP000920	3478	3359	n.a.	glipizide; 29094-61-9; Glucotrol; Glydiazinamide; Melizide; Sucrazide; Glupizide; Glucozide; Glibenese; Napizide; Mindiab; Minidiab; Glupitel; Dipazide; Minodiab; Ozidia; Glucotrol XL; Glucolip; Glibetin; Aldiab; Minidab; Glipid; Glican; Digrin; Glidiab; Glyde; Gluco-Rite; Glide; Glipizida; Glipizidum; Glipizidum [INN-Latin]; Glipizida [INN-Spanish]; Metaglip; CP 28720; K 4024; K-4024; CP-28720; TK 1320; C21H27N5O4S; UNII-X7WDT95N5C; CP 28,720; Glipizide (Glucotrol); EINECS 249-427-6; BRN 0903495; CHEMBL1073; X7WDT95N5C; 1-Cyclohexyl-3-((p-(2-(5-methyl	C21H27N5O4S	ZJJXGWJIGJFDTL-UHFFFAOYSA-N	N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide	Pfizer Pharmaceuticals	Hypoglycemic Agents
PMDBD1217	Glyburide	Therapeutic substance	Drug	10238-21-8	DB01016	PA449782	D00336	DAP000037	3488	3368	n.a.	Glibenclamide; glyburide; 10238-21-8; Glybenclamide; Micronase; Diabeta; Glynase; Daonil; Euglucon; Maninil; Semi-daonil; Apo-Glibenclamide; Euglucon 5; Neogluconin; Bastiverit; Azuglucon; Orabetic; Euglykon; Euglucan; Renabetic; Prodiabet; Glucolon; Duraglucon; Yuglucon; Glibenil; Betanase; Benclamin; Tiabet; Libanil; Glibil; Glibens; Dibelet; Glimide; Gilemal; Suraben; Humedia; Glimel; Glybenzcyclamide; Melix; Adiab; Pira; Med-Glionil; Normoglucon; Hexaglucon; Glucohexal; Glibenbeta; Glucoremed; Praeciglucon; Lisaglucon; Gewaglucon; Lederglib; Glucobene	C23H28ClN3O5S	ZNNLBTZKUZBEKO-UHFFFAOYSA-N	5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide	n.a.	n.a.
PMDBD1222	Guanfacine	Therapeutic substance	Drug	29110-47-2	DB01018	PA449825	D08031	DAP000900	3519	3399	n.a.	GUANFACINE; 29110-47-2; Guanfacinum [INN-Latin]; Guanfacina [INN-Spanish]; Guanfacine [INN:BAN]; UNII-30OMY4G3MK; N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide; EINECS 249-442-8; 30OMY4G3MK; N-amidino-2-(2,6-dichlorophenyl)acetamide; CHEBI:5558; N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide; SPD 503; C9H9Cl2N3O; Guanfacinum; Guanfacina; Guanfacine Monohydrochloride; NCGC00015469-05; Lon798; Guanfacine (INN); Estulic (TN); Tenex (Salt/Mix); Estulic (Salt/Mix)	C9H9Cl2N3O	INJOMKTZOLKMBF-UHFFFAOYSA-N	N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide	n.a.	n.a.
PMDBD418	Haloperidol	Therapeutic Substance	Approved Drug	52-86-8	DB00502	PA449841	D00136	DAP000313	3559	3438	n.a.	haloperidol; 52-86-8; Haldol; Serenace; Aloperidin; Aloperidol; Brotopon; Eukystol; Einalon S; Ulcolind; Serenase; Uliolind; Serenelfi; Aloperidolo; Halojust; Vesalium; Halopoidol; Galoperidol; Pernox; Mixidol; Halopal; Sernel; Sernas; Linton; Dozic; Aldo; Lealgin compositum; Keselan; Peluces; Bioperidolo; Haldol Solutab; McN-JR-1625; Haloperidolum; Aloperidon; Fortunan; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one; Aloperidolo [DCIT]; Aloperidolo [Italian]; Haloperidolum [INN-Latin]; NSC 170973; R-1625; R 1625; C21H	C21H23ClFNO2	LNEPOXFFQSENCJ-UHFFFAOYSA-N	4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one	Janssen Pharmaceutica	Antipsychotic Agents
PMDBD419	Haloprogin	Therapeutic Substance	Approved Drug	777-11-7	DB00793	PA164768737	D00339	DAP001332	3561	3440	n.a.	haloprogin; Mycanden; 777-11-7; Halotex; Mycilan; Polik; M-1028 (Meiji); Haloproginum [INN-Latin]; Haloprogine [INN-French]; Haloprogina [INN-Spanish]; M 1028; C9H4Cl3IO; 2,4,5-Trichlorophenyl iodopropargyl ether; UNII-AIU7053OWL; 3-Iodo-2-propynyl 2,4,5-trichlorophenyl ether; Ether, 3-iodo-2-propynyl 2,4,5-trichlorophenyl; EINECS 212-286-6; Haloprogine; 2,4,5-Trichlorophenyl-gamma-iodopropargyl ether; 2,4,5-Trichlorophenyl gamma-iodopropargil ether; NSC 100071; (3-Iod-2-propinyl)-(2,4,5-trichlorphenyl)ether; BRN 1976771; CHEMBL1	C9H4Cl3IO	CTETYYAZBPJBHE-UHFFFAOYSA-N	1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene	n.a.	Antifungal Agents
PMDBD423	Hexachlorophene	Therapeutic Substance	Approved Drug	70-30-4	DB00756	PA449871	D00859	DAP001050	3598	3472	n.a.	hexachlorophene; 70-30-4; Hexachlorophen; Hexachlorofen; Nabac; Almederm; Fostril; Exofene; pHisoHex; Tersaseptic; Steraskin; Hexophene; Gamophene; Phisodan; Dermadex; Septisol; Distodin; Hexafen; Gamophen; Surofene; Septofen; Hexabalm; Acigena; Turgex; Steral; Hexide; Germa-Medica; Surgi-Cen; Surgi-Cin; Cotofilm; Ritosept; Hexosan; Fomac; Fesia-sin; Ster-zac; Soy-dome; Neosept V; G-Eleven; Hexachlorophane; Hexascrub; Bilevon; Phiso-Scrub; Septi-Soft; TRICHLOROPHENE; Hexa-Germ; 6,6'-Methylenebis(2,4,5-trichlorophenol); Hexaclorofeno; Armohex; Hexachlorop	C13H6Cl6O2	ACGUYXCXAPNIKK-UHFFFAOYSA-N	3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol	n.a.	Antiinfective Agents
PMDBD425	Hexetidine	Therapeutic Substance	Approved Drug	141-94-6	DB08958	n.a.	D07068	n.a.	3607	3481	n.a.	hexetidine; 141-94-6; Oraldene; Hexoral; Glypesin; Hextril; Elsix; Collu hextril; Triocil; Triscol; Sterisil; Sterilate; Duranil Aerosol; Hexetidinum; Collu-Hextril; Steri/Sol; Drossadin; Paradenyl; Oraseptic; Steri/Sol (VAN); Caswell No. 033BB; Hexetidinum [INN-Latin]; Hexetidina [INN-Spanish]; NSC-17764; NSC 17764; 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine; UNII-852A84Y8LS; C21H45N3; 5-Amino-1,3-bis(2-ethylhexyl)hexahydro-5-methylpyrimidine; EINECS 205-513-5; MLS0022	C21H45N3	DTOUUUZOYKYHEP-UHFFFAOYSA-N	1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine	n.a.	n.a.
PMDBD1225	Hydralazine	Therapeutic substance	Drug	86-54-4	DB01275	PA449894	D08044	DAP000728	3637	3511	n.a.	hydralazine; 1-Hydrazinophthalazine; Hydralazin; 1-Hydrazinylphthalazine; Hypophthalin; 86-54-4; Hydrazinophthalazine; Apresoline; Apressin; Apresolin; Idralazina; 6-Hydralazine; 1(2H)-Phthalazinone, hydrazone; Hydrallazine; Hidralazina; Aprezolin; Hidralazin; Hipoftalin; 1-Phthalazinylhydrazine; phthalazin-1-ylhydrazine; Hydralazinum; Hydrazone 1(2H)-phthalazinone; Ciba 5968; 59275-69-3; Apressin (pharmaceutical); (E)-1-Hydrazono-1,2-dihydrophthalazine; Idralazina [DCIT]; Idralazina [Italian]; Hidralazina [Spanish]; Hydralazine [INN:B	C8H8N4	RPTUSVTUFVMDQK-UHFFFAOYSA-N	phthalazin-1-ylhydrazine	n.a.	n.a.
PMDBD1226	Hydrochlorothiazide	Therapeutic substance	Drug	58-93-5	DB00999	PA449899	D00340	DAP000750	3639	3513	n.a.	hydrochlorothiazide; 58-93-5; HCTZ; Hypothiazide; Esidrix; Oretic; Hydrodiuretic; Servithiazid; Hydrosaluric; Hidrotiazida; Dichlotiazid; Hydrochlorthiazide; Hydrochlorothiazid; Vetidrex; Idrotiazide; Thiuretic; Maschitt; Aquarills; Newtolide; Disalunil; Diclotride; Dichlotride; Megadiuril; Hypothiazid; Aquarius; Nefrix; Hidril; Drenol; Esidrex; Hydril; Chlorosulthiadil; Hidrochlortiazid; Hydro-Diuril; Hydro-Aquil; Jen-Diril; Dihydrochlorothiazide; HydroDIURIL; Dihydrochlorothiazid; Dihydrochlorothiazidum; Moduretic; Apresazide; Urodiazin; Neoflume	C7H8ClN3O4S2	JZUFKLXOESDKRF-UHFFFAOYSA-N	6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	n.a.	n.a.
PMDBD1228	Hydroflumethiazide	Therapeutic substance	Drug	135-09-1	DB00774	PA164752557	D00654	DAP000747	3647	3521	n.a.	hydroflumethiazide; 135-09-1; Glomerulin; Diuredemina; Hidroflumetiazid; Hydroflumethizide; Hidroalogen; Flutizide; Diurometon; Spandiuril; Robezon; Saluron; Enjit; Trifluoromethylhydrothiazide; Leodrine; Vergonil; Hydrenox; Diucardin; Bristurin; Rodiuran; Olmagran; Elodrine; Finuret; Bristab; Sisuril; Rontyl; Hydol; Trifluoromethylhydrazide; NaClex; Di-ademil; Dihydroflumethazide; Dihydroflumethiazide; Hydroflumethazide; Elodrin; Metforylthiadiazin; Methforylthiazidine; Metflorylthiazidine; Rivosil; Idroflumetiazide; Hidroflumetiazida; Metforylt	C8H8F3N3O4S2	DMDGGSIALPNSEE-UHFFFAOYSA-N	1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide	n.a.	n.a.
PMDBD1231	Ibuprofen	Therapeutic substance	Drug	15687-27-1	DB01050	PA449957	D00126	DAP000780	3672	3544	n.a.	ibuprofen; 15687-27-1; 2-(4-Isobutylphenyl)propanoic acid; Brufen; Motrin; Advil; Nurofen; Nuprin; Liptan; Dolgit; Ibuprocin; Buburone; Ibumetin; Anflagen; Medipren; Butylenin; Lamidon; Ebufac; Mynosedin; Haltran; Epobron; Trendar; Roidenin; Apsifen; Nobfen; Bluton; Rufen; PediaProfen; Andran; Nobgen; Adran; 2-[4-(2-methylpropyl)phenyl]propanoic acid; Nobfelon; Tabalon; Inabrin; Suspren; Rebugen; Pantrop; Brufort; (RS)-Ibuprofen; Urem; Anco; Ibu-slo; Brufanic; Ibuprohm; Napacetin; Ibufen; Ibren; 4-Isobutylhydratropic acid; p-Isobutylhydratropic acid; Proar	C13H18O2	HEFNNWSXXWATRW-UHFFFAOYSA-N	2-[4-(2-methylpropyl)phenyl]propanoic acid	n.a.	n.a.
PMDBD1235	Imipramine	Therapeutic substance	Drug	50-49-7	DB00458	PA449969	D08070	DAP001154	3696	3568	n.a.	imipramine; Melipramine; Imidobenzyle; 50-49-7; Antideprin; Melipramin; Berkomine; Dimipressin; Tofranil; Intalpram; Nelipramin; Timolet; Dynaprin; Janimine; Irmin; Dpid; Dyna-zina; Impramine; Promiben; Iramil; Imiprin; Censtin; Censtim; Imipramina; Declomipramine; Imipraminum; Imipramin; Imizin; Tofranil, base; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; Psychoforin; Imavate; Imizine; Eupramin; Surplix; Imipramina [Italian]; Imipramine [INN:BAN]; Imipraminum [INN-Latin]; Imipramina [INN-Spanish]; N-(gamma-Dimethylam	C19H24N2	BCGWQEUPMDMJNV-UHFFFAOYSA-N	3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine	n.a.	n.a.
PMDBD1236	Indapamide	Therapeutic substance	Drug	26807-65-8	DB00808	PA449975	D00345	DAP000498	3702	3574	n.a.	indapamide; 26807-65-8; Noranat; Tertensif; Veroxil; Lozol; Indaflex; Indamol; Fludex; Arifon; Natrilix; Pressurai; Tandix; Ipamix; Bajaten; Indapamida; Metindamide; Cormil; Damide; Indapamidum; Indapamidum [INN-Latin]; Indapamida [INN-Spanish]; SE-1520; 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline; SE 1520; RHC 2555; USV 2555; Indapamide (Lozol); S-1520; 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide; 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide; 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamo	C16H16ClN3O3S	NDDAHWYSQHTHNT-UHFFFAOYSA-N	4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide	n.a.	n.a.
PMDBD446	Indomethacin	Therapeutic Substance	Approved Drug	53-86-1	DB00328	PA449982	D00141	DAP000617	3715	3584	n.a.	indomethacin; 53-86-1; indometacin; Indocin; Indometacine; Indomethacine; Indocid; Metindol; Amuno; Indomethazine; Imbrilon; Tannex; Indomethacinum; Metartril; Infrocin; Indoptic; Artrivia; Inflazon; Indomecol; Mikametan; Methazine; Indoptol; Confortid; Artracin; Sadoreum; Reumacide; Idomethine; Artrinovo; Indomed; Metacen; Indomee; Inacid; Lausit; Indacin; Dolovin; Mobilan; Indo-tablinen; Indo-rectolmin; Inteban sp; Indometicina; Indometacyna; Mezolin; Indo-Lemmon; Indocin Sr; Indometa	C19H16ClNO4	CGIGDMFJXJATDK-UHFFFAOYSA-N	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid	Recordati Rare Diseases Inc	Antiinflammatory Agents
PMDBD450	Iohexol	Therapeutic Substance	Approved Drug	66108-95-0	DB01362	PA450061	D01817	n.a.	3730	3599	n.a.	iohexol; 66108-95-0; Nycodenz; Omnipaque; Exypaque; Iohexolum; Omnipaque 240; Omnipaque 70; Omnipaque 140; Omnipaque 350; Omnipaque 300; Omnipaque 210; Omnipaque 180; Iohexolum [INN-Latin]; UNII-4419T9MX03; CHEBI:31709; EINECS 266-164-2; WIN 39424; BRN 2406632; N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide; 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; WIN-39424; 4419T9MX03; NCGC00166000-01; DSSTox_CID_3157; 5-(N-2,3-Dih	C19H26I3N3O9	NTHXOOBQLCIOLC-UHFFFAOYSA-N	5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide	n.a.	n.a.
PMDBD451	Iopanoic acid	Therapeutic Substance	Approved Drug	96-83-3	DB08946	n.a.	n.a.	n.a.	3735	3604	n.a.	IOPANOIC ACID; Iodopanoic acid; 96-83-3; Telepaque; Cholevid; Polognost; Iopagnost; Iopanoicum; iopanic acid; Jopanoic acid; Copanoic; Colepax; Cistobil; Jopagnost; Choladine; Bilijodon; 2-(3-Amino-2,4,6-triiodobenzyl)butanoic acid; 2-(3-Amino-2,4,6-triiodobenzyl)butyric acid; Teletrast; Acidum iopanoicum; Iodopanic acid; NSC 41706; Acide iopanoique [French]; Acidum iopanoicum [INN-Latin]; Acido iopanoico [INN-Spanish]; Acide iopanoique [INN-French]; Acido iopanoico [Latin,Spanish]; HSDB 3345; 2-[(3-amino-2,4,6-triiodophenyl)methyl]bu	C11H12I3NO2	OIRFJRBSRORBCM-UHFFFAOYSA-N	2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid	n.a.	n.a.
PMDBD454	Irbesartan	Therapeutic Substance	Approved Drug	138402-11-6	DB01029	PA450084	D00523	DAP000364	3749	3618	n.a.	irbesartan; 138402-11-6; Aprovel; Avapro; Karvea; SR-47436; BMS-186295; BMS 186295; SR 47436; UNII-J0E2756Z7N; CHEMBL1513; 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; CHEBI:5959; C25H28N6O; J0E2756Z7N; NCGC00095122-01; AK-57149; DSSTox_CID_3169; DSSTox_RID_76900; 2-Butyl-3-[2'-(1H-tetrazol-5-yl)	C25H28N6O	YOSHYTLCDANDAN-UHFFFAOYSA-N	2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one	Bristol-Myers Squibb	Antihypertensive Agents
PMDBD1240	Isocarboxazid	Therapeutic substance	Drug	59-63-2	DB01247	PA450101	D02580	DAP000577	3759	3628	n.a.	isocarboxazid; 59-63-2; Isocarboxazide; Marplan; Isocarbonazid; Enerzer; Benazide; N'-Benzyl-5-methylisoxazole-3-carbohydrazide; Isocarboxyzid; Isocarbossazide; Marplon; Isocarbossazide [DCIT]; Maraplan; Isocarboxazidum [INN-Latin]; Isocarboxazide [INN-French]; Isocarboxazida [INN-Spanish]; BMIH; N'-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide; Ro 5-0831; Ro 5-0831/1; N'-Benzyl N-methyl-5-isoxazolecarboxylhydrazide-3; 3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide; 5-Methyl-3-isoxazolecarboxylic acid 2-benzylhy	C12H13N3O2	XKFPYPQQHFEXRZ-UHFFFAOYSA-N	N'-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide	n.a.	n.a.
PMDBD459	Isoconazole	Therapeutic Substance	Approved Drug	27523-40-6	DB08943	n.a.	D04624	n.a.	3760	3629	n.a.	Isoconazole; 27523-40-6; Travogen; Isoconazol [INN-Spanish]; Isoconazolum [INN-Latin]; EINECS 248-508-3; CHEBI:83667; 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole; Isoconazolum; Isoconazol; 1-(2,4-Dichloro-beta-((2,6-dichlorobenzyl)oxy)phenethyl)imidazole; 1-(2-(2,4-Dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)1H-imidazole; DSSTox_CID_25447; DSSTox_RID_80886; DSSTox_GSID_45447; 1-(2-(2,4-Dichlorophenyl)-2-((2,6-dichlorophenyl)methoxy)ethyl)-1H-imidazole; 1H-Imidazole, 1-(2-(2,4-dichlorop	C18H14Cl4N2O	MPIPASJGOJYODL-UHFFFAOYSA-N	1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole	n.a.	n.a.
PMDBD1241	Isradipine	Therapeutic substance	Drug	75695-93-1	DB00270	PA450131	D00349	DAP000134	3784	3652	n.a.	isradipine; 75695-93-1; DynaCirc; Isradipin; Lomir; Isrodipine; Prescal; Esradin; Dynacirc CR; Clivoten; Dynacrine; Isradipinum [Latin]; Isradipino [Spanish]; Rebriden; DynaCire; PN 200-110; PN-200-110; DynaCire CR; (+-)-Isradipine; (+/-)-Isradipine; Isradipine (Dynacirc); PN 200; C19H21N3O5; 3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester; 3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester; Isopropyl methyl (+-)	C19H21N3O5	HMJIYCCIJYRONP-UHFFFAOYSA-N	3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate	n.a.	n.a.
PMDBD467	Ketoconazole	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	65277-42-1	DB01026	PA450146	D00351	DAP000630	3823	3691	NPC471614	ketoconazole; Nizoral; 79156-75-5; 1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone; 65277-42-1; NSC317629; Ketozole; CHEBI:48339; NSC-317629; R-41400; 1-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethanone; Ketokonazol; fungarest;fungoral; SCHEMBL8408; Oprea1_683648; US8987315, Ketoconazole; CHEMBL157101; GTPL2568; SCHEMBL18258319; CTK5E6507; J02AB02; DTXSID20273956; BDBM151585; HMS3267K04; Piperazine, (+	C26H28Cl2N4O4	XMAYWYJOQHXEEK-UHFFFAOYSA-N	1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone	Johnson & Johnson 	Antifungal Agents
PMDBD468	Ketoprofen	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	22071-15-4	DB01009	PA450149	D00132	DAP000623	3825	3693	NPC329556	ketoprofen; 22071-15-4; 2-(3-Benzoylphenyl)propanoic acid; Orudis; 2-(3-Benzoylphenyl)propionic acid; Ketoprofene; m-Benzoylhydratropic acid; Profenid; Oruvail; 3-Benzoylhydratropic acid; Capisten; Alrheumat; Alrheumun; Epatec; Actron; Aneol; Orudis (TN); Orudis KT; Ketoprophene; Ketoprofeno; RP-19583; racemic-Ketoprofen; 2-[3-(phenylcarbonyl)phenyl]propanoic acid; RP 19583; 2-(m-Benzoylphenyl)propionic acid; Ketoprofenum [INN-Latin]; Ketoprofene [INN-French]; Racemic ketoprofen; Ketoprofeno [INN-Spanish]; 3-BENZOYL-ALPHA-METHYLBENZENE	C16H14O3	DKYWVDODHFEZIM-UHFFFAOYSA-N	2-(3-benzoylphenyl)propanoic acid	ProEthic Pharmaceuticals	Analgesics
PMDBD1244	Labetalol	Therapeutic substance	Drug	36894-69-6	DB00598	PA164743150	D08106	DAP000038	3869	3734	n.a.	labetalol; 36894-69-6; Labetolol; Albetol; Ibidomide; Normodyne; Labetalolum; Trandate; Labetalolum [INN-Latin]; 2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide; Labetalol [INN:BAN]; AH 5158; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; ScH 15719W; UNII-R5H8897N95; HSDB 6537; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; EINECS 253-258-3; CHEBI:6343; AH-5158; 2-Hydroxy-5-(1-hydroxy-2-(	C19H24N2O3	SGUAFYQXFOLMHL-UHFFFAOYSA-N	2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide	n.a.	n.a.
PMDBD1247	Lamotrigine	Therapeutic substance	Drug	84057-84-1	DB00555	PA450164	D00354	DAP000039	3878	3741	n.a.	lamotrigine; 84057-84-1; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; Lamictal; Lamictal Cd; Lamotriginum [Latin]; Lamictal XR; Lamotrigina [Spanish]; Lamotriginum; Lamotrigina; BW-430C; Lamictal ODT; BW 430C; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; UNII-U3H27498KS; EINECS 281-901-8; CHEMBL741; C9H7Cl2N5; LTG;BW430C; MLS000069685; CHEBI:6367; U3H27498KS; Lamotrigine, 98%; NCGC00015605-06; Labileno; SMR000058464; Lamito	C9H7Cl2N5	PYZRQGJRPPTADH-UHFFFAOYSA-N	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine	n.a.	n.a.
PMDBD472	Lansoprazole	Therapeutic Substance	Approved Drug	103577-45-3	DB00448	PA450180	D00355	DAP000725	3883	3746	n.a.	lansoprazole; 103577-45-3; Prevacid; Bamalite; Monolitum; Ogastro; Lansoprazol; Limpidex; Agopton; Lanzor; Opiren; Prevacid SoluTab; Takepron; Lanzopral; Zoton; Lansopep; Lanproton; Mesactol; Lasoprol; Lancid; Ketian; Blason; Prezal; Lanston; Aprazol; Ulpax; Lanz; Pro Ulco; AG-1749; Lansoprazolum; Compraz; Prosogan; Ilsatec; Suprecid; Zoprol; Dakar; Promp; Prevacid Iv; Lanzol-30; AG 1749; Lansoprazol [INN-Spanish]; Lansox; Lansoprazolum [INN-Latin]; Lanzo; A-65006; Prevacid 24HR; CHEBI:6375; HSDB 7204; 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]m	C16H14F3N3O2S	MJIHNNLFOKEZEW-UHFFFAOYSA-N	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole	n.a.	n.a.
PMDBD473	Leflunomide	Therapeutic Substance	Approved Drug	75706-12-6	DB01097	PA450192	D00749	DAP000636	3899	3762	n.a.	leflunomide; 75706-12-6; Arava; lefunamide; Leflunomidum; Leflunomida; HWA 486; 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide; Leflunomidum [INN-Latin]; HWA-486; SU 101 (pharmaceutical); Leflunomida [INN-Spanish]; SU101; Arava (TN); 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide; 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide; UNII-G162GK9U4W	C12H9F3N2O2	VHOGYURTWQBHIL-UHFFFAOYSA-N	5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide	Sanofi-Aventis	Antiinflammatory Agents
PMDBD1255	Letrozole	Therapeutic substance	Drug	112809-51-5	DB01006	PA450196	D00964	DAP000626	3902	3765	n.a.	letrozole; 112809-51-5; Femara; 4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile; Letrozol; CGS 20267; CGS-20267; LETRAZOLE; Femera; 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile; UNII-7LKK855W8I; 4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile; HSDB 7461; 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile; C17H11N5; CHEMBL1444; 4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE; 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile; 7L	C17H11N5	HPJKCIUCZWXJDR-UHFFFAOYSA-N	4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile	n.a.	n.a.
PMDBD490	Loperamide	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	53179-11-6	DB00836	PA450262	D08144	DAP000425	3955	3818	NPC316906	loperamide; 53179-11-6; Imodium; Ioperamide; Loperamidum; Loperamida; Loperamidum [INN-Latin]; Loperamida [INN-Spanish]; Loperamide [INN:BAN]; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide; UNII-6X9OC3H4II; Maalox Anti-Diarrheal; C29H33ClN2O2; EINECS 258-416-5; R-18553; CHEMBL841; BRN 1558273; 6X9OC3H4II; 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide; CHEBI:6532; 4-(4	C29H33ClN2O2	RDOIQAHITMMDAJ-UHFFFAOYSA-N	4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide	Janssen Pharmaceutica	Antidiarrheals
PMDBD494	Loratadine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	79794-75-5	DB00455	PA450266	D00364	DAP000101	3957	3820	NPC116961	loratadine; 79794-75-5; Claritin; Loratidine; Clarityn; Alavert; Lisino; Clarityne; Loracert; Loradex; Loratyne; Fristamin; Claritine; Lorastine; Lertamine; Histaloran; Bonalerg; Civeran; Versal; Loranox; Allertidin; Polaratyne; Rinomex; Rhinase; Nularef; Claratyne; Optimin; Loritine; Anhissen; Sohotin; Sensibit; Restamine; Lorfast; Loraver; Lesidas; Clarinase; Biloina; Aerotina; Velodan; Sanelor; Lowadina; Lorantis; Loradif; Alerpriv; Lergy; Alarin; Tadine; Pylor; Zeos; Sch 29851; Sinhistan Dy; Talorat Dy; Bedix Loratadina; Claritin Reditabs; Clarinase Repera	C22H23ClN2O2	JCCNYMKQOSZNPW-UHFFFAOYSA-N	ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate	Schering-Plough Corporation	Antihistamines
PMDBD1260	Lorazepam	Therapeutic substance	Drug	846-49-1	DB00186	PA450267	D00365	DAP000237	3958	3821	n.a.	lorazepam; Ativan; o-Chloroxazepam; 846-49-1; o-Chlorooxazepam; Temesta; Tavor; Delormetazepam; Sedatival; Duralozam; Bonatranquan; Anxiedin; Almazine; Lorabenz; Idalprem; Emotival; Punktyl; Orfidal; Laubeel; Wypax; Quait; Lorax; Loraz; Apo-Lorazepam; Lorazepam Intensol; Norlormetazepam; Aplacassee; Sidenar; Novhepar; Lozepam; Lorazin; Larpose; Kalmalin; Efasedan; Azurogen; Tranqipam; Sinestron; Sedizepan; Rocosgen; Lorapam; Lorsedal; Lorazep; Lorazene; Equitam; Aplacasse; Silence; Renaquil; Loridem; Lorenin; Anzepam; Tolid; Merlit; Lorat; Loram; Bonton; Trapax	C15H10Cl2N2O2	DIWRORZWFLOCLC-UHFFFAOYSA-N	7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one	n.a.	n.a.
PMDBD495	Losartan	Therapeutic Substance	Approved Drug	114798-26-4	DB00678	PA450268	D08146	DAP000523	3961	3824	n.a.	losartan; 114798-26-4; DUP 89; Lortaan; LOSARTAN POTASSIUM; Cozaar; Hyzaar; Losartan [INN:BAN]; Losartan monopotassium salt; UNII-JMS50MPO89; C22H23ClN6O; MK-954; DuP-753; CHEBI:6541; JMS50MPO89; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol; [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]ph	C22H23ClN6O	PSIFNNKUMBGKDQ-UHFFFAOYSA-N	[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol	Merck & Co	Antihypertensive Agents
PMDBD1264	Malathion 	Environmental Chemicals	Pesticides	121-75-5	DB00772	PA164748092	D00534	DAP000895	4004	3864	n.a.	malathion; Carbophos; 121-75-5; Carbofos; Mercaptothion; Karbofos; Phosphothion; Prioderm; Maldison; Carbetox; Ethiolacar; Sadophos; Cythion; Oleophosphothion; Chemathion; Sadofos; Malagran; Fosfotion; Carbetovur; Moscarda; Malakill; Malathon; Malaspray; Malaphos; Fosfothion; Malphos; Fyfanon; Malatox; Taskil; Sumitox; Malafor; Cimexan; Malatol; Malamar; Etiol; Ovide; Emmatos extra; Ortho Malathion; Siptox I; Hilthion; Mercaptotion; Malacide; Malation; Forthion; Extermathion; Malathion E50; Malasol; Malmed; Kypfos; Malamar 50; Carbethoxy malathion; Kop-thio	C10H19O6PS2	JXSJBGJIGXNWCI-UHFFFAOYSA-N	diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate	n.a.	n.a.
PMDBD1266	Maprotiline	Therapeutic substance	Drug	10262-69-8	DB00934	PA450322	D02566	DAP001150	4011	3871	n.a.	maprotiline; 10262-69-8; Maprotylina [Polish]; Maprotilin; Maprotylina; Maprotilinum [INN-Latin]; Maprotilina [INN-Spanish]; 276-Ba; UNII-2U1W68TROF; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine; CHEBI:6690; EINECS 233-599-4; 3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine; BRN 2385493; 3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)-N-methylpropan-1-amine; 2U1W68TROF; BA-34276; BA-34276 [As Hydrochloride]; NCG	C20H23N	QSLMDECMDJKHMQ-UHFFFAOYSA-N	N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine	n.a.	n.a.
PMDBD511	Mebendazole	Therapeutic Substance	Approved Drug	31431-39-7	DB00643	PA164776669	D00368	DAP000950	4030	3890	n.a.	mebendazole; 31431-39-7; Vermox; Telmin; Mebenvet; Pantelmin; Vermirax; Ovitelmin; Mebenoazole; Mebutar; Bantenol; Lomper; MBDZ; Vermicidin; Verpanyl; Besantin; Noverme; Mebendazol; Sufil; Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate; Mebendazolum; Versid; Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester; 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester; Methyl 5-benzoyl-2-benzimidazolecarbamate; Methyl 5-benzoyl-2-benzimidazolylcarbamate; Mebendazolum [INN-Latin]; Mebendazol [INN-Spanish]; R 17635; Methyl 5-be	C16H13N3O3	OPXLLQIJSORQAM-UHFFFAOYSA-N	methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate	Janssen Pharmaceutica	Antinematodal Agents
PMDBD1271	Mefenamic Acid	Therapeutic substance	Drug	61-68-7	DB00784	PA450347	D00151	DAP000779	4044	3904	n.a.	mefenamic acid; 61-68-7; Ponstel; 2-[(2,3-dimethylphenyl)amino]benzoic acid; Ponstan; Mephenamic acid; Parkemed; Coslan; Ponalar; Mefacit; Methenamic acid; 2-((2,3-Dimethylphenyl)amino)benzoic acid; Mephenaminic acid; Mefenaminsaeure; Vialidon; Lysalgo; Tanston; Bonabol; Bafameritin-M; Tamany Bonsan; Ponstan forte; Acide mefenamique; Pontal; Namphen; Mefanamic acid; Bafhameritin-M; Ponstyl; CN-35355; Mefenacid; Ponstil; N-2,3-Xylylanthranilic acid; 2-(2,3-Dimethylanilino)benzoic acid; HL 1; Mefedolo; Mycasaal; Rolan; INF-3355; INF 3355; Acido m	C15H15NO2	HYYBABOKPJLUIN-UHFFFAOYSA-N	2-(2,3-dimethylanilino)benzoic acid	n.a.	n.a.
PMDBD517	Mefloquine	Therapeutic Substance	Approved Drug	53230-10-7	DB00358	PA450348	D04895	DAP001310	4046	3906	n.a.	mefloquine; Lariam; GNF-Pf-5544; 49752-90-1; 53230-10-7; alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; WR-142490; CHEMBL416956; CHEBI:63681; Mefloquinone; [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol; melfoquine; Mefaquin; Meflokin; rac-mefloquine; [2,8-bis(trifluoromethyl)quinolin-4-yl](piperidin-2-yl)methanol; (2,8-bis(trifluoromethyl)quinolin-4-yl)(piperidin-2-yl)methanol; EINECS 256-468-3; Ro-21-5998-001; Spectrum_001312; Spectrum5_001122; Spectrum3_000953; Prestwick3_000126; Spectrum2_001	C17H16F6N2O	XEEQGYMUWCZPDN-UHFFFAOYSA-N	[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol	n.a.	n.a.
PMDBD521	Memantine	Therapeutic Substance	Approved Drug	19982-08-2	DB01043	PA10364	D08174	DAP000493	4054	3914	n.a.	memantine; 19982-08-2; 3,5-dimethyladamantan-1-amine; 1-Amino-3,5-dimethyladamantane; Namenda; Ebixa; 3,5-Dimethyl-1-adamantanamine; Memantina; Memantinum [INN-Latin]; Memantina [INN-Spanish]; Memantin; Memantinum; 1,3-Dimethyl-5-adamantanamine; Memantine [INN]; 3,5-Dimethyl-1-aminoadamantane; Memantine [INN:BAN]; 3,5-Dimethyl-1-adamantylamine; UNII-W8O17SJF3T; HSDB 7327; 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine; CHEMBL807; 3,5-dimethyladamantanylamine; W8O17SJF3T; D-145; CHE	C12H21N	BUGYDGFZZOZRHP-UHFFFAOYSA-N	3,5-dimethyladamantan-1-amine	Merz & Co GmbH	n.a.
PMDBD1275	Menadione	Therapeutic substance	Drug	58-27-5	DB00170	PA450358	D02335	DNC001501	4055	3915	n.a.	menadione; 58-27-5; Vitamin K3; 2-Methyl-1,4-naphthoquinone; Menaphthone; 2-methylnaphthalene-1,4-dione; 2-Methylnaphthoquinone; Thyloquinone; 2-Methyl-1,4-naphthalenedione; Panosine; Klottone; Kayquinone; Kappaxin; Kayklot; Kolklot; Menaphthon; Menadion; Kipca; Kanone; Prokayvit; Kaergona; Aquinone; Mitenone; Kativ-G; Aquakay; Mitenon; Koaxin; Kaykot; Kareon; Hemodal; Synkay; Karcon; K-Thrombyl; K-Vitan; Kipca-Oil Soluble; Juva-K; Vitamin K2(0); Vitamin K0; Vitamin K 3; 2-Methyl-1,4-naphthochinon; Menaquinone 0; Menaphtone; Menadionum; Usaf ek-5185	C11H8O2	MJVAVZPDRWSRRC-UHFFFAOYSA-N	2-methylnaphthalene-1,4-dione	n.a.	n.a.
PMDBD1277	Meprobamate	Therapeutic substance	Drug	57-53-4	DB00371	PA450377	D00376	DAP001507	4064	3924	n.a.	meprobamate; Meprobamat; Meprospan; Equanil; Miltown; Meprocompren; Amepromat; Meprobam; Tranmep; Meproban; Dapaz; Neuramate; Metranquil; Meprocon; Mepantin; Lepetown; Ipsotian; Equilium; Equatrate; Carbaxin; Biobamate; Ansiatan; Anastress; Holbamate; Despasmol; Cirponyl; Biobamat; Miltamato; Meprotil; Meprotan; Meprosan; Meproleaf; Meprindon; Mepranil; Mepavlon; Margonil; Harmonin; Dicandiol; Calmadin; Auxietil; Anxietil; Ansiowas; Metractyl; Meprotabs; Meprosin; Meprodil; Mepiosine; Libiolan; Crestanil; Calmiren; Ayeramate; Andaksin; Anatimon; Anathylmon; Mi	C9H18N2O4	NPPQSCRMBWNHMW-UHFFFAOYSA-N	[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate	n.a.	n.a.
PMDBD525	Mesalazine	Therapeutic Substance	Approved Drug	89-57-6	DB00244	PA450384	D00377	DAP000729	4075	3933	n.a.	5-Aminosalicylic acid; mesalamine; Mesalazine; 5-Amino-2-hydroxybenzoic acid; 89-57-6; Asacol; Pentasa; Claversal; Canasa; 5-ASA; Salofalk; Rowasa; m-Aminosalicylic acid; Mesasal; Lialda; Fisalamine; Lixacol; Apriso; p-Aminosalicylsaeure; sfRowasa; Mesalazinum; Asacolitin; Mesalazina; 5-amino-2-hydroxy-benzoic acid; Asacol HD; Mesalazinum [Latin]; 5-Amino Salicylic Acid; Mesalamine [USAN]; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; 2-Hydroxy-5-aminobenzoic acid; 3-carbox	C7H7NO3	KBOPZPXVLCULAV-UHFFFAOYSA-N	5-amino-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD530	Metformin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	657-24-9	DB00331	PA450395	D04966	DAP000205	4091	3949	NPC230775	metformin; 657-24-9; 1,1-Dimethylbiguanide; N,N-dimethylimidodicarbonimidic diamide; Metiguanide; Metformine; Dimethylbiguanide; Haurymelin; Gliguanid; Fluamine; Flumamine; Melbin; Diabex; N,N-Dimethylbiguanide; Glumetza; Islotin; Glifage; Siofor; N1,N1-Dimethylbiguanide; DMGG; NNDG; Dimethyldiguanide; N,N-Dimethyldiguanide; Metformina [DCIT]; Metformina [Spanish]; Metforminum [INN-Latin]; Metformine [INN-French]; Metformin [USAN:INN:BAN]; 1,1-Dimethyl biguanide; LA-6023; BIGUANIDE, 1,1-DIMETHY	C4H11N5	XZWYZXLIPXDOLR-UHFFFAOYSA-N	3-(diaminomethylidene)-1,1-dimethylguanidine	Bristol-Myers Squibb	Hypoglycemic Agents
PMDBD1283	Methazolamide	Therapeutic substance	Drug	554-57-4	DB00703	PA450413	D00655	DAP000599	4100	21122102	n.a.	methazolamide; 554-57-4; Neptazane; Methenamide; Neptazaneat; Naptazane; Metazolamide [DCIT]; N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide; Methazolamidum [INN-Latin]; Metazolamida [INN-Spanish]; UNII-W733B0S9SD; (Z)-methazolamide; CHEBI:6822; C5H8N4O3S2; HSDB 3269; EINECS 209-066-7; L584601; BRN 0232387; UNII-DA43GW06P1; MLS000028532; CHEMBL288100; W733B0S9SD; DA43GW06P1; Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylide	C5H8N4O3S2	FLOSMHQXBMRNHR-UHFFFAOYSA-N	N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide	n.a.	n.a.
PMDBD1286	Methocarbamol	Therapeutic substance	Drug	532-03-6	DB00423	PA164749506	D00402	n.a.	4107	3964	n.a.	methocarbamol; 532-03-6; Robaxin; Lumirelax; Parabaxin; Metocarbamolo; Relestrid; Myolaxene; Miolaxene; Metofenia; Tresortil; Romethocarb; Etroflex; Surquetil; Reflexyn; Neuraxin; Methocal; Miorilas; Metocarbamol; Miowas; Robinax; Delaxin; Avetil; Perilax; Metofenina; Guaiacol glyceryl ether carbamate; Guaiphenesin carbamate; Guaiphenesine carbamate; Glycerylguaiacolate carbamate; Glycerylguajacol-carbamat; Forbaxin; AHR 85; 2-Hydroxy-3-(2-methoxyphenoxy)propyl carbamate; Methocarbamolum; Robaxine; Robaxan; Robaxon; 1,2-Propanediol, 3-(2-metho	C11H15NO5	GNXFOGHNGIVQEH-UHFFFAOYSA-N	[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate	n.a.	n.a.
PMDBD537	Methoxsalen	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	298-81-7	DB00553	PA450433	D00139	DAP000996	4114	3971	NPC33320	methoxsalen; 8-Methoxypsoralen; 298-81-7; XANTHOTOXIN; Ammoidin; Meladinine; Xanthotoxine; 8-MOP; Oxsoralen; Meloxine; Meladinin; Oxypsoralen; Puvalen; 9-Methoxy-7H-furo[3,2-g]chromen-7-one; Meladoxen; Ammodin; Uvadex; Methoxa-Dome; 8-Methoxypsoralene; Oxsoralen-ultra; New-Meladinin; Methoxalen; Geroxalen; Puvamet; Oxsoralen lotion; Zanthotoxin; Oxsoralen Ultra; 9-methoxyfuro[3,2-g]chromen-7-one; Psoralon-MOP; 9-Methoxypsoralen; 8-MP; 8-Methoxyfuranocoumarin; Proralone-mop; 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one; O-methylxanthotoxol; Me	C12H8O4	QXKHYNVANLEOEG-UHFFFAOYSA-N	9-methoxyfuro[3,2-g]chromen-7-one	n.a.	Anticancer Agents
PMDBD541	Methylphenidate	Therapeutic Substance	Approved Drug	113-45-1	DB00422	PA450464	D04999	DAP000024	4158	4015	n.a.	methylphenidate; Methylphenidan; Phenidylate; Concerta; Calocain; Plimasine; Meridil; Methyl phenidate; Methyl phenidylacetate; 113-45-1; Ritalin; Metilfenidato [Italian]; Methylfenidan; Methylphenidatum; Metilfenidato [INN-Spanish]; Methylphenidatum [INN-Latin]; 4311/B Ciba; Methyl phenidyl acetate; methyl phenyl(piperidin-2-yl)acetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; alpha-Phenyl-2-piperidineacetic acid methyl ester; NCI-C56280; HSDB 3126; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester; Methyl (2-phenyl-2-(	C14H19NO2	DUGOZIWVEXMGBE-UHFFFAOYSA-N	methyl 2-phenyl-2-piperidin-2-ylacetate	Novartis	Central Nervous System Stimulants
PMDBD1289	Metoclopramide	Therapeutic substance	Drug	364-62-5	DB01233	PA450475	D00726	DAP000530	4168	4024	n.a.	metoclopramide; 364-62-5; Methochlopramide; Metochlopramide; Primperan; Reliveran; Metaclopramide; Reglan; Metaclopromide; Moriperan; Metoclol; Plasil; Maxolon; 2-Methoxy-5-chloroprocainamide; Metoclopramida; 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; Methoclopramide; Metoclopramidum; Elieten; Plasil (pharmaceutical); Metoclopramidum [INN-Latin]; Metoclopramida [INN-Spanish]; Cerucal; 5-Chloro-2-methoxyprocainamide; Clopra; 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide; Metocobil; Maxeran; Gastromax	C14H22ClN3O2	TTWJBBZEZQICBI-UHFFFAOYSA-N	4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide	n.a.	n.a.
PMDBD1290	Metolazone	Therapeutic substance	Drug	17560-51-9	DB00524	PA164781022	D00431	DAP000749	4170	4026	n.a.	metolazone; 17560-51-9; Zaroxolyn; Diulo; Mykrox; Microx; Metalozone; Oldren; Metenix; 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide; Metolazonum; Metolazona; Metolazonum [INN-Latin]; Metolazona [INN-Spanish]; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; SR-720-22; SR 720-22; Metolazone (Zaroxolyn); 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide	C16H16ClN3O3S	AQCHWTWZEMGIFD-UHFFFAOYSA-N	7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide	n.a.	n.a.
PMDBD546	Metronidazole	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	443-48-1	DB00916	PA450484	D00409	DAP000534	4173	4029	NPC332382	metronidazole; 443-48-1; Flagyl; Metronidazol; 2-Methyl-5-nitroimidazole-1-ethanol; Anagiardil; Trichazol; MetroGel; Novonidazol; Metronidaz; Gineflavir; Trivazol; Trichopol; Meronidal; Danizol; Mexibol; Vagilen; Clont; Bayer 5360; Giatricol; 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethanol; Trikacide; Trichomol; Sanatrichom; Flagemona; Trichocide; Takimetol; Metronidazolo; Tricocet; Efloran; Acromona; Trimeks; Trikamon; Monasin; Monagyl; Wagitran; Vagimid; Trikozol; Orvagil; Entizol; Deflamon; Atrivyl; Vertisal; Trikojol; Trichex; Flagesol; Tricom; Nalox	C6H9N3O3	VAOCPAMSLUNLGC-UHFFFAOYSA-N	2-(2-methyl-5-nitroimidazol-1-yl)ethanol	Pfizer Pharmaceuticals	Antiinfective Agents
PMDBD1292	Metyrapone	Therapeutic substance	Drug	54-36-4	DB01011	PA450486	D00410	DAP000424	4174	4030	n.a.	metyrapone; 54-36-4; 2-Methyl-1,2-di-3-pyridyl-1-propanone; Metopirone; Methopyrapone; Metopiron; Methopyrinine; Methopirapone; Methapyrapone; Metyrapon; Methopyrone; Methbipyranone; Metopyrone; Mepyrapone; Metroprione; Metapyron; Metirapona; Metyraponum; Metapirone; Su 4885; 2-methyl-1,2-dipyridin-3-ylpropan-1-one; Metyraponum [INN-Latin]; Metirapona [INN-Spanish]; 2-Methyl-1,2-di-3-pyridinyl-1-propanone; UNII-ZS9KD92H6V; 2-Methyl-1,2-bis(3-pyridyl)-1-propanone; NSC 25265; 1,2-Di-3-pyridyl-2	C14H14N2O	FJLBFSROUSIWMA-UHFFFAOYSA-N	2-methyl-1,2-dipyridin-3-ylpropan-1-one	n.a.	n.a.
PMDBD1293	Mexiletine	Therapeutic substance	Drug	31828-71-4	DB00379	PA450488	n.a.	DAP000505	4178	4034	n.a.	Mexiletine; 31828-71-4; 1-(2,6-dimethylphenoxy)propan-2-amine; Mexitil; Mexiletina; Mexilitine; Mexiletinum; Mexiletinum [INN-Latin]; Mexiletina [INN-Spanish]; 1-(2,6-Dimethylphenoxy)-2-propanamine; Mexiletine [INN:BAN]; 1-Methyl-2-(2,6-xylyloxy)ethylamine; 2-(2-aminopropoxy)-1,3-dimethylbenzene; 1-(2',6'-Dimethylphenoxy)-2-aminopropane; EINECS 250-825-7; CHEMBL558; 1-methyl-2-(2,6-xylyloxy)ethanamine; BRN 2092205; 1-(2,6-Dimethylphenoxy)-2-aminop	C11H17NO	VLPIATFUUWWMKC-UHFFFAOYSA-N	1-(2,6-dimethylphenoxy)propan-2-amine	n.a.	n.a.
PMDBD548	Miconazole	Therapeutic Substance	Approved Drug	22916-47-8	DB01110	PA450494	D00882	DAP000154	4189	4044	n.a.	miconazole; 22916-47-8; Monistat; Monistat IV; Daktarin IV; Miconazol; Miconazolum; Miconazolo; Minostate; Dactarin; MJR 1762; Miconazolum [INN-Latin]; Vusion; Miconazolo [DCIT]; Monistat-Derm; Florid(nitrate); 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole; Miconazol [INN-Spanish]; Brentan; R 18134; 1-(2-((2,4-Dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole; Miconazole 3; NSC 170986; C18H14Cl4N2O; 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole; CCRIS 7924; Micona	C18H14Cl4N2O	BYBLEWFAAKGYCD-UHFFFAOYSA-N	1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole	Janssen Pharmaceutica	Antifungal Agents
PMDBD1297	Mirtazapine	Therapeutic substance	Drug	85650-52-8	DB00370	PA450522	D00563	DAP000010	4205	4060	n.a.	mirtazapine; 85650-52-8; Remeron; Remergil; Mepirzepine; Zispin; 61337-67-5; Remergon; Mirtazepine; Rexer; 6-Azamianserin; Remeron SolTab; Mirtazipine; Mepirzapin; Promyrtil; Norset; Mirtazapina; Avanza; ORG 3770; Mirtazapinum; Mirtazapinum [INN-Latin]; Mirtazapina [INN-Spanish]; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; Org-3770; Mirtazapine [USAN:INN:BAN]; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; EINECS 288-060-6; CHEMBL654; 1,2,3,4,10,14b-Hexahydro-2-methylpyraz	C17H19N3	RONZAEMNMFQXRA-UHFFFAOYSA-N	5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene	n.a.	n.a.
PMDBD554	Mitotane	Therapeutic Substance	Approved Drug	53-19-0	DB00648	PA164746157	D00420	DAP000033	4211	4066	n.a.	mitotane; 53-19-0; Mitotan; Lysodren; o,p'-DDD; Chlodithane; Chloditan; Khlodithan; Chlodithan; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 2,4'-Ddd; Mitotano; 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene; NCI-C04933; Mitotanum [INN-Latin]; o,p'-TDE; 2,4'-Dichlorodiphenyldichloroethane; o,p-Tde; o,p'-Dichlorodiphenyldichloroethane; Mitotano [INN-Spanish]; 2,4'-Dichlorophenyldichlorethane; CB313; 1-Chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)	C14H10Cl4	JWBOIMRXGHLCPP-UHFFFAOYSA-N	1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene	Bristol Myers Squibb	Anticancer Agents
PMDBD1300	Mitoxantrone	Therapeutic substance	Drug	65271-80-9	DB01204	PA450526	D08224	DAP000057	4212	4067	n.a.	mitoxantrone; 65271-80-9; Mitozantrone; Mitoxanthrone; DHAQ; Dihydroxyanthraquinone; Mitoxantron; Novantrone; Mitoxantrona; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitoxantrona [INN-Spanish]; Mitoxantrone [INN]; NSC 279836; UNII-BZ114NVM5P; DHAD; NSC279836; NSC-279836; Mitoxantrone (INN); CCRIS 7604; 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; C22H28N4O6; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; BRN 2795126; BZ114NVM5P; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino	C22H28N4O6	KKZJGLLVHKMTCM-UHFFFAOYSA-N	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	n.a.	n.a.
PMDBD1302	Modafinil	Therapeutic substance	Drug	68693-11-8	DB00745	PA450530	D01832	n.a.	4236	4088	n.a.	modafinil; 68693-11-8; Provigil; Modiodal; 2-[(diphenylmethyl)sulfinyl]acetamide; Modafinilum [Latin]; 2-(Benzhydrylsulfinyl)acetamide; Modafinilo [Spanish]; Alertec; CRL 40476; Modafinil [USAN:INN]; (+-)-Modafinil; 2-benzhydrylsulfinylacetamide; CRL-40476; 2-((Diphenylmethyl)sulfinyl)acetamide; Modavigil; CEP 1538; CHEMBL1373; C15H15NO2S; DEA No. 1680; CHEBI:77585; 2-(diphenylmethyl)sulfinylacetamide; CEP-1538; 2-(Diphenyl-methanesulfinyl)-acetamide; NCGC00095176-03; Sparlon; DSSTox_CID_3329	C15H15NO2S	YFGHCGITMMYXAQ-UHFFFAOYSA-N	2-benzhydrylsulfinylacetamide	n.a.	n.a.
PMDBD565	Nabumetone	Therapeutic Substance	Approved Drug	42924-53-8	DB00461	PA450572	D00425	DAP000735	4409	4256	n.a.	nabumetone; 42924-53-8; Relafen; 4-(6-methoxynaphthalen-2-yl)butan-2-one; Arthaxan; Nabumetona; Relifex; Relifen; Listran; 4-(6-Methoxy-2-naphthyl)-2-butanone; nabumeton; Mebutan; Consolan; Balmox; Relif; Flambate; Unimetone; Dolsinal; Prodac; Nabumetonum [INN-Latin]; Nabumetonum; Nabuser; 4-(6-Methoxy-2-naphthalenyl)-2-butanone; BRL-14777; UNII-LW0TIW155Z; BRL 14777; MLS000069541; 4-(2-Methoxynaphthalen-6-yl)butan-2-one; BRL14777; BRN 2103472; LW0TIW155Z; SMR000058835; CHEBI:7443; NCGC00016853-01	C15H16O2	BLXXJMDCKKHMKV-UHFFFAOYSA-N	4-(6-methoxynaphthalen-2-yl)butan-2-one	Nobex Corp	n.a.
PMDBD566	Nadifloxacin	Therapeutic Substance	Approved Drug	124858-35-1	DB12447	n.a.	n.a.	n.a.	4410	4257	n.a.	nadifloxacin; 124858-35-1; OPC-7251; Nadixa; Acuatim; S-Nadifloxacin; Opc 7251; Nadifloxacine [INN-French]; Nadifloxacinum [INN-Latin]; Nadifloxacino [INN-Spanish]; jinofloxacin; NDFX; CCRIS 4066; C19H21FN2O4; CHEBI:31889; NCGC00164620-01; Nadifloxacino; Nadifloxacinum; Nadifloxacine; DSSTox_RID_81654; DSSTox_CID_26483; DSSTox_GSID_46483; 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid; 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy	C19H21FN2O4	JYJTVFIEFKZWCJ-UHFFFAOYSA-N	7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid	n.a.	n.a.
PMDBD569	Naftopidil	Therapeutic Substance	Approved Drug	57149-07-2	DB12092	n.a.	n.a.	n.a.	4418	4265	n.a.	naftopidil; 57149-07-2; KT-611; Flivas; Naftopidil [INN]; Avishot; Naftopidilum [Latin]; Naftopidil (Flivas); BM-15275; Naftopidil (unspecified); BRN 0629965; 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol; CHEMBL142635; C24H28N2O3; 4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol; NCGC00015718-06; (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol; (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol; 4-(2-Methoxyphenyl)-alpha-((1-naphtha	C24H28N2O3	HRRBJVNMSRJFHQ-UHFFFAOYSA-N	1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol	n.a.	n.a.
PMDBD1308	Nalidixic acid	Therapeutic substance	Antibiotics	389-08-2	DB00779	PA164746384	D00183	DAP000817	4421	4268	n.a.	nalidixic acid; 389-08-2; Nalidixin; Nalidixate; Nevigramon; Uronidix; Nalidixan; Innoxalon; Nalitucsan; Unaserus; Sicmylon; NegGram; Nalidic acid; Nalidixinic acid; Wintomylon; Nogram; Naxuril; Jicsron; Urisal; Dixinal; Dixiben; Nalurin; Cybis; Nalix; 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; Nalidicron; Urodixin; Uriclar; Uralgin; Kusnarin; Betaxina; Nicelate; Narigix; Specifin; Specifen; Negram; Uroman; Uriben; Uropan; Uroneg; Poleon; Naldixic acid; Acide nalidixique; Eucistin; Acido nalidixico; Acide nalidixico; Acidum	C12H12N2O3	MHWLWQUZZRMNGJ-UHFFFAOYSA-N	1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid	n.a.	n.a.
PMDBD1311	Naratriptan	Therapeutic substance	Drug	121679-13-8	DB00952	PA450597	D08255	DAP000890	4440	4287	n.a.	naratriptan; 121679-13-8; N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide; UNII-QX3KXL1ZA2; N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; QX3KXL1ZA2; CHEMBL1278; N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide; CHEBI:7478; Colatan; naratriptanum; Naramig (TN); Naratriptan (INN); NCGC00181786-01; Naratriptan [INN:BAN]; PubChem2191; GTPL45; SCHEMBL68753; BIDD:GT0312; ZINC4076; DTXSID7023354; HY-B	C17H25N3O2S	AMKVXSZCKVJAGH-UHFFFAOYSA-N	N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide	n.a.	n.a.
PMDBD1313	Nefazodone	Therapeutic substance	Drug	83366-66-9	DB01149	PA450603	D08257	DAP000042	4449	4294	n.a.	nefazodone; 83366-66-9; Nefazodonum [Latin]; Nefazodona [Spanish]; Nefazodona; Nefazodonum; Nefazodone [INN:BAN]; UNII-59H4FCV1TF; 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one; CHEMBL623; 59H4FCV1TF; CHEBI:7494; Nefadar; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; 1-(3-(4-(3-Chlorpheyl-1-piperazinylpropyl)-3-ethyl-4,5-dihydro-4-(2-phenoxyethyl)-1,2,4-triazol-5-on	C25H32ClN5O2	VRBKIVRKKCLPHA-UHFFFAOYSA-N	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one	n.a.	n.a.
PMDBD582	Nevirapine	Therapeutic Substance	Approved Drug	129618-40-2	DB00238	PA450616	D00435	DAP000184	4463	4308	n.a.	nevirapine; 129618-40-2; Viramune; BI-RG-587; Nevirapine anhydrous; Viramune XR; NVP; BIRG 0587; 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; UNII-99DK7FVK1H; 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE; 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one; Nevirapine (Viramune); BIRG-0587; HSDB 7164; CHEMBL57; NEV; NSC 641530; 99DK7FVK1H; 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE; 11-Cyc	C15H14N4O	NQDJXKOVJZTUJA-UHFFFAOYSA-N	2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one	Boehringer Ingelheim	Anti-HIV Agents
PMDBD1318	Nicardipine	Therapeutic substance	Drug	55985-32-5	DB00622	PA450620	n.a.	DAP000486	4474	4319	n.a.	nicardipine; 55985-32-5; Nicardipinum; Nicardipinum [INN-Latin]; Nicardipino [INN-Spanish]; Nicardipine [INN:BAN]; Cardene; CHEBI:7550; C26H29N3O6; EINECS 259-932-3; Cardene (TN); BRN 0504321; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-di	C26H29N3O6	ZBBHBTPTTSWHBA-UHFFFAOYSA-N	5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	n.a.	n.a.
PMDBD586	Niclosamide	Therapeutic Substance	Approved Drug	50-65-7	DB06803	PA165958408	D00436	n.a.	4477	4322	n.a.	niclosamide; 50-65-7; Niclocide; 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide; Tredemine; Phenasal; Bayluscid; Fenasal; Yomesan; Helmiantin; Dichlosale; Atenase; Devermin; Cestocid; Vermitid; Radeverm; Mansonil; Iomesan; Sagimid; Iomezan; Devermine; Nasemo; Sulqui; Lintex; 2',5-Dichloro-4'-nitrosalicylanilide; Mato; Fedal-Telmin; Bayer 73; Zestocarp; Radewerm; Bayer 2353; Chemagro 2353; BAY 2353; C13H8Cl2N2O4; 5-Chloro-2'-chloro-4'-nitrosalicylanilide; nicolsamide; HL 2447; WR	C13H8Cl2N2O4	RJMUSRYZPJIFPJ-UHFFFAOYSA-N	5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide	n.a.	n.a.
PMDBD588	Nifedipine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	21829-25-4	DB01115	PA450631	D00437	DAP000529	4485	4330	NPC190945	nifedipine; 21829-25-4; Adalat; Procardia; Procardia XL; Cordipin; Corinfar; Adalat CC; Fenihidine; Oxcord; Citilat; Fenihidin; dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nifediac; Adalate; Bay-a-1040; Afeditab CR; Hexadilat; Nifedical; Introcar; Coracten; Tibricol; Kordafen; Pidilat; Sepamit; Anifed; Adapine; Zenusin; Orix; Adalat LA; Nifedipinum; Afeditab; Nifedipino; 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester; Adipine XL; 3,5-Pyridinedicarboxylic acid, 1,4-di	C17H18N2O6	HYIMSNHJOBLJNT-UHFFFAOYSA-N	dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	Bayer	Analgesics
PMDBD591	Nilutamide	Therapeutic Substance	Approved Drug	63612-50-0	DB00665	PA450632	D00965	DAP000302	4493	4337	n.a.	nilutamide; 63612-50-0; Anandron; Nilandron; Nilandrone; 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione; Nilutamidum; Nilutamida; 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione; Nilutamidum [Latin]; Nilutamida [Spanish]; RU-23908; Nilutamide [USAN:INN:BAN]; RU 23908; RU 23908-10; 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin; UNII-51G6I8B902; C12H10F3N3O4; BRN 0841906; CHEMBL1274; CHEBI:7573; 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imid	C12H10F3N3O4	XWXYUMMDTVBTOU-UHFFFAOYSA-N	5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione	Aventis Pharmaceuticals Inc.	Anticancer Agents
PMDBD592	Nimesulide	Therapeutic Substance	Approved Drug	51803-78-2	DB04743	PA137179528	D01049	DPR000079	4495	4339	n.a.	nimesulide; 51803-78-2; N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide; Mesulid; Aulin; Flogovital; Sulidene; Nimed; R-805; 4-NITRO-2-PHENOXYMETHANESULFONANILIDE; Nisulid; Nimesulidum [INN-Latin]; Nimesulida [INN-Spanish]; R 805; UNII-V4TKW1454M; 4-Nitro-2-phenoxy-methanesulfonanilide; 4'-Nitro-2'-phenoxymethanesulfonanilide; EINECS 257-431-4; 4'-Nitro-2'-phenoxymethansulfonanilid; BRN 2421175; CHEMBL56367; MLS000069680; V4TKW1454M; CHEBI:4	C13H12N2O5S	HYWYRSMBCFDLJT-UHFFFAOYSA-N	N-(4-nitro-2-phenoxyphenyl)methanesulfonamide	n.a.	n.a.
PMDBD593	Nimodipine	Therapeutic Substance	Approved Drug	66085-59-4	DB00393	PA450633	D00438	DAP000306	4497	4341	n.a.	nimodipine; 66085-59-4; Nimotop; Periplum; Nimodipino; Nimodipinum; Admon; Nimodipinum [INN-Latin]; Nimodipino [INN-Spanish]; BAY e 9736; Bay-e-9736; Bay-E 9736; Nimodipine-d7; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; DRG-0139; CHEBI:7575; Nimodipine (Nimotop); 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester; EINECS 266-127-0; BRN 0459792; MLS000863294; 3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl	C21H26N2O7	UIAGMCDKSXEBJQ-UHFFFAOYSA-N	3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	Bayer Pharmaceuticals Corporation	Vasodilator Agents
PMDBD1321	Nisoldipine	Therapeutic substance	Drug	63675-72-9	DB00401	PA450634	D00618	DAP000595	4499	4343	n.a.	nisoldipine; 63675-72-9; Sular; Nisocor; Zadipina; Nisoldipinum; Baymycard; Syscor; Nisoldipinum [INN-Latin]; Nisoldipino [INN-Spanish]; Bay k 5552; 3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Bay-k-5552; BAY-k 5552; CHEBI:76917; methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; EINECS 264-407-7; BRN 0454188; CHEMBL441428; Nisoldipin; Nisoldipino; C20H24N2O6; (+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarbox	C20H24N2O6	VKQFCGNPDRICFG-UHFFFAOYSA-N	3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	n.a.	n.a.
PMDBD595	Nitrazepam	Therapeutic Substance	Approved Drug	146-22-5	DB01595	PA10242	D00531	DAP000691	4506	4350	n.a.	nitrazepam; 146-22-5; Benzalin; Neozepam; Remnos; Mogadon; Imeson; Neuchlonic; Nitrados; Eunoctin; Apodorm; Imesont; Calsmin; Trazenin; Sonebon; Radedorm; Surem; Hipsal; Nelmat; Hipnax; Epibenzalin; Unisomnia; Epinelbon; Sonnolin; Somitran; Nitrenpax; Pelson; Paxisyn; Nelbon; Dumolid; Relact; Cerson; N-Desmethylnimetazepam; Persopit; Ibrovek; Gerson; Eatan; Dormo-Puren; Dormin-5; Mitidin; Eatan N; 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; Nitrazepamum; Mogadone; Megadon; Magadon; Mogadan; Nitrazepamum [INN-Latin]; Ro 4-5360; LA 1	C15H11N3O3	KJONHKAYOJNZEC-UHFFFAOYSA-N	7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	n.a.	Antianxiety Agents
PMDBD596	Nitrendipine	Therapeutic Substance	Approved Drug	39562-70-4	DB01054	PA146096020	D00629	DAP001263	4507	4351	n.a.	nitrendipine; 39562-70-4; Baypress; Bayotensin; Nidrel; Nitrendipin; Nitrendipinum; Nitrendipino; Bylotensin; Deiten; Bay-e-5009; BAY e 5009; Nitrendipinum [INN-Latin]; Nitrendipino [INN-Spanish]; 3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester; CHEBI:7582; EINECS 254-513-1; BRN 0498823; MLS000069349; C18H20N2O6; MFCD00082255	C18H20N2O6	PVHUJELLJLJGLN-UHFFFAOYSA-N	5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	n.a.	Antihypertensive Agents
PMDBD600	Nitroglycerin	Therapeutic Substance	Approved Drug	55-63-0	DB00727	PA450644	D00515	DNC001024	4510	4354	n.a.	nitroglycerin; Glyceryl trinitrate; Trinitroglycerin; Nitroglycerol; Nitroglycerine; Nitrostat; Trinitroglycerol; Glycerol trinitrate; Nitro-dur; 55-63-0; Minitran; Nitroderm; Nitroglyn; Nitrospan; Nitronet; Tridil; Transderm-nitro; Transderm Nitro; Sustonit; Nitrocine; Epinitril; Susadrin; Perlinganit; Nitrolingual; Nitrolan; Trinitrin; Natispray; Lenitral; Nitrong; Niong; Nitro-Bid; Nitroderm TTS; Nitroretard; Nitroplast; Corditrine; Trinitrosan; Rectogesic; Nitroglicerina; Cordipatch; Perglottal; Nitrorectal; Gilustenon; Trinitrolong; Temponitrin	C3H5N3O9	SNIOPGDIGTZGOP-UHFFFAOYSA-N	1,3-dinitrooxypropan-2-yl nitrate	n.a.	Vasodilator Agents
PMDBD607	Norfloxacin	Therapeutic Substance	Approved Drug	70458-96-7	DB01059	PA450654	D00210	DAP000654	4539	4380	n.a.	norfloxacin; 70458-96-7; Norfloxacine; Noroxin; Chibroxin; Baccidal; Sebercim; MK-366; Norfloxacinum; Norfloxacino; Barazan; Fulgram; NFLX; AM-715; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; Lexinor; Zoroxin; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Norfloxacine [INN-French]; Norfloxacinum [INN-Latin]; Norfloxacino [INN-Spanish]; AM 715; MK-0366; MK 0366; 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid; 1,4-Dihydro-1-ethyl	C16H18FN3O3	OGJPXUAPXNRGGI-UHFFFAOYSA-N	1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid	n.a.	Antibiotics
PMDBD1323	Nortriptyline	Therapeutic substance	Drug	72-69-5	DB00540	PA450657	D08288	DAP001152	4543	4384	n.a.	nortriptyline; Aventyl; Desmethylamitriptyline; Desitriptilina; Sensaval; Noritren; 72-69-5; Ateben; Avantyl; Noramitriptyline; Demethylamitriptyline; Lumbeck; Pamelor; Nortryptiline; Nortryptyline; Demethylamitryptyline; Nortriptylinum; Psychostyl; Nortriptilina [DCIT]; Nortriptyline [INN:BAN]; Vividyl; Acetexa; Nortriptylinum [INN-Latin]; UNII-BL03SY4LXB; CCRIS 9175; 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methyl	C19H21N	PHVGLTMQBUFIQQ-UHFFFAOYSA-N	N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine	n.a.	n.a.
PMDBD611	Ofloxacin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	82419-36-1	DB01165	PA450684	D00453	DAP000655	4583	4422	NPC330683	ofloxacin; 82419-36-1; Floxin; Ofloxacine; Tarivid; Oxaldin; Oflocet; Visiren; Ocuflox; OFLX; Ofloxacino; Ofloxacinum; Exocin; Hoe-280; DL-8280; Ofloxacin Otic; Floxin otic; Ofloxacina [DCIT]; Ofloxacinum [Latin]; Ofloxacine [French]; Ofloxacino [Spanish]; HOE 280; FLOXIN IN DEXTROSE 5%; DL 8280; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; DL-ofloxacin; PT 01; ORF 18489; CHEBI:7731; CCRIS 5233	C18H20FN3O4	GSDSWSVVBLHKDQ-UHFFFAOYSA-N	7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid	Janssen Pharmaceutica	Antibiotics
PMDBD614	Olanzapine	Therapeutic Substance	Approved Drug	132539-06-1	DB00334	PA450688	D00454	DAP000022	135398745	10442212	n.a.	olanzapine; 132539-06-1; Zyprexa; Zyprexa Zydis; Olansek; Zalasta; Zyprexa Intramuscular; Zyprexa Velotab; LY-170053; 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine; Zypadhera; Lanzac; LY 170053; 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Olanzapin; UNII-N7U69T4SZR; LY170053; C17H20N4S; 2-methyl-4-(4-methylpiperazin-1-yl	C17H20N4S	KVWDHTXUZHCGIO-UHFFFAOYSA-N	2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine	Eli Lilly	Antipsychotic Agents
PMDBD619	Omeprazole	Therapeutic Substance	Approved Drug	73590-58-6	DB00338	PA450704	D00455	DAP000180	4594	4433	n.a.	omeprazole; 73590-58-6; Losec; Prilosec; Antra; Esomeprazole; Omeprazon; Audazol; Zegerid; Parizac; Omepral; Omapren; Mopral; Miol; Logastric; Indurgan; Gastroloc; Epirazole; Emeproton; Ceprandal; Sanamidol; Prazidec; Secrepina; Peptilcer; Inhibitron; Gibancer; Dudencer; Dizprazol; Ulcometion; Pepticum; Inhipump; Gastrimut; Belmazol; Zefxon; Ompanyt; Omeprol; Miracid; Mepral; Ulcozol; Ulcesep; Omizac; Zoltum; Ramezol; Prysma; Omisec; Omezol; Ulceral; Ozoken; Ultop; Ulsen; Lomac; Elgam; Zimor; Desec; Omid; Omed; Ocid; OMEP; Prazolit; Pepticus; Paprazol; Omezolan; Nopra	C17H19N3O3S	SUBDBMMJDZJVOS-UHFFFAOYSA-N	6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole	AstraZeneca	Antiulcer Agents
PMDBD1331	Ondansetron	Therapeutic substance	Drug	99614-02-5	DB00904	PA450705	D00456	DAP000221	4595	4434	n.a.	ondansetron; 99614-02-5; Zofran; Zudan; Zophren; 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one; Zofran ODT; Zuplenz; ondansetron (Zofran); 116002-70-1; GR 38032X; GR-38032F; 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one; GR 38032; BRN 3622981; CHEBI:7773; C18H19N3O; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one; 1,2,3,9-Tetrahydro-9-methyl-3-((	C18H19N3O	FELGMEQIXOGIFQ-UHFFFAOYSA-N	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one	n.a.	n.a.
PMDBD628	Oxaprozin	Therapeutic Substance	Approved Drug	21256-18-8	DB00991	PA450730	D00463	DAP000622	4614	4453	n.a.	oxaprozin; 21256-18-8; Daypro; 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid; Alvo; 3-(4,5-Diphenyloxazol-2-yl)propanoic acid; Oxaprozinum; Oxaprozine; Deflam; Voir; Oxaprozine [INN-French]; Oxaprozinum [INN-Latin]; WY-21743; Oxaprozina [INN-Spanish]; Oxaprozina; 4,5-Diphenyl-2-oxazolepropionic acid; WY-21,743; 4,5-Diphenyl-2-oxazolepropanoic acid; WY 21743; NSC310839; Oxaprozinum;Wy21743; 3-(4,5-Diphenyl-2-oxazolyl)propenoic acid; beta-(4,5-Diphenyloxazol-2-yl)propionic acid; UNII-MHJ80W9L	C18H15NO3	OFPXSFXSNFPTHF-UHFFFAOYSA-N	3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid	Gd Searle Llc	Antiinflammatory Agents
PMDBD1336	Oxazepam	Therapeutic substance	Drug	604-75-1	DB00842	PA450731	D00464	DAP000243	4616	4455	n.a.	oxazepam; Tazepam; Serax; Adumbran; 604-75-1; Droxacepam; Ansioxacepam; Praxiten; Noctazepam; Quilibrex; Anxiolit; Durazepam; Psiquiwas; Nesontil; Zaxopam; Drimuel; Serpax; Sobril; Seresta; Serenal; Sedigoa; Rondar; Pacienx; Murelax; Limbial; Isodin; Bonare; Aplakil; Serepax; Serenid; Propax; Astress; Vaben; Hi-Long; Nortemazepam; Azutranquil; Sigacalm; Psicopax; Uskan; (RS)-Oxazepam; Tarchomin; Nozepam; (+-)-Oxazepam; Serenid-D; Lederpam; Oxazepamum; Abboxapam; Oxozepam; Tacepam; Oxanid; Alepam; Anxiolit retard; QUEN; Tranquo-buscopan-wirkstoff; Oxa-puren; Z10	C15H11ClN2O2	ADIMAYPTOBDMTL-UHFFFAOYSA-N	7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one	n.a.	n.a.
PMDBD639	Pantoprazole	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	102625-70-7	DB00213	PA450774	D05353	DAP000724	4679	4517	NPC316756	pantoprazole; 102625-70-7; Protonix; Pantozol; Pantoprazol; Pantoprazolum; BY-1023; Pantoloc; Pantoprazolum [INN-Latin]; Pantoprazol [INN-Spanish]; SK&amp;F-96022; BY 1023; SK&amp;F 96022; Protonix I.V.; SKF-96022; Pantozol Control; SK-96022; C16H15F2N3O4S; HSDB 7292; CHEMBL1502; 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole; CHEBI:7915; Pantoprazole sodium hydrate; 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl	C16H15F2N3O4S	IQPSEEYGBUAQFF-UHFFFAOYSA-N	6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole	Wyeth; Altana; Solvay	Antiulcer Agents
PMDBD640	Papaverine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	58-74-2	DB01113	PA164745550	D07425	DAP000959	4680	4518	NPC195268	papaverine; Papaverin; Papanerine; Robaxapap; 58-74-2; Papanerin; Pavabid; 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline; Papaverina; Papaverine [BAN]; 6,7-Dimethoxy-1-veratrylisoquinoline; Papaverina [Italian]; NSC 136630; UNII-DAA13NKG2Q; S-M-R; Papaverine (BAN); 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline; 1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline; EINECS 200-397-2; DAA13NKG2Q; BRN 0312930	C20H21NO4	XQYZDYMELSJDRZ-UHFFFAOYSA-N	1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline	n.a.	Vasodilator Agents
PMDBD650	Pentobarbital	Therapeutic Substance	Approved Drug	76-74-4	DB00312	PA450859	D00499	DAP000671	4737	4575	n.a.	pentobarbital; Pentobarbitone; Nembutal; Mebubarbital; Ethaminal; Mebumal; Pentobarbituric acid; Neodorm; Rivadorm; Dorsital; Nebralin; Pentobarbiturate; 76-74-4; Pentabarbitone; Neodorm (new); Pentabarbital; Pentobarbitalum; Aethaminalum; 5-Ethyl-5-(sec-pentyl)barbituric acid; 5-Ethyl-5-(1-methylbutyl)barbituric acid; Nembutal (VAN); Neodorm (VAN); Pentobarbital (VAN); Pentobarbitone (VAN); Pentobarbitale [DCIT]; 5-Ethyl-5-(1-methylbutyl)malonylurea; 5-Ethyl-5-(1-methylbu	C11H18N2O3	WEXRUCMBJFQVBZ-UHFFFAOYSA-N	5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione	Oak Pharmaceuticals Inc	Hypnotics and Sedatives
PMDBD1355	Pentoxifylline	Therapeutic substance	Drug	6493/5/6	DB00806	PA450864	D00501	DAP000048	4740	4578	n.a.	pentoxifylline; Trental; Oxpentifylline; 6493-05-6; Pentoxifyllin; Torental; Pentoxyphylline; Dimethyloxohexylxanthine; Pentoxiphyllium; Vazofirin; Pentoxiphylline; Pentoxyfylline; Rentylin; 3,7-Dimethyl-1-(5-oxohexyl)xanthine; Pentoxyphyllin; 1-(5-Oxohexyl)theobromine; 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione; 3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione; BL-191; BL 191; 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione; Pentoxyfilline; Pe	C13H18N4O3	BYPFEZZEUUWMEJ-UHFFFAOYSA-N	3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione	n.a.	n.a.
PMDBD655	Perphenazine	Therapeutic Substance	Approved Drug	58-39-9	DB00850	PA450882	D00503	DAP000100	4748	4586	n.a.	perphenazine; 58-39-9; Perphenazin; Trilafon; Perfenazine; Etaperazine; Ethaperazine; Etaperazin; Fentazin; Thilatazin; Perphenan; Chlorpiprazine; Decentan; Chlorperphenazine; Triphenot; Trilifan; Emesinal; Trifaron; Tranquisan; Perfenazina; F-mon; Perphenazinum; Sch 3940; Perfenazina [Italian]; 2-(4-(3-(2-Chloro-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol; Perphenazinum [INN-Latin]; Perfenazina [INN-Spanish]; 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; UNII-FTA7XXY4EZ; C21H26ClN3OS; PZC; 2-[4-[3-(2-Chloropheno	C21H26ClN3OS	RGCVKNLCSQQDEP-UHFFFAOYSA-N	2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol	Schering-Plough Corporation	Antipsychotic Agents
PMDBD657	Phenacetin	Therapeutic Substance	Approved Drug (Withdrawn)	62-44-2	DB03783	PA450897	D00569	DNC001117	4754	4590	n.a.	phenacetin; 62-44-2; Acetophenetidin; N-(4-Ethoxyphenyl)acetamide; Acetphenetidin; Acetophenetidine; Acetophenetin; Phenacetine; p-Acetophenetidide; 4'-Ethoxyacetanilide; Contradouleur; Phenazetin; Contradol; Codempiral; Achrocidin; Commotional; 4-Ethoxyacetanilide; p-Acetophenetidine; Phenedina; Phenacet; Pertonal; Pyraphen; Phenacitin; Phenacetinum; Fenidina; Phenidin; Fenacetina; p-Ethoxyacetanilide; Kalmin; Phenin; Fenina; p-Acetophenetide; p-Acetphenetidin; Tetracydin; Phenazetina; Veganine; Sinutab; Edrisal	C10H13NO2	CPJSUEIXXCENMM-UHFFFAOYSA-N	N-(4-ethoxyphenyl)acetamide	n.a.	n.a.
PMDBD658	Phenazopyridine	Therapeutic Substance	Approved Drug	94-78-0	DB01438	PA164746899	D08346	n.a.	4756	4592	n.a.	phenazopyridine; 94-78-0; Gastracid; 3-(Phenylazo)-2,6-pyridinediamine; Urogesic; Pyrazofen; Baridium; Pyridiate; Viridium; Geridium; Gastrotest; 2,6-Diamino-3-phenylazopyridine; Fenazopiridina; Eridium; Phenazopyridinum; 2,6-Diamino-3-(phenylazo)pyridine; Phenazopyridine [INN:BAN]; UNII-K2J09EMJ52; Fenazopiridina [INN-Spanish]; Phenazopyridinum [INN-Latin]; NSC 145895; 3-(phenyldiazenyl)pyridine-2,6-diamine; HSDB 3153; EINECS 202-363-2; BRN 0184497; K2J09EMJ5	C11H11N5	QPFYXYFORQJZEC-UHFFFAOYSA-N	3-phenyldiazenylpyridine-2,6-diamine	n.a.	n.a.
PMDBD661	Phenindione	Therapeutic Substance	Approved Drug	n.a.	DB00498	PA164784031	D08354	DAP000769	4760	4596	n.a.	phenindione; 83-12-5; 2-Phenyl-1,3-indandione; 2-Phenyl-1H-indene-1,3(2H)-dione; Dindevan; Rectadione; Phenylindanedione; Phenylindione; Phenyline; Fenhydren; Phenillin; Phenhydren; Emandione; Athrombon; Theradione; Diophindane; Pindione; Fenilin; Danedion; Fenindion; Emandion; Tromazal; Phenylin; Diadilan; Phenylen; Hemolidione; Eridione; Danilone; Hedulin; Trombol; Indema; Bindan; Dineval; Indon; Thrombasal; Cronodione; Indion; 2-Phenylindandione; 2-Phenyl-1,3-diketohydrindene; Phenindionum; Phenyllin; Fenindio	C15H10O2	NFBAXHOPROOJAW-UHFFFAOYSA-N	2-phenylindene-1,3-dione	n.a.	Anticoagulants
PMDBD1361	Phenoxybenzamine	Therapeutic substance	Drug	59-96-1	DB00925	PA450919	n.a.	DAP000478	4768	4604	n.a.	phenoxybenzamine; Dibenyline; Dibenzyline; Dibenylin; Bensylyt; Benzylyt; 59-96-1; Dibenylene; Dibenzyran; Fenoxibenzamina; Fenossibenzamina [DCIT]; Fenossibenzamina; Phenoxybenzaminum [INN-Latin]; Fenoxibenzamina [INN-Spanish]; Phenoxybenzamine [INN:BAN]; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine; 688A; A 688; NSC 37448; CCRIS 505; 2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine; HSDB 400	C18H22ClNO	QZVCTJOXCFMACW-UHFFFAOYSA-N	N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine	n.a.	n.a.
PMDBD674	Pioglitazone	Therapeutic Substance	Approved Drug	111025-46-8	DB01132	PA450970	D08378	DAP000272	4829	4663	n.a.	Pioglitazone; 111025-46-8; Actos; 105355-27-9; Pioglitazonum; Pioglitazona; Glustin; Zactos; Pioglitazonum [INN-Latin]; Pioglitazona [INN-Spanish]; Duetact; U 72107; Pioglitazone [INN:BAN]; AD-4833; 5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione; CHEBI:8228; Pioglitazone (Actos); HSDB 7322; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione; Actos (TN); 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; C19H20N2O3S; 105390-47-4; AD 4833; 5-[4-[2-(5-ETHYL-2-PYRIDYL	C19H20N2O3S	HYAFETHFCAUJAY-UHFFFAOYSA-N	5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	Takeda Pharmaceuticals	Hypoglycemic Agents
PMDBD698	Pranlukast	Therapeutic Substance	Approved Drug	103177-37-3	DB01411	PA134698661	n.a.	DAP000977	4887	4718	n.a.	Pranlukast; 103177-37-3; Ono-1078; pranlukast hydrate; N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide; UNII-TB8Z891092; CCN 00401; RS 411; CHEMBL21333; Azlaire; 150821-03-7; 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran; TB8Z891092; NCGC00181765-01; N-(4-OXO-2-(1H-TETRAZOL-5-YL)-4H-CHROMEN-8-YL)-4-(4-PHENYLBUTOXY)BENZAMIDE; N-(4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide; 8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;	C27H23N5O4	NBQKINXMPLXUET-UHFFFAOYSA-N	N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide	n.a.	Antiasthmatic Agents
PMDBD1376	Praziquantel	Therapeutic substance	Drug	55268-74-1	DB01058	PA164764583	D00471	DAP000695	4891	4722	n.a.	praziquantel; 55268-74-1; Droncit; Biltricide; Pyquiton; Cesol; Embay 8440; Azinox; Cutter Tape Tabs; Praziquantelum [INN-Latin]; 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one; CCRIS 4114; MLS000038419; 2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one; Praziquantel (Biltricide); EINECS 259-559-6; BRN 0761557; SMR000037139; 2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one; 2-(cyclohexanecarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyraz	C19H24N2O2	FSVJFNAIGNNGKK-UHFFFAOYSA-N	2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one	n.a.	n.a.
PMDBD1377	Prazosin	Therapeutic substance	Drug	19216-56-9	DB00457	PA451093	D08411	DAP000300	4893	4724	n.a.	prazosin; 19216-56-9; Furazosin; Prazosine; Prazocin; Prazosinum; Prazosina; Prazosinum [INN-Latin]; Prazosine [INN-French]; Prazosina [INN-Spanish]; Prazosin [INN:BAN]; [3H]-Prazosin; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; UNII-XM03YJ541D; (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone; HSDB 3298; CHEMBL2; C19H21N5O4; Min	C19H21N5O4	IENZQIKPVFGBNW-UHFFFAOYSA-N	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone	n.a.	n.a.
PMDBD1381	Primidone	Therapeutic substance	Drug	125-33-7	DB00794	PA451105	D00474	DAP000678	4909	4740	n.a.	primidone; 125-33-7; Primaclone; Mysoline; Liskantin; 2-Deoxyphenobarbital; Lepimidin; Mylepsinum; Misodine; Primidon; Neurosyn; Mylepsin; Mizodin; Lepsiral; Sertan; Primoline; Milepsin; Hexadiona; Majsolin; Prysoline; Primakton; Prilepsin; Misolyne; 2-Desoxyphenobarbital; Midone; Mysedon; Mizolin; Cyral; Medi-Pets; Primacone; Desoxyphenobarbitone; Pyrimidone Medi-pets; Resimatil; Primidonum; Primidona; Primacione; 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione; Roe 101; 5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione; 4,6(1H,5H)-Pyrimidinedione, 5-eth	C12H14N2O2	DQMZLTXERSFNPB-UHFFFAOYSA-N	5-ethyl-5-phenyl-1,3-diazinane-4,6-dione	n.a.	n.a.
PMDBD1382	Probenecid	Therapeutic substance	Drug	57-66-9	DB01032	PA451106	D00475	DAP001292	4911	4742	n.a.	probenecid; 57-66-9; 4-(Dipropylsulfamoyl)benzoic acid; Probenecid acid; Benemid; Probecid; Benecid; Probalan; Benuryl; Tubophan; Probexin; Uricosid; Prolongine; Probenemid; Apurina; Proben; Synergid R; p-(Dipropylsulfamoyl)benzoic acid; 4-[(dipropylamino)sulfonyl]benzoic acid; Probenecidum; Probenecida; Probenecide; Robenecid; Benemide; Probenid; 4-((Dipropylamino)sulfonyl)benzoic acid; Polycillin-BRB; 4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; Probenecidum [	C13H19NO4S	DBABZHXKTCFAPX-UHFFFAOYSA-N	4-(dipropylsulfamoyl)benzoic acid	n.a.	n.a.
PMDBD1383	Procainamide	Therapeutic substance	Drug	1951/6/9	DB01035	PA451108	n.a.	DAP000516	4913	4744	n.a.	PROCAINAMIDE; 51-06-9; Novocainamide; Biocoryl; Novocamid; 4-amino-N-(2-diethylaminoethyl)benzamide; Procaine amide; Pronestyl; Procamide; Novocainamid; Novocaine amide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; Procainamida; Procainamidum; Procan; Procapan (free base); p-Aminobenzoic diethylaminoethylamide; p-Amino-N-(2-diethylaminoethyl)benzamide; Procainamide [INN:BAN]; Procainamidum [INN-Latin]; Procainamida [INN-Spanish]; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; UNII-L39WTC366D; NSC 27461; CHEBI:8428; HSDB 3170; EINECS 200	C13H21N3O	REQCZEXYDRLIBE-UHFFFAOYSA-N	4-amino-N-[2-(diethylamino)ethyl]benzamide	n.a.	n.a.
PMDBD707	Procarbazine	Therapeutic Substance	Approved Drug	671-16-9	DB01168	PA451112	D08423	DAP000986	4915	4746	n.a.	procarbazine; 671-16-9; Procarbazin; Ibenzmethyzin; Natulan; Ibenzmethyzine; Procarbazin [German]; Procarbazinum; Procarbazina; Procarbazinum [INN-Latin]; Procarbazina [INN-Spanish]; N-Isopropyl-4-((2-methylhydrazinyl)methyl)benzamide; Procarbazine [INN:BAN]; 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine; p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide; 1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine; 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide	C12H19N3O	CPTBDICYNRMXFX-UHFFFAOYSA-N	4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide	Sigma-Tau Pharmaceuticals	Anticancer Agents
PMDBD1385	Promethazine	Therapeutic substance	Drug	60-87-7	DB01069	PA451128	D00494	DAP000334	4927	4758	n.a.	promethazine; Proazamine; Diphergan; 60-87-7; Promethazin; Phensedyl; Phenargan; Promezathine; Protazine; Promazinamide; Isophenergan; Prothazin; Histargan; Thiergan; Provigan; Diprozin; Prometazin; Diprazine; Vallergine; Fenetazina; Hiberna; Fenazil; Dimapp; Avomine; Prorex; Aprobit; Phargan; Fargan; Tanidil; Procit; Pyrethiazine; Promethacon; Promethegan; Lilly 1516; Prometazina; Atosil; Promethiazine; Promethazinum; Antiallersin; Promesan; Proazaimine; Prometasin; Pilpophen; Pilothia; Iergigan; Fenetazine; Camergan; Promacot; Pipolphene; Lercigan; Prome	C17H20N2S	PWWVAXIEGOYWEE-UHFFFAOYSA-N	N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine	n.a.	n.a.
PMDBD1386	Propafenone	Therapeutic substance	Drug	54063-53-5	DB01182	PA451131	D08435	DAP000497	4932	4763	n.a.	propafenone; 54063-53-5; Rythmol; Propafenona; Propafenonum; Propafenonum [INN-Latin]; Propafenona [INN-Spanish]; Propafenone [INN:BAN]; GNF-Pf-4594; 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; EINECS 258-955-6; CHEMBL631; 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one; CHEBI:63619; 1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one; 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one; NCGC00015819-06; 1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)	C21H27NO3	JWHAUXFOSRPERK-UHFFFAOYSA-N	1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one	n.a.	n.a.
PMDBD1388	Propranolol	Therapeutic substance	Drug	525-66-6	DB00571	PA451145	D08443	DAP000089	4946	4777	n.a.	propranolol; Propanolol; beta-Propranolol; 525-66-6; Betalong; Propanalol; Euprovasin; Anapriline; Dociton; Avlocardyl; Proprasylyt; Reducor; Propanix; Inderal; propranololo; Corpendol; Betadren; Sumial; Sawatal; Racemic propranolol; Propranololum; D,L-Propranolol; (+-)-Propranolol; Propranololo [DCIT]; Propranolol [INN:BAN]; Propanolol [INN-Spanish]; Propranololum [INN-Latin]; CCRIS 3082; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; AY-20694; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; CHEMBL27; EINECS 208-378-0	C16H21NO2	AQHHHDLHHXJYJD-UHFFFAOYSA-N	1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol	n.a.	n.a.
PMDBD1391	Protriptyline	Therapeutic substance	Drug	438-60-8	DB00344	PA451168	D08447	DAP000863	4976	4805	n.a.	protriptyline; Protryptyline; Amimetilina; Triptil; 438-60-8; Vivactil; Protriptyline [INN:BAN]; Protriptylinum [INN-Latin]; 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; Protriptilina [INN-Spanish]; 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine; 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene; Vivactyl; Triptyl; Maximed; UNII-4NDU154T12; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine; HSDB 3391; N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-me	C19H21N	BWPIARFWQZKAIA-UHFFFAOYSA-N	N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine	n.a.	n.a.
PMDBD715	Pyrimethamine	Therapeutic Substance	Approved Drug	58-14-0	DB00205	PA451193	D00488	DAP000633	4993	4819	n.a.	pyrimethamine; 58-14-0; Daraprim; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; Chloridine; Diaminopyritamin; Ethylpyrimidine; Pirimetamin; Chloridin; Pirimecidan; Chloridyn; Pyrimethamin; Pirimetamina; Malocide; Primethamine; Erbaprelina; Khloridin; Darachlor; Tindurin; Malocid; Maloprim; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; Malacid; Darapram; Daraprime; Pyremethamine; Pyrimethaminum; Daraclor; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; RP 4753; 2,4-Diamino-5-ch	C12H13ClN4	WKSAUQYGYAYLPV-UHFFFAOYSA-N	5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine	n.a.	Antimalarials
PMDBD1397	Rabeprazole	Therapeutic substance	Drug	117976-89-3	DB01129	PA451216	D08463	DAP000727	5029	4853	n.a.	rabeprazole; 117976-89-3; Aciphex; Habeprazole; Pariets; Rabeprazole [INN:BAN]; CHEBI:8768; LY307640; HSDB 7321; Sodium rabeprazole; 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole; 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; AK-55871; 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2	C18H21N3O3S	YREYEVIYCVEVJK-UHFFFAOYSA-N	2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole	n.a.	n.a.
PMDBD1398	Raloxifene	Therapeutic substance	Drug	84449-90-1	DB00481	PA451221	n.a.	DAP000792	5035	4859	n.a.	raloxifene; 84449-90-1; Keoxifene; Raloxifenum [Latin]; Raloxifeno [Spanish]; Raloxifenum; Raloxifeno; Raloxifene [INN:BAN]; LY 139481; LY-139481; UNII-YX9162EO3I; Optruma; CCRIS 7129; HSDB 7460; CHEMBL81; (6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone; (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone; YX9162EO3I; C28H27NO4S; CHEBI:8772; RAL; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]metha	C28H27NO4S	GZUITABIAKMVPG-UHFFFAOYSA-N	[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone	n.a.	n.a.
PMDBD732	Rebamipide	Therapeutic Substance	Approved Drug	90098-04-7	DB11656	n.a.	n.a.	n.a.	5042	4866	n.a.	rebamipide; 90098-04-7; Proamipide; Mucosta; 111911-87-6; OPC-12759; Pramipide; Rebamipide [INN:JAN]; Rebamipidum [INN-Latin]; Rebamipide hydrate; OPC 12759; CCRIS 3585; 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid; 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid; 139344-42-6; NCGC00095161-01; 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid; 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid; (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-y	C19H15ClN2O4	ALLWOAVDORUJLA-UHFFFAOYSA-N	2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid	n.a.	n.a.
PMDBD748	Riluzole	Therapeutic Substance	Approved Drug	1744-22-5	DB00740	PA451251	D00775	DAP000527	5070	4892	n.a.	riluzole; 1744-22-5; Rilutek; 2-Amino-6-(trifluoromethoxy)benzothiazole; 6-(trifluoromethoxy)benzo[d]thiazol-2-amine; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine; RP-54274; Riluzol; 2-amino-6-trifluoromethoxybenzothiazole; 2-amino-6-(trifluoromethoxy)benzo[d]thiazole; PK-26124; Riluzolum [INN-Latin]; Riluzol [INN-Spanish]; RP 54274; UNII-7LJ087RS6F; C8H5F3N2OS; Riluzole (Rilutek); MLS000069369; Amino-2 trifluoromethoxy-6 benzothiazole; 6-Trifluoromethoxy-benzothiazol-2-ylamine; 2-Be	C8H5F3N2OS	FTALBRSUTCGOEG-UHFFFAOYSA-N	6-(trifluoromethoxy)-1,3-benzothiazol-2-amine	Sanofi-Aventis	Anticonvulsants
PMDBD1403	Rimantadine	Therapeutic substance	Drug	13392-28-4	DB00478	PA164748038	D08483	DAP001087	5071	4893	n.a.	rimantadine; 13392-28-4; 1-(1-Adamantyl)ethanamine; 1-(Adamantan-1-yl)ethanamine; 1-(adamantan-1-yl)ethan-1-amine; alpha-Methyl-1-adamantanemethylamine; Rimantadine [INN:BAN]; alpha-Methyladamantanemethylamine; Rimantadinum [INN-Latin]; Remantadine; 1-(1-Adamantyl)ethylamin; Rimantadina [INN-Spanish]; 1-Adamantan-1-yl-ethylamine; RIMANTADIN; HSDB 7438; CHEMBL959; BRN 2715740; .alpha.-Methyladamantanemethylamine; 1-(1-adamantyl)-ethylamine; 1-(tricyclo[3.3.1.1~3,7~]dec-1-yl)ethanamine	C12H21N	UBCHPRBFMUDMNC-UHFFFAOYSA-N	1-(1-adamantyl)ethanamine	n.a.	n.a.
PMDBD750	Risperidone	Therapeutic Substance	Approved Drug	106266-06-2	DB00734	PA451257	D00426	DAP000003	5073	4895	n.a.	risperidone; 106266-06-2; Risperidal; Risperdal; Rispolept; Risperdal Consta; Sequinan; Risperin; Rispolin; Apexidone; Risperidal M-Tab; Risperidonum; Risperidona; Risperidonum [Latin]; Risperidona [Spanish]; Risperdal M-Tab; Psychodal; Belivon; Spiron; R 64 766; C23H27FN4O2; UNII-L6UH7ZF8HC; R-64766; R 64766; R 64,766; CHEMBL85; L6UH7ZF8HC; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; BRN 4891881; CHEBI:8871	C23H27FN4O2	RAPZEAPATHNIPO-UHFFFAOYSA-N	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	Janssen-Cilag	Antipsychotic Agents
PMDBD1406	Ropinirole	Therapeutic substance	Drug	91374-21-9	DB00268	PA164749035	D08489	DAP001515	5095	4916	n.a.	ropinirole; 91374-21-9; ropinirol; ReQuip; Ropinirolum; Ropinirolum [INN-Latin]; Ropinirol [INN-Spanish]; SKF 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one; SK&amp;F 101468; UNII-030PYR8953; 4-(2-(dipropylamino)ethyl)indolin-2-one; CHEMBL589; CHEBI:8888; 030PYR8953; NCGC00015893-02; DSSTox_RID_80742; DSSTox_CID_25195; DSSTox_GSID_45195; Ropinirole [INN:BAN]; Ropitor (TN); CAS-91374-21-9; SK&amp;F-101468-A; 4-(2-(Dipropylamino)ethyl)-1,3-dihydro-2H-indol-2-one	C16H24N2O	UHSKFQJFRQCDBE-UHFFFAOYSA-N	4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one	n.a.	n.a.
PMDBD757	Roxatidine acetate	Therapeutic Substance	Approved Drug	78628-28-1	DB08806	PA165958424	D08495	n.a.	5105	4926	n.a.	ROXATIDINE ACETATE; 78628-28-1; Aceroxatidine; Pifatidine; Roxatidinum; Roxatidina; Roxane; Roxatidinum [Latin]; Roxatidina [Spanish]; UNII-ZUP3LSD0DO; ZUP3LSD0DO; BRN 5829308; C19H28N2O4; 2-Oxo-2-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)ethyl acetate; 2-(Acetyloxy)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)acetamide; [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate; Acetamide, 2-(acetyloxy)-N-(3-(3-(1-piperidinylmethyl	C19H28N2O4	SMTZFNFIKUPEJC-UHFFFAOYSA-N	[2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate	n.a.	n.a.
PMDBD761	Saccharin	Therapeutic Substance; Dietary Substance; Herbal Substance	Investigational Drug; Dietary Compounds; Artificial Sweetener; Medicinal Herbal Compounds	n.a.	DB12418	n.a.	n.a.	n.a.	5143	4959	NPC328793	saccharin; 81-07-2; o-Benzoic sulfimide; o-Sulfobenzimide; Saccharine; Saccharimide; Benzosulfimide; Benzoic sulfimide; o-Benzosulfimide; Saccharinose; Benzosulphimide; Garantose; Saccharinol; Gluside; Benzosulfinide; Hermesetas; Saccharol; Sweeta; Saccharin insoluble; Glucid; Saccharin acid; 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide; Benzoic sulphimide; Saccharina; Zaharina; Kandiset; Sucrette; Sacarina; Sykose; Saxin; Benzo-2-sulphimide; o-Benzoyl sulfimide; Sucre edulcor; o-Benzoic sulphimide; Benzoylsulfonic Imide; o-Sulfobenzoic acid im	C7H5NO3S	CVHZOJJKTDOEJC-UHFFFAOYSA-N	1,1-dioxo-1,2-benzothiazol-3-one	n.a.	n.a.
PMDBD762	Salmeterol	Therapeutic Substance	Approved Drug	89365-50-4	DB00938	PA451300	D05792	DAP000947	5152	4968	n.a.	Salmeterol; 89365-50-4; Serevent; Aeromax; Astmerole; Salmeterolum [Latin]; GR 33343X; SALMATEROL; 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol; SN408D; HSDB 7315; 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol; 136112-01-1; Salmeterol-fluticasone propionate mixt.; CHEBI:64064; (+-)-4-Hydroxy-alpha'-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol; (+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol; Salmeterol 	C25H37NO4	GIIZNNXWQWCKIB-UHFFFAOYSA-N	2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol	GlaxoSmithKline	Bronchodilator Agents
PMDBD808	Sulfadiazine	Therapeutic Substance	Approved Drug	68-35-9	DB00359	PA451539	D00587	DAP001238	5215	5026	n.a.	sulfadiazine; 68-35-9; Sulphadiazine; Sulfapyrimidine; Sulfadiazin; Sulfazine; Sulfadiazene; Adiazine; Debenal; Adiazin; Sulfapyrimidin; Liquadiazine; Pyrimal; 2-Sulfanilamidopyrimidine; Theradiazine; Spofadrizine; Cremodiazine; Terfonyl; Quadramoid; Quadetts; Neotrizine; Microsulfon; Cremotres; Sulfonsol; Sulfolex; Sterazine; Piridisir; Truozine; Trifonamide; Sulfatryl; Sanodiazine; Palatrize; Eskadiazine; Diazolone; Deltazina; Neazine; Pirimal; Trisem; Sulfose; Diazin; Sulfanilamidopyrimidine; Honey diazine; Triple Sulfas; Tri-Sulfameth; Lipo-Levaz	C10H10N4O2S	SEEPANYCNGTZFQ-UHFFFAOYSA-N	4-amino-N-pyrimidin-2-ylbenzenesulfonamide	Lilly	Antiinfective Agents
PMDBD668	Picosulfuric acid	Therapeutic Substance	Approved Drug	10040-34-3	DB09268	n.a.	n.a.	n.a.	5243	5053	n.a.	Picosulfuric acid; Picosulfate; UNII-95D580798S; 10040-34-3; 95D580798S; Picosulphate; CHEMBL1741134; SCHEMBL18552552; CTK8A7124; DTXSID70143251; ZINC3873921; Phenol, 4,4'-(2-pyridinylmethylene)bis-, 1,1'-bis(hydrogen sulfate); DB09268; LS-187202; NS00004849; picosulfuric acid;sodium picosulfate;Picosulfate sodium; Bis(sulfuric acid)2-pyridinylmethylenebis(1,4-phenylene) ester; (pyridin-2-ylmethanediyl)dibenzene-4,1-diyl bis(hydrogen sulfate)	C18H15NO8S2	UJIDKYTZIQTXPM-UHFFFAOYSA-N	[4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate	n.a.	n.a.
PMDBD789	Sotalol	Therapeutic Substance	Approved Drug	3930-20-9	DB00489	PA451457	n.a.	DAP000372	5253	5063	n.a.	sotalol; 3930-20-9; beta-Cardone; Sotalolum; DL-Sotalol; Sotalol [INN:BAN]; Sotalolum [INN-Latin]; MJ-1999; N-(4-(1-Hydroxy-2-(isopropylamino)ethyl)phenyl)methanesulfonamide; .beta.-Cardone; 4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide; CCRIS 4204; CHEMBL471; 4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid; CHEBI:63622; N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide; N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]met	C12H20N2O3S	ZBMZVLHSJCTVON-UHFFFAOYSA-N	N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide	Bristol-Myers Squibb	Antiarrhythmic Agents
PMDBD439	Imatinib	Therapeutic Substance	Approved Drug	152459-95-5	DB00619	PA10804	D01441	DNC001383	5291	5101	n.a.	Imatinib; 152459-95-5; STI571; Glivec; Imatinib (STI571); sti-571; Cgp 57148; Imatinib [INN:BAN]; Imatinib free base; STI 571; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; UNII-BKJ8M8G5HI; Imatinib Methansulfonate; CCRIS 9076; CGP 57148B; CGP-57148; BKJ8M8G5HI; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE	C29H31N7O	KTUFNOKKBVMGRW-UHFFFAOYSA-N	4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Novartis AG	Anticancer Agents
PMDBD1493	Vorinostat	Therapeutic substance	Drug	149647-78-9	DB02546	PA164748224	D06320	DAP001082	5311	5120	n.a.	Vorinostat; 149647-78-9; SAHA; suberoylanilide hydroxamic acid; Zolinza; N-hydroxy-N'-phenyloctanediamide; Suberanilohydroxamic acid; N1-hydroxy-N8-phenyloctanediamide; MK-0683; MK0683; Vorinostat (SAHA, MK0683); SAHA cpd; N'-hydroxy-N-phenyloctanediamide; CCRIS 8456; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; N-Hyrdroxy-N'-phenyloctanediamide; UNII-58IFB293JI; Vorinostat (SAHA); SHH; CHEMBL98; 58IFB293JI; CHEBI:45716; WIN64652; NSC701852; MFCD00945317; NSC-701852; NCGC00168085-02; NCGC00168085-01	C14H20N2O3	WAEXFXRVDQXREF-UHFFFAOYSA-N	N'-hydroxy-N-phenyloctanediamide	n.a.	n.a.
PMDBD1427	Sulfamethoxazole	Therapeutic substance	Drug	723-46-6	DB01015	PA451544	D00447	DNC001393	5329	5138	n.a.	sulfamethoxazole; 723-46-6; Sulphamethoxazole; Gantanol; Sulfisomezole; Sulfamethoxazol; Metoxal; Sulfamethylisoxazole; 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; Simsinomin; Radonil; Sinomin; Sulphamethoxazol; Sulpha-methoxizole; Bactrim; Sulfamethalazole; Azo-gantanol; Sulphamethylisoxazole; Urobak; Sulfamethoxizole; 3-Sulfanilamido-5-methylisoxazole; Gantanol-DS; 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; Bactrimel; Gamazole; Ro 4-2130; 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; Sulphisomezole; 5-Me	C10H11N3O3S	JLKIGFTWXXRPMT-UHFFFAOYSA-N	4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide	n.a.	n.a.
PMDBD810	Sulfanilamide	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	63-74-1	DB00259	PA451545	D08543	DNC001391	5333	5142	NPC315403	sulfanilamide; 4-Aminobenzenesulfonamide; 63-74-1; Sulphanilamide; Sulphonamide; Sulfamine; Sulfonylamide; p-Aminobenzenesulfonamide; Prontosil Album; Streptasol; Bacteramid; p-Sulfamoylaniline; Sulfonamide P; p-Aminobenzenesulfamide; Streptoclase; Estreptocida; Exoseptoplix; Sulfanidyl; p-Sulfamidoaniline; Sulfocidine; Sulfamidyl; Sulfanil; Sulfanalone; Sulfana; Sulfanilimidic acid; p-Anilinesulfonamide; p-Aminophenylsulfonamide; 4-Aminobenzene-1-Sulfonamide; Therapol; Streptagol; Strepamide; Septoplex; Pysoc	C6H8N2O2S	FDDDEECHVMSUSB-UHFFFAOYSA-N	4-aminobenzenesulfonamide	n.a.	n.a.
PMDBD811	Sulfapyridine	Therapeutic Substance	Approved Drug	144-83-2	DB00891	PA164779050	D02434	DAP001200	5336	5145	n.a.	sulfapyridine; 144-83-2; Sulphapyridine; 2-Sulfapyridine; Sulfidin; 2-Sulfanilamidopyridine; Sulfidine; 2-Sulfanilylaminopyridine; Streptosilpyridine; Piridazol; Pyridazol; Eubasinum; Coccoclase; Haptocil; Eubasin; Plurazol; Relbapiridina; Thioseptal; Septipulmon; Pyriamid; Adiplon; Trianon; Dagenan; Ronin; 2-Sulfanilamidopyridin; Solfapiridina; N-2-Pyridylsulfanilamide; Sulfapyridinum; Sulfapiridina; 4-amino-N-pyridin-2-ylbenzenesulfonamide; N1-2-Pyridylsulfanilamide; 2-(p-Aminobenzenesulphonamido)pyridine	C11H11N3O2S	GECHUMIMRBOMGK-UHFFFAOYSA-N	4-amino-N-pyridin-2-ylbenzenesulfonamide	n.a.	Dermatologic Agents
PMDBD813	Sulfinpyrazone	Therapeutic Substance	Approved Drug	57-96-5	DB01138	PA451550	D00449	DAP000794	5342	5149	n.a.	sulfinpyrazone; 57-96-5; Sulphinpyrazone; (+/-)-SULFINPYRAZONE; Anturane; Sulfinpyrazon; Anturan; Diphenylpyrazone; Sulfoxyphenylpyrazolidine; Anturanil; Anturidin; Enturen; Anturano; Sulfinpyrazine; 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)pyrazolidine-3,5-dione; USAF GE-13; Sulfinpyrazonum; Enturan; Anturen; NSC 75925; Anturane (TN); Sulfinpyrazonum [INN-Latin]; G 28315; Sulfinpirazona [INN-Spanish]; 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; 1,2-Diphe	C23H20N2O3S	MBGGBVCUIVRRBF-UHFFFAOYSA-N	4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione	n.a.	Uricosuric Agents
PMDBD819	Sulpiride	Therapeutic Substance	Approved Drug	15676-16-1	DB00391	PA164745485	D01226	DAP000310	5355	5162	n.a.	sulpiride; 15676-16-1; Sulpyrid; Sulpirid; Dolmatil; Aiglonyl; Dogmatil; Guastil; Dobren; (RS)-(+/-)-sulpiride; (+/-)-Sulpiride; Sursumid; Mirbanil; Misulvan; Splotin; Abilit; Neogama; Miradol; Meresa; Omperan; Eglonyl; Sernevin; Dogmatyl; Psicocen; Pyrkappl; Coolspan; Calmoflorine; Zemorcon; Stamonevrol; Lisopiride; Isnamide; Darleton; Alimoral; Kylistro; Fardalan; Championyl; Ozoderpin; Norestran; Mariastel; Eusulpid; Desmenat; Suprium; Omiryl; Normum; Eglonil; Valirem; Restful; Dresent; Fidelan; Equilid; Nufarol; Enimon; N-[(1-ethylpyrrolidin-2-yl)methyl]	C15H23N3O4S	BGRJTUBHPOOWDU-UHFFFAOYSA-N	N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide	n.a.	n.a.
PMDBD380	Gatifloxacin	Therapeutic Substance	Approved Drug	112811-59-3	DB01044	PA449738	D08011	DAP001387	5379	5186	n.a.	Gatifloxacin; 112811-59-3; Tequin; Zymar; Gatiflo; AM-1155; Gatispan; Gatiquin; Zymaxid; Gatilox; Gaity; AM 1155; CG 5501; BMS-206584; Gatifloxacine; Gatifloxacin [USAN:INN]; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; gatifloxacin anhydrous; GTFX; BMS 206584-01; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic a	C19H22FN3O4	XUBOMFCQGDBHNK-UHFFFAOYSA-N	1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	Bristol-Myers Squibb	Antiinfective Agents
PMDBD1436	Tegafur	Therapeutic substance	Drug	17902-23-7	DB09256	n.a.	D01244	n.a.	5386	5193	n.a.	tegafur; Ftorafur; 17902-23-7; Futraful; Fluorofur; Sinoflurol; Citofur; Florafur; Neberk; Fental; Furafluor; Nitobanil; Furofutran; Furflucil; Franroze; Coparogin; Fulfeel; Exonal; Sunfral; Lifril; Lamar; Riol; Tefsiel C; FT-207; Phthorafur; 1-(2-Tetrahydrofuryl)-5-fluorouracil; 5-Fluoro-1-(tetrahydro-2-furyl)uracil; Racemic Ftorafur; Phthorafur [Czech]; MJF-12264; 5-fluoro-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; NSC-148958; Tegafurum [INN-Latin]; 5-Fluoro-1-(tetr	C8H9FN2O3	WFWLQNSHRPWKFK-UHFFFAOYSA-N	5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione	n.a.	n.a.
PMDBD1441	Temazepam	Therapeutic substance	Drug	846-50-4	DB00231	PA451608	D00370	DAP000238	5391	5198	n.a.	temazepam; Restoril; Hydroxydiazepam; Methyloxazepam; Oxydiazepam; Levanxol; Levanxene; Euhypnos; Crisonar; Signopam; N-Methyloxazepam; Normison; Remestan; Mabertin; Planum; 3-Hydroxydiazepam; 846-50-4; Euipnos; Cerepax; Tenox; Temaz; Normitab; Nocturne; Temtabs; Nortem; Dasuen; Norkotral Tema; temazep von ct; Pronervon T; Temazepamum; Temador; Nomapam; Lenal; Uvamin Retard; Wy-3917; Neodorm SP; ER 115; Temazepamum [INN-Latin]; Ro 5-5345; WY 3917; K-3917; NSC 246303; Tema	C16H13ClN2O2	SEQDDYPDSLOBDC-UHFFFAOYSA-N	7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one	n.a.	n.a.
PMDBD829	Temozolomide	Therapeutic Substance	Approved Drug	85622-93-1	DB00853	PA451609	D06067	DAP000987	5394	5201	n.a.	temozolomide; 85622-93-1; Methazolastone; Temodar; Temodal; Temozolamide; 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; Temozolomidum [Latin]; Temozolodida [Spanish]; Temozolomidum; CCRG-81045; CCRG 81045; Sch 52365; NSC 362856; Sch-52365; M&amp;B-39831; CCRIS 8996; NSC-362856; MB 39831; M&amp;B 39831; 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; UNII-YF1K15M17Y; M &amp; B 39831; BRN 5547136; 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide	C6H6N6O2	BPEGJWRSRHCHSN-UHFFFAOYSA-N	3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide	Schering-Plough	Anticancer Agents
PMDBD1442	Terazosin	Therapeutic substance	Drug	63590-64-7	DB01162	PA451612	D08569	DAP000371	5401	5208	n.a.	terazosin; Terazosine; 63590-64-7; Fosfomic; Flumarc; Vasomet; Blavin; Hytrin; Terazosinum; Terazosina; Terazosinum [INN-Latin]; Terazosine [INN-French]; Terazosina [INN-Spanish]; Terazosin HCl; Terazosin [INN:BAN]; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine; CHEMBL611; MLS000069703; Abbott-45975; CHEBI:9445; C19H25N5O4; SMR000058309; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine; 6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine; 6,7-di	C19H25N5O4	VCKUSRYTPJJLNI-UHFFFAOYSA-N	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone	n.a.	n.a.
PMDBD1444	Terbutaline	Therapeutic substance	Drug	23031-25-6	DB00871	PA451616	n.a.	DAP000246	5403	5210	n.a.	terbutaline; Terbutalin; 23031-25-6; Brican; Bricanyl; Bricaril; Brethine; Brethaire; Bricar; Bricyn; Terbutalinum; Terbutalina [DCIT]; Terbutaline sulfate; Terbutalina; 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; Terbutalinum [INN-Latin]; Terbutalino [INN-Spanish]; (+-)-Terbutaline; Terbutaline [INN:BAN]; KWD 2019; KWD-2019; TERBUTALINE HEMISULFATE; 5-(2-(tert-Butylamino)-1-hydroxyethyl)benzene-1,3-diol; EINECS 245-385-8; BRN 2370513; 5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL; CHEBI:9449	C12H19NO3	XWTYSIMOBUGWOL-UHFFFAOYSA-N	5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol	n.a.	n.a.
PMDBD834	Terfenadine	Therapeutic Substance	Approved Drug	50679-08-8	DB00342	PA451619	D00521	DAP000102	5405	5212	n.a.	terfenadine; 50679-08-8; Seldane; Triludan; Ternadin; Teldane; Allerplus; Teldanex; Terdin; Aldaban; Terfenadina; Terfen; RMI-9918; RMI 9918; Terfenadinum [INN-Latin]; Terfenadina [INN-Spanish]; MDL 9918; HSDB 6508; C32H41NO2; MDL-9918; EINECS 256-710-8; BRN 5857899; 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol; CHEMBL17157; alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; MLS000028499; CHEBI:9453; Cyater; alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperid	C32H41NO2	GUGOEEXESWIERI-UHFFFAOYSA-N	1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol	Marion Merrell. Dow, Inc.	Antihistamines
PMDBD1447	Thalidomide	Therapeutic substance	Drug	50-35-1	DB01041	PA451644	D00754	DAP000865	5426	5233	n.a.	thalidomide; 50-35-1; Thalomid; Sedoval; 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione; (+/-)-THALIDOMIDE; Psychotablets; Corronarobetin; Theophilcholine; Psycholiquid; Telargean; Talargan; Profarmil; Neosydyn; Hippuzon; Ectiluran; Thalinette; Softenon; Shinnibrol; Sedisperil; Polygripan; Pantosediv; Neufatin; Neosedyn; Tensival; Talismol; Softenil; Quetimid; Nevrodyn; Neurosedin; Nerosedyn; Glutanon; Gastrinide; Enterosediv; Contergan; Calmorex; Asmadion; Algosediv; Valgraine; Sedimide; Sandormin; Quietoplex; Noctosediv; Neurosedym; Neurodyn; Dist	C13H10N2O4	UEJJHQNACJXSKW-UHFFFAOYSA-N	2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione	n.a.	n.a.
PMDBD1452	Thioridazine	Therapeutic substance	Drug	50-52-2	DB00679	PA451666	D00373	DAP000476	5452	5253	n.a.	thioridazine; Mellaril; Thioridazin; 50-52-2; Melleril; Meleril; Malloryl; Sonapax; Mellaril-S; Melleretten; Mellerette; Mellerets; Mallorol; dl-Thioridazine; Tioridazina; Melleryl; TP-21; Melleril (liquid); Thioridazinum; (+-)-Thioridazine; Thioridazine prolongatum; 10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine; Orsanil; Tioridazina [INN-Spanish]; Thioridazinum [INN-Latin]; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; HSDB 	C21H26N2S2	KLBQZWRITKRQQV-UHFFFAOYSA-N	10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine	n.a.	n.a.
PMDBD1456	Ticlopidine	Therapeutic substance	Drug	55142-85-3	DB00208	PA451686	D08594	DAP000723	5472	5273	n.a.	ticlopidine; 55142-85-3; 5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; Ticlid; Ticlopidinum; Ticlopidina; PCR 5332; Ticlopidine [INN:BAN]; Ticlopidinum [INN-Latin]; Ticlopidina [INN-Spanish]; UNII-OM90ZUW7M1; 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; EINECS 259-498-5; C14H14ClNS; BRN 1216802; 5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine; OM90ZUW7M1; CHEBI:9588; 5-[(2-chlorophenyl)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine; Ticlopidine-d4; Thieno(3,2-c)pyridine, 4,5,6	C14H14ClNS	PHWBOXQYWZNQIN-UHFFFAOYSA-N	5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine	n.a.	n.a.
PMDBD849	Tinidazole	Therapeutic Substance	Approved Drug	19387-91-8	DB00911	PA10813	D01426	n.a.	5479	5279	n.a.	tinidazole; 19387-91-8; Tindamax; Tinidazol; Fasigyn; Trimonase; 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole; Simplotan; Tricolam; Fasigin; Bioshik; Sorquetan; Pletil; timidazole; 1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole; Tinidazol [INN-Spanish]; Tinidazolum [INN-Latin]; CP 12574; 1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole; UNII-033KF7V46H; CCRIS 7621; C8H13N3O4S; CP-12574; CHEBI:63627; HSDB 7362; 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-ni	C8H13N3O4S	HJLSLZFTEKNLFI-UHFFFAOYSA-N	1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole	Presutti Laboratories	n.a.
PMDBD850	Tioconazole	Therapeutic Substance	Approved Drug	65899-73-2	DB01007	PA164746156	D00890	DAP001268	5482	5282	n.a.	tioconazole; 65899-73-2; Trosyl; Vagistat-1; Vagistat; Trosyd; Gyno-trosyd; Fungibacid; Tioconazolum; Zoniden; Tioconazolum [INN-Latin]; Tioconazol [INN-Spanish]; Tz-3; UK-20349; C16H13Cl3N2OS; UK 20349; EINECS 265-973-8; BRN 0573867; Tioconazol; CHEBI:77898; 1-(2,4-Dichloro-beta-((2-chloro-3-thenyl)-oxy)phenethyl)imidazole; (+-)-1-(2,4-Dichloro-beta-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole; 1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; NCGC00167430-01; 1-(2,4-Dichloro-(beta-(2-chloro-3-thenyl)ox	C16H13Cl3N2OS	QXHHHPZILQDDPS-UHFFFAOYSA-N	1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole	n.a.	Antifungal Agents
PMDBD1458	Tizanidine	Therapeutic substance	Drug	51322-75-9	DB00697	PA451701	n.a.	DAP000234	5487	5287	n.a.	tizanidine; 51322-75-9; Sirdalud; Ternelin; Zanaflex; Tizanidinum; Tizanidina; Tizanidinum [INN-Latin]; Tizanidina [INN-Spanish]; 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine; Tizanidine [INN:BAN]; 5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole; UNII-6AI06C00GW; BRN 0618691; CHEMBL1079; 6AI06C00GW; CHEBI:63629; NCGC00160529-01; 2,1,3-Benzot	C9H8ClN5S	XFYDIVBRZNQMJC-UHFFFAOYSA-N	5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine	n.a.	n.a.
PMDBD855	Tolazamide	Therapeutic Substance	Approved Drug	1156-19-0	DB00839	PA164774902	D00379	DAP000919	5503	5302	n.a.	tolazamide; 1156-19-0; Tolinase; Norglycin; Tolanase; Tolazolamide; Diabewas; Tolazamidum; Tolazamida; 1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea; N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea; U-17835; 4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide; NCI-C03327; 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea; Tolazamidum [INN-Latin]; Tolazamida [INN-Spanish]; U 17835; CCRIS 591; NSC-70762; UNII-9LT1BRO48Q; EINECS 214-588-3; Benzenesulfonamide, N-[[(hexahydro-1H-aze	C14H21N3O3S	OUDSBRTVNLOZBN-UHFFFAOYSA-N	1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea	n.a.	Hypoglycemic Agents
PMDBD1459	Tolbutamide	Therapeutic substance	Drug	64-77-7	DB01124	PA451718	D00380	DAP000136	5505	5304	n.a.	tolbutamide; 64-77-7; Orinase; Artosin; Tolbutamid; Diabetol; Tolumid; Dolipol; Arkozal; Rastinon; Aglicid; Diaben; Orabet; 1-Butyl-3-tosylurea; Willbutamide; Tolylsulfonylbutylurea; Diasulfon; Butamide; Tolbusal; Pramidex; Ipoglicone; Dirastan; Diabuton; Glyconon; Diabetamid; Orezan; Oralin; Toluina; Oterben; Drabet; Toluvan; Orinaz; Mobenol; Butamid; Artozin; 1-Butyl-3-(p-tolylsulfonyl)urea; Sk-tolbutamide; N-n-Butyl-N'-tosylurea; Tolbutamida; Tolbutamidum; 1-p-Toluenesulfonyl-3-butylurea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tol	C12H18N2O3S	JLRGJRBPOGGCBT-UHFFFAOYSA-N	1-butyl-3-(4-methylphenyl)sulfonylurea	n.a.	n.a.
PMDBD857	Tolnaftate	Therapeutic Substance	Approved Drug	2398-96-1	DB00525	PA164752438	D00381	DAP001237	5510	5309	n.a.	tolnaftate; 2398-96-1; Tolnaphthate; Tonoftal; Tinactin; Sporiline; Tolsanil; Tinaderm; Aftate; Chinofungin; Focusan; Tinavet; Dermoxin; Pitrex; Naphthiomate T; Phytoderm; Tritin; Timoped; HI-Alazin; Fungistop; Tolnaftatum; Tolnaftato; Sorgoa; Tniaderm; Dungistop; Separin; Tolnaftato [DCIT]; Naphthiomate-T; Hi-alarzin; O-2-Naphthyl m,N-dimethylthiocarbanilate; Tolnaftatum [INN-Latin]; Sch 10144; Tolnaftato [INN-Spanish]; 2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate; Tinavet (Veterinary); m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester	C19H17NOS	FUSNMLFNXJSCDI-UHFFFAOYSA-N	O-naphthalen-2-yl N-methyl-N-(3-methylphenyl)carbamothioate	Schering-Plough	Antifungal Agents
PMDBD1472	Trazodone	Therapeutic substance	Drug	19794-93-5	DB00656	PA451744	D08626	DAP000104	5533	5332	n.a.	trazodone; Trazodon; 19794-93-5; Trazonil; Trazalon; Desirel; Beneficat; Trazodil; Sideril; Trazodona; Trazodonum; Trazodonum [INN-Latin]; Trazodona [INN-Spanish]; Trazodonum [Latin]; Trazodona [Spanish]; Trazodone [INN:BAN]; UNII-YBK48BXK30; C19H22ClN5O; EINECS 243-317-1; CHEMBL621; BRN 0628010; YBK48BXK30; CHEBI:9654; Oleptro; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; 2-(3-[4-(3-Chlorophenyl)-1-piperazi	C19H22ClN5O	PHLBKPHSAVXXEF-UHFFFAOYSA-N	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one	n.a.	n.a.
PMDBD1474	Triamterene	Therapeutic substance	Drug	396-01-0	DB00384	PA451752	D00386	DAP000575	5546	5345	n.a.	triamterene; 396-01-0; 6-phenylpteridine-2,4,7-triamine; 2,4,7-Triamino-6-phenylpteridine; Dyrenium; Dytac; Pterophene; Triteren; Triamteril; Triamteren; Pterofen; Teridin; Taturil; Diurene; Ademine; Noridil; Ademin; Urocaudal; Triampur; Noridyl; Jatropur; Dyren; Teriam; Diren; Ditak; Tri-Span; Triamteril complex; Trispan; 6-Phenyl-2,4,7-pteridinetriamine; Diucelpin; Triamthiazid; Triurene; Tricilone; Triamizide; Esiteren; Diuteren; Dinazide; Masuharmin; Jenateren; Diutensat; Renezide; Kalspare; Hypertorr; Hidiurese; Dytenzide; Dyberzide; Isobar; Amtere	C12H11N7	FNYLWPVRPXGIIP-UHFFFAOYSA-N	6-phenylpteridine-2,4,7-triamine	n.a.	n.a.
PMDBD1475	Triazolam	Therapeutic substance	Drug	28911-01-5	DB00897	PA451753	D00387	DAP000244	5556	5355	n.a.	triazolam; Halcion; 28911-01-5; Songar; Clorazolam; Novidorm; Triazolamum [INN-Latin]; 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; U-33,030; DEA No. 2887; CCRIS 1932; U 33030; UNII-1HM943223R; HSDB 6759; EINECS 249-307-3; CHEMBL646; U-33030; BRN 1226643; 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; C17H12Cl2N4; CHEBI:9674; 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine; 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro	C17H12Cl2N4	JOFWLTCLBGQGBO-UHFFFAOYSA-N	8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine	n.a.	n.a.
PMDBD869	Triclosan	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	3380-34-5	DB08604	n.a.	D06226	n.a.	5564	5363	NPC205213	triclosan; 3380-34-5; 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL; 2,4,4'-Trichloro-2'-hydroxydiphenyl ether; Irgasan; Cloxifenolum; Triclosanum; Irgasan DP300; Stri-Dex Face Wash; Lexol 300; Stri-Dex Cleansing Bar; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; Triclosanum [INN-Latin]; CH 3565; DP-300; Caswell No. 186A; C12H7Cl3O2; UNII-4NM5039Y5X; HSDB 7194; CHEBI:164200; Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl; EINECS 222-182-2; CHEMBL849; EPA Pestic	C12H7Cl3O2	XEFQLINVKFYRCS-UHFFFAOYSA-N	5-chloro-2-(2,4-dichlorophenoxy)phenol	n.a.	Antibiotics
PMDBD1478	Trifluoperazine	Therapeutic substance	Drug	117-89-5	DB00831	PA451771	D08636	DAP000034	5566	5365	n.a.	trifluoperazine; Trifluperazine; Trifluoroperazine; 117-89-5; Triperazine; Triflurin; Trifluoperazin; Trifluoperazina; Trifluoromethylperazine; Flurazine; Stelazine; Triphthasine; Trifluroperizine; Trifluoperazinum; Trifluoperazine hydrochloride; Trifluoperazina [Italian]; RP 7623; Fluoperazine; Trifluoperazine [INN:BAN]; TFP; Trifluoperazinum [INN-Latin]; Trifluoperazina [INN-Spanish]; Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine	C21H24F3N3S	ZEWQUBUPAILYHI-UHFFFAOYSA-N	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	n.a.	n.a.
PMDBD873	Trihexyphenidyl	Therapeutic Substance	Approved Drug	144-11-6	DB00376	PA164747026	D08638	DAP001532	5572	5371	n.a.	trihexyphenidyl; Benzhexol; Triphenidyl; Parkinane retard; 144-11-6; Trihexyphenidyle; Benzhexolum; Sedrena (free base); Trihexyphenidylum; Trihexyphenidyle [INN-French]; Trihexyphenidylum [INN-Latin]; Trihexifenidilo [INN-Spanish]; Trihexyphenidyl [INN:BAN]; 1-cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol; HSDB 3196; EINECS 205-614-4; NSC 12268; 1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol; BRN 0088959; CHEB	C20H31NO	HWHLPVGTWGOCJO-UHFFFAOYSA-N	1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol	Lederle Laboratories Div American Cyanamid Co	Antiparkinson Agents
PMDBD1479	Trimethobenzamide	Therapeutic substance	Drug	138-56-7	DB00662	PA164764516	D08643	n.a.	5577	5375	n.a.	trimethobenzamide; 138-56-7; Tigan; N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide; Trimetobenzamida; Trimethobenzamidum; Trimetobenzamida [INN-Spanish]; Trimethobenzamidum [INN-Latin]; Trimethobenzamide [INN]; UNII-W2X096QY97; HSDB 3198; EINECS 205-332-1; CHEBI:27796; 4-(2-Dimethylaminoethoxy)-N-(3,4,5-trimethoxybenzoyl)benzylamine; W2X096QY97; Tribenzagan; Stemetic; N-((2-Dimethylaminoethoxy)benzyl)-3,4,5-trimethoxybenzamide; Benzacot; Trimethobenzamide (INN)	C21H28N2O5	FEZBIKUBAYAZIU-UHFFFAOYSA-N	N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide	n.a.	n.a.
PMDBD877	Trimethoprim	Therapeutic Substance	Approved Drug	738-70-5	DB00440	PA451788	D00145	DAP000927	5578	5376	n.a.	trimethoprim; 738-70-5; Proloprim; Trimpex; Trimetoprim; Monotrimin; Monotrim; Trimopan; Bactramin; 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine; Wellcoprim; Monoprim; Trimanyl; Syraprim; Uretrim; Triprim; 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine; Trimethoprime; Trimethoprimum; Abaprim; Apo-Sulfatrim; Zamboprim; Sulfoxaprim; Sulfamar; Sinotrim; Pancidim; NIH 204; Bacticel; Wellcoprin; Urobactrim; Streptoplus; Kombinax; Colizole; Briscotrim; Biosulten; Bethaprim; Antrimox; Trisulfam; Trisulcom; Sugaprim; Novotrimel; Lagatrim; Fermagex; Es	C14H18N4O3	IEDVJHCEMCRBQM-UHFFFAOYSA-N	5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine	GlaxoSmithKline	Antiinfective Agents
PMDBD878	Troglitazone	Therapeutic Substance	Approved Drug	97322-87-7	DB00197	PA451799	D00395	DAP001337	5591	5389	n.a.	troglitazone; 97322-87-7; Rezulin; Romglizone; Prelay; CS-045; Romozin; Noscal; CS 045; Rezulin (TN); GR 92132X; CCRIS 8969; GR92132X; CI-991; GR-92132X; CI 991; CHEBI:9753; C24H27NO5S; (+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione; 5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione; Troglitazone (CS-045); BRN 4338399; NCGC00164445-01; DSSTox_CID_3719; DSSTox_RID_77162; DSSTox_GSID_23719; 2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7	C24H27NO5S	GXPHKUHSUJUWKP-UHFFFAOYSA-N	5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	Daiichi Sankyo Pharma Development	Antiinflammatory Agents
PMDBD1488	Venlafaxine	Therapeutic substance	Drug	93413-69-5	DB00285	PA451866	D08670	DAP000054	5656	5454	n.a.	venlafaxine; 93413-69-5; Elafax; D,L-Venlafaxine; Venlafaxina; Venlafaxinum; 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol; Venlafaxine [INN:BAN]; Venlafaxinum [INN-Latin]; Venlafaxin; Venlafaxina [INN-Spanish]; 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol; Efectin; CHEBI:9943; HSDB 6699; NCGC00095109-01; DSSTox_CID_3737; DSSTox_RID_77175; DSSTox_GSID_23737; Venlafexine; Venlafa	C17H27NO2	PNVNVHUZROJLTJ-UHFFFAOYSA-N	1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol	n.a.	n.a.
PMDBD907	Zafirlukast	Therapeutic Substance	Approved Drug	107753-78-6	DB00549	PA451949	D00411	DAP000091	5717	5515	n.a.	zafirlukast; 107753-78-6; Accolate; Olmoran; ICI-204219; Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate; Accoleit; ICI 204219; C31H33N3O6S; ICI 204,219; UNII-XZ629S5L50; Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate; Zafirlukast (Accolate); CHEMBL603; Aeronix; CHEBI:10100; XZ629S5L50; 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide; NCGC00164547-06; NCGC00164547-01; Vanticon; DSSTox_C	C31H33N3O6S	YEEZWCHGZNKEEK-UHFFFAOYSA-N	cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate	AstraZeneca plc	Antiasthmatic Agents
PMDBD908	Zaleplon	Therapeutic Substance	Approved Drug	151319-34-5	DB00962	PA451952	D00530	DAP000266	5719	5517	n.a.	zaleplon; 151319-34-5; Sonata; Zerene; CL-284846; SKP-1041; N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide; ZAL-846; CL 284846; LJC 10846; CL 284,846; DEA No. 2781; ZAL 846; L846; L-846; UNII-S62U433RMH; LJC-10846; 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide; N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide; S62U433RMH; CHEBI:10102; 3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide; N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide; NCGC0016	C17H15N5O	HUNXMJYCHXQEGX-UHFFFAOYSA-N	N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide	King Pharm	Hypnotics and Sedatives
PMDBD915	Zonisamide	Therapeutic Substance	Approved Drug	68291-97-4	DB00909	PA451978	D00538	DAP000500	5734	5532	n.a.	zonisamide; 68291-97-4; Zonegran; 1,2-Benzisoxazole-3-methanesulfonamide; Excegram; Exceglan; 1,2-benzoxazol-3-ylmethanesulfonamide; Zonisamidum [Latin]; Zonisamida [Spanish]; AD-810; Zonisamidum; Zonisamida; CI-912; 3-(Sulfamoylmethyl)-1,2-benzisoxazole; CI 912; AD 810; benzo[d]isoxazol-3-ylmethanesulfonamide; PD 110843; 1-(1,2-Benzoxazol-3-Yl)methanesulfonamide; Benzo[d]isoxazol-3-yl-methanesulfonamide; PD-110843; HSDB 7293; UNII-459384H98V; BRN 1077076; SPR_2; C8H8N2O3S; 1-(1,2-benzisoxazol-3-yl)methanesulfonamide; Excegran; NCGC00	C8H8N2O3S	UBQNRHZMVUUOMG-UHFFFAOYSA-N	1,2-benzoxazol-3-ylmethanesulfonamide	Eisai	Analgesics
PMDBD916	Zotepine	Therapeutic Substance	Approved Drug	26615-21-4	DB09225	n.a.	D01321	n.a.	5736	5534	n.a.	zotepine; 26615-21-4; Nipolept; Lodopin; Zoleptil; Zotepina; Zotepinum; Compound-4; Zotepina [Spanish]; Zotepinum [INN-Latin]; Zotepina [INN-Spanish]; C18H18ClNOS; UNII-U29O83JAZW; 2-Chloro-11-(2-(dimethylamino)ethoxy)dibenzo(b,f)thiepin; 2-Chlor-11-(2-dimethylaminoaethoxy)-dibenzo(b,f)-thiepin; BRN 1435710; U29O83JAZW; CHEMBL285802; CHEBI:32316; 2-[(8-chlorodibenzo[b,f]thiepin-10-yl)oxy]-N,N-dimethylethanamine; 2-Chloro-11-(2-dimethylaminoethoxy)-dibenzo(b,f)thiepine; NCGC00182081-02; 2-Chlor-11-(2-dimethylaminoaethoxy)-dibenzo	C18H18ClNOS	HDOZVRUNCMBHFH-UHFFFAOYSA-N	2-(3-chlorobenzo[b][1]benzothiepin-5-yl)oxy-N,N-dimethylethanamine	n.a.	n.a.
PMDBD259	Dexamethasone	Therapeutic Substance	Approved Drug	n.a.	DB01234	PA449247	D00292	DAP000007	5743	5541	n.a.	dexamethasone; 50-02-2; Decadron; Maxidex; Dexamethazone; Dexasone; Hexadrol; Oradexon; Prednisolone F; Hexadecadrol; Millicorten; Desametasone; Cortisumman; Decaspray; Calonat; Dexacort; Auxiron; Dexason; Azium; Fluormethylprednisolone; Aeroseb-Dex; Visumetazone; Mediamethasone; Desamethasone; Superprednol; Deltafluorene; Turbinaire; Dextelan; Dexameth; Decaderm; Gammacorten; Fortecortin; Dexadeltone; Dexacortal; Dekacort; Dectancyl; Decasone; Mymethasone; Dinormon; Dexapolcort; Dexalona; Dexacortin; Desameton; Desadrene; Aphtasolon; Dergramin; Dexone	C22H29FO5	UREBDLICKHMUKA-CXSFZGCWSA-N	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	Swiss Pharma	Antiinflammatory Agents
PMDBD1130	Cortisone Acetate	Therapeutic substance	Drug	1950/4/4	DB01380	PA449130	D00973	n.a.	5745	5543	n.a.	CORTISONE ACETATE; Cortisone 21-acetate; 50-04-4; Cortone acetate; Incortin; Biocort acetate; Scheroson; Artriona; Cortadren; Cortisyl; Adreson; Irisone acetate; Cortelan; Cortistab; Ricortex; Corlin; Cortogen acetate; Compound E acetate; Cortisone (acetate); Cortisone monoacetate; NSC 49420; Cortisone, 21-acetate; Cortilen; UNII-883WKN7W8X; 11-Dehydro-17-hydroxycorticosterone-21-acetate; CCRIS 3661; 11-Dehydro-17-hydroxycorticosterone acetate; EINECS 200-006-5; 17-Hydroxy-3,11,20	C23H30O6	ITRJWOMZKQRYTA-RFZYENFJSA-N	[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	n.a.	n.a.
PMDBD1227	Hydrocortisone	Therapeutic substance	Drug	50-23-7	DB00741	PA449905	D00088	DAP000718	5754	5551	n.a.	hydrocortisone; Cortisol; 50-23-7; Cetacort; Acticort; Hydrocortisyl; Hydrasson; Cobadex; Signef; Hytone; Cortef; Hycort; Optef; 17-Hydroxycorticosterone; Kendall's compound F; Hydrocortone; Hycortol; Efcorbin; Cortiment; Cortifan; Corticreme; Cortanal; Traumaide; Permicort; Ficortril; Dermacort; Tarcortin; Hycortole; Cortispray; Proctocort; Genacort; Efcortelan; Dermolate; Cortonema; Cortenema; Cleiton; Alacort; Cortril; Dihydrocostisone; Hytone lotion; Hydro-Adreson; Hidro-Colisona; Scheroson F; Reichstein's substance M; Incortin-H; Polcort H; Esider	C21H30O5	JYGXADMDTFJGBT-VWUMJDOOSA-N	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD1378	Prednisolone	Therapeutic substance	Drug	50-24-8	DB00860	PA451096	D00472	DAP000419	5755	5552	n.a.	prednisolone; 50-24-8; Metacortandralone; Hydroretrocortine; Predonine; Meticortelone; Deltacortril; Deltahydrocortisone; Prenolone; Hydroretrocortin; Delta-Cortef; PRDL; Hydrodeltalone; Hydrodeltisone; Deltacortenol; Prednelan; Precortancyl; Paracotol; Lentosone; Dydeltrone; Dicortol; Delcortol; Decaprednil; Sterolone; Predonin; Predniliderm; Fernisolone; Donisolone; Cortalone; Scherisolon; Rolisone; Hydeltrone; Estilsona; Codelcortone; Prednicen; Precortisyl; Precortilon; Paracortol; Hydeltra; Erbasona; Erbacort; Deltisilone; Cotogesic; Prelone; St	C21H28O5	OIGNJSKKLXVSLS-VWUMJDOOSA-N	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD315	Estradiol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	50-28-2	DB00783	PA449503	D00105	DAP000854	5757	5554	NPC48342	estradiol; beta-Estradiol; 17beta-Estradiol; 50-28-2; Oestradiol; Dihydrofolliculin; Estrace; Ovocyclin; progynon; Dihydrotheelin; Dihydroxyestrin; Vivelle; Gynoestryl; Gynergon; Diogynets; Aquadiol; Diogyn; Oestroglandol; Ovahormon; Femestral; Estrovite; Primofol; Follicyclin; Profoliol; Ginosedol; Corpagen; Aerodiol; Perlatanol; Ovastevol; Ovasterol; Oestergon; Macrodiol; Dimenformon; Lamdiol; Femogen; Evorel; Divigel; Vagifem; Altrad; Climara; Bardiol; Syndiol; Dihydromenformon; estradiol-17beta; cis-Estradiol; Estraderm TTS; Trocosone; Estroclim; Est	C18H24O2	VOXZDWNPVJITMN-ZBRFXRBCSA-N	(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol	n.a.	Estrogens
PMDBD739	Reserpine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	50-55-5	DB00206	PA451236	D00197	DAP000755	5770	5566	NPC88923	reserpine; 50-55-5; Serpalan; Serpasil; Serpivite; Apoplon; Hypersil; Alserin; Rausedil; Raupasil; Elserpine; Deserpine; Serpanray; Reserpin; Rauwasedin; Raunervil; Rausedyl; Hiserpia; Sandril; Resine; Serpate; Rivasin; (-)-Reserpine; Rau-Sed; Reserpamed; Helfoserpin; Eskaserpine; Reserpanca; Maviserpin; Bioserpine; Austrapine; Ascoserpina; Mayserpine; Hiposerpil; Enipresser; Rauserpine; Purserpine; Mephaserpin; Restran; Resercen; Rauwilid; Rausingle; Raurine; Raupoid; Rauloydin; Raudiford; Quiescin; Eskaserp; Benazyl; Reserpina; Reserpil; Reserpene; Reserba	C33H40N2O9	QEVHRUUCFGRFIF-MDEJGZGSSA-N	methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	n.a.	Antihypertensive Agents
PMDBD355	Floxuridine	Therapeutic Substance	Approved Drug	50-91-9	DB00322	PA449652	D04197	DAP001245	5790	5586	n.a.	floxuridine; 50-91-9; 5-Fluorodeoxyuridine; 2'-Deoxy-5-fluorouridine; Fluorodeoxyuridine; FUDR; Floxuridin; Deoxyfluorouridine; 5-Fluoro-2'-deoxyuridine; Fluoruridine deoxyribose; 5FdU; Floxuridinum; Floxiridina; 5-Fluoro-2-desoxyuridine; FdUrd; beta-5-Fluoro-2'-deoxyuridine; 5 Fluorodeoxyuridine; Floxuridinum [INN-Latin]; 5-Fluorouracil 2'-deoxyriboside; Floxiridina [INN-Spanish]; 5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione; 5-Fluoro-2-deoxyuridine; 5-Fluorouracil deoxyribo	C9H11FN2O5	ODKNJVUHOIMIIZ-RRKCRQDMSA-N	5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	Heidelberger	n.a.
PMDBD1421	Spironolactone	Therapeutic substance	Drug	1952/1/7	DB00421	PA451483	D00443	DAP000297	5833	5628	n.a.	spironolactone; 52-01-7; Aldactone; Spirolactone; Verospiron; Spirolang; Verospirone; Euteberol; Spiroctan; Acelat; Aldactone A; Spironocompren; Uractone; Spiresis; Spiridon; Urusonin; Melarcon; Xenalon; Spirone; Alderon; Dira; Spiro-Tablinen; Spironolactone A; spironolattone; Aquareduct; Aldopur; Spironolactonum; Espironolactona; Deverol; Almatol; Aldace; Altex; Spironolattone [DCIT]; Berlactone; SC 9420; Spironolactonum [INN-Latin]; Espironolactona [INN-Spanish]; SC-9420; UNII-27O7W4T232; C24H32O4S; HSDB 3184; EINECS 200-133-6; NSC 150399; BRN 005	C24H32O4S	LXMSZDCAJNLERA-ZHYRCANASA-N	S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate	n.a.	n.a.
PMDBD505	Lynestrenol	Therapeutic Substance	Approved Drug	52-76-6	DB12474	n.a.	n.a.	n.a.	5857	5648	n.a.	LYNESTRENOL; 52-76-6; Linestrenol; Ethynylestrenol; Ethinylestrenol; Orgametrol; Orgametril; Lynoestrenol; Exluton; Endometril; Exlution; Exlutona; Orgametil; 3-Desoxynorlutin; Ethynloestrenol; Lynenol; Lynstranol; Exluten; Ethinyloestranol; Ethinyl oestrenol; NSC-37725; Org 485-50; IND 1006; Linestrenolo [DCIT]; 17alpha-Ethynylestrenol; 17-alpha-Ethynylestrenol; 17-alpha-Ethynyloestrenol; UNII-N2Z8ALG4U5; Lynestrenolum [INN-Latin]; Linestrenol [INN-Spanish]; CCRIS 9093; EINECS 200-151-4; Lynoestrenol [Progestins]; NSC 37725; Estr-4-en-17be	C20H28O	YNVGQYHLRCDXFQ-XGXHKTLJSA-N	(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	n.a.	n.a.
PMDBD1379	Prednisone	Therapeutic substance	Drug	1953/3/2	DB00635	PA451100	D00473	DAP001041	5865	5656	n.a.	prednisone; 53-03-2; Dehydrocortisone; Deltasone; Decortin; Meticorten; Orasone; Ultracorten; Rectodelt; Dacortin; Encorton; Deltacortone; Deltacortisone; Sterapred; Decortisyl; Colisone; Encortone; Decortancyl; Deltison; Prednison; Prednilonga; Paracort; Ancortone; Cortan; 1,2-Dehydrocortisone; Liquid Pred; Di-Adreson; Zenadrid; Ultracortene; Prednisonum; Hostacortin; Dekortin; Bicortone; Supercortil; Servisone; Prednidib; Panafcort; Lisacort; Cortidelt; Pronison; Prednizon; Enkorton; Diadreson; Winpred; Cotone; Nurison; Lodotra; Juvason; Wojtab; Panasol	C21H26O5	XOFYZVNMUHMLCC-ZPOLXVRWSA-N	(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione	n.a.	n.a.
PMDBD1183	Estrone	Therapeutic substance	Drug	53-16-7	DB00655	PA449512	D00067	DAP001020	5870	5660	n.a.	estrone; 53-16-7; folliculin; OESTRONE; Theelin; estrovarin; follicular hormone; Estrugenone; Kestrone; Estron; Follicunodis; Hormestrin; Thelykinin; Oestronum; Aquacrine; Disynformon; Destrone; Oestroperos; Oestroform; Hiestrone; Glandubolin; Folliculine; Kolpon; Oestrin; Folisan; Folipex; Femidyn; Menagen; Unden; Ketohydroxyestrin; Ketohydroxyoestrin; Estrone-A; Endofolliculina; Thelestrin; Hormofollin; Crinovaryl; Wynestron; Thynestron; Solliculin; Menformon; Hormovarine; Follestrol; Folikrin; Estrusol; Crystogen; Cristallovar; Ovifollin; Ketodestrin	C18H22O2	DNXHEGUUPJUMQT-CBZIJGRNSA-N	(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one	n.a.	n.a.
PMDBD438	Idoxuridine	Therapeutic Substance	Approved Drug	54-42-2	DB00249	PA164781019	D00342	DAP000997	5905	5694	n.a.	idoxuridine; 5-Iodo-2'-deoxyuridine; 54-42-2; 5-Iododeoxyuridine; Idoxuridin; Iododeoxyridine; Iodoxuridine; (+)-5-Iodo-2'-deoxyuridine; IUDR; Joddeoxiuridin; 2'-Deoxy-5-iodouridine; Stoxil; Herplex; Dendrid; Idoxene; Allergan 211; IDUR; Kerecid; Virudox; Iduridin; 5IUDR; Idoxuridinum; Antizona; Idoxuridina; Heratil; Allergan 201; IDU; 5-Iodouracil deoxyriboside; Idossuridina [DCIT]; IdUrd; 5-IUDR; Iduoculos; 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil; Herplex liquifilm; Idoxuridinum [INN-Latin]; Idoxuridina [INN-Spanish]; Ophthalmadine; Sp	C9H11IN2O5	XQFRJNBWHJMXHO-RRKCRQDMSA-N	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione	n.a.	n.a.
PMDBD1364	Pilocarpine	Therapeutic substance	Drug	92-13-7	DB01085	PA450962	D00525	DAP001113	5910	5699	n.a.	pilocarpine; Pilokarpin; 92-13-7; Pilocarpol; Syncarpine; Pilocarpin; Salagen; Pilokarpol; (+)-Pilocarpine; Isoptocarpine; Ocusert pilo; Ocusert pilo-20; Ocusert Pilo-40; Ocusert P 20; Pilocarpine chloride; UNII-01MI4Q9DI3; (3S,4R)-3-Ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one; (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one; HSDB 3163; Pilocarpine monohydrochloride; EINECS 202-128-4; CHEMBL550; AI3-50523; CHEBI:8207; 01MI4Q9DI3; (3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl	C11H16N2O2	QCHFTSOMWOSFHM-WPRPVWTQSA-N	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one	n.a.	n.a.
PMDBD178	Chloramphenicol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	56-75-7	DB00446	PA448927	D00104	DAP001356	5959	5744	NPC159589	chloramphenicol; 56-75-7; Chloromycetin; Chlornitromycin; Levomycetin; Halomycetin; Levomicetina; Globenicol; Chlorocid; Chloroamphenicol; Oleomycetin; Detreomycin; Chlorocol; Chloramex; Alficetyn; Fenicol; Leukomycin; Enteromycetin; Sificetina; Juvamycetin; Cloramicol; Chloramficin; Aquamycetin; D-Chloramphenicol; Chloramfilin; Amphenicol; Novophenicol; Intramycetin; Stanomycetin; Levomitsetin; Laevomycetinum; Dextromycetin; Micochlorine; Ciplamycetin; Mediamycetine; Detreomycine; Chloronitrin; Loromisin; Leukomyan; Isicetin; Embacetin; Econochlo	C11H12Cl2N2O5	WIIZWVCIJKGZOK-RKDXNWHRSA-N	2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	Aventis Pharmaceuticals Inc.	Antibiotics
PMDBD1384	Progesterone	Therapeutic substance	Drug	57-83-0	DB00396	PA451123	D00066	DAP000549	5994	5773	n.a.	progesterone; 57-83-0; Pregn-4-ene-3,20-dione; Agolutin; Luteohormone; Crinone; 4-Pregnene-3,20-dione; Utrogestan; Syngesterone; Progestin; Luteol; Corpus luteum hormone; Progesterol; Pregnenedione; Glanducorpin; Progestron; Gestormone; Prometrium; Corlutin; Cyclogest; Progestone; Gestone; Methylpregnone; Progesteronum; Progestasert; Progestronol; Hormoflaveine; Piaponon; Lutocylin; Lutociclina; Luteovis; Luteosan; Luteopur; Luteogan; Hormoluton; Flavolutan; Syngestrets; Proluton; Progekan; Nalutron; Lutoform; Gynlutin; Gesterol; Fologenon; Corporin	C21H30O2	RJKFOVLPORLFTN-LEKSSAKUSA-N	(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD836	Testosterone propionate	Therapeutic Substance	Approved Drug	57-85-2	DB01420	PA164751373	D00959	n.a.	5995	5774	n.a.	testosterone propionate; 57-85-2; Agovirin; Androteston; Aquaviron; Hormoteston; Androlon; Enarmon; Bio-testiculina; Androtest P; Testonique; Androsteston; Sterandryl; Testolets; Synerone; Solvotest; Pantestin; Orchistin; Masenate; Uniteston; Tostrin; Testormol; Synandrol; Testoxyl; Testosid; Testogen; Testodrin; Telipex; Propiokan; Andronate; Testrex; Testodet; Testaform; Orchiol; Nasdol; Vulvan; Enarmon-oil; Okasa-Mascul; Neo-Hombreol; Andrusol-P; Oreton propionate; Recthormone testosterone; NSC 9166; Testosteroni propionas; Testosteron propionate	C22H32O3	PDMMFKSKQVNJMI-BLQWBTBKSA-N	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate	n.a.	n.a.
PMDBD1037	Apomorphine	Therapeutic substance	Drug	58-00-4	DB00714	PA164781163	D07460	DAP000281	6005	5783	n.a.	apomorphine; L-Apomorphine; Apomorphin; Apomorfin; Apokyn; Uprima; R-(-)-Apomorphine; Ixense; 58-00-4; Apomorphine hydrochloride; (-)-10,11-Dihydroxyaporphine; 6abeta-Aporphine-10,11-diol; UNII-N21FAR7B4S; Apomorphine [BAN]; HSDB 3289; C17H17NO2; 6a-beta-Aporphine-10,11-diol; Apomorphine hydrochloride hemihydrate; CHEMBL53; EINECS 200-360-0; VR-040; N21FAR7B4S; Apormorphine; CHEBI:48538; Apomorphine (BAN); (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol; NCGC00025349-02; Apomorphinium chloride hemihydrate; DSST	C17H17NO2	VMWNQDUVQKEIOC-CYBMUJFWSA-N	(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol	n.a.	n.a.
PMDBD1445	Tetrabenazine	Therapeutic substance	Drug	58-46-8	DB04844	PA140222719	D08575	DAP000756	6018	5796	n.a.	TETRABENAZINE; 58-46-8; Nitoman; Tetrabenzaine; 718635-93-9; Rubigen; Tetrabenzine; tetra Benazin; Xenazine; Tetrabenazine Racemate; Tetrabenazinum [INN-Latin]; Tetrabenazina [INN-Spanish]; Tetrabenazine (Racemate); Ro 1-9569; 3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one; Tetrabenazinum; 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one; NSC 169886; Ro 1-9569/12; MLS003106727; CHEMBL117785; Tetrabenazine [INN:BAN]; CHEBI:64028; (-)-tetrabenazine; 1,3	C19H27NO3	MKJIEFSOBYUXJB-UHFFFAOYSA-N	9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one	n.a.	n.a.
PMDBD466	Kanamycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	n.a.	DB01172	PA450137	n.a.	DNC000201	6032	5810	NPC43850	kanamycin; KANAMYCIN A; Kanamycin Base; 59-01-8; Kanamycine; Kanamicina [Italian]; KM (the Antibiotic); Kanamycin [INN:BAN]; Kanamycine [INN-French]; Kanamycinum [INN-Latin]; UNII-EQK9Q303C5; CHEBI:17630; HSDB 3107; C18H36N4O11; EINECS 200-411-7; BRN 0061647; 4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside; EQK9Q303C5; KAN; 8063-07-8; Kanamycinum; Kanamicina; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucop	C18H36N4O11	SBUJHOSQTJFQJX-NOAMYHISSA-N	(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	n.a.	n.a.
PMDBD371	Folic acid	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	59-30-3	DB00158	PA449692	D00070	DAP001309	6037	5815	NPC147983	nan	C19H19N7O6	OVBPIULPVIDEAO-LBPRGKRZSA-N	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid	n.a.	n.a.
PMDBD1362	Phenylephrine	Therapeutic substance	Drug	59-42-7	DB00388	PA450935	D08365	DAP000224	6041	5818	n.a.	phenylephrine; L-Phenylephrine; 59-42-7; Metasympatol; Mezaton; Neosynephrine; Metasynephrine; Metaoxedrin; m-Oxedrine; Metaoxedrine; Visadron; Mesatone; Mesaton; m-Sympatol; Isophrin; m-Synephrine; m-Sympathol; R(-)-Phenylephrine; Metaoxedrinum; Mesatonum; Phenylephrinum; Fenilefrina; m-Methylaminoethanolphenol; Neo-Synephrine; Isophrim; 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol; Ak-dilate; Ah-Chew; Mydfrin; Cyclomydril; Fenilefrina [INN-Spanish]; Phenylephrinum [INN-Latin]; l-(3-Hydroxyphenyl)-N-methylethanolamine	C9H13NO2	SONNWYBIRXJNDC-VIFPVBQESA-N	3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol	n.a.	n.a.
PMDBD476	Levodopa	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	59-92-7	DB01235	PA450213	D00059	DAP000209	6047	5824	NPC161593	levodopa; L-dopa; 59-92-7; 3,4-dihydroxy-L-phenylalanine; 3-Hydroxy-L-tyrosine; Dopar; Larodopa; Bendopa; Levopa; 3-(3,4-Dihydroxyphenyl)-L-alanine; Cidandopa; Insulamina; Maipedopa; Eldopal; Dopasol; Dopaidan; Prodopa; Pardopa; Eldopar; Syndopa; Dopalina; 3,4-Dihydroxyphenylalanine; Dihydroxy-L-phenylalanine; (-)-Dopa; Helfo-Dopa; Dopaflex; Brocadopa; Deadopa; Dopal-fher; Dopastral; Dopaston; Doparkine; Eurodopa; Eldopatec; Veldopa; Doprin; Doparl; (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; L-3,4-Dihydroxyphenylalanine; Dopa; Levedopa	C9H11NO4	WTDRDQBEARUVNC-LURJTMIESA-N	(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid	Orion Corp	n.a.
PMDBD1031	Ampicillin	Therapeutic substance	Antibiotics	69-53-4	DB00415	PA448419	D00204	DAP000432	6249	6013	n.a.	ampicillin; 69-53-4; Aminobenzylpenicillin; Ampicillin acid; Amcill; Polycillin; Principen; Penbritin; Ampicilline; Omnipen; Totacillin; Synpenin; Tokiocillin; Pentrexyl; Novo-ampicillin; anhydrous ampicillin; D-Ampicillin; D-(-)-Ampicillin; Ultrabion; Sumipanto; Semicillin; Rosampline; Penicline; Divercillin; Campicillin; Ultrabron; Totalciclina; Racenacillin; Pentrexl; Orbicilina; Grampenil; Delcillin; Copharcilin; Austrapen; Amplital; Ampifarm; Ampichel; Princillin; Penbrock; Guicitrina; Duphacillin; Britacil; Bonapicillin; Amplipenyl; Ampipenin	C16H19N3O4S	AVKUERGKIZMTKX-NJBDSQKTSA-N	(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD1136	Cytarabine	Therapeutic substance	Drug	147-94-4	DB00987	PA449177	D00168	DNC001551	6253	6017	n.a.	cytarabine; 147-94-4; Cytosine arabinoside; Ara-C; Arabinocytidine; Cytosar; Tarabine; Udicil; Alexan; Cytosar-U; 1-beta-D-Arabinofuranosylcytosine; Cytarabina; Aracytin; Arabitin; Erpalfa; Arafcyt; Depocyt; DepoCyte; Arabinofuranosylcytosine; Cytarabin; Arabinosylcytosine; Aracytidine; Cytosine beta-D-arabinofuranoside; Cytosinearabinoside; Cytosine-beta-D-arabinofuranoside; Cytarabinoside; Cytarabinum; Citarabina; Cytonal; beta-D-Arabinosylcytosine; Depocyt (liposomal); Cytosine arabinofuranoside; Cytarabinum [INN-Latin]; Citarabina [INN	C9H13N3O5	UHDGCWIWMRVCDJ-CCXZUQQUSA-N	4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	n.a.	n.a.
PMDBD872	Trifluridine	Therapeutic Substance	Approved Drug	70-00-8	DB00432	PA451775	D00391	DAP000760	6256	6020	n.a.	Trifluridine; TRIFLUOROTHYMIDINE; 70-00-8; Viroptic; 5-Trifluorothymidine; Trifluoromethyldeoxyuridine; Trifluridina; Virophta; Trifluridinum; F3TDR; F3DThd; TFDU; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; Trifluridinum [INN-Latin]; Trifluridina [INN-Spanish]; Trifluorothymine deoxyriboside; 2'-Deoxy-5-(trifluoromethyl)uridine; 5-Trifluoro-2'-deoxythymidine; 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; 2'-Deoxy-5-trifluoromethyluridine	C10H11F3N2O5	VSQQQLOSPVPRAZ-RRKCRQDMSA-N	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione	Monarch Pharmaceuticals	Antiviral Agents
PMDBD1281	Mestranol	Therapeutic substance	Drug	72-33-3	DB01357	PA450388	D00575	DAP001014	6291	6054	n.a.	mestranol; 72-33-3; Norquen; Menophase; Devocin; Ovastol; Ethynylestradiol 3-methyl ether; Mestranolum; 3-Methoxyethynylestradiol; EE(sub3)ME; delta-MVE; Ethynylestradiol methyl ether; 3-Methylethynylestradiol; EE3ME; Inostral (steroid); Mestranolo [DCIT]; 3-O-Methylethynylestradiol; Compound 33355; Inostral; 3-Methylethynyloestradiol; 3-Methoxyethynyloestradiol; Mestranolum [INN-Latin]; 3-Methoxy-17alpha-ethynylestradiol; Caswell No. 547A; Ethinylestradiol 3-methyl ether; Ethinyloestradiol 3-methyl ether; SC 4725; Ethynyloestradiol 	C21H26O2	IMSSROKUHAOUJS-MJCUULBUSA-N	(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol	n.a.	n.a.
PMDBD880	Tryptophan	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	73-22-3	DB00150	PA10323	D00020	DAP001316	6305	6066	NPC203468	L-tryptophan; 73-22-3; tryptophan; L-Tryptophane; h-Trp-oh; (S)-Tryptophan; Tryptophane; Optimax; tryptacin; trofan; Ardeytropin; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; Pacitron; Indole-3-alanine; L-beta-3-Indolylalanine; Kalma; L-Tryptofan; L-Trp; L-(-)-Tryptophan; 3-Indol-3-ylalanine; Tryptan; Lyphan; Tryptophan (VAN); Tryptophan (H-3); 1-beta-3-Indolylalanine; Tryptophanum [Latin]; Triptofano [Spanish]; 1H-Indole-3-alanine; 1beta-3-Indolylalanine; triptofano; 2-Amino-3-indolylpropanoic acid; Tryptophanum; Tryptophane [French]; (S	C11H12N2O2	QIVBCDIJIAJPQS-VIFPVBQESA-N	(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid	n.a.	Antidepressants
PMDBD538	Methsuximide	Therapeutic Substance	Approved Drug	77-41-8	DB05246	PA164743145	D00404	DAP001253	6476	6231	n.a.	METHSUXIMIDE; Mesuximide; 77-41-8; Celontin; Petinutin; Methsuximid; Metsuccimide; 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione; Mesuximidum; mesuximid; alpha-Methylphensuximide; N,2-Dimethyl-2-phenylsuccinimide; 1,3-Dimethyl-3-phenylsuccinimide; Metosuccimmide [DCIT]; Mesuximidum [INN-Latin]; Mesuximida [INN-Spanish]; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; PM 396; 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione	C12H13NO2	AJXPJJZHWIXJCJ-UHFFFAOYSA-N	1,3-dimethyl-3-phenylpyrrolidine-2,5-dione	Pfizer Pharmaceuticals	Anticonvulsants
PMDBD1060	Bisphenol A	Environmental Chemicals	Bisphenols	1980/5/7	DB06973	n.a.	n.a.	n.a.	6623	6371	n.a.	Bisphenol A; 80-05-7; 2,2-Bis(4-hydroxyphenyl)propane; 4,4'-Isopropylidenediphenol; Bisphenol; Diphenylolpropane; 4,4'-Bisphenol A; Diano; 4,4'-(propane-2,2-diyl)diphenol; 2,2-Bis(p-hydroxyphenyl)propane; Biphenol A; Parabis A; DIAN; Rikabanol; p,p'-Bisphenol A; p,p'-Isopropylidenebisphenol; Bisphenol-A; Bisferol A; 2,2-Di(4-phenylol)propane; p,p'-Dihydroxydiphenylpropane; Ipognox 88; Pluracol 245; 4,4'-Dihydroxydiphenylpropane; 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol	C15H16O2	IISBACLAFKSPIT-UHFFFAOYSA-N	4-[2-(4-hydroxyphenyl)propan-2-yl]phenol	n.a.	n.a.
PMDBD1288	Methylprednisolone	Therapeutic substance	Drug	83-43-2	DB00959	PA450466	D00407	DAP001040	6741	6485	n.a.	methylprednisolone; 83-43-2; Medrol; Metilprednisolone; Medrone; Urbason; 6alpha-Methylprednisolone; Metilbetasone; Medrate; Dopomedrol; Promacortine; Besonia; Metastab; Mesopren; Solomet; Noretona; Moderin; Wyacort; Urbasone; Metrisone; Medesone; Methylprednisolon; Suprametil; Sieropresol; Metysolon; Esametone; Reactenol; Firmacort; Metrocort; Methyleneprednisolone; Nirypan; Medixon; Lemod; Artisone-wyeth; Medrol dosepak; 6-alpha-Methylprednisolone; Medrol adt pak; Predni N Tablinen; Medlone 21; Metilprednisolone [DCIT]; Summicort;; Metilpredniso	C22H30O5	VHRSUDSXCMQTMA-PJHHCJLFSA-N	(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD461	Isosorbide dinitrate	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	87-33-2	DB00883	PA450125	D00516	DAP001057	6883	6619	NPC85078	ISOSORBIDE DINITRATE; 87-33-2; Sorbide nitrate; Isordil; Sorbidnitrate; Nitrosorbide; Dinitrosorbide; Isoket; Vascardin; Sorbitrate; Sorbidilat; Sorbonit; Isotrate; Isorbid; Flindix; Carvasin; Dilatrate-SR; Sorbislo; Sorbangil; Nitrosorbid; Myorexon; Iso-Bid; ISDN; Cedocard; Nitrosorbon; Cornilat; Vasodilat; Corosorbide; Claodical; Vasorbate; Resoidan; Harrical; Difutrat; Carvanil; Emoper; Tinidil; Sorquad; Rigedal; Cardis; Korodil; Maycor; Lomilan; Coronex; Xanyl; Nosim; Sorbide, dinitrate; Isordil Tembids; Rifloc Retard; Dilatrate; Dinitroisosorbide; Car	C6H8N2O8	MOYKHGMNXAOIAT-JGWLITMVSA-N	[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate	Biovail Corporation 	Vasodilator Agents
PMDBD1360	Phenformin	Therapeutic substance	Drug	114-86-3	DB00914	PA1000	D08351	DAP000206	8249	7953	n.a.	PHENFORMIN; 114-86-3; N-Phenethylbiguanide; Fenformin; Phenformine; Phenethyldiguanide; Fenformina; Phenylethylbiguanide; Pedg; Glukopostin; Cronoformin; Phenformix; Fenormin; Fenfoduron; Retardo; Dibiraf; Glyphen; Dibotin; Diabis; Debeone; Db-retard; beta-PEBG; Normoglucina; Lentobetic; Insoral; Azucaps; Feguanide; Debinyl; DB Comb; Dibein; 1-Phenethylbiguanide; D Bretard; beta-Phenethylbiguanide; Phenforminum; Fenformina [INN-Spanish]; Phenformine [INN-French]; Phenforminum [INN-Latin]; N-(2-Ph	C10H15N5	ICFJFFQQTFMIBG-UHFFFAOYSA-N	1-(diaminomethylidene)-2-(2-phenylethyl)guanidine	n.a.	n.a.
PMDBD579	Neomycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	1404-04-2	DB00994	PA450608	D08260	DAP000036	8378	n.a.	NPC176381	Framycetin; neomycin; NEOMYCIN B; Soframycin; Mycifradin; Fradiomycin; Actiline; Soframycine; Neomas; Framycetinum; Framycetine; Framicetina; Antibiotique; Fradiomycinum; Myacyne; Framygen; Neolate; Nivemycin; Actilin; Enterfram; Caswell No. 595; Vonamycin powder V; Neomcin; Neomycin B sulfate; Neomin; Fradiomycin B; Neo-Rx; Neomicina [DCIT]; 119-04-0; Framycetinum [INN-Latin]; Neomycine [INN-French]; Neomycinum [INN-Latin]; Framycetine [INN-French]; Framicetina [INN-Spanish]; Framycetin [INN:BAN:DCF]; 1404-04-2; NEOMYCIN SULFATE; CCRIS 5462	C23H46N6O13	PGBHMTALBVVCIT-VCIWKGPPSA-N	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	n.a.	Antibiotics
PMDBD191	Cianidanol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	154-23-4	DB14086	n.a.	n.a.	n.a.	9064	8711	NPC219876	(+)-catechin; Cianidanol; CATECHIN; 154-23-4; Catechuic acid; Cyanidanol; Catechinic acid; D-Catechin; Catergen; (+)-Cyanidanol; (+)-Catechol; Cianidol; (+)-Cyanidan-3-ol; (+)-Catechin Hydrate; Biocatechin; D-(+)-Catechin; D-Catechol; Dexcyanidanol; Catechin (flavan); Catechol (flavan); (2R,3S)-Catechin; (2R,3S)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; Gambier; (2R,3S)-(+)-Catechin; Cianidanolum; Catechu; Transepar; Katha; Cutch (dye); (+)-Cianidanol; 3,3',4',5,7-Flavanpentol; KB-53; (+)-Cyanidanol-3; CCRIS 6855; Ciani	C15H14O6	PFTAWBLQPZVEMU-DZGCQCFKSA-N	(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol	n.a.	n.a.
PMDBD1027	Aminophylline	Therapeutic substance	Drug	317-34-0	DB01223	PA164781029	D00227	DAP000613	9433	9062	n.a.	aminophylline; 317-34-0; Aminophyllin; Phyllocontin; Theophyllamine; Somophyllin; Cardophyllin; Aminodur; Truphylline; Theophylline ethylenediamine; Phyllindon; Peterphyllin; Methophylline; Metaphylline; Inophylline; Diuxanthine; Variaphylline; Thephyldine; Metaphyllin; Eurphyllin; Diaphylline; Theophyldine; Theolamine; Syntophyllin; Stenovasan; Phylcardin; Linampheta; Genophyllin; Aminocardol; Vasofilina; Theophyllaminum; Norofilina; Neophyiline; Ethophylline; Cardophylin; Cardiofilina; Theolone; Theodrox; Euufillin; Minaphil; Diophllin; Grifomin	C16H24N10O4	FQPFAHBPWDRTLU-UHFFFAOYSA-N	1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine	n.a.	n.a.
PMDBD377	Galantamine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	357-70-0	DB00674	PA449726	D04292	DAP000559	9651	9272	NPC78359	galanthamine; Galantamine; 357-70-0; (-)-Galanthamine; Lycoremine; Lycoremin; Jilkon; Reminyl; Razadyne; Galanthaminum; Nivalin; Razadyne ER; Galantaminum [INN-Latin]; Galantamina [INN-Spanish]; UNII-0D3Q044KCA; NSC 100058; BRN 0093736; HSDB 7361; Reminyl (TN); Galantamina; CHEMBL659; 0D3Q044KCA; (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol; CHEBI:42944; Galanthamine base; NCGC00017256-04; Galantaminum; (-)-Galantamine; GNT; Galantamine [USAN:INN]; Galanthamine HBr; (1S,12S,14R)-9-m	C17H21NO3	ASUTZQLVASHGKV-JDFRZJQESA-N	(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol	Janssen Pharmaceutica	Parasympathomimetics
PMDBD1056	Betamethasone	Therapeutic substance	Drug	378-44-9	DB00443	PA164754818	D00244	DAP001043	9782	9399	n.a.	betamethasone; 378-44-9; Betadexamethasone; Flubenisolone; Betamethazone; Visubeta; Rinderon; Betapredol; Betacortril; Betacorlan; Betasolon; Betametasone; Celestene; Betnelan; Methazon; Betsolan; Betamamallet; Cidoten; Bebate; Becort; Bedifos; beta-Methasone; Desacort-Beta; Rinderon A; beta-Methasone alcohol; Betafluorene; Celestone; Betamethasone cream; Betametasona; Betamethasonum; Betamethasone alcohol; Betametasone [DCIT]; Hormezon; 9alpha-Fluoro-16beta-methylprednisolone; Betamethasonum [INN-Latin]; Celestone Syrup and Tablets; Betameta	C22H29FO5	UREBDLICKHMUKA-DVTGEIKXSA-N	(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD364	Fluorometholone	Therapeutic Substance	Approved Drug	426-13-1	DB00324	PA164781355	D01367	DAP001047	9878	9494	n.a.	fluorometholone; 426-13-1; Oxylone; Fluormetholone; Flumetholon; Delmeson; Cortilet; FML Liquifilm; Fluor-Op; Trilcin; Fluoromethalone; FML Forte; Fluormetholonum; Fluorometolona; Fluorometholonum; Neo-Oxylone; Fluorometolone [DCIT]; FML-S Liquifilm; Fluormetholon; Fluorometolona [INN-Spanish]; Fluorometholonum [INN-Latin]; NSC 33001; component of Neo-Oxylone; UNII-SV0CSG527L; FML; U 8614; (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	C22H29FO4	FAOZLTXFLGPHNG-KNAQIMQKSA-N	(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one	Alcon Laboratories	Antiallergic Agents
PMDBD240	Cyproterone acetate	Therapeutic Substance	Approved Drug	427-51-0	DB04839	PA10049	D01368	DAP000906	9880	9496	n.a.	CYPROTERONE ACETATE; 427-51-0; Androcur; Cyproterone 17-O-acetate; Cyproteroneacetate; Cyproteron acetate; Cyproteron-R acetate; Cyprosterone acetate; NSC-81430; SH 714; UNII-4KM2BN5JHF; SH 80714; Cyproterone 17alpha-acetate; SH-714; CCRIS 4385; HSDB 3592; Cyproterone acetate [USAN:JAN]; EINECS 207-048-3; NSC 81430; 4KM2BN5JHF; C24H29ClO4; MLS000859908; Cyproterone 17.alpha.-acetate; CHEMBL139835; (1R,3aS,3bR,7aR,8aS,8bS,8cS,10a	C24H29ClO4	UWFYSQMTEOIJJG-FDTZYFLXSA-N	[(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate	n.a.	n.a.
PMDBD177	Chenodeoxycholic acid	Herbal Substance	Medicinal Herbal Compounds	474-25-9	DB06777	PA165958403	D00163	n.a.	10133	9728	n.a.	chenodeoxycholic acid; Chenodiol; Chenic acid; Chenix; Cdca; Chenodeoxycholate; 474-25-9; Chenodesoxycholic acid; Gallodesoxycholic acid; Chendol; Anthropodeoxycholic acid; Anthropodesoxycholic acid; Chenofalk; Anthropododesoxycholic acid; Chenodesoxycholsaeure; Henohol; Xenbilox; Chenique Acid; Chenocholic acid; Chenodiol [USAN]; 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid; Sodium chenodeoxycholate; Acido chenodeoxicholico; Chenodesoxycholsaeure [German]; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Acide chenodeoxycholique	C24H40O4	RUDATBOHQWOJDD-BSWAIDMHSA-N	(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	Sigma Tau Pharmaceuticals Inc	n.a.
PMDBD420	Hesperidin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	520-26-3	DB04703	PA449867	D01038	n.a.	10621	10176	NPC79056	hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesper bitabs; Hesperetin-rutinosid; Hesperetin 7-rhamnoglucoside; Hesperidine; Ciratin; (S)-(-)-Hesperidin; NSC 44184; UNII-E750O06Y6O; CCRIS 3940; Hesperitin-7-rutinoside; EINECS 208-288-1; BRN 0075140; Hesperetin 7-rutinoside; MLS001304066; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one; CHEBI:28775; USAF CF-3; Hesperidin, 	C28H34O15	QUQPHWDTPGMPEX-QJBIFVCTSA-N	(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one	n.a.	n.a.
PMDBD527	Metamfetamine	Therapeutic Substance	Approved Drug	537-46-2	DB01577	PA450403	n.a.	DAP001496	10836	10379	n.a.	METHAMPHETAMINE; Metamfetamine; d-Methamphetamine; d-Deoxyephedrine; d-Desoxyephedrine; d-N-Methylamphetamine; Metamphetamine; d-Methylamphetamine; Methylamphetamine; d-Phenylisopropylmethylamine; N-Methylamphetamine; (S)-Methamphetamine; Norodin; (+)-Methylamphetamine; d-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropane; Desyphed; (+)-N-Methylamphetamine; (S)-Methylamphetamine; (+)-(S)-Deoxyephedrine; Methyl-beta-phenylisopropylamine; 1-Phenyl-2-methylaminopropane; (S)-(+)-Deoxyephedrine; Metamfetamina; Metamfetaminum; Stimulex	C10H15N	MYWUZJCMWCOHBA-VIFPVBQESA-N	(2S)-N-methyl-1-phenylpropan-2-amine	Ovation Pharma	Central Nervous System Stimulants
PMDBD475	Levocarnitine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	541-15-1	DB00583	PA450154	D02176	DAP000958	10917	10455	NPC295832	L-carnitine; Levocarnitine; 541-15-1; vitamin BT; (R)-Carnitine; Carnitor; Carnitine; (-)-Carnitine; Karnitin; (-)-L-Carnitine; L-(-)-Carnitine; Carnitene; Levocarnitina; Metina; L-Carnitine inner salt; Levocarnitinum; Carniking; Carnovis; Carnitolo; Carnilean; Carrier; Lefcar; L(-)-Carnitine; Levocarnitinum [Latin]; Levocarnitina [Spanish]; Carniking 50; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; Levocarnitine [USAN:INN]; gamma-Trimethyl-beta-hydroxybutyrobetaine; bicarnesine; gamma-Trimethyl-ammonium-beta-hydroxybut	C7H15NO3	PHIQHXFUZVPYII-ZCFIWIBFSA-N	(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate	n.a.	n.a.
PMDBD182	Chlorotrianisene	Therapeutic Substance	Approved Drug	569-57-3	DB00269	PA164768822	D00269	DAP001012	11289	10815	n.a.	chlorotrianisene; 569-57-3; Chlortrianizen; Chlortrianisestrol; TACE; Chlorotrianisine; Chlortrianisen; Chlorotrianizen; Chlorestrolo; Chloortrianisestrol; Khlortrianizen; Hormonisene; Clorotrisin; Merbentul; Clorestrolo; Metace; Anisene; Rianil; Chlortrianisoestrolum; Chlortrianisene; Chlorotrisin; Tri-p-anisylchloroethylene; Chlortrianisenum; Tace-fn; Tris(p-methoxyphenyl)chloroethylene; Clorotrianiseno; Trianisestrol; Triagen; Chlorotrianisenum [INN-Latin]; Chlorotrianisenum; Tace (pharmaceutical); Clorotrianiseno [INN-Spanish]; Chloro	C23H21ClO3	BFPSDSIWYFKGBC-UHFFFAOYSA-N	1-[1-chloro-2,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene	n.a.	Anticancer Agents
PMDBD471	Lactulose	Therapeutic Substance	Approved Drug	4618-18-2	DB00581	PA164748762	D00352	n.a.	11333	10856	n.a.	lactulose; Duphalac; D-Lactulose; Chronulac; Bifiteral; Constilac; Cephulac; Cholac; Lactulosa; Isolactose; Constulose; Laevolac; Heptalac; Portalac; Laxilose; Lactulosum; Generlac; Enulose; Acilac; Lactulosum [Latin]; Lactulosa [Spanish]; Lattulosio [Italian]; Lactulosum [INN-Latin]; Lactulosa [INN-Spanish]; UNII-9XH2P2N8EP; 4-O-beta-D-Galactopyranosyl-D-fructose; EINECS 225-027-7; BRN 6278818; BRN 0093773; 9XH2P2N8EP; 4-O-beta-D-Galactopyranosyl-D-fructofuranose; 4-beta-D-Galactosido-(1,4)-D-fructose; D-Fructose, 4-O-beta-D-galactopyran	C12H22O11	JCQLYHFGKNRPGE-FCVZTGTOSA-N	(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD519	Megestrol acetate	Therapeutic Substance	Approved Drug	595-33-5	DB00351	PA450351	D00952	DAP000861	11683	11192	n.a.	MEGESTROL ACETATE; 595-33-5; Megace; Megestryl acetate; Megace ES; Niagestin; Magestin; Megeron; Ovarid; Ovaban; Pallace; Ovaban (Veterinary); Megestat; Megestrol-17-acetate; NSC-71423; UNII-TJ2M0FR8ES; BDH 1298; Maygace; CCRIS 372; SC10363; 17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate; SC 10363; EINECS 209-864-5; 6-Dehydro-6-methyl-17alpha-acetoxyprogesterone; 17alpha-Acetoxy-6-dehydro-6-methylprogesterone; 6-Methyl-6-dehydro-17alpha-acetoxyprogesterone; 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate; TJ2M0	C24H32O4	RQZAXGRLVPAYTJ-GQFGMJRRSA-N	[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate	n.a.	n.a.
PMDBD314	Erythromycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	114-07-8	DB00199	PA449493	D00140	DAP000111	12560	12041	NPC227622	erythromycin; Erythromycin A; 114-07-8; E-Mycin; Abomacetin; Erythrocin; Erythromycinum; Erymax; Emgel; Erythromycine; Eritromicina; Erythro-Statin; Ilotycin; E-Glades; Eryacne; (-)-ERYTHROMYCIN; Erythromycin base; Torlamicina; Robimycin; Abboticin; Erycette; Ery-Tab; E-Base; erythro; Erythroguent; Propiocine; Erythromid; Erycinum; Mephamycin; Dumotrycin; Eritrocina; Stiemycin; Pantomicina; Erythrogran; Ilocaps; Erygel; Ermycin; Sansac; Eryderm; Erycin; Erycen; Dotycin; Wemid; Aknin; ERYC; Eryc Sprinkles; Theramycin Z; Erythra-Derm; Kesso-Mycin	C37H67NO13	ULGZDMOVFRHVEP-RWJQBGPGSA-N	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	Eli Lilly	Antibiotics
PMDBD477	Levonorgestrel	Therapeutic Substance	Approved Drug	797-63-7	DB00367	PA450218	D00950	DAP001207	13109	12560	n.a.	Levonorgestrel; norgestrel; 797-63-7; D-Norgestrel; (-)-Norgestrel; Microval; Postinor; Levonova; Mirena; Jadelle; Neogest; Ovrette; Plan B; NORPLANT; Norplant 2; Microlution; Follistrel; Triciclor; Microgyn; Triagynon; Microlut; Ovranette; Monovar; Nordet; Trigoa; 18-Methylnorethisterone; Microgynon CD; Microgest ED; Norplant II; Ovral-Lo; Logynon ED; Levlen ED; Trinordiol 28; Trinordiol 21; Microgynon 28; Microgynon 21; d(-)-Norgestrel; Monofeme 28; Stediril 30; Nordette 21; Nordette 28; Minivlar 30; Neogynon 21; Levonelle; Trifeme 28; Preven; Tri-Le	C21H28O2	WWYNJERNGUHSAO-XUDSTZEESA-N	(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD1490	Vinblastine	Therapeutic substance	Drug	865-21-4	DB00570	PA451877	n.a.	DAP000785	13342	12773	n.a.	vinblastine; Vinblastin; Vincaleucoblastin; Vincaleukoblastine; Vincoblastine; Rozevin; Nincaluicolflastine; Vinblastina [DCIT]; 865-21-4; Vinblastine [INN:BAN]; Vinblastinum [INN-Latin]; Velbe; VR-8; UNII-5V9KLZ54CY; CCRIS 9002; HSDB 3263; NCI-C04842; C46H58N4O9; NDC 0002-1452-01; EINECS 212-734-0; NSC 47842; Velban; CHEMBL159; 29060-LE; 5V9KLZ54CY; Vinblastinum; Vinblastina; VLB; (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(metho	C46H58N4O9	JXLYSJRDGCGARV-CFWMRBGOSA-N	methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate	n.a.	n.a.
PMDBD316	Estradiol Valerate	Therapeutic Substance	Approved Drug	979-32-8	DB13956	n.a.	n.a.	n.a.	13791	13194	n.a.	estradiol valerate; 979-32-8; Delestrogen; Estradiol 17-valerate; Estradiol valerianate; Neofollin; Estraval; Progynova; Femogex; Progynon-Depot; Oestradiol valerate; Climaval; Atladiol; Pharlon; Duratrad; Deladiol; Estate; Dura-estradiol; Exten strone; Repo-Estra; Depo estro med; Delestrogen 4X; Estraval PA; Estraval 2X; Estroval-10; Delahormone unimatic; Depo-Estro-Med; Femogen-L.A.; Primogyna; Gynokadin; Ronfase; Pelanin; Merimono; Cyclocur; Postoval; Nuvelle; Estradiol Depot; Primogyn-Depot; Gynogen L.A. 20; Gynogen L.A. 40; Gynogen L.A. 10	C23H32O3	RSEPBGGWRJCQGY-RBRWEJTLSA-N	[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate	n.a.	n.a.
PMDBD888	Vancomycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	1404-90-6	DB00512	PA451850	D00212	DAP001330	14969	14253	NPC314743	VANCOMYCIN; Vancocin; Vancoled; Vancomycinum; Vancomycine; Vancomicina; 1404-90-6; VANCOR; Vancomycinum [INN-Latin]; Vancomycine [INN-French]; Vancomicina [INN-Spanish]; UNII-6Q205EH1VU; HSDB 3262; EINECS 215-772-6; CHEMBL262777; 6Q205EH1VU; CHEBI:28001; Vancomycin (USP); vancomicin; vanomycin; Vancomycin [USP:INN:BAN]; Vancomycin [USAN:INN:BAN]; Vancomycin hydrochloride from Streptomyces orientalis; C66H75Cl2N9O24; Viomycin derivative; [(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-d	C66H75Cl2N9O24	MYPYJXKWCTUITO-LYRMYLQWSA-N	(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid	n.a.	n.a.
PMDBD408	Glycyrrhizin	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	14982	n.a.	NPC202666	Glycyrrhizic acid; glycyrrhizin; Glycyrrhizinic acid; 1405-86-3; Glycyron; Glycyrrhetinic acid glycoside; glyzyrrhizin; Glizigen; 18-beta-Glycyrrhizic acid; Glycyrrizin; Liquorice; UNII-6FO62043WK; Rizinsan K2 A2 (free acid); HSDB 496; CHEBI:15939; EINECS 215-785-7; C42H62O16; Glycyrrhizin [JAN]; NSC 167409; NSC 234419; BRN 0077922; CHEMBL441687; NSC 2800; beta-Glycyrrhizin; Dipotassium glycyrrhizinate; 6FO62043WK; NSC-234419; NSC-167409; DSSTox_RID_82047; DSSTox_CID_27006; DSSTox_GSID_47006; Glycyram	C42H62O16	LPLVUJXQOOQHMX-QWBHMCJMSA-N	(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid	n.a.	n.a.
PMDBD528	Metaxalone	Therapeutic Substance	Approved Drug	1665-48-1	DB00660	PA164747189	D00773	n.a.	15459	14709	n.a.	METAXALONE; 1665-48-1; Skelaxin; Methaxalonum; Zorane; Metaxalon; Methoxolone; 5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one; Metazolone; Metazalone; Metaxolone; AHR-438; Metaxalonum [Latin]; Metassalone [DCIT]; Metaxalonum [INN-Latin]; Metaxalona [INN-Spanish]; AHR 438; 5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one; 5-(3,5-Xyloloxymethyl)oxazolidin-2-one; Metaxalona [Spanish]; CL 39,148; NSC 170959; Metaxalone [USAN:INN:BAN]	C12H15NO3	IMWZZHHPURKASS-UHFFFAOYSA-N	5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one	Elan Corp plc	n.a.
PMDBD1025	Amiloride	Therapeutic substance	Drug	2609-46-3	DB00594	PA448368	D07447	DAP000187	16231	15403	n.a.	AMILORIDE; Amipramidin; 2609-46-3; Midamor; Guanamprazine; Amipramizide; Amipramizid; Guanamprazin; Amilorida; Amiloridum; Amyloride; Amiloridum [INN-Latin]; Amilorida [INN-Spanish]; 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; Amiloride [INN:BAN]; N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide; C6H8ClN7O; UNII-7DZO8EB0Z3; CCRIS 6545; EINECS 220-024-7; 3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide; N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid; Amiloride hydrochloride hydrate; Pyrazinecarboxamide	C6H8ClN7O	XSDQTOBWRPYKKA-UHFFFAOYSA-N	3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide	n.a.	n.a.
PMDBD671	Pimozide	Therapeutic Substance	Approved Drug	2062-78-4	DB01100	PA450965	D00560	DAP000316	16362	15520	n.a.	pimozide; 2062-78-4; Orap; Opiran; Pimozidum; Pimozidum [INN-Latin]; McN-JR-6238; R-6238; Primozida [INN-Spanish]; R 6238; UNII-1HIZ4DL86F; R6238; NSC 170984; McN-JR 6238; CCRIS 9172; C28H29F2N3O; EINECS 218-171-7; BRN 0729089; 1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone; 1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone; 1HIZ4DL86F; CHEMBL1423; 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine; 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-o	C28H29F2N3O	YVUQSNJEYSNKRX-UHFFFAOYSA-N	3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one	Janssen Pharmaceutica	Antipsychotic Agents
PMDBD804	Streptomycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	57-92-1	DB01082	PA451512	n.a.	DAP000144	19649	18508	NPC94319	streptomycin; 57-92-1; Strepcen; Streptomycin A; Gerox; Streptomycine; Streptomycin sulphate; Agrimycin; Chemform; Streptomycin sulfate; CHEBI:17076; UNII-Y45QSO73OB; Agrept; Neodiestreptopab; NSC-14083; Y45QSO73OB; Streptomycin A sulfate; Streptomycinum; Hokko-mycin; 2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside; Caswell No. 804; Streptomyzin [German]; Streptomicina [Italian]; Streptomycin [INN:BAN]; Estreptomicina [INN-Spanish]; CCRIS 	C21H39N7O12	UCSJYZPVAKXKNQ-HZYVHMACSA-N	2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	n.a.	n.a.
PMDBD200	Cladribine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	4291-63-8	DB00242	PA449027	D01370	DAP000565	20279	19105	NPC314152	Cladribine; 2-Chloro-2'-deoxyadenosine; 4291-63-8; Leustatin; 2-Chlorodeoxyadenosine; 2-CdA; Cladarabine; Chlorodeoxyadenosine; CldAdo; Litak; 2-Chloro-2'-deoxy-beta-adenosine; Cladaribine; 2-chloro-deoxyadenosine; 2ClAdo; RWJ 26251; UNII-47M74X9YT5; MLS000028377; NSC 105014-F; RWJ-26251; NSC 105014; BRN 0624220; (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; SMR000058553; Leustat; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-chloro-6-amino-9-(2-deoxy-beta	C10H12ClN5O3	PTOAARAWEBMLNO-KVQBGUIXSA-N	(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	n.a.	Anticancer Agents
PMDBD1197	Flucloxacillin	Therapeutic substance	Antibiotics	5250-39-5	DB00301	PA164781042	D04196	DAP001163	21319	20037	n.a.	Flucloxacillin; FLOXACILLIN; Floxapen; 5250-39-5; flucloxacilina; Flucloxacilline; Flucloxacillinum; flucloxacillin sodium; Flucloxacilline [INN-French]; Flucloxacilina [INN-Spanish]; Flucloxacillinum [INN-Latin]; Floxacillin [USAN]; BRL 2039; 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin; Flucloxacillin-Sodium; C19H17ClFN3O5S; UNII-43B2M34G2V; Floxacillin (USAN); CHEBI:5098; Flucloxacillin (INN); Floxapen (TN); EINECS 226-051-0; Floxacillin sodium salt; 43B2M34G2V; BRL-2039; Flucloxacillin [INN]	C19H17ClFN3O5S	UIOFUWFRIANQPC-JKIFEVAISA-N	(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD278	Dihydrostreptomycin sulfate	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	21653	n.a.	NPC121479	Dihydrostreptomycin sulfate; Didromycin; Didromycine; Panstreptin; 5490-27-7; UNII-T7D4876IUE; Abiocine; Dihydrostreptomycin 3/2 sulfate; Dihydrostreptomycin Sulfate [USP]; DIHYDROSTREPTOMYCIN SESQUISULFATE; EINECS 226-823-7; AI3-50133; T7D4876IUE; Dihydrostreptomycin sequisulphate; Dihydrostreptomycin sulfate (2:3)(salt); Dihydrostreptomycin sulfate (USP); D-Streptamine, O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-5-deoxy-3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl-(1-4)-N,N'-bis(aminoiminomethyl)-, sulfate (2:	C42H88N14O36S3	CZWJCQXZZJHHRH-YCRXJPFRSA-N	2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid	n.a.	n.a.
PMDBD1489	Vidarabine	Therapeutic substance	Drug	24356-66-9	DB00194	PA451876	D00406	DAP000642	21704	20400	n.a.	Vidarabine; Adenine arabinoside; Ara-A; 5536-17-4; Arabinosyladenine; Vira-A; Spongoadenosine; Araadenosine; 9-beta-D-Arabinofuranosyladenine; Arabinosyl adenine; Arabinoside adenine; Arasena-A; Vidarabine anhydrous; Vidarabin; Vira ATM; Vidarabina [DCIT]; (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-BETA-D-ARABINOFURANOSYL-ADENINE; 9beta-D-Arabinofuranosyladenine; 9-beta-Arabinoadenosine; beta-D-Arabinosyladenine; araA; Adenine-beta-D-arabinofuranoside; Vidarabinum [INN-Latin]; UNII-3XQD2ME	C10H13N5O4	OIRDTQYFTABQOQ-UHTZMRCNSA-N	(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	n.a.	n.a.
PMDBD1114	Chromium	Environmental Chemicals	Heavy Metals	7440-47-3	DB11136	n.a.	n.a.	n.a.	23976	22412	n.a.	Cr; Chromium; 7440-47-3; Chrome; Chrom; Chromium compounds; Chromium, elemental; cromo; Chromium metal; Chrome [French]; Chrom [German]; chromide(1-); chromium atom; Chromium, metal; CCRIS 159; UNII-0R0008Q3JB; HSDB 910; EINECS 231-157-5; 24Cr; CHEBI:28073; Chromium, metal and insol. salts; 0R0008Q3JB; Chromium, metal and chromium(III) compounds; Chromium metal [Chromium and chromium compounds]; Chromium, 99+%, pure, powder; MFCD00010944; Dinakrome; chromium anion; BioChrome; chromide(-I); Chromium Yeast Dark; Chromium Trituration; Chromi	Cr	VYZAMTAEIAYCRO-UHFFFAOYSA-N	chromium	n.a.	n.a.
PMDBD1072	Camptothecin	Therapeutic substance	Drug	7689/3/4	DB04690	PA153590860	n.a.	n.a.	24360	22775	n.a.	camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; Camptothecine (8CI); Camptothecine (S,+); CHEMBL65; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; UNII-XT3Z54Z28A; MLS000766223; XT3Z54Z28A; CHEBI:27656; NSC-94600; AK-39842; (+)-Camptothecin, 98%; Q-200785; (S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H	C20H16N2O4	VSJKWCGYPAHWDS-FQEVSTJZSA-N	(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione	n.a.	n.a.
PMDBD803	Stanozolol	Therapeutic Substance	Approved Drug	10418-03-8	DB06718	PA165958391	D00444	n.a.	25249	23582	n.a.	stanozolol; Winstrol; Androstanazole; 10418-03-8; Androstanazol; Stromba; Tevabolin; Stanazolol; Winstrol Depot; Strombaject; Estazol; Winstroid; Anabol; Winstrol V; Estanozolol; Stanozololum; Stanozolo [DCIT]; Androstanazole (VAN); WIN 14833; Stanozolol (1'H form); Winstrol-V; Stanozololum [INN-Latin]; Estanozolol [INN-Spanish]; UNII-4R1VB9P8V3; Androstanazolestanazol; HSDB 3185; Stanozolol (2'H form); EINECS 233-894-8; NSC 43193; NSC 233046; 4R1VB9P8V3; CHEBI:9249	C21H32N2O	LKAJKIOFIWVMDJ-IYRCEVNGSA-N	(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol	n.a.	n.a.
PMDBD1076	Carbendazim	Environmental Chemicals	Pesticides	10605-21-7	DB13009	n.a.	n.a.	n.a.	25429	23741	n.a.	Carbendazim; 10605-21-7; Carbendazole; Mecarzole; Bavistin; Carbendazime; Carbendazol; Thicoper; Derosal; Bavistan; Medamine; Funaben; Methyl 2-benzimidazolecarbamate; Garbenda; BMK (fungicide); Kemdazin; Carbendazym; Supercarb; Equitdazin; Agrizim; Kolfugo; Karben; Delsene; Custos; Stempor; Bitosen; Bengard; Battal; Myco; Bavistin 3460; carbendazine; Methyl benzimidazol-2-ylcarbamate; Pillarstin; Falicarben; Fungisol; Triticol; Stein; Spin; Bercema-Bitosen; Kolfugo Extra; Preventol BCM; Antibac MF; Carben VL; Funaben 3; BCM (fungicide); METHYL 1H-BEN	C9H9N3O2	TWFZGCMQGLPBSX-UHFFFAOYSA-N	methyl N-(1H-benzimidazol-2-yl)carbamate	n.a.	n.a.
PMDBD553	Misonidazole	Therapeutic Substance	Investigational Drug	13551-87-6	DB11716	n.a.	n.a.	n.a.	26105	24317	n.a.	Misonidazole; 13551-87-6; Ro 7-0582; SRI 1354; Misonidazolum [INN-Latin]; Misonidazol [INN-Spanish]; CCRIS 1160; 1-methoxy-3-(2-nitro-1H-imidazol-1-yl)propan-2-ol; EINECS 236-931-6; 1-(2-Hydroxy-3-methoxypropyl)-2-nitroimidazole; 1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-ol; SR 1354; BRN 0613655; NSC-261,037; alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol; 1-(2-NITRO-1-IMIDAZOLYL)-3-METHOXY-2-PROPANOL; MLS003115361; 1-(2'-hydroxy-3'-methoxypropyl)-2-nitroimidazole; NSC261037; NSC-261037; 1H-Imidazole-1-ethanol, alpha-(m	C7H11N3O4	OBBCSXFCDPPXOL-UHFFFAOYSA-N	1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-ol	n.a.	n.a.
PMDBD260	Diacerein	Therapeutic Substance	Approved Drug	13739-02-1	DB11994	n.a.	n.a.	n.a.	26248	24456	n.a.	Diacerein; 13739-02-1; Diacetylrhein; Diacerhein; Fisiodar; Artrodar; 1,8-DIACETOXY-3-CARBOXYANTHRAQUINONE; DIACERIN; 4,5-Diacetylrhein; Diacereine [French]; Diacereinum [Latin]; Diacereina [Spanish]; SF-277; 4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid; UNII-4HU6J11EL5; C19H12O8; EINECS 237-310-2; BRN 2184909; MLS000028577; 4HU6J11EL5; 1,8-Diacetoxyanthraquinone-3-carboxylic acid; M01AX21; AC-201; 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic 	C19H12O8	TYNLGDBUJLVSMA-UHFFFAOYSA-N	4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid	n.a.	n.a.
PMDBD1414	Selegiline	Therapeutic substance	Drug	14611-51-9	DB01037	PA451316	D03731	DAP000579	26757	24930	n.a.	selegiline; L-Deprenalin; Emsam; Eldepryl; L-Deprenyl; (-)-selegiline; Jumex; 14611-51-9; Carbex; Zelapar; Deprenyl; (-)-Deprenil; Selegilinum; Selegilina; Selegilinum [INN-Latin]; Selegilina [INN-Spanish]; UNII-2K1V7GP655; l-E 250; N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine; CHEMBL972; CHEBI:9086; 2K1V7GP655; Otrasel; (R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine; (R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin; selgene; Anipryl; Selegyline; Benzeneethana	C13H17N	MEZLKOACVSPNER-GFCCVEGCSA-N	(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine	n.a.	n.a.
PMDBD474	Levamisole	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	14769-73-4	DB00848	PA450205	D08114	DAP000570	26879	25037	NPC469974	levamisole; 14769-73-4; Levamisol; L-Tetramisole; Wormicid; Lepuron; Ketrax; LEVOMYSOL; Ergamisol; Levamisolum; (S)-(-)-Levamisole; Vermisol 150; Levamisol [INN-Spanish]; Levamisolum [INN-Latin]; (-)-Tetramisole; (S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole; Levamisole [INN:BAN]; (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole; TCMDC-125847; dl-Tetramisole; UNII-2880D3468G; EINECS 238-836-5; CHEMBL1454; L-2,3,5,6-Tetrahyro-6-phenylimidazo(2,1-b)thiaz	C11H12N2S	HLFSDGLLUJUHTE-SNVBAGLBSA-N	(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole	Janssen Pharmaceutica	Anticancer Agents
PMDBD838	Thiamphenicol	Therapeutic Substance	Approved Drug	15318-45-3	DB08621	n.a.	n.a.	n.a.	27200	25315	n.a.	thiamphenicol; 15318-45-3; Thiophenicol; (+)-Thiamphenicol; Dextrosulphenidol; Raceophenidol; D-Thiocymetin; D-Thiophenicol; Thiamcol; Thiocymetin (TN); Armai (TN); Thiocymetin; Tiamfenicolo [DCIT]; UNII-FLQ7571NPM; Tiamfenicol [INN-Spanish]; Thiamphenicol (Thiophenicol); Macphenicol; C12H15Cl2NO5S; Urfamicina; Thiamphenicolum [INN-Latin]; Descocin; Urfamycine; Igralin; Hyrazin; Dexawin; Rincrol; Neomyson; Masatirin; Efnicol; WIN-5063-2; Unaseran-D; Thiamphenicol [USAN:INN:BAN:JAN]; EINECS 239-355-3; RACEPHENICOL; NSC 522822; FLQ7571NPM; MLS0	C12H15Cl2NO5S	OTVAEFIXJLOWRX-NXEZZACHSA-N	2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide	n.a.	n.a.
PMDBD1265	Manganese	Environmental Chemicals	Heavy Metals	7439-96-5	DB06757	n.a.	D04854	n.a.	27854	25916	n.a.	Manganese(2+); Manganese(II); Manganous ion; Manganese (Mn2+); Mn2+; Manganese ion(2+); Manganese cation; MANGANESE(II) ION; Manganese, ion (Mn2+); Manganese(2+)ions; Manganese cation (2+); UNII-H6EP7W5457; 16397-91-4; Mn(II); Mn++; Mn(2+); H6EP7W5457; 15365-82-9; manganese ion; Manganous cation; Manganous dication; Manganese dication; manganese (II); MnII; Manganese(2+) ion; Mn(II) (incorrect); ion (Mn2+); Manganese cation (Mn2+); Hexaaquamanganese(2+) ion; at. no. 25; Manganese(2+), hexaaqua-, ion; CTK4C7940; CHEBI:29035; DTXSID00167687	Mn+2	WAEMQWOKJMHJLA-UHFFFAOYSA-N	manganese(2+)	n.a.	n.a.
PMDBD624	Ornidazole	Therapeutic Substance	Approved Drug	16773-42-5	DB13026	n.a.	n.a.	n.a.	28061	26102	n.a.	Ornidazole; 16773-42-5; Tiberal; Ornidazolum; Madelen; Ro 7-0207; Ornidazol; 1-chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol; 1-(3-Chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole; 1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)-2-propanol; NSC 95075; 1-(2-Hydroxy-3-chloropropyl)-2-methyl-5-nitroimidazole; Ornidazole [USAN:INN]; Ornidazolum [INN-Latin]; Ornidazol [INN-Spanish]; Ro-70207; CCRIS 9030; CHEBI:75176; EINECS 240-826-0; C7H10ClN3O3; BRN 0614299	C7H10ClN3O3	IPWKIXLWTCNBKN-UHFFFAOYSA-N	1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol	n.a.	n.a.
PMDBD246	Danazol	Therapeutic Substance	Approved Drug	17230-88-5	DB01406	PA164749056	D00289	DAP001017	28417	26436	n.a.	danazol; Danocrine; 17230-88-5; Chronogyn; Danol; Winobanin; Danazole; Cyclomen; Danazolum; Ladogal; Danzol; Danokrin; Danatrol; Danazolum [INN-Latin]; WIN 17757; UNII-N29QWW3BUO; WIN-17757; CCRIS 6747; EINECS 241-270-1; N29QWW3BUO; NSC 270916; Danovaol; 17-alpha-Pregn-4-en-20-yno(2,3-d)isoxazol-17-ol; 17alpha-Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol; 17-alpha-2,4-Pregnadien-20-yno(2,3-d)isoxazol-17-ol; CHEBI:4315; anatrol; NCGC00164400-01; Panacrine; Danoval; Danogen; DSSTox_CID	C22H27NO2	POZRVZJJTULAOH-LHZXLZLDSA-N	(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol	n.a.	Fertility Agents
PMDBD529	Metergoline	Therapeutic Substance	Approved Drug	17692-51-2	DB13520	n.a.	D07218	n.a.	28693	26687	n.a.	metergoline; Liserdol; Metergolin; Methergoline; Metergolina; 17692-51-2; Metergolinum; Metergolinum [Latin]; Metergolina [DCIT]; Metergolina [Spanish]; Metergoline [INN:BAN]; Substance 355/255; C25H29N3O2; Metergolinum [INN-Latin]; 1-Methyl-N-carbobenzyloxydihydro-D-lysergamin; FI-6337; MLS000069437; UNII-1501393LY5; AHR 3009; 1-Methyl-8-beta-carbobenzyloxyaminomethyl-10-alpha-ergoline; EINECS 241-686-3; 1,6-Dimethyl-8-beta-carbobenzyloxaminomethyl-10-alpha-ergoline; FI 6337	C25H29N3O2	WZHJKEUHNJHDLS-QTGUNEKASA-N	benzyl N-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate	n.a.	n.a.
PMDBD1142	Daunorubicin	Therapeutic substance	Drug	20830-81-3	DB00694	PA449212	D07776	DNC000517	30323	28163	n.a.	daunorubicin; Daunomycin; 20830-81-3; Acetyladriamycin; Leukaemomycin C; Rubidomycin; Cerubidine; Daunorubicine; Daunorrubicina; Daunamycin; Daunarubicinum; (+)-Daunomycin; Cerubidin; DaunoXome; Rubomycin C; Daunorubicinum; Daunoblastin; Rubomycin; Daunorubicinum [INN-Latin]; RP 13057; Daunorubicin [INN:BAN]; RCRA waste no. U059; FI6339; NSC-82151; DaunoXome (TN); FI 6339; UNII-ZS7284E0ZP; CCRIS 914; ZS7284E0ZP; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methox	C27H29NO10	STQGQHZAVUOBTE-VGBVRHCVSA-N	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	n.a.	n.a.
PMDBD488	Lofexidine 	Therapeutic Substance	Approved Drug	31036-80-3	DB04948	PA164744510	n.a.	DAP000064	30668	28460	n.a.	Lofexidine; 31036-80-3; Lofexidinum; Lofexidina; Lofexidinum [INN-Latin]; Lofexidina [INN-Spanish]; 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole; Britlofex; 2-[1-(2,6-dichlorophenoxy)ethyl]-2-imidazoline; 2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline; Lofexidine [INN:BAN]; 2-(1-(2,6-Dichlorophenoxy)ethyl)-4,5-dihydro-1H-imidazole; CHEMBL17860; CHEBI:51368; Lucemyra; 1H-Imidazole, 2-(1-(2,6-dichlorop	C11H12Cl2N2O	KSMAGQUYOIHWFS-UHFFFAOYSA-N	2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole	US WorldMeds	Antihypertensive Agents
PMDBD662	Phenoxyethanol	Therapeutic Substance	Approved Drug	122-99-6	DB11304	n.a.	n.a.	n.a.	31236	13848467	n.a.	2-PHENOXYETHANOL; 122-99-6; Phenoxyethanol; Ethylene glycol monophenyl ether; Phenyl cellosolve; Phenoxytol; Phenoxethol; Phenoxetol; Ethylene glycol phenyl ether; Phenoxyethyl alcohol; 2-Phenoxyethan-1-Ol; 1-Hydroxy-2-phenoxyethane; Rose ether; Phenylmonoglycol ether; Arosol; Dowanol EP; 2-Phenoxyethyl alcohol; Glycol monophenyl ether; 2-Hydroxyethyl phenyl ether; Phenylglycol; Fenyl-cellosolve; 2-Fenoxyethanol; Dowanol EPH; 2-Phenoxy-ethanol; Emery 6705; Emeressence 1160; Fenylcelosolv; Marlophen P; beta-Hydroxye	C8H10O2	QCDWFXQBSFUVSP-UHFFFAOYSA-N	2-phenoxyethanol	n.a.	n.a.
PMDBD290	Doxorubicin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	23214-92-8	DB00997	PA449412	D03899	DNC000163	31703	29400	NPC261012	doxorubicin; Adriamycin; 23214-92-8; Doxil; Doxorubicine; Adriablastin; Adriblastina; Doxorubicinum; 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; Adriamycin semiquinone; Doxorubicinum [INN-Latin]; Doxorubicine [INN-French]; Doxorubicina [INN-Spanish]; FI 106; Doxorubicin [USAN:INN:BAN]; Hydroxydaunorubicin; CCRIS 739; HSDB 3070; NDC 38242-874; UNII-80168379AG; NCI-C01514; EINECS 245-495-6; CHEMBL53463; Doxorubicina; CHEBI:28748; NSC 123127	C27H29NO11	AOJJSUZBOXZQNB-TZSSRYMLSA-N	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	Sequus Pharmaceuticals Inc	Anticancer Agents
PMDBD677	Pivampicillin	Therapeutic Substance	Approved Drug	33817-20-8	DB01604	PA164776912	n.a.	DAP001171	33478	30899	n.a.	Pivampicillin; Pivaloylampicillin; Pivaloyloxymethyl ampicillinate; Pivampicilina; Pivampicillinum; Pivampicilline; Ampicillin pivaloyloxymethyl ester; 33817-20-8; Pivampicillinum [INN-Latin]; Pivampicilline [INN-French]; Pivampicilina [INN-Spanish]; Pivampicillin [INN:BAN]; MK 191; UNII-0HLM346LL7; EINECS 251-688-6; 0HLM346LL7; CHEBI:8255; C22H29N3O6S; DSSTox_RID_80890; DSSTox_CID_25459; DSSTox_GSID_45459; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxo	C22H29N3O6S	ZEMIJUDPLILVNQ-ZXFNITATSA-N	2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	Antibiotics
PMDBD42	Amoxicillin	Therapeutic Substance	Approved Drug	26787-78-0	DB01060	PA448406	D07452	DAP000443	33613	31006	n.a.	amoxicillin; Amoxycillin; 26787-78-0; Amoxicillin anhydrous; Amoxicilline; p-Hydroxyampicillin; Amopenixin; Amolin; Moxal; D-Amoxicillin; Clamoxyl; Amoxicillinum; Amoxicilina; Amoxil; Delacillin; Histocillin; Piramox; Aspenil; Amoxivet; Vetramox; Unicillin; Flemoxin; Efpenix; Cemoxin; Bristamox; Anemolin; AMPC; Amoxiden; Amoclen; Amoxi; Sumox; Amoxi-Mast; Sawamox PM; Metafarma capsules; Metifarma capsules; Imacillin; Moxatag; Moxacin; Ibiamox; Amopen; Robamox; Hiconcil; DisperMox; Amoxicillin trihydrate; Amoxicillinum [INN-Latin]; Amoxicilline [INN-Fr	C16H19N3O5S	LSQZJLSUYDQPKJ-NJBDSQKTSA-N	(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	AstraZeneca	Antibiotics
PMDBD1469	Tramadol	Therapeutic substance	Drug	27203-92-5	DB00193	PA451735	D08623	DAP000140	33741	31105	n.a.	Tramadol; (+)-Tramadol; 27203-92-5; cis-Tramadol; Ralivia flashtab; Ralivia ER; Tramadolum [INN-Latin]; Tramadol [INN:BAN]; 123154-38-1; (R,R) tramadol; Tramal; EINECS 248-319-6; UNII-0NG5TTM63P; 0NG5TTM63P; CHEBI:75725; (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol; Ryzolt; 181289-58-7; NCGC00159343-02; Tramadon; (+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol; Racemic tramadol; DSSTox_CID_3691; DSSTox_RID_77150; DSSTox_GSID_23691	C16H25NO2	TVYLLZQTGLZFBW-ZBFHGGJFSA-N	(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol	n.a.	n.a.
PMDBD585	Nicergoline	Therapeutic Substance	Approved Drug	27848-84-6	DB00699	PA164743014	D01290	DAP000902	34040	31373	n.a.	nicergoline; 27848-84-6; Nimergoline; Nimergoline base; Nicotergoline; Nicergolin [German]; Nicergolina [DCIT]; Nicergolinum [INN-Latin]; UNII-JCV8365FWN; C24H26BrN3O3; FI 6714; RP 19651; EINECS 248-694-6; Sermion (TN); NSC 150531; 10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate; BRN 4828393; JCV8365FWN; Nicergolinum; CHEBI:31902; 1-Methyl-lumilysergol 8-(5-bromonicotinate) 10-methyl ether; 10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate (ester); (+)-10-Methoxy-1,6-dimethylergoline-8-beta-methan	C24H26BrN3O3	YSEXMKHXIOCEJA-FVFQAYNVSA-N	[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate	n.a.	Vasodilator Agents
PMDBD629	Oxcarbazepine	Therapeutic Substance	Approved Drug	28721-07-5	DB00776	PA450732	D00533	DAP000528	34312	31608	n.a.	OXCARBAZEPINE; 28721-07-5; Trileptal; Oxcarbamazepine; Oxcarbazepinum; Oxcarbazepina; GP 47680; 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; KIN-493; GP-47680; Oxcarbazepinum [INN-Latin]; 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide; Oxcarbazepina [INN-Spanish]; 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide; UNII-VZI5B1W380; MLS000084586; SPN-804; EINECS 249-188-8; CHEMBL1068; SMR00004	C15H12N2O2	CTRLABGOLIVAIY-UHFFFAOYSA-N	5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide	Norvatis Phamaceuticals Corporation	Anticonvulsants
PMDBD1077	Carbidopa	Therapeutic substance	Drug	28860-95-9	DB00190	PA448794	D00558	DAP000592	34359	31640	n.a.	carbidopa; 28860-95-9; Lodosyn; (S)-(-)-carbidopa; Carbidopa anhydrous; N-Aminomethyldopa; alpha-Methyldopahydrazine; L-alpha-Methyldopahydrazine; S-(-)-Carbidopa; (S)-carbidopa; Carbidopum; Carbidopum [INN-Latin]; Carbidopa (anhydrous); Hadrazino-alpha-methyldopa; S(-)-CARBIDOPA; L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid; UNII-KR87B45RGH; MK 486; CCRIS 5093; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid; (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid; (2S)-3-(3,4-dihydro	C10H14N2O4	TZFNLOMSOLWIDK-JTQLQIEISA-N	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid	n.a.	n.a.
PMDBD909	Zidovudine	Therapeutic Substance	Approved Drug	30516-87-1	DB00495	PA451954	D00413	DAP000701	35370	32555	n.a.	zidovudine; Azidothymidine; 30516-87-1; 3'-Azido-3'-deoxythymidine; Retrovir; AZT; Zidovudinum; Compound S; Zidovudina; ZIDOVUDINE [AZT]; zidovudin; BW A509U; Zidovudinum [Latin]; Zidovudina [Spanish]; BWA509U; ZDV; DRG-0004; 3'-Azido-2',3'-Dideoxythymidine; UNII-4B9XT59T7S; 3'-Deoxy-3'-azidothymidine; CCRIS 105; Aztec; NSC 602670; BW-A509U; HSDB 6515; BW-A-509U; 3'-Azido-3'-deoxythymidine (AIDS); CHEMBL129; BW-A 509U; MLS000028548; 4B9XT59T7S; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2	C10H13N5O4	HBOMLICNUCNMMY-XLPZGREQSA-N	1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	GlaxoSmithKline	Anti-HIV Agents
PMDBD325	Etofenamate	Therapeutic Substance	Approved Drug	30544-47-9	DB08984	n.a.	D04102	n.a.	35375	32560	n.a.	ETOFENAMATE; 30544-47-9; Rheumon; Bayrogel; Rheumon gel; UNII-KZF0XM66JC; Etofenamatum [INN-Latin]; Etofenamato [INN-Spanish]; Bay d 1107; 2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate; C18H18F3NO4; TVX 485; 2-(2-Hydroxyethoxy)ethyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate; WHR 5020; EINECS 250-231-8; KZF0XM66JC; BRN 2953263; 2-(2-hydroxyethoxy)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate; WHR-5020; Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-(2-hydroxyethoxy)ethyl ester; NCGC00016804-01	C18H18F3NO4	XILVEPYQJIOVNB-UHFFFAOYSA-N	2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate	n.a.	n.a.
PMDBD853	Tobramycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	32986-56-4	DB00684	PA451704	D00063	DAP000110	36294	33377	NPC314408	tobramycin; 32986-56-4; Nebramycin 6; Nebramycin factor 6; Nebramycin VI; 3'-Deoxykanamycin B; Tobramicin; Nebcin; Tobradistin; Tobrex; Aktob; Tobi; Deoxykanamycin B; NEBRAMYCIN; Tobralex; Tobramycin Base; Tobi Podhaler; 1-Epitobramycin; Tobramycetin; Tobracin; Nebicin; Gotabiotic; Tobacin; Tobrased; Bethkis; Tobramaxin; Tenebrimycin; Tobramitsetin; Tenemycin; TOBRAMYCIN SULFATE; UNII-VZ8RRZ51VK; C18H37N5O9; Tobramycine [INN-French]; Tobramycinum [INN-Latin]; Tobramicina [INN-Spanish]; Tobracin (TN); NSC 180514; Tobrex (TN); HSDB 3259; Lilly 476	C18H37N5O9	NLVFBUXFDBBNBW-PBSUHMDJSA-N	(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	n.a.	n.a.
PMDBD636	Paclitaxel	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	33069-62-4	DB01229	PA450761	D00491	DNC001411	36314	10368587	NPC208553	paclitaxel; TAXOL; 33069-62-4; Taxol A; Abraxane; Paxene; Yewtaxan; Plaxicel; Paxceed; Onxol; Ebetaxel; ABI-007; Genaxol; Capxol; LipoPac; Paclitaxel (Taxol); Genetaxyl; Genexol; Intaxel; TaxAlbin; Zisu; OncoGel; NSC-125973; EmPAC; ABI 007; UNII-P88XT4IS4D; MBT 0206; NSC125973; Mitotax; HSDB 6839; DHP 107; DRG-0190; NK 105; QW 8184; P88XT4IS4D; BMS-181339-01; CHEMBL428647; 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine; CHEBI:45863; nab-paclit	C47H51NO14	RCINICONZNJXQF-MZXODVADSA-N	[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate	Celgene Summit, NJ	n.a.
PMDBD327	Etoposide	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	33419-42-0	DB00773	PA449552	D00125	DAP000786	36462	33510	NPC185498	etoposide; 33419-42-0; VePesid; Toposar; trans-Etoposide; Lastet; (-)-Etoposide; Zuyeyidal; Etoposidum; Etoposido; Etoposidum [INN-Latin]; VP-16; Etoposide (VP16); VP 16-213; Vepesid J; VP 16 (pharmaceutical); Etoposido [INN-Spanish]; Etopophos (phosphate salt); VP 16; VP-16-213; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; VP 16213; UNII-6PLQ3CP4P3; NK 171; NSC 141540; NSC-141540; CCRIS 2392; HSDB 6517; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); EINECS 251-509-1; Epipodophyllotoxin VP-162	C29H32O13	VJJPUSNTGOMMGY-MRVIYFEKSA-N	(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one	Bristol Myers Squibb Co Pharmaceutical Research Institute	Anticancer Agents
PMDBD1454	Ticarcillin	Therapeutic substance	Antibiotics	34787-01-4	DB01607	PA451684	n.a.	DAP000458	36921	33876	n.a.	TICARCILLIN; 34787-01-4; Ticarcillinum; Ticarcilina; Ticarcilline; Ticarcilina [INN-Spanish]; Ticarcillinum [INN-Latin]; Ticarcilline [INN-French]; Ticar; CHEBI:9587; Ticarcillin [INN:BAN]; UNII-F93UJX4SWT; C15H16N2O6S2; EINECS 252-213-5; F93UJX4SWT; alpha-carboxy-3-thienylmethylpenicillin; BRL-2288; (2S,5R,6R)-6-{[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1	C15H16N2O6S2	OHKOGUYZJXTSFX-KZFFXBSXSA-N	(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD742	Ribavirin	Therapeutic Substance	Approved Drug	36791-04-5	DB00811	PA451241	D00423	DNC001210	37542	34439	n.a.	ribavirin; 36791-04-5; Tribavirin; Rebetol; Virazole; Copegus; Vilona; Ribavirine; Ribamide; Ribasphere; Ribamidil; Viramid; Ribamidyl; Rebetron; Varazid; RTCA; Ribavirin Capsules; Ribavirinum; Ribavirina; Ribavirinum [INN-Latin]; Ribavirine [INN-French]; ICN-1229; Ribavirina [INN-Spanish]; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; DRG-0028; SCH 18908; UNII-49717AWG6K; Ribavirin (Copegus)	C8H12N4O5	IWUCXVSUMQZMFG-AFCXAGJDSA-N	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide	Hoffmann-La Roche pharmaceutical company	Antiviral Agents
PMDBD111	Bezafibrate	Therapeutic Substance	Approved Drug	41859-67-0	DB01393	PA162364313	D01366	DAP001182	39042	35728	n.a.	bezafibrate; 41859-67-0; Bezalip; Cedur; Bezafibrat; Befizal; Sklerofibrat; Bezatol; Azufibrat; Bezafibratum; Bezafibrato; Bezafibratum [INN-Latin]; Bezafibrato [INN-Spanish]; Bezafibrato [Spanish]; Bezatol SR (TN); BM-15.075; BM 15075; LO 44; BF-759; 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid; UNII-Y9449Q51XH; Difaterol; CCRIS 9085; 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid; BM 15.075; EINECS 255-567-9; C19H20ClNO4; BRN 4267656; BM-15075; MLS000028533; durabezur; CHEMBL264374; Reducterol	C19H20ClNO4	IIBYAHWJQTYFKB-UHFFFAOYSA-N	2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid	n.a.	Antilipemic Agents
PMDBD1307	Nadolol	Therapeutic substance	Drug	42200-33-9	DB01203	PA450573	D00432	DAP000122	39147	35815	n.a.	nadolol; 42200-33-9; Corgard; Solgol; (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; Anabet; SQ-11725; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; CHEMBL649; Nadololum [INN-Latin]; MLS000028580; SMR000058975; DSSTox_CID_3342; EN300-50860; DSSTox_RID_76983; DSSTox_GSID_23342; CCRIS 1048; HSDB 6532; EINECS 255-706-3; SR-01000000251; 2,3-Naphthalenediol, 	C17H27NO4	VWPOSFSPZNDTMJ-UCWKZMIHSA-N	(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol	n.a.	n.a.
PMDBD281	Diltiazem	Therapeutic Substance	Approved Drug	42399-41-7	DB00343	PA449334	D07845	DAP001262	39186	35850	n.a.	diltiazem; 42399-41-7; Cardizem; d-cis-Diltiazem; Endrydil; Anoheal; Dilticard; Dilcontin; Acalix; Dilzen; Dilta-Hexal; Dilt-cd; Incoril AP; Diltiazemum; Diltzac; Dilren; Cardil; Tiazac; (+)-diltiazem; Tiamate; Diltiazem [INN:BAN]; Diltiazemum [INN-Latin]; (+)-cis-diltiazem; Diltiazen; UNII-EE92BBP03H; HSDB 6528; CHEMBL23; EINECS 255-796-4; BRN 3573079; EE92BBP03H; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; CHEBI:101278; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methox	C22H26N2O4S	HSUGRBWQSSZJOP-RTWAWAEBSA-N	[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate	Valeant International Barbados Srl	Antihypertensive Agents
PMDBD1358	Permethrin	Environmental Chemicals	Pesticides	52645-53-1	DB04930	PA164743137	D05443	DAP001235	40326	36845	n.a.	Permethrin; 52645-53-1; Transpermethrin; Ambush; 1RS,cis-Permethrin; 1RS-trans-Permethrin; Transpermethrin [ISO]; Pounce; (+-)-cis-Permethrin; trans-(+-)-Permethrin; NRDC 148; NRDC 146; (+-)-trans-Permethrin; (+-)-cis-Fmc 33297; FMC 35171; Elimite; Kudos; UNII-509F88P9SZ; (3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate; BRN 4153590; Permethrine; (+)-trans-Permethrin; Permetrina; Perthrine; Perigen; Dragnet; Ambushfog; Stomoxin; Stomoxi; Permasect; Kaleait; Ectiban; Corsair; Chinetrin; Acticin; Stomozan	C21H20Cl2O3	RLLPVAHGXHCWKJ-UHFFFAOYSA-N	(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate	n.a.	n.a.
PMDBD584	Nicardipine hydrochloride	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	41114	n.a.	NPC63370	NICARDIPINE HYDROCHLORIDE; 54527-84-3; Nicardipine HCl; Cardene; Perdipine; Nicodel; Loxen; YC-93; Angioglebil; Bionicard; Nicardil; Perdipina; Lincil; Dagan; Nicardipine (Hydrochloride); Dafil; Cardene SR; YC-93 hydrochloride; RS-69216; RS-69216-XX-07-0; YC 93; EINECS 259-198-4; Nicardipine hydrochloride [USAN:JAN]; MLS000069782; 69441-18-5; SMR000058487; Cardene (TN); 3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride; 2-(Benzylmethylamino)ethyl methyl 1,4-dih	C26H30ClN3O6	AIKVCUNQWYTVTO-UHFFFAOYSA-N	5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride	n.a.	n.a.
PMDBD1232	Idarubicin	Therapeutic substance	Drug	58957-92-9	DB01177	PA449961	n.a.	DAP000050	42890	39117	n.a.	IDARUBICIN; 58957-92-9; 4-Demethoxydaunorubicin; 4-Demethoxydaunomycin; Idarubicin Hcl; Idarubicina; Idamycin; Idarubicine [INN-French]; Idarubicinum [INN-Latin]; Idarubicina [INN-Spanish]; Idarubicin [INN:BAN]; IMI 30; UNII-ZRP63D75JW; IMI-30; CCRIS 5083; NSC 256439; NSC-256439; ZRP63D75JW; CHEBI:42068	C26H27NO9	XDXDZDZNSLXDNA-TZNDIEGXSA-N	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione	n.a.	n.a.
PMDBD162	Ceforanide	Therapeutic Substance	Approved Drug	60925-61-3	DB00923	PA164746057	D00259	DAP001175	43507	39656	n.a.	CEFORANIDE; 60925-61-3; Precef; Ceforanidum; Ceforanido; Ceforanidum [INN-Latin]; Ceforanido [INN-Spanish]; BL-S786; BL-S 786; Radacef; UNII-8M1YF8951V; C20H21N7O6S2; (6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CHEBI:3495; 8M1YF8951V; 7-(o-(Aminomethyl)phenylacetamido)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid; (6R,7R)-7-(2-(alpha-Amino-o-tolyl)acetamido)-3-(((1-(carbo	C20H21N7O6S2	SLAYUXIURFNXPG-CRAIPNDOSA-N	(6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	Antibiotics
PMDBD1365	Piperacillin	Therapeutic substance	Antibiotics	66258-76-2	DB00319	PA450975	D00466	DAP001164	43672	39798	n.a.	piperacillin; Pipracil; 61477-96-1; Piperacillin anhydrous; Piperacilline; PIPERACILLIN SODIUM; PIPC; Piperacillin hydrate; Pipril; Cl-227193; Piperacillin [INN]; Piperacillin (INN); CHEBI:8232; CCRIS 7362; UNII-9I628532GX; (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; C23H27N5O7S; EINECS 262-811-8; CHEMBL702; T-1220; 9I628532GX; (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylac	C23H27N5O7S	IVBHGBMCVLDMKU-GXNBUGAJSA-N	(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD642	Paroxetine	Therapeutic Substance	Approved Drug	61869-08-7	DB00715	PA450801	D02362	DAP001428	43815	39888	n.a.	paroxetine; 61869-08-7; Paxil; Paxil CR; Paxetil; Seroxat; Frosinor; Paroxetinum; Paroxetina; Motivan; Casbol; Aropax; Paroxetinum [INN-Latin]; PaxPar; Paroxetina [INN-Spanish]; BRL 29060; FG 7051; Pexeva; Paroxetine [USAN:INN:BAN]; BRL-29060; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine; UNII-41VRH5220H; (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine; (3s,4r)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; [3H]Paroxetine; C19H20FNO3	C19H20FNO3	AHOUBRCZNHFOSL-YOEHRIQHSA-N	(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine	GlaxoSmithKline	Antidepressants
PMDBD143	Captopril	Therapeutic Substance	Approved Drug	62571-86-2	DB01197	PA448780	D00251	DAP000589	44093	40130	n.a.	captopril; 62571-86-2; Capoten; L-Captopril; Lopirin; Captopryl; Cesplon; Tensoprel; Captolane; Captoril; Dilabar; Acepress; Garranil; Tenosbon; Hypertil; Alopresin; Acepril; Lopril; Captoprilum; Aceplus; Acediur; (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid; Tensobon; Isopresol; Apopril; Asisten; Captoprilum [INN-Latin]; SQ-14225; SQ 14225; D-2-Methyl-3-mercaptopropanoyl-L-proline; D-3-Mercapto-2-methylpropanoyl-L-proline; Lopirin [Switzerland]; SQ 14,225; 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline; SA 333	C9H15NO3S	FAKRSMQSSFJEIM-RQJHMYQMSA-N	(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid	Bristol-Myers Squibb	Antihypertensive Agents
PMDBD160	Cefoperazone	Therapeutic Substance	Approved Drug	62893-19-0	DB01329	PA448849	n.a.	DAP000450	44185	40206	n.a.	Cefoperazonum [INN-Latin]; Cefoperazono [INN-Spanish]; Cefoperazon; Cefoperazone [INN:BAN]; C25H27N9O8S2; EINECS 263-749-4; BRN 0603333; (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; CP 52640; Epitope ID:174845; SCHEMBL16091123; BCP24490	C25H27N9O8S2	GCFBRXLSHGKWDP-WTKTZPJXSA-N	(6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1249	Latamoxef 	Therapeutic substance	Antibiotics	64952-97-2	DB04570	PA164743144	D08109	DAP001181	47499	43215	n.a.	Latamoxef; moxalactam; Lamoxactam; 64952-97-2; Latamoxefum; Oxa-cephem; Festamoxin; LMOX; Latamoxefum [INN-Latin]; Moxam; Listeria mox supplement; Latamoxef [INN:BAN]; Shiomarin; CHEBI:599928; EINECS 265-287-9; S-6059; 1-Oxacephalosporin; Disodium Moxalactam; Lilly 127935; Latamoxef (INN); Ly127935; C20H20N6O9S; Spectrum_000971; Prestwick0_000819; Spectrum4_000064; Prestwick1_0	C20H20N6O9S	JWCSIUVGFCSJCK-CAVRMKNVSA-N	(6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD587	Nicorandil	Therapeutic Substance	Approved Drug	65141-46-0	DB09220	n.a.	D01810	n.a.	47528	43240	n.a.	NICORANDIL; 65141-46-0; Ikorel; SG-75; Dancor; 2-Nicotinamidoethyl nitrate; Sigmart; Adancor; Nicorandilum; SG 75; 2-(nicotinamido)ethyl nitrate; N-(2-Hydroxyethyl)nicotinamide nitrate; Nicorandilum [INN-Latin]; 2-(pyridine-3-carbonylamino)ethyl nitrate; 2-(Nicotinamido)ethyl nitrat; N-(2-Hydroxyethyl)nicotinamide nitrate (ester); Nicorandil (Ikorel); UNII-260456HAM0; CHEBI:31905; EINECS 265-514-1; N-[2-(NITROOXY)ETHYL]-3-PYRIDINECARBOXAMIDE; BRN 0481451	C8H9N3O4	LBHIOVVIQHSOQN-UHFFFAOYSA-N	2-(pyridine-3-carbonylamino)ethyl nitrate	Chugai; Roche; Sanofi-Aventis; Merk KGaA; Pfizer; 3M Pharmaceutical	Vasodilator Agents
PMDBD154	Cefadroxil	Therapeutic Substance	Approved Drug	50370-12-2	DB01140	PA448835	D00257	DAP000446	47965	43630	n.a.	cefadroxil; 50370-12-2; Cephadroxil; Cefadroxil anhydrous; D-Cefadroxil; Cefadroxilum; Cefadroxilo; Duricef; BL-S578; UNII-Q525PA8JJB; CHEBI:3479; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CDX; Q525PA8JJB; Oracefal; Cefadroxilum [INN-Latin]; Cefadroxilo [INN-Spanish]; BL-S 578; S-578; S 578; DSSTox_CID_2749; Cefadroxil, 95-105%; DSSTox_RID_76714; DSSTox_GSID_22749	C16H17N3O5S	BOEGTKLJZSQCCD-UEKVPHQBSA-N	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Pharco B international	Antibiotics
PMDBD1083	Cefaclor	Therapeutic substance	Antibiotics	53994-73-3	DB00833	PA164749137	D00256	DAP000442	51039	46260	n.a.	cefaclor; 53994-73-3; Cephaclor; Ceclor; Cefaclor anhydrous; Cefaclorum; Kefral; Panoral; Raniclor; Cefaclorum [INN-Latin]; UNII-3Z6FS3IK0K; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; Lilly 99638; S 6472; CHEBI:3478; CCL; Ceclor CD; 3Z6FS3IK0K; MLS000069617; Cefaclor, 96%; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; NCGC00022612-04; Alfacet; SMR000058250; DSSTox_CID_2748; DSSTox_RID_76713; DSSTox_GSID_22748; (6R,7R)-7-((R)-2-amino-2-phenylace	C15H14ClN3O4S	QYIYFLOTGYLRGG-GPCCPHFNSA-N	(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1349	Pefloxacin	Therapeutic substance	Antibiotics	70458-92-3	DB00487	PA164742856	D02306	DAP001001	51081	46291	n.a.	Pefloxacin; 70458-92-3; Pefloxacine; Pefloxacino; Pefloxacinum; PFLX; Pefloxacin [INN-French]; Pefloxacinum [INN-Latin]; Pefloxacino [INN-Spanish]; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; AM-725; 1584RB; UNII-2H52Z9F2Q5; EU-5306; EU 5306; C17H20FN3O3; EINECS 274-611-8; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; 1589 RB; BRN 0567618; CHEBI:50199; 2H52Z9F2Q5; 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid	C17H20FN3O3	FHFYDNQZQSQIAI-UHFFFAOYSA-N	1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD164	Cefotetan	Therapeutic Substance	Approved Drug	69712-56-7	DB01330	PA164784033	D00260	DAP000451	53025	47904	n.a.	cefotetan; 69712-56-7; Cefotetanum; Cefotan; Cefotetanum [INN-Latin]; ICI 156834; MLS002153829; CHEBI:3499; ICI-156834; YM 09330; (6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; SMR001233197; Cefotetan, 95-103%; 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehyd	C17H17N7O8S4	SRZNHPXWXCNNDU-RHBCBLIFSA-N	(6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	AstraZeneca	Antibiotics
PMDBD496	Lovastatin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	75330-75-5	DB00227	PA450272	D00359	DAP000551	53232	48085	NPC97577	lovastatin; 75330-75-5; mevinolin; Mevacor; MK-803; Lovalord; Nergadan; Mevinacor; Altoprev; Artein; Lovalip; 6alpha-Methylcompactin; Hipovastin; Lovasterol; Paschol; Closterol; Teroltrat; Tecnolip; Rovacor; Cholestra; Rodatin; Lozutin; Lovastin; Lipofren; Lestatin; Hipolip; Colevix; Taucor; Lipdip; Belvas; Monacolin K; Lovastatine [French]; Lovastatinum [Latin]; Lovastatina [Spanish]; 6-alpha-Methylcompactin; Lovastatine; Altocor; Lipivas; Mevlor; Sivlor; MSD 803; MK 803; UNII-9LHU78OQFD; MLS000069585; HSDB 6534; 9LHU78OQFD; BRN 3631989; 2beta,6alpha-D	C24H36O5	PCZOHLXUXFIOCF-BXMDZJJMSA-N	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate	Atos Pharma	Anticholesteremic Agents
PMDBD783	Simvastatin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	79902-63-9	DB00641	PA451363	D00434	DAP001519	54454	49179	NPC36491	simvastatin; 79902-63-9; Zocor; Synvinolin; Sinvacor; Denan; Lipex; MK-733; Sivastin; Lodales; Simvastatine; Simovil; Colemin; Cholestat; Medipo; Pantok; Simvastatina; Simvastatinum; Nivelipol; Labistatin; Rendapid; Velostatin; Vasotenal; Zocord; Corolin; Zorced; Coledis; Simvastatin lactone; Simvastatin (Zocor); Lipovas; Simvoget; Simvacor; Simcard; Simlup; Rechol; Simvastatinum [Latin]; Simvastatine [French]; Simvastatina [Spanish]; MK-0733; (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8	C25H38O5	RYMZZMVNJRMUDD-HGQWONQESA-N	[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate	Merck & Co	Anticholesteremic Agents
PMDBD1375	Pravastatin	Therapeutic substance	Drug	81093-37-0	DB00175	PA451089	D08410	DAP000550	54687	49398	n.a.	pravastatin; 81093-37-0; Pravastatinum; Pravastatine; Pravastatina; Pravachol; Eptastatin; PRAVASTATIN SODIUM; Pravastatin acid; Pravastatinum [Latin]; Pravastatine [French]; Pravastatina [Spanish]; Pravastatin [INN:BAN]; UNII-KXO2KT9N0G; CCRIS 7557; KXO2KT9N0G; CHEMBL1144; (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthale	C23H36O7	TUZYXOIXSAXUGO-PZAWKZKUSA-N	(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid	n.a.	n.a.
PMDBD1067	Cabergoline	Therapeutic substance	Drug	81409-90-7	DB00248	PA448708	D00987	DAP000251	54746	49452	n.a.	cabergoline; 81409-90-7; Dostinex; Cabaser; Cabaseril; Cabergolinum [Latin]; Cabergolina [Spanish]; Cabergolinum; Cabergolina; FCE-21336; UNII-LL60K9J05T; C26H37N5O2; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; FCE 21336; BRN 6020775; LL60K9J05T; CHEBI:3286; Galastop; DSSTox_CID_2719; 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea; 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbam	C26H37N5O2	KORNTPPJEAJQIU-KJXAQDMKSA-N	(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide	n.a.	n.a.
PMDBD721	Quinapril	Therapeutic Substance	Approved Drug	85441-61-8	DB00881	PA451205	D03752	DAP000588	54892	49565	n.a.	quinapril; 85441-61-8; Quinaprilum [Latin]; Quinaprilum; Accupril; UNII-RJ84Y44811; CHEBI:8713; Accuretic; RJ84Y44811; (3S)-2-{N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; Quinapril [INN:BAN]; Quinapril [USP:INN:BAN]; Quinapril (INN); Quinapril (Korec); Spectrum_001597; Spectrum3_001551; Spectrum2_000825; Spectrum5_001075; Spectrum4_00072	C25H30N2O5	JSDRRTOADPPCHY-HSQYWUDLSA-N	(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	Pfizer Pharmaceuticals	Antihypertensive Agents
PMDBD549	Mifepristone	Therapeutic Substance	Approved Drug	84371-65-3	DB00834	PA450500	D00585	DAP000090	55245	49889	n.a.	mifepristone; 84371-65-3; Mifegyne; Mifeprex; RU-486; Korlym; Corlux; RU486; RU 486; Mifepriston; Mifepristonum [Latin]; Mifepristona [Spanish]; RU 38486; RU-38486; UNII-320T6RNW1F; Mifepristone [USAN:INN:BAN]; HSDB 6841; R 38486; BRN 5779404; RU 486-6; MLS000069785; 320T6RNW1F; VGX-410C; CHEBI:50692; VGX-410; Mifepristone, 98%; (8S,11R,13S,14S,17S)-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; NCGC00025179-05; SMR000058481; DSSTox_CID	C29H35NO2	VKHAHZOOUSRJNA-GCNJZUOMSA-N	(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one	HRA Pharma	n.a.
PMDBD463	Itraconazole	Therapeutic Substance	Approved Drug	84625-61-6	DB01167	PA450132	D00350	DAP000631	55283	49927	n.a.	itraconazole; 84625-61-6; Oriconazole; Sporanox; Sporanox (TN); Itrizole (TN); ITCZ; Itraconazole (Sporanox); Itraconazol [Spanish]; Itraconazolum [Latin]; cis-Itraconazole; 84604-65-9; DSSTox_CID_3180; DSSTox_RID_76908; DSSTox_GSID_23180; ITZ; A1-01739; C35H38Cl2N8O4; 1-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one; 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl	C35H38Cl2N8O4	VHVPQPYKVGDNFY-ZPGVKDDISA-N	2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one	n.a.	n.a.
PMDBD1207	Fosinopril	Therapeutic substance	Drug	98048-97-6	DB00492	PA449710	D00622	DAP000582	55891	7875352	n.a.	fosinopril; 98048-97-6; CHEBI:5163; (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid; 474519-28-3; (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; C30H46NO7P; (4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline; SR-05000001490; SCHEMBL15626; CHEMBL3306578; DTXSID1023079; HMS2089P08; HMS3715N21; (2S,4S)-4-cyclohexyl-1-[2-[[(1S	C30H46NO7P	BIDNLKIUORFRQP-FKDWWROVSA-N	(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	n.a.	n.a.
PMDBD765	Sarafloxacin	Therapeutic Substance	Approved Drug	98105-99-8	DB11491	n.a.	n.a.	n.a.	56208	50727	n.a.	Sarafloxacin; 98105-99-8; Sarafloxacinum; Sarafloxacino; Difloxacino; Sarafloxacine; Difloxacinum; Difloxacine; 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Sarafloxacin [INN:BAN]; Difloxacinum [Latin]; Difloxacine [French]; Difloxacino [Spanish]; Abbott 57135; UNII-RC3WJ907XY; Sarafloxacine [INN-French]; Sarafloxacinum [INN-Latin]; Sarafloxacino [INN-Spanish]; HSDB 7035; RC3WJ907XY; Saraflox; 3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazin	C20H17F2N3O3	XBHBWNFJWIASRO-UHFFFAOYSA-N	6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD1400	Ranolazine	Therapeutic substance	Drug	95635-55-5	DB00243	PA164746007	n.a.	DAP000875	56959	51354	n.a.	RANOLAZINE; 95635-55-5; Ranexa; N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide; CVT-303; Ranolazine (Ranexa); N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide; 142387-99-3; RS-43285-003; CHEBI:87690; N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide; CVT 303; C24H33N3O4; NCGC00015897-02; DSSTox_RID_80743; DSSTox_CID_25196; DSSTox_GSID_45196; (-)-Ranolazine; Ran4; Latixa; RAN D	C24H33N3O4	XKLMZUWKNUAPSZ-UHFFFAOYSA-N	N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide	n.a.	n.a.
PMDBD352	Finasteride	Therapeutic Substance	Approved Drug	98319-26-7	DB01216	PA449627	D00321	DAP000045	57363	51714	n.a.	finasteride; 98319-26-7; Proscar; Propecia; Finastid; Prostide; Chibro-Proscar; MK-906; Finpecia; Finasteridum; Finasterida; Finasteridum [INN-Latin]; Finasterida [INN-Spanish]; MK 906; UNII-57GNO57U7G; MK-0906; MK 0906; CCRIS 7438; HSDB 6793; (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide; CHEMBL710; N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carbox	C23H36N2O2	DBEPLOCGEIEOCV-WSBQPABSSA-N	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide	Merck	Antihyperplasia Agents
PMDBD441	Imiquimod	Therapeutic Substance	Approved Drug	99011-02-6	DB00724	PA449972	D02500	DAP000278	57469	51809	n.a.	IMIQUIMOD; 99011-02-6; Aldara; Zyclara; 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; Beselna; 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine; 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline; R 837; 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline; R-837; 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine; S-26308; UNII-P1QW714R7M; S 26308; 9050-31-1; C14H16N4; MFCD00866946; CHEMBL1282; 1-isobutylimidazo[4,5-c]quinolin-4-amine; P1QW714R7M; 1-(2-Methylpropyl)-1H-imidazole[4,5	C14H16N4	DOUYETYNHWVLEO-UHFFFAOYSA-N	1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine	INova Pharmaceuticals 	Antiviral Agents
PMDBD778	Sertindole	Therapeutic Substance	Approved Drug	106516-24-9	DB06144	PA164784002	D00561	DAP000832	60149	54229	n.a.	SERTINDOLE; 106516-24-9; SerLect; Serdolect; Sertindol; Lu 23-174; Sertindolum; Sertindolum [INN-Latin]; Sertindol [INN-Spanish]; Lu-23-174; UNII-GVV4Z879SP; 1-(2-{4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]piperidin-1-yl}ethyl)imidazolidin-2-one; GVV4Z879SP; CHEMBL12713; CHEBI:9122; 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one; 1-(2-(4-(5-Chloro-1-(p-fluorophenyl)indol-3-yl)piperidino)ethyl)-2-imidazolidinone; 1-(2-(4-(5-Chloro-1-(4-fluorophenyl)-1H-indole-3-yl)-1-piperidinyl)ethy	C24H26ClFN4O	GZKLJWGUPQBVJQ-UHFFFAOYSA-N	1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one	n.a.	Antipsychotic Agents
PMDBD1189	Exemestane	Therapeutic substance	Drug	107868-30-4	DB00990	PA449563	D00963	DAP000625	60198	54278	n.a.	EXEMESTANE; 107868-30-4; Aromasin; 6-Methyleneandrosta-1,4-diene-3,17-dione; Fce 24304; Exemestanum; Exemestano; Exemestanum [INN-Latin]; Exemestano [INN-Spanish]; FCE-24304; 6-Methylene-androsta-1,4-diene-3,17-dione; Exemestane [USAN:INN:BAN]; UNII-NY22HMQ4BX; HSDB 7463; FCE24304; 6-methylideneandrosta-1,4-diene-3,17-dione; Aromasine; NY22HMQ4BX; PNU-155971; CHEBI:4953; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3	C20H24O2	BFYIZQONLCFLEV-DAELLWKTSA-N	(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione	n.a.	n.a.
PMDBD798	Sparfloxacin	Therapeutic Substance	Approved Drug	110871-86-8	DB01208	PA451472	D00590	DAP000161	60464	54517	n.a.	sparfloxacin; 110871-86-8; Zagam; AT-4140; CI-978; Spara; SPFX; CI 978; PD-131501; AT 4140; Sparfloxacinum [INN-Latin]; Sparfloxacine [INN-French]; DRG-0143; PD 131501; Esparfloxacino [INN-Spanish]; UNII-Q90AGA787L; CHEBI:9212; CP 103826; 111542-93-9; BRN 3658018; Q90AGA787L; Sparfloxacine; cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Sparfloxacin	C19H22F2N4O3	DZZWHBIBMUVIIW-DTORHVGOSA-N	5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid	Square pharma	Antibiotics
PMDBD910	Zileuton	Therapeutic Substance	Approved Drug	111406-87-2	DB00744	PA451955	D00414	DAP000591	60490	54531	n.a.	ZILEUTON; 111406-87-2; Zyflo; Leutrol; 1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea; Zyflo CR; Zileutonum; Abbott 64077; Zileutonum [INN-Latin]; N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea; A-64077; A 64077; 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea; Zyflo (TN); ABBOTT-64077; CHEMBL93; 1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea; N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea; (+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea; (+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hyd	C11H12N2O2S	MWLSOWXNZPKENC-UHFFFAOYSA-N	1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea	Cornerstone Therapeutics Inc	Antiinflammatory Agents
PMDBD1453	Tiagabine	Therapeutic substance	Drug	115103-54-3	DB00906	PA451682	n.a.	DAP000164	60648	54661	n.a.	tiagabine; 115103-54-3; Gabitril; (R)-Tiagabine; Tiagabinum; Tiagabina; Tiagabinum [INN-Latin]; Tiagabina [INN-Spanish]; Tiagabine [INN:BAN]; Tiagabine [INN]; Abbott-70569; UNII-Z80I64HMNP; Tiagabine (INN); ABBOTT-70569-1; Gabitril (TN); CHEMBL1027; Z80I64HMNP; ABT-569; CHEBI:9586; NO-328; (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid; A-70569-1; Gabatril; NO 329; (3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid; (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxyl	C20H25NO2S2	PBJUNZJWGZTSKL-MRXNPFEDSA-N	(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid	n.a.	n.a.
PMDBD1465	Topotecan	Therapeutic substance	Drug	123948-87-8	DB01030	PA451729	D08618	DAP000648	60700	54705	n.a.	topotecan; 123948-87-8; Hycamtin; Topotecan lactone; Hycamptamine; Topotecane; Hycamtamine; Topotecanum; Topotecane [INN-French]; Topotecanum [INN-Latin]; (S)-Topotecan; Topotecan [INN:BAN]; SKF-104864-A; SK&amp;F-104864-A; 9-Dimethylaminomethyl-10-hydroxycamptothecin; UNII-7M7YKX2N15; C23H23N3O5; NSC609699; CHEMBL84; Hycamtin (TN); 7M7YKX2N15; CHEBI:63632; SK-S-104864-A; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETH	C23H23N3O5	UCFGDBYHRUNTLO-QHCPKHFHSA-N	(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione	n.a.	n.a.
PMDBD384	Gemcitabine	Therapeutic Substance	Approved Drug	95058-81-4	DB00441	PA449748	D02368	DAP001246	60750	54753	n.a.	gemcitabine; 95058-81-4; 2'-Deoxy-2',2'-difluorocytidine; 2',2'-Difluorodeoxycytidine; GEMCITABINE HYDROCHLORIDE; Gamcitabine; DFdCyd; dFdC; UNII-B76N6SBZ8R; LY188011; Gemcitabinum [INN-Latin]; Gemcitabina [INN-Spanish]; 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; DDFC; 103882-84-4; B76N6SBZ8R; 2',2'-difluoro-2'-deoxycytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; CHEBI:175901; Gem	C9H11F2N3O4	SDUQYLNIPVEERB-QPPQHZFASA-N	4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Eli Lilly	Anticancer Agents
PMDBD69	Aripiprazole	Therapeutic Substance	Approved Drug	129722-12-9	DB01238	PA10026	D01164	DAP000076	60795	54790	n.a.	Aripiprazole; 129722-12-9; Abilify; Abilitat; Abilify Discmelt; OPC-14597; aripiprazol; Discmelt; Opc 14597; OPC 31; OPC-31; 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril; UNII-82VFR53I78; C23H27Cl2N3O2; 7-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUTOXY)-3,4-DIHYDROQUINOLIN-2(1H)-ONE; HSDB 7320; CHEMBL1112; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 2(1H)-Quinolinone, 7-[4-[4-(	C23H27Cl2N3O2	CEUORZQYGODEFX-UHFFFAOYSA-N	7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one	Bristol-Myers Squibb; Otsuka Pharmaceutical Co., Ltd	Antipsychotic Agents
PMDBD78	Atorvastatin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	134523-00-5	DB01076	PA448500	D07474	DAP000553	60823	54810	NPC102008	atorvastatin; 134523-00-5; Cardyl; Tozalip; Xavator; Lipitor; Torvast; Sotis; ATORVASTATIN CALCIUM; Atorvastatin [INN:BAN]; 110862-48-1; UNII-A0JWA85V8F; CCRIS 7159; C33H35FN2O5; HSDB 7039; Lipitor (TN); (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid; A0JWA85V8F; CHEMBL1487; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; CI 981; CHEBI:39548; (betaR,deltaR)-2-(p-Fluorophenyl)-b	C33H35FN2O5	XUKUURHRXDUEBC-KAYWLYCHSA-N	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid	Pfizer Pharmaceuticals	Anticholesteremic Agents
PMDBD1246	Lamivudine	Therapeutic substance	Drug	134678-17-4	DB00709	PA450163	D00353	DAP000167	60825	54812	n.a.	lamivudine; 134678-17-4; Epivir; Zeffix; Heptovir; Epivir-HBV; Hepitec; Heptodin; 3TC; BCH-189; (-)-2'-Deoxy-3'-thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 3'-Thia-2',3'-dideoxycytidine; 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; GR109714X; GR-109714X; (-)-BCH-189; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; (-)NGPB-21; (-)-BCH 189; 136891-12-8; UNII-2T8Q726O95; HSDB 7155; GR 109714X; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 4-ami	C8H11N3O3S	JTEGQNOMFQHVDC-NKWVEPMBSA-N	4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one	n.a.	n.a.
PMDBD294	Duloxetine	Therapeutic Substance	Approved Drug	116539-59-4	DB00476	PA10066	D01179	DAP000494	60835	54822	n.a.	duloxetine; 116539-59-4; (S)-Duloxetine; Cymbalta; Yentreve; DULOXETINE HYDROCHLORIDE; Duloxetine [INN:BAN]; (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine; LY 248686; UNII-O5TNM5N07U; Ariclaim; Xeristar; LY248686; HSDB 7368; Yentreve (TN); O5TNM5N07U; (S)-N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine; CHEBI:36795; (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine; (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine; LY-248686; methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophe	C18H19NOS	ZEUITGRIYCTCEM-KRWDZBQOSA-N	(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine	Eli Lilly	Antidepressants
PMDBD455	Irinotecan	Therapeutic Substance	Approved Drug	97682-44-5	DB00762	PA450085	D08086	DAP001339	60838	54825	n.a.	irinotecan; 97682-44-5; (+)-Irinotecan; Camptosar; Irinotecanum; Irinotecanum [INN-Latin]; Irinotecan lactone; Irinotecan mylan; Irinophore C; Irinotecan [INN:BAN]; CPT-11; Onivyde; HSDB 7607; CHEMBL481; UNII-7673326042; (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate; CHEBI:80630; C33H38N4O6; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOX	C33H38N4O6	UWKQSNNFCGGAFS-XIFFEERXSA-N	[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate	Pfizer Pharmaceuticals	Anticancer Agents
PMDBD887	Valsartan	Therapeutic Substance	Approved Drug	137862-53-4	DB00177	PA451848	D00400	DAP000363	60846	54833	n.a.	valsartan; 137862-53-4; Diovan; Tareg; Provas; CGP 48933; CGP-48933; Exforge; (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid; UNII-80M03YXJ7I; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; CHEMBL1069; (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; 80M03YXJ7I; CHEBI:9927; 137863-60-6; C24H29N5O3; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazo	C24H29N5O3	ACWBQPMHZXGDFX-QFIPXVFZSA-N	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid	Norvatis Phamaceuticals Corporation	Antihypertensive Agents
PMDBD1495	Zolmitriptan	Therapeutic substance	Drug	139264-17-8	DB00315	PA451975	D00415	DAP000077	60857	54844	n.a.	zolmitriptan; 139264-17-8; Zomig; Zomigoro; Zomigon; Flezol; 311C90; Zomig-ZMT; Zomig ZMT; Zomig Nasal Spray; UNII-2FS66TH3YW; Zolmitriptan (Zomig); C16H21N3O2; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; CHEMBL1185; 2FS66TH3YW; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; CHEBI:10124; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl	C16H21N3O2	ULSDMUVEXKOYBU-ZDUSSCGKSA-N	(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one	n.a.	n.a.
PMDBD1018	Adefovir Dipivoxil	Therapeutic substance	Drug	142340-99-6	DB00718	PA10005	D01655	DNC001135	60871	54855	n.a.	ADEFOVIR DIPIVOXIL; 142340-99-6; Hepsera; Preveon; Adefovir pivoxil; bis-POM PMEA; GS-0840; GS 840; GS 0840; GS-840; Adefovir dipivoxyl; [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate; UNII-U6Q8Z01514; C20H32N5O8P; Adefovir dipivoxil [USAN]; Adefovir dipivoxil (USAN); Adefovir di(pivaloyloxymethyl) ester; U6Q8Z01514; Adefovir Dipivoxil (Preveon, Hepsera); (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate; NCGC00164	C20H32N5O8P	WOZSCQDILHKSGG-UHFFFAOYSA-N	[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate	n.a.	n.a.
PMDBD1172	Emtricitabine	Therapeutic substance	Drug	143491-57-0	DB00879	PA10069	D01199	DAP001084	60877	54859	n.a.	Emtricitabine; 143491-57-0; Emtriva; Coviracil; (-)-FTC; 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; 524W91; Racivir; dOTFC; BW-524W91; BW524W91; 2-FTC; (-)-2'-Deoxy-5-fluoro-3'-thiacytidine; FTC; BW 524W91; 2',3',5-FTC; 143491-54-7; UNII-G70B4ETF4S; DRG-0208; 2'-Deoxy-5-fluoro-3'-thiacytidine; BW 1592; CHEBI:31536; 3'-Thia-2'.3'-dideoxy-5-fluorocytidine; HSDB 7337; FTC-(-); 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine; 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine; 4-amino-5-fluoro-1-[(	C8H10FN3O3S	XQSPYNMVSIKCOC-NTSWFWBYSA-N	4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one	n.a.	n.a.
PMDBD141	Capecitabine	Therapeutic Substance	Approved Drug	154361-50-9	DB01101	PA448771	D01223	DAP000761	60953	54916	n.a.	CAPECITABINE; 154361-50-9; Xeloda; Capecitabin; Captabin; 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine; Ro 09-1978; Ro 09-1978/000; UNII-6804DJ8Z9U; N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine; 5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine; C15H22FN3O6; Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate; Capiibine; Pentyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin	C15H22FN3O6	GAGWJHPBXLXJQN-UORFTKCHSA-N	pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate	Roche	Anticancer Agents
PMDBD434	Hypochlorite	Therapeutic Substance	Approved Drug	14380-61-1	DB11123	n.a.	n.a.	n.a.	61739	55632	n.a.	Hypochlorite; Hypochlorite ion; 14380-61-1; UNII-T5UM7HB19N; T5UM7HB19N; Hypochlorites; hypochloride; hypochorite; hypochiorite; Hypochlorit; oxidochlorate(1-); UN3212; Hypochlorous acidanion; Hypochlorite (8CI,9CI); ClO(-); DTXSID8073136; [ClO](-); CHEBI:29222; CTK0H5052; DB11123; HYPOCHLORITES, INORGANIC, N.O.S.; Q409049; Hypochlorites, inorganic, n.o.s. [UN3212]  [Oxidizer]	ClO-	WQYVRQLZKVEZGA-UHFFFAOYSA-N	hypochlorite	n.a.	n.a.
PMDBD1483	Trovafloxacin	Therapeutic substance	Antibiotics	147059-72-1	DB00685	PA164749184	n.a.	DAP000652	62959	16736478	n.a.	Trovafloxacin; 147059-72-1; TVFX; Trovafloxacin [INN]; UNII-9F388J00UK; Trovafloxacin (INN); 7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; CP-99219; CHEBI:9763; C20H15F3N4O3; 9F388J00UK; Trovan (oral); 7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; Fluorinated quinolone; CP-99,219; trovafloxacine; trovafloxacinum; trovafloxacino; TR6	C20H15F3N4O3	WVPSKSLAZQPAKQ-SOSAQKQKSA-N	7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid	n.a.	n.a.
PMDBD298	Efavirenz	Therapeutic Substance	Approved Drug	154598-52-4	DB00625	PA449441	D00896	DAP000709	64139	57715	n.a.	efavirenz; 154598-52-4; Sustiva; Stocrin; DMP-266; DMP 266; EFV; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; UNII-JE6H2O27P8; L 743726; HSDB 7163; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; L-743,726; (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE	C14H9ClF3NO2	XPOQHMRABVBWPR-ZDUSSCGKSA-N	(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one	n.a.	Anti-HIV Agents
PMDBD547	Mevastatin	Therapeutic Substance	Approved Drug	73573-88-3	DB06693	n.a.	n.a.	n.a.	64715	58262	n.a.	Mevastatin; compactin; 73573-88-3; ML-236B; Mevastatine; Mevastatinum; Mevastatina; Mevastatinum [INN-Latin]; Antibiotic ML 236B; Mevastatin [INN]; CS 500; Compactin (penicillium); Mevastatine [INN-French]; UNII-1UQM1K0W9X; ML 236 B; Mevastatina [INN-Spanish]; CCRIS 4505; Mevastatin (Compactin); [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate; 1UQM1K0W9X; CHEMBL54440; CHEBI:34848; Compactin, Mevastatinum, Mevastatina; ML236B; Compactin;ML236B; 7-(1	C23H34O5	AJLFOPYRIVGYMJ-INTXDZFKSA-N	[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate	n.a.	n.a.
PMDBD95	Baicalin	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	64982	n.a.	NPC237435	Baicalin; 21967-41-9; Baicalein 7-O-glucuronide; 7-D-Glucuronic acid-5,6-dihydroxyflavone; Baicalein-7-O-glucuronide; CHEMBL485818; CHEBI:2981; UNII-347Q89U4M5; 5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid; 347Q89U4M5; (2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; 5,6,7-trihydroxyflavone 7-O-beta-D-glucuronide; BAICAILIN; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl; 3156	C21H18O11	IKIIZLYTISPENI-ZFORQUDYSA-N	(2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid	n.a.	n.a.
PMDBD772	Secoisolariciresinol	Therapeutic Substance	Investigational Drug	29388-59-8	DB12179	n.a.	n.a.	n.a.	65373	58845	n.a.	Secoisolariciresinol; 29388-59-8; (-)-Secoisolariciresinol; UNII-M8QRJ7JEJH; CCRIS 7790; M8QRJ7JEJH; EINECS 249-599-2; CHEMBL368347; CHEBI:65004; (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol; (2R,3R)-2,3-bis(4-hydroxy-3-methoxybenzyl)butane-1,4-diol; (R-(R*,R*))-2,3-Bis((4-hydroxy-3-methoxyphenyl)methyl)butane-1,4-diol; RR-secoisolariciresinol; (-) secoisolariciresinol; (+/-)-Secoisolariciresinol; 8R,8'R-secoisolariciresinol; MLS001424213; BIDF1039; SCHEMBL12427083; CTK4C5737; DTXSID50183615; HMS2052G03; HMS	C20H26O6	PUETUDUXMCLALY-HOTGVXAUSA-N	(2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol	n.a.	n.a.
PMDBD1295	Milnacipran	Therapeutic substance	Drug	92623-85-3	DB04896	PA164752812	D08222	DAP001155	65833	9797657	n.a.	Milnacipran; 92623-85-3; Milnacipranum [Latin]; Midalcipran; Ixel; UNII-ES1O38J3C4; Milnacipran [INN]; F 2207; (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide; ES1O38J3C4; Milnacipran (INN); Dalcipran; (+-)-Milnacipran; Milnacipran HCl; 96847-55-1; F2207; Milnacipranum; Milnace; Dextromilnacipran; (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide; (+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamid	C15H22N2O	GJJFMKBJSRMPLA-HIFRSBDPSA-N	(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide	n.a.	n.a.
PMDBD669	Pidotimod	Therapeutic Substance	Approved Drug	121808-62-6	DB11364	n.a.	D07261	n.a.	65944	59348	n.a.	Pidotimod; 121808-62-6; (R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid; PGT/1A; Pidotomod; Pidotimod [INN]; Pidotimodum [INN-Latin]; CCRIS 7271; UNII-785363R681; BRN 6636310; Pidotimod (INN); NCGC00160516-01; (R-(R*,S*))-3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid; (R)-3-((S)-(5-Oxo-2-pyrrolidinyl)carbonyl)-thiazolidin-4-carbonsaeure [German]; 785363R681; C9H12N2O4S; (R)-3-((S)-5-Oxoprolyl)-4-thiazolidinecarboxylic acid; Pidotimodum; Polimod; Pigitil; (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrol	C9H12N2O4S	UUTKICFRNVKFRG-WDSKDSINSA-N	(4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid	n.a.	n.a.
PMDBD738	Repaglinide	Therapeutic Substance	Approved Drug	135062-02-1	DB00912	PA451234	D00594	DAP000133	65981	59377	n.a.	Repaglinide; 135062-02-1; Prandin; NovoNorm; GlucoNorm; AG-EE 623 ZW; Repaglinidum [INN-Latin]; Repaglinida [INN-Spanish]; AG-EE 388 ZW; (S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; AGEE-623ZW; UNII-668Z8C33LU; C27H36N2O4; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; CHEMBL1272; 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid; CHEBI:8805; 668Z8C33LU	C27H36N2O4	FAEKWTJYAYMJKF-QHCPKHFHSA-N	2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid	Novo Nordisk	Hypoglycemic Agents
PMDBD828	Telmisartan	Therapeutic Substance	Approved Drug	144701-48-4	DB00966	PA451605	D00627	DAP000766	65999	59391	n.a.	Telmisartan; 144701-48-4; Micardis; Pritor; BIBR 277; Kinzalmono; BIBR-277; 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid; BIBR 277SE; Telmisattan; Telmisartan [INN]; UNII-U5SYW473RQ; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; BIBR-277SE; BIBR-277-SE; 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; CHEMBL1017; U5SYW473RQ; CHEBI:9434; 4'-((4-Methyl-6-(1-methyl	C33H30N4O2	RMMXLENWKUUMAY-UHFFFAOYSA-N	2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid	Boehringer Ingelheim	Antihypertensive Agents
PMDBD779	Sertraline	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	79617-96-2	DB01104	PA451333	D02360	DAP000051	68617	61881	NPC320656	sertraline; 79617-96-2; (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine; (+)-Sertraline; Sertralina; Sertralinum; Sertralinum [Latin]; Sertralina [Spanish]; Zoloft; Sertraline [INN:BAN]; Lustral; Cp 51974; UNII-QUC7NX6WMB; sertraline (Zoloft); Sertraline [Zoloft]; (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; cis-(+)-sertraline; HSDB 7037; (1S,4S)-sertraline; QUC7NX6WMB; CHEMBL809; BRN 5753709; CHEBI:9123; TBA-2010_Sertraline_1; 1-Naphthalenamine, 4-(3,4-dichlorophenyl)	C17H17Cl2N	VGKDLMBJGBXTGI-SJCJKPOMSA-N	(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine	Pfizer Inc	Antidepressants
PMDBD71	Artemisinin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	63968-64-9	DB13132	PA165111696	n.a.	n.a.	68827	62060	NPC260977	artemisinin; Qinghaosu; 63968-64-9; Artemisinine; Arteannuin; Artemisine; (+)-Artemisinin; Huanghuahaosu; Artemisinina; Artemisininum; Qinghosu; Quing Hau Sau; Qing Hau SU; Artemisinin [INN]; Qinghaosu [Chinese]; Artemisinine [French]; Artemisininum [Latin]; Artemisinina [Spanish]; Qing Hau Sau [Chinese]; UNII-9RMU91N5K2; Artemisia annua L., extract; NSC 369397; Qing Hau Sau; CHEBI:223316; BRN 4194670; Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one; 9RMU91N5K2; C15H22O5; Astemisinin	C15H22O5	BLUAFEHZUWYNDE-NNWCWBAJSA-N	(1R,4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one	n.a.	n.a.
PMDBD1158	Dienogest	Therapeutic substance	Drug	65928-58-7	DB09123	n.a.	n.a.	n.a.	68861	62093	n.a.	Dienogest; 65928-58-7; Dienogestrel; Dienogestril; Dinagest; Dienogestum; Endometrion; Natazia; STS 557; Visanne; STS-557; Dienogestum [Latin]; UNII-46M3EV8HHE; MJR-35; 17alpha-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; BAY86-5258; BAY 86-5258; 46M3EV8HHE; 2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile; CHEBI:70708; 17-alpha-Cyanomethyl-17-beta-hydroxy-estra-4,9(10)-dien-3-one; 17-alpha-Cyanomethyl-17-beta-hydroxyestra-4,9(10)-diene-3-one	C20H25NO2	AZFLJNIPTRTECV-FUMNGEBKSA-N	2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile	n.a.	n.a.
PMDBD293	Drospirenone	Therapeutic Substance	Approved Drug	67392-87-4	DB01395	PA164749409	D03917	DAP001206	68873	62105	n.a.	Drospirenone; 67392-87-4; Dihydrospirorenone; Dehydrospirorenone; Drospirenona; 1,2-Dihydrospirorenone; Drospirenonum; DRSP; Drospirenonum [INN-Latin]; Drospirenona [INN-Spanish]; ZK 30595; ZK30595; CCRIS 6523; UNII-N295J34A25; EINECS 266-679-2; BRN 4765500; ZK-30595; CHEBI:50838; N295J34A25; DSSTox_RID_81639; 6-beta,7-beta;15-beta,16-beta-Dimethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone; DSSTox_CID_26465; DSSTox_GSID_46465; (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-1	C24H30O3	METQSPRSQINEEU-HXCATZOESA-N	(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione	n.a.	Contraceptive Agents
PMDBD1042	Artemether	Therapeutic substance	Drug	71963-77-4	DB06697	PA165111698	D02483	n.a.	68911	62138	n.a.	Artemether; beta-Artemether; 71963-77-4; Dihydroartemisinin methyl ether; Artemisininelactol methyl ether; Methyl-dihydroartemisinine; Artemetherum; Artemetero; beta-Dihydroartemisinin methyl ether; SM 224; Artemetheri; Artemetherum [INN-Latin]; Artemetero [INN-Spanish]; Dihydroquinghaosu methyl ether; HSDB 7456; CHEBI:195280; NSC 665970; Artenam; CPD000469218; Artemos; Artemether Labeled d3; SM-224; (1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane; C16H26O	C16H26O5	SXYIRMFQILZOAM-HVNFFKDJSA-N	(1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane	n.a.	n.a.
PMDBD1312	Nebivolol	Therapeutic substance	Drug	118457-14-0	DB04861	PA151958426	D05127	DAP000942	71301	64421	n.a.	Nebivolol; 99200-09-6; Nebivololum [Latin]; 2,2'-Azanediylbis(1-(6-fluorochroman-2-yl)ethanol); Dexnebivolol; CHEBI:64019; 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]; Nebivolol [USAN:INN:BAN]; 118457-14-0; R-65824; C22H25F2NO4; R65,824; 118457-16-2; alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol); (1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-[[(2R)-2-[(2S)-6-fluoro-3,4	C22H25F2NO4	KOHIRBRYDXPAMZ-UHFFFAOYSA-N	1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol	n.a.	n.a.
PMDBD1165	Dofetilide	Therapeutic substance	Drug	115256-11-6	DB00204	PA449389	D00647	DAP000495	71329	64435	n.a.	Dofetilide; 115256-11-6; Tikosyn; Dofetilida; Dofetilidum; Dofetilidum [INN-Latin]; Dofetilida [INN-Spanish]; UK 68798; UK-68798; Dofetilide (Tikosyn); UK-68,798; UNII-R4Z9X1N2ND; UK 68,798; C19H27N3O5S2; beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; 1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane; CHEMBL473; R4Z9X1N2ND; CHEBI:4681; N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide; NCGC00164549-01; DSSTox_	C19H27N3O5S2	IXTMWRCNAAVVAI-UHFFFAOYSA-N	N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide	n.a.	n.a.
PMDBD1233	Iloperidone	Therapeutic substance	Drug	133454-47-4	DB04946	PA161199368	D02666	n.a.	71360	64459	n.a.	Iloperidone; 133454-47-4; Zomaril; Fanapt; Fanapta; HP 873; HP-873; Iloperidone (Fanapt); UNII-VPO7KJ050N; 4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone; C24H27FN2O4; VPO7KJ050N; CHEMBL14376; 1-(4-(3-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxyphenyl)ethanone; CHEBI:65173; 1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone; NCGC00188864-01; 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]eth	C24H27FN2O4	XMXHEBAFVSFQEX-UHFFFAOYSA-N	1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone	n.a.	n.a.
PMDBD899	Voriconazole	Therapeutic Substance	Approved Drug	137234-62-9	DB00582	PA10233	D00578	DAP001271	71616	64684	n.a.	Voriconazole; 137234-62-9; Vfend; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; UK-109496; UK 109496; Voriconazole [USAN:INN:BAN]; UNII-JFU09I87TR; DRG-0301; UK-109,496; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol; VCZ; CHEMBL638; JFU09I87TR; CPD000466350; (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; CHEBI:10023; C16H14F3N5O; 4-Pyrimidineethanol, alpha-(2,4-di	C16H14F3N5O	BCEHBSKCWLPMDN-MGPLVRAMSA-N	(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol	Pfizer	Antifungal Agents
PMDBD771	Secnidazole	Therapeutic Substance	Approved Drug	3366-95-8	DB12834	n.a.	n.a.	n.a.	71815	64839	n.a.	Secnidazole; 3366-95-8; Secnidazol; Flagentyl; Secnidazolum; Secnidazolum [INN-Latin]; RP 14539; PM 185184; Secnidazol [INN-Spanish]; 1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol; 1-(2-Methyl-5-nitro-1-imidazolyl)-2-propanol; 1-(2-Methyl-5-nitro-imidazol-1-yl)-propan-2-ol; PM-185184; Secnidazole (Flagentyl); SYM-1219; EINECS 222-134-0; RP-14539; MLS000559043; 1-(2-Hydroxypropyl)-2-methyl-5-nitroimidazol; 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol; NCGC00095158-01; SMR000149359; alpha,2-Dimethyl-5-nitroimidazole-1-ethanol	C7H11N3O3	KPQZUUQMTUIKBP-UHFFFAOYSA-N	1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol	Lupin	n.a.
PMDBD308	Epicatechin	Therapeutic Substance	Investigational Drug	490-46-0	DB12039	n.a.	n.a.	n.a.	72276	65230	n.a.	(-)-Epicatechin; Epicatechin; 490-46-0; L-Epicatechin; (-)-Epicatechol; l-Acacatechin; epi-Catechin; Epicatechol; (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; l-Epicatechol; (2R,3R)-(-)-Epicatechin; UNII-34PHS7TU43; epi-Catechol; CCRIS 7097; EINECS 207-710-1; NSC 81161; CHEBI:90; (-)epicatechin; 34PHS7TU43; 2-(3,4-Dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; NSC81161; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopy	C15H14O6	PFTAWBLQPZVEMU-UKRRQHHQSA-N	(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol	n.a.	n.a.
PMDBD775	Sennoside A	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	73111	n.a.	NPC76112	Sennoside A; 81-27-6; Senna extract; Senokot; UNII-2F1O30GVXH; NSC 112929; EINECS 201-339-9; 2F1O30GVXH; CHEBI:9112; 8013-11-4; C42H38O20; sennoside; Sennoside-A; SENNA; Glaxenna; Sennalax; Gentlax; Senolax; Dosaflex; Moivat; Exprep; Amyran; Senan; Sennae folium; Black Draught; NSC112929; Tisasen A; Senna (powdered); Sennoside A, G; NCGC00095095-01; GLYSENNIDE; Sennoside A;sennoside A; DSSTox_CID_3576; Se	C42H38O20	IPQVTOJGNYVQEO-KGFNBKMBSA-N	(9R)-9-[(9R)-2-carboxy-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid	n.a.	n.a.
PMDBD79	Atovaquone	Therapeutic Substance	Approved Drug	95233-18-4	DB01117	PA448502	D00236	DAP000156	74989	10482034	n.a.	ATOVAQUONE; 95233-18-4; Mepron; Wellvone; Acuvel; Atavaquone; 566C80; Mepron (antipneumocystic); cis-Atovaquone; BW 566C; 566C; 94015-53-9; Atovaquone (Atavaquone); DRG-0084; 137732-39-9; 2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone; UNII-Y883P1Z2LT; C22H19ClO3; BW 566C-80; HSDB 7083; 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione; 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; 2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE; Y883P1Z2LT; CHEBI:5755	C22H19ClO3	BSJMWHQBCZFXBR-UHFFFAOYSA-N	3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione	GlaxoSmithKline	Antifungal Agents
PMDBD1407	Rosiglitazone	Therapeutic substance	Drug	122320-73-4	DB00412	PA451283	D00596	DAP000271	77999	70383	n.a.	rosiglitazone; 122320-73-4; Avandia; Brl-49653; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione; Rosiglizole; Brl 49653; rosiglitazone (Avandia); BRL49653; Avandaryl; TDZ 01; Rosiglitazone [INN:BAN]; Avandamet; C18H19N3O3S; CHEBI:50122; Rosigilitazone; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate	C18H19N3O3S	YASAKCUCGLMORW-UHFFFAOYSA-N	5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	n.a.	n.a.
PMDBD1057	Bexarotene	Therapeutic substance	Drug	153559-49-0	DB00307	PA164752250	D03106	DAP000276	82146	74139	n.a.	Bexarotene; 153559-49-0; Targretin; Targrexin; Targretyn; LGD 1069; LGD1069; Bexaroten; LG100069; LGD-1069; UNII-A61RXM4375; LG 1069; HSDB 7453; p-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid; 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid; 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]benzoic acid; 166175-31-1; CHEMBL1023; LG-100069; LG 100069; Targret; CHEBI:50859; A61RXM4375; 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]	C24H28O2	NAVMQTYZDKMPEU-UHFFFAOYSA-N	4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid	n.a.	n.a.
PMDBD201	Clarithromycin	Therapeutic Substance	Approved Drug	81103-11-9	DB01211	PA449028	D00276	DAP000410	84029	10342604	n.a.	clarithromycin; 81103-11-9; Biaxin; 6-O-Methylerythromycin; Klaricid; 6-O-Methylerythromycin a; Clarithromycine; Clathromycin; Abbott-56268; A-56268; Macladin; Veclam; Kofron; Klacid; Clarith; Clarithromycinum; Naxy; TE-031; Biaxin XL; Mabicrol; Clambiotic; Bicrolid; Astromen; Claricide; Clacine; Abbotic; Klaciped; Heliclar; Claribid; Klarin; Cyllid; Zeclar; Maclar; Klarid; Mavid; Helas; Biaxin filmtab; Adel; Klax; Biaxin HP; Biaxin xl filmtab; Klaricid Pediatric; DRG-0099; UNII-H1250JIK0A; Claritromicina [INN-Spanish]; Clari	C38H69NO13	AGOYDEPGAOXOCK-KCBOHYOISA-N	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	n.a.	n.a.
PMDBD1234	Imidacloprid	Environmental Chemicals	Pesticides	105827-78-9	DB11421	n.a.	n.a.	n.a.	86418	77934	n.a.	1-((6-Chloro-3-pyridinyl)methyl)-4,5-dihydro-N-nitro-imidazol-2-amine; 1-((6-chloro-3-pyridinyl)methyl)-n-nitro-4,5-dihydro-1h-imidazol-2-amine; MLS001304087; HMS3373H06; HMS2231F05; BDBM50212288; AKOS015895351; SMR000718777; SC-18937; DB-042420; FT-0656073; 292-EP2308857A1; 292-EP2305658A1; 292-EP2298076A1; 292-EP2280009A1; 292-EP2275422A1; 292-EP2274983A1; 292-EP2377845A1; 292-EP2308858A1; 292-EP2298077A1; 292-EP2281812A1; FT-0631157; 292-EP2314583A1; 292-EP2311816A1; 292-EP2292608A1; NS00000361; 292-EP2311817A1; 292-EP2305662A1; 29	C9H10ClN5O2	YWTYJOPNNQFBPC-UHFFFAOYSA-N	N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide	n.a.	n.a.
PMDBD866	Tretazicar	Therapeutic Substance	Investigational Drug	21919-05-1	DB04253	n.a.	n.a.	n.a.	89105	80403	n.a.	Tretazicar; 21919-05-1; CB 1954; CB1954; 5-(1-Aziridinyl)-2,4-dinitrobenzamide; 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE; 5-Aziridino-2,4-dinitrobenzamide; CB-1954; 5-Aziridinyl-2,4-dinitrobenzamide; Tretazicar [INN]; 2,4-Dinitroethyleneiminobenzamide; 2,4-Dinitro-5-ethyleneiminobenzamide; NSC 115829; CHEMBL23330; CCRIS 1631; UNII-7865D5D01M; NSC-115829; 7865D5D01M; BRN 5825582; CB1; C9H8N4O5; SMR000326847; 5-[aziridin-1-yl]-2,4-dinitrobenzamide; aziri	C9H8N4O5	WOCXQMCIOTUMJV-UHFFFAOYSA-N	5-(aziridin-1-yl)-2,4-dinitrobenzamide	n.a.	n.a.
PMDBD1320	Nicotine 	Environmental Chemicals	Other	1954/11/5	DB00184	PA450626	D03365	DAP000175	89594	80863	n.a.	nicotine; L-Nicotine; 54-11-5; (-)-Nicotine; (S)-Nicotine; (S)-3-(1-methylpyrrolidin-2-yl)pyridine; Habitrol; 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine; (S)-(-)-Nicotine; Nicotrol; Nicoderm; Nicocide; Fumetobac; Micotine; Tendust; Nico-dust; Nicoderm Cq; Nicotine alkaloid; Nico-Fume; Emo-nik; Mach-Nic; Nic-Sal; Nikotin [German]; Nicotine polacrilex; Nikotyna [Polish]; Flux MAAG; XL All Insecticide; Ortho N-5 dust; Ortho N-4 dust; Nicotina [Italian]; Niagara P.A. dust; Prostep; Nicotina; Nicorette; Nikotyna; Destruxol orchid spray; Nicotrol Inh	C10H14N2	SNICXCGAKADSCV-JTQLQIEISA-N	3-[(2S)-1-methylpyrrolidin-2-yl]pyridine	n.a.	n.a.
PMDBD1303	Moexipril	Therapeutic substance	Drug	103775-10-6	DB00691	PA164769059	n.a.	DAP000586	91270	82418	n.a.	MOEXIPRIL; Univasc; 103775-10-6; Uniretic; Moexiprilum [INN-Latin]; UNII-WT87C52TJZ; WT87C52TJZ; CHEMBL1165; Moexipril [INN:BAN]; CHEBI:6960; RS-10085; (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid; Moexiprilum; Moexipril (INN); (S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; C27H34N2O7; PubChem18219; SCHEMBL34030; 109715-88-0; BIDD:GT0007; GTPL6571; DTXSID902	C27H34N2O7	UWWDHYUMIORJTA-HSQYWUDLSA-N	(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD401	Gliquidone	Therapeutic Substance	Approved Drug	33342-05-1	DB01251	PA164744895	D02430	DAP000924	91610	82719	n.a.	Gliquidone; 33342-05-1; Glurenorm; Beglynor; Gliquidonum; Gliquidonum [INN-Latin]; Gliquidona [INN-Spanish]; ARDF 26 SE; ARDF 26; C27H33N3O6S; UNII-C7C2QDD75P; EINECS 251-463-2; BRN 1559726; C7C2QDD75P; ARDF-26; 3-Cyclohexyl-1-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-isoquinolin-2-yl)ethyl]phenyl]sulfonyl-urea; MFCD00631870; 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea; glycvidon; glikvidon; NCGC00016819-01; Beglynora; Gliquidona; CAS-33342-05-1; DSSTox_CID_3096; DSSTox_RID_76873	C27H33N3O6S	LLJFMFZYVVLQKT-UHFFFAOYSA-N	1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea	Boehriger Ingelheim	Hypoglycemic Agents
PMDBD1259	Lopinavir	Therapeutic substance	Drug	192725-17-0	DB01601	PA450264	D01425	DAP000708	92727	83706	n.a.	Lopinavir; 192725-17-0; ABT-378; Aluviran; ABT 378; A 157378.0; A-157378.0; RS-346; UNII-2494G1JF75; CHEBI:31781; Lopinavir (ABT-378); LPV; (alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide; Koletra; A 157378; A-157378-0; 2494G1JF75; N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE; (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)ace	C37H48N4O5	KJHKTHWMRKYKJE-SUGCFTRWSA-N	(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide	n.a.	n.a.
PMDBD440	Imipenem	Therapeutic Substance	Approved Drug	64221-86-9	DB01598	PA449968	n.a.	DAP000459	104838	94631	n.a.	imipenem; Imipemide; 64221-86-9; N-Formimidoylthienamycin; Tienamycin; Imipenem anhydrous; Imipenemum; N-formimidoyl thienamycin; Imipenem hydrate; imipen; MK 0787; CHEBI:471744; Imipenem, N-Formimidoyl thienamycin; 74431-23-5; UNII-Q20IM7HE75; Imipenem (INN); Primaxin; (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure; MK-0787; CHEMBL148; Q20IM7HE75; (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxyl	C12H17N3O4S	ZSKVGTPCRGIANV-ZXFLCMHBSA-N	(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	Merck & Co	Antibiotics
PMDBD9	7-ethyl-10-hydroxycamptothecin	Therapeutic Substance	Investigational Drug	86639-52-3	DB05482	n.a.	n.a.	n.a.	104842	94634	n.a.	7-Ethyl-10-hydroxycamptothecin; 86639-52-3; SN-38; SN 38 lactone; SN 38; 7-Ethyl-10-hydroxy-camptothecin; 10-Hydroxy-7-ethylcamptothecin; SN38; 7-Ethyl-10-hydroxy-20(S)-camptothecin; UNII-0H43101T0J; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; NK012; NK-012; NK 012; CHEBI:8988; 7-Ethyl-10-hydroxy camptothecin; NSC673596; 0H43101T0J; (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (+)-7-ETHY	C22H20N2O5	FJHBVJOVLFPMQE-QFIPXVFZSA-N	(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione	NeoPharm	n.a.
PMDBD122	Bosentan	Therapeutic Substance	Approved Drug	147536-97-8	DB00559	PA10034	D01227	DNC000341	104865	94651	n.a.	Bosentan; 147536-97-8; Tracleer; Ro 47-0203; Ro-47-0203; Bosentan [USAN:INN:BAN]; C27H29N5O6S; UNII-XUL93R30K2; p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; Ro 47-0203/039; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; CHEMBL957; XUL93R30K2; Actelion; CHEBI:51450; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; NCGC00167440-01; bosentan a	C27H29N5O6S	GJPICJJJRGTNOD-UHFFFAOYSA-N	4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide	Actelion Pharmaceuticals	Antihypertensive Agents
PMDBD725	Racecadotril	Therapeutic Substance	Approved Drug	81110-73-8	DB11696	n.a.	n.a.	n.a.	107751	96913	n.a.	Racecadotril; 81110-73-8; Acetorphan; Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate; Racecadotril [INN]; Racecadotril (Acetorphan); Racecadotril (INN); AK-72817; 112573-73-6; Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester; (+-)-N-(2-((Acetylthio)methyl)-1-oxo-3-phenylpropyl)glycine phenylmethyl ester; Glycine, N-[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-,phenylmethyl ester [CAS]; C21H23NO4S; benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate; Glycine, N-(2-((acet	C21H23NO4S	ODUOJXZPIYUATO-UHFFFAOYSA-N	benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate	n.a.	n.a.
PMDBD385	Geniposide	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	107848	n.a.	NPC255677	Geniposide; 24512-63-8; UNII-145295QLXY; Jasminoidin; CHEBI:5299; 145295QLXY; Cyclopenta[c]py	C17H24O10	IBFYXTRXDNAPMM-BVTMAQQCSA-N	methyl (1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate	n.a.	n.a.
PMDBD1193	Fingolimod	Therapeutic substance	Drug	162359-55-9	DB08868	n.a.	D10001	n.a.	107970	97087	n.a.	Fingolimod; 162359-55-9; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol; 2-Amino-2-(4-octylphenethyl)propane-1,3-diol; UNII-3QN8BYN5QF; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol; Fingolimod [INN]; Gilenya (TN); 3QN8BYN5QF; CHEMBL314854; CHEBI:63115; Fingolimod (INN); FTY720 free base; C19H33NO2; 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol; 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol; 1,3-Propane	C19H33NO2	KKGQTZUTZRNORY-UHFFFAOYSA-N	2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol	n.a.	n.a.
PMDBD245	Daidzin	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	552-66-9	DB02115	n.a.	n.a.	n.a.	107971	97088	NPC161749	Daidzin; 552-66-9; Daidzoside; Daidzein 7-O-glucoside; Daidzein 7-glucoside; Daidzein-7-glucoside; daidzein-7-o-glucoside; daidzein 7-O-beta-D-glucoside; UNII-4R2X91A5M5; 7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; BRN 0059741; CHEBI:42202; 4R2X91A5M5; Daidzein-7-O-beta-D-glucopyranoside; Daidzin, 98%; DZN; 3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside; Dadzin; NPI 031D; 2vle; Daidzin (Daidzein-7-O-?-D-glucopyranoside); Daidzin, analytical standard; MLS006010640; 4-18-00-01808 (Beils	C21H20O9	KYQZWONCHDNPDP-QNDFHXLGSA-N	3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one	n.a.	n.a.
PMDBD890	Vardenafil	Therapeutic Substance	Approved Drug	224785-90-4	DB00862	PA10229	D08668	DAP000414	135400189	99300	n.a.	Vardenafil; Levitra; 224785-90-4; Vivanza; UNII-UCE6F4125H; HSDB 7304; Levitra (TN); BAY38-9456; CHEMBL1520; UCE6F4125H; 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE; VDN; CHEBI:46295; Vardenafil-d5; BAY 38-9456; 2-(2-Ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3H-imidazo(5,1-f)(1,2,4)triazin-4-one; 224789-15-5; 1-((3-(3,4-Dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine; 2-(2-et	C23H32N6O4S	SECKRCOLJRRGGV-UHFFFAOYSA-N	2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one	Bayer Pharmaceuticals Corporation	Antiimpotence Agents
PMDBD822	Tadalafil	Therapeutic Substance	Approved Drug	171596-29-5	DB00820	PA10333	D02008	DAP000615	110635	99301	n.a.	Tadalafil; Cialis; 171596-29-5; Ic351; Tadanafil; ADCIRCA; IC 351; ICOS 351; GF 196960; IC-351; UNII-742SXX0ICT; HSDB 7303; (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione; CHEMBL779; 742SXX0ICT; GF-196960; (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione	C22H19N3O4	WOXKDUGGOYFFRN-IIBYNOLFSA-N	(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione	Eli Lilly	Antiimpotence Agents
PMDBD1368	Pivmecillinam	Therapeutic substance	Antibiotics	32886-97-8	DB01605	PA164750167	D02889	DAP001174	115163	16735658	n.a.	Pivmecillinam; Amdinocillin Pivoxil; 32886-97-8; Pivmecilinamo; Pivmecillinamum; Pivamdinocillin; Selexid; Pivmecillinamum [INN-Latin]; Pivmecilinamo [INN-Spanish]; UNII-1WAM1OQ30B; amdinocillin, pivaloyloxymethyl ester; Coactabs; Amdinocillin pivoxil [USAN]; Pivmecillinam (INN); 1WAM1OQ30B; Amdinocillin pivoxil (USAN); CHEBI:51210; Pivmecillinam [INN]; Ro-109071; RO-10-9071; Ro 10-9071; [(2,2-dimethylpropanoyl)oxy]methyl (2S,5R,6R)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxy	C21H33N3O5S	NPGNOVNWUSPMDP-HLLBOEOZSA-N	2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD638	Paliperidone	Therapeutic Substance	Approved Drug	144598-75-4	DB01267	PA163518919	D05339	DAP000847	115237	103109	n.a.	Paliperidone; 144598-75-4; 9-Hydroxyrisperidone; Invega; PALLIPERIDONE; R-76477; 9-hydroxy risperidone; C23H27FN4O3; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; R 76477; CHEMBL1621; RO-76477; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydr	C23H27FN4O3	PMXMIIMHBWHSKN-UHFFFAOYSA-N	3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one	Johnson & Johnson	n.a.
PMDBD1322	Nitisinone	Therapeutic substance	Drug	104206-65-7	DB00348	PA164777037	n.a.	DAP000774	115355	103195	n.a.	Nitisinone; 104206-65-7; Orfadin; Nitisone; NTBC; 2-(2-nitro-4-(trifluoromethyl)benzoyl)cyclohexane-1,3-dione; 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione; Nitisinone [USAN:INN]; 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione; SC 0735; 2-(2-Nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione; Nitisinone-13C6; UNII-K5BN214699; C14H10F3NO5; 2-(Alpha,alpha,alpha-trifluoro-2-nitro-p-tuluoyl)-1,3-cyclohexanedione; SC-0735; CHEMBL1337; CHEBI:50378; 1,3-Cyclohexanedione, 2-[2-nitro-4-(trifluoromethyl)ben	C14H10F3NO5	OUBCNLGXQFSTLU-UHFFFAOYSA-N	2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione	n.a.	n.a.
PMDBD1124	Clofarabine	Therapeutic substance	Drug	123318-82-1	DB00631	PA164754863	n.a.	DAP000849	119182	106472	n.a.	Clofarabine; 123318-82-1; Clolar; Evoltra; Clofarex; CAFdA; Cl-F-Ara-A; C1-F-Ara-A; UNII-762RDY0Y2H; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; CHEBI:681569; (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 762RDY0Y2H; (2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2-chloro-9-(	C10H11ClFN5O3	WDDPHFBMKLOVOX-AYQXTPAHSA-N	(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol	n.a.	n.a.
PMDBD826	Tazobactam	Therapeutic Substance	Approved Drug	89786-04-9	DB01606	PA164764504	D00660	DAP000926	123630	110216	n.a.	Tazobactam; 89786-04-9; Tazobactam acid; Tazobactamum; YTR-830H; YTR 830H; Zosyn; UNII-SE10G96M8W; CHEMBL404; CL-298741; YTR 830; SE10G96M8W; CHEBI:9421; YTR 830 H; (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide; Tazobactamum [INN-Latin]; CCRIS 2203; Cl 298741; BRN 4787943; (2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmeth	C10H12N4O5S	LPQZKKCYTLCDGQ-WEDXCCLWSA-N	(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Gepach International	Antiinfective Agents
PMDBD382	Gefitinib	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	184475-35-2	DB00317	PA131301952	D01977	DAP000657	123631	110217	NPC56271	Gefitinib; 184475-35-2; Iressa; ZD1839; Irressat; gefitinib (zd1839); N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; ZD 1839; ZD-1839; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; UNII-S65743JHBS; CCRIS 9011; 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazoli	C22H24ClFN4O3	XGALLCVXEZPNRQ-UHFFFAOYSA-N	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine	AstraZeneca	Anticancer Agents
PMDBD1149	Desloratadine	Therapeutic substance	Drug	100643-71-8	DB00967	PA164776964	D03693	DAP000331	124087	110575	n.a.	Desloratadine; 100643-71-8; Clarinex; Descarboethoxyloratadine; Neoclarityn; Sch-34117; Aerius; Azomyr; Desloratidine; Denosin; 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; Sch 34117; Descarboethoxyoratidine; UNII-FVF865388R; CHEMBL1172; 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; MLS000559042; CHEBI:291342; FVF865388R; 5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8	C19H19ClN2	JAUOIFJMECXRGI-UHFFFAOYSA-N	13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene	n.a.	n.a.
PMDBD535	Methotrexate	Therapeutic Substance	Approved Drug	n.a.	DB00563	PA450428	D00142	DNC000933	126941	112728	n.a.	methotrexate; 59-05-2; Rheumatrex; Amethopterin; Trexall; Metatrexan; Hdmtx; Abitrexate; Methylaminopterinum; (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; Methylaminopterin; MTX; 4-Amino-10-methylfolic acid; Methotrexate hydrate; Metotrexato; Methotrexatum; Maxtrex; Rasuvo; A-Methopterin; A-Methpterin; Folex-Pfs; Methotrexat-Ebewe; N-Bismethylpteroylglutamic acid; NSC-740; NCI-C04671; Antifolan; Metotressato [DCIT]; Mexate-Aq; CL-14377; UNII-YL5FZ2Y5U1; Methotrex	C20H22N8O5	FBOZXECLQNJBKD-ZDUSSCGKSA-N	(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid	n.a.	n.a.
PMDBD1434	Tamsulosin	Therapeutic substance	Drug	106133-20-4	DB00706	PA451583	n.a.	DAP000086	129211	114457	n.a.	TAMSULOSIN; 106133-20-4; (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide; Tamsulosinum; Tamsulosine; Tamsulosina; (-)-Tamsulosin; Tamsulosine [INN-French]; Tamsulosinum [INN-Latin]; Tamsulosina [INN-Spanish]; Tamsulosin [INN:BAN]; UNII-G3P28OML5I; (r)-(-)-tamsulosin; Flomax (TN); CHEMBL836; G3P28OML5I; CHEBI:9398; 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide; 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide; Flowmax; Amsulosin; Q-101875	C20H28N2O5S	DRHKJLXJIQTDTD-OAHLLOKOSA-N	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide	n.a.	n.a.
PMDBD1409	Rufinamide	Therapeutic substance	Drug	106308-44-5	DB06201	PA166131606	D05775	n.a.	129228	114471	n.a.	Rufinamide; 106308-44-5; Inovelon; Banzel; 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide; Cgp 33101; CGP-33101; 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide; Xilep; RUF-331; RUF 331; UNII-WFW942PR79; C10H8F2N4O; 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide; E 2080; WFW942PR79; E-2080; NCGC00165883-02; E2080; DSSTox_CID_26506; DSSTox_RID_81675; DSSTox_GSID_46506; 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide; 1H-1,2	C10H8F2N4O	POGQSBRIGCQNEG-UHFFFAOYSA-N	1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide	n.a.	n.a.
PMDBD806	Sulbactam	Therapeutic Substance	Approved Drug	68373-14-8	DB09324	n.a.	D02223	n.a.	130313	115306	n.a.	SULBACTAM; 68373-14-8; sulbactam acid; Betamaze; Penicillanic Acid Sulfone; Sulbactamum; (2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide; penicillanic acid 1,1-dioxide; UNII-S4TF6I2330; CP 45899; CHEMBL403; CP-45899; (2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide; CP-45,899; CHEBI:9321; S4TF6I2330; Sulbactam;Penicillanic acid sulfone; Sulbactam [INN:BAN]; Sulbactamum [INN-Latin]; DSSTox_CID_3605; MFCD00867005; DSSTox_RID_77104; (2S,5R)-3,3-dim	C8H11NO5S	FKENQMMABCRJMK-RITPCOANSA-N	(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	Kowa Pharmaceuticals America	n.a.
PMDBD334	Febuxostat	Therapeutic Substance	Approved Drug	144060-53-7	DB04854	PA165958521	D01206	n.a.	134018	118173	n.a.	Febuxostat; 144060-53-7; Adenuric; Uloric; 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid; Tei-6720; Tei 6720; Feburic; TMX 67; TMX-67; Zurig; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid; UNII-101V0R1N2E; Febuxostat (Uloric); C16H16N2O3S; 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid; 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID; CHEMBL1164729; 101V0R1N2E; NCGC00182059-02; 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl	C16H16N2O3S	BQSJTQLCZDPROO-UHFFFAOYSA-N	2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid	Takeda	n.a.
PMDBD75	Aspartame	Therapeutic Substance; Dietary Substance; Herbal Substance	Dietary Compounds; Artificial Sweetener; Medicinal Herbal Compounds	22839-47-0	DB00168	PA448493	D02381	n.a.	134601	118630	NPC197470	aspartame; 22839-47-0; Nutrasweet; Asp-phe-ome; Asp-Phe methyl ester; Aspartam; Canderel; L-Aspartyl-L-phenylalanine methyl ester; Aspartamum; Aspartylphenylalanine methyl ester; Aspartamo; Sweet dipeptide; Tri-sweet; Dipeptide sweetener; Equal; Methyl aspartylphenylalanate; H-Asp-Phe-OMe; 1-Methyl N-L-alpha-aspartyl-L-phenylalanate; Aspartam [INN-French]; Aspartamum [INN-Latin]; methyl L-alpha-aspartyl-L-phenylalaninate; Aspartamo [INN-Spanish]; UNII-Z0H242BBR1; 3-Amino-N-(alpha-methoxycarbonylphenethyl) su	C14H18N2O5	IAOZJIPTCAWIRG-QWRGUYRKSA-N	(3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid	n.a.	n.a.
PMDBD830	Tempol	Therapeutic Substance	Investigational Drug	2226-96-2	DB12449	n.a.	n.a.	n.a.	137994	121639	n.a.	tempol; TMPN; HyTEMPO; 4-hydroxy-2,2,6,6-tetramethyl-piperidinooxy; 4-Oxypiperidol; Nitroxyl 2; 4-hydroxy-2,2,6,6-tetramethyl piperidinyloxy; 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl; 4-Hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl; Tetramethylpiperidino-N-oxyl; UNII-U78ZX2F65X; Tetramethylpiperidinol N-oxyl; U78ZX2F65X; CCRIS 4555; NR 1; 4-Hydroxy Tempo, Free Radical; 2,2,6,6-Tetramethyl-4-piperidinol-N-oxyl; 4-Hydroxy-2,2,6,6-tetramethylpiperidinooxy; 2,2,6,6-Tetramethyl-4-piperidinol 1-oxyl; 4-Hydroxy-TEMPO, free radi	C9H18NO2	UZFMOKQJFYMBGY-UHFFFAOYSA-N	nan	Georgetown University; Mitos Pharmaceuticals Inc	n.a.
PMDBD1180	Escitalopram	Therapeutic substance	Drug	128196-01-0	DB01175	PA10074	n.a.	DAP000741	146570	129277	n.a.	Escitalopram; (S)-Citalopram; 128196-01-0; S(+)-Citalopram; (+)-Citalopram; Seroplex; S-(+)-Citalopram; Cipralex; Escitalopram [INN]; (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; UNII-4O4S742ANY; Esertia; Escitalopram (INN); CHEMBL1508; R-Citalopram; 4O4S742ANY; CHEBI:36791; (+)-(S)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile	C20H21FN2O	WSEQXVZVJXJVFP-FQEVSTJZSA-N	(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile	n.a.	n.a.
PMDBD1045	Atazanavir	Therapeutic substance	Drug	198904-31-3	DB01072	PA10251	D07471	DNC000332	148192	130642	n.a.	Atazanavir; 198904-31-3; Latazanavir; Zrivada; BMS-232632; BMS 232632; Atazanavir [INN:BAN]; CGP 73547; Atazanavir Base; UNII-QZU4H47A3S; CGP-73547; ATV; HSDB 7339; Reyataz (TN); QZU4H47A3S; CHEMBL1163; CHEBI:37924; NCGC00182552-01; DSSTox_RID_82887; DSSTox_CID_28617; DSSTox_GSID_48691; DR7; (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER; atazanavirum	C38H52N6O7	AXRYRYVKAWYZBR-GASGPIRDSA-N	methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate	n.a.	n.a.
PMDBD1257	Levofloxacin	Therapeutic substance	Antibiotics	100986-85-4	DB01137	PA450214	D08120	DAP000160	149096	131410	n.a.	LEVOFLOXACIN; 100986-85-4; Levaquin; Quixin; Cravit; Iquix; (-)-Ofloxacin; Ofloxacin S-(-)-form; Levofloxacine; (S)-Ofloxacin; Tavanic; Levofloxacino; Levofloxacinum; Elequine; Oftaquix; L-Ofloxacin; Floxacin; DR-3355; (S)-(-)-Ofloxacin; Levofloxacin hydrate; Levofloxacine [INN-French]; Levofloxacinum [INN-Latin]; Levofloxacino [INN-Spanish]; HR 355; DR3355; Levofloxacin [USAN:INN:JAN]; RWJ 25213-097; UNII-RIX4E89Y14; RWJ-25213; MP-376; CCRIS 4074; Levofloxacin (Levaquin); Levaquin (TN); (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-pip	C18H20FN3O4	GSDSWSVVBLHKDQ-JTQLQIEISA-N	(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid	n.a.	n.a.
PMDBD329	Ezetimibe	Therapeutic Substance	Approved Drug	163222-33-1	DB00973	PA10816	D01966	DAP000717	150311	132493	n.a.	Ezetimibe; 163222-33-1; Zetia; Ezetrol; Ezedoc; Sch 58235; SCH-58235; (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; UNII-EOR26LQQ24; (-)-Sch 58235; Ezetimibe (Zetia); EOR26LQQ24; CHEBI:49040; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one; DSSTox_CID_24223; DSSTox_RID_80127; DSSTox_GSID_44223; (3R,4S)-1-(p-Flu	C24H21F2NO3	OLNTVTPDXPETLC-XPWALMASSA-N	(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one	Schering-Plough	Anticholesteremic Agents
PMDBD1179	Ertapenem	Therapeutic substance	Antibiotics	153832-46-3	DB00303	PA164777032	D07908	DAP000431	150610	132758	n.a.	Ertapenem; 153832-46-3; Ertapenem [INN]; UNII-G32F6EID2H; Ertapenem (INN); Ertapenem sodium; Invanz (TN); G32F6EID2H; (4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; C22H25N3O7S; CHEBI:404903; (4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (1R,5S,6S,8R,2'S,4'S)-2-(2-(3-carboxyphenylcarbamoyl)	C22H25N3O7S	JUZNIMUFDBIJCM-ANEDZVCMSA-N	(4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD562	Moxifloxacin	Therapeutic Substance	Approved Drug	151096-09-2	DB00218	PA450555	D08237	DAP000158	152946	134802	n.a.	moxifloxacin; 151096-09-2; Moxifloxacin [INN:BAN]; Moxeza; 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; UNII-U188XYD42P; U188XYD42P; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid; CHEBI:63611; BAY 12-8039; Izilox; 1-Cyclopropyl-6-Fluoro-8-Methoxy-7-[(4as,7as)-Octahydro-6h-Pyrrolo[3,4-B]pyridin-6-Yl]-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid	C21H24FN3O4	FABPRXSRWADJSP-MEDUHNTESA-N	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid	Bayer AG	Antibiotics
PMDBD1310	Naproxen	Therapeutic substance	Drug	22204-53-1	DB00788	PA450595	D00118	DAP000968	156391	137720	n.a.	NAPROXEN; 22204-53-1; (S)-Naproxen; (+)-Naproxen; Naprosyn; Naproxene; Equiproxen; Aleve; (S)-(+)-Naproxen; Laraflex; d-Naproxen; (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Naproxenum; Calosen; Nycopren; Naproxeno; Naprosyne; Bonyl; Naixan; Reuxen; Axer; (+)-(S)-Naproxen; Ec-Naprosyn; (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; Flexipen; Clinosyn; Artrixen; Anexopen; Acusprain; Leniartil; Danaprox; Bipronyl; Artroxen; Novonaprox; Arthrisil; Napren; Naposin; Napflam; Genoxen; Daprox; Atiflan	C14H14O3	CMWTZPSULFXXJA-VIFPVBQESA-N	(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid	n.a.	n.a.
PMDBD1117	Cinacalcet	Therapeutic substance	Drug	226256-56-0	DB01012	PA164776671	D03504	DAP000256	156419	137743	n.a.	Cinacalcet; 226256-56-0; AMG073; AMG-073; AMG 073; UNII-UAZ6V7728S; Parareg; (R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine; UAZ6V7728S; CHEBI:48390; N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine; N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine; N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine; (R)-alpha-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine; CNC; Cinacalcet (USAN); KRN-1493; N-[	C22H22F3N	VDHAWDNDOKGFTD-MRXNPFEDSA-N	N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine	n.a.	n.a.
PMDBD1328	Olmesartan	Therapeutic substance	Drug	144689-24-7	DB00275	PA164742950	D01204	DAP001412	158781	139674	n.a.	Olmesartan; 144689-24-7; Olmesartan Acid; Votum; Olme sartan; RNH-6270; UNII-8W1IQP3U10; CHEMBL1516; 8W1IQP3U10; CHEBI:48416; 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid; 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid	C24H26N6O3	VTRAEEWXHOVJFV-UHFFFAOYSA-N	5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid	n.a.	n.a.
PMDBD1439	Telbivudine	Therapeutic substance	Drug	3424-98-4	DB01265	PA164760861	D06675	DAP000698	159269	140081	n.a.	Telbivudine; Epavudine; 2'-Deoxy-L-thymidine; L-Thymidine; beta-L-Thymidine; Telbivudin; Tyzeka; L-dT; L-Deoxythymidine; 3424-98-4; Sebivo; NV-02B; LDT600; beta-L-2'-Deoxythymidine; LdT; NV 02B; UNII-2OC4HKD3SF; CHEBI:63624; LDT-600; 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 2OC4HKD3SF; 26879-47-0; 1-(2-deoxy-beta-L-ribofuranosyl)-5-methyluracil; 1-((2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; Thymine, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)	C10H14N2O5	IQFYYKKMVGJFEH-CSMHCCOUSA-N	1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione	n.a.	n.a.
PMDBD1343	Paromomycin	Therapeutic substance	Antibiotics	7542-37-2	DB01421	PA164784023	n.a.	DAP000407	165580	145115	n.a.	paromomycin; Aminosidin; AMINOSIDINE; Hydroxymycin; Paucimycin; Crestomycin; Estomycin; Monomycin A; catenulin; Paromomycin I; Neomycin E; 7542-37-2; Paramomycin Sulfate; Humatin; Paucimycinum; Paromomycinum; Paromomicina; Zygomycin A1; Paromomycine; UNII-61JJC8N5ZK; Gabbromycin; Paromomycin [INN]; Paromomycin (INN); R 400; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside; Antibiotic 503-3; 61JJC8N5ZK; Gabromycin; Am	C23H45N5O14	UOZODPSAJZTQNH-LSWIJEOBSA-N	(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	n.a.	n.a.
PMDBD313	Erlotinib	Therapeutic Substance	Approved Drug	183321-74-6	DB00530	PA134687924	D07907	DAP001010	176870	154044	n.a.	Erlotinib; 183321-74-6; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; OSI-774; UNII-J4T82NDH7E; NSC 718781; CHEMBL553; J4T82NDH7E; [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; CHEBI:114785; NCGC00164574-01; AK142763; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine; DSSTo	C22H23N3O4	AAKJLRGGTJKAMG-UHFFFAOYSA-N	N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine	OSI Pharma	Anticancer Agents
PMDBD252	Deflazacort	Therapeutic Substance	Approved Drug	14484-47-0	DB11921	n.a.	D03671	n.a.	189821	164861	n.a.	DEFLAZACORT; 14484-47-0; Oxazacort; Calcort; Azacort; Flantadin; Emflaza; Deflan; Cortax; MDL 458; UNII-KR5YZ6AE4B; Lantadin; DL-458-IT; L-5458; KR5YZ6AE4B; C25H31NO6; MDL-458; Dezacor; DSSTox_CID_378; Deflazacortum [INN-Latin]; DSSTox_RID_75552; DSSTox_GSID_20378; Deflazacortum; Enzocort; Decortil; Deflanil; EINECS 238-483-7; Deflazacort (Calcort); 2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acet	C25H31NO6	FBHSPRKOSMHSIF-GRMWVWQJSA-N	[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate	n.a.	n.a.
PMDBD424	Hexestrol	Therapeutic Substance	Approved Drug	84-16-2	DB07931	n.a.	n.a.	n.a.	192197	166848	n.a.	hexestrol; meso-Hexestrol; 84-16-2; Hexoestrol; Hexanoestrol; Hexestrofen; Estra-Plex; Hormoestrol; Mesohexestrol; Synestrol; Erythrohexestrol; Cycloestrol; Estronal; Estrifar; Syntrogene; Synthovo; Extra-plex; Hexron; Threo-hexestrol; Erythro-hexestrol; Hexestrol (VAN); Sinestrol; meso hexestrol; meso-3,4-Di(p-hydroxyphenyl)-n-hexane; UNII-10BI795R7D; CCRIS 9073; meso-3,4-Bis(p-hydroxyphenyl)-n-hexane; Dihydrostilbestrol; HSDB 2149; 4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol; EINECS 201-518-1; gamma,delta-Di(p-hydroxyphenyl)-hex	C18H22O2	PBBGSZCBWVPOOL-HDICACEKSA-N	4-[(3S,4R)-4-(4-hydroxyphenyl)hexan-3-yl]phenol	n.a.	n.a.
PMDBD879	Troleandomycin	Therapeutic Substance	Approved Drug	n.a.	DB13179	PA127840611	D01322	DAP000411	202225	16707	n.a.	TROLEANDOMYCIN; Triacetyloleandomycin; Oleandomycin triacetate; Oleandocetine; Tribiocillina; Oleandomycin triacetyl ester; Evramicina; Cyclamycin; Troleandomycine; Troleandomicina; Triocetin; Troleandomycinum; Triacetyloleandomycinum; 2751-09-9; Treolmicina; Matromicina; UNII-C4DZ64560D; Oleandomycin, triacetate (ester); CHEBI:45735; C4DZ64560D; TAO; Wytrion; Viamicina; Triolan; Aovine; Treis-Micina; Matromycin T; Tao (VAN); Troleandomycine [INN-French]; Troleandomycinum [INN-Latin]; Troleandomicina [INN-Spanis	C41H67NO15	LQCLVBQBTUVCEQ-QTFUVMRISA-N	[(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate	n.a.	n.a.
PMDBD729	Ramelteon	Therapeutic Substance	Approved Drug	196597-26-9	DB00980	PA164744896	n.a.	DAP000070	208902	181000	n.a.	Ramelteon; 196597-26-9; Rozerem; TAK-375; (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide; UNII-901AS54I69; CHEMBL1218; (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide; N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide; TAK375; (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide; 901AS54I69; (-)-N-(2-(((8S)-1,6,7,8-Tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)propanamide; Ramelteon [USAN]; N-{2-[(8S)-1,6,7,8-tetra	C16H21NO2	YLXDSYKOBKBWJQ-LBPRGKRZSA-N	N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide	Takeda	Hypnotics and Sedatives
PMDBD1141	Darunavir	Therapeutic substance	Drug	206361-99-1	DB01264	PA163522472	D03656	DAP001086	213039	184733	n.a.	Darunavir; 206361-99-1; Prezista; TMC114; TMC-114; UIC-94017; Darunavirum; TMC 114; Darunavirum [INN-Latin]; UNII-YO603Y8113; CHEMBL1323; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; CHEBI:367163; Darunavir-d9; YO603Y8113; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; NCGC00168773-01	C27H37N3O7S	CJBJHOAVZSMMDJ-HEXNFIEUSA-N	[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate	n.a.	n.a.
PMDBD1253	Lenalidomide	Therapeutic substance	Drug	191732-72-6	DB00480	PA162363968	D04687	DAP001255	216326	187515	n.a.	Lenalidomide; 191732-72-6; Revlimid; Revimid; CC-5013; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; Lenalidomide (CC-5013); CDC 501; IMiD3; CC 5013; CDC-501; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; Revlimid (TN); CHEBI:63791; 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; NCGC00167491-01; AK-47482	C13H13N3O3	GOTYRUGSSMKFNF-UHFFFAOYSA-N	3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione	n.a.	n.a.
PMDBD1245	Lacosamide	Therapeutic substance	Drug	175481-36-4	DB06218	PA166160048	D07299	n.a.	219078	189902	n.a.	Lacosamide; 175481-36-4; Erlosamide; (R)-2-acetamido-N-benzyl-3-methoxypropanamide; Harkoseride; Vimpat; Erlosamide [INN]; SPM 927; SPM-927; UNII-563KS2PQY5; (2R)-2-acetamido-N-benzyl-3-methoxypropanamide; ADD 234037; CHEMBL58323; 563KS2PQY5; (2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide; NCGC00253740-01; (2R)-N-benzyl-2-acetamido-3-methoxypropanamide; (R)-2-Acetylamino-N-benzyl-3-methoxy-propionamide; 175481-26-2; 2-(acetylamino)-N-benzyl-3-methoxypropanami	C13H18N2O3	VPPJLAIAVCUEMN-GFCCVEGCSA-N	(2R)-2-acetamido-N-benzyl-3-methoxypropanamide	n.a.	n.a.
PMDBD188	Cholic acid	Herbal Substance	Medicinal Herbal Compounds	81-25-4	DB02659	PA166160055	D10699	n.a.	221493	192176	NPC80089	cholic acid; 81-25-4; Colalin; Cholalic acid; Cholalin; cholate; Cholsaeure; Cholbam; NSC-6135; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; UNII-G1JO7801AE; HSDB 982; (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; Cholic acid [USAN]; 3,7,12-Trihydroxycholanic acid; MFCD00003672; G1JO7801AE	C24H40O5	BHQCQFFYRZLCQQ-OELDTZBJSA-N	(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	n.a.	n.a.
PMDBD1182	Estramustine	Therapeutic substance	Drug	2998-57-4	DB01196	PA449507	D04066	DAP001307	259331	227635	n.a.	estramustine; 2998-57-4; Estramustinum; Estramustina; Estramustinum [INN-Latin]; Estramustina [INN-Spanish]; UNII-35LT29625A; Estradiol 3-(N,N-bis(2-chloroethyl)carbamate); 17beta-Estradiol 3-(bis(2-chloroethyl)carbamate); CHEMBL1575; CHEBI:4868; NSC-89201; 35LT29625A; [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate; NCGC00164581-01; estramustin; DSSTox_CID_26458; DSSTox_RID_81632; DSSTox_GSID_46458; C23H31Cl2NO3; Estradiol 3-[bis(2-chl	C23H31Cl2NO3	FRPJXPJMRWBBIH-RBRWEJTLSA-N	[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate	n.a.	n.a.
PMDBD751	Ritonavir	Therapeutic Substance	Approved Drug	155213-67-5	DB00503	PA451260	D00427	DAP000169	392622	347980	n.a.	ritonavir; 155213-67-5; Norvir; ABT-538; Abbott 84538; A-84538; ABBOTT-84538; DRG-0244; UNII-O3J8G9O825; CHEBI:45409; HSDB 7160; RTV; O3J8G9O825; Ritonavir, 98%; NSC693184; NSC-693184; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]car	C37H48N6O5S2	NCDNCNXCDXHOMX-XGKFQTDJSA-N	1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate	Abbott Laboratories	Anti-HIV Agents
PMDBD574	Naringenin	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	480-41-1	DB03467	PA151958361	n.a.	n.a.	439246	388383	NPC32441	naringenin; 480-41-1; (S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; pelargidanon; naringetol; (2S)-Naringenin; salipurpol; Asahina; (S)-Naringenin; Naringenine; Salipurol; UNII-HN5425SBF2; CCRIS 5839; C15H12O5; YSO1; (-)-(2S)-Naringenin; CHEMBL9352; (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; AI3-23355; HN5425SBF2; CHEBI:17846; NSC 11855; (-)-Naringenin; Flavanone, 4',5,7-trihydroxy- (8CI); (2S)-5,7-dihydroxy-2-(4-hydrox	C15H12O5	FTVWIRXFELQLPI-ZDUSSCGKSA-N	(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one	n.a.	n.a.
PMDBD1354	Pentostatin	Therapeutic substance	Drug	53910-25-1	DB00552	PA450863	D00155	DAP000566	439693	388759	n.a.	pentostatin; Deoxycoformycin; Nipent; 53910-25-1; 2'-Deoxycoformycin; CO-Vidarabine; Covidarabine; Vidarbine; NSC-218321; 2'-DCF; YK-176; Co-V; PD-ADI; UNII-395575MZO7; Vira A deaminase inhibitor; 2'-Dexoycoformycin; CI-825; PD-81565; (R)-Deoxycoformycin; 395575MZO7; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol; NCGC00182045-01; 8R-2'-Deoxycoformycin; (R)-2'-Deoxycoformycin; Deaminase inhibitor (PD); dCF; NSC 218321; Pentostatinum [INN-Latin]; Pentostatine [INN-French]; Pentost	C11H16N4O4	FPVKHBSQESCIEP-JQCXWYLXSA-N	(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol	n.a.	n.a.
PMDBD1394	Quinidine	Therapeutic substance	Drug	56-54-2	DB00908	PA451209	D08458	DAP000515	441074	389880	n.a.	quinidine; 56-54-2; (+)-Quinidine; Pitayine; beta-Quinine; (8R,9S)-Quinidine; (9S)-6'-Methoxycinchonan-9-ol; Cin-Quin; Conquinine; Conchinin; Quinidex; Chinidin; Kinidin; Conchinine; chinidinum; quinidina; Quiniduran; Chinidine; UNII-ITX08688JL; Quinaglute; Quinidine sulfate; CHEBI:28593; (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol; alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol; Quinicardine; CHEMBL1294; (1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methan	C20H24N2O2	LOUPRKONTZGTKE-LHHVKLHASA-N	(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol	n.a.	n.a.
PMDBD524	Meropenem	Therapeutic Substance	Approved Drug	96036-03-2	DB00760	PA164764445	D02222	DAP000441	441130	389924	n.a.	meropenem; 96036-03-2; Merrem; Meropenem anhydrous; Meropenemum; Antibiotic SM 7338; MERONEM; SM-7338; 119478-56-7; MEPM; UNII-YOP6PX0BAO; CHEBI:43968; Meropenemum [INN-Latin]; Meropenem [INN]; Meropenem (INN); Meropenem Hydrate; YOP6PX0BAO; (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Merrem I.V.; ICI-194660	C17H25N3O5S	DMJNNHOOLUXYBV-PQTSNVLCSA-N	(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	AstraZeneca	Antibiotics
PMDBD415	Griseofulvin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	126-07-8	DB00400	PA449814	D00209	DAP000539	441140	389934	NPC234053	griseofulvin; 126-07-8; (+)-Griseofulvin; Amudane; Fulvicin; Grisactin; Grisefuline; Griseofulvina; Grizeofulvin; Griseofulvinum; Grisovin; Grifulvin; Spirofulvin; Grisofulvin; Fulcin; Likuden; Lamoryl; Grysio; Griseofulvine; Poncyl; Curling factor; Griscofulvin; Fulvistatin; Delmofulvina; Greosin; Fulvinil; Fulvina; Fulcine; Murfulvin; Grisetin; Grifulin; Gresfeed; Fungivin; Guservin; Griseomix; Grisactin Ultra; Neo-Fulcin; Biogrisin-FP; Fulvican grisactin; Griseofulvin-forte; Griseofulvin forte; Fulvicin-U/F; Fulvicin P/G; Fulvicin-P/G; Griseofulvi	C17H17ClO6	DDUHZTYCFQRHIY-RBHXEPJQSA-N	(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione	n.a.	Antifungal Agents
PMDBD1088	Cefoxitin	Therapeutic substance	Antibiotics	35607-66-0	DB01331	PA448856	D02345	DAP000452	441199	389981	n.a.	cefoxitin; 35607-66-0; Mefoxin; CEPHOXITIN; Cefoxitinum; Cefoxitina; Rephoxitin; Cefoxitine; Mefoxitin; ceftoxitin; UNII-6OEV9DX57Y; Cenomycin; CFX; CHEBI:209807; CHEMBL996; 6OEV9DX57Y; AK118716; DSSTox_CID_2764; DSSTox_RID_76721; DSSTox_GSID_22764; CA	C16H17N3O7S2	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N	(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD275	Digitoxin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	71-63-6	DB01396	PA449316	D00297	DAP000120	441207	389987	NPC72260	digitoxin; Digitoxoside; 71-63-6; Digitoxinum; Unidigin; Crystodigin; Digitoksin; Crystodigin (TN); Cardidigin; Carditoxin; Cardigin; Coramedan; Digitophyllin; Digipural; Tardigal; Digisidin; Acedoxin; Purpurid; Cristapurat; Myodigin; Digimerck; Digicor; UNII-E90NZP2L9U; Digitaline nativelle; DigitoXin, USP; Asthenthilo; Digitoxosidum; Lanatoxin; Digitrin; Natigal; Glucodigin; Digilong; Carditalin; Purodigin; Ditaven; Digitoksim; Monodigitoxoside; Mono-glycocard; De-Tone; Digitoxigenin tridigitoxoside; Crystalline digitalin; Digitossina [DCIT]; Pur	C41H64O13	WDJUZGPOPHTGOT-XUDUSOBPSA-N	3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	n.a.	Antiarrhythmic Agents
PMDBD1161	Dimenhydrinate	Therapeutic substance	Drug	523-87-5	DB00985	PA449338	D00520	DAP000333	441281	10210	n.a.	Prestwick_892; CHEBI:4604; SCHEMBL1249592; HMS1568F12; NCGC00017026-01; 2-(diphenylmethoxy)-N,N-dimethylethanaminium 8-chloro-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide; A829056; 8-chloro-1,3-dimethyl-2-oxo-6-purinolate; 2-(diphenylmethyl)oxyethyl-dimethylammonium; 8-chloranyl-1,3-dimethyl-2-oxidanylidene-purin-6-olate; 2-(diphenylmethyl)oxyethyl-dimethyl-azanium	C24H28ClN5O3	KKRAMGIVRBZVCD-UHFFFAOYSA-N	2-benzhydryloxyethyl(dimethyl)azanium;8-chloro-1,3-dimethyl-2-oxopurin-6-olate	n.a.	n.a.
PMDBD550	Miglitol	Therapeutic Substance	Approved Drug	72432-03-2	DB00491	PA164776726	D00625	DAP000712	441314	390074	n.a.	MIGLITOL; 72432-03-2; Glyset; (2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol; Bay-m-1099; UNII-0V5436JAQW; Miglitol (Glyset); Seibule; CHEMBL1561; CHEBI:6935; 0V5436JAQW; Diastabol; Bay m 1099; Miglitolum [Latin]; 1,5-dideoxy-1,5-[(2-hydroxyethyl)imino]-D-glucitol; Plumarol; DSSTox_CID_3323; (2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-3,4,5-piperidinetriol; DSSTox_RID_76977; DSSTox_GSID_23323; Bay 1099; C8H17NO5; Miglitolum; EINECS 276-661-6; SMR000466381; Glyset (TN); CAS-72432-03-2	C8H17NO5	IBAQFPQHRJAVAV-ULAWRXDQSA-N	(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol	n.a.	Hypoglycemic Agents
PMDBD1051	Bacampicillin 	Therapeutic substance	Antibiotics	50972-17-3	DB01602	PA164745461	n.a.	DAP001162	441397	390135	n.a.	bacampicillin; Bacampicilline; 50972-17-3; bacampicillinum; Bacampicilina; CHEBI:2968; 1'-Ethoxycarbonyloxyethyl-(6-D-alpha-aminophenylacetamido)penicillanate; Bacampicillin [INN:BAN]; BAPC; Bacampicilline [INN-French]; Bacampicilina [INN-Spanish]; Bacampicillinum [INN-Latin]; 1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; UNII-8GM2J22278; 6-((R)-2-Amino-2-phenylacetamido)penicillansaeure-(1-(ethoxycarbonyloxy)ethylester	C21H27N3O7S	PFOLLRNADZZWEX-FFGRCDKISA-N	1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD484	Linezolid	Therapeutic Substance	Approved Drug	165800-03-3	DB00601	PA450233	D00947	DAP000398	441401	390139	n.a.	linezolid; 165800-03-3; Zyvox; (S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide; Zyvoxid; PNU-100766; Zyvoxam; U-100766; PNU 100766; U 100766; UNII-ISQ9I6J12J; C16H20FN3O4; HSDB 7478; N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; CHEMBL126; ISQ9I6J12J; N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide; CHEBI:63607; Linezolid, 98%; Acetamide, N-[	C16H20FN3O4	TYZROVQLWOKYKF-ZDUSSCGKSA-N	N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	Pfizer Pharmaceuticals	Antibiotics
PMDBD392	Ginsenoside Re	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	441921	n.a.	NPC208594	Ginsenoside Re; 52286-59-6; Ginsenoside B2; Panaxoside RE; ginsenoside-Re; UNII-46F3R0BL3I; Chikusetsusaponin IVc; 51542-56-4; NSC 308877; CHEMBL510095; 46F3R0BL3I; CHEBI:77148; EINECS 257-814-6; NSC-308877; 2-O-(6-Deoxy-alpha-L-mannopyranosyl)-(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-beta-D-glucopyranoside; (20S)-ginsenoside Re; SCHEMBL669738; CTK8F0918; HY-N	C48H82O18	PWAOOJDMFUQOKB-WCZZMFLVSA-N	(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol	n.a.	n.a.
PMDBD393	Ginsenoside Rf	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	441922	n.a.	NPC245280	Ginsenoside Rf; 52286-58-5; ginsenoside-rf; UNII-JOS8BON5YW; Panaxoside RF; JOS8BON5YW; CHEBI:67986; GINSENOSIDE- RF; CHEMBL1773987; DTXSID90904205; Ginsenoside Rf, analytical standard; HY-N0601; MFCD00210509; AKOS027251120; ZINC238809500; CS-3841; SC-46561; AS-56543; X1153; N1917; C08945; 286G585; Q-100589; Q27104950; Ginsenoside Rf, primary pharmaceutical reference standard; (beta,6alpha,12beta)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; (3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-e	C42H72O14	UZIOUZHBUYLDHW-XUBRWZAZSA-N	(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD394	Ginsenoside Rg1	Herbal Substance	Medicinal Herbal Compounds	22427-39-0	DB06750	n.a.	n.a.	n.a.	441923	390498	NPC114874	Ginsenoside RG1; 22427-39-0; Panaxoside A; Sanchinoside C1; Panaxoside Rg1; Ginsenoside A2; Sanchinoside Rg1; UNII-PJ788634QY; (20S)-ginsenoside Rg1; CHEBI:67987; PJ788634QY; (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside; Ginsenoside g1; CHEMBL501637; Panaxoside A;; Ginsenoside A2;; Ginsenoside Rg1;; EINECS 244-989-9; Panax ginseng extract; Dammarane, -D-glucopyranoside; BIDD:ER0075; SCHEMBL19875635	C42H72O14	YURJSTAIMNSZAE-HHNZYBFYSA-N	(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD665	Phorbol	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	442070	n.a.	NPC163004	PHORBOL; 17673-25-5; UNII-XUZ76S9127; CHEBI:8116; 4beta-Phorbol; 4-beta-Phorbol; XUZ76S9127; (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one; 4,9,12-beta,13,20-Pentahydroxy-1,6-tigliadien-3-on; CCRIS 694; 4,9,12beta,13,20-pentahydroxy-1,6-tigliadien-3-on; 4,9,12beta,13,20-pentahydroxytiglia-1,6-dien-3-one; HSDB 4328; 4-.beta.-Phorbol; NSC 154778	C20H28O6	QGVLYPPODPLXMB-UBTYZVCOSA-N	(1S,2S,6R,10S,11R,13S,14R,15R)-1,6,13,14-tetrahydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyltetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dien-5-one	n.a.	n.a.
PMDBD575	Naringin	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	442428	n.a.	NPC142860	naringin; 10236-47-2; Naringoside; Naringin hydrate; UNII-N7TD9J649B; Naringenin 7-O-neohesperidoside; Naringenine-7-rhamnosidoglucoside; 4'5-diOH-Flavone-7-rhgluc; N7TD9J649B; CHEMBL451532; CHEBI:28819; C27H32O14; aurantiin; Naringenin 7-Rhamnoglucoside; Naringenin-7-beta-neohesperidoside; Naringenin 7-O-[alpha-L-rhamnosyl-(1-&gt;2)-beta-D-glucoside]; EINECS 233-566-4; 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-d	C27H32O14	DFPMSGMNTNDNHN-ZPHOTFPESA-N	(2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one	n.a.	n.a.
PMDBD645	Pedunculagin	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	442688	n.a.	NPC31034	Pedunculagin; CHEMBL506204; CHEBI:7948; 7045-42-3; C10236; DTXSID20990656; BDBM50242262; Q7160092; 2,3,4,5,6,7,11,17,18,19,20,21,22-Tridecahydroxy-10a,11,12a,13,25a,25b-hexahydrodibenzo[g,i]dibenzo[6',7':8',9'][1,4]dioxecino[2',3':4,5]pyrano[3,2-b][1,5]dioxacycloundecine-9,15,24,27-tetrone	C34H24O22	IYMHVUYNBVWXKH-ZITZVVOASA-N	(1R,2S,19R,22R)-7,8,9,12,13,14,20,28,29,30,33,34,35-tridecahydroxy-3,18,21,24,39-pentaoxaheptacyclo[20.17.0.02,19.05,10.011,16.026,31.032,37]nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaene-4,17,25,38-tetrone	n.a.	n.a.
PMDBD1463	Tolvaptan	Therapeutic substance	Drug	150683-30-0	DB06212	n.a.	D01213	n.a.	443894	391976	n.a.	(R)-(+)-Tolvaptan; 331947-66-1; UNII-1E2497LPNY; 1E2497LPNY; (R)-N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; N-[4-[[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepin-1-yl]-oxomethyl]-3-methylphenyl]-2-methylbenzamide; Samsca (TN); Tolvaptan (JAN/USAN/INN); MLS006011965; SCHEMBL1650272; CHEMBL4303142; QCR-237; DTXSID00332136; ZINC538658; N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methy	C26H25ClN2O3	GYHCTFXIZSNGJT-XMMPIXPASA-N	N-[4-[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methylphenyl]-2-methylbenzamide	n.a.	n.a.
PMDBD897	Vinpocetine	Therapeutic Substance	Approved Drug	42971-09-5	DB12131	n.a.	n.a.	n.a.	443955	392007	n.a.	vinpocetine; 42971-09-5; Cavinton; Ceractin; Apovincaminic acid ethyl ester; Ethyl apovincamin-22-oate; TCV-3B; Ethyl (+)-apovincaminate; RGH-4405; Vinpocetinum [INN-Latin]; cis-Apovincaminic acid ethyl ester; RGH 4405; (+)-Apovincaminic acid ethyl ester; Ethyl (+)-cis-apovincaminate; (+)-cis-Apovincaminic acid ethyl ester; Apovincaminate d'ethyle [French]; AY 27,255; UNII-543512OBTC; 3-alpha,16-alpha-Apovincaminic acid ethyl ester; Eburnamenine-14-carboxylic acid ethyl ester; Ethyl apovincaminate; EINECS 256-028-0; BRN 0900803	C22H26N2O2	DDNCQMVWWZOMLN-IRLDBZIGSA-N	ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate	n.a.	Vasodilator Agents
PMDBD898	Voglibose	Therapeutic Substance	Investigational Drug	83480-29-9	DB04878	PA164752433	D01665	DAP001104	444020	392046	n.a.	voglibose; 83480-29-9; Glustat; Basen; AO-128; UNII-S77P977AG8; A-71100; CHEMBL476960; S77P977AG8; Voglibose [USAN:INN]; Voglibosum [INN-Latin]; Voglibosa [INN-Spanish]; DSSTox_CID_1442; DSSTox_RID_76161; DSSTox_GSID_21442; (1S,2S,3R,4S,5S)-5-[(1,3-dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol; (1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol; CCRIS 4540; Voglibosum; Voglibosa; Basen OD; 3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydrox	C10H21NO7	FZNCGRZWXLXZSZ-CIQUZCHMSA-N	(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol	Takeda	Hypoglycemic Agents
PMDBD1140	Darifenacin	Therapeutic substance	Drug	133099-04-4	DB00496	PA164774901	D01699	DAP001131	444031	392054	n.a.	Darifenacin; Enablex; Emselex; 133099-04-4; UNII-APG9819VLM; UK-88525; APG9819VLM; CHEMBL1346; (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide; CHEBI:391960; 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide; [3H]darifenacin; 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; NCGC00168775-01; Darifenacin (USAN/INN); Darifenacin [USAN:INN:BAN]; 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-y	C28H30N2O2	HXGBXQDTNZMWGS-RUZDIDTESA-N	2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide	n.a.	n.a.
PMDBD740	Resveratrol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	501-36-0	DB02709	PA165291838	n.a.	DNC001205	445154	392875	NPC161571	resveratrol; 501-36-0; trans-resveratrol; 3,4',5-Trihydroxystilbene; 3,5,4'-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; (E)-resveratrol; 3,4',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Resvida; 3,4',5-Trihydroxy-trans-stilbene; SRT-501; SRT501; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 3,5,4'-Trihydroxy-trans-stilbene; Resveratol; trans-3,4',5-trihydroxystilbene; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Resveratrol, natural; UNII-Q369O8926L; CHEBI:45713; C14H12O3; tr	C14H12O3	LUKBXSAWLPMMSZ-OWOJBTEDSA-N	5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol	Sirtris Pharma	n.a.
PMDBD821	Tacrolimus	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	104987-11-3	DB00864	PA451578	D00107	DAP000162	445643	393220	NPC99864	tacrolimus; 104987-11-3; Prograf; Protopic; Fujimycin; FK506; Tacrolimus anhydrous; Advagraf; Modigraf; Protopy; Fk-506; Anhydrous Tacrolimus; tacrolimus (fk506); Tsukubaenolide; FR-900506; LCP-Tacro; FK 506; 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN; UNII-Y5L2157C4J; Astagraf XL; Tacrolimus hydrate; (-)-FK 506; Prograf (TN); FR900506; CHEMBL269732; CHEBI:61049; Y5L2157C4J; TACROLIMUS MONOHYDRATE; K506; Tacrolimus (anhydrous); NCGC00163470-03; Prograft; Tacrolimus [USAN]; CCRIS 7124; Graceptor; Envarsus; Avagraf; L 679934; Envarsus XR	C44H69NO12	QJJXYPPXXYFBGM-LFZNUXCKSA-N	(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone	Fujisawa; Sucampo	Immunosuppressive Agents
PMDBD755	Rosuvastatin	Therapeutic Substance	Approved Drug	287714-41-4	DB01098	PA134308647	D08492	DAP000555	446157	393589	n.a.	Rosuvastatin; 287714-41-4; ZD4522; UNII-413KH5ZJ73; CHEMBL1496; CHEBI:38545; 413KH5ZJ73; ZD-4522; (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[meth	C22H28FN3O6S	BPRHUIZQVSMCRT-VEUZHWNKSA-N	(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid	AstraZeneca	Anticholesteremic Agents
PMDBD1306	Mycophenolic Acid	Therapeutic substance	Drug	24280-93-1	DB01024	PA164748728	n.a.	DAP000784	446541	393865	n.a.	mycophenolic acid; 24280-93-1; Mycophenolate; Myfortic; Melbex; Mycophenolsaeure; Lilly-68618; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acido micofenolico; Micofenolico acido; NSC-129185; Acide mycophenolique; Acidum mycophenolicum; CCRIS 5565; NSC 129185; UNII-HU9DX48N0T; (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 483-60-3; Ly 68618; Micofenolico acido [Spanish]; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum [INN-Latin]; Acid	C17H20O6	HPNSFSBZBAHARI-RUDMXATFSA-N	(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid	n.a.	n.a.
PMDBD1122	Clindamycin	Therapeutic substance	Antibiotics	18323-44-9	DB01190	PA449035	D00277	DAP000409	446598	27005	n.a.	clindamycin; 18323-44-9; Dalacine; Chlolincocin; Clinimycin; Dalacin C; Sobelin; Cleocin; UNII-3U02EL437C; 7-Chlorolincomycin; 7-Chloro-7-deoxylincomycin; Clindamycine; Antirobe; Klimicin; ClindaDerm; 3U02EL437C; U 21251; Klindan 300; 7-Deoxy-7(S)-chlorolincomycin; 7(S)-Chloro-7-deoxylincomycin; C18H33ClN2O5S; methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside; HSDB 3037; Clindamycinum; Clindamicina; U-21251; EINECS 242-209-1; (2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4	C18H33ClN2O5S	KDLRVYVGXIQJDK-AWPVFWJPSA-N	(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide	n.a.	n.a.
PMDBD123	Brivudine	Therapeutic Substance	Approved Drug	69304-47-8	DB03312	n.a.	n.a.	n.a.	446727	394011	n.a.	Brivudine; 69304-47-8; BVDU; Brivudin; Helpin; (E)-5-(2-Bromovinyl)-2'-deoxyuridine; Bromovinyldeoxyuridine; Zostex; Brivudine [INN]; 5-BROMOVINYLDEOXYURIDINE; Brivudinum [INN-Latin]; Brivudina [INN-Spanish]; (E)-5-(2-Bromovinyl)-deoxyuridine; C11H13BrN2O5; CCRIS 2831; UNII-2M3055079H; 5-(2-bromovinyl)-2'-deoxyuridine; NSC 633770; trans-5-(2-Bromovinyl)-2'-deoxyuridine; Brivudine (INN); RP-101; MFCD00058585; NCGC00093656-01; 2M3055079H	C11H13BrN2O5	ODZBBRURCPAEIQ-PIXDULNESA-N	5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	n.a.	n.a.
PMDBD1206	Fosfomycin	Therapeutic substance	Antibiotics	23155-02-4	DB00828	PA164748039	D04253	DAP000767	446987	394204	n.a.	FOSFOMYCIN; phosphomycin; Phosphonomycin; 23155-02-4; Fosfonomycin; Fosfocina; Veramina; Fosfomicina; Fosfomycinum; Fosfomycine; Antibiotic 833A; Phosphonemycin; [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid; UNII-2N81MY12TE; (2R-cis)-(3-Methyloxiranyl)phosphonic acid; (1R,2S)-epoxypropylphosphonic acid; L-cis-1,2-epoxypropylphosphonic acid; (-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid; CHEMBL1757; 2N81MY12TE; CHEBI:28915; FCM; (1R,2	C3H7O4P	YMDXZJFXQJVXBF-STHAYSLISA-N	[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid	n.a.	n.a.
PMDBD88	Azithromycin	Therapeutic Substance	Approved Drug	83905-01-5	DB00207	PA448519	n.a.	DNC001539	447043	10482163	n.a.	azithromycin; Zithromax; 83905-01-5; Sumamed; Zitromax; Zmax; Azithromycinum; Azithromycine; Hemomycin; Azitrocin; Azasite; Azenil; Zitrotek; Misultina; Zithrax; Azitromax; Mixoterin; Setron; Aziwok; Zitrim; Tromix; Aztrin; Zifin; Tobil; Zmas; Zeto; Azithromycinum [Latin]; Azithromycine [French]; Zithromax IV; AZITHROMYCIN DIHYDRATE; CP-62993; Z-Pak; Aritromicina [Spanish]; CP 62993; UNII-J2KLZ20U1M; DRG-0104; C38H72N2O12; CCRIS 1961; HSDB 7205; Azithromycin (anhydrous); BRN 5387583; J2KLZ20U1M; Azythromycin; CHEBI:2955; Azithromycin (AIDS Initiative	C38H72N2O12	MQTOSJVFKKJCRP-BICOPXKESA-N	(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one	n.a.	n.a.
PMDBD520	Melphalan	Therapeutic Substance	Approved Drug	148-82-3	DB01042	PA450354	D00369	DAP000791	460612	405297	n.a.	melphalan; 148-82-3; Alkeran; Melfalan; L-PAM; Phenylalanine mustard; L-Sarcolysine; L-Sarcolysin; L-Phenylalanine mustard; p-L-Sarcolysin; Levofalan; Melphalanum; Levopholan; Melfalano; Levofolan; L-Sarkolysin; 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; Phenylalanine nitrogen mustard; p-Di-(2-chloroethyl)amino-L-phenylalanine; p-Bis(beta-chloroethyl)aminophenylalanine; 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; Melphalanum [INN-Latin]; p-N-Bis(2-chloroethyl)amino-L-phenylalanine; Melfalano [INN-Spanish]; 4-(Bis(2-chloroet	C13H18Cl2N2O2	SGDBTWWWUNNDEQ-LBPRGKRZSA-N	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid	n.a.	Anticancer Agents
PMDBD1372	Posaconazole	Therapeutic substance	Drug	171228-49-2	DB01263	PA151958574	D02555	DAP001101	468595	411709	n.a.	Posaconazole; 171228-49-2; Noxafil; Sch 56592; Posaconazole SP; SCH56592; SCH-56592; UNII-6TK1G07BHZ; Schering 56592; CHEMBL1397; 6TK1G07BHZ; 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one; 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-5-(2,4-DIFLUOROPHENYL)TETRAHYDROFURAN-3-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)PHENYL)-1-((2S,3S)-2-HYDROXYPENTAN-3-YL)-1H-1,2,4-TRIAZOL-5(4H)-ONE; CHEBI:6435	C37H42F2N8O4	RAGOYPUPXAKGKH-XAKZXMRKSA-N	4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one	n.a.	n.a.
PMDBD780	Shikonin	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	479503	n.a.	NPC246693	shikonin; 517-89-5; Isoarnebin 4; (R)-5,8-Dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione; (-)-Shikonin; (+)-Shikonin; 5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methyl-pent-3-enyl]naphthalene-1,4-dione; Tokyo Violet; CHEBI:81068; NSC 252844; CCRIS 6492; Shikonin S; 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-en-1-yl]-1,4-dihydronaphthalene-1,4-dione; BRN 2058010; (R)-(+)-Shikonin; SR-05000001466; HSDB 8100; (+)-5,8-Dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthoquinone; 1,4-Naphthalenedione, 5,8-dihydr	C16H16O5	NEZONWMXZKDMKF-SNVBAGLBSA-N	5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-enyl]naphthalene-1,4-dione	n.a.	n.a.
PMDBD856	Tolfenamic acid	Therapeutic Substance	Approved Drug	13710-19-5	DB09216	PA166049189	D01183	n.a.	610479	530683	n.a.	tolfenamic acid; 13710-19-5; Clotam; Tolfedine; 2-[(3-Chloro-2-methylphenyl)amino]benzoic Acid; N-(3-Chloro-2-methylphenyl)anthranilic acid; Acido tolfenamico; Acide tolfenamique; Acidum tolfenamicum; GEA 6414; 2-(3-Chloro-2-methylanilino)benzoic acid; N-(2-Methyl-3-chlorophenyl)anthranilic acid; UNII-3G943U18KM; N-(3-Chloro-o-tolyl)-anthranilic acid; N-(3-Chloro-ortho-tolyl) anthranilic acid; CHEBI:32243; 3G943U18KM; NCGC00016705-05	C14H12ClNO2	YEZNLOUZAIOMLT-UHFFFAOYSA-N	2-(3-chloro-2-methylanilino)benzoic acid	n.a.	n.a.
PMDBD1327	Oleic acid	Dietary Substances	Dietary Compounds	112-80-1	DB04224	n.a.	D02315	n.a.	637517	553123	n.a.	Elaidic acid; 112-79-8; trans-Oleic acid; 9-octadecenoic acid; trans-9-Octadecenoic acid; (E)-octadec-9-enoic acid; (E)-Oleic acid; trans-Octadec-9-enoic acid; (9E)-octadec-9-enoic acid; Elaidinsaeure; Elaidinsaure; acide elaidique; 9-elaidic acid; trans-Elaidic acid; Octadec-9-enoic acid; 9E-octadecenoic acid; UNII-4837010H8C; trans-.DELTA.9-Octadecenoic acid; (9E)-Octadecenoic acid; EINECS 204-006-6; MFCD00063954; NSC 26988; 9-trans-Octadecenoic acid; trans-delta(sup 9)-Octad	C18H34O2	ZQPPMHVWECSIRJ-MDZDMXLPSA-N	(E)-octadec-9-enoic acid	n.a.	n.a.
PMDBD5	2-chloro-5-nitro-N-phenylbenzamide	Therapeutic Substance	Investigational Drug	n.a.	DB07863	n.a.	n.a.	n.a.	644213	559235	n.a.	GW9662; 22978-25-2; 2-Chloro-5-nitro-N-phenylbenzamide; GW 9662; 2-Chloro-5-nitrobenzanilide; GW-9662; MLS001056751; CHEBI:79993; MFCD01215270; 2-Chloro-5-nitro-N-phenyl-benzamide; 2-Chloro-5-nitro-N-4-phenylbenzamide; SMR000326735; (2-chloro-5-nitrophenyl)-N-benzamide; SR-01000075999; Tocris-1508; Spectrum5_001989; Lopac-M-6191; DSSTox_RID_79570; DSSTox_CID_20723; Lopac0_000798; DSSTox_GSID_40723; KBioSS_000361; BSPBio_001021; KBioGR_000361; SCHEMBL420231; CHEMBL375270; GTPL3442; cid_644213; DTXS	C13H9ClN2O3	DNTSIBUQMRRYIU-UHFFFAOYSA-N	2-chloro-5-nitro-N-phenylbenzamide	n.a.	n.a.
PMDBD1294	Mezlocillin	Therapeutic substance	Antibiotics	51481-65-3	DB00948	PA164750540	D05021	DAP001180	656511	570894	n.a.	MEZLOCILLIN; 51481-65-3; Mezlin; Mezlocillinum; Mezlocilline; Mezlocilina; MEZLOCILLIN SODIUM; Multocillin; Mezlocillin acid; UNII-OH2O403D1G; CHEBI:6919; OH2O403D1G; (2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid; NCGC00167470-01; Mezlocillinum [INN-Latin]; Mezlocilline [INN-French]; Mezlocil	C21H25N5O8S2	YPBATNHYBCGSSN-VWPFQQQWSA-N	(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD44	Amygdalin	Herbal Substance; Dietary Substance	Medicinal Herbal Compounds; Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	656516	n.a.	NPC266389	amygdalin; 29883-15-6; (R)-Amygdalin; D-Amygdalin; (R)-Laenitrile; (R)-Amygdaloside; UNII-214UUQ9N0H; D(-)-Mandelonitrile-beta-D-gentiobioside; D-Mandelonitrile-beta-D-glucosido-6-beta-D-glucoside; Amygdaloside; 214UUQ9N0H; R-Amygdalin; CHEBI:17019; Vitamin B17; Mandelonitrile-beta-gentiobioside; 6-O-BETA-D-GLUCOSIDO-BETA-D-GLUCOSIDE; (2R)-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy](phenyl)acetonitrile; HSDB 3559; EINECS 249-925-3; NSC-15780; NSC 15780; BRN 0066856; Benzeneacetonitrile, alpha-((6-O-beta-D-glucopyranos	C20H27NO11	XUCIJNAGGSZNQT-JHSLDZJXSA-N	(2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile	n.a.	n.a.
PMDBD1337	Oxtriphylline	Therapeutic substance	Drug	4499-40-5	DB01303	PA164748137	D02017	DAP000868	656652	25044543	n.a.	OXTRIPHYLLINE; Choline theophyllinate; 4499-40-5; Choline theophylline; UNII-3K045XR58X; Oxtriphylline [USP]; Choline salt with theophylline (1:1); 3K045XR58X; Oxtriphylline (USP); Choline theophyllinate (INN); Choline theophyllinate [INN]; Theocolin; Colina teofillinato; Cholini theophyllinas; Teofilinato de colina; Oxtriphylline pediatric; Theophyllinate de choline; cholintheophyllinat; Theocolin (TN); Choline thieophyllinate; Theophyline and choline; Choline theophylline (JAN); SCHEMBL4629; SCHEMBL152854; CHEMBL1200434; DTXSID20	C12H21N5O3	SOELXOBIIIBLRJ-UHFFFAOYSA-M	1,3-dimethyl-2-oxopurin-6-olate;2-hydroxyethyl(trimethyl)azanium	n.a.	n.a.
PMDBD359	Fludarabine	Therapeutic Substance	Approved Drug	21679-14-1	DB01073	PA449655	D01907	DAP000567	657237	571392	n.a.	Fludarabine; 21679-14-1; F-Ara-A; 2-Fluoro Ara-A; 9-beta-D-Arabinofuranosyl-2-fluoroadenine; (2R,3S,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Fludarabine [INN]; Fludarabinum [Latin]; Fludarabina [Spanish]; 2-F-ara-A; Fludarabine (INN); NSC 118218; CCRIS 3382; Fludarabine (Fludara); (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 2-Fluoro-9-beta-D-arabinofuranosyladenine; (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-d	C10H12FN5O4	HBUBKKRHXORPQB-FJFJXFQQSA-N	(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	Genzyme Corp	Anticancer Agents
PMDBD1389	Propylthiouracil	Therapeutic substance	Drug	51-52-5	DB00550	PA451156	D00562	DAP001247	657298	571424	n.a.	propylthiouracil; 51-52-5; 6-Propyl-2-thiouracil; Propacil; Procasil; Prothiurone; Prothyran; 2-Mercapto-6-propylpyrimidin-4-ol; Propycil; Thiuragyl; Protiural; Prothiucil; Prothycil; Propyl-Thiorist; Propyl-Thyracil; 6-N-Propylthiouracil; Propythiouracil; Propilthiouracil; 6-Propylthiouracil; Propyl-Thiorit; Propylthiorit; Thyreostat II; 6-Thio-4-propyluracil; 6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; 6-N-Propyl-2-thiouracil; Propylthiouracile; PTU (thyreostatic); Propiltiouracilo; 4-Propyl-2-thiouracil; Propylthiouracilum; 2-M	C7H10N2OS	KNAHARQHSZJURB-UHFFFAOYSA-N	6-propyl-2-sulfanylidene-1H-pyrimidin-4-one	n.a.	n.a.
PMDBD1169	Doxepin	Therapeutic substance	Drug	1668-19-5	DB01142	PA449409	D07875	DAP000177	667468	3046	n.a.	doxepin; Cidoxepin; cis-doxepin; Doxepine; (Z)-Doxepin; UNII-F96TTB8728; 1668-19-5; Cidoxepinum; Cidoxepina; CHEMBL101740; 3607-18-9; CHEBI:36691; F96TTB8728; Cidoxepin [INN]; 3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine; (3Z)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine; (3z)-3-(Dibenzo[b,E]oxepin-11(6h)-Ylidene)-N,N-Dimethylpropan-1-Amine; Doxepin (Z)-isomer	C19H21NO	ODQWQRRAPPTVAG-BOPFTXTBSA-N	(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine	n.a.	n.a.
PMDBD268	Dienestrol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	13029-44-2	DB00890	PA164745534	D00898	DAP001015	667476	580857	NPC26244	dienestrol; Dehydrostilbestrol; Dienoestrol; 84-17-3; (E,E)-Dienestrol; Cycladiene; Dienol; Estraguard; Dehydrostilboestrol; Oestrodienol; Willnestrol; Hormofemin; Estragard; Dienesterol; Oestrovis; para-Dien; alpha-Dienestrol; E,E-Dienestrol; Dienestrol (E,E); Dienoestrol bp; Follidiene; Estrodienol; Oestrodiene; Restrol; 13029-44-2; Oestrasid; p,p'-(Diethylideneethylene)diphenol; Di(p-oxyphenyl)-2,4-hexadiene; Oestroral; Dinestrol; Follormon; Teserene; Sexadien; Gynefollin; Estroral; Agaldog; Retalon; Dinovex; 3,4-Bis(4-hydroxyphenyl)-2,4-hex	C18H18O2	NFDFQCUYFHCNBW-SCGPFSFSSA-N	4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol	n.a.	Estrogens
PMDBD326	Etomidate	Therapeutic Substance	Approved Drug	33125-97-2	DB00292	PA164743987	D00548	DAP000669	667484	580864	n.a.	Etomidate; 33125-97-2; (+)-Etomidate; Amidate; Etomidatum; Etomidato; (R)-ETHYL 1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLATE; Hypnomidate; D-Etomidate; (d)-Etomidate; UNII-Z22628B598; (+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate; R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate; ethyl 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate; CHEMBL681; (R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester; ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate; Etomidatum [INN-Latin]; CHEBI:4910; Etom	C14H16N2O2	NPUKDXXFDDZOKR-LLVKDONJSA-N	ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate	Janssen Pharmaceutica	Analgesics
PMDBD523	Mercaptopurine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	50-44-2	DB01033	PA450379	D04931	DAP000147	667490	580869	NPC189314	6-Mercaptopurine; mercaptopurine; 50-44-2; Purinethol; Mercapurin; 6-Thiopurine; Leukerin; Mercaleukin; Leupurin; 6-Thioxopurine; Puri-Nethol; Ismipur; 7H-purine-6-thiol; Mern; 6-Thiohypoxanthine; 6-Mercaptopurin; 6-Purinethiol; Purimethol; Purinethiol; 6-MP; Purine-6-thiol; 9H-Purine-6-thiol; 6 MP; 3H-Purine-6-thiol; 1,9-dihydro-6H-purine-6-thione; Mercaleukim; 1,7-Dihydro-6H-purine-6-thione; 1H-Purine-6(9H)-thione; Mercaptopurine (6-MP); 3,7-dihydropurine-6-thione; Merkaptopuryna; Me	C5H4N4S	GLVAUDGFNGKCSF-UHFFFAOYSA-N	3,7-dihydropurine-6-thione	Novopharm	Anticancer Agents
PMDBD136	Caffeic acid	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	689043	n.a.	NPC294902	caffeic acid; 3,4-Dihydroxycinnamic acid; 331-39-5; 3-(3,4-dihydroxyphenyl)acrylic acid; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3,4-Dihydroxybenzeneacrylic acid; trans-caffeic acid; trans-Caffeate; 3,4-Dihydroxy-trans-cinnamate; 501-16-6; 3-(3,4-Dihydroxyphenyl)propenoic acid; UNII-U2S3A33KVM; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 3-(3,4-Dihydroxyphenyl)-2	C9H8O4	QAIPRVGONGVQAS-DUXPYHPUSA-N	(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid	n.a.	n.a.
PMDBD845	Thiothixene	Therapeutic Substance	Approved Drug	3313-26-6	DB01623	PA451669	D00374	DAP000318	941651	819430	n.a.	thiothixene; cis-Thiothixene; Tiotixene; Navane; (Z)-Thiothixene; 3313-26-6; Thiothixine; Tiotixenum [INN-Latin]; Tiotixeno [INN-Spanish]; Thiothixene (Z); Orbinamon; Navaron; Navan; Thiothixene hydrochloride; UNII-7318FJ13YJ; NSC-108165; MLS000028463; (9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide; SMR000058396; 5591-45-7; 7318FJ13YJ; CP-12,252-1 base; cis-N,N-Dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)thioxanthene-2-sulfonamide; Tiotixenum; Tiotixeno; CP-12,252-1; P-4657-B; CP 12252-1	C23H29N3O2S2	GFBKORZTTCHDGY-UWVJOHFNSA-N	(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide	Pfizer Pharmaceuticals	Antipsychotic Agents
PMDBD318	Eszopiclone	Therapeutic Substance	Approved Drug	138729-47-2	DB00402	PA162630444	n.a.	DAP000933	969472	839530	n.a.	Eszopiclone; 138729-47-2; (S)-Zopiclone; Lunesta; Estorra; Esopiclone; (+)-Zopiclone; Eszopiclone [USAN:INN]; ( )-Zopiclone; SEP-190; UNII-UZX80K71OE; CHEBI:53760; HSDB 7472; SEP-225441; UZX80K71OE; (5S)-6-(5-CHLOROPYRID-2-YL)-5-(4-METHYLPIPERAZIN-1-YL)CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRAZINE; (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate; [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate; (5	C17H17ClN6O3	GBBSUAFBMRNDJC-INIZCTEOSA-N	[(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate	GSK	Hypnotics and Sedatives
PMDBD233	Curcumin	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	458-37-7	DB11672	n.a.	n.a.	n.a.	969516	839564	NPC109083	curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Turmeric yellow; Curcuma; Indian saffron; Turmeric; Kacha haldi; Gelbwurz; Curcumin I; Souchet; Haldar; Haidr; Halud; Halad; Merita earth; Yellow Ginger; Terra Merita; Yellow Root; Safran d'Inde; Yo-Kin; Golden seal; Curcuma oil; Orange Root; Oils, curcuma; C.I. Natural Yellow 3; Curcumine; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; Hydrastis; Indian turmeric; Yellow puccoon; Diferaloylmethane; Turmeric extract; Kurkumin [Czech]; Tumeric yellow; Turmeric oil; Oi	C21H20O6	VFLDPWHFBUODDF-FCXRPNKRSA-N	(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	n.a.	n.a.
PMDBD1285	Methimazole	Therapeutic substance	Drug	60-56-0	DB00763	PA450422	D00401	DNC001429	1349907	1131173	n.a.	methimazole; 60-56-0; thiamazole; Tapazole; 2-Mercapto-1-methylimidazole; Methimazol; 1-Methylimidazole-2-thiol; Thymidazol; Metazolo; Thymidazole; Mercazolyl; Mercazole; Thycapzol; Metothyrine; Metothyrin; Merkazolil; Mercaptazole; Thiamazol; Strumazol; Favistan; Basolan; 1-Methyl-1H-imidazole-2-thiol; Thycapsol; Metotirin; Danantizol; Frentirox; Thacapzol; Merkastan; Metizol; Mercasolyl; Methylmercaptoimidazole; 1-Methyl-2-mercaptoimidazole; Methiamazole; Tiamazol; Usaf el-30; Mercazolylum; 3-met	C4H6N2S	PMRYVIKBURPHAH-UHFFFAOYSA-N	3-methyl-1H-imidazole-2-thione	n.a.	n.a.
PMDBD816	Sulindac	Therapeutic Substance	Approved Drug	38194-50-2	DB00605	PA451565	D00120	DAP000569	1548887	1265915	n.a.	sulindac; Clinoril; 38194-50-2; Arthrocine; Sulindac sulfoxide; Sulindacum; Sulindaco; Mobilin; Aflodac; Sulreuma; MK 231; Sulindacum [INN-Latin]; Sulindaco [INN-Spanish]; MK-231; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; CHEBI:9352; CCRIS 3305; C20H17FO3S; cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; EINECS 253-819-2; BRN 2951842; Reumofil; Citireuma; Clisundac; Algocet	C20H17FO3S	MLKXDPUZXIRXEP-MFOYZWKCSA-N	2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid	Merck & Co	Antiinflammatory Agents
PMDBD142	Capsaicin	Dietary Substance	Dietary Compounds	404-86-4	DB06774	n.a.	D00250	n.a.	1548943	1265957	NPC255550	Capsaicin; 404-86-4; Zostrix; CAPSAICINE; (E)-Capsaicin; Qutenza; E-CAPSAICIN; Styptysat; Axsain; Isodecenoic acid vanillylamide; trans-8-Methyl-N-vanillyl-6-nonenamide; NGX-4010; Capsaicin [USAN]; Caswell No. 158; FEMA No. 3404; Transacin; (E)-8-Methyl-N-vanillyl-6-nonenamide; trans-Capsaicin; NCI-C56564; UNII-S07O44R1ZM; NSC 56353; CCRIS 1588; CHEBI:3374; HSDB 954; ALGRX 4975; C18H27NO3; Capsaicin (JAN/USP); ZOSTRIX (TN); N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide; EINECS 206-96	C18H27NO3	YKPUWZUDDOIDPM-SOFGYWHQSA-N	(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide	Samyang Corp	n.a.
PMDBD1203	Fluvastatin	Therapeutic substance	Drug	93957-54-1	DB01095	PA449688	D07983	DAP000554	1548972	1265982	n.a.	fluvastatin; Fluvastatine; Fluvastatinum; Fluvastatina; Fluvastatine [INN-French]; Fluvastatinum [INN-Latin]; Fluvastatina [INN-Spanish]; Cranoc; 93957-54-1; Fluindostatin; CHEBI:5136; CHEMBL350239; Fluvastatin [INN:BAN]; 155229-76-8; C24H26FNO4; XU 62320; XU-62320; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Fluvastatin (INN); (+-)-fluvastatin; Fluvas (TN); (3S,5R)-FLUVASTATIN SODIUM SALT; (3S,5R)-fluvastatin; Prestwick3_000859; rac-(3R,5S)-fluvastatin; SCHEMBL2847; SCHEMBL2849; BS	C24H26FNO4	FJLGEFLZQAZZCD-JUFISIKESA-N	(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid	n.a.	n.a.
PMDBD1443	Terbinafine	Therapeutic substance	Drug	91161-71-6	DB00857	PA451614	D02375	DAP000753	1549008	1266005	n.a.	terbinafine; 91161-71-6; Lamisil; Lamasil; Lamisil Tablet; Lamisil AT; SF-86-327; (E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine; SF 86-327; terbinafin; UNII-G7RIW8S0XP; (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine; Terbinafina; (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine; G7RIW8S0XP; CHEMBL822; BRN 4256376; CHEBI:9448; Terbinafinum; Zabel; NCGC00159346-02; (2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine; (2E)-N,6,6-trimethyl-N-(naphthalen	C21H25N	DOMXUEMWDBAQBQ-WEVVVXLNSA-N	(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine	n.a.	n.a.
PMDBD522	Merbromin	Therapeutic Substance	Approved Drug	129-16-8	DB13392	n.a.	D00861	n.a.	2724062	8029248	n.a.	nan	C20H9Br2HgNa2O6	KQSRXDXJGUJRKE-UHFFFAOYSA-L	disodium;[2,7-dibromo-9-(2-carboxylatophenyl)-3-oxido-6-oxoxanthen-4-yl]mercury;hydrate	n.a.	n.a.
PMDBD276	Digoxin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	20830-75-5	DB00390	PA449319	D00298	DAP000744	2724385	2006532	NPC173555	digoxin; 20830-75-5; 12beta-Hydroxydigitoxin; Lanoxicaps; Lanoxin; Digosin; Digoxin Pediatric; Lanicor; Digacin; Dilanacin; CHEBI:4551; MLS000069819; Lanacordin; Cardiogoxin; SMR000059217; Rougoxin; Mapluxin; Lenoxin; Lanacrist; Dynamos; Eudigox; Davoxin; Vanoxin; Digoxine; Neo-Lanicor; (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-&gt;4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-&gt;4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; Lanoxin PG; Digoxin Nativelle; SK-Digoxin; UNII-73K41	C41H64O14	LTMHDMANZUZIPE-PUGKRICDSA-N	3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	GlaxoSmithKline	Antiarrhythmic Agents
PMDBD1433	Tamoxifen	Therapeutic substance	Drug	10540-29-1	DB00675	PA451581	D08559	DAP000108	2733526	2015313	n.a.	tamoxifen; 10540-29-1; trans-Tamoxifen; Soltamox; Crisafeno; Diemon; Tamoxifene; Tamoxen; Citofen; Oncomox; Valodex; Retaxim; Tamizam; Istubol; Tamoxifeno; Tamoxifenum; Tamoxifene [INN-French]; Tamoxifenum [INN-Latin]; Tamoxifeno [INN-Spanish]; Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; ICI-46474; ICI 47699; CCRIS 3275; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; UNII-094ZI81Y45; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; HSDB 6782	C26H29NO	NKANXQFJJICGDU-QPLCGJKRSA-N	2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine	n.a.	n.a.
PMDBD1187	Ethionamide	Therapeutic substance	Drug	536-33-4	DB00609	PA164768738	D00591	DAP001141	2761171	2041901	n.a.	ethionamide; 536-33-4; 2-ethylpyridine-4-carbothioamide; Ethioniamide; Ethyonomide; Ethinamide; Thioamide; Etioniamid; Etionamid; Amidazine; Ethylisothiamide; Trecator; 2-Ethylthioisonicotinamide; Trecator-SC; Tubenamide; Iridocin; Etionizine; Etionizin; Etiocidan; Ethimide; Amidazin; Tubermin; Thianide; Tuberoid; Trekator; Thioniden; Sertinon; Rigenicid; Isotiamida; Iridozin; Tuberoson; Trescazide; Trescatyl; Nicotion; Itiocide; Fatoliamid; Etionizina; Aetina; Tianid; Etionid; Isothin; Ethina; Aetiva; Thianid; Tebe	C8H10N2S	AEOCXXJPGCBFJA-UHFFFAOYSA-N	2-ethylpyridine-4-carbothioamide	n.a.	n.a.
PMDBD1413	Scopolamine	Therapeutic substance	Drug	51-34-3	DB00747	PA451308	D00138	DNC000757	3000322	10194106	n.a.	scopolamine; Hyoscine; (-)-Hyoscine; Scopine (-)-tropate; 51-34-3; Hyosol; l-Scopolamine; (-)-Scopolamine; Transderm-Scop; 6,7-Epoxytropine tropate; Scopine tropate; Atrochin; Atroquin; Isopto Hyoscine; Epoxytropine tropate; Scopolamine hydrobromide; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; UNII-DL48G20X8X; Oscine; Scopamin; Beldavrin; Transderm scop; alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester; Skopolamin; Hyosceine; Scop; DL48G20X8X; CHEMBL3084722; CHEBI:16794; LSM-4015	C17H21NO4	STECJAGHUSJQJN-USLFZFAMSA-N	[(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate	n.a.	n.a.
PMDBD1258	Lincomycin	Therapeutic substance	Drug	154-21-2	DB01627	PA164749212	D00223	DAP000839	3000540	2272112	n.a.	lincomycin; 154-21-2; Lincomycinum; Cillimycin; Lincomicina; Lincomycin A; UNII-BOD072YW0F; CHEMBL1447; Lincomycine; Lincolnensin; Jiemycin; Lincocin; Lincomycin, (2S-cis)-Isomer; C18H34N2O6S; Lincomycin (USAN/INN); BOD072YW0F; Lincolcina; CHEBI:6472; Lincomycine [French]; Lincomycinum [INN-Latin]; Lincomycine [INN-French]; Lincomicina [INN-Spanish]; U-10149; Methyl 6,8-dideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside	C18H34N2O6S	OJMMVQQUTAEWLP-KIDUDLJLSA-N	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide	n.a.	n.a.
PMDBD731	Ranitidine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	66357-35-5	DB00863	PA451224	D00422	DAP000340	3001055	4863	NPC320751	ranitidine; 66357-35-5; Raticina; ZANTAC; Gastrosedol; Rantacid; Ptinolin; Quantor; Ranitiget; Ranisen; Raniogas; Ranidine; Microtid; Taural; Ulceranin; Ranitidina; Zantadin; Xanidine; Weichilin; Ranitidinum; Duractin; Zantab; Weidos; Verlost; Urantac; Raniter; Radinat; Logast; Istomar; Atural; Acidex; Achedos; Randin; Mauran; Ezopta; Vesyca; Sampep; Gastrial; Coralen; Vizerul; Quicran; Axoban; Ratic; Ranin; Ul-Pep; Zantic; Rantidine; Ranitidine HCL; Ranitidinum [INN-Latin]; Ranitidina [INN-Spanish]; Ranitidine [USAN:BAN:INN]; Ranitidine Base; (E)-ranitidine	C13H22N4O3S	VMXUWOKSQNHOCA-UKTHLTGXSA-N	(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine	GlaxoSmithKline	Antiulcer Agents
PMDBD1440	Telithromycin	Therapeutic substance	Antibiotics	191114-48-4	DB00976	PA10202	D01078	DAP000109	3002190	2273373	n.a.	Telithromycin; Ketek; 191114-48-4; HMR3647; UNII-KI8H7H19WL; HMR-3647; Levviax; HMR 3647; RU 66647; RU-66647; KI8H7H19WL; RU66647; DSSTox_RID_81629; DSSTox_CID_26455; DSSTox_GSID_46455; HSDB 7359; CAS-191114-48-4; HMR3647;RU66647; Telithromycin [USAN:INN:BAN]; NCGC00164575-01; SCHEMBL5100; CHEMBL1136; DTXSID3046455; CHEBI:29688; HY-A0062; ZINC9574770; Erythromycin, 3-de((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-11,12-dideoxy-6-O-methyl-3-oxo-12,11-(oxycarbonyl((4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)imino	C43H65N5O10	LJVAJPDWBABPEJ-PNUFFHFMSA-N	(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone	n.a.	n.a.
PMDBD1267	Maraviroc	Therapeutic substance	Drug	376348-65-1	DB04835	PA164768835	n.a.	DNC001487	3002977	20078004	n.a.	Maraviroc; 376348-65-1; Selzentry; Celsentri; UK-427857; UK-427,857; UK 427857; UNII-MD6P741W8A; MD6P741W8A; MVC; 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide; CHEMBL1201187; CHEBI:63608; NCGC00183109-02; 4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide; Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-meth	C29H41F2N5O	GSNHKUDZZFZSJB-HLMSNRGBSA-N	4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide	n.a.	n.a.
PMDBD859	Toremifene	Therapeutic Substance	Approved Drug	89778-26-7	DB00539	PA451731	n.a.	DAP000793	3005573	2275722	n.a.	toremifene; Acapodene; Farestone; Z-Toremifene; 89778-26-7; Toremifeno; Toremifenum; Toremifenum [Latin]; Toremifeno [Spanish]; FC-1157a; GTx 006; Toremifene [INN:BAN]; UNII-7NFE54O27T; GTx-006; C26H28ClNO; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine; CHEBI:9635; 7NFE54O27T; (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylami	C26H28ClNO	XFCLJVABOIYOMF-QPLCGJKRSA-N	2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine	Prostrakan Inc	Anticancer Agents
PMDBD1314	Nelarabine	Therapeutic substance	Drug	121032-29-9	DB01280	PA164752425	D05134	DAP000985	3011155	2280207	n.a.	Nelarabine; Nelzarabine; 121032-29-9; Arranon; Atriance; 506U78; GW 506U78; GW-506U78; 506U; 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine; NSC-686673; Nelarabine (Arranon); CHEBI:63612; UNII-60158CV180; 9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; Nelzarabine (USAN); MAY; NCGC00181098-01; S1213; 60158CV180; (2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; DSSTox_RID_81952; DSSTox_CID_26842; DSSTox_GSID_46842; ArranonG; 9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; GW506U78	C11H15N5O5	IXOXBSCIXZEQEQ-UHTZMRCNSA-N	(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	n.a.	n.a.
PMDBD602	Nizatidine	Therapeutic Substance	Approved Drug	76963-41-2	DB00585	PA164752234	D00440	DAP000339	3033637	4356	n.a.	nizatidine; 76963-41-2; Axid; Acinon; Zanizal; Nizax; Naxidine; Distaxid; Cronizat; Calmaxid; Galitidin; Gastrax; Ulcosol; Panaxid; Nizaxid; Antizid; Ulxid; Tazac; Zinga; LY-139037; Niaztidine; Splendil ER; Axid Ar; ZE-101; Nizatidinum; ZL-101; Nizatidinum [Latin]; Nizatidine-d3; Nizatidina; Nizatidina [Spanish]; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; (E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine; HSDB 3574; C12H21N5O2S	C12H21N5O2S2	SGXXNSQHWDMGGP-IZZDOVSWSA-N	(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine	Eli Lilly	Antiulcer Agents
PMDBD1166	Dolasetron	Therapeutic substance	Drug	115956-12-2	DB00757	PA449390	n.a.	DAP000368	3033818	30845229	n.a.	dolasetron; 115956-12-2; LSM-5418; Anzemet Cinv; 1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer; SCHEMBL42064; SCHEMBL42063; BIDD:GT0287; ZINC2688; DTXSID4048276; CHEMBL2368925; CHEBI:94561; HY-B0750; s5326; 3594AH; BDBM50451546; ZINC100019093; ZINC103105084; AKOS025404537; ZINC100038399; AKOS022184758; DB00757; CS-3747; CCG-267749; AS-74586; (2alpha,6alpha,8alpha,9abeta)-octahydro-3-oxo-2,6-methano-2h-quinolizin-8-yl-1h-indole-3-carboxylate; 115956-13-3; AB00698337-03; SR-05000001488	C19H20N2O3	UKTAZPQNNNJVKR-AKJUYKBHSA-N	[(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate	n.a.	n.a.
PMDBD478	Levosimendan	Therapeutic Substance	Approved Drug	141505-33-1	DB00922	PA164749138	D04720	DAP000797	3033825	2298414	n.a.	LEVOSIMENDAN; 141505-33-1; Simdax; (-)-OR-1259; UNII-C6T4514L4E; OR-1259; CHEBI:50567; C6T4514L4E; ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile; Levosimedan; OR 1259; Mesoxalonitrile (-)-(p((R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazone; DSSTox_RID_81620; DSSTox_CID_26445; (R)-((4-(1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono) propanedintrile; DSSTox_GSID_46445; (R)-Simendan; Levosimendan [INN]; levosimendanum	C14H12N6O	WHXMKTBCFHIYNQ-SECBINFHSA-N	2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile	Abbott Laboratories	Cardiotonic Agents
PMDBD1395	Quinine	Therapeutic substance	Drug	130-95-0	DB00468	PA451213	n.a.	DAP000491	3034034	84989	n.a.	Quinine; 130-95-0; Chinin; Chinine; (8S,9R)-Quinine; 6'-Methoxycinchonidine; (-)-Quinine; (R)-(-)-quinine; chininum; quinina; Quinoline alkaloid; Quinine, Anhydrous; Qualaquin; UNII-A7V27PHC7A; quinine bisulphate; quinine sulfate; Quinine anhydrous; CHEBI:15854; Quinine HCl; Chinin [German]; 6-Methoxycinchonine; A7V27PHC7A; Quinine sulphate; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; Aflukin; Quinine, tannate; 6'-Methoxycinchonan-9-ol; NSC 192949; 130-89-2; (R)-(-)-Qu	C20H24N2O2	LOUPRKONTZGTKE-WZBLMQSHSA-N	(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol	n.a.	n.a.
PMDBD1050	Azoxystrobin	Environmental Chemicals	Pesticides	131860-33-8	DB07401	n.a.	n.a.	n.a.	3034285	2298772	n.a.	Azoxystrobin; 131860-33-8; Amistar; Bankit; Heritage; Quadris; Icia-5504; UNII-NYH7Y08IPM; HSDB 7017; TCMDC-125883; ICI-A 5504; NYH7Y08IPM; EINECS Annex I Index 607-256-00-X; CHEBI:40909; C22H17N3O5; methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyprop-2-enoate; NCGC00163818-04; methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate; Methyl (E)-2-(2-(6-(2-cyanopheoxy)pyrimidin-4-yloxy)phenyl)-3-methoxypropenoate; methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-me	C22H17N3O5	WFDXOXNFNRHQEC-GHRIWEEISA-N	methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-methoxyprop-2-enoate	n.a.	n.a.
PMDBD249	Dasatinib	Therapeutic Substance	Approved Drug	302962-49-8	DB01254	PA162372878	D03658	DAP000004	3062316	2323020	n.a.	Dasatinib; 302962-49-8; Sprycel; BMS-354825; BMS 354825; BMS354825; Dasatinib anhydrous; Dasatinib (anhydrous); Dasatinib (BMS-354825); N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; anh. dasatinib; Dasatinib [USAN]; UNII-X78UG0A0RN; anhydrous dasatinib; dasatinib (anh.); N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)pi	C22H26ClN7O2S	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide	Bristol Myers Squibb	Anticancer Agents
PMDBD1438	Telavancin	Therapeutic substance	Antibiotics	372151-71-8	DB06402	n.a.	n.a.	n.a.	3081362	2338980	n.a.	Telavancin; Vibativ; UNII-XK134822Z0; 372151-71-8; TD-6424; CHEBI:71229; XK134822Z0; Telavancin [INN]; telavancinum; telavancina; telavancine; HSDB 8194; TD6424; SCHEMBL8287015; CHEMBL507870; GTPL10925; DTXSID10873383; DB06402; LS-192933; T-1455; Telavancin, Antibiotic for Culture Media Use Only; Q7695658; N(3'')-[2-(decylamino)ethyl]-29-{[(phosphonomethyl)amino]methyl}vancomycin	C80H106Cl2N11O27P	ONUMZHGUFYIKPM-MXNFEBESSA-N	(1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-[2-(decylamino)ethylamino]-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-36-[(phosphonomethylamino)methyl]-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadec	n.a.	n.a.
PMDBD62	Apramycin	Therapeutic Substance; Herbal Substance	Approved Drug (veterinary medicine); Medicinal Herbal Compounds	37321-09-8	DB04626	n.a.	D02322	DNC000243	3081545	2339128	NPC315036	apramycin; Nebramycin II; Nebramycin factor 2; Apramycinum; Apramycine; Apramicina; 37321-09-8; UNII-388K3TR36Z; Ambylan; Apralan; CHEBI:2790; 4-O-(3alpha-Amino-6alpha-((4-amino-4-deoxy-alpha-D-glucopyranosyl)oxy)-2,3,4,5abeta,6,7,8,8aalpha-octahydro-8beta-hydroxy-7beta-(methylamino)pyrano(3,2-b)pyran-2alpha-yl)-2-deoxy-D-streptamine; 4-O-((8R)-2-Amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine; 388K3TR36Z; Ap	C21H41N5O11	XZNUGFQTQHRASN-XQENGBIVSA-N	(2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol	n.a.	n.a.
PMDBD785	Sitagliptin	Therapeutic Substance	Approved Drug	486460-32-6	DB01261	PA164748978	D08516	DAP000639	4369359	3571948	n.a.	Sitagliptin; 486460-32-6; Januvia; MK-0431; Xelevia; Sitagliptin phosphate; UNII-QFP0P1DV7Z; Tesavel; LEZ763; QFP0P1DV7Z; Sitagliptan; (R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE; (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; CHEBI:40237; (3R)	C16H15F6N5O	MFFMDFFZMYYVKS-SECBINFHSA-N	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one	Merck & Co	Hypoglycemic Agents
PMDBD1460	Tolcapone	Therapeutic substance	Drug	134308-13-7	DB00323	PA451720	D00786	DAP000607	4659569	3848682	n.a.	Tolcapone; 134308-13-7; Tasmar; Ro 40-7592; (3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone; 3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone; Ro-40-7592; (3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone; (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone; UNII-CIF6334OLY; CCRIS 7904; CIF6334OLY; CHEMBL1324; C14H11NO5; CHEBI:63630; Ro-407592; NCGC00181767-01; 4'-methyl-3,4-dihydroxy-5-nitrobenzophenone; 3,4-dihydroxy-5-nitro-4'-methylbenzophenone; DSSTox_CID_3685	C14H11NO5	MIQPIUSUKVNLNT-UHFFFAOYSA-N	(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone	n.a.	n.a.
PMDBD717	Quercetin	Herbal Substance	Medicinal Herbal Compounds	117-39-5	DB04216	n.a.	n.a.	DAP001419	5280343	4444051	NPC20791	quercetin; 117-39-5; Meletin; Sophoretin; Xanthaurine; Quercetine; Quercetol; Quertine; 3,3',4',5,7-Pentahydroxyflavone; Quercitin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; Flavin meletin; 3,5,7,3',4'-Pentahydroxyflavone; Cyanidelonon 1522; T-Gelb bzw. grun 1; C.I. Natural Yellow 10; Quercetin content; Kvercetin; Quertin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; C.I. Natural red 1; Kvercetin [Czech]; Natural Yellow 10; C.I. 75670; CI Natural Yellow 10; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy	C15H10O7	REFJWTPEDVJJIY-UHFFFAOYSA-N	2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one	n.a.	Hypoglycemic Agents
PMDBD881	Tylosin	Therapeutic Substance; Herbal Substance	Approved Drug (veterinary medicine); Medicinal Herbal Compounds	1401-69-0	DB11475	n.a.	D02490	n.a.	5280440	4444097	NPC316205	Tylosin; Tylosine; Tylocine; tylosin tartrate; Tilosina; Tylosinum; 1401-69-0; Tylosin A; Fradizine; Tylan; UNII-YEF4JXN031; YEF4JXN031; CHEBI:17658; Vubityl 200; Tylosinum [INN-Latin]; Tylosine [INN-French]; Tilosina [INN-Spanish]; HSDB 7022; EINECS 215-754-8; AI3-29799; SR-05000002057; Tylosin [USP:INN:BAN]; Tylan (TN); Tylosin (USP/INN); SCHEMBL3081; BSPBio_003548; SPECTRUM1505312; CHEMBL42743; SCHEMBL16931534; HY-B0519A; HMS1922B22; Pharmakon1600-01505312; HMS2093B11; Antibiotic obtained from cultures of Streptomyces fradiae, or the sa	C46H77NO17	WBPYTXDJUQJLPQ-VMXQISHHSA-N	2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	n.a.	n.a.
PMDBD485	Linoleic acid	Herbal Substance	Medicinal Herbal Compounds	60-33-3	DB14104	n.a.	n.a.	n.a.	5280450	4444105	NPC85813	linoleic acid; 60-33-3; Linolic acid; (9Z,12Z)-octadeca-9,12-dienoic acid; Telfairic acid; cis,cis-Linoleic acid; Grape seed oil; cis,cis-9,12-Octadecadienoic acid; Linoleate; Emersol 315; cis-9,cis-12-Octadecadienoic acid; 9,12-Linoleic acid; Unifac 6550; 9Z,12Z-octadecadienoic acid; 9Z,12Z-Linoleic acid; Extra Linoleic 90; 9-cis,12-cis-Linoleic acid; Polylin 515; Emersol 310; all-cis-9,12-Octadecadienoic acid; (Z,Z)-9,12-Octadecadienoic acid; Polylin No. 515; Oils, grape; alpha-Linoleic acid; Linoleic; acide linoleique; 9,12-Octad	C18H32O2	OYHQOLUKZRVURQ-HZJYTTRNSA-N	(9Z,12Z)-octadeca-9,12-dienoic acid	n.a.	n.a.
PMDBD1070	Calcitriol	Therapeutic substance	Drug	32222-06-3	DB00136	PA448717	D00129	DAP000289	5280453	4444108	n.a.	calcitriol; Rocaltrol; Calcijex; Topitriol; 32222-06-3; 1alpha,25-Dihydroxyvitamin D3; Silkis; Soltriol; 1alpha,25-Dihydroxycholecalciferol; Dihydroxyvitamin D3; 1,25-DHCC; Calcitriolum; 1,25-Dihydroxyvitamin D; Vectical; 1,25-DIHYDROXYCHOLECALCIFEROL; 1alpha,25(OH)2D3; 1,25-Dihydroxyvitamin D3; 1alpha,25-Dihydroxyvitamin D; 1-alpha,25-Dihydroxyvitamin D3; Calcitriolum [INN-Latin]; UNII-FXC9231JVH; DN-101; 1,25-Dihydroxycholecaliferol; CCRIS 5522; Ro 21-5535; HSDB 3482; 1-alpha,25-Dihydroxycholecalciferol; EINECS 250-963-8; DN 101; CHE	C27H44O3	GMRQFYUYWCNGIN-NKMMMXOESA-N	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	n.a.	n.a.
PMDBD760	Rutin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	153-18-4	DB01698	PA451291	n.a.	n.a.	5280805	4444362	NPC176740	RUTIN; 153-18-4; rutoside; Phytomelin; Quercetin 3-rutinoside; Birutan; Eldrin; Rutin trihydrate; Myrticolorin; Rutabion; Venoruton; 3-Rutinosyl quercetin; Bioflavonoid; Paliuroside; Tanrutin; Osyritrin; Rutine; Rutozyd; 3-Rhamnoglucosylquercetin; Melin; Quercetin-3-rutinoside; Quercetin 3-O-rutinoside; Rutinum; Rutosido; Rutosidum; Globularicitrin; Violaquercitrin; Globulariacitrin; Rutinic acid; Birutan Forte; Birutin; Quercetin rhamnoglucosine; Vitamin P; Quercetin-3beta-rutinoside; UNII-5G06TVY3R7; Rutosid; Ilixanthin; Oxyritin; Rutinion ac	C27H30O16	IKGXIBQEEMLURG-NVPNHPEKSA-N	2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one	n.a.	n.a.
PMDBD386	Genistein	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	446-72-0	DB01645	PA165109660	n.a.	DCL000330	5280961	4444448	NPC39426	genistein; 446-72-0; Prunetol; Genisteol; 4',5,7-Trihydroxyisoflavone; Genisterin; Sophoricol; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 5,7,4'-Trihydroxyisoflavone; Bonistein; Differenol A; Genestein; NPI 031L; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; C.I. 75610; SIPI 807-1; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; UNII-DH2M523P0H; NSC 36586; CCRIS 7675; NSC36586; CHEMBL44; EINECS 207-174-9	C15H10O5	TZBJGXHYKVUXJN-UHFFFAOYSA-N	5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one	DSM Nutritional Products	n.a.
PMDBD128	Budesonide	Therapeutic Substance	Approved Drug	51333-22-3	DB01222	PA448681	D00246	DAP000320	5281004	4444479	n.a.	budesonide; Rhinocort; Entocort; 51333-22-3; Preferid; Budeson; Rhinocort Aqua; Pulmicort; Micronyl; Cortivent; Spirocort; Respules; Bidien; Entocort EC; Pulmicort Respules; Budesonidum; Uceris; Rhinocort alpha; Pulmicort Flexhaler; Budesonidum [INN-Latin]; Budesonido [INN-Spanish]; Budesonide [USAN:INN:BAN:JAN]; S 1320; CCRIS 5230; CHEBI:3207; MAP-0010; EINECS 257-139-7; MLS000028507; Budesonide MMX; 51372-29-3; 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione; S-1320	C25H34O6	VOVIALXJUBGFJZ-KWVAZRHASA-N	(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	AstraZeneca	Antiinflammatory Agents
PMDBD1091	Cefprozil	Therapeutic substance	Antibiotics	92665-29-7	DB01150	PA164746342	n.a.	DAP000447	5281006	4444481	n.a.	cefprozil; Cefprozil anhydrous; Cefzil; Arzimol; Procef; Cefprozilum; Cefprozilo; Serozil; Cronocef; Cefprozilum [INN-Latin]; 92665-29-7; Cefprozilo [INN-Spanish]; Brisoral; BMY 28100; trans-Cefprozil; (E)-cefprozil; Cefprozil hydrate; S1SDI2FJIY; UNII-S1SDI2FJIY; Cefzil (TN); 92676-86-3; Cefprozil hydrate (Cefzil); Cefprozil (INN); Cefprozil (TN); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carb	C18H19N3O5S	WDLWHQDACQUCJR-ZAMMOSSLSA-N	(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD558	Montelukast	Therapeutic Substance	Approved Drug	158966-92-8	DB00471	PA450546	D08229	DAP000309	5281040	4444507	n.a.	montelukast; 158966-92-8; Singulair; Montelukast [INN:BAN]; UNII-MHM278SD3E; (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; MK 0476; CHEMBL787; MHM278SD3E; CHEBI:50730; 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)me	C35H36ClNO3S	UCHDWCPVSPXUMX-TZIWLTJVSA-N	2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid	Schering-Plough Corporation	Antiasthmatic Agents
PMDBD1151	Dexchlorpheniramine Maleate	Therapeutic substance	Drug	2438-32-6	DB09555	n.a.	n.a.	n.a.	5281070	4444527	n.a.	Dexchlorpheniramine maleate; 2438-32-6; (+)-Chlorpheniramine maleate; Polaramine; d-Chlorpheniramine maleate; Mylaramine; Dexchlorpheniramine (maleate); UNII-B10YD955QW; Dextrochlorpheniramine maleate; Dexchloropheniramine maleate; Chlorpheniramine d-form maleate; CHEBI:4465; S-(+)-Chlorpheniramine maleate salt; B10YD955QW; Dexchlorpheniramine maleate [USP]; S-(+)-Chlorpheniramine maleate; Dexchlorpheniramine maleate (USP); EINECS 219-450-6; SR-01000075763; polar amine; DeXchlorpheniramine Maleate, USP; (+)-2-(p-Chloro-alpha-(2	C20H23ClN2O4	DBAKFASWICGISY-DASCVMRKSA-N	(Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine	n.a.	n.a.
PMDBD1329	Olopatadine	Therapeutic substance	Drug	113806-05-6	DB00768	PA450698	n.a.	DAP001062	5281071	4444528	n.a.	Olopatadine; Patanol; 113806-05-6; OLOPATADINE HYDROCHLORIDE; Olopatadine [INN:BAN]; UNII-D27V6190PM; Pazeo; KW-4679; ALO-4943A; (Z)-2-(11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid; D27V6190PM; 140462-76-6; {(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid; 11-((Z)-3-(Dimeth	C21H23NO3	JBIMVDZLSHOPLA-LSCVHKIXSA-N	2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid	n.a.	n.a.
PMDBD563	Mycophenolate mofetil	Therapeutic Substance	Approved Drug	128794-94-5	DB00688	PA450566	D00752	DNC000397	5281078	4444535	n.a.	mycophenolate mofetil; 128794-94-5; CellCept; RS 61443; RS-61443; TM-MMF; Myfenax; 115007-34-6; Mycophenolic acid morpholinoethyl ester; UNII-9242ECW6R0; CHEBI:8764; HSDB 7436; Cellcept (TN); 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate; (E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate; C23H31N	C23H31NO7	RTGDFNSFWBGLEC-SYZQJQIISA-N	2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate	Roche	Immunosuppressive Agents
PMDBD306	Entacapone	Therapeutic Substance	Approved Drug	130929-57-6	DB00494	PA164748726	D00781	DAP000608	5281081	4444537	n.a.	ENTACAPONE; 130929-57-6; Comtan; Comtess; Entacaponum; OR-611; Entacapona; Entacaponum [INN-Latin]; Entacapona [INN-Spanish]; OR 611; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; UNII-4975G9NM6T; CHEMBL953; (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; CHEBI:4798; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; C14H15N3O5; 4975G9NM6T; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide; (E)-2	C14H15N3O5	JRURYQJSLYLRLN-BJMVGYQFSA-N	(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide	Norvatis Phamaceuticals Corporation	Antiparkinson Agents
PMDBD284	Diosmin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	520-27-4	DB08995	n.a.	D07858	n.a.	5281613	4444932	NPC209296	diosmin; 520-27-4; Diosimin; Barosmin; Venosmine; Diosmil; Diosmine; Flebosten; Daflon; Diovenor; Tovene; Ven-Detrex; Veno-V; Diosminum; Rioven; Diosmetin 7-O-rutinoside; UNII-7QM776WJ5N; 7QM776WJ5N; CHEBI:4631; 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside; C28H32O15; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; Buchu Resin; Diosmin, analytical standard; DSSTox_CID_25892; DSSTox_RID_81206; DSSTox_GSID_458	C28H32O15	GZSOSUNBTXMUFQ-YFAPSIMESA-N	5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one	n.a.	n.a.
PMDBD244	Daidzein	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	486-66-8	DB13182	n.a.	n.a.	n.a.	5281708	4445025	NPC234560	daidzein; 486-66-8; 4',7-Dihydroxyisoflavone; Daidzeol; 7,4'-Dihydroxyisoflavone; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; UNII-6287WC5J2L; CCRIS 7600; K 251b; EINECS 207-635-4; MFCD00016954; BRN 0231523; CHEMBL8145; 4',7-Dihydroxy-iso-flavone; d-(+)-alpha-methylbenzylamine; CHEBI:28197; 6287WC5J2L; Daidzein,(S); Daidzein, 98%	C15H10O4	ZQSIJRDFPHDXIC-UHFFFAOYSA-N	7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one	n.a.	n.a.
PMDBD714	Puerarin	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	3681-99-0	DB12290	n.a.	n.a.	n.a.	5281807	4445119	NPC124478	Puerarin; 3681-99-0; Kakonein; CHEBI:8633; UNII-Z9W8997416; Daidzein-8-C-glucoside; NPI 031G; Z9W8997416; Puerarin, analytical standard; 7-hydroxy-3-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one; Q63408673; NSC 380711; BRN 0064198; AC1NQZ4N; 8-beta-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; NSC-380711; Kudzu Root Extract; 7,4'-Dihydroxy-8-C-glucosylisoflavone; SureCN8581666; 4-19-00-03200 (Beilstein Handbook Reference); MLS002473178	C21H20O9	HKEAFJYKMMKDOR-VPRICQMDSA-N	7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one	n.a.	n.a.
PMDBD299	Ellagic acid	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	476-66-4	DB08846	n.a.	n.a.	n.a.	5281855	4445149	NPC178134	ellagic acid; 476-66-4; Benzoaric acid; Elagostasine; Lagistase; Eleagic acid; Alizarine Yellow; 2,3,7,8-Tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione; Ellagic acid dihydrate; Llagic acid; Acide ellagique; Acido elagico; Acidum ellagicum; C.I. 55005; Gallogen (VAN); Gallogen (astringent); C.I. 75270; Ellagate; UNII-19YRN3ZS9P; Ellagic acid [INN:DCF]; CCRIS 774; Acido elagico [INN-Spanish]; Gallogen, astringent; Acide ellagique [INN-French]; Acidum ellagicum [INN-Latin]; MLS000069632; C14H6O8; EINECS 207-508-3; MFCD00006914; NSC407	C14H6O8	AFSDNFLWKVMVRB-UHFFFAOYSA-N	6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione	n.a.	n.a.
PMDBD193	Cilnidipine	Therapeutic Substance	Approved Drug	132203-70-4	DB09232	n.a.	D01173	n.a.	5282138	4445338	n.a.	cilnidipine; 132203-70-4; Cinalong; FRC-8653; Siscard; Atelec; FRC 8653; 3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cilnidipine [INN]; CHEBI:31399; (+-)-(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Cilnidipine, 99%; 2-methoxyethyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00162150-01; Cinaldipine; DSSTox_RID_81530; DSSTox_CID_26309; DSSTox_GSID_46309; 1,4-Di	C27H28N2O7	KJEBULYHNRNJTE-DHZHZOJOSA-N	3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate	Fuji Viscera Pharmaceutical	n.a.
PMDBD465	Josamycin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	16846-24-5	DB01321	PA164749133	D01235	DAP000887	5282165	4445361	NPC314451	josamycin; Leucomycin A3; Turimycin A5; Kitasamycin A3; Josamycine; Antibiotic yl-704 A3; Josamicina; Josamycinum; Josamycinum [INN-Latin]; Josamycine [INN-French]; Josamicina [INN-Spanish]; 16846-24-5; Yl-704 A3; Leucomycin V, 3-acetate 4B-(3-methylbutanoate); UNII-HV13HFS217; EN-141; Josacine; EINECS 240-871-6; Leucomycin V 3-acetate 4b-(3-methylbutanoate); Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate); HV13HFS217; Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate); JM; CHEBI:31739; ST075007; Stereoisomer of 4-(acetyl	C42H69NO15	XJSFLOJWULLJQS-NGVXBBESSA-N	[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate	n.a.	n.a.
PMDBD25	Alfacalcidol	Therapeutic Substance	Approved Drug	41294-56-8	DB01436	PA164746469	D01518	n.a.	5282181	4445376	n.a.	alfacalcidol; 1-Hydroxycholecalciferol; 1alpha-Hydroxyvitamin D3; 41294-56-8; 1alpha-Hydroxycholecalciferol; Alphacalcidol; Alfarol; alpha-Calcidol; One-Alpha; Alfacalcidolum; 1-Hydroxyvitamin D3; Un-Alpha; 1alpha-Hydroxy-vitamin D3; Etalpha; Oxydevit; UNII-URQ2517572; Sinovul; CHEBI:31186; EinsAlpha; (5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol; Alpha D 3; URQ2517572; Bondiol; 1 alpha-hydroxyvitamin D3; Alfacalcidolum [INN-Latin]; Alfacalcidol [INN:BAN:JAN]; CCRIS 3341; 1alpha-hydroxyvitam	C27H44O2	OFHCOWSQAMBJIW-AVJTYSNKSA-N	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	n.a.	n.a.
PMDBD788	Sorivudine	Therapeutic Substance	Investigational Drug	77181-69-2	DB11998	n.a.	n.a.	n.a.	5282192	4445384	n.a.	SORIVUDINE; Bravavir; Usevir; Brovavir; 77181-69-2; BVAU; BV-Ara-U; YN-72; Bromovinyluridine; 5-Bromovinyl-araU; BV-araU; SQ-32756; Sorivudinum [INN-Latin]; Sorivudina [INN-Spanish]; UNII-C7VOZ162LV; ARYS-01; CCRIS 5285; (E)-5-(2-Bromovinyl)uridine; DRU-0136; C7VOZ162LV; (E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil; CHEMBL70046; 1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil; (+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil; SQ 32,756; (E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione	C11H13BrN2O6	GCQYYIHYQMVWLT-HQNLTJAPSA-N	5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	n.a.	n.a.
PMDBD864	Tranilast	Therapeutic Substance	Approved Drug	53902-12-8	DB07615	n.a.	D02027	n.a.	5282230	4445411	n.a.	tranilast; 53902-12-8; Rizaben; trans-Tranilast; Tranilastum; 70806-55-2; MK 341; N-(3,4-Dimethoxycinnamoyl)anthranilic acid; Tranilastum [INN-Latin]; Tranilast [USAN:INN:JAN]; UNII-HVF50SMY6E; SB-252218; MK-341; Tranilast (SB 252218); 3,4-DAA; n-(3',4'-dimethoxycinnamoyl) anthranilic acid; HVF50SMY6E; MLS000028468; CHEBI:77572; 2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid; Tranilast (trans-); (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid; NCGC00018185-05	C18H17NO5	NZHGWWWHIYHZNX-CSKARUKUSA-N	2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid	Kissei	n.a.
PMDBD1095	Ceftibuten	Therapeutic substance	Antibiotics	97519-39-6	DB01415	PA164744555	D00922	DAP000456	5282242	4445419	n.a.	ceftibuten; 97519-39-6; Ceftibuteno; Ceftibutenum; Ceftibutene; Cedax; cis-ceftibuten; UNII-IW71N46B4Y; Cephem; cis-Ceftibutin; Sch-39720; 7432-S; Antibiotic 7432S; Sch 39720; Cephalosporin 7432-S; CHEBI:3510; IW71N46B4Y; Isocef; (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; Ceftibuten hydrate; Ceftibutene [INN-French]; Ceftibutenum [INN-Latin]; CETB; Ceftibuteno [INN-Spanish]; Ceftibuten [USAN:INN:BAN]; S 7432; (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-c	C15H14N4O6S2	UNJFKXSSGBWRBZ-BJCIPQKHSA-N	(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1298	Misoprostol	Therapeutic substance	Drug	59122-46-2	DB00929	PA450523	D00419	DAP000358	5282381	4445541	n.a.	misoprostol; 59122-46-2; Cytotec; Isprelor; Misoprostolum [INN-Latin]; SC-29333; Misodel; SC 29333; CCRIS 6859; HSDB 3573; BRN 4155643; NCGC00162445-02; Misoprostolum; Misotol; Misoprost; methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate; Misotac; Misogon; Misopess; GyMiso; Cytotec (TN); Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate; misoprostol (methyl ester); (11-alpha,13E)-(+-)-1	C22H38O5	OJLOPKGSLYJEMD-URPKTTJQSA-N	methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate	n.a.	n.a.
PMDBD221	Codeine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	76-57-3	DB00318	PA449088	D03580	DAP000213	5284371	4447447	NPC43069	codeine; Methylmorphine; Codeine anhydrous; Codicept; l-Codeine; Coducept; Morphine monomethyl ether; 76-57-3; Morphine 3-methyl ether; (-)-Codeine; O3-Methylmorphine; codeinum; Morphine-3-methyl ether; Codein; Norcodine, N-methyl; Norcodeine, N-methyl; CODEINE BASE; Codeine polistirex; codeina; CCRIS 7555; Morphine-3-methyl ester; HSDB 3043; UNII-UX6OWY2V7J; O(3)-methylmorphine; CHEBI:16714; EINECS 200-969-1; UX6OWY2V7J; Codeine Anhydrate	C18H21NO3	OROGSEYTTFOCAN-DNJOTXNNSA-N	(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol	Forest Pharmaceuticals	Analgesics
PMDBD1013	Acitretin	Therapeutic substance	Drug	55079-83-9	DB00459	PA448039	D02754	DAP000743	5284513	4447573	n.a.	Acitretin; 55079-83-9; Etretin; Soriatane; Neotigason; Acitretine; all-trans-Acitretin; Retinoid etretin; Acitretinum; Acitretina; TMMP; Ro 10-1670; Acitretinum [Latin]; Acitretine [French]; Acitretina [Spanish]; (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid; UNII-LCH760E9T7; Ro 10-1670/000; CCRIS 5534; Ro-10-1670; all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid; (all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic aci	C21H26O3	IHUNBGSDBOWDMA-AQFIFDHZSA-N	(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid	n.a.	n.a.
PMDBD1014	Acrivastine	Therapeutic substance	Drug	87848-99-5	DB09488	n.a.	D02760	n.a.	5284514	4447574	n.a.	ACRIVASTINE; 87848-99-5; Semprex; Acrivastin; Acrivastinum; Acrivastina; Acrivastinum [Latin]; BW-825C; BW 825C; Acrivastina [Spanish]; BW A825C; Acrivastine [USAN:INN:BAN]; UNII-A20F9XAI7W; A20F9XAI7W; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; CHEBI:83168; C22H24N2O2; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; BW825C; NCGC00182053-02; 2-Propenoic acid,3-[6-[(1E)-1-(4-methylp	C22H24N2O2	PWACSDKDOHSSQD-IUTFFREVSA-N	(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid	n.a.	n.a.
PMDBD1220	Granisetron	Therapeutic substance	Drug	109889-09-0	DB00889	PA449809	D04370	DAP000295	5284566	10482033	n.a.	granisetron; 109889-09-0; Sustol; Sancuso; Granisetronum; Kevatril; APF530; UNII-WZG3J2MCOL; CHEBI:5537; APF 530; WZG3J2MCOL; 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide; CHEMBL1290003; BRL 43694; BRL-43694; 1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide; BRL 43964; 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide; 1-Methyl-N-[(1r,5s)-9-Methyl-9-Azabicyclo[3.3.1]nonan-3-Yl]indazole-3-Carboxamide; SR-05000001492; BIDD:GT0	C18H24N4O	MFWNKCLOYSRHCJ-AGUYFDCRSA-N	1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide	n.a.	n.a.
PMDBD493	Loracarbef	Therapeutic Substance	Approved Drug	76470-66-1	DB00447	PA164754806	D00916	DAP000434	5284585	4447635	n.a.	loracarbef; Lorabid; Loracarbefum; 76470-66-1; loracarbef anhydrous; UNII-W72I5ZT78Z; Loribid; W72I5ZT78Z; Loracarbefum [INN-Latin]; CHEBI:47544; KT 3777; LY-163892; LY163892; LY 163892; Loracarbef [USAN:INN:BAN]; Anhydrous loracarbef; Loracarbef (INN); Lorbef (TN); LORACABEF; CHEMBL1013; LORACARBEF, ANHYDROUS; SCHEMBL34153; BIDD:GT0753; DTXSID7023223; CTK2H7568; HMS3713L04; HY-B1682; ZINC1530993; 1-Azabicyclo(4.2.0)o	C16H16ClN3O4	JAPHQRWPEGVNBT-UTUOFQBUSA-N	(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Eli Lilly	Antibiotics
PMDBD572	Naloxone	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	465-65-6	DB01183	PA450586	D08249	DAP000097	5284596	4447644	NPC201055	naloxone; l-Naloxone; 465-65-6; Narcan; n-Allylnoroxymorphone; (-)-Naloxone; Nalossone [DCIT]; EN 1530 base; Naloxonum [INN-Latin]; Naloxonum; Naloxona; Naloxona [INN-Spanish]; Narcanti; N-Allyl-noroxymorphone; 1-N-Allyl-14-hydroxynordihydromorphinone; Naloxone [INN:BAN]; HSDB 3279; UNII-36B82AMQ7N; 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; l-N-Allyl-14-hydroxynordihydromorphinone; 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one; EINECS 207-365-7; NSC 70413; l-N-Al	C19H21NO4	UZHSEJADLWPNLE-GRGSLBFTSA-N	(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	n.a.	n.a.
PMDBD1464	Topiramate	Therapeutic substance	Drug	97240-79-4	DB00273	PA451728	D00537	DAP000137	5284627	4447672	n.a.	topiramate; 97240-79-4; Topamax; Epitomax; Topamax Sprinkle; Topiramatum; Tipiramate; McN-4853; Tipiramato; Topiramato; Tipiramate [French]; Tipiramato [Spanish]; McN 4853; Topiramatum [INN-Latin]; topiramatum [Latin]; Topiramato [INN-Spanish]; RWJ-17021-000; RWJ-17021; C12H21NO8S; 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate; UNII-0H73WJJ391; USL255; USL-255; BRN 5988957	C12H21NO8S	KJADKKWYZYXHBB-XBWDGYHZSA-N	[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate	n.a.	n.a.
PMDBD1218	Glyphosate	Environmental Chemicals	Pesticides	1071-83-6	DB04539	n.a.	n.a.	DNC000698	5288464	4450646	n.a.	DB04539; carboxy-N-(phosphonomethyl)methanaminium; (Carboxylatomethyl)aminiomethylphosphonic acid dianion	C3H9NO5P+	XDDAORKBJWWYJS-UHFFFAOYSA-O	carboxymethyl(phosphonomethyl)azanium	n.a.	n.a.
PMDBD560	Morphine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	57-27-2	DB00295	PA450550	D08233	DAP000071	5288826	4450907	NPC232533	morphine; Morphia; Morphinum; Morphium; Morphin; (-)-Morphine; Morphina; DepoDur; Ospalivina; Meconium; Moscontin; Morphinism; Duromorph; MS Contin; l-Morphine; 57-27-2; Roxanol; Morfina; Dulcontin; MORPHINE SULFATE; Infumorph; Nepenthe; Dreamer; Morpho; Kadian; Unkie; Avinza; Hocus; Hard stuff; Cube juice; Oramorph SR; Statex SR; Ms Emma; Morphin [German]; Morfina [Italian]; Duramorph; Morphina [Italian]; M-Eslon; Morphine [BAN]; CCRIS 5762; HSDB 2134; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; UNII-76I7G6D29C; CHEBI:17303; CHEMBL70	C17H19NO3	BQJCRHHNABKAKU-KBQPJGBKSA-N	(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol	Eurohealth International Sarl	Analgesics
PMDBD470	Lacidipine	Therapeutic Substance	Approved Drug	103890-78-4	DB09236	n.a.	D04657	n.a.	5311217	4470736	n.a.	Lacidipine; 103890-78-4; Lacipil; Motens; GR-43659X; Lacidipinum [Latin]; Lacidipino [Spanish]; Lacidipine (Lacipil, Motens); UNII-260080034N; GR 43659X; GR 43659 X; C26H33NO6; Lacimen; DSSTox_CID_26429; DSSTox_RID_81607; DSSTox_GSID_46429; 4-(o-((E)-2-Carboxyvinyl)phenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, 4-tert-butyl diethyl ester; diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate; 260080034N; Lacidipinum; Lacidipino; Lacirex; trans 	C26H33NO6	GKQPCPXONLDCMU-CCEZHUSRSA-N	diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate	n.a.	n.a.
PMDBD576	Nateglinide	Therapeutic Substance	Approved Drug	105816-04-4	DB00731	PA450600	D01111	DAP000918	5311309	10482084	n.a.	nateglinide; 105816-04-4; Starlix; Starsis; Fastic; Trazec; A-4166; AY-4166; SDZ-DJN-608; DJN-608; DJN 608; Nateglinide [INN]; UNII-41X3PWK4O2; SDZ-DJN 608; AY 4166; AY4166; A 4166; CHEMBL783; SDZ DJN 608; N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine; 41X3PWK4O2; senaglinide; CHEBI:31897; 105816-06-6; (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; (2R)-2-[[oxo-(4-propan-2-ylcycl	C19H27NO3	OELFLUMRDSZNSF-OFLPRAFFSA-N	(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid	Norvatis Phamaceuticals Corporation	Hypoglycemic Agents
PMDBD1431	Sunitinib	Therapeutic substance	Drug	557795-19-4	DB01268	PA162372840	D06402	DCL000646	5329102	4486264	n.a.	Sunitinib; 557795-19-4; Sutent; Sunitinib malate; SU11248; SU-11248; Su-011248; Sunitinib Base; SU 11248; 342641-94-5; UNII-V99T50803M; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; CHEMBL535; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide; CHEBI:38940; 341031-54-7; NSC750690; V99T50803M; (Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-d	C22H27FN4O2	WINHZLLDWRZWRT-ATVHPVEESA-N	N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide	n.a.	n.a.
PMDBD243	Dacarbazine	Therapeutic Substance	Approved Drug	n.a.	DB00851	PA449197	D00288	DAP000533	135398738	10481959	n.a.	dacarbazine; DTIC; Deticene; 4342-03-4; Biocarbazine; DTIC-Dome; Biocarbazine R; ICDMT; Decarbazine; ICDT; DTIE; 4-(Dimethyltriazeno)imidazole-5-carboxamide; Dacarbazinum [INN-Latin]; Dacarbazino [INN-Spanish]; NSC-45388; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; Di-me-triazenoimidazolecarboxamide; NSC45388; 5-(Dimethyltriazeno)imidazole-4-carboxamide; (Dimethyltriazeno)imidazolecarboxamide; NSC 45388; 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; NCI-C04717; 4-(5)-(	C6H10N6O	FDKXTQMXEQVLRF-ZHACJKMWSA-N	4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide	n.a.	n.a.
PMDBD812	Sulfasalazine	Therapeutic Substance	Approved Drug	599-79-1	DB00795	PA451547	D00448	DAP000153	5339	10605946	n.a.	sulfasalazine; 599-79-1; Salicylazosulfapyridine; Azulfidine; Salazosulfapyridine; Sulphasalazine; Salazopyrin; Asulfidine; Salazopyridin; Sulcolon; Azopyrin; Accucol; Colo-Pleon; Salazopiridazin; Salisulf; Reupirin; Benzosulfa; Azopyrine; Salazosulfapyridin; w-t Sasp oral; Sulfasalazin; Azulfidine EN; Sulfazalazine; Sulfasalazinum; Sulfasalazina; Azulfidine EN-tabs; Salazosulfapiridina; Sas-500; Salazosulfapyridinum; Azosulfidin; SASP; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; Salazo-sulfapyridinum; S.A.S.-500; 5-(4-(2-Pyridylsulfa	C18H14N4O5S	NCEXYHBECQHGNR-UHFFFAOYSA-N	2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid	n.a.	n.a.
PMDBD1309	Naltrexone	Therapeutic substance	Drug	16590-41-3	DB00704	PA450588	D05113	DAP000379	5360515	4514524	n.a.	naltrexone; 16590-41-3; ReVia; Vivitrol; N-Cyclopropylmethylnoroxymorphone; Vivitrex; Celupan; Naltrexonum [INN-Latin]; Naltrexona [INN-Spanish]; UNII-5S6W795CQM; N-Cyclopropylmethyl-14-hydroxydihydromorphinone; Naltrexone [USAN:INN:BAN]; CCRIS 3506; HSDB 6750; 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; EINECS 240-649-9; UM-792; 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one; BRN 3596648; 5S6W795CQM; CHEBI:7465; (-)-Naltrexone; Nemexin; EN-1639A [AS HYDROCHLORIDE]; DSSTox_RID_81532; DSSTox_	C20H23NO4	DQCKKXVULJGBQN-XFWGSAIBSA-N	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one	n.a.	n.a.
PMDBD1152	Dextromethorphan	Therapeutic substance	Drug	125-71-3	DB00514	PA449273	D03742	DNC000541	5360696	13109865	n.a.	dextromethorphan; d-Methorphan; delta-Methorphan; Dextromorphan; 125-71-3; Dextromethorfan; Delsym; Dextrometorfano; Destrometerfano; Albutussin; Dextromethorphane; Dextromethorphanum; Dextromethorfan [Czech]; Destrometerfano [DCIT]; BA 2666; Dextrometorfano [INN-Spanish]; Benylin DM; Dextromethorphanum [INN-Latin]; Dextromethorphane [INN-French]; HSDB 3056; Dextromethorphan [USP:INN:BAN]; UNII-7355X3ROTS; 3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan; Dextrometorphan; Romilar; Morphinan, 3-methoxy-17-methyl-, (9alpha,13alph	C18H25NO	MKXZASYAUGDDCJ-NJAFHUGGSA-N	(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene	n.a.	n.a.
PMDBD158	Cefixime	Therapeutic Substance	Approved Drug	79350-37-1	DB00671	PA164768821	D00258	DAP000439	5362065	4514923	n.a.	CEFIXIME; 79350-37-1; Cephoral; Cefixima; Cefiximum; Cefspan; Cefiximum [Latin]; (-)-Cefixim; Cefixima [Spanish]; Oroken; Cefixoral; Cefixim; FK-027; UNII-XZ7BG04GJX; CL-284635; (E)-Cefixime; Unixime; Suprax; FR-17027; XZ7BG04GJX; MLS002222332; CHEBI:472657; Cefixime Anhydrous; CFIX; Cefixime, 98%; Cefixime hydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; SMR001307271; Necopen; Tricef; Denvar; FK 027; BRN 6025058; FR 17027; CL	C16H15N5O7S2	OKBVVJOGVLARMR-QSWIMTSFSA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Wyeth Pharmaceuticals	Antibiotics
PMDBD98	Benazepril	Therapeutic Substance	Approved Drug	86541-75-5	DB00542	PA448561	D07499	DAP000584	5362124	4514935	n.a.	benazepril; 86541-75-5; Benazeprilum [Latin]; Benazeprilum; Lotrel; Benazepril [INN:BAN]; CGS-14824-A; UNII-UDM7Q7QWP8; CGS-14824A; UDM7Q7QWP8; CHEMBL838; CHEBI:3011; 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; benazapril; benzaz	C24H28N2O5	XPCFTKFZXHTYIP-PMACEKPBSA-N	2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid	Norvatis Phamaceuticals Corporation	Antihypertensive Agents
PMDBD730	Ramipril	Therapeutic Substance	Approved Drug	87333-19-5	DB00178	PA451223	D00421	DAP000581	5362129	4514937	n.a.	ramipril; 87333-19-5; Tritace; Altace; Carasel; Triatec; Ramace; Delix; Vesdil; Acovil; Cardace; Lostapres; Quark; Hytren; Ramiprilum [Latin]; Hoe-498; Ramiprilum; Pramace; HOE 498; Altace (TN); UNII-L35JN3I7SJ; L35JN3I7SJ; CHEMBL1168; CHEBI:8774; C23H32N2O5; (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure; (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3	C23H32N2O5	HDACQVRGBOVJII-JBDAPHQKSA-N	(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid	Sanofi-Aventis	Antihypertensive Agents
PMDBD1238	Indinavir	Therapeutic substance	Drug	150378-17-9	DB00224	PA449977	n.a.	DAP000168	5362440	4515036	n.a.	indinavir; 150378-17-9; Compound J; MK-639; UNII-9MG78X43ZT; CHEBI:44032; Indinavir [USAN]; (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; 9MG78X43ZT; C36H47N5O4; L-735524; Indinavir [USAN:INN:BAN]; Indinavir monohydrate; L-735,524; D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-pipera	C36H47N5O4	CBVCZFGXHXORBI-PXQQMZJSSA-N	(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide	n.a.	n.a.
PMDBD745	Rifampicin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	13292-46-1	DB01045	PA451250	D00211	DNC000965	135398735	10468813	NPC317567	Rifampicin; rifampin; Rifadin; Rimactane; Rimactan; Rifamycin AMP; 13292-46-1; Rifaldazine; Rifaprodin; Tubocin; Riforal; Rifa; Rifampicinum; Archidyn; Rifoldine; Rifoldin; Rimactizid; Rimazid; Rifagen; Rifampicin SV; R/AMP; Rimactazid; Rifobac; Fenampicin; Doloresum; Sinerdol; Rifaldin; Rifadine; Rifinah; Rifamor; Benemicin; Rifaldazin; Eremfat; Arficin; Arzide; Rifcin; Rifam; L-5103 Lepetit; Dione 21-acetate; Rifampicine [French]; Rifampicina; Abrifam; Rifampicinum [INN-Latin]; Rifampicina [INN-Spanish]; Ba 41166/E; 3-(((4-Methyl-1-piperazinyl)imino	C43H58N4O12	JQXXHWHPUNPDRT-WLSIYKJHSA-N	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	n.a.	n.a.
PMDBD1174	Enalapril	Therapeutic substance	Drug	75847-73-3	DB00584	PA449456	D07892	DAP001374	5388962	4534998	n.a.	enalapril; 75847-73-3; Vasotec; Enalaprilum; Enalaprila; Lexxel; Enalaprilum [INN-Latin]; Enalaprila [INN-Spanish]; UNII-69PN84IO1A; Enalapril Richet; CHEMBL578; Gadopril; 69PN84IO1A; CHEBI:4784; C20H28N2O5; (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester; NCGC00021569-04; Enalapril [INN:BAN]; N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; DSSTox_CID_2982; DSSTox_RID_76817; DSSTox_GSID_22982; (S)-1-{(S)-2-[1-((S)-Ethoxycarbony	C20H28N2O5	GBXSMTUPTTWBMN-XIRDDKMYSA-N	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid	n.a.	n.a.
PMDBD598	Nitrofural	Therapeutic Substance	Approved Drug	59-87-0	DB00336	PA164754877	D00862	n.a.	5447130	4566720	n.a.	nitrofurazone; Nitrofural; Furacilin; 59-87-0; Furacin; Furacillin; Furaldon; Furacine; Aldomycin; Nifuzon; 5-Nitro-2-furaldehyde semicarbazone; Actin-N; Nitrozone; Mastofuran; Furazone; Chemofuran; Furacycline; Furacoccid; Furaziline; Furacinetten; Babrocid; Otofuran; Nitrofurazan; Monafuracin; Furesol; Mammex; Amifur; Alfucin; Furazol W; 5-Nitrofurfural semicarbazone; Nitrofurol; Fuvacillin; Furametral; Biofuracina; Becafurazone; Monofuracin; Dermofural; Furatsilin; Monafuracis; Furaseptyl; Yatrocin; Otofural; Nifurid; Furfurin; Furaderm; Fracine; Co	C6H6N4O4	IAIWVQXQOWNYOU-FPYGCLRLSA-N	[(E)-(5-nitrofuran-2-yl)methylideneamino]urea	n.a.	n.a.
PMDBD1071	Calcium	Therapeutic substance	Drug	7440-70-2	DB01373	PA164712582	n.a.	n.a.	5460341	4573905	n.a.	Ca; 7440-70-2; Calcium; Elemental calcium; Calcium, elemental; UNII-SY7Q814VUP; HSDB 273; EINECS 231-179-5; UN1401; SY7Q814VUP; MFCD00085314; Calcium, 99%, granular; Calcium, 99%, turnings; Calcium compounds; Kalzium; calcium atom; Calcium ingot; Calcium Chelate; Calcium standard solution, for AAS, 1 mg-ml Ca in 2 to 5% HNO3; Bio Lacta Cal; calcium(0); Calcium, Natural Milk; Calcium, granular, 99%; 20Ca; EC 231-179-5; Calcium Milk Calcium 28%; Calcium Krebs 21% 40M; Calcium Sweet Chelate 20%; Calcium Oratate 11% 40M; KSC377C8L; Ca(0); Ca	Ca	OYPRJOBELJOOCE-UHFFFAOYSA-N	calcium	n.a.	n.a.
PMDBD1098	Cefuroxime	Therapeutic substance	Antibiotics	55268-75-2	DB01112	PA448868	D00262	DAP000445	5479529	4586393	n.a.	cefuroxime; Cephuroxime; Cefuroxim; Cefuroximo; 55268-75-2; Cefuroximum; Sharox; Zinacef Danmark; Zinacef; Biofuroksym; Cefuril; Cefuroximum [INN-Latin]; Cefuroximo [INN-Spanish]; UNII-O1R9FJ93ED; Cefuroxime [USAN:INN:BAN]; C16H16N4O8S; EINECS 259-560-1; BRN 5783190; O1R9FJ93ED; CHEBI:3515; Kefurox; (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbon	C16H16N4O8S	JFPVXVDWJQMJEE-IZRZKJBUSA-N	(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1097	Ceftriaxone	Therapeutic substance	Antibiotics	73384-59-5	DB01212	PA448866	D07659	DAP000145	5479530	4586394	n.a.	ceftriaxone; Biotrakson; Rocephin; Rocefin; 73384-59-5; Ceftriazone; Ceftriaxonum [INN-Latin]; Ceftriaxona [INN-Spanish]; Ceftriaxona; Ceftriaxonum; Rocephine; CEFTRIAXONE SODIUM; Ro 139904; DRG-0071; Ceftriaxon; Rocephalin; CHEBI:29007; C18H18N8O7S3; UNII-75J73V1629; EINECS 277-405-6; CTRX; CHEMBL161; Ro 13-9904; Ro-13-9904; Longacef; 75J73V1629; 78384-59-5; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)t	C18H18N8O7S3	VAAUVRVFOQPIGI-SPQHTLEESA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1085	Cefepime	Therapeutic substance	Antibiotics	88040-23-7	DB01413	PA164754876	D02376	DAP000455	5479537	4586395	n.a.	cefepime; Maxipime; Cefepima; Cefepimum [Latin]; Cefepima [Spanish]; Cefepimum; 88040-23-7; Axepim; BMY 28142; BMY-28142; E-Cefepime; CFPM; UNII-807PW4VQE3; 807PW4VQE3; CHEBI:478164; 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime); Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxi	C19H24N6O5S2	HVFLCNVBZFFHBT-ZKDACBOMSA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD863	Trandolapril	Therapeutic Substance	Approved Drug	87679-37-6	DB00519	PA451737	D00383	DAP000583	5484727	4588590	n.a.	trandolapril; 87679-37-6; Mavik; Gopten; Odrik; Trandolaprilum [Latin]; RU-44570; RU44570; RU 44570; UNII-1T0N3G9CRC; CCRIS 6594; 1T0N3G9CRC; C24H34N2O5; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; NCGC00182079-02; Trandolaprilum; Udrik; DSSTox_CID_3692; DSSTox_RID_77151; DSSTox_GSID_23692; (2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; Odric; Preran; Trandolapril [INN:BAN]; 1H-I	C24H34N2O5	VXFJYXUZANRPDJ-WTNASJBWSA-N	(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid	Abbott Laboratories	Antihypertensive Agents
PMDBD1143	Deferasirox	Therapeutic substance	Drug	201530-41-8	DB01609	PA164760843	D03669	n.a.	214348	10770206	n.a.	Deferasirox; 201530-41-8; Exjade; ICL 670; ICL670A; ICL 670A; ICL-670A; Deferasiroxum; Deferasiroxum [INN-Latin]; ICL-670; ICL670; UNII-V8G4MOF2V9; CGP-72670; Deferasirox (Exjade); CHEBI:49005; 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; 4-(3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid; V8G4MOF2V9; C21H15N3O4; NCGC00181754-01; DSSTox_CID_28522; DSSTox_RID_82794; DSSTox_GSID_48596; 1044764-54-6; Jadenu; Benzoic acid, 4-(3,5-bis(2-hydr	C21H15N3O4	BOFQWVMAQOTZIW-UHFFFAOYSA-N	4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid	n.a.	n.a.
PMDBD1087	Cefotaxime	Therapeutic substance	Antibiotics	63527-52-6	DB00493	PA448852	D07647	DAP000146	5742673	4674877	n.a.	cefotaxime; Cephotaxime; 63527-52-6; Cefotaxime acid; E-cefotaxime; UNII-N2GI8B1GK7; Cefotaximum; Claforan; Cefotaxima; N2GI8B1GK7; CHEBI:204928; Cefotaxime [INN:BAN]; Cefotaximum [INN-Latin]; HR 756; Cefotaxima [INN-Spanish]; 60846-21-1; RU 24756; C16H17N5O7S2; Omnatax; Taxim; EINECS 264-299-1; RU 24662; 4kot; (6R,7R)-3-(Acetoxymethyl)-7-(()-2-(2-amino-4-thiazolyl)-2-methoxyimino	C16H17N5O7S2	GPRBEKHLDVQUJE-QSWIMTSFSA-N	(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD618	Olsalazine	Therapeutic Substance	Approved Drug	15722-48-2	DB01250	PA450700	D00727	n.a.	22419	10642377	n.a.	Olsalazine; 15722-48-2; Olsalazina; Azodisal; Olsalazinum; 5,5'-Azobis(salicylic acid); Olsalazinum [Latin]; Olsalazina [Spanish]; 3,3'-Azobis(6-hydroxybenzoic acid); Olsalazine [INN:BAN]; C.I. Mordant Yellow 5; UNII-ULS5I8J03O; ULS5I8J03O; CHEBI:7770; C14H10N2O6; mordant yellow 5; Rasal; 3,3'-diazene-1,2-diylbis(6-hydroxybenzoic acid); (E)-5,5'-(diazene-1,2-diyl)bis(2-hydroxybenzoic acid); Mirtazanine; Dipentium; Olsalazin; Olsalazine (INN); 5,5'-azodisalicylic aci	C14H10N2O6	QQBDLJCYGRGAKP-UHFFFAOYSA-N	5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD744	Rifabutin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	72559-06-9	DB00615	PA451249	D00424	DAP000656	135398743	10482168	NPC314987	RIFABUTIN; Ansamycin; Mycobutin; Rifabutine; Ansatipine; Ansatipin; Alfacid; 72559-06-9; LM-427; Rifabutinum [Latin]; Rifabutine [French]; Rifabutina [Spanish]; Antibiotic LM 427; 4-N-isobutylspiropiperidylrifamycin S; LM 427; HSDB 3577; DRG-0085; 1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin XIV; 4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S; BRN 3584778; NCGC00090762-01; DSSTox_CID_10773; DSSTox_RID_79103; DSSTox_GSID_33960; RBT	C46H62N4O11	ZWBTYMGEBZUQTK-PVLSIAFMSA-N	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate	Adria Laboratories 	Antibiotics
PMDBD746	Rifapentine	Therapeutic Substance	Approved Drug	61379-65-5	DB01201	PA164783809	D00879	DAP000426	135403821	10482075	n.a.	RIFAPENTINE; Priftin; 61379-65-5; Cyclopentylrifampicin; Rifapentin; Priftin (TN); Rifamycin AF/ACPP; CHEBI:45304; MDL-473; MDL 473; 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; DL 473; UNII-XJM390A33U; KTC 1; XJM390A33U; Cyclopentyl rifampin; DL-473; R-773; R 77-3; Rifapentinum [Latin]; Rifapentina [Spanish]; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca	C47H64N4O12	WDZCUPBHRAEYDL-GZAUEHORSA-N	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	n.a.	n.a.
PMDBD96	Balsalazide	Therapeutic Substance	Approved Drug	80573-04-2	DB01014	PA448536	D07488	DAP000733	54585	10662422	n.a.	BALSALAZIDE; 80573-04-2; Balsalazido; Balsalazidum; Balsalazida; Balsalazidum [Latin]; Balsalazido [Spanish]; Balsalazida [Spanish]; Balsalazide Disodium; Balsalazide [INN:BAN]; (E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid; UNII-P80AL8J7ZP; Colazide; (E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; P80AL8J7ZP; CHEBI:267413; C17H15N3O6; (E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid; 5-[4-(2-carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid	C17H15N3O6	IPOKCKJONYRRHP-UHFFFAOYSA-N	5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid	n.a.	Antiinflammatory Agents
PMDBD1341	Palonosetron	Therapeutic substance	Drug	135729-56-5	DB00377	PA10352	D07175	DAP000367	6337614	4892289	n.a.	Palonosetron; 135729-61-2; Aloxi; Palonosetron [INN]; 2-Qhbiqo; UNII-5D06587D6R; Aloxi (TN); CHEBI:85161; Palonosetron (INN); 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one; 5D06587D6R; (-)-Palonosetron; (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one; (3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one; (S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(	C19H24N2O	CPZBLNMUGSZIPR-NVXWUHKLSA-N	(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one	n.a.	n.a.
PMDBD747	Rifaximin	Therapeutic Substance	Approved Drug	80621-81-4	DB01220	PA164752443	D02554	DAP001006	6436173	10482302	n.a.	Rifaximin; Rifaxidin; Rifacol; Xifaxan; 80621-81-4; Rifaximine; Rifamycin L 105; Rifamycin L 105SV; Fatroximin; Normix; Rifaximina; Rifamixin; Ritacol; Rifaximine [French]; Rifaximinum [Latin]; Rifaximina [Spanish]; C43H51N3O11; UNII-L36O5T016N; L 105SV; L 105 (Ansamacrolide antibiotic); L 105; BRN 3584528; Rifaximin [USAN:INN]; CHEBI:75246; L36O5T016N; Rifaximin, 98%; Rifaximin (Xifaxan); Rifaximinum; 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4-c)rifamycin SV; (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydrox	C43H51N3O11	NZCRJKRKKOLAOJ-XRCRFVBUSA-N	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate	n.a.	n.a.
PMDBD801	Spiramycin	Therapeutic Substance	Approved Drug	24916-50-5	DB06145	n.a.	n.a.	n.a.	6440717	4944970	n.a.	Foromacidine A; Demycarosylturimycin H; Spiramycin I; Spiramycin A; Spiramycin 1; spiramycin; Foromacidin; Foromacidin A; C43H74N2O14; 8025-81-8; 24916-50-5; NSC55926; Rovamycinetrade mark; NSC64393; IC 5902; CHEBI:85260; DB06145; LS-145761; J-015730; UNII-71ODY0V87H component ACTOXUHEUCPTEW-KWBWCIJSSA-N; [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)	C43H74N2O14	ACTOXUHEUCPTEW-KWBWCIJSSA-N	2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	n.a.	n.a.
PMDBD1188	Everolimus	Therapeutic substance	Drug	159351-69-6	DB01590	PA164746311	D02714	DAP001223	6442177	21106307	n.a.	Zortress; SDZ-RAD; SDZ RAD; RAD; Everolimus; 40-O-(2-hydroxyethyl)-rapamycin; RAD001; RAD, SDZ; 40-O-(2-Hydroxyethyl)rapamycin; RAD 001; Certican; Afinitor; 001, RAD; 42-O-(2-Hydroxyethyl)rapamycin; 159351-69-6; Votubia; Afinitor Disperz; CHEBI:68478; RAD-001; UNII-9HW64Q8G6G; 9HW64Q8G6G; NCGC00167512-01; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9	C53H83NO14	HKVAMNSJSFKALM-GKUWKFKPSA-N	(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone	n.a.	n.a.
PMDBD287	Dirithromycin	Therapeutic Substance	Approved Drug	62013-04-1	DB00954	PA449368	D03865	DAP000888	6473883	4976073	n.a.	Dirithromycin; Diritromicina; Dirithromycinum; Dirithromycine; 62013-04-1; Dynabac; LY 237216; LY-237216; UNII-1801D76STL; MLS000028564; (9S)-9-Deoxo-11-deoxy-9,11-(imino((1R)-2-(2-methoxyethoxy)ethylidene)oxy)erythromycin; SMR000058954; MLS001074061; CHEBI:474014; 1801D76STL; Diritromicina [Spanish]; Dirithromycine [French]; Dirithromycinum [Latin]; (1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-3-ethyl-2,10-dihydroxy-15-[(2-methoxyethoxy)methyl]-2,6,8,10,12,17-hexamethyl-5-oxo-9-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-h	C42H78N2O14	WLOHNSSYAXHWNR-DWIOZXRMSA-N	(1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,10-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one	n.a.	n.a.
PMDBD1049	Azlocillin	Therapeutic substance	Antibiotics	37091-66-0	DB01061	PA164749135	D02339	DAP001169	6479523	4980416	n.a.	azlocillin; 37091-66-0; Azlocillinum; Azlocilline; Azlocilina; Azlocillinum [INN-Latin]; Azlocilline [INN-French]; Azlocilina [INN-Spanish]; UNII-HUM6H389W0; CHEBI:2956; HUM6H389W0; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(2R)-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; EINECS 253-348-2; 6-((R)-2	C20H23N5O6S	JTWOMNBEOCYFNV-NFFDBFGFSA-N	(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD608	Norgestimate	Therapeutic Substance	Approved Drug	35189-28-7	DB00957	PA164744346	D05209	DAP001210	6540478	5022837	n.a.	NORGESTIMATE; Dexnorgestrel acetime; 35189-28-7; Norgestimato; Norgestimatum; Norgestimatum [INN-Latin]; Norgestimato [INN-Spanish]; UNII-C291HFX4DY; RWJ 10131; ORF 10131; D 138; (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester); ORF-10131; C291HFX4DY; CHEBI:50815; d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime; (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime; 20799-27-3; NCGC00181353-01; norgestrel oxime acetate; DSSTox_RID_82018; DSSTox_	C23H31NO3	KIQQMECNKUGGKA-NMYWJIRASA-N	[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate	n.a.	Contraceptive Agents
PMDBD599	Nitrofurantoin	Therapeutic Substance	Approved Drug	67-20-9	DB00698	PA450640	D00439	DAP000998	6604200	5036498	n.a.	nitrofurantoin; 67-20-9; Macrodantin; 5-Nitrofurantoin; Furadantin; Furadonine; Furadantoin; Furadontin; Furadoine; Furadantine; Nifurantin; Furantoin; Nitrofuradantin; Nitrofurantoine; Welfurin; Furatoin; Furachel; Berkfurin; Urofurin; Urantoin; Novofuran; Furadonin; Parfuran; Zoofurin; Trantoin; Orafuran; Macrobid; Furobactina; Chemiofuran; Urodin; Nitoin; Furalan; Urizept; Ituran; Furina; Cystit; Urolong; Cyantin; Furadantine mc; Uro-Tablinen; Fur-ren; Macrofuran; Nitrofurantoina; Furadoninum; Furaloid; Nierofu; Benkfuran; Dantafur; Nitrex; Macpac; Nitr	C8H6N4O5	NXFQHRVNIOXGAQ-YCRREMRBSA-N	1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione	Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co	Antiinfective Agents
PMDBD590	Nifurtimox	Therapeutic Substance	Approved Drug	23256-30-6	DB11820	n.a.	n.a.	n.a.	6842999	5246596	n.a.	NIFURTIMOX; Lampit; Bayer 2502; 23256-30-6; BAY 2502; Nifurtimox [INN:BAN]; Nifurtimoxum [INN-Latin]; CCRIS 2201; CHEBI:7566; EINECS 245-531-0; BAYER-2502; BAY-A2502; C10H13N3O5S; BAY-2502; DNDI1613515; 4-Thiomorpholinamine, 3-methyl-N-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide; 4-((5-Nitrofurfurylidene)amino)-3-methylthiomorpholine-1,1-dioxide; 1-((5-Nitrofurfurylidene)amino)-2-methyltetrahydro-1,4-thiazine-4,4-dioxide; 4-Thiomorpholinamine, 3-methyl-N-[(5-nitro-2-furanyl)methylene]-, 1,1-dioxide; 3-Methyl-4-(5'-nitrofuryl	C10H13N3O5S	ARFHIAQFJWUCFH-IZZDOVSWSA-N	(E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine	Bayer healthcare pharmaceuticals	n.a.
PMDBD627	Oxaliplatin	Therapeutic Substance	Approved Drug	61825-94-3	DB00526	PA131285527	D01790	DAP000062	6857599	8062727	n.a.	oxaliplatine; CHEBI:31941; Diaminocyclohexane Oxalatoplatinum; DB00526; (SP-4-2)[(1R,2R)-cyclohexane-1,2-diamine-kappa(2)N,N'][ethanedioato(2-)-kappa(2)O(1),O(2)]platinum	C8H16N2O4Pt+2	ZROHGHOFXNOHSO-BNTLRKBRSA-N	(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)	n.a.	n.a.
PMDBD1138	Dantrolene	Therapeutic substance	Drug	7261-97-4	DB01219	PA449208	D02347	DNC001623	6914273	5290202	n.a.	dantrolene; Dantrolenum [INN-Latin]; Dantroleno [INN-Spanish]; 7261-97-4; Dantroleno; UNII-F64QU97QCR; F-368; Dantrolenum; Ryanodex; 1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin; HSDB 3050; C14H10N4O5; EINECS 230-684-8; BRN 0705189; F64QU97QCR; 1-(((5-(4-Nitrophenyl)-2-furanyl)methylene)amino)-2,4-imidazolidinedione; 833480-90-3; 1-[[5-(p-Nitrophenyl)furfurylidene]amino]hydantoin; 2,4-Imidazo	C14H10N4O5	OZOMQRBLCMDCEG-VIZOYTHASA-N	1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione	n.a.	n.a.
PMDBD758	Roxithromycin	Therapeutic Substance	Approved Drug	80214-83-1	DB00778	PA164750505	D01710	DAP000885	6915744	5291557	n.a.	roxithromycin; Rulide; Roxitromicina; Roxithromycinum; Roxithromycine; 80214-83-1; RU 965; RU 28965; UNII-21KOF230FA; Rulid; CHEBI:48935; Roxithromycinum [Latin]; Roxithromycine [French]; Roxitromicina [Spanish]; 21KOF230FA; RU-965; RU-28965; 9-(O-((2-Methoxyethoxy)methyl)oxime)erythromycin; CCRIS 3461; (9E)-erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); (E)-roxithromycin; Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); BRN 4286925; Rulide (TN); 9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin; SR-05000001850; Erythromycin, 9	C41H76N2O15	RXZBMPWDPOLZGW-XMRMVWPWSA-N	(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one	Sanofi-Aventis	Antibiotics
PMDBD156	Cefdinir	Therapeutic Substance	Approved Drug	91832-40-5	DB00535	PA164768739	D00917	DAP000436	6915944	5291705	n.a.	cefdinir; 91832-40-5; Omnicef; CFDN; Cefdinirum; Cefdinyl; Cefzon; FK-482; CI-983; FK 482; Cefdinirum [INN-Latin]; UNII-CI0FAO63WC; (E)-Cefdinir; BMY 28488; CI 983; Cefdinir (Omnicef); CHEBI:3485; PD-134393; PD 134393; BMY-28488; CI0FAO63WC; (-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; Cefdirnir; C14H13N5O5S2; Ceftinex; Cefdinir [USAN:INN]; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acet	C14H13N5O5S2	RTXOFQZKPXMALH-GHXIOONMSA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Abbott Laboratories	Antibiotics
PMDBD390	Ginsenoside Rb2	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	6917976	n.a.	NPC63368	Ginsenoside Rb2; Ginsenoside C; 11021-13-9; UNII-N219O0L31C; NSC 308878; Ginsenoside-Rb2; CHEBI:77152; N219O0L31C; EINECS 234-251-4; (20S)-ginsenoside Rb2; CHEMBL449303; HY-N0040; 20-[(6-O-a-L-arabinopyranosyl-ss-D-glucopyranosyl)oxy]-12ss-hydroxydammar-24-en-3ss-yl 2-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; 20-((6-O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosyl	C53H90O22	NODILNFGTFIURN-GZPRDHCNSA-N	(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD1171	Dutasteride	Therapeutic substance	Drug	164656-23-9	DB01126	PA164749300	D03820	DAP000044	6918296	5293502	n.a.	Dutasteride; 164656-23-9; Avodart; GG-745; GI-198745; GI 198745; UNII-O0J6XJN02I; GG 745; O0J6XJN02I; (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide; CHEMBL1200969; Avolve; CHEBI:521033; Dutasteride, 99%	C27H30F6N2O2	JWJOTENAMICLJG-QWBYCMEYSA-N	(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide	n.a.	n.a.
PMDBD895	Vilazodone	Therapeutic Substance	Approved Drug	163521-12-8	DB06684	n.a.	D09698	n.a.	6918314	5293518	n.a.	Vilazodone; 163521-12-8; 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide; UNII-S239O2OOV3; EMD 515259; CHEMBL439849; S239O2OOV3; CHEBI:70707; 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide; 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide; EMD-68-843; EMD-515259; SB 659746A; SB-659746-A; Vilazodone [USAN:INN]; vilazodona; vilazodonum; HSDB 8197; Vilazodone	C26H27N5O2	SGEGOXDYSFKCPT-UHFFFAOYSA-N	5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide	Genaissance and Merck KGaA	n.a.
PMDBD63	Aprepitant	Therapeutic Substance	Approved Drug	170729-80-3	DB00673	PA164747039	D02968	DNC000952	135413536	5293568	n.a.	Aprepitant; 170729-80-3; Emend; MK-0869; MK-869; L-754030; UNII-1NF15YR6UY; C23H21F7N4O3; 1NF15YR6UY; CHEMBL1471; CHEBI:499361; MK 869; MK 0869; 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; MK0869; L 754030; 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)m	C23H21F7N4O3	ATALOFNDEOCMKK-OITMNORJSA-N	3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one	Merck & Co	Antiemetics
PMDBD1374	Prasugrel	Therapeutic substance	Drug	150322-43-3	DB06209	PA154410481	D05597	n.a.	6918456	5293653	n.a.	Prasugrel; 150322-43-3; Effient; Efient; CS-747; Prasugrel (Effient); 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate; LY640315; LY-640315; CS 747; CHEBI:87723; Prasugrel, 98%; 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate; 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)e	C20H20FNO3S	DTGLZDAWLRGWQN-UHFFFAOYSA-N	[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate	n.a.	n.a.
PMDBD1024	Ambrisentan	Therapeutic substance	Drug	177036-94-1	DB06403	PA165860521	n.a.	n.a.	6918493	5293690	n.a.	Ambrisentan; 177036-94-1; Letairis; Volibris; BSF 208075; LU-208075; (S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid; UNII-HW6NV07QEC; HW6NV07QEC; LU 208075; CHEMBL1111; (S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; BSF-208075; (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid; DSSTox_CID_26282; DSSTox_RID_81508; DSSTox_GSID_46282; LU208075	C22H22N2O4	OUJTZYPIHDYQMC-LJQANCHMSA-N	(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid	n.a.	n.a.
PMDBD180	Chlorhexidine	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	55-56-1	DB00878	PA164776863	D07668	DAP001326	9552079	2612	NPC125416	chlorhexidine; 55-56-1; Tubulicid; Rotersept; Fimeil; Soretol; Hexadol; Chlorohexidine; Chlorhexidinum; Chlorhexidin; Sterilon; Nolvasan; Cloresidina [DCIT]; Chlorhexidin [Czech]; Chlorhexidinum [INN-Latin]; Clorhexidina [INN-Spanish]; Hibistat; Chlorhexidine [INN:BAN]; 1,6-Bis(p-chlorophenyldiguanido)hexane; 1,6-Di(4'-chlorophenyldiguanido)hexane; UNII-R4KO0DY52L; 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane; Exidine; CCRIS 9230; C22H30Cl2N10; 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide); 1,1'-Hexamethylene bis(5-(p-chlorophen	C22H30Cl2N10	GHXZTYHSJHQHIJ-UHFFFAOYSA-N	(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine	G. D. Pharmaceuticals	Antibiotics
PMDBD91	Aztreonam	Therapeutic Substance	Approved Drug	78110-38-0	DB00355	PA448523	D00240	DAP000117	5742832	4674940	n.a.	aztreonam; Azactam; 78110-38-0; Primbactam; SQ-26776; NSC646279; CHEMBL158; SQ 26776; Azthreonam; UNII-G2B4VE5GH8; NSC-646279; 2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropionic Acid; rel-Aztreonam; G2B4VE5GH8; MFCD00072145; SQ-28429; CHEBI:161680; SR-01000841814; Squibb 26776; Aztreonam (Azactam, Cayston); Azetreonam; E-Aztreonam; Prestwick_914; PubChem13620; Prestwick2_000185; Prestwick3_000185; BSPBio_000109	C13H17N5O8S2	WZPBZJONDBGPKJ-VEHQQRBSSA-N	2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid	n.a.	n.a.
PMDBD1213	Gemifloxacin	Therapeutic substance	Antibiotics	175463-14-6	DB01155	PA10088	D08012	DAP000851	9571107	7845573	n.a.	Gemifloxacin; 175463-14-6; Gemifloxacin [INN]; Gemifloxacin mesylate; Factive; Gemifioxacin; LB-20304; SB 265805; Gemifloxacin (INN); LB 20304; CHEMBL430; 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid; CHEBI:101853; SB-265805; LB 20304a; 7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid	C18H20FN5O4	ZRCVYEYHRGVLOC-HYARGMPZSA-N	7-[(4Z)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid	n.a.	n.a.
PMDBD12	Acarbose	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	56180-94-0	DB00284	PA448010	D00216	DCL000309	9811704	23264314	NPC314306	UNII-T58MSI464G; T58MSI464G; BIDD:GT0622; BAYG5421; SCHEMBL4606191; HSDB 7984; HY-B0089; ZINC96309558; Acarbose [USAN:USP:INN:BAN:JAN]; DS-3277; CS-1787; DB00284; (2R,3R,4R,5R)-4-(((2R,3R,4R,5S,6R)-5-(((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,3,5,6-tetrahydroxyhexanal; D-Glucose,O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohe	C25H43NO18	CEMXHAPUFJOOSV-XGWNLRGSSA-N	(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal	n.a.	n.a.
PMDBD300	Eltrombopag	Therapeutic Substance	Approved Drug	496775-61-2	DB06210	n.a.	D03978	n.a.	135449332	19879943	n.a.	Eltrombopag; 496775-61-2; Promacta; Revolade; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; SB497115; UNII-S56D65XJ9G; Eltrombopag-Isomer; (ZE)-Eltrombopag; SB-497115; S56D65XJ9G; CHEMBL461101; 1807882-48-9; CHEBI:85010; Eltrombopag (SB-497115-GR); NCGC00274067-01; 376591-99-0; Eltrombopag [INN]; SB 497115; Eltrombopag/; HSDB 8212	C25H22N4O4	SVOQIEJWJCQGDQ-UHFFFAOYSA-N	3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid	GlaxoSmithKline	n.a.
PMDBD28	Aloin	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	9866696	n.a.	NPC48130	aloin; Alloin; Aloin A; Aloin, curaco; Aloin, Cape; Aloin(mixture of A&amp;B); CHEMBL497001; CHEBI:73222; 10-beta-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)anthracen-9(10H)-one; (1S)-1,5-anhydro-1-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl]-D-glucitol; 8015-61-0; 10-(1',5'-Anhydroglucosyl)aloe-emodin-9-anthrone; 10-beta-D-Glucopyranosyl-1,8-dihydroxy-3-hydroxymethyl-9(10H)-anthrone; 10-(1,5'-Anhydroglucosyl)aloe-emodin-9-anthrone; SCHEMBL4974144; 10-beta-D-Glucopyranosyl-1,8-dihydroxy-3-(hydr	C21H22O9	AFHJQYHRLPMKHU-CGISPIQUSA-N	1,8-dihydroxy-3-(hydroxymethyl)-10-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10H-anthracen-9-one	n.a.	n.a.
PMDBD773	Secoisolariciresinol diglucoside	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	9917980	n.a.	NPC278961	Secoisolariciresinol diglucoside; 158932-33-3; Secoisolarisiresinol diglucoside; Seco-isolariciresinol diglucoside; (R,R)-Secoisolariciresinol diglucoside; UNII-T9281L29MV; T9281L29MV; SDG; Secoisolariciresinol diglycoside; C32H46O16; Secoisolariciresinol-Diglucoside; SCHEMBL16307898; CHEMBL2425486; DTXSID40432760; HY-N6937; s3780; ZINC67940726; CCG-270376; EBD2202224; Y0185; X1171; CS-0100998; 244S820; Q4161320; beta-D-Glucopyranose, diglycoside with 2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-1,4-butanediol, [R-(R*,R*)]- (9CI); (2	C32H46O16	SBVBJPHMDABKJV-PGCJWIIOSA-N	(2R,3R,4S,5S,6R)-2-[(2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD482	Linagliptin	Therapeutic Substance	Approved Drug	668270-12-0	DB08882	n.a.	D09566	n.a.	10096344	8271879	n.a.	Linagliptin; 668270-12-0; Tradjenta; BI 1356; Ondero; BI-1356; Linagliptin (BI-1356); UNII-3X29ZEJ4R2; BI-1356-BS; ione; 3X29ZEJ4R2; CHEMBL237500; CHEBI:68610; C25H28N8O2; (R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione; 8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione; (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dion	C25H28N8O2	LTXREWYXXSTFRX-QGZVFWFLSA-N	8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione	Boehringer Ingelheim	n.a.
PMDBD1344	Pazopanib	Therapeutic substance	Drug	444731-52-6	DB06589	n.a.	D05380	n.a.	10113978	8289501	n.a.	Pazopanib; 444731-52-6; GW786034; UNII-7RN5DR86CK; Pazopanib (GW-786034); 790713-33-6; 7RN5DR86CK; GW 78603; 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; CHEBI:71219; 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide; NCGC00188865-01; DSSTox_RID_82929; DSSTox_CID_28659; DSSTox_GSID_48733; 5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indaz	C21H23N7O2S	CUIHSIWYWATEQL-UHFFFAOYSA-N	5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide	n.a.	n.a.
PMDBD94	Bacitracin	Therapeutic Substance	Approved Drug	1405-87-4	DB00626	PA448531	D00128	DAP000710	10909430	9084687	n.a.	Bacitracin A; Bacitracin A2a; UNII-DDA3RRX0P7; Fortracin; DDA3RRX0P7; Mycitracin; Altracin; 22601-59-8; CHEBI:35862; Topitracin; Penitracin; Zutracin; Ayfivin; EINECS 245-115-9; NSC 45737; Parentracin; Bacitracine; Topitrasin; Bacitracina; Baciliquin; Baciim; Septa; Spectrocin Plus; Bacitek ointment; Ak-Tracin; Baci-rx; Baci-Jel; Bacitracinum [Latin]; Bacitracine [French]; Bacitracina [Spanish]; Bactine Triple Antibiotic; Bacitracin A (B015); USAF	C66H103N17O16S	CLKOFPXJLQSYAH-ABRJDSQDSA-N	(4R)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid	n.a.	Antibiotics
PMDBD769	Saxagliptin	Therapeutic Substance	Approved Drug	361442-04-8	DB06335	PA165958362	D08996	n.a.	11243969	9419005	n.a.	Saxagliptin; Onglyza; 361442-04-8; BMS-477118; BMS 477118; OPC-262; UNII-8I7IO46IVQ; 8I7IO46IVQ; CHEMBL385517; CHEBI:71272; BMS-477118-11; axagliptin; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile; BMS477118; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; Saxagliptin [INN]; Saxagliptine; Saxagliptin (BMS	C18H25N3O2	QGJUIPDUBHWZPV-SGTAVMJGSA-N	(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile	Bristol-Myers Squibb; AstraZeneca	n.a.
PMDBD396	Ginsenoside Rg5	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	11550001	n.a.	NPC159036	Ginsenoside Rg5; 186763-78-0; Ginsenoside-Rg5; CHEBI:67992; CHEMBL400244; HY-N0908; ZINC95613310; CS-3850; Q27136475	C42H70O12	NJUXRKMKOFXMRX-RNCAKNGISA-N	(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD372	Fostamatinib	Therapeutic Substance	Approved Drug	901119-35-5	DB12010	n.a.	n.a.	n.a.	11671467	9846198	n.a.	Fostamatinib; 901119-35-5; Fostamatinib (R788); R788; Fostamatinib(R788); Tavalisse; UNII-SQ8A3S5101; R-788 Free acid; R 788; R-788; R-935788 Free acid; SQ8A3S5101; R7935788; [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate; Fostamatinib/R788; [6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-3-Oxo-2,3-Dihydro-4h-Pyrido[3,2-B][1,4]oxazin-4-Yl]methyl Dihydrogen Phosphate; 2H-Pyrido(3,2-b)-1,4-oxazin-3(4H	C23H26FN6O9P	GKDRMWXFWHEQQT-UHFFFAOYSA-N	[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate	Rigel Pharmaceuticals	n.a.
PMDBD1325	Nystatin	Therapeutic substance	Drug	1400-61-9	DB00646	PA450666	D00202	DAP000879	11953884	10468627	n.a.	Mycostatin (TN); SCHEMBL3232; Nystatin (JP17/USP/INN); CHEBI:7660; LMPK06000001; D00202; C06572; (21E,23E,25E,27E,31E,33E)-20-[(3-amino-3,6-dideoxy-D-mannopyranosyl)oxy]-4,6,8,11,12,16,18,36-octahydroxy-35,37,38-trimethyl-2,14-dioxooxacyclooctatriaconta-21,23,25,27,31,33-hexaene-17-carboxylic acid	C47H75NO17	ZDFDJJJGIRGMBE-AFARJNEBSA-N	(21E,23E,25E,27E,31E,33E)-20-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-4,6,8,11,12,16,18,36-octahydroxy-35,37,38-trimethyl-2,14-dioxo-1-oxacyclooctatriaconta-21,23,25,27,31,33-hexaene-17-carboxylic acid	n.a.	n.a.
PMDBD457	Isoaminile	Therapeutic Substance	Approved Drug	77-51-0	DB08944	n.a.	D08088	n.a.	12162152	64873333	n.a.	DB08944; (2R,4S)-2-Phenyl-2-isopropyl-4-(dimethylamino)pentanenitrile	C16H24N2	WFLSCFISQHLEED-GOEBONIOSA-N	(2R,4S)-4-(dimethylamino)-2-phenyl-2-propan-2-ylpentanenitrile	n.a.	n.a.
PMDBD391	Ginsenoside Rc	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	12855889	n.a.	NPC220427	Ginsenoside Rc; 11021-14-0; ginsenoside-Rc; Panaxoside RC; UNII-0K83B0L786; NSC 310104; CHEBI:77154; 0K83B0L786; EINECS 234-253-5; BRN 1677618; CHEMBL451702; HY-N0042; 20-[(6-O-a-L-arabinofuranosyl-ss-D-glucopyranosyl)oxy]-12ss-hydroxydammar-24-en-3ss-yl 2-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; 20-((6-O-alpha-L-Arabinofuranosyl-beta-D-glucopyranosyl)oxy)-12beta-hydroxydammar-24-en-3beta-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; MFCD00133368; s9266; AKOS037514670; CCG-270633; CS-3837; NCGC00485983-01; AS-56539	C53H90O22	JDCPEKQWFDWQLI-LUQKBWBOSA-N	(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD437	Idebenone	Therapeutic Substance	Approved Drug	58186-27-9	DB09081	n.a.	D01750	n.a.	12881464	14944546	n.a.	SCHEMBL7407419; DB09081; NS00073405; 6-(12-hydroxydodecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone; 2-(12-hydroxydodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	C21H34O5	VMHWZDULLBLUMS-UHFFFAOYSA-N	2-(12-hydroxydodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	n.a.	n.a.
PMDBD1096	Ceftobiprole	Therapeutic substance	Antibiotics	209467-52-7	DB04918	n.a.	D08885	n.a.	135413542	23350302	n.a.	Ceftobiprole; 209467-52-7; UNII-5T97333YZK; 5T97333YZK; BAL9141-000; Ro-63-9141; ceftobiprol; Zeftera; ceftobiprolum; BAL-9141; Ro-639141; Ceftobiprole [USAN:INN]; Ceftobiprole (USAN/INN); SCHEMBL158871; SCHEMBL2671901; CHEMBL520642; SCHEMBL19236292; DTXSID40870229; CHEBI:140407; DB04918; BAL-9141000; Ro 63-9141; BAL 9141-000; BAL-9141-000; HY-112579; CS-0047547; Ro-63-9141/000; D08885; Ceftobiprole, Antibiotic for Culture Media Use Only	C20H22N8O6S2	VOAZJEPQLGBXGO-SDAWRPRTSA-N	(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD841	Thimerosal	Therapeutic Substance	Approved Drug	54-64-8	DB11590	n.a.	D00864	n.a.	16684434	5697	n.a.	thimerosal; Thiomersal; 54-64-8; Thiomersalate; Mercurothiolate; Sodium merthiolate; Sodium ethylmercurithiosalicylate; MERTHIOLATE; Thiomersalat; Thimersalate; Thimerosalum; Thimerosalate; Thimerosol; Ethylmercurithiosalicylate sodium; Ethylmercurithiosalicylic acid sodium salt; Thiomersalum; Mertorgan; Merphol; Tiomersal; Merzonin; Merfamin; Nosemack; Estivin; Elicide; Mercurothiolatum; Merzonin sodium; Aeroaid spray; Merthiolate salt; Merthiolate sodium; Vitaseptol Loesung; Merseptyl (VAN); Ethyl(2-mercaptobenzoato-S)mercury sodium sa	C9H9HgNaO2S	RTKIYNMVFMVABJ-UHFFFAOYSA-L	sodium;(2-carboxylatophenyl)sulfanyl-ethylmercury	n.a.	n.a.
PMDBD1137	Dalbavancin	Therapeutic substance	Antibiotics	171500-79-1	DB06219	n.a.	D03640	n.a.	23724878	30791917	n.a.	Dalvance; Zeven; Xydalba; BI-397; Dalvance (TN); Zeven (TN); Dalbavancin (USAN/INN); a a-1; GTPL10876; D03640	C88H100Cl2N10O28	KGPGQDLTDHGEGT-VBZOGQDBSA-N	(2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22R,34S,37R,40R)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylund	n.a.	n.a.
PMDBD1419	Solithromycin	Therapeutic substance	Antibiotics	760981-83-7	DB09308	n.a.	n.a.	n.a.	25242512	25056854	n.a.	Solithromycin; CEM-101; Solithera; OP-1068; CEM 101; 760981-83-7; UNII-9U1ETH79CK; OP 1068; 9U1ETH79CK; Solithromycin [USAN:INN]; CEM101; SCHEMBL19114493; CHEMBL1232510; GTPL10859; OPT-1068; EX-A2272; OP1068; ZINC95627834; AKOS032947334; Solithromycin; CEM-101; OP-1068; DB09308; compound 3 [PMID: 30258539]; CS-5053; HY-17593; T4288; T-4288; Q7558263; 2H-Oxacyclotetradecino(4,3-d)oxazole-2,6,8,14(1H,7H,9H)-tetrone, 1-(4-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)butyl)-4-ethyl-7-     fluorooctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl	C43H65FN6O10	IXXFZUPTQVDPPK-ZAWHAJPISA-N	(1S,2R,5S,7R,8R,9R,11R,13R,14R)-15-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-5-fluoro-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone	n.a.	n.a.
PMDBD1491	Vinorelbine	Therapeutic substance	Drug	71486-22-1	DB00361	PA451881	D08680	DAP000765	44424639	4470974	n.a.	vinorelbine; Vinorelbine Ditartarate; Vinorelbin; Vinorelbinum [Latin]; Vinorelbina [Spanish]; methyl (1R,9R,10R,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(12S,14R)-16-ethyl-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraene-10-carboxylate	C45H54N4O8	GBABOYUKABKIAF-GHYRFKGUSA-N	methyl (1R,9R,10R,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate	n.a.	n.a.
PMDBD464	Ivermectin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	70288-86-7	DB00602	PA450133	D00804	DAP000261	46936176	30776735	NPC469812	SCHEMBL44295; DB00602; W-5275	C95H146O28	SPBDXSGPUHCETR-CVSKBELMSA-N	(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2R)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-	n.a.	n.a.
PMDBD389	Ginsenoside Rb1	Therapeutic Substance; Herbal Substance	Investigational Drug; Medicinal Herbal Compounds	41753-43-9	DB06749	n.a.	n.a.	n.a.	46937026	8073937	NPC208650	Q27095725	C54H92O23	JRZQHNRYHFRTFZ-MHMDWUMYSA-N	(2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(2S)-2-[(1R,3S,5R,8R,9R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-1,4,4,8,14-pentamethyl-1,2,3,5,6,7,9,10,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD1399	Raltegravir	Therapeutic substance	Drug	518048-05-0	DB06817	n.a.	D06676	n.a.	54671008	16445111	n.a.	Raltegravir; 518048-05-0; Raltegravir (MK-0518); MK-0518; MK0518; UNII-22VKV8053U; N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide; MK 0518; 22VKV8053U; NCGC00184997-01; AK326327; DSSTox_CID_28586; DSSTox_RID_82857; DSSTox_GSID_48660; Isentress(TM); N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide; Raltegravir (INN); CAS-518048-05-0; Raltegravir [USAN	C20H21FN6O5	CZFFBEXEKNGXKS-UHFFFAOYSA-N	N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide	n.a.	n.a.
PMDBD1170	Doxycycline	Therapeutic substance	Antibiotics	564-25-0	DB00254	PA449415	D07876	DAP001371	54671203	10469369	n.a.	doxycycline; Vibramycin; 564-25-0; Doxytetracycline; Doxiciclina; Doxycyclinum; Oracea; Monodox; Doxy-Caps; Vibravenos; Doxycycline (anhydrous); Vibra-tabs; 6-Deoxytetracycline; Doxycycline hyclate; Vibramycine; Deoxymykoin; Investin; Doxivetin; Doxitard; Liviatin; Azudoxat; Spanor; Ronaxan; Doxycen; 6alpha-Deoxy-5-oxytetracycline; Doxy-Puren; Doxy-Tabs; alpha-Doxycycline; alpha-6-Deoxyoxytetracycline; 5-Hydroxy-alpha-6-deoxytetracycline; Doxycyclin; 6-alpha-Deoxy-5-oxytetracycline; Dossiciclina [DCIT]; 6-Deoxyoxytetracycline; Doxiciclina [	C22H24N2O8	SGKRLCUYIXIAHR-AKNGSSGZSA-N	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	n.a.	n.a.
PMDBD1339	Oxytetracycline	Therapeutic substance	Drug	79-57-2	DB00595	PA450757	n.a.	DAP000401	54675779	10482174	n.a.	oxytetracycline; Terramycin; 79-57-2; Oxyterracine; Oxyterracin; Oxytetracyclin; Oxymycin; Terrafungine; Oxitetracyclin; Oxitetraciclina; Ryomycin; Biostat; Adamycin; Geomycin; Oxytetracyclinum; Oxitetracyclinum; 5-Hydroxytetracycline; Oxytetracycline (anhydrous); Solkaciclina; Oxyterracyne; Ursocycline; Terramitsin; Riomitsin; Oksisyklin; Lenocycline; Imperacin; Ursocyclin; Berkmycen; Proteroxyna; Geotilin; Fanterrin; Dabicycline; Tarocyn; Oxypam; Macocyn; Teravit; Tarosin; Tetran; Antibiotic TM 25; Oxytetracycline amphoteric; Liquamycin LA 200	C22H24N2O9	OWFJMIVZYSDULZ-PXOLEDIWSA-N	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	n.a.	n.a.
PMDBD1296	Minocycline	Therapeutic substance	Antibiotics	10118-90-8	DB01017	PA450519	D05045	DAP000405	54675783	16735907	n.a.	minocycline; 10118-90-8; Minocyclin; Minociclina; Minocin; Minomycin; Minocyn; Dynacin; Minocyclinum [INN-Latin]; Minociclina [INN-Spanish]; CL 59806; MINO; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; UNII-FYY3R43WGO; Tri-minocycline; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; CHEBI:50694; HSDB 3130; FYY3R43WGO; BRN 3077644; Minocyclinum; C23H27N3O7; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-diox	C23H27N3O7	FFTVPQUHLQBXQZ-KVUCHLLUSA-N	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	n.a.	n.a.
PMDBD265	Dicumarol	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	54676038	n.a.	NPC229113	dicumarol; dicoumarol; 66-76-2; Bishydroxycoumarin; dicoumarin; melitoxin; bis-hydroxycoumarin; Antitrombosin; Dicumarine; Dicoumal; Baracoumin; Acavyl; Dicuman; Acadyl; Trombosan; Kumoran; Dufalone; Dicumol; Temparin; Cumid; Cuma; Dicumaol R; 3,3'-Methylenebis(4-hydroxycoumarin); Bis(4-hydroxycoumarin-3-yl)methane; Dicoumarolum; Anathrombase; Dicumarolum; Apekumarol; Dicumarinum; Dicoumerol; Bis-3,3'-(4-hydroxycoumarinyl)methane; Di-(4-hydroxy-3-coumarinyl)methane; Dicumarolo [DCIT]; Dwukumarol [Polish]; 3,3'-methylenebis(4-hydroxy-2H-chro	C19H12O6	DOBMPNYZJYQDGZ-UHFFFAOYSA-N	4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one	n.a.	Anticoagulants
PMDBD1366	Piroxicam	Therapeutic substance	Drug	36322-90-4	DB00554	PA450985	D00127	DAP000181	54676228	10442653	n.a.	piroxicam; 36322-90-4; Feldene; Piroxicamum; Pyroxycam; Roxicam; Piroftal; BAXO; CP-16171; CP 16171; Piroxicamum [INN-Latin]; CHF 1251; UNII-13T4O6VMAM; 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide; NSC 666076; 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; Piroxicam (Feldene); CCRIS 3719; C15H13N3O4S; 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide; EINECS 252-974-3; BRN 0627692; 13T4O6VMAM; 4-Hydroxy-2-methyl-N-2-pyrid	C15H13N3O4S	QYSPLQLAKJAUJT-UHFFFAOYSA-N	4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide	n.a.	n.a.
PMDBD14	Acenocoumarol	Therapeutic Substance	Approved Drug	152-72-7	DB01418	PA452632	D07064	DAP000772	54676537	10443441	n.a.	ACENOCOUMAROL; Acenocoumarin; Nicoumalone; 152-72-7; Nitrowarfarin; Nitrovarfarian; Nicumalon; Sinthrome; Sintrom; Acenocumarol; Syncoumar; Sinkumar; Syncumar; Acenocumarolo; Sincoumar; Sinthrom; Acenokumarin; Ascumar; Syntrom; Zotil; Acenocoumarolum; Neositron; Sintroma; Acenocumarolum; Nitrophenylacetylethyl-4-hydroxycoumarine; Acenocoumarolum [INN-Latin]; Trombostop; Acitrom; Acenokumarin [Czech]; Acenocumarolo [DCIT]; Acenocoumarol [INN]; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; G-23350; 3-(alpha-Acetonyl-p-nitrobenzyl)-4-hy	C19H15NO6	VABCILAOYCMVPS-UHFFFAOYSA-N	4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-2-one	n.a.	n.a.
PMDBD1274	Meloxicam	Therapeutic substance	Drug	71125-38-7	DB00814	PA450353	D00969	DAP000971	54677470	10442740	n.a.	meloxicam; 71125-38-7; Mobic; Movalis; Metacam; Mobicox; Mobec; Meloxicam (Mobic); Parocin; Movatec; Meloxicamum [Latin]; UH-AC 62XX; 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Meloxicamum; 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide; UNII-VG2QF83CGL; UHAC-62XX; CCRIS 9139; C14H13N3O4S2; VG2QF83CGL; CHEMBL599; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; MLS000028587; CHEBI:6741	C14H13N3O4S2	ZRVUJXDFFKFLMG-UHFFFAOYSA-N	4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide	n.a.	n.a.
PMDBD900	Warfarin	Therapeutic Substance; Herbal Substance	Approved Drug; Medicinal Herbal Compounds	81-81-2	DB00682	PA451906	n.a.	DAP000770	54678486	10442445	NPC2989	warfarin; 81-81-2; Coumadin; Coumafene; Coumafen; Prothromadin; Zoocoumarin; Coumarins; Vampirinip II; Panwarfin; Warfarine; Coumefene; Solfarin; Maveran; Kumader; Dethnel; Dethmor; Brumolin; Kypfarin; Kumadu; Rosex; Frass-Ratron; Athrombine-K; Mar-Frin; Rattentraenke; Temus W; Rodafarin; Warfarat; Rattunal; Ratorex; Kumatox; Ratron; Vampirinip iii; D-Con; Tox-hid; Rats-no-more; Ratten-Koederrohr; Rat-Trol; Rat-Gard; Rat-Kill; Rat-Ola; Rat-Mix; Ro-Deth; Rat-a-way; Coumaphene; Ratoxin; Rat &amp; mice bait; Martin's mar-frin; Rat-B-gon; Maag Rattentod Cum	C19H16O4	PJVWKTKQMONHTI-UHFFFAOYSA-N	4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one	Pharmaceutical Research Assoc Inc	Anticoagulants
PMDBD1145	Demeclocycline	Therapeutic substance	Drug	127-33-3	DB00618	PA164745513	D00290	DAP000402	54680690	10482117	n.a.	demeclocycline; Demethylchlortetracycline; DMCT; Ledermycin; Demethylchlortetracyclin; Declomycin; 6-Demethyl-7-chlorotetracycline; 127-33-3; 7-Chloro-6-demethyltetracycline; Novotriclina; Demeclocyclinum; Demeclociclina; Sumaclina; Diuciclin; Demetraclin; Demeclor; Perciclina; Demethylchlortetracyclinum; Demethylchlorotetracycline; Deganol; 6-Demethylchlorotetracycline; Tri-demethylchlortetracycline; Clortetrin; Mexocine; DMCT (antibiotic); DMCTC; Demeclocyclinum [INN-Latin]; Demeclociclina [INN-Spanish]; 6-Demethylchlortetracycline	C21H21ClN2O8	GUXHBMASAHGULD-SEYHBJAFSA-N	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	n.a.	n.a.
PMDBD1457	Tigecycline 	Therapeutic substance	Antibiotics	220620-09-7	DB00560	PA164746412	D01079	DAP000880	54686904	10482314	n.a.	Tigecycline; 220620-09-7; Tygacil; WAY-GAR-936; GAR-936; TBG-MINO; GAR 936; CHEBI:149836; Tigecycline hydrate; (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; UNII-70JE2N95KR; 70JE2N95KR; Tigecyclin; (4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1; (4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-diox	C29H39N5O8	SOVUOXKZCCAWOJ-HJYUBDRYSA-N	(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	n.a.	n.a.
PMDBD504	Lymecycline	Therapeutic Substance	Approved Drug	992-21-2	DB00256	PA164747190	D06884	DAP000881	54707177	20121315	n.a.	Lymecycline; N-Lysinomethyltetracycline; Lymecyclinum; Limeciclina; Tetralysal; Tetracycline-L-methylenelysine; Tetracycline-L-methylene lysine; 992-21-2; Mucomycin; UNII-7D6EM3S13P; Infaciclina; Ciclolysal; Vebicyclysal; Tetralisal; Lisinbiotic; Ciclisin; Armyl; 7D6EM3S13P; N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine; (+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydro	C29H38N4O10	PZTCVADFMACKLU-UEPZRUIBSA-N	(2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-aminohexanoic acid	n.a.	n.a.
PMDBD80	Auranofin	Therapeutic Substance	Approved Drug	34031-32-8	DB00995	PA448510	D00237	DAP000757	70788951	5293650	n.a.	Ridaura; AURANOFIN; Triethylphosphine gold; SK&amp;F-39162; SK-39162; 2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold; Auranofina; Auranofinum; Auranofine; Auroafen; CHEMBL1366; GTPL6306; CHEBI:2922; BDBM50153291; DB00995; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold2,3,4,6-tetraacetate; (2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-kappaS(1))(triethylphosphine)gold; gold(+1) cation; (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane	C20H35AuO9PS	IRPYFWIZKIOHQN-XTZHGVARSA-N	gold;(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphanium	n.a.	n.a.
PMDBD307	Epacadostat	Therapeutic Substance	Investigational Drug	1204669-58-8	DB11717	n.a.	n.a.	n.a.	135564890	34448418	n.a.	Epacadostat; 1204669-58-8; IDO inhibitor 1; 1204669-37-3; INCB 024360; Epacadostat (INCB024360); Epacadostat(INCB 024360); INCB-024360; UNII-71596A9R13; N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-{[2-(sulfamoylamino)ethyl]amino}-1,2,5-oxadiazole-3-carboximidamide; AK174791; 71596A9R13; (Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine; N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-[[2-(sulfamoylamino)ethyl]amino]-1,2,5-oxadiazole-3-carboximidamide; BBJ; Epacadostat [USAN:IN	C11H13BrFN7O4S	FBKMWOJEPMPVTQ-UHFFFAOYSA-N	N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboximidamide	n.a.	n.a.
PMDBD447	Insulin human	Therapeutic Substance	Approved Drug	11061-68-0	DB00030	PA164744571	D03230	DAP000802	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD452	Ipilimumab	Therapeutic Substance	Approved Drug	477202-00-9	DB06186	n.a.	D04603	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD487	Liraglutide	Therapeutic Substance	Approved Drug	204656-20-2	DB06655	PA165958364	D06404	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD449	Iocetamic acid	Therapeutic Substance	Approved Drug	16034-77-8	DB09403	n.a.	n.a.	n.a.	n.a.	25724	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD796	Soybean oil	Dietary Substance	Foods	8001-22-7	DB09422	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD147	Carboxymethylcellulose	Therapeutic Substance	Approved Drug	n.a.	DB11059	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD690	Polysorbate 80	Therapeutic Substance	Approved Drug	9005-65-6	DB11063	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD644	Pectin	Herbal Substance	Medicinal Herbal Compounds	9000-69-5	DB11158	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD906	Xylitol	Therapeutic Substance; Herbal Substance	 	87-99-0	DB11195	n.a.	D00061	n.a.	n.a.	6646	NPC197207	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD776	Sennosides	Therapeutic Substance	Investigational Drug	517-43-1	DB11365	n.a.	n.a.	n.a.	n.a.	5010	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD262	Diclazuril	Therapeutic Substance	Approved Drug (veterinary medicine)	101831-37-2	DB11398	n.a.	D03794	n.a.	n.a.	401855	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD305	Enrofloxacin	Therapeutic Substance	Investigational Drug	93106-60-6	DB11404	n.a.	D02473	n.a.	n.a.	64326	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD336	Fenbendazole	Therapeutic Substance	Approved Drug	43210-67-9	DB11410	n.a.	D04140	n.a.	n.a.	3217	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD354	Florfenicol	Therapeutic Substance	Approved Drug (veterinary medicine)	73231-34-2	DB11413	n.a.	D04194	n.a.	n.a.	102776	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD844	Thiostrepton	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	DB11467	n.a.	n.a.	n.a.	n.a.	10469505	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD342	Fentiazac	Therapeutic Substance	Approved Drug	18046-21-4	DB13217	n.a.	D01975	n.a.	n.a.	26854	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD867	Tribenoside	Therapeutic Substance	Approved Drug	10310-32-4	DB13227	n.a.	n.a.	n.a.	n.a.	169970	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD818	Suloctidil	Therapeutic Substance	Approved Drug	54767-75-8	DB13340	n.a.	n.a.	n.a.	n.a.	5036698	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD699	Pranoprofen	Therapeutic Substance	Approved Drug	52549-17-4	DB13514	n.a.	n.a.	n.a.	n.a.	4719	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD633	Oxolinic acid	Therapeutic Substance	Approved Drug	14698-29-4	DB13627	n.a.	D02301	n.a.	n.a.	4467	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD594	Niridazole	Therapeutic Substance	Approved Drug	61-57-4	DB13661	n.a.	n.a.	n.a.	n.a.	5868	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD407	Glycyrrhizic acid	Therapeutic Substance	Approved Drug	1405-86-3	DB13751	n.a.	D00157	n.a.	n.a.	14263	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD479	Lidoflazine	Therapeutic Substance	Approved Drug	3416-26-0	DB13766	PA165818137	n.a.	n.a.	n.a.	3789	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD759	Rufloxacin	Therapeutic Substance	Approved Drug	101363-10-4	DB13772	n.a.	D02474	n.a.	n.a.	52489	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD675	Pipemidic acid	Therapeutic Substance	Approved Drug	51940-44-4	DB13823	n.a.	n.a.	n.a.	n.a.	4665	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD589	Nifuroxazide	Therapeutic Substance	Approved Drug	965-52-6	DB13855	n.a.	n.a.	n.a.	n.a.	4495115	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD206	Clinafloxacin	Therapeutic Substance	Approved Drug	105956-97-6	DB14025	n.a.	D02539	n.a.	n.a.	54184	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD431	Hycanthone	Therapeutic Substance	Approved Drug	3105-97-3	DB14061	n.a.	D00541	n.a.	n.a.	3508	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD134	Butylparaben	Environmental Chemicals	Unclassified Substance	94-26-8	DB14084	n.a.	D01420	n.a.	n.a.	6916	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD790	Soy isoflavones	Dietary Substance	Dietary Compounds	n.a.	DB14101	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD832	Tenofovir	Therapeutic Substance	Investigational Drug	147127-20-6	DB14126	PA10204	n.a.	n.a.	n.a.	408154	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD397	Ginsenosides	Therapeutic Substance	Investigational Drug	74749-74-9	DB14152	n.a.	n.a.	n.a.	n.a.	2342730	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD405	Glycyrrhiza glabra	Herbal Substance	Medicinal Herb	84775-66-6	DB14312	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD770	Scutellaria baicalensis root	Therapeutic Substance	Investigational Drug	n.a.	DB14364	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD555	Mometasone furoate	Therapeutic Substance	Approved Drug	83919-23-7	DB14512	n.a.	D00690	n.a.	n.a.	390091	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD280	Diloxanide furoate	Therapeutic Substance	Approved Drug	3736-81-0	DB14638	n.a.	D02480	n.a.	n.a.	18400	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD492	Loperamide oxide	Therapeutic Substance	Investigational Drug	106900-12-3	DB14661	n.a.	n.a.	n.a.	n.a.	64511	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD253	Deleobuvir	Therapeutic Substance	Investigational Drug	863884-77-9	DB14850	PA166128130	n.a.	n.a.	n.a.	29773345	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD2	1-b-D-arabinofuranosyl-5-(E)-(2-bromovinyl)uracil	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD3	2,8-DHQ (including 2,4-DHQ)	Environmental Chemicals	Human Metabolite	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD4	2-amino-3,6-dihydro-3H-imidazo[4,5-f]quinoline	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD6	3,3-dimethyl-1-butanol	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	12233	n.a.	n.a.	3,3-Dimethylbutan-1-ol; 3,3-DIMETHYL-1-BUTANOL; 624-95-3; 3,3-Dimethylbutanol; Neohexanol; UNII-543OYD666T; tert-HEXYL ALCOHOL; 3,3-Dimethyl-butan-1-ol; EINECS 210-872-6; NSC 54158; CHEMBL25029; 543OYD666T; tert-Hexanol; NSC54158; PubChem3096; 3,3dimethyl-1-butanol; 3,3-dimethyl butan-1-ol; 1-Butanol, 3,3-dimethyl; ACMC-1B71I; SCHEMBL13695; KSC495S2N; DTXSID3060796; CTK3J5926; 3,3-Dimethyl-1-butanol, 98%; ACT02969; ZINC1685024; BCP21756; KS-000000BZ; BDBM50026474; ANW-34234; NSC-54158; BBL10	C6H14O	DUXCSEISVMREAX-UHFFFAOYSA-N	3,3-dimethylbutan-1-ol	n.a.	n.a.
PMDBD7	3,4-Dihydro-5-Methyl-Isoquinolinone	Therapeutic Substance	Investigational Drug	n.a.	n.a.	n.a.	n.a.	n.a.	148140	n.a.	n.a.	129075-56-5; 5-methyl-3,4-dihydroisoquinolin-1(2H)-one; 3,4-Dihydro-5-methyl-1(2H)-isoquinolinone; 3,4-DIHYDRO-5-METHYL-ISOQUINOLINONE; PD-128763; CHEBI:41928; PD128763; CHEMBL125200; 3,4-dihydro-5-methylisoquinolinone; 5-Methyl-3,4-dihydro-1(2H)-isoquinolinone; 5-methyl-1,2,3,4-tetrahydroisoquinolin-1-one; PD 128763; dihydroisoquinolinone, 1; 5-methyl- 3,4-dihydroisoquinolin-1(2H)-one; ACMC-1C7L4; SCHEMBL831538; AMBZ0075; CTK4B6146; BDBM2	C10H11NO	RLLZPXDJYADIEU-UHFFFAOYSA-N	5-methyl-3,4-dihydro-2H-isoquinolin-1-one	n.a.	n.a.
PMDBD8	5-fluorouracil	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3385	n.a.	n.a.	5-Fluorouracil; fluorouracil; 51-21-8; 5-FU; Fluoroplex; Efudex; Adrucil; Carac; Fluracil; 5-fluoropyrimidine-2,4(1H,3H)-dione; Fluoroblastin; Kecimeton; Carzonal; Timazin; Efudix; Arumel; Fluril; 5-Fluoracil; Queroplex; Fluracilum; Ulup; Phthoruracil; Fluro Uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Fluorouracilum; Ftoruracil; Efurix; Fluri; 5 Fluorouracil; 5-Fluoropyrimidine-2,4-dione; Effluderm (free base); Fluorouracilo; Fluroblastin; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4(1H,3H)-Pyrimidinedione, 5-fluo	C4H3FN2O2	GHASVSINZRGABV-UHFFFAOYSA-N	5-fluoro-1H-pyrimidine-2,4-dione	n.a.	n.a.
PMDBD10	Abacavir Sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441384	n.a.	n.a.	Abacavir sulfate; 188062-50-2; Ziagen; Abacavir sulphate; Abacavir (sulfate); 1592U89 sulfate; UNII-J220T4J9Q2; Abacavir Hemisulfate; J220T4J9Q2; 136777-48-5; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, sulfate (2:1); bis([(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl]methanol); sulfuric acid; HSDB 7154; Abacavir sulfate [USAN:USP]; bis({(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol) sulfate	C28H38N12O6S	WMHSRBZIJNQHKT-FFKFEZPRSA-N	[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;sulfuric acid	n.a.	n.a.
PMDBD11	Acacia catechu	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD13	Acecainide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4342	n.a.	n.a.	N-Acetylprocainamide; Acecainide; 32795-44-1; Acekainid; NAPA; Acecainida; Acecainidum; N-Acetyloprokainamid; Acecainide [INN]; Acekainid [Polish]; 4'-((2-(Diethylamino)ethyl)carbamoyl)acetanilide; Acecainidum [INN-Latin]; Acecainida [INN-Spanish]; N-Acetyloprokainamid [Polish]; UNII-910Q707V6F; CHEBI:60728; BRN 2868559; CHEMBL1097; MLS000069490; 4-acetamido-N-[2-(diethylamino)ethyl]benzamide; 910Q707V6F; SMR000059070	C15H23N3O2	KEECCEWTUVWFCV-UHFFFAOYSA-N	4-acetamido-N-[2-(diethylamino)ethyl]benzamide	n.a.	n.a.
PMDBD15	Acesulfame-potassium	Dietary Substance	Dietary Compounds; Artificial Sweetener	n.a.	n.a.	n.a.	n.a.	n.a.	23683747	n.a.	n.a.	Acesulfame potassium; Acesulfam-K; Potassium acesulfame; Hoe 095; UNII-23OV73Q5G9; CCRIS 1032; 23OV73Q5G9; EINECS 259-715-3; Acesulfame-K; H733293; Acesulfame potassium salt; 1,2,3-Oxathiazin-4(3H)-one, 6-methyl-, 2,2-dioxide, potassium salt; Acesulfame potassium [NF]; Potassium 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide; 6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide, potassium salt; Acesulfame-potassium; Acesulfam K; SCHEMBL17454392; LS-1366; EC 259-715-3; potassium 6-methyl-2,2-dioxo-4-oxathiazinolate; Q132037; A830716	C4H4KNO4S	WBZFUFAFFUEMEI-UHFFFAOYSA-M	potassium;6-methyl-2,2-dioxooxathiazin-4-olate	n.a.	n.a.
PMDBD17	Acetopromazine maleate salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6420038	n.a.	n.a.	Acepromazine maleate; 3598-37-6; Anatran; Acetopromazine maleate; Acetopromazine maleate salt; UNII-37862HP2OM; Notensil maleate; NSC 264522; 37862HP2OM; EINECS 222-748-9; DSSTox_CID_27763; DSSTox_RID_82540; DSSTox_GSID_47783; A 23051; Phenothiazine, 2-acetyl-10-(3-(dimethylamino)propyl)-, maleate; Maleate acide de l'acetyl 3-dimethylamino 3-propyl-10-phenothiazine; Maleate acide de l'acetyl 3-dimethylamino 3-propyl-10-phenothiazine [French]; SR-05000001648; NCGC00016634-01; Ethanone, 1-(10-(3-(dimethylamino)propyl)-10H-pheno	C23H26N2O5S	FQRHOOHLUYHMGG-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	n.a.	n.a.
PMDBD20	Activated soy pod fiber	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD21	Agaricus bisporus	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD24	Alexidine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	102678	n.a.	n.a.	Alexidine dihydrochloride; 1715-30-6; Alexidine HCl; ALEXIDINE HYDROCHLORIDE; Alexidine (dihydrochloride); UNII-I2A7616PY1; I2A7616PY1; N,N''-Bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride; NCGC00094996-01; 1,1'-Hexamethylenebis(5-(2-ethylhex-1-yl))biguanide dihydrochloride; DSSTox_CID_25881; DSSTox_RID_81197; DSSTox_GSID_45881; 2,4,11,13-Tetraazatetradecanediimidamide, N1,N14-bis(2-ethylhexyl)-3,12-diimino-, hydrochloride (1:2); 2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(2	C26H58Cl2N10	BRJJFBHTDVWTCJ-UHFFFAOYSA-N	1-[N'-[6-[[amino-[[N'-(2-ethylhexyl)carbamimidoyl]amino]methylidene]amino]hexyl]carbamimidoyl]-2-(2-ethylhexyl)guanidine;dihydrochloride	n.a.	n.a.
PMDBD27	Aloe vera	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD31	Alverine citrate salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	21718	n.a.	n.a.	ALVERINE CITRATE; 5560-59-8; Alverine (citrate); Antispasmin; Spacolin; ALVERINE CITRATE SALT; Gamatran citrate; NSC 35459; Alverine dihydrogen citrate; UNII-9JFB58YK1E; NCI 85x; 9JFB58YK1E; MLS000069524; CHEBI:53785; N-Ethyl-3,3'-diphenyldipropylamine citrate (1:1); NSC-35459; NCGC00017047-01; SMR000058631; CAS-5560-59-8; DSSTox_CID_25562; DSSTox_RID_80959; DSSTox_GSID_45562; N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate; SR-01000003029; Alverine citrate [USAN:NF]; Alverrine citrate; Alveri	C26H35NO7	RYHCACJBKCOBTJ-UHFFFAOYSA-N	N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acid	n.a.	n.a.
PMDBD33	Amethopterin (R,S)	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4112	n.a.	n.a.	Amethopterin; DL-Amethopterin; 60388-53-6; (+)-Amethopterin; Mexate; DL-Methotrexate; Methylaminopterin; (+/-)Amethopterin; Abitrexate; Ledertrexate; TCMDC-123832; 6-Mtx (DL); METHOTREXATE(+/-); Amethopterin (R,S); EINECS 262-213-7; Antifolan; MLS002701970; N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid; N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid; NSC 117356	C20H22N8O5	FBOZXECLQNJBKD-UHFFFAOYSA-N	2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid	n.a.	n.a.
PMDBD34	Amikacin hydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	16218899	n.a.	n.a.	Amikacin hydrate; MLS002207279; 1257517-67-1; SMR001306795; SCHEMBL2172496; CHEMBL1879513; BDBM91426; cid_16218899; C22H43N5O13.H2O; 2212AH; Amikacin hydrate, aminoglycoside antibiotic; 1257517-67-1,37517-28-5(freebase)	C22H45N5O14	DTSOZYYWEZJFSS-XTHCGPPUSA-N	(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;hydrate	n.a.	n.a.
PMDBD37	Amiodarone hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441325	n.a.	n.a.	Amiodarone hydrochloride; 19774-82-4; Amiodarone HCL; Nexterone; Amiodar; Uro-Septra; Amiodarone (hydrochloride); Pacerone; Rythmarone; Ritmocardyl; Trangorex; Miodrone; Atlansil; Renodoron; Cordarex; Angoron; Amiodaronum hydrochloride; UNII-976728SY6Z; 51087 N HCl; (2-Butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)methanone hydrochloride; MLS000028520; L 3428 labaz; NSC-85442; 976728SY6Z; HSDB 6525; SMR000058296; SKF 33134-A; SKF 33134 A; EINECS 243-293-2; NSC 85442; DSSTox_CID_17185; DSSTox_RID_79304; DSSTox_GSID_3718	C25H30ClI2NO3	ITPDYQOUSLNIHG-UHFFFAOYSA-N	(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone;hydrochloride	n.a.	n.a.
PMDBD38	Amiprilose hydrochloride	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	9798098	n.a.	n.a.	amiprilose; Therafectin; AMIPRILOSE HYDROCHLORIDE; Amiprilose HCl; 60414-06-4; UNII-546994B3VA; SM-1213 (Free base); Amiprilose hydrochloride [USAN]; 56824-20-5; 546994B3VA; Amiprilose hydrochloride (USAN); Therafectin (TN); MLS002154029; CHEMBL1256946; AKOS016010143; AKOS015845775; CCG-220845; 3-O-(3-(Dimethylamino)propyl)-1,2-O-isopropylidene-alpha-D-glucofuranose hydrochloride; AK115821; SMR001233356; AX8053495; D02911; 414A064; Q27261179; alpha-D-Glucofuranose, 3-O-(3-(dimethylamino)propyl)-1,2-O-(1-methylethylidene)-, hydroch	C14H28ClNO6	RJNRORZRFGUAKL-ADMBVFOFSA-N	(1R)-1-[(3aR,5R,6S,6aR)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol;hydrochloride	n.a.	n.a.
PMDBD40	Amodiaquin dihydrochloride dihydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64646	n.a.	n.a.	Amodiaquin dihydrochloride dihydrate; 6398-98-7; Amodiaquine dihydrochloride dihydrate; Amodiaquine hydrochloride; UNII-K6PW2S574L; Amodiaquin (dihydrochloride dihydrate); 4-((7-Chloroquinolin-4-yl)amino)-2-((diethylamino)methyl)phenol dihydrochloride dihydrate; K6PW2S574L; Amodiaquine hydrochloride [USP]; NCGC00017063-01; AK164307; CAS-6398-98-7; Amodiaquine hydrochloride (USP); 4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;dihydrate;dihydrochloride; CHEBI:50652; CAM-AQ 1; Amodiaquin dihydrochlorid-2-wasse	C20H28Cl3N3O3	YVNAYSHNIILOJS-UHFFFAOYSA-N	4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;dihydrate;dihydrochloride	n.a.	n.a.
PMDBD43	Ampicillin trihydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23565	n.a.	n.a.	AMPICILLIN TRIHYDRATE; 7177-48-2; Aminobenzylpenicillin trihydrate; Trafarbiot; Amperil; Ampinova; Cymbi; Amcap; Ampicillin 3-wasser; UNII-HXQ6A1N7R6; alpha-Aminobenzylpenicillin trihydrate; CCRIS 267; NCI-C56086; HXQ6A1N7R6; CHEBI:31209; (D-(-)-alpha-Aminobenzyl)penicillin trihydrate; vidopen; Principen '125'; AMPICILLIN/AMPICILLIN TRIHYDRATE; Principen '250'; Principen '500'; (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate; C16H25N3O7S; OMNIPEN 	C16H25N3O7S	RXDALBZNGVATNY-CWLIKTDRSA-N	(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate	n.a.	n.a.
PMDBD47	Anethole-trithione	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	637563	n.a.	n.a.	ANETHOLE; trans-Anethole; 4180-23-8; 104-46-1; (E)-Anethole; p-Propenylanisole; Anise camphor; cis-Anethol; Isoestragole; Anethol; trans-Anethol; p-Anethole; Oil of aniseed; Monasirup; (E)-Anethol; 4-Propenylanisole; Aniskampfer; trans-p-Propenylanisole; (E)-p-Propenylanisole; p-1-Propenylanisole; (E)-1-Methoxy-4-(prop-1-en-1-yl)benzene; (E)-1-(4-Methoxyphenyl)propene; Nauli gum; trans-4-(1-Propenyl)anisole; trans-p-Anethole; 1-methoxy-4-[(1E)-prop-1-en-1-yl]benzene; (E)-1-Methoxy-4-(1-propenyl)benzene; trans-p-Metho	C10H12O	RUVINXPYWBROJD-ONEGZZNKSA-N	1-methoxy-4-[(E)-prop-1-enyl]benzene	n.a.	n.a.
PMDBD48	Anthocyanidins	Herbal Substance	Plant Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD50	Anti-PD-L1 therapy	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD51	Anti-TNF antibobies	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD52	Antibiotic	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD53	Antibiotic (extensive treatment)	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD54	Anticancer drugs	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD55	Antidiabetic drugs	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD56	Antiobiotics	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD57	Anti‑PD1 therapy	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD58	Antrodia cinnamomea	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD60	Apple juice	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD61	Apple juice colloid	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD64	Aqueous soy extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD65	Aqueous soy extract (fermented soy product)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD66	Aqueous soy extract (hypecholesterolemic plus unfermented soy product)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD67	Aqueous soy extract (hypercholesterolemic plus isoflavone-supplemented fermented soy product)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD68	Arabinoxylan-oligosaccharides	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD70	Arsenic	Environmental Chemicals	Toxic Agents; Heavy Metals	n.a.	n.a.	n.a.	n.a.	n.a.	5359596	n.a.	n.a.	7440-38-2; As; Arsenic; Arsenicals; Arsenic compounds; Arsenic, inorganic; Arsenic-75; Arsen; Grey arsenic; Gray arsenic; Arsenic Black; Metallic arsenic; Colloidal arsenic; Agent SA; Arsenic, elemental; Arsenowodor [Polish]; Arsen [German,Polish]; Arsenic hydride (AsH3); Arsenwasserstoff [German]; UNII-V1I29R0RJQ; CCRIS 55; Arsenic and arsenic compounds; UNII-N712M78A8G; HSDB 510; HSDB 509; EINECS 232-066-3; EINECS 231-148-6; UN2188; UN1558; Arsenic, organic compounds; UN 2188; V1I29R0RJQ; N712M78A8G; Arsenic and certain arsenic compounds	As	RQNWIZPPADIBDY-UHFFFAOYSA-N	arsenic	n.a.	n.a.
PMDBD72	Artificial sweetener cyclamate	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD73	Aryl hydrocarbon receptor activator	Environmental Chemicals	Industrial Chemicals and Pollutants; Toxic Agents	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD74	Asenapine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6917875	n.a.	n.a.	Asenapine maleate; 85650-56-2; Saphris; Asenapine (maleate); Org 5222; Sycrest; Org-5222; 1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-, trans-, (Z)-2-butenedioate (1:1); trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole maleate; Asenapine maleate [USAN]; Asenapine/; C17H16ClNO.C4H4O4; Saphris (TN); EINECS 288-064-8; trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole maleate; (S,S)-Asenapine Maleate; SCHEMBL175228; Ase	C21H20ClNO5	GMDCDXMAFMEDAG-CHHFXETESA-N	(Z)-but-2-enedioic acid;(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene	n.a.	n.a.
PMDBD77	Astragali radix	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD81	Avermectin B1a	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6434889	n.a.	n.a.	AVERMECTIN B1A; 65195-55-3; abamectin component B1a; Abamectin B1a; Avermectin B(1)a; Abamectine [French]; Abamectinum [Latin]; Abamectina [Spanish]; Caswell No. 063AB; Antibiotic C 076B1a; Abamectin komponente B1a; 5-O-Demethylavermectin A1a; UNII-K54ZMM929K; Avermectin; EINECS 265-610-3; K54ZMM929K; CHEBI:29534; DSSTox_CID_3892; DSSTox_RID_77221; DSSTox_GSID_23892; Abamectina; Abamectine; C48H72O14; Abamectin / Avermectin B1A; Ab	C48H72O14	RRZXIRBKKLTSOM-XPNPUAGNSA-N	(1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-[(2S)-butan-2-yl]-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one	n.a.	n.a.
PMDBD82	Azacytidine-5	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6420049	n.a.	n.a.	Azacytidine-5; Prestwick_972; Prestwick1_000866; Prestwick2_000866; Prestwick0_000866; SPBio_002832; SCHEMBL16187746; HMS1570N13	C8H12N4O5	NMUSYJAQQFHJEW-OEXCPVAWSA-N	4-amino-1-[(3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one	n.a.	n.a.
PMDBD83	Azaguanine-8	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	135403646	n.a.	n.a.	8-AZAGUANINE; 134-58-7; Azaguanine-8; Guanazolo; Azaguanine; Pathocidine; Pathocidin; Guanazol; Triazologuanine; Azan; 8 AG; NSC-749; SK 1150; 5-Amino-1H-v-triazolo(d)pyrimidin-7-ol; AZG; 5-Amino-7-hydroxy-1H-v-triazolo(d)pyrimidine; 5-Amino-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one; SF-337; 5-Amino-1,6-dihydro-7H-v-triazolo(4,5-d)pyrimidin-7-one; 5-amino-1H-triazolo[4,5-d]pyrimidin-7-ol; 5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one; 5-Amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol; 7H-1,2,3-Triazolo[4,5-d]pyrim	C4H4N6O	LPXQRXLUHJKZIE-UHFFFAOYSA-N	5-amino-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one	n.a.	n.a.
PMDBD86	Azelastine HCl	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54360	n.a.	n.a.	AZELASTINE HYDROCHLORIDE; AZELASTINE HCl; 79307-93-0; Astelin; Optivar; Allergodil; Rhinolast; Azeptin; Azelastine (hydrochloride); Astepro; Optilast; W-2979M; E-0659; CHEBI:2951; 37932-96-0; A-5610; A 5610; 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one hydrochloride; Azelastine hydrochloride [USAN:JAN]; NCGC00095173-01; DSSTox_RID_81243; 4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone monohydrochloride; DSSTox_CID_25945	C22H25Cl2N3O	YEJAJYAHJQIWNU-UHFFFAOYSA-N	4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride	n.a.	n.a.
PMDBD87	Azetirelin	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	65841	n.a.	n.a.	Azetirelin; 95729-65-0; UNII-70J5AWG54Q; 70J5AWG54Q; Azetirelinum; Azetireline; Azetirelina; Azetirelin [INN]; YM-14673; Azetirelinum [INN-Latin]; Azetireline [INN-French]; Azetirelina [INN-Spanish]; SCHEMBL195158; CHEMBL2104559; DTXSID20241938; Q27265867; (-)-N-(((2S)-4-Oxo-2-azetidinyl)carbonyl)-L-histidyl-L-prolinamide; Nalpha-[(S)-4-OXO-AZETIDINE-2-CARBONYL]-L-HISTIDYL-L-PROLINAMIDE	C15H20N6O4	WBGUMUGCONUXFK-DCAQKATOSA-N	(2S)-1-[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxamide	n.a.	n.a.
PMDBD89	Azlocillin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23685176	n.a.	n.a.	AZLOCILLIN SODIUM; Azlocillin sodium salt; Securopen; Azlin; 37091-65-9; Monosodium azlocillin; Azlocillin (sodium salt); UNII-DWV1EFW947; Sodium azlocillin; CHEBI:51864; DWV1EFW947; C20H22N5O6SNa; EINECS 253-347-7; Azlocillin sodium [USP]; Sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-((R)-2-(2-oxo-1-imidazolidinecarboxamido)-2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Azlin (TN); SCHEMBL192700; CHEMBL1201041; HY-B0529A; HMS3714F03; HMS2097F03	C20H22N5NaO6S	UVOCNBWUHNCKJM-XFAPPKAWSA-M	sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD90	Azo dyes	Environmental Chemicals	Industrial Chemicals and Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD92	B-GOSr (prebiotic oligosaccharide)	Therapeutic Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD93	Bacampicillin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441398	n.a.	n.a.	Bacampicillin hydrochloride; 37661-08-8; bacampicillin HCl; Spectrobid; Bacampicillin (hydrochloride); Bacampicillin hydrochoride; BAPC; Ambaxin; Velbacil; Penglobe; Bacacil; Ambacamp; CHEBI:2969; DSSTox_CID_25466; DSSTox_RID_80897; DSSTox_GSID_45466; EINECS 253-580-4; UNII-PM034U953T; C21H27N3O7S.HCl; Spectrobid (TN)	C21H28ClN3O7S	IWVTXAGTHUECPN-ANBBSHPLSA-N	1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride	n.a.	n.a.
PMDBD97	Bawei Xileisan	Herbal Substance	TCM Formula	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD99	Benfluorex hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	198015	n.a.	n.a.	Benfluorex hydrochloride; 23642-66-2; Mediaxal; Lipophoral; Balans; Benfluorex (hydrochloride); EINECS 245-801-8; NCGC00094832-01; 2-(alpha-Methyl-3-(trifluoromethyl)phenylethylamino)ethyl benzoat; DSSTox_CID_25854; DSSTox_RID_81175; 2-[[1-Methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl benzoate hydrochloride; DSSTox_GSID_45854; W-110575; 2-((alpha-Methyl-m-(trifluoromethyl)phenethyl)amino)ethanol benzoate (ester); Benfluorex HCl; 2-{(1-METHYL-2-[3-(TRIFLUOROMETHYL)PHENYL]ETHYL}AMINO)ETHYL BENZOATE HYDROCHLORIDE; 2-((	C19H21ClF3NO2	NLOALSPYZIIXEO-UHFFFAOYSA-N	2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl benzoate;hydrochloride	n.a.	n.a.
PMDBD100	Benzathine benzylpenicillin	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	15232	n.a.	n.a.	1538-09-6; Benzathine benzylpenicillin; Penduran; Pendepon; Debecillin; BENZATHINE PENICILLIN G; Dibencillin; Diaminocillina; Benzethacil; Lentocillin; Extenicilline; Benzacillin; Longacilina; Penidure; Penditan; Duropenin; Wycillina; Longicil; Leomypen; Benzapen; Moldamin; Durabiotic; Debecylina; Penadur; Dibencil; Cillenta; Neolin; Bica-penicillin; Dura-penita; Bicillin I; Diamine penicillin; Bicillin 1; Penadur L-A; Pen-Di-Ben; Megacillin suspension; Benzathin penicillin G; Penicillin G, benzathine; UNII-SSZ1S4I0US; Benzylpenicillinum benzat	C48H56N6O8S2	BVGLIYRKPOITBQ-ANPZCEIESA-N	N,N'-dibenzylethane-1,2-diamine;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD102	Benzethonium chloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	8478	n.a.	n.a.	benzethonium chloride; 121-54-0; Quatrachlor; Phemeride; Hyamine; Benzethoniumchloride; Phemerol Chloride; Hyamine 1622; Phemithyn; Kylacol; Disilyn; Solamin; Diapp; Polymine D; Benzetonium chloride; Anti-germ 77; Benzethonii chloridum; Antiseptol; Cloruro de benzetonio; Banagerm; Chlorure de benzethonium; Inactisol; Benzethonium chloride 1622; Microklenz; Benzethoni chloridum; UNII-PH41D05744; p-tert-Octylphenoxyethoxyethyldimethylbenzylammonium chloride; MFCD00011742; Formula 144; Benzethonium chloride, 97%; Phemerol chloride monohydr	C27H42ClNO2	UREZNYTWGJKWBI-UHFFFAOYSA-M	benzyl-dimethyl-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride	n.a.	n.a.
PMDBD104	Benzydamine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	65464	n.a.	n.a.	Benzydamine hydrochloride; 132-69-4; Benzydamine HCl; Benzindamine hydrochloride; Benzidamine hydrochloride; Benalgin; Epirotin; Enzamin; Dorinamin; Difflam; Benzidan; Salyzoron; Ririlim; Oxinazin; Imotryl; Benzyrin; Riripen; Indolin; Flogaton; Tantum; Tamas; Verax; Benzydamine (hydrochloride); UNII-K2GI407R4Q; EINECS 205-076-0; AF 864; Benzydamine hydrochloride [USAN:JAN]; K2GI407R4Q; AF-864; 1-Benzyl-3-gamma-dimethylaminopropoxy-1H-indazole hydrochloride; 1-benzyl-3-(3-[dimethylamino]propoxy)-1h-indazole hydrochloride; 1-Benzyl-3-(3-(d	C19H24ClN3O	HNNIWKQLJSNAEQ-UHFFFAOYSA-N	3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine;hydrochloride	n.a.	n.a.
PMDBD105	Benzylpenicillin sodium	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23668834	n.a.	n.a.	Penicillin G sodium; Penicillin G sodium salt; 69-57-8; Benzylpenicillin sodium; Crystapen; American penicillin; Pencillin G sodium; Sodium penicillin G; BENZYLPENICILLIN SODIUM SALT; Sodium benzylpenicillinate; Sodium penicillin II; Veticillin; Penilaryn; Mycofarm; Novocillin; Sodium penicillin; Kesso-Pen; Pen-A-Brasive; Sodium benzylpenicillin G; Monosodium benzylpenicillin; Benzylpenicillinic acid sodium salt; Sodium benzylpenicillin; Penicillin G, sodium; Sugracillin sodium salt; Penicillin G Sodium, Crystalline; Sodium benzylp	C16H17N2NaO4S	FCPVYOBCFFNJFS-LQDWTQKMSA-M	sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD106	Bepridil hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	50088	n.a.	n.a.	BEPRIDIL HYDROCHLORIDE; Bepridil HCl; 68099-86-5; Vascor; 74764-40-2; 1978CERM; EINECS 268-472-2; MLS000028456; 1-Isobutoxy-2-pyrrolidino-3-(N-benzylanilino)propane hydrochloride; CERM 1978; SMR000058419; 1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, monohydrochloride; Bepridil hydrochloride hydrate; N-Benzyl-beta-((2-methylpropoxy)methyl)-N-phenylpyrrolidine-1-ethylamine monohydrochloride; CHEBI:52712; SR-01000075304; Prestwick_697; Opera_ID_594; Bepridil Monohydrochloride; C24H34N2O.HCl	C24H35ClN2O	JXBBWYGMTNAYNM-UHFFFAOYSA-N	N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline;hydrochloride	n.a.	n.a.
PMDBD108	Betamethasone acetate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	443967	n.a.	n.a.	BETAMETHASONE ACETATE; 987-24-6; Betamethasone 21-acetate; beta-Methasone acetate; UNII-TI05AO53L7; TI05AO53L7; CHEBI:31275; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-acetate; (11beta,16beta)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate; [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; EINECS 213-578-6; 9-fluoro-11beta,17-dihydroxy-16be	C24H31FO6	AKUJBENLRBOFTD-QZIXMDIESA-N	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	n.a.	n.a.
PMDBD109	Betamethasone valerate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	16533	n.a.	n.a.	BETAMETHASONE VALERATE; Betnovate; Betamethasone 17-valerate; 2152-44-5; Betaderm; Luxiq; beta-Val; Celestoderm; Bextasol; Betatrex; Bedermin; Valnac; Dermovaleas; Betnovateat; Betneval; Tokuderm; Dermosol; beta-Methasone 17-valerate; Betamethasone-17-valerate; Ecoval 70; Topagen (Veterinary); Gentocin (Veterinary); UNII-9IFA5XM7R2; 9IFA5XM7R2; CHEBI:31277; C27H37FO6; Betamethasone valerate (Betnovate); EINECS 218-439-3; [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,1	C27H37FO6	SNHRLVCMMWUAJD-SUYDQAKGSA-N	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate	n.a.	n.a.
PMDBD110	Betaxolol hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	107952	n.a.	n.a.	Betaxolol hydrochloride; 63659-19-8; Betaxolol HCL; Betoptima; Lokren; Kerlone; Betaxolol (hydrochloride); Betoptic; Kerlon; Betaxolo Hydrochloride; Betoptic S; Betaxolol hydrochloride (Betoptic); EINECS 264-384-3; alo 1401-02; MLS000863279; SL 75 212-10; 1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride; SMR000058420; SL 75.212-10; 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride; 1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol	C18H30ClNO3	CHDPSNLJFOQTRK-UHFFFAOYSA-N	1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride	n.a.	n.a.
PMDBD114	BILR355	Therapeutic Substance	Investigational Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3010663	n.a.	n.a.	BILR 355; 380378-81-4; CHEMBL1630842; BILR-355; UNII-V7T28EEE1C; BILR355; V7T28EEE1C; BILR 355 BS; DIP007; SCHEMBL5080040; CTK4H9172; DTXSID30191455; ZINC593585; BDBM50058303; 11-ethyl-5-methyl-8-[2-(1-oxidoquinolin-1-ium-4-yl)oxyethyl]dipyrido[[?],[?]][1,4]diazepin-6-one; 5,11-Dihydro-11-e	C25H23N5O3	BEMBRAMZGVDPMH-UHFFFAOYSA-N	2-ethyl-9-methyl-13-[2-(1-oxidoquinolin-1-ium-4-yl)oxyethyl]-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one	n.a.	n.a.
PMDBD119	Black tea	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD120	Black tea extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD125	Bromocriptine mesylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	31100	n.a.	n.a.	BROMOCRIPTINE MESYLATE; Bromocriptine mesilate; Bromocryptine mesylate; Pravidel; Parlodel; 22260-51-1; Bagren; Bromergon; CB-154 mesylate; Bromocriptine methanesulfonate; (+)-Bromocriptine methanesulfonate; UNII-FFP983J3OD; 2-Bromo-alpha-ergocryptine mesylate; Bromocryptine methanesulfonate; CB 154; Bromocriptine (mesylate); EINECS 244-881-1; FFP983J3OD; 2-Bromo-alpha-ergocryptine methanesulfonate; CHEBI:3182; 2-Bromine-alpha-ergocryptine methanesulfonate; 2-Bromo-alpha-ergokryptine-mesilate [German]; CB-154; 2-Bromoergocryptine	C33H44BrN5O8S	NOJMTMIRQRDZMT-GSPXQYRGSA-N	(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid	n.a.	n.a.
PMDBD132	Butenafine Hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	443867	n.a.	n.a.	Butenafine hydrochloride; 101827-46-7; Butenafine HCL; Mentax; KP-363; Butenafine (Hydrochloride); UNII-R8XA2029ZI; CHEBI:31325; N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride; Mentax-TC; R8XA2029ZI; 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine hydrochloride; 1-Naphthalenemethanamine, N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-, hydrochloride (1:1); N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-1-naphthalenemethanamine hydrochloride; N-(4-(tert-butyl)benzyl)-N-meth	C23H28ClN	LJBSAUIFGPSHCN-UHFFFAOYSA-N	1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine;hydrochloride	n.a.	n.a.
PMDBD133	Butoconazole nitrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	47471	n.a.	n.a.	BUTOCONAZOLE NITRATE; 64872-77-1; Femstat; Gynomyk; Gynazole-1; Mycelex-3; Exelgyn; Femstat One; Femstat 3; RS-35887; Butoconazole (nitrate); Butaconazole nitrate; RS 35887; CHEBI:3241; C19H17Cl3N2S.HNO3; RS-35887-00-10-3; (+-)-1-(4-(p-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)imidazole mononitrate; (+-)-1-(4-(4-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1H-imidazole mononitrate; AK164492; DSSTox_RID_80888; DSSTox_CID_25452; 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole;nitric acid; DSSTox_GSID_	C19H18Cl3N3O3S	ZHPWRQIPPNZNML-UHFFFAOYSA-N	1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole;nitric acid	n.a.	n.a.
PMDBD137	Calcitonin	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	16220016	n.a.	n.a.	Calcitonin-salmon; Thyrocalcitonin (salmon); Cibacalcin; Salmon calcitonin; Tonocalcin; Salcatonin; Calcimonta; Salmocalcin; Porostenina; Osseocalcina; Miracalcic; Cibacalcine; Calcitoran; Ostostabil; Calcihexal; Bionocalcin; Rulicalcin; Prontocalcin; Eptacalcin; Staporos; Stalcin; Salcatyn; Ostosalm; Osteobion; Miacalcin; Citonina; Riostin; Oseototal; Catonin; Calcinil; Biocalcin; Salmofar; Quosten; Osteovis; Kalsimin; Ipocalcin; Calsynar; Calogen; Calcioton; Astronin; Steocin; Caltine; Calciben; Salcat; Ucecal; Casalm; Cadens; Karil; Sical; Calco; Isi-ca	C145H240N44O48S2	BBBFJLBPOGFECG-VJVYQDLKSA-N	(4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-oxoethyl)-7-[(1R)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amin	n.a.	n.a.
PMDBD138	Calycosin-7-O-b-D-glucoside	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD139	Camellia sinensis	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD140	Camylofine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23724817	n.a.	n.a.	5892-41-1; camylofin dihydrochloride; Camylofin hydrochloride; Camylofine dihydrochloride; W-110066; Acamylophenine hydrochloride (JAN); Camylofin Chlorhydrate; Camylophenine dihydrochloride; C19H34Cl2N2O2; SCHEMBL12481408; CHEMBL4303602; CTK8J4872; CHEBI:31158; DTXSID70974421; ZX-AT013334; 3-Methylbutyl {[2-(diethylamino)ethyl]amino}(phenyl)acetate dihydrochloride; OR60053; CCG-213987; W0021; SW220091-1; D01759; SR-01000872770; SR-01000872770-1; Q23766546; Camylofine dihydrochloride, analytical standard, for drug analysis; Isopent	C19H34Cl2N2O2	ZHRVNCCPAKIGRH-UHFFFAOYSA-N	3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate;dihydrochloride	n.a.	n.a.
PMDBD144	Carbadox	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	135511839	n.a.	n.a.	CARBADOX; 6804-07-5; Mecadox; Getroxel; MLS001333201; SMR000857182; (E)-2-((2-(methoxycarbonyl)hydrazono)methyl)quinoxaline 1,4-dioxide; Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-,methyl ester; DSSTox_CID_23913; DSSTox_RID_80088; DSSTox_GSID_43913; Fortigro; W-104691; C11H10N4O4; Fortrigo; Karbadox [Czech]; N-[(E)-(1-hydroxy-4-oxido-quinoxalin-4-ium-2-ylidene)methyl]iminocarbamic acid methyl ester; CAS-6804-07-5; Carbadoxum [INN-Latin]; SR-05000001715; Carbadox [USAN:INN:BAN]; CCRIS 3002; HSDB 7028; EINECS	C11H10N4O4	OVGGLBAWFMIPPY-WUXMJOGZSA-N	methyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate	n.a.	n.a.
PMDBD145	Carbenoxolone disodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	636402	n.a.	n.a.	CARBENOXOLONE SODIUM; Biogastrone; Carbenoxolone disodium; Bioral; Duogastrone; Sanodin; 7421-40-1; UNII-F1MP7242Z5; Gastrausil; Neogel; Berkobiogastrone; Ulcus-tablinen; Carbenoxolone disodium salt; Terulcon tabletten; F1MP7242Z5; Sodium carbenoxolone; Carbenoxolon dinatrium; Carbenoxolon-dinatrium; Carbenoxolone, disodium salt; DSSTox_RID_80969; DSSTox_CID_25572; DSSTox_GSID_45572; Disodium glycyrrhetinyl succina; Carbenoxolone sodium [USAN:JAN]; EINECS 231-044-0; Glycyrrhetinic acid hydrogen succinate, disodium salt; Bioplex; 18-b	C34H48Na2O7	BQENDLAVTKRQMS-SBBGFIFASA-L	disodium;(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxylatopropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate	n.a.	n.a.
PMDBD146	Carbetapentane citrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	90010	n.a.	n.a.	Carbetapentane citrate; Pentoxyverine citrate; 23142-01-0; Loucarbate; Pentoxiverine citrate; Carbetapentane citrate salt; Toclase; Toclase citrate; Carbetapentane (citrate); Carbetapentone citrate; UNII-4SH0MFJ5HJ; Carbetapentane citrate [NF]; EINECS 245-449-5; 4SH0MFJ5HJ; 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate citrate; 2-(2(Diethylamino)ethoxy)ethyl 1-phenyl-cyclopentanecarboxylate citrate (1:1); Ethanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester) citrate; 2-(2-(Diethylamin	C26H39NO10	AKJDEXBCRLOVTH-UHFFFAOYSA-N	2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid	n.a.	n.a.
PMDBD149	Carmustine, Etoposide, Cytarabine and melphalan combination	Therapeutic Substance	Drug Combination	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD152	CB954	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD153	Cefaclor hydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	51038	n.a.	n.a.	Cefaclor monohydrate; 70356-03-5; Cefaclor hydrate; Distaclor; Ceclor; Panacef; Kefolor; Alfatil; Alfatil Kapseln; Compound 99638; Muco Panoral; Kefolor Suspension; Cefaclor-1-wasser; Panoral; Lilly 99638 hydrate; Raniclor; UNII-69K7K19H4L; Cefaclor (monohydrate); 69K7K19H4L; Ceclor CD; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; Cefachlor; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2	C15H16ClN3O5S	WKJGTOYAEQDNIA-IOOZKYRYSA-N	(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate	n.a.	n.a.
PMDBD155	Cefazolin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23675322	n.a.	n.a.	CEFAZOLIN SODIUM; 27164-46-1; Cefazoline sodium; Cefazolin sodium salt; Ancef; Zolicef; Kefzol; Sodium cefazolin; Sodium cephazolin; Cefazil; Monosodium cefazolin; Cefazolin (sodium); Totacef; Cefamedin; Gramaxin; Biazolina; CEFAZOLIN AND DEXTROSE; CHEBI:3483; UNII-P380M0454Z; Cephazolin Sodium; Sodium CEZ; Cefalomicina; Cefabiozim; Zolisint; Neofazol; Cefacidal; Lampocef; Zolin; Recef; MLS000028706; Bor-Cefazol; CEZ sodium; Firmacef; Cefazina; Liviclina; Atirin; P380M0454Z; SMR000058708; Lilly 46083; SKF 41558; SK&amp;F-41558; ANCEF IN PLASTIC CO	C14H13N8NaO4S3	FLKYBGKDCCEQQM-WYUVZMMLSA-M	sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD157	Cefepime hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	9571075	n.a.	n.a.	Cefepime HCl; Cefepime hydrochloride; 123171-59-5; Cefepime hydrochloride monohydrate; Cefepime (Dihydrochloride Monohydrate); Cefepime chloride hydrochloride hydrate; Cefepime dihydrochloride hydrate; CHEBI:31368; BMY-28142 2HCl.H2O; UNII-I8X1O0607P; CFPM; cefepime dihydrochloride; cefepime dihydrochloride monohydrate; I8X1O0607P; BMY 28142 2HCl.H2O; cefepime hydrochloride hydrate; Cefepime In Plastic Container; Cefepime hydrochloride [USAN:USP]; Maxipime (TN); NCGC00017147-01; DSSTox_RID_80996; DSSTox_CID_25603; DSSTox_GSID_45	C19H28Cl2N6O6S2	LRAJHPGSGBRUJN-OMIVUECESA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride	n.a.	n.a.
PMDBD159	Cefmetazole sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23666711	n.a.	n.a.	CEFMETAZOLE SODIUM; 56796-39-5; Zefazone; Cefmetazon; CEFMETAZOLE SODIUM SALT; CMZ sodium; CS 1170 sodium; SKF 83088 sodium; Cefmetazole (sodium); cefmetazone; UNII-37Y9VR4W7A; Zefazone In Plastic Container; CHEBI:3490; U 72791A; Metafar; 37Y9VR4W7A; Sodium cefmetazole; U-72791A; DSSTox_RID_80985; DSSTox_CID_25590; DSSTox_GSID_45590; Sodium (6R,7S)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; CMZ; 5-Thia-1-azabicyclo(4.2.0)oct-2-e	C15H16N7NaO5S3	BITQGIOJQWZUPL-PBCQUBLHSA-M	sodium;(6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD161	Cefoperazone dihydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6420003	n.a.	n.a.	Cefoperazone dihydrate; 113826-44-1; Prestwick_735; SCHEMBL3758644; CHEMBL1697715; DTXSID70423565; HMS2096A15; HMS3713A15; HMS1569A15; CCG-220327; Cefoperazone dihydrate, VETRANAL(TM), analytical standard; Cefoperazone dihydrate, United States Pharmacopeia (USP) Reference Standard; Cefoperazone dihydrate, European Pharmacopoeia (EP) Reference Standard	C25H31N9O10S2	OMYIZCZQILAOGB-BYLXUVCXSA-N	(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrate	n.a.	n.a.
PMDBD163	Cefotaxime sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	10695961	n.a.	n.a.	CEFOTAXIME SODIUM; CEFOTAXIME SODIUM SALT; 64485-93-4; (+)-Cefotaxime sodium salt; Sodium cefotaxime; Cefotaxime (sodium salt); Tolycar; Claforan; Pretor; UNII-258J72S7TZ; HR 756; Tolycor; Zariviz; Ralopar; C16H16N5NaO7S2; Claforan sodium; MLS000028559; CHEBI:3498; 258J72S7TZ; RU 24756; Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate; HR-756; Cefotax; SMR000058812; Cefotaxime sodium salt (syn-isomer); EINECS 264-915-9; MLS002222330; CEFOTAXIME NA-SALT; Cefotaxim sodium salt; SMR001307269; CLAFORAN IN DEXTROSE 	C16H16N5NaO7S2	AZZMGZXNTDTSME-JUZDKLSSSA-M	sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD165	Cefotiam hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	47896	n.a.	n.a.	Cefotiam dihydrochloride; CEFOTIAM HYDROCHLORIDE; 66309-69-1; Halospor; Pansporin; Pansporine; Ceradon; Spizef; Cefotiam (hydrochloride); Pansporin Ampullen; Abbott 48999; UNII-H7V12WDZ93; SCE 963; EINECS 266-312-6; H7V12WDZ93; Abbott-48999; C18H23N9O4S3.2HCl; CGP-14221/E; 7(R)-(2-(2-Amino-4-thiazolyl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid dihydrochloride; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-ox	C18H25Cl2N9O4S3	BWRRTAXZCKVRON-DGPOFWGLSA-N	(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrochloride	n.a.	n.a.
PMDBD166	Cefoxitin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23667300	n.a.	n.a.	CEFOXITIN SODIUM; Cefoxitin sodium salt; 33564-30-6; Cenomycin; Cefoxitin (sodium); Mefoxitin; Merxin; Betacef; UNII-Q68050H03T; Monosodium cefoxitin; Cefoxil; MLS000028557; Cefoxotin sodium; CHEBI:3501; Q68050H03T; SMR000058809; Cefoxitin sodium salt, 94%; Mefoxithin; Farmoxin; MEFOXIN IN PLASTIC CONTAINER; EINECS 251-574-6; MK 206; MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER; NCGC00183034-01; L 620388; MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; C16H16N3NaO7S2; Prestwick_12; Sodium (6R-cis)-3-((carbamoyloxy)methyl)-7-metho	C16H16N3NaO7S2	GNWUOVJNSFPWDD-XMZRARIVSA-M	sodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD167	Cefsulodin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	656644	n.a.	n.a.	cefsulodin sodium; 52152-93-9; Sulcephalosporin; Cefsulodin sodium salt hydrate; Cefsulodine sodium; CEFSULODIN SODIUM SALT; Cefsulodin Sodium Salt, Hydrate; Pseudomonil; UNII-2D087186PY; Abbott 46811; Abbott-46811; Cefsulodin (sodium); Cefomonil; Tilmapor; Takesulin; Pseudocef; Monaspor; CHEBI:31380; Pyocefal; Ulfaret; 2D087186PY; Abbott-468 11; CGP 7174E; SCE 129; Takesulin (TN); Cefsulodin sodium [USAN:JAN]; EINECS 257-692-4; CGP-7174/E; Prestwick_977; C22H20N4O8S2; 4-Carbamoyl-1-(((6R,7R)-2-carboxy-8-oxo-7-((2R)-2-phenyl-2-sulfoacet	C22H19N4NaO8S2	REACMANCWHKJSM-DWBVFMGKSA-M	sodium;(6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[[(2R)-2-phenyl-2-sulfonatoacetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD168	Ceftazidime pentahydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6536864	n.a.	n.a.	Ceftazidime pentahydrate; Tazidime; Fortaz; Ceftazidime hydrate; Tazicef; Pentacef; Fortum; Ceptaz; 78439-06-2; SN 401 pentahydrate; CHEBI:3509; Modacin; GR-20263; GR 20263; Tazidime In Plastic Container; Fortam; LY-139381; LY 139381; Fortaz (TN); 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-az	C22H32N6O12S2	NMVPEQXCMGEDNH-TZVUEUGBSA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;pentahydrate	n.a.	n.a.
PMDBD169	Cefuroxime sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23670318	n.a.	n.a.	CEFUROXIME SODIUM; Cefuroxime sodium salt; Biociclin; Anaptivan; Sodium cefuroxime; Zinacef; 56238-63-2; Ultroxim; Spectrazolr; Colifossim; Curoxime; Curoxima; Medoxim; Lifurox; Kesint; Furoxil; Cefumax; Cefofix; Bioxima; Ketocef; Cefurex; Curoxim; Curocef; Cefuroxim Lilly; Cefuroxim Hexal; Cefuroxima Fabra; Cefuroxim MN; Cefuroxim AJ; Cefuroxim curasan; Cefuroxima Richet; Cetroxil [inj.]; Cefuroxim Genericsn; Cefuroxim Fresenius; Sharox [inj.]; Zinnat [inj.]; Froxal [inj.]; Cefuroxim Norcox [inj.]; Kefurox; Cefuroxime (sodium); KEFUROX IN PLAST	C16H15N4NaO8S	URDOHUPGIOGTKV-JTBFTWTJSA-M	sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD171	Centurion cultivar blueberry extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD172	Cephalosporanic acid, 7-amino	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441328	n.a.	n.a.	7-Aminocephalosporanic acid; 957-68-6; 7-ACA; 7-Aminocephalosporinic acid; 7beta-Aminocephalosporanic acid; 7-ACS; UNII-9XI67897RG; CHEBI:2255; (7R)-7-aminocephalosporanic acid; Cephalosporanic acid, 7-amino; (7R)-7-Aminocephalosporanate; (6R,7R)-3-(acetoxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 9XI67897RG; MFCD00005177; (6R,7R)-3-[(acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; DSSTox_CID_25342; DSSTox_RID_80810; DSSTox_GSID_45342; 3-acetoxymethyle	C10H12N2O5S	HSHGZXNAXBPPDL-HZGVNTEJSA-N	(6R,7R)-3-(acetyloxymethyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD173	Cephalosporins	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD174	Cephalothin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23675321	n.a.	n.a.	CEPHALOTHIN SODIUM; 58-71-9; cefalotin sodium; Sodium cephalothin; Cephalothin sodium salt; Sodium cefalotin; Sodium cephalotin; Cefalotina sodica; Seffin; Keflin; Toricelocin; Cefalothine; Cepovenin; Synclotin; Ceporacin; Cefalotin sodium salt; Microtin; Lospoven; Cet Injektionsfl; Tokiosarl Ampullen; Keflin In Plastic Container; Cephalothin (sodium); Cephalotin sodium salt; Lovvalline Injektionsfl; Lilly 38253; UNII-C22G6EYP8B; Keflin N Injektionsflaschen; Cefalotina sodica [Spanish]; Cefalothin sodium; EINECS 200-394-6; C22G6EYP8B; CH	C16H15N2NaO6S2	VUFGUVLLDPOSBC-XRZFDKQNSA-M	sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD176	Checkpoint inhibitor therapy	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD179	Chlorcyclizine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	62413	n.a.	n.a.	CHLORCYCLIZINE HYDROCHLORIDE; CHLORCYCLIZINE HCl; Eramide; Perazil; 1620-21-9; 14362-31-3; Di-Paralene; Chlorcyclizinium chloride; Chlorcyclizine chloride; Chlorcyclizine (hydrochloride); Chlorcyclizine monohydrochloride; EINECS 238-335-1; NSC 169496; NSC-169496; 1-(p-Chlorobenzhydryl)-4-methylpiperazine monohydrochloride; 1-((4-Chlorophenyl)(phenyl)methyl)-4-methylpiperazine hydrochloride; 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine monohydrochloride; Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydro	C18H22Cl2N2	MSIJLVMSKDXAQN-UHFFFAOYSA-N	1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine;hydrochloride	n.a.	n.a.
PMDBD184	Chlorpheniramine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281068	n.a.	n.a.	Chlorpheniramine maleate; 113-92-8; Piriton; Chlorphenamine Maleate; Neorestamin; Lorphen; Allerclor; Synistamin; Kloromin; Ibioton; Antagonate; Chlormene; Allergin; Piriex; Alunex; Dehist; Chlor-tripolon; C-Meton; Histadur dura-tabs; Chlor-Trimeton OD; Pyridamal 100; Pyridamal-100; Polaronil [German]; Carbinoxamide maleate; Chlor-Trimeton Allergy; Chlor-Trimeton Injection; Histaspan-Plus; Histaspan-D; NCI-C55265; Chlorpheniramine (maleate); dl-Chlorpheniramine maleate; Ru-Tuss Capsules; Polaronil; Chloroprophenpyridamine maleate; CCRIS 141	C20H23ClN2O4	DBAKFASWICGISY-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine	n.a.	n.a.
PMDBD185	Chlorpromazine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6240	n.a.	n.a.	Chlorpromazine hydrochloride; 69-09-0; Chlorpromazine Hcl; Sonazine; Promacid; Klorpromex; Chloractil; Plegomazin; Hebanil; Propaphenin; Taroctyl; Promapar; Marazine; Klorproman; Hybernal; Tranzine; Promachel; Hibernal; Promexin; Norcozine; Neurazine; Lomazine; Unitensen; Megatil; Aminazinum; Chlorpromazinium chloride; Fenactil monohydrochloride; Aminazin monohydrochloride; Chloropromazine monohydrochloride; Ampliactil monohydrochloride; Hibanil; Megaphen hydrochloride; Contomin hydrochloride; Chlorpromazine (hydrochloride); Chlorpromazine 	C17H20Cl2N2S	FBSMERQALIEGJT-UHFFFAOYSA-N	3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;hydrochloride	n.a.	n.a.
PMDBD186	Chlorprothixene hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282478	n.a.	n.a.	Chlorprothixene hydrochloride; Chlorprothixene HCl; Minithixen; 6469-93-8; UNII-268KCR965N; cis-Chlorprothixene hydrochloride; trans-N714; (Z)-Chlorprothixene hydrochloride; C18H18ClNS.HCl; EINECS 229-289-3; NSC 78193; NSC 56379; NSC 169899; (E)-Chlorprothixene hydrochloride; trans-Chlorprothixene hydrochloride; 268KCR965N; Truxal hydrochloride; NSC 78192; NSC 56378; NSC 64084; cis-2-Chloro-9-(3-(dimethylamino)propylidene)thioxanthene, hydrochloride; (Z)-2-Chloro-9-(3-dimethylaminopropylidene)thioxanthene hydrochloride; Thioxant	C18H19Cl2NS	YWKRLOSRDGPEJR-KIUKIJHYSA-N	(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride	n.a.	n.a.
PMDBD187	Chlortetracycline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54682468	n.a.	n.a.	Chlortetracycline hydrochloride; Isphamycin; Aureociclina; Chlorotetracycline hydrochloride; 64-72-2; Aureocycline; Aureocarmyl; Clorocipan; Auxeomycin; Aureomycin hydrochloride; B-Aureo; Tetra 5; CLTC; AUREOMYCIN; Biomycin hydrochloride; Psittacin hydrochloride; Biomitsin hydrochloride; Fermycin Soluble; Chlortetracycline HCl; Aureomycin monohydrochloride; Chlortetracyclinium chloride; 7-Chlorotetracycline hydrochloride; Aurofac 100; Aureovit 12C80; Chlortetracycline (hydrochloride); UNII-O1GX33ON8R; Chlortetracycline, monohydrochl	C22H24Cl2N2O8	QYAPHLRPFNSDNH-MRFRVZCGSA-N	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD190	Choline-containing compounds	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD192	Cichorium intybus	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD195	Cinnamon essential oil	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD199	Ciprofloxacin hydrochloride monohydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	62998	n.a.	n.a.	86393-32-0; Ciprofloxacin hydrochloride hydrate; Ciprofloxacin hydrochloride monohydrate; Ciloxan; Oftacilox; Ceprimax; Proquin XR; Cipro; Floxacipron; Supraflox; Sophixin; Plenolyt; Phaproxin; Globuce; Flociprin; Felixene; Disfabac; Cunesin; Citeral; Ophaflox; Novoquin; Novidat; Microgan; Loxacid; Keefloxin; Cipronex; Ciflosin; Siprogut; Roflazin; Proxacin; Cipropol; Ciprofur; Belmacina; Suiflox; Renator; Quinoflox; Megaflox; Inkamil; Ciproktan; Ciprocinal; Piprol; Flunas; Sepcen; Quipro; Ofitin; Ciflan; Strox; Lypro; Cilox; Cipad; Cenin; Catex; Nixin; Bay o	C17H21ClFN3O4	ARPUHYJMCVWYCZ-UHFFFAOYSA-N	1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride	n.a.	n.a.
PMDBD202	Clavulanate potassium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD203	Clemastine fumarate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281069	n.a.	n.a.	CLEMASTINE FUMARATE; 14976-57-9; Tavist; Agasten; Mecloprodine; Aloginan; Xolamin; Trabest; Marsthine; Maikohis; Reconin; Kinotomin; Inbestan; Masletine; Lacretin; Anhistan; Alphamin; Tavegyl; Tavegil; Piloral; Lecasol; Fuluminol; Clemanil; Clemastine hydrogen fumarate; Mallermin-F; Telgin-G; Meclastine fumarate; Tavist-1; Clemastine (fumarate); Meclastine hydrogen fumarate; UNII-19259EGQ3D; HSDB 6507; Contac 12 Hour Allergy; EINECS 239-055-2; CHEBI:3739; 19259EGQ3D; C21H26ClNO.C4H4O4; (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenz	C25H30ClNO5	PMGQWSIVQFOFOQ-YKVZVUFRSA-N	(E)-but-2-enedioic acid;(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine	n.a.	n.a.
PMDBD204	Clemizole	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2782	n.a.	n.a.	Clemizole; 442-52-4; Histacur; Clemizol; Histakool; Lergopenin; Clemizolum; 1-(4-Chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzo[d]imidazole; Depocural; 1-(p-Chlorobenzyl)-2-pyrrolidylmethylenebenzimidazole; UNII-T97CB3796L; NSC 46261; CHEBI:52140; T97CB3796L; 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole; NSC-46261; 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole; 1H-Benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrro	C19H20ClN3	CJXAEXPPLWQRFR-UHFFFAOYSA-N	1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole	n.a.	n.a.
PMDBD205	Clemizole hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5309446	n.a.	n.a.	Clemizole hydrochloride; 1163-36-6; Clemizole HCl; Clemizole (hydrochloride); Allercur; Reactrol; UNII-85W6I13D8M; Allercure hydrochloride; Clemizole hydrochloride [JAN]; MLS000120342; 85W6I13D8M; SMR000058430; AL 20; EINECS 214-605-4; DSSTox_RID_80695; DSSTox_CID_25136; DSSTox_GSID_45136; P 48; Clemizole hydrochloride (JAN); Clemizole.HCl; 1H-Benzimidazole, 1-[(4-chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-, hydrochloride (1:1); 1-[(4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1H-benzimidazole hydrochloride; 1-p-Chlorobenz	C19H21Cl2N3	DNFMJYXRIMLMBZ-UHFFFAOYSA-N	1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole;hydrochloride	n.a.	n.a.
PMDBD208	Clindamycin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	16051951	n.a.	n.a.	Clindamycin hydrochloride; Clindamycin Hcl; 21462-39-5; Cleocin; Clindamycin (hydrochloride); Cleocin hydrochloride; UNII-T20OQ1YN1W; T20OQ1YN1W; Cleocin HCl; C18H33ClN2O5S.HCl; BenzaClin; 58207-19-5; CLINDAMYCIN ALCOHOLATE; Dalacin (TN); Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-?-D-galacto-octopyranoside hydrochloride; Clinsol; Clintabs; MFCD07793327; Antirobe vet.; (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]pro	C18H34Cl2N2O5S	AUODDLQVRAJAJM-XJQDNNTCSA-N	(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD211	Clofilium tosylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	175533	n.a.	n.a.	Clofilium tosylate; 92953-10-1; UNII-13ZVF1051K; N-(4-(4-Chlorophenyl)butyl)-N,N-diethylheptan-1-aminium 4-methylbenzenesulfonate; 13ZVF1051K; NCGC00017142-01; CAS-92953-10-1; DSSTox_RID_80994; DSSTox_CID_25601; DSSTox_GSID_45601; Benzenebutanaminium, 4-chloro-N,N-diethyl-N-heptyl-, salt with 4-methylbenzenesulfonicacid (1:1); A1-01947; MLS002154263; GNF-Pf-3889; 4-Chloro-N,N-Diethyl-N-Heptyl-Benzenebutanaminiusaltwith4-Methylbenzenes; clofilium tosylateclofilium tosylate; SMR001233522; Prestwick_682	C28H44ClNO3S	MOQZYUUHIWPDQC-UHFFFAOYSA-M	4-(4-chlorophenyl)butyl-diethyl-heptylazanium;4-methylbenzenesulfonate	n.a.	n.a.
PMDBD212	Clomiphene citrate (Z,E)	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD213	Clomipramine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	68539	n.a.	n.a.	Clomipramine hydrochloride; 17321-77-6; Clomipramine HCL; Anafranil; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride; Anaphranil; 3-Chloroimipramine hydrochloride; Chloroimipramine monohydrochloride; Chlorimipramine hydrochloride; UNII-2LXW0L6GWJ; Clomipramine (hydrochloride); Clomipramine Monohydrochloride; Clomicalm; EINECS 241-344-3; 2LXW0L6GWJ; MLS000028511; CHEBI:3755; SMR000058295; I615; Anafranil (TN); C19H23ClN2.HCl; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dib	C19H24Cl2N2	WIMWMKZEIBHDTH-UHFFFAOYSA-N	3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride	n.a.	n.a.
PMDBD216	Clopidogrel sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	115366	n.a.	n.a.	Clopidogrel bisulfate; 120202-66-6; Clopidogrel hydrogen sulfate; Iscover; Plavix; 135046-48-9; Clopidogrel bisulphate; (S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; Clopidogrel hemisulfate; CLOPIDOGREL SULFATE; Clopidogrel sulphate; clopidogrel hydrogen sulphate; Clopidogrel (hydrogen sulfate); UNII-08I79HTP27; 113665-84-2; Clopidogrel (Plavix); SR 25990C; (S)-(+)-Clopidogrel Sulfate; SR-25990C; 08I79HTP27; PM-103; MFCD05865229; Myogrel; SR-25990; Clopidogrel hydrogensulfate; Plavix (TN	C16H18ClNO6S2	FDEODCTUSIWGLK-RSAXXLAASA-N	methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid	n.a.	n.a.
PMDBD217	Closantel	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	42574	n.a.	n.a.	Closantel; 57808-65-8; N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide; Closantelum [INN-Latin]; C22H14Cl2I2N2O2; EINECS 260-967-1; NSC 335306; CHEMBL12131; MLS001332593; N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide; CHEBI:77054; R 31520; NCGC00166312-01; SMR000857079; N-(5-Chloro-4-((4-chlorophenyl)cyanomethyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide; DSSTox_CID_20662; 5'-Chloro-alpha(sup 4)-(p-chlorophenyl)-alpha(sup 4)-cyano	C22H14Cl2I2N2O2	JMPFSEBWVLAJKM-UHFFFAOYSA-N	N-[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide	n.a.	n.a.
PMDBD219	Cloxacillin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23675320	n.a.	n.a.	Cloxacillin sodium; Cloxacillin sodium salt; 642-78-4; Cloxacillin sodium anhydrous; Sodium cloxacillin; Sodium orbenin; Monosodium cloxacillin; Sodium syntarpen; Austrastaph; Staphybiotic; Gelstaph; Ekvacillin; Ankerbin; Orbenin sodium; Prevencilina P; Prostaphlin A; Prostaphilin A; BRL 1621 sodium salt; Tegopen; Syntarpen sodium salt; UNII-MWQ645MKMF; BRL-1621 sodium salt; Cloxacillin (sodium); EINECS 211-390-9; MWQ645MKMF; 3-o-Chlorophenyl-5-methyl-4-isoxazolylpenicillin sodium; Sodium 3-(o-chlorophenyl)-5-methyl-4-isoxazolylpeni	C19H17ClN3NaO5S	SCLZRKVZRBKZCR-SLINCCQESA-M	sodium;(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD220	Cocoa drink	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD224	Colistin sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD226	Common azole treatment	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD227	Conventional soy milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD228	Conventional soy milk (26.5% β-conglycinin/38.7% glycinin)	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD229	CpG oligodeoxynucleotides	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD230	CpG-oligonucleotide immunotherapy	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD231	CTLA-4 blockade	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD232	Curcuma longa	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD235	Cyclobenzaprine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	22576	n.a.	n.a.	Cyclobenzaprine hydrochloride; 6202-23-9; Cyclobenzaprine HCL; Flexeril; Flexiban; Amrix; Lisseril; Tensodox; Cycloflex; Cloben; Cyben; Novo-Cycloprine; MK 130 hydrochloride; 3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine hydrochloride; Cyclobenzaprine (hydrochloride); Proheptatriene hydrochloride; Proheptatriene monohydrochloride; TNX-102; UNII-0VE05JYS2P; Yurelax; Proheptatrien monohydrochloride; EINECS 228-264-4; NSC 78206; NSC 173379; NSC 169900; 10,11delta-Amitriptyline hydrochloride; 0VE05JYS2P; CHEBI:3997	C20H22ClN	VXEAYBOGHINOKW-UHFFFAOYSA-N	N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride	n.a.	n.a.
PMDBD238	Cyclosporin A	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5284373	n.a.	n.a.	cyclosporin A; cyclosporine; Ciclosporin; 59865-13-3; Cyclosporine A; Cyclosporin; Neoral; Ciclosporine; Sandimmun; Sang-35; Sandimmune; Ciclosporinum; Ciclosporina; Equoral; Neoplanta; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; 83HN0GTJ6D; MLS001333756; CHEBI:4031; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A); DSSTox_GSID_203	C62H111N11O12	PMATZTZNYRCHOR-CGLBZJNRSA-N	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone	n.a.	n.a.
PMDBD239	Cyproheptadine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	13770	n.a.	n.a.	cyproheptadine hydrochloride; 969-33-5; Cyproheptadine Hcl; Cipractin; Anarexol; Nuran; Periactin hydrochloride; Antegan; Peritol; Periactin syrup; Cycloheptadine hydrochloride; component of Dronactin; Periactinol (VAN); Cyproheptadiene hydrochloride; Cyproheptadine (hydrochloride); Periactinol hydrochloride; 41354-29-4; Cyproheptadine chlorhydrate; Cyproheptadine hydrochloride anhydrous; UNII-0S9323MCT0; VUFB3511; EINECS 213-535-1; NSC 169911; Cyproheptadine Hydrochloride (anhydrous); C21H21N.HCl; CPD000058431; MLS000028462; AI3-269	C21H22ClN	ZPMVNZLARAEGHB-UHFFFAOYSA-N	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride	n.a.	n.a.
PMDBD241	Cysteine-S-conjugates of xenobiotics	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD247	Dantrolene sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6604100	n.a.	n.a.	DANTROLENE SODIUM; Dantrolene sodium salt; Dantrium; Sodium dantrolene; Dantrolene (sodium); 14663-23-1; Dantrolene, Sodium Salt; UNII-28F0G1E0VF; Dantamacrin; Dantrix; Dantrolene Sodium (anhydrous); Dantrolene sodium [USAN:BAN:JAN]; EINECS 238-706-8; Dantrolene sodium anhydrous; 28F0G1E0VF; 1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin sodium; Ryanodex; F 440; Dantrolene sodium hemiheptahydrate; 2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-, sodium salt; 24868-20-0; Dantrolene Sodium Hydrate	C14H9N4NaO5	KSRLIXGNPXAZHD-HAZZGOGXSA-M	sodium;3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-2-oxo-4H-imidazol-5-olate	n.a.	n.a.
PMDBD248	Darifenacin hydrobromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	444030	n.a.	n.a.	Darifenacin hydrobromide; darifenacin HBr; 133099-07-7; Darifenacin (hydrobromide); Emselex; UNII-CR02EYQ8GV; UK 88525-04 hydrobromide; CR02EYQ8GV; CHEBI:31455; UK-88525-04; DSSTox_RID_81899; DSSTox_CID_26780; DSSTox_GSID_46780; (S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide; (S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide h	C28H31BrN2O2	UQAVIASOPREUIT-VQIWEWKSSA-N	2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide	n.a.	n.a.
PMDBD250	Daunorubicin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	62770	n.a.	n.a.	23541-50-6; DAUNORUBICIN HCL; DAUNORUBICIN HYDROCHLORIDE; Daunomycin hydrochloride; Cerubidine; Daunoblastina; Ondena; Daunomycin HCL; Rubidomycin hydrochloride; daunorubicinol hydrochloride; RP 13057 hydrochloride; Daunoblastin; Rubomycin; Daunomycin chlorohydrate; Daunomycin, hydrochloride; UNII-UD984I04LZ; Daunorubicin (Hydrochloride); CCRIS 915; EINECS 245-723-4; C27H29NO10.HCl; AI3-44887; UD984I04LZ; NDC 0082-4155; (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-tr	C27H30ClNO10	GUGHGUXZJWAIAS-QQYBVWGSSA-N	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride	n.a.	n.a.
PMDBD251	Dealcoholized red wine	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD254	Demecarium bromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5965	n.a.	n.a.	DEMECARIUM BROMIDE; 56-94-0; Humorsol; Visumatic; Tosmilen; Frumtosnil; Tosmilene; Visumiotic; Tosmicil; Tonilen; Demekastigmine bromide; Demekarium bromide; Demecarii bromidum; Bromuro de demecario; Bromure de demecarium; Demecarii bromidum [INN-Latin]; BC 48; UNII-61D5V4OKTP; Bromuro de demecario [INN-Spanish]; Bromure de demecarium [INN-French]; HSDB 2168; EINECS 200-301-9; 3,3'-(((Decane-1,10-diylbis(methylazanediyl))bis(carbonyl))bis(oxy))bis(N,N,N-trimethylbenzenaminium) bromide; 61D5V4OKTP; (m-Hydroxyphenyl)trimethylammoniu	C32H52Br2N4O4	YHKBUDZECQDYBR-UHFFFAOYSA-L	trimethyl-[3-[methyl-[10-[methyl-[3-(trimethylazaniumyl)phenoxy]carbonylamino]decyl]carbamoyl]oxyphenyl]azanium;dibromide	n.a.	n.a.
PMDBD255	Demeclocycline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54686764	n.a.	n.a.	DEMECLOCYCLINE HYDROCHLORIDE; 64-73-3; Demeclocycline HCL; Detravis; Clortetrin; Ledermycine; Ledermicina; Veraciclina; Elkamicina; Detracin; Demeplus; 7-Chloro-6-demethyltetracycline hydrochloride; Declomycin hydrochloride; Ledermycin; Demeclocycline (hydrochloride); Demethylchlortetracycline hydrochloride; UNII-29O079NTYT; 6-Demethyl-7-chlorotetracycline hydrochloride; Demethylchlorotetracycline hydrochloride; Mexocine; EINECS 200-592-2; MLS000028422; Demeclocycline hydrochloride (internal use); 29O079NTYT; CHEBI:59725	C21H22Cl2N2O8	OAPVUSSHCBRCOL-KBHRXELFSA-N	(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD256	Deptropine citrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6604492	n.a.	n.a.	Deptropine citrate; Deptropine dihydrogen citrate; UNII-05LW13XKKR; 05LW13XKKR; Deptrin; Brontina; CHEBI:50190; NCGC00017039-01; CAS-2169-75-7; DIBENZHEPTROPINE CITRATE; 2169-75-7; EINECS 218-516-1; Deptropine FNA; NSC 169431; DSSTox_RID_80954; DSSTox_CID_25557; DSSTox_GSID_45557; SCHEMBL466848; CHEMBL1475191; 3-alpha-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yloxy)tropane citrate; DTXSID4045557; CHEMBL2107603; 3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yloxy)tropane citrate; Tropane, 3alpha-((10,11-dihydro-5H-dibenzo(a,d)cy	C29H35NO8	CHQGYMXXKZPWOI-IIPFOPBBSA-N	2-hydroxypropane-1,2,3-tricarboxylic acid;(1R,5S)-8-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)-8-azabicyclo[3.2.1]octane	n.a.	n.a.
PMDBD257	Dequalinium dichloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	10649	n.a.	n.a.	dequalinium chloride; 522-51-0; Dequalinium Dichloride; Dequafungan; Decabis; Danical; Gorgine; Decosan; Dekuarin; Optipect; Grocreme; Erosept; Eriosept; Decaminum; Phylletten; Vaster; Evazol; Efisol; Angils; Dequalinium (Chloride); Dequalinii chloridum; Rumilet; Labosept; Dekamin; Sentril; Sanoral; Polycidine; Dequavet; Dequavagyn; Dekadin; Decamine; Oralgol; Dequadin; Ivazil; Cloruro de decalinio; Sorot; BAQD 10; Dequalin chloride; Chlorure de dequalinium; Dynexan-mhp; Dequalinum Chloride; Decamine (pharmaceutical); UNII-XYS8INN1I6; Dequalinio clo	C30H40Cl2N4	LTNZEXKYNRNOGT-UHFFFAOYSA-N	1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine;dichloride	n.a.	n.a.
PMDBD258	Deshipu stachyose granules	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD261	Diacetamate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	17499	n.a.	n.a.	Diacetamate; 2623-33-8; 4-Acetamidophenyl acetate; 4'-Acetoxyacetanilide; Acetaminophen acetate; 4-Acetoxyacetanilide; P-ACETOXYACETANILIDE; N,O-Diacetyl-4-aminophenol; Diacetamat; 4-(Acetylamino)phenyl acetate; N-Acetyl-4-aminophenyl acetate; UNII-BFG1TY61BG; NSC 6083; (4-acetamidophenyl) acetate; NSC 33893; N-[4-(Acetyloxy)phenyl]acetamide; BFG1TY61BG; Acetaminophen Acetate (Acetaminophen Impurity); NCGC00160605-01; Acetanilide, acetate (ester); Diacetam	C10H11NO3	UJAOSPFULOFZRR-UHFFFAOYSA-N	(4-acetamidophenyl) acetate	n.a.	n.a.
PMDBD264	Dicloxacillin sodium salt hydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23675786	n.a.	n.a.	Dicloxacillin sodium; DICLOXACILLIN SODIUM MONOHYDRATE; Dicloxacillin sodium hydrate; 13412-64-1; Dicloxacillin sodium salt hydrate; Pathocil; Diclocil; Dycill; Brispen; Dicloxacillin sodium salt monohydrate; Dynapen; Digloxilline; Stampen; Noxaben; Biocloxin; Constaphyl; Novapen; Diflor; Clocil; Ciclex; BRL-1702; Pen-Sint; Sodium dicloxacillin monohydrate; Staphcillin A banyu; Sodium dicloxacillin hydrate; Dichlorstapenor sodium; MDI-PC; Bayer 5488; UNII-4HZT2V9KX0; BLP-1011; Dicloxacillin (Sodium hydrate); CHEBI:52019; 4HZT2V9KX0; P-1011	C19H18Cl2N3NaO6S	SIGZQNJITOWQEF-VICXVTCVSA-M	sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate	n.a.	n.a.
PMDBD267	Dicyclomine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441344	n.a.	n.a.	Dicyclomine hydrochloride; Dicyclomine Hcl; 67-92-5; Dicycloverine hydrochloride; Procyclomin; Stannitol; Spasmoject; Icramin; Bentomine; Sawamin; Mamiesan; Benacol; Antispas; Dyspas; Atumin; Dibent; Ametil; Oxityl-P; Wyovin hydrochloride; Diocyl hydrochloride; Merbentyl; Kolantyl hydrochloride; Dicyclomine (hydrochloride); UNII-CQ903KQA31; BENTYL PRESERVATIVE FREE; Dicycloverin hydrochloride; 2-Diethylaminoethyl bicyclohexyl-1-carboxylate hydrochloride; Bentyl hydrochloride; EINECS 200-671-1; NSC 404381; Bentylol hydrochloride; MLS00002	C19H36ClNO2	GUBNMFJOJGDCEL-UHFFFAOYSA-N	2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate;hydrochloride	n.a.	n.a.
PMDBD269	Diet rich in fiber	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD270	Dietary choline	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD271	Dietary fiber	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD272	Dietary phosphatidylcholine	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD274	Diflorasone diacetate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	71414	n.a.	n.a.	Diflorasone diacetate; 33564-31-7; Florone E; Apexicon e; Psorcon; Diflorasone di(acetate); UNII-7W2J09SCWX; EINECS 251-575-1; BRN 2318163; 7W2J09SCWX; MLS001076548; MLS000069559; CHEBI:31483; 6alpha,9-Difluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-diacetate; NCGC00022003-03; SMR000058814; 6alpha-Fluorobetamethasone-17,21 diacetate; DSSTox_RID_81024; DSSTox_CID_25646; U-34865; DSSTox_GSID_45646	C26H32F2O7	BOBLHFUVNSFZPJ-JOYXJVLSSA-N	[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	n.a.	n.a.
PMDBD277	Dihydrodaidzein	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	176907	n.a.	n.a.	dihydrodaidzein; 17238-05-0; 7-hydroxy-3-(4-hydroxyphenyl)chroman-4-one; Dihydrodaidzein (keto); Dihydrodazein; (+/-)-Dihydrodaidzein; 7,4'-Dihydroxyisoflavanone; 2,3-dihydro-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-Benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; 4',7-dihydroxy-Isoflavanone; SCHEMBL131543; (R,S)-2,3-Dihydrodaidzein; SCHEMBL16152440; CHEBI:75842; CTK8C3008; DTXSID70912308; BID0517; ZX-AFC001619; HY-N1461; ANW-69504; LMPK12050447; ACM17238050; AK-61048; LS-19336	C15H12O4	JHYXBPPMXZIHKG-UHFFFAOYSA-N	7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one	n.a.	n.a.
PMDBD279	Dihydroxyphenylalanine (DOPA)	Therapeutic Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD282	Dimethisoquin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	176907	n.a.	n.a.	dihydrodaidzein; 17238-05-0; 7-hydroxy-3-(4-hydroxyphenyl)chroman-4-one; Dihydrodaidzein (keto); Dihydrodazein; (+/-)-Dihydrodaidzein; 7,4'-Dihydroxyisoflavanone; 2,3-dihydro-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-Benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; 4',7-dihydroxy-Isoflavanone; SCHEMBL131543; (R,S)-2,3-Dihydrodaidzein; SCHEMBL16152440; CHEBI:75842; CTK8C3008; DTXSID70912308; BID0517; ZX-AFC001619; HY-N1461; ANW-69504; LMPK12050447; ACM17238050; AK-61048; LS-19336	C15H12O4	JHYXBPPMXZIHKG-UHFFFAOYSA-N	7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one	n.a.	n.a.
PMDBD289	Doxazosin mesylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	62978	n.a.	n.a.	Doxazosin mesylate; 77883-43-3; Cardura; Carduran; Cardular; Cardura XL; Tensiobas; Doxazomerck; Dedralen; Cardenalin; Progandol; Diblocin; Doxazosin AZU; Prostadilat; Kaltensif; Doxolbran; Cardoxan; Cardoral; Alfadil; Normathen; Doxazosin (mesylate); Tonocardin; Doxaben; Doksura; Supressin; Benur; Diblocin Uro; Cardular Uro; Diblocin PP; Cardular PP; Doxazosin mesilate; HSDB 7082; MLS000028455; UK 33,274-27; (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate; SMR000058441	C24H29N5O8S	VJECBOKJABCYMF-UHFFFAOYSA-N	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid	n.a.	n.a.
PMDBD291	Doxorubicin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	443939	n.a.	n.a.	Doxorubicin Hydrochloride; 25316-40-9; Doxorubicin HCl; ADRIAMYCIN HYDROCHLORIDE; Adriblastina; Adriacin; Rubex; Doxorubicin (Adriamycin) HCl; Adriamycin PFS; Adriamycin RDF; Doxorubicin (hydrochloride); UNII-82F2G7BL4E; Hydroxydaunorubicin hydrochloride; Adriblastin; ADRIAMYCIN, HYDROCHLORIDE; Lipodox; MLS001401460; 82F2G7BL4E; NSC 123127; Hydroxydaunorubicin; SMR000058570; KW-125; DSSTox_RID_78854; DSSTox_RID_80678; DSSTox_CID_10636; DSSTox_GSID_30636; DSSTox_GSID_45111; CCRIS 740; Duxocin; Adrosal; EINECS 246-818-3; Adriamycin hydroch	C27H30ClNO11	MWWSFMDVAYGXBV-RUELKSSGSA-N	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride	n.a.	n.a.
PMDBD292	Doxycycline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54685920	n.a.	n.a.	Doxycycline hydrochloride; Doxycycline HCl; 10592-13-9; Doxigalumicina; Doxylin; Doxycycline hyclate; Doxycycline (hydrochloride); Biocamycin; Tecacin; Samecin; Roximycin; Novadox; Midoxin; Mespafin; Liomycin; Tetradox; Nivocilin; Vibradox; Tanamicin; Idocyklin; Ecodox; UNII-4182Z6T2ET; Doxy-tablinen; Vibra-tabs; Vibramycin hyclate; Doxy-II; RETENS; Vibramycin hydrochloride; CHEBI:652992; 4182Z6T2ET; 24390-14-5; Doxycycline Hydrochloride [JAN]; Deoxyoxytetracycline hydrochloride; EINECS 234-198-7; Doxycycline, Hyclate; DSSTox_CID_25405; DSSTo	C22H25ClN2O8	PTNZGHXUZDHMIQ-CVHRZJFOSA-N	(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD296	Eburnamonine (-)	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	71203	n.a.	n.a.	Vinburnine; (-)-Eburnamonine; Vincamone; eburnamonine; 4880-88-0; Eburnal; l-Eburnamonine; Eburnamonine (-); Eburnal ritardo; cis-Vincamone; Vinburnine [INN]; Vincamona [Spanish]; Vinburninum [INN-Latin]; Vinburnina [INN-Spanish]; UNII-G54D0HMY25; CH-846; (-)-Eburnamonina [Spanish]; 3-alpha,16-alpha-Eburnamonine; Eburnamonine (-)-form; EINECS 225-490-5; CH 846; NSC 322920; 3alpha,16alpha-Eburnamonine; G54D0HMY25; CHEBI:4740; (3alpha,16alpha)-Eburnamenin-14(15H)-one; (3-alpha,16-alpha)-Eburnamin-14(15H)-one; Vinburnine (INN); NSC322920	C19H22N2O	WYJAPUKIYAZSEM-MOPGFXCFSA-N	(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one	n.a.	n.a.
PMDBD297	Econazole nitrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	68589	n.a.	n.a.	Econazole nitrate; 24169-02-6; Ifenec; Pevaryl; Gyno-pevaryl; Epi-pevaryl; Spectazole; Econazole (nitrate); Econazole nitrate salt; 68797-31-9; (+-)-Econazole nitrate; Gyno-Pevaryl 150; Palavale; NSC 243115; CCRIS 6031; R 14827; EINECS 246-053-5; MLS000028626; Econazole nitrate (Spectazole); SQ 13050; R 14,827; NSC-243115; SMR000058732; DSSTox_CID_5226; 1-(2,4-Dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)imidazole nitrate; Imidazole, 1-(2,4-dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)-, mononitrate; 1-(2-((4-Chlorophenyl)methoxy)-2	C18H16Cl3N3O4	DDXORDQKGIZAME-UHFFFAOYSA-N	1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid	n.a.	n.a.
PMDBD301	Emulsifiers (P80 and CMC)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD302	Enalapril maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5388961	n.a.	n.a.	Enalapril maleate; 76095-16-4; Renitec; Glioten; Crinoren; Benalapril; Renivace; Innovace; Naprilene; Baripril; Enapren; Dabonal; Vasotec; Xanef; Vapresan; Prilenap; Konveril; Inoprilat; Hipoartel; Enaprin; Enapril; Elfonal; Analept; Amprace; Repantril; Pressotec; Minipril; Lotrial; Vasopril; Tensazol; Ristalen; Regomed; Norpril; Neotensin; Naritec; Lipraken; Kenopril; Feliberal; Enalasyn; Enaladil; Enacard; Ecapril; Defluin; Coprilor; Converten; Controlvas; Biocronil; Alphrin; Acetensil; Reniten; Renavace; Invoril; Innovade; Eupressin; Enarenal; Enapres; Denapr	C24H32N2O9	OYFJQPXVCSSHAI-QFPUQLAESA-N	(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid	n.a.	n.a.
PMDBD303	Enilconazole	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	37175	n.a.	n.a.	IMAZALIL; Enilconazole; 35554-44-0; Deccozil; Chloramizol; Imaverol; Fungaflor; Eniloconazol (SP); Deccozil S 75; Enilconazole (BPC); Magnate; Fungazil; Florasan; Clinafarm; R 23979; 1-(2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole; Enilconazol; Caswell No. 497AB; CGA 41333; Imazalil [ANSI:BSI:ISO]; C14H14Cl2N2O; 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole; Enilconazole [USAN:BAN:INN]; CHEBI:83829; HSDB 6672; EINECS 252-615-0	C14H14Cl2N2O	PZBPKYOVPCNPJY-UHFFFAOYSA-N	1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole	n.a.	n.a.
PMDBD309	Epimedium grandiflorum top (flavonoids)	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD311	Ergonovine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6437065	n.a.	n.a.	Ergonovine maleate; ergometrine maleate; Metriclavin; Cornocentin; Ermetrin; Ergomet; Oxytocic; Ergometrine hydrogen maleate; Crude ergot; Ergometrine maleate (1:1); Ergotocin maleate; Ergometrin maleate; 129-51-1; Ergonovine hydrogen maleate; Ergotrate; D-Ergonovine maleate; Ergonovine, maleate (1:1); Ergometrine acid maleate; UNII-YMH3D0ZJWV; YMH3D0ZJWV; EINECS 204-953-5; Ergonovine, maleate (1:1) (salt); NSC 93752; Ergonovine maleate [USP]; CHEBI:31554; Ergotrate Maleate; Ergonovine maleate (USP); 9,10-Didehydro-N-((S)-2-hydroxy-1	C23H27N3O6	YREISLCRUMOYAY-IIPCNOPRSA-N	(6aR,9R)-N-[(2S)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid	n.a.	n.a.
PMDBD312	Ergotamine tartrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	9787	n.a.	n.a.	ergotamine tartrate; Ergotamine D-tartrate; Ergotamine bitartrate; UNII-MRU5XH3B48; 379-79-3; Gynergen; MRU5XH3B48; Cornutamin; Migretamine; Ergotartrate; Wigrettes; Secupan; Exmigra; Lingran; Lingraine; Secagyn; Femergin; Ergate; Avetol; Ergam; Neo-ergotin; Gotamine tartrate; Medihaler ergotamine; Rigetamin; Ergomar; Ergostat; Ergotamine hemitartrate; DSSTox_CID_5253; Ergotamine tartrate (VAN); ETIN; DSSTox_RID_77717; DSSTox_GSID_25253; CCRIS 487; Ergotamine, tartrate (2:1); Ergotamine tartrate (2:1) (salt); EINECS 206-835-9; NSC 41869; CAS-3	C70H76N10O16	CJMJLDQKTOJACI-BGQAIRJTSA-N	(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(2R,3R)-2,3-dihydroxybutanedioic acid	n.a.	n.a.
PMDBD317	Estropipate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5284555	n.a.	n.a.	Estropipate; 7280-37-7; Piperazine estrone sulfate; Piperazine estronesulfate; Ogen; Harmogen; UNII-SVI38UY019; Ortho-Est; Sulestrex; SVI38UY019; Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1); OGEN 5; OGEN 2.5; OGEN 1.25; OGEN .625; EINECS 230-696-3; piperazine (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate; Piperazine oestrone sulphate; Conjugated estrogens: piperazine estrone sulfate; Estrone hydrogen sulfate compound with piperazine	C22H32N2O5S	HZEQBCVBILBTEP-ZFINNJDLSA-N	[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine	n.a.	n.a.
PMDBD320	Ethaverine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5702159	n.a.	n.a.	Ethaverine hydrochloride; 985-13-7; Ethaquin; Consenil; Papetherine; Laverin; Neopavrin; Paveroid; Isovex; Cebral; ETHAVERINE HCl; Perperine; Perparine; Perparin; Barbonin hydrochloride; UNII-6Z6T599E49; Perparin hydrochloride; Perperine hydrochloride; Perparine hydrochloride; Papetherine hydrochloride; 1-(3,4-Diethoxybenzyl)-6,7-diethoxyisoquinoline hydrochloride; 6Z6T599E49; EINECS 213-573-9; NSC 525044; DSSTox_RID_82536; DSSTox_CID_27759; DSSTox_GSID_47779; 6,7-Diethoxy-1-(3,4-diethoxybenzyl)isoquinoline hydrochloride; ISOQUINOLINE	C24H30ClNO4	UPUDVKWQBVIKBG-UHFFFAOYSA-N	1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxyisoquinoline;hydrochloride	n.a.	n.a.
PMDBD321	Ethopropazine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3290	n.a.	n.a.	ethopropazine; Profenamine; Parsidol; Isothiazine; Ethopromazine; Isothazine; Prophenaminum; Prophenamine; Phenopropazine; Parsitan; Parkin; Profenaminum; Parsotil; Parfezine; Rodipal; Isopthazine; Profenamina; Ethapropazine; Profenamina [Italian]; Fempropazine; Isotazin; Profenaminum [INN-Latin]; Profenamina [INN-Spanish]; 522-00-9; 10-(2-Diethylaminopropyl)phenothiazine; Profenamine [INN:BAN]; 2-Diethylamino-1-propyl-N-dibenzoparathiazine; SKF 2538; RP 3356; SC 2538; N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine; 10-[2-(Diet	C19H24N2S	CDOZDBSBBXSXLB-UHFFFAOYSA-N	N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine	n.a.	n.a.
PMDBD322	Ethopropazine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	122824	n.a.	n.a.	Ethopropazine hydrochloride; Profenamine hydrochloride; 1094-08-2; Profenamine HCl; Ethopropazine HCl; Pardisol; Lysivane; Parphezein; Parfezin; Dibutil; Profenamine monohydrochloride; Parphezin; Isothazine hydrochloride; Parsidol (VAN); Lysivane hydrochloride; Parsidol hydrochloride; Parsidol monohydrochloride; 10-(2-(Diethylamino)propyl)phenothiazine monohydrochloride; EINECS 214-134-4; NSC 64074; NSC 169467; N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethylamine monohydrochloride; ethopropazine monohydrochloride; CHEMBL12009	C19H25ClN2S	VXPCQISYVPFYRK-UHFFFAOYSA-N	N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride	n.a.	n.a.
PMDBD330	Fadrozole hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	59694	n.a.	n.a.	FADROZOLE HYDROCHLORIDE; 102676-31-3; Afema; Fadrozole HCl; CGS 16949A; Fadrozole.HCl; CGS 16949; 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride; CCRIS 4597; Fadrozole hydrochloride [USAN]; CHEMBL468419; 4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile monohydrochloride; Fadrozole hydrochloride (USAN); Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-, monohydrochloride; Fadrozole monohydrochloride; Arensin; 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-Benzonitrile	C14H14ClN3	UKCVAQGKEOJTSR-UHFFFAOYSA-N	4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;hydrochloride	n.a.	n.a.
PMDBD333	Famprofazone	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3326	n.a.	n.a.	Famprofazone; 22881-35-2; Famprofazonum; Famprofazon; Famprofazone [INN:BAN]; Famprofazonum [INN-Latin]; Famprofazona [INN-Spanish]; EINECS 245-284-9; BRN 5768367; C24H31N3O; DSSTox_RID_80877; DSSTox_CID_25435; 3-(N-Methyl-(alpha-methyl-beta-phenyl)-e	C24H31N3O	GNUXVOXXWGNPIV-UHFFFAOYSA-N	1-methyl-5-[[methyl(1-phenylpropan-2-yl)amino]methyl]-2-phenyl-4-propan-2-ylpyrazol-3-one	n.a.	n.a.
PMDBD338	Fendiline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5702162	n.a.	n.a.	Fendiline hydrochloride; 13636-18-5; Fendiline HCl; Fendiline (hydrochloride); MLS000069570; 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine hydrochloride; NCGC00094891-01; SMR000058827; DSSTox_CID_25860; DSSTox_RID_81180; DSSTox_GSID_45860; SR-01000003123; NCGC00018223-06; 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;hydrochloride; Prestwick_568; Sensit (TN); Fendiline(hydrochloride); Opera_ID_555; CAS-13636-18-5; MLS002222223; MLS001076126; SPECTRUM1501026; SCHEMBL666530; CHEMBL1405922; DTXSID2045860; CTK8F9736; REGID_for_CID_5702162	C23H26ClN	NJXWZWXCHBNOOG-UHFFFAOYSA-N	3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;hydrochloride	n.a.	n.a.
PMDBD343	Fermentable fibre (inulin)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD344	Fermented aqueous soy extract (by Enterococcus faecium and Lactobacillus helveticus)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD345	Fermented soy milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD346	Fermented soy milk (by Enterococcus faecium)	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD347	Fermented soy milk (by Lactobacillus plantarum)	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD348	Fermented soy product	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD349	Fermented soybean milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD350	Fexofenadine HCl	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	63002	n.a.	n.a.	FEXOFENADINE HYDROCHLORIDE; 153439-40-8; FEXOFENADINE HCL; Allegra; Telfast; 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid hydrochloride; MDL 16,455A; Fexofenadine (hydrochloride); 138452-21-8; Fexofenidine hydrochloride; Terfenadine carboxylate hydrochloride; MDL 16455; MDL-16455A; MDL-16455; DSSTox_CID_28642; C32H40ClNO4; DSSTox_RID_82912; DSSTox_GSID_48716; 2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride; 2-[4-[1	C32H40ClNO4	RRJFVPUCXDGFJB-UHFFFAOYSA-N	2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid;hydrochloride	n.a.	n.a.
PMDBD351	Fibre	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD356	Flucloxacillin sodium	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23667629	n.a.	n.a.	flucloxacillin sodium; 1847-24-1; Floxacillin sodium; Floxapen sodium; Flucloxacillin sodium salt; Floxacillin Na salt; Sodium flucloxacillin; Monosodium flucloxacillin; Stafopen sodium salt; Staphylex Sodium salt; MFI-PC; UNII-05F65O42VK; EINECS 217-428-0; Flucloxacillin-Sodium; NSC 277175; Floxacillin sodium salt; CHEBI:31615; 05F65O42VK; Floxapen (TN); 5-Methyl-3-(2-chloro-6-fluorophenyl)-4-isoxazolylpenicillin sodium; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazoly	C19H16ClFN3NaO5S	OTEANHMVDHZOPB-SLINCCQESA-M	sodium;(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD362	Flunarizine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282407	n.a.	n.a.	Flunarizine dihydrochloride; 30484-77-6; flunarizine hydrochloride; Flunarizine 2HCl; Flunarizine HCl; Flunarizine diHCl; Flunarizine (dihydrochloride); KW-3149; UNII-C11102TO53; 1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride; EINECS 250-216-6; Flunarizine hydrochloride [USAN:JAN]; R 14950; C11102TO53; 27064-95-5; (E)-1-(Bis-(p-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride; 1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride	C26H28Cl2F2N2	RXKMOPXNWTYEHI-RDRKJGRWSA-N	1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine;dihydrochloride	n.a.	n.a.
PMDBD363	Flunixin meglumine	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	39212	n.a.	n.a.	FLUNIXIN MEGLUMINE; 42461-84-7; Flunixin meglumin; Banamine; Flumeglumine; Flunixin-S; Sch 14714 meglumine; Flunixin N-methylglucanine; Flunixin (meglumine); Banamine (Veterinary); UNII-8Y3JK0JW3U; Sch-14714 meglumine; EINECS 255-836-0; 8Y3JK0JW3U; finadyne; CHEBI:76144; 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt; 1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate; 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid comp	C21H28F3N3O7	MGCCHNLNRBULBU-WZTVWXICSA-N	(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid	n.a.	n.a.
PMDBD368	Fluphenazine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	67356	n.a.	n.a.	Fluphenazine dihydrochloride; Fluphenazine hydrochloride; 146-56-5; Prolixin; Anatensol; Permitil; Moditen; Tensofin; Fluphenazine (dihydrochloride); OMCA; Lyorodin; Mirenil; Trancin; Liogen; FLUPHENAZINE HCL; Squibb 4918; Flufenazin; Calmansial; Fluphenazine chloride; Permitil hydrochloride; UNII-ZOU145W1XL; Fluorophenazine dihydrochloride; Dapotum; CCRIS 4032; EINECS 205-674-1; NSC 179197; ZOU145W1XL; Valamina; MFCD00055212; 1-(2-Hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine dihydrochloride; A 4077	C22H28Cl2F3N3OS	MBHNWCYEGXQEIT-UHFFFAOYSA-N	2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride	n.a.	n.a.
PMDBD369	Fluspirilen	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3396	n.a.	n.a.	Fluspirilene; Redeptin; Imap; 1841-19-6; Fluspirilen; Fluspirilenum [INN-Latin]; Fluspirileno [INN-Spanish]; McN-JR-6218; Fluspiriline; R 6218; 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; Fluspirilene [USAN:INN:BAN]; UNII-C5QA4GLR9M; EINECS 217-418-6; C5QA4GLR9M; BRN 0633853; 1-Phenyl-4-oxo-8-(4,4-bis(4-fluorophenyl)butyl)-1,3,8-triazaspiro(4,5)decane; CHEMBL46516; R-6218; 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro-(4.5)decan-4-one; NCGC00015424-11; NCGC00015424-04; Fluspirilenum	C29H31F2N3O	QOYHHIBFXOOADH-UHFFFAOYSA-N	8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	n.a.	n.a.
PMDBD370	Fluvoxamine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	9560989	n.a.	n.a.	FLUVOXAMINE MALEATE; Luvox; 61718-82-9; Fevarin; Luvox CR; Fluvoxamine (maleate); UNII-5LGN83G74V; DU23000; SME 3110; DU-23000; 5LGN83G74V; 54739-18-3; Floxyfral; Faverin; (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate; 5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate; 5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1); 54739-20-7; 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-but	C19H25F3N2O6	LFMYNZPAVPMEGP-PIDGMYBPSA-N	(Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine	n.a.	n.a.
PMDBD373	Freeze-dried doenjang	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD374	Furaltadone hydrochloride	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	9576185	n.a.	n.a.	Furaltadone hydrochloride; Furaltadone HCl; 3759-92-0; Furasol hydrochloride; Furaltadone (hydrochloride); NF-260; NF-902 hydrochloride; NSC 53270; levo-5-(Morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-2-oxazolidinone hydrochloride; 2-Oxazolidinone, 5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, L-, monohydrochloride; CCRIS 1041; EINECS 223-169-4; NF-269; 2-Oxazolidinone,5-(4-morpholinylmethyl)-3-[[(5-nitro-2-furanyl)methylene]amino]-,monohydrochloride; 3031-51-4; 2818-22-6; C13H16N4O6.HCl; C13H16N4O6.ClH; SR-010	C13H17ClN4O6	PPSVFZXMDMUIGB-FJUODKGNSA-N	5-(morpholin-4-ylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one;hydrochloride	n.a.	n.a.
PMDBD376	Fusidic acid sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23672955	n.a.	n.a.	Fusidate sodium; Sodium fusidate; 751-94-0; FUSIDIC ACID SODIUM SALT; Sodium fusidin; Fucidine; Fucidina; Intertulle fucidin; Fusidic acid sodium; ZN 6-NA; Fusidin; Fusidate Sodium [USAN]; Fusidic acid, sodium salt; Fusidic acid (sodium salt); UNII-J7P3696BCQ; SQ-16360; SQ 16360; EINECS 212-030-3; J7P3696BCQ; Fusidate sodium (USAN); Sodium 3alpha,11alpha,16beta-trihydroxy-29-nor-8alpha,9beta,13alpha,14beta-dammara-17(20),24-dien-21-oate 16-acetate; Fusin; SMR000326707; 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11	C31H47NaO6	HJHVQCXHVMGZNC-JCJNLNMISA-M	sodium;(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate	n.a.	n.a.
PMDBD379	Ganoderma lucidum	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD381	GBR 12909 dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	104920	n.a.	n.a.	67469-78-7; Vanoxerine dihydrochloride; GBR 12909 dihydrochloride; Vanoxeamine; Vanoxerine hydrochloride; GBR-12909 dihydrochloride; GBR-12909; Vanoxerine dihydrochloride(GBR12909); UNII-MWO1IP03EV; Vanoxerine 2HCl; I 893; I-893; 1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride; MWO1IP03EV; GBR12909 dihydrochloride; 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine dihydrochloride; 1-(2-[bis(4-Fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride; CHE	C28H34Cl2F2N2O	MIBSKSYCRFWIRU-UHFFFAOYSA-N	1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine;dihydrochloride	n.a.	n.a.
PMDBD383	Gegen Qilian decoction	Herbal Substance	TCM Formula	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD388	Gentamicine sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6419933	n.a.	n.a.	Gentamicine sulfate; Gentamicin, sulfate (salt); Gentamicin sulfate salt; GENTAMICIN SULPHATE; Prestwick_240; CHEMBL1200643; EBD9010; HMS1568O22; HMS3712O22; HMS2095O22; AKOS026750085; CCG-220160; gentamicin sulfate (water content 10%); AS-35221; AB0089061; J10041; SR-01000872641; 405G410; SR-01000872641-1; Gentamicin sulfate, meets EP, USP testing specifications; Gentamicin sulfate, meets USP testing specifications, powder; Gentamicin sulfate, European Pharmacopoeia (EP) Reference Standard; Gentamicin sulfate salt, potency: &gt	C60H125N15O25S	RDEIXVOBVLKYNT-HDZPSJEVSA-N	(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric aci	n.a.	n.a.
PMDBD395	Ginsenoside Rg3	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	9918693	n.a.	n.a.	Ginsenoside Rg3; 14197-60-5; (20S)-Propanaxadiol; 20S-propanaxadiol; (20S)-ginsenoside Rg3; 20(S)-Propanaxidiol; UNII-227D367Y57; 20(S)-Ginsenoside Rg3; CHEMBL398412; CHEBI:67991; 227D367Y57; 20(S)-Ginsenoside-Rg3; 20s-ginsenoside rg3; (R)Ginsenoside-Rg3; (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Rg3; Ginsenoside Rg3,(S); 2'(R)-Ginsenoside-Rg3; GTPL7658; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy	C42H72O13	RWXIFXNRCLMQCD-JBVRGBGGSA-N	(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD398	Glafenine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3085326	n.a.	n.a.	Glafenine hydrochloride; 65513-72-6; Glafenin hydrochloride; glafenine HCl; Glafenine (hydrochloride); DSSTox_CID_25497; DSSTox_RID_80916; DSSTox_GSID_45497; SR-01000473478; C19H17ClN2O4.ClH; Prestwick_628; Glafenine(hydrochloride); NCGC00016909-01; CAS-65513-72-6; MLS002154254; SCHEMBL970807; CHEMBL1572751; DTXSID7045497; KS-00001FBC; HY-B1153A; CTK8G0041; HMS1568L08; Tox21_110678; 2430AH; Tox21_110678_1; AKOS024374941; MCULE-3160845237; CCG-220293; CS-6517; Benzoic acid, 2-((7-chloro-4-quinolinyl)amino)-, 2,3-dihydroxypropyl ester, m	C19H18Cl2N2O4	CEUMONXVSJOJIH-UHFFFAOYSA-N	2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate;hydrochloride	n.a.	n.a.
PMDBD402	Glucuronidated compound	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD403	Glucuronides	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD404	Gluten	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD406	Glycyrrhiza uralensis	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD409	Grape antioxidant dietary fiber	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD410	Grape pomace cocentrate and grape seed extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD411	Grape-derived polyphenols	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD412	Green tea	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD413	Green tea extracts	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD414	Green tea leaves powder	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD416	Guanadrel sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	68552	n.a.	n.a.	Guanadrel sulfate; Hylorel; 22195-34-2; Hyloride; CL-1388R; CL 1388R; U 28288D; Guanadrel sulfate [USAN]; HSDB 6536; Hylorel (TN); Guanadrel Hemisulfate; U-28288D; U 28,288D; CHEBI:5556; (1,4-Dioxaspiro(4.5)dec-2-ylmethyl)guanidine sulfate (2:1); N-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate(2:1); U-28,288D; Guanidine (1,4-dioxaspiro(4.5)dec-2-ylmethyl)-, sulfate (2:1); Guanadrel sulfate (USAN); guanadrel sulfate (2:1); Anarel; Guanadrel sulfate [USAN:USP]; NCGC00016758-01; CAS-22195-34-2; DSSTox_CID_25432; DSSTox_RID_8087	C20H40N6O8S	RTEVGQJRTFFMLL-UHFFFAOYSA-N	2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine;sulfuric acid	n.a.	n.a.
PMDBD417	Halofantrine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	37392	n.a.	n.a.	HALOFANTRINE HYDROCHLORIDE; 36167-63-2; Halfan; Halofantrino [Spanish]; (+-)-Halofantrine hydrochloride; WR 171669; Halofantrine Hydrochloride [USAN]; WR-171,669; EINECS 252-895-4; UNII-2B7ENL644K; C26H30Cl2F3NO.HCl; WR-171669; 2B7ENL644K; NCGC00016833-01; DSSTox_CID_25464; 9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride; 1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl; DSSTox_RID_80895	C26H31Cl3F3NO	WANGFTDWOFGECH-UHFFFAOYSA-N	3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride	n.a.	n.a.
PMDBD421	Heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD422	Heterocyclic amines	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD426	High-fat (saturated and unsaturated)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD427	High-fat and high-sugar diet	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD428	High-fiber diets	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD429	High-flavanol cocoa powder extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD432	Hydrazine	Environmental Chemicals	Industrial Chemicals; Medicinal chemicals	n.a.	n.a.	n.a.	n.a.	n.a.	9321	n.a.	n.a.	HYDRAZINE; Diamine; 302-01-2; Levoxine; Diazane; Hydrazine base; Nitrogen hydride; Oxytreat 35; Hydrazyna; Hydrazines; Hydrazin; Hydrazyna [Polish]; Hydrazine, anhydrous; Hydrazine (anhydrous); RCRA waste number U133; hydrazinyl; UNII-27RFH0GB4R; CCRIS 335; HSDB 544; EINECS 206-114-9; UN3293; UN2029; H2NNH2; RCRA waste no. U133; 27RFH0GB4R; N2H4; CHEBI:15571; HYDRAZINE (HYDRAZINE SULFATE); Hydrazine solution; HDZ; Hydrazine/Hydrazine sulfate; Amerzine; amino nitrogen; Zerox; Catalyzed hydrazine; Scav-Ox II; Zerox (Salt/Mix); Amerzine (Salt/Mix	H4N2	OAKJQQAXSVQMHS-UHFFFAOYSA-N	hydrazine	n.a.	n.a.
PMDBD433	Hydrocortisone base	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5754	n.a.	n.a.	hydrocortisone; Cortisol; 50-23-7; Cetacort; Acticort; Hydrocortisyl; Hydrasson; Cobadex; Signef; Hytone; Cortef; Hycort; Optef; 17-Hydroxycorticosterone; Kendall's compound F; Hydrocortone; Hycortol; Efcorbin; Cortiment; Cortifan; Corticreme; Cortanal; Traumaide; Permicort; Ficortril; Dermacort; Tarcortin; Hycortole; Cortispray; Proctocort; Genacort; Efcortelan; Dermolate; Cortonema; Cortenema; Cleiton; Alacort; Cortril; Dihydrocostisone; Hytone lotion; Hydro-Adreson; Hidro-Colisona; Scheroson F; Reichstein's substance M; Incortin-H; Polcort H; Esider	C21H30O5	JYGXADMDTFJGBT-VWUMJDOOSA-N	(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one	n.a.	n.a.
PMDBD436	Ibutilide fumarate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281065	n.a.	n.a.	IBUTILIDE FUMARATE; 122647-32-9; Corvert; Ibutilide hemifumarate; Ibutilide Fumarate [USAN]; U-70226E; U 70226E; MFCD01715410; Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1); Ibutilide (fumarate); U70226E; (+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt); (+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate; (+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1	C44H76N4O10S2	PCIOHQNIRPWFMV-WXXKFALUSA-N	(E)-but-2-enedioic acid;N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide	n.a.	n.a.
PMDBD442	Incretin	Environmental Chemicals	Human Metabolite	n.a.	n.a.	n.a.	n.a.	n.a.	16140499	n.a.	n.a.	Incretin; Incretins; Insulin-releasing polypeptide; Glucose-Dependent Insulin-Releasing Hormone; 54241-84-8; Gastric Inhibitory Polypeptide human, &gt;=95% (HPLC); gastric inhibitory polypeptide (human)-Asn-Ile-Thr-Gln-OH	C226H338N60O66S	MGXWVYUBJRZYPE-YUGYIWNOSA-N	(2S)-5-amino-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propano	n.a.	n.a.
PMDBD444	Indatraline hydrochloride	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	10314472	n.a.	n.a.	Indatraline hydrochloride; 96850-13-4; CPD000449273; NCGC00094042-01; Lu 19-005; SMR000449273; SR-01000075409; 86939-10-8; Indatraline HCl; DSSTox_CID_22631; DSSTox_RID_80062; DSSTox_GSID_42631; MLS001423997; MLS000758200; Indatraline hydrochloride, solid; DTXSID3042631; CHEMBL1256749; CTK8G0299; (1r,3s)-indatraline hydrochloride; REGID_for_CID_10314472; Tox21_500684; Tox21_111238; BN0274; AKOS024456685; CCG-100795; NC00045; LP00684; NCGC00261369-01; CAS-96850-13-4; I-119; EU-0100684; B6799; SR-01000075409-1; SR-01000075409-3; (1R,3S)-rel-3	C16H16Cl3N	QICQDZXGZOVTEF-MELYUZJYSA-N	(1R,3S)-3-(3,4-dichlorophenyl)-N-methyl-2,3-dihydro-1H-inden-1-amine;hydrochloride	n.a.	n.a.
PMDBD448	Intact soy protein isolate	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD453	Ipsalazide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	72003	n.a.	n.a.	Ipsalazide; Ipsalazidum [Latin]; Ipsalazida [Spanish]; Ipsalazido [Spanish]; 80573-03-1; UNII-499H4332KZ; BX 650 A; BX-650A; 499H4332KZ; (E)-5-((4-(((Carboxymethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; (E)-p-((3-Carboxy-4-hydroxyphenyl)azo)hippuric acid; Ipsalazidum; Ipsalazida; Ipsalazido; Ipsalazide [INN:BAN]; Ipsalazide [BAN:INN]; Ipsalazide (free base); SCHEMBL596652; SCHEMBL11165440; CHEMBL2104872; ZINC4216628; LS-36378; Q27259264	C16H13N3O6	CQSRTOJJBONKMC-UHFFFAOYSA-N	5-[[4-(carboxymethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD456	Irsogladine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282435	n.a.	n.a.	irsogladine maleate; 84504-69-8; Gaslon; Irsogladine (maleate); MN-1695; UNII-66GVU60EPQ; 66GVU60EPQ; 57381-28-9; Irsogladine HBr; 6-(2,5-DICHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE MALEATE; DSSTox_RID_79454; 1,3,5-Triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-, (Z)-2-butenedioate (1:1); DSSTox_CID_20234; DSSTox_GSID_40234; s-Triazine, 2,4-diamino-6-(2,5-dichlorophenyl)-, maleate; Gaslon N; CAS-84504-69-8; Dicloguamine maleate;MN1695; Irsogladine maleate [JAN]; CCRIS 8107; C9H7Cl2N5.C4H4O4; Iosogladine maleate; NCGC00160397-01; Dic	C13H11Cl2N5O4	PJLVTVAIERNDEQ-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine	n.a.	n.a.
PMDBD460	Isoflavones	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD469	Ketorolac tromethamine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	84003	n.a.	n.a.	Ketorolac tromethamine; Ketorolac tris salt; 74103-07-4; Toradol; Acular; Ketorolac tromethamine salt; Acular LS; Ketorolac (tromethamine salt); Acular PF; Acuvail; Syntex; Ketorolac trometamol; SPRIX; Acular Preservative Free; Ketorolac (Toradol); Lixidol; Dolac; 2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate; Toradol (TN); (+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris salt; (+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(h	C19H24N2O6	BWHLPLXXIDYSNW-UHFFFAOYSA-N	2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid	n.a.	n.a.
PMDBD480	Lignans	Herbal Substance; Dietary Substance	Medicinal Herbal Compounds; Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD483	Lincomycin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64710	n.a.	n.a.	Lincomycin hydrochloride; LINCOMYCIN HCL; 859-18-7; Frademicina; Lincomycin (hydrochloride); 7179-49-9; UNII-GCW8Y9936L; C18H34N2O6S.HCl; Mycivin; Lincomix; Lincogap; GCW8Y9936L; Lincomix 20; Pura Ject 100; NCGC00159326-02; Lincolnensin, hydrochloride; DSSTox_RID_82556; DSSTox_CID_27780; DSSTox_GSID_47803; Antibiotic 124a, hydrochloride; Lincomycin hydrochloride anhydrous; EINECS 212-726-7; U 10149a; Lincocin Hydrochloride; (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)pro	C18H35ClN2O6S	POUMFISTNHIPTI-BOMBIWCESA-N	(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD486	Linum usitatissimum	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD489	Lomefloxacin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	68624	n.a.	n.a.	Lomefloxacin hydrochloride; 98079-52-8; Lomefloxacin HCl; Maxaquin; Okacyn; Uniquin; Bareon; Ny-198; Mazaquin; SC-47111; Lomefloxacin (hydrochloride); NY 198; CCRIS 2581; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; Lomefloxacin hydrochloride [USAN:JAN]; CHEBI:6518; MFCD00214312; Lomefloxacin hydrochloride (Maxaquin); L-6500; DSSTox_RID_80931; DSSTox_CID_25527; DSSTox_GSID_45527; (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarbox	C17H20ClF2N3O3	KXEBLAPZMOQCKO-UHFFFAOYSA-N	1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;hydrochloride	n.a.	n.a.
PMDBD491	Loperamide hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	71420	n.a.	n.a.	Loperamide hydrochloride; 34552-83-5; Loperamide HCl; Imodium; Suprasec; Loperyl; Lopemin; Fortasec; Lopemid; Dissenten; Tebloc; Imosec; Imodium A-D; Maalox Antidiarrheal; BREK; BLOX; Loperamide (hydrochloride); UNII-77TI35393C; PJ185; EINECS 252-082-4; Maalox Anti-Diarrheal; C29H33ClN2O2.HCl; MLS000069779; 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride; CHEBI:6533; R 18553; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride; 4-(p-Chloroph	C29H34Cl2N2O2	PGYPOBZJRVSMDS-UHFFFAOYSA-N	4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide;hydrochloride	n.a.	n.a.
PMDBD497	Lovastatin related compounds	Therapeutic Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD498	Low glycinin soy milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD499	Low glycinin soy milk (49.5% β-conglycinin/6% glycinin)	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD500	Low-fiber diet	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD501	Low-fibre diet	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD502	Loxapine succinate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	71399	n.a.	n.a.	Loxapine succinate; 27833-64-3; Loxapine succinate salt; Loxapac; Cloxazepin; Daxolin; Loxapine (succinate); Lederle; UNII-X59SG0MRYU; Loxapine,succinate; CCRIS 1917; EINECS 248-682-0; X59SG0MRYU; CL 71563; CPD000058470; MLS000069383; Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1); NCGC00016160-02; SMR000058470; CAS-27833-64-3; DSSTox_RID_80764; DSSTox_CID_25227; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1); DSSTox_GSID_45227; C22H24ClN3O5; CL-71563	C22H24ClN3O5	YQZBAXDVDZTKEQ-UHFFFAOYSA-N	butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine	n.a.	n.a.
PMDBD506	Mafenide hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	67313	n.a.	n.a.	Mafenide hydrochloride; 138-37-4; 4-Aminomethylbenzenesulfonamide hydrochloride; 4-(Aminomethyl)benzenesulfonamide hydrochloride; Marfanil; Masudin; Morfanil; Homosulfamine; Homosulfamine hydrochloride; Mafenide HCl; Emilene hydrochloride; Sulfamylon hydrochloride; Sulfbenzamine hydrochloride; 4-Homosulfanilamide hydrochloride; Mesudin hydrochloride; Ambamide hydrochloride; Mesudrin hydrochloride; Neofamid hydrochloride; Homosulfanilamide hydrochloride; Maphenide hydrochloride; Mafenide (hydrochloride); p-Aminomethylphenylsulfo	C7H11ClN2O2S	SIACJRVYIPXFKS-UHFFFAOYSA-N	4-(aminomethyl)benzenesulfonamide;hydrochloride	n.a.	n.a.
PMDBD507	Magnoloside A	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	21629882	n.a.	n.a.	Magnoloside A; 113557-95-2; ZINC252586492; W1954	C29H36O15	QLZWUGOYBODRLF-QQLYGORSSA-N	[(2R,3R,4R,5R,6R)-2-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-4-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate	n.a.	n.a.
PMDBD509	Marine oil	Dietary Substance	Nutrient Supplement	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD510	Maru cultivar blueberry extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD513	Mebhydroline 1,5-naphtalenedisulfonate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	22529	n.a.	n.a.	Mebhydrolin napadisylate; 6153-33-9; Diazoline; Mebhydrolin napadisilate; Diazolin; Incidal; Mebhydroline Napadisylate; Omeril; Diazolinum; Mebhydrolin (napadisylate); Mebhydroline 1,5-naphthalenedisulfonate salt; UNII-O5G04RB25M; EINECS 228-170-3; mebhydroline 1,5-naphthalenedisulfonate; O5G04RB25M; Mebhydrolin 1,5-naphtalenedisulfonate; Mebhydroline 1,5-naphtalenedisulfonate; NCGC00017059-01; CAS-6153-33-9; 1,5-Naphthalenedisulfonic acid, compd. with 2,3,4,5-tetrahydro-2-methyl-5-(phenylmethyl)-1H-pyrido(4,3-b)indole (1:2)	C48H48N4O6S2	CJUOSBUQOWKEKJ-UHFFFAOYSA-N	5-benzyl-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole;naphthalene-1,5-disulfonic acid	n.a.	n.a.
PMDBD514	Meclocycline sulfosalicylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54676538	n.a.	n.a.	Meclocycline sulfosalicylate; Mecloderm; Meclutin; Meclan; Meclan Cream; 73816-42-9; UNII-46VZA7RX2B; Meclocycline sulfosalicylate salt; Meclocycline 5-sulfosalicylate; EINECS 277-614-2; 46VZA7RX2B; Meclocycline (Sulfosalicylate Salt); (4S,4aR,5S,5aR,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide mono(5-sulfosalicylate) (salt); C22H21ClN2O8.C7H6O6S; Benzoic acid, 2-hydroxy-5-sulfo-, compd. with (4S-(4alpha,4aalpha,5alpha,5aalpha,1	C29H27ClN2O14S	WVJKUGVVYXCLFV-CCHMMTNSSA-N	(4S,4aR,5S,5aR,12aR)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;2-hydroxy-5-sulfobenzoic acid	n.a.	n.a.
PMDBD515	Meclofenamic acid sodium salt monohydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23663959	n.a.	n.a.	Meclomen; Meclodol; Lenidolor; meclofenamate sodium hydrate; UNII-94NJ818U2W; 67254-91-5; Meclofenamic acid sodium salt monohydrate; Meclofenamate sodium monohydrate; CHEBI:76232; 94NJ818U2W; NCGC00017062-01; CAS-6385-02-0; Meclomen (TN); DSSTox_RID_80964; DSSTox_CID_25567; DSSTox_GSID_45567; CL-583.NA SALT; Meclofenamate Sodium [USAN]; 2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid sodium salt monohydrate; Prestwick_829; SCHEMBL3504; Meclofenamate sodium (USP); MLS002222266; sodium meclofenamate monohydrate; C14H10Cl2NO2.Na.H	C14H12Cl2NNaO3	QHJLLDJTVQAFAN-UHFFFAOYSA-M	sodium;2-(2,6-dichloro-3-methylanilino)benzoate;hydrate	n.a.	n.a.
PMDBD516	Meclozine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64713	n.a.	n.a.	Meclizine dihydrochloride; 1104-22-9; Meclozine dihydrochloride; Bonamine; Meclizine hydrochloride; 1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride; Postafen; Vertizine; Diadril; Taizer; V-Cline; Duremesin; Ancolan dihydrochloride; Postafene dihydrochloride; meclizine diHCl; Meclizine (dihydrochloride); NSC 28728; Parachloramine dihydrochloride; Meclizine hydrochloride anhydrous; EINECS 214-164-8; UNII-V5604WJ3XP; UNII-408UZ554UD; V5604WJ3XP; Meclizine 2HCl; 408UZ554UD; 1-[(4-chlorophenyl)(phenyl)met	C25H29Cl3N2	VCTHNOIYJIXQLV-UHFFFAOYSA-N	1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;dihydrochloride	n.a.	n.a.
PMDBD518	Mefloquine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	65329	n.a.	n.a.	Mefloquine hydrochloride; Mefloquine HCL; 51773-92-3; Mephaquin; Mefloquine (hydrochloride); WR 142490 hydrochloride; NSC 157387; UNII-326VC85GV6; Ro 21-5998/001; EINECS 257-412-0; 326VC85GV6; DSSTox_RID_82568; DSSTox_CID_27796; DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride; DSSTox_GSID_47819; Loriam; MLS001332559; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol hydrochloride; (R*,S*)-(1)-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol mono	C17H17ClF6N2O	WESWYMRNZNDGBX-YLCXCWDSSA-N	(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol;hydrochloride	n.a.	n.a.
PMDBD526	Mesoridazine besylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	36207	n.a.	n.a.	MESORIDAZINE BESYLATE; 32672-69-8; Mesoridazine benzenesulfonate; NC 123; UNII-T4G2I958J2; C21H26N2OS2.C6H6O3S; Mesoridazine besylate [USP]; CHEBI:6781; T4G2I958J2; mesoridazine besilate; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate; benzenesulfonic acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine; (+-)-10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate; Mesoridazine besylate (USP)	C27H32N2O4S3	CRJHBCPQHRVYBS-UHFFFAOYSA-N	benzenesulfonic acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine	n.a.	n.a.
PMDBD531	Methacycline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54685047	n.a.	n.a.	METHACYCLINE HYDROCHLORIDE; 3963-95-9; Methacycline HCl; Metacycline hydrochloride; Rondomycin; Ciclobiotic; Germiciclin; Adriamicina; Metadomus; Metilenbiotic; Physiomycine; Globociclina; Optimycin; Megamycine; Londomycin; Rindex; UNII-9GJ0N7ZAP0; Methacycline (hydrochloride); Methacycline monohydrochloride; EINECS 223-568-3; NSC 356465; 9GJ0N7ZAP0; C22H23ClN2O8; CHEBI:6806; NSC-356465; DSSTox_RID_80840; DSSTox_CID_25382; DSSTox_GSID_45382; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-d	C22H23ClN2O8	VXPSARQTYDZXAO-CCHMMTNSSA-N	(4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD532	Methantheline bromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5883	n.a.	n.a.	METHANTHELINE BROMIDE; Banthine; Methanthelinium bromide; Dixamone bromide; Ulcudexter; Frenogastrico; Gastrosedan; Resobantin; Vagantin; Doladene; Vagamin; Metantyl; Gastron; Methelina; Metaxan; Xanteline; Banthin; Asabaine; Ulcine; Avagal; 53-46-3; MTB 51; Metantelinio bromuro [DCIT]; UNII-090519SAPF; SC 2910; Banthine bromide; Methanthine bromide; Methanthelinii bromidum [INN-Latin]; EINECS 200-176-0; NSC 32145; Bromuro de metantelinio [INN-Spanish]; Bromure de methanthelinum [INN-French]; 090519SAPF; Xanthene-9-carboxylic acid, ester w	C21H26BrNO3	PQMWYJDJHJQZDE-UHFFFAOYSA-M	diethyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium;bromide	n.a.	n.a.
PMDBD533	Methiazole	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6604471	n.a.	n.a.	Methiazole; 74239-55-7; N-[6-(propan-2-ylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester; Prestwick-14D11; Prestwick3_001080; Prestwick0_001080; Prestwick2_001080; Prestwick1_001080; Methiazole, 98% (TLC); BSPBio_001100; MLS002154145; SPBio_003000; SCHEMBL9882802; BPBio1_001210; CHEMBL1354363; CTK8G0826; CHEBI:94268; DTXSID50424979; HMS3715G22; HMS3370O02; HMS2231A21; HMS2098G22; HMS1571G22; ZINC4245701; CCG-221080; NCGC00017007-01; NCGC00017007-02; SMR001233449; AB00514034; SR-01000841828; SR-01000841828-2; BRD-K02764365-001-05-2	C12H15N3O2S	SXJIZQPZESTWLD-UHFFFAOYSA-N	methyl N-(6-propan-2-ylsulfanyl-1H-benzimidazol-2-yl)carbamate	n.a.	n.a.
PMDBD534	Methiothepin maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5358812	n.a.	n.a.	Methiothepin maleate; METITEPINE MALEATE; 19728-88-2; CHEBI:64202; NSC281816; 8-Methylthio-10-(4-methylpiperazino)-10,11-dihydrodibenzo(b,f)thiepin maleate; 1-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methylpiperazine maleate; MLS000756636; 1-methyl-4-[8-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazine (2Z)-but-2-enedioate; 20229-30-5; SR-01000075560; Prestwick_739; Piperazine, 1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methyl-, (2Z)-2-butenedioate (1:1); SPECTRUM150363	C24H28N2O4S2	IWDBEHWZGDSFHR-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine	n.a.	n.a.
PMDBD536	Methotrimeprazine maleat salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282484	n.a.	n.a.	levomepromazine maleate; Methotrimeprazine maleate; 7104-38-3; Levo Mepromazine Maleate; UNII-5KN5Y9V01K; 5KN5Y9V01K; Methoprazine; Methotrimeprazine maleat salt; Levomepromazinmaleat; Hirnamin (TN); [(2R)-3-(2-methoxyphenothiazin-10-yl)-2-methylpropyl]dimethylamine, (2Z)but-2- enedioic acid; (Z)-but-2-enedioic acid;(2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; Levomepromazine maleate [USAN:JAN]; EINECS 230-412-8; NCGC00016681-01; CAS-7104-38-3; DSSTox_RID_80853; DSSTox_CID_25399; DSSTox_GSID_45399; SCHE	C23H28N2O5S	IFLZPECPTYCEBR-VIEYUMQNSA-N	(Z)-but-2-enedioic acid;(2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine	n.a.	n.a.
PMDBD539	Methyl benzethonium chloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5702238	n.a.	n.a.	Methylbenzethonium chloride; 25155-18-4; Methyl benzethonium chloride; UNII-NN7590IUQX; NN7590IUQX; Benzyldimethyl(2-(2-((4-(1,1,3,3-tetramethylbutyl)-o-tolyl)oxy)ethoxy)ethyl)ammonium chloride; MLS002153966; Quat20; Quat 20; SR-05000002081; benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride; SMR001233305; Prestwick_9; C28H44ClNO2; SPECTRUM1503253; SCHEMBL136062; METHYLBENZTHONIUM CHLORIDE; CHEMBL1321398; HMS502B21; HMS2235G10; HMS1570M11; Pharmakon1600-01503253; HMS3371P01; HMS209	C28H44ClNO2	QWZLBLDNRUUYQI-UHFFFAOYSA-M	benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride	n.a.	n.a.
PMDBD540	Methylmercury	Environmental Chemicals	Industrial Chemicals and Pollutants; Toxic Agents	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD542	Methysergide maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281073	n.a.	n.a.	Methysergide maleate; 129-49-7; Deseril-retard; Methysergide hydrogen maleate; Desernil bismaleate; Deseril; Methysergide bimaleate; Methysergide maleate salt; UNII-2U7H1466GH; EINECS 204-950-9; NSC 186061; Methysergide maleate [USP]; 1-Methyl-D-lysergic acid butanolamide dimaleate; 2U7H1466GH; Lysergamide, N-((1-hydroxymethyl)propyl)-1-methyl-, maleate; (+)-N-((1-Hydroxymethyl)propyl)-1-methyl-D-lysergamide bimaleate; 1-(Hydroxymethyl)propylamide of 1-methyl-(+)-lysergic acid hydrogen maleate; Methysergide maleate (USP)	C25H31N3O6	LWYXFDXUMVEZKS-ZVFOLQIPSA-N	(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid	n.a.	n.a.
PMDBD543	Metitepine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5358812	n.a.	n.a.	Methiothepin maleate; METITEPINE MALEATE; 19728-88-2; CHEBI:64202; NSC281816; 8-Methylthio-10-(4-methylpiperazino)-10,11-dihydrodibenzo(b,f)thiepin maleate; 1-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methylpiperazine maleate; MLS000756636; 1-methyl-4-[8-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazine (2Z)-but-2-enedioate; 20229-30-5; SR-01000075560; Prestwick_739; Piperazine, 1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methyl-, (2Z)-2-butenedioate (1:1); SPECTRUM150363	C24H28N2O4S2	IWDBEHWZGDSFHR-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine	n.a.	n.a.
PMDBD544	Metixene hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64722	n.a.	n.a.	metixene hydrochloride; Contalyl; Methixene hydrochloride; Tremaril hydrochloride; 1553-34-0; Methixart; Tremaril wonder; Methixene HCl; Methixene hydrochloride anhydrous; N 715; EINECS 216-300-1; 9-(1-Methyl-3-piperidylmethyl)thiaxanthene hydrochloride; 9-(1'-Methylpiperidine-3'-methyl)thioxanthene hydrochloride; NSC 78194; 1-Methyl-3-(thioxanthen-9-ylmethyl)-1-piperidine hydrochloride; 1-Pipecoline, 3-(thioxanthen-9-yl)methyl-, hydrochloride; Thioxanthene, 9-(1-methyl-3-piperidylmethyl)-, hydrochloride; Piperidine, 1-meth	C20H24ClNS	RSXZRFHNNTTWCB-UHFFFAOYSA-N	1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;hydrochloride	n.a.	n.a.
PMDBD545	Metoprolol tartrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441308	n.a.	n.a.	56392-17-7; Selectadril; Metoproferm; Metocard; Jeprolol; Cardoxone; Arbralene; Topromel; Prolaken; Metomerck; Mepolol; Sigaprolol; Selopral; Metoberag; Bloksan; Vasocardin; Selokeen; Ritmolol; Metoprolin; Metolol; Metoberta; Kapodine; Beprolo; Azumetop; Prelis; Bloxan; Minax; Metoprolol acis; Metop; Lanoc; Beloc; Metoprolol-rpm; Metoprolol-Wolf; Slow lopresor; Metoprolol Atid; Slow-Lopresor; Apo-Metoprolol; Metoprolol Verla; Metoprolol PB; Metoprolol AL; Metoprolol Stada; Metoprolol-GRY; Meto-Isis; Metoprolol Basics; Proken M; Metoprolol Heumann; Meto	C34H56N2O12	YGULWPYYGQCFMP-CEAXSRTFSA-N	(2R,3R)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol	n.a.	n.a.
PMDBD552	Minocycline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54685925	n.a.	n.a.	MINOCYCLINE HYDROCHLORIDE; 13614-98-7; Minocycline HCl; Arestin; Minomycin; Vectrin; Minocycline chloride; Minocin; Minomax; Periocline; Solodyn; Tri-mino; Minocycline (hydrochloride); Dynacin; Mynocine hydrochloride; Tri-minocycline; UNII-0020414E5U; EINECS 237-099-7; Minocycline hydrochloride (internal use); C23H27N3O7.HCl; Minocycline, Hydrochloride; 0020414E5U; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride; DSSTox_RID_80306; DSST	C23H28ClN3O7	WTJXVDPDEQKTCV-VQAITOIOSA-N	(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD556	Monensin sodium salt	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	23667299	n.a.	n.a.	Monensin sodium salt; Monensin sodium; Sodium monensin; 22373-78-0; DSSTox_RID_80970; DSSTox_CID_25573; DSSTox_GSID_45573; Monensin A sodium salt; NSC343257; C36H61NaO11; NCGC00017089-01; CAS-22373-78-0; MLS002153986; SCHEMBL4057708; DTXSID2045573; CHEMBL1908308; HMS2097E18; HMS3714E18; HY-N0150; Tox21_110771; Tox21_113191; s2324; AKOS025147337; CCG-220748; AM84797; SMR001233320; CS-0007881; dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate	C36H61NaO11	XOIQMTLWECTKJL-FBZUZRIGSA-M	sodium;(2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate	n.a.	n.a.
PMDBD557	Monomeric-rich fraction grape seed extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD559	Moricizine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	34632	n.a.	n.a.	MORICIZINE HYDROCHLORIDE; Moracizine hydrochloride; 29560-58-5; Ethmozine; Ethmosine; Moricizine HCl; Etmozin; Ethmozin; UNII-71OK3Z1ESP; 71OK3Z1ESP; MLS000830274; Moricizine hydrochloride [USP]; EN 313; moracizine HCl; SMR000036736; Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate hydrochloride; Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate hydrochloride; Ethyl ether of 10-(beta-morpholylpropionyl)phenthiazinecarbamino acid hydrochloride; DSSTox_RID_82543; DSSTox_CID_27766; DSSTox_GSID_47786	C22H26ClN3O4S	GAQAKFHSULJNAK-UHFFFAOYSA-N	ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate;hydrochloride	n.a.	n.a.
PMDBD561	Moxalactam disodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441242	n.a.	n.a.	MOXALACTAM DISODIUM; Moxam; latamoxef sodium; latamoxef disodium; Disodium latamoxef; 64953-12-4; Shiomarin; Moxalactam disodium salt; Shionogi 6059S; Antibiotic 6059-S; 6059-S; LY-127935; DSSTox_RID_80988; DSSTox_CID_25595; DSSTox_GSID_45595; LY 127935; EINECS 265-288-4; 6059S; Moxalactam disodium (USAN); S-6059; Moxalactam disodium [USAN:USP]; Shiomarin (TN); Prestwick_33; NCGC00017130-01; N-((6R,7R)-2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-en-7-yl)-2-(p-hydroxyphenyl)m	C20H18N6Na2O9S	GRIXGZQULWMCLU-HUTAOCTPSA-L	disodium;(6R,7R)-7-[[2-carboxylato-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD564	N6-methyladenosine	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	102175	n.a.	n.a.	N6-Methyladenosine; N-Methyladenosine; 1867-73-8; 6-Methyladenosine; N(6)-Methyladenosine; 6-Methylaminopurinosine; 6-Methylaminopurine riboside; 6-Methylaminopurine D-riboside; N6-methyladenosine (m6A); 6-Methylaminopurine ribonucleoside; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol; UNII-CLE6G00625; CHEBI:21891; (N-6)-Methyladenosine; N(6)-monomethyladenosine; CHEMBL383144; CLE6G00625; NSC 29409; M6A; NSC-29409; (2R,3S,4R,5R)-2-Hydroxymethyl-5-(6-methylamino-p	C11H15N5O4	VQAYFKKCNSOZKM-IOSLPCCCSA-N	(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolane-3,4-diol	n.a.	n.a.
PMDBD567	Nafcillin sodium salt monohydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23704143	n.a.	n.a.	Nafcillin sodium salt monohydrate; NAFCILLIN SODIUM; Nafcillin sodium monohydrate; 7177-50-6; Nafcillin sodium hydrate; Nafcil; UNII-49G3001BCK; Nafcillin (sodium monohydrate); Wy 3277; CHEBI:51919; 49G3001BCK; WY-3277; NCGC00017070-01; CAS-7177-50-6; DSSTox_RID_80967; DSSTox_CID_25570; DSSTox_GSID_45570; Nafcillin natrium-1-wasser; SMR000653476; Naphthicillin; Nafcillin sodium [USAN:USP]; Unipen (TN); Nafcillin sodium (USP); Monosodium (2S,5R,6R)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-c	C21H23N2NaO6S	OCXSDHJRMYFTMA-KMFBOIRUSA-M	sodium;(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate	n.a.	n.a.
PMDBD568	Nafronyl oxalate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	312915	n.a.	n.a.	Nafronyl oxalate; 3200-06-4; Naftidrofuryl oxalate; Nafronyl oxalate salt; Naftidrofuryl (oxalate); 2-(Diethylamino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)methyl)propanoate oxalate; Dusodril; Dubimax; Praxilene; Iridus; LS-121; EU-1806; DSSTox_RID_80935; DSSTox_CID_25533; DSSTox_GSID_45533; naftidrofuryl hydrogen oxalate; UNII-5ADB8D9388; CHEMBL1439099; SMR000539007; 2-Furanpropanoic acid, tetrahydro-a-(1-naphthalenylmethyl)-,2-(diethylamino)ethyl ester, ethanedioate (1:1); Nafronyl oxalate salt, analytical standar	C26H35NO7	SSAJNPNVUYMUCI-UHFFFAOYSA-N	2-(diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate;oxalic acid	n.a.	n.a.
PMDBD570	Naftopidil dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	11957660	n.a.	n.a.	NAFTOPIDIL DIHYDROCHLORIDE; 57149-08-3; Naftopidil DiHCl; Avishot; Flivas; 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol dihydrochloride; C24H30Cl2N2O3; 1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthoxy)-2-propanol dihydrochloride; SR-01000002977; Naftopidil dihydrochloride [MI]; Naftopidil 2HCl; KT-611 dihydrochloride; Naftopidil.Dihydrochloride; EU-0100941; Naftopidil (dihydrochloride); SCHEMBL1322047; CHEMBL1593765; HMS1571C11; KS-00000GR4; Tox21_500941; s1387	C24H30Cl2N2O3	HZVCEQMJXMUXJF-UHFFFAOYSA-N	1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;dihydrochloride	n.a.	n.a.
PMDBD571	Nalidixic acid sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3864541	n.a.	n.a.	Nalidixic acid sodium salt; Baktogram; 3374-05-8; Nalidixic acid sodium; Sodium nalidixate; NALIDIXATE SODIUM; Dixilina; Chemiurin; Nalidixic acid (sodium salt); UNII-Y7NU182221; Nalidixate sodium anhydrous [USAN]; EINECS 222-159-7; Y7NU182221; Win 18320; sodium 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate; Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate; 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium salt; Nalidixate sodium anhydrous; 1,8-Naphthy	C12H11N2NaO3	ROKRAUFZFDQWLE-UHFFFAOYSA-M	sodium;1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate	n.a.	n.a.
PMDBD573	Naproxen(+)	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	156391	n.a.	n.a.	NAPROXEN; 22204-53-1; (S)-Naproxen; (+)-Naproxen; Naprosyn; Naproxene; Equiproxen; Aleve; (S)-(+)-Naproxen; Laraflex; d-Naproxen; (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Naproxenum; Calosen; Nycopren; Naproxeno; Naprosyne; Bonyl; Naixan; Reuxen; Axer; (+)-(S)-Naproxen; Ec-Naprosyn; (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid; Flexipen; Clinosyn; Artrixen; Anexopen; Acusprain; Leniartil; Danaprox; Bipronyl; Artroxen; Novonaprox; Arthrisil; Napren; Naposin; Napflam; Genoxen; Daprox; Atiflan	C14H14O3	CMWTZPSULFXXJA-VIFPVBQESA-N	(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid	n.a.	n.a.
PMDBD578	Nefazodone HCl	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54911	n.a.	n.a.	NEFAZODONE HYDROCHLORIDE; 82752-99-6; Nefazodone Hcl; Dutonin; Serzone; Menfazona; Rulivan; Reseril; Nefazodone (hydrochloride); 1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one hydrochloride; BMY 13754; 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; BMY-13754; Nefadar; UNII-27X63J94GR; MJ-13754-1; CHEBI:7495; MJ 13,754-1; 27X63J94GR; 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-pheno	C25H33Cl2N5O2	DYCKFEBIOUQECE-UHFFFAOYSA-N	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride	n.a.	n.a.
PMDBD580	Neoprontosil	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	8625	n.a.	n.a.	Neoprontosil; AZOSULFAMIDE; 132-38-7; CHEMBL237251; PRONTOCIL; Neoprontosil, disodium salt; Neoprontsil; AABSSN; 2,7-Naphthalenedisulfonic acid, 6-(acetylamino)-3-[[4-(aminosulfonyl)phenyl]azo]-4-hydroxy-, disodium salt; DTXSID0074500; CTK0H9987; ZINC28863804; BDBM50221406; ZINC261161909; NS00041391; 6-acetamido-4-hydroxy-3-((4-sulfamoylphen	C18H16N4O10S3	RALNLQYPLYWQRT-UHFFFAOYSA-N	6-acetamido-4-hydroxy-3-[(4-sulfamoylphenyl)diazenyl]naphthalene-2,7-disulfonic acid	n.a.	n.a.
PMDBD581	Neostigmine bromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	8246	n.a.	n.a.	neostigmine bromide; 114-80-7; Neoserine bromide; Eustigmin bromide; neo-Proserin; Proserine bromide; Stigmanol bromide; Synstigmin bromide; Leostigmine bromide; Prostigmin; Philostigmin bromide; Kirkstigmine bromide; Stigmosan bromide; Prostigmin bromide; Neostigmine methyl bromide; Prostigmine bromide; Vagostigmine bromide; Syntostigmin bromide; Neostigmini bromidum; Synstigmini bromidum; Vagostigmin; 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide; Syntostigmine bromide; Synthostigmine bromide; Syntostigmin (tab	C12H19BrN2O2	LULNWZDBKTWDGK-UHFFFAOYSA-M	[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide	n.a.	n.a.
PMDBD597	Nitrobenzodiazepine	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD604	Nonfermented soybean milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD605	Nopal	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD606	Norcyclobenzaprine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD609	Novobiocin sodium salt	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	54730021	n.a.	n.a.	Novobiocin sodium salt; 1476-53-5; Albamycin;Cathomycin; CHEMBL2079809; HMS3374H11; HMS3656A08; VA11981; MCULE-6200351849; AK163556; SC-20129; AS-57689; FT-0673157; Z1583387385; sodium 4-[(7-{[4-(carbamoyloxy)-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy}-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)carbamoyl]-2-(3-methylbut-2-en-1-yl)benzen-1-olate; Benzamide,N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-a-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl	C31H35N2NaO11	WWPRGAYLRGSOSU-UHFFFAOYSA-M	sodium;4-[[7-(4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl)oxy-4-hydroxy-8-methyl-2-oxochromen-3-yl]carbamoyl]-2-(3-methylbut-2-enyl)phenolate	n.a.	n.a.
PMDBD610	NSAIDs	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD612	Oil tea	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD613	Okara (soy pulp/soy fiber)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD615	Oligofructose	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD616	Oligomeric-rich fraction grape seed extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD617	Olmesartan medoxomil	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	130881	n.a.	n.a.	Olmesartan medoxomil; 144689-63-4; Benicar; Olmetec; CS-866; Cs 866; UNII-6M97XTV3HD; 6M97XTV3HD; C29H30N6O6; NCGC00095136-01; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester; Olvance; Olsertain; Benevas	C29H30N6O6	UQGKUQLKSCSZGY-UHFFFAOYSA-N	(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate	n.a.	n.a.
PMDBD620	Oorethindrone acetate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD621	Oorgestimate	Therapeutic Substance	Approved Drug	35189-28-7	DB00957	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD622	Ooscapine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD625	Orphenadrine citrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	83823	n.a.	n.a.	Orphenadrine citrate; 4682-36-4; Banflex; Flexon; Flexoject; Orphenadrine dihydrogen citrate; Orphenadrine (Citrate); X-Otag; Plenactol; Flexor; Euflex; Tega-Flex; Norflex (pharmaceutical); 2-hydroxypropane-1,2,3-tricarboxylic acid; dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine; Orphenadrine citrate salt; EINECS 225-137-5; Orphenadrine citrate [USP]; Orphenadrine citrate (Norflex); CHEBI:7790; 4596-23-0; NCGC00094745-01; N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1); Orphenadrine citrate (	C24H31NO8	MMMNTDFSPSQXJP-UHFFFAOYSA-N	N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid	n.a.	n.a.
PMDBD626	Oxacillin sodium	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23667631	n.a.	n.a.	Oxacillin sodium salt; OXACILLIN SODIUM; Oxabel; 1173-88-2; Prostaphlin; Staphcillin V; Oxabel Sodium salt; Monosodium oxacillin; Bristopen; Stapenor; Resistopen; Micropenin; Sodium oxacillin; Oxacillin (sodium salt); Oxacillin sodium (VAN); Oxacillin sodium anhydrous; UNII-4TWD2995UP; Cryptocillin; CHEBI:52134; BRL 1400; EINECS 214-636-3; Bactocill; Sodium methylphenylisoaxazolylpenicillin; NSC 527712; 4TWD2995UP; 5-Methyl-3-phenyl-4-isoxazolyl penicillin, sodium; SQ-16423; Bactocill In Plastic Container; 4-Thia-1-azabicyclo[3.2.0]he	C19H18N3NaO5S	VDUVBBMAXXHEQP-SLINCCQESA-M	sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD630	Oxethazaine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4621	n.a.	n.a.	Oxethazaine; Oxetacaine; 126-27-2; Oxethacaine; Mucaine; Oxaethacainum; Oxaine; Stomacain; Muthesa; Betalgil; Topicain; Oxethacaina [Italian]; oxethazine; Tepilta; Oxetacainum [INN-Latin]; Oxetacaina [INN-Spanish]; UNII-IP8QT76V17; CCRIS 4692; EINECS 204-780-5; WY 806; FH 099; BRN 2404063; CHEMBL127592; IP8QT76V17; CHEBI:31947; Wy-806; Oxetacaine (INN); Oxetacaine [INN]; 2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); NCGC00016382-01; CAS-126-27-2; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)amino	C28H41N3O3	FTLDJPRFCGDUFH-UHFFFAOYSA-N	2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide	n.a.	n.a.
PMDBD631	Oxibendazol	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD632	Oxiconazole Nitrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	9556529	n.a.	n.a.	Oxiconazole nitrate; Oxistat; Myfungar; Oceral; 64211-46-7; oxiconazole; Sgd 301-76; ST 813; UNII-RQ8UL4C17S; EINECS 264-730-3; Oxiconazole nitrate [USAN:JAN]; ST-813; RQ8UL4C17S; CHEBI:7826; 2',4'-Dichloro-2-imidazol-1-ylacetophenone (Z)-(O-(2,4-dichlorobenzyl)oxime), mononitrate; RO-13-8996; NCGC00095170-01; DSSTox_RID_81241; 2',4'-Dichloro-2-imidazol-1-ylacetophenone (Z)-(o-(2,4-dichlorobenzyl))oxime nitrate; DSSTox_CID_25943; DSSTox_GSID_45943; Ro 13-8996; Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, O-((2,4-dichl	C18H14Cl4N4O4	WVNOAGNOIPTWPT-NDUABGMUSA-N	(Z)-1-(2,4-dichlorophenyl)-N-[(2,4-dichlorophenyl)methoxy]-2-imidazol-1-ylethanimine;nitric acid	n.a.	n.a.
PMDBD634	Oxybutynin chloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	91505	n.a.	n.a.	Oxybutynin chloride; Oxybutynin hydrochloride; 1508-65-2; Oxybutynin HCl; Dridase; Tropax; Oxybutynin (chloride); Ditropan Xl; Oxibutinina hydrochloride; EINECS 216-139-7; 4-(Diethylamino)but-2-ynyl cyclohexylphenylglycolate hydrochloride; alpha-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester hydrochloride; MLS000069688; MJ 4309-1; SMR000058490; 4-Diethylamino-2-butynyl phenyl(cyclohexyl)glycolate hydrochloride; 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolate hydrochloride	C22H32ClNO3	SWIJYDAEGSIQPZ-UHFFFAOYSA-N	4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride	n.a.	n.a.
PMDBD635	Oxytetracycline dihydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54680691	n.a.	n.a.	Oxytetracycline dihydrate; 6153-64-6; OXTC; Oxytetracyclini dihydras; Hydroxytetrazyklindihydrat; Oxytetracyclinium dihydricum; UNII-X20I9EN955; CCRIS 9079; Oxytetracycline (dihydrate); X20I9EN955; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide dihydrate; Terramycin (TN); Oxytetracycline base; DSSTox_CID_3412; DSSTox_RID_77015; DSSTox_GSID_23412; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-met	C22H28N2O11	IMLJLCJZQLGHJS-JEKSYDDFSA-N	(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate	n.a.	n.a.
PMDBD641	Parbendazole	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	26596	n.a.	n.a.	Parbendazole; 14255-87-9; Helmatac; Methyl (5-butyl-1H-benzo[d]imidazol-2-yl)carbamate; Worm Guard; Verminum; Parbendazol; Helatac; PBDZ; SKF 29044; UNII-N4X8WVX2UG; Carbamic acid, (5-butyl-1H-benzimidazol-2-yl)-, methyl ester; Parbendazol [INN-Spanish]; Parbendazolum [INN-Latin]; METHYL 5-BUTYL-2-BENZIMIDAZOLECARBAMATE; SK&amp;F 29044; 5-Butyl-2-(carbomethoxyamino)benzimidazole; TCMDC-131798; EINECS 238-133-3; SKF-29044; N4X8WVX2UG; 5-Butyl-2-benzimidazolecarbamic acid methyl ester; methyl N-(6-butyl-1H-benzimidazol-2-yl)carbam	C13H17N3O2	YRWLZFXJFBZBEY-UHFFFAOYSA-N	methyl N-(6-butyl-1H-benzimidazol-2-yl)carbamate	n.a.	n.a.
PMDBD643	Partially hydrolyzed soy protein isolate	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD646	Pefloxacine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	51081	n.a.	n.a.	Pefloxacin; 70458-92-3; Pefloxacine; Pefloxacino; Pefloxacinum; PFLX; Pefloxacin [INN-French]; Pefloxacinum [INN-Latin]; Pefloxacino [INN-Spanish]; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; AM-725; 1584RB; UNII-2H52Z9F2Q5; EU-5306; EU 5306; C17H20FN3O3; EINECS 274-611-8; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; 1589 RB; BRN 0567618; CHEBI:50199; 2H52Z9F2Q5; 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid	C17H20FN3O3	FHFYDNQZQSQIAI-UHFFFAOYSA-N	1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD647	Pemirolast potassium	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	443866	n.a.	n.a.	PEMIROLAST POTASSIUM; 100299-08-9; Alamast; Pemilaston; Pemirolast potassium salt; BMY 26517; UNII-497A17OUUE; BMY-26517; Alegysal; CCRIS 3562; Pemirolast potassium [USAN:JAN]; TWT-8152; 497A17OUUE; TBX; DSSTox_RID_81773; DSSTox_CID_26623; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one, potassium salt; DSSTox_GSID_46623; potassium 5-(9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)tetrazol-1-ide; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one Potassium Salt; 4H-Pyrido(1,2-a)pyrimidin-4-one, 9-methyl	C10H7KN6O	NMMVKSMGBDRONO-UHFFFAOYSA-N	potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one	n.a.	n.a.
PMDBD648	Penbutolol sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	38010	n.a.	n.a.	PENBUTOLOL SULFATE; 38363-32-5; Levatol; Penbutolol sulfato [Spanish]; CCRIS 1108; HOE 39-893d; UNII-US71433228; HOE 893d; EINECS 253-906-5; (-)-Terbuclomine; US71433228; (-)-1-(tert-Butylamino)-3-(o-cyclopentylphenoxyl)-2-propanol sulfate; (S)-1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)-2-propanol sulfate (2:1) (salt); (S)-1-(2-Cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-2-propanol sulfate (2:1) (salt); Hoe-893d; Penbutolol sulfato; (S)-Bis(di-tert-butyl(3-(2-cyclopentylphenoxy)-2-hydroxypropyl)ammonium) sulphate; C1	C36H60N2O8S	FEDSNBHHWZEYTP-ZFQYHYQMSA-N	(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol;sulfuric acid	n.a.	n.a.
PMDBD649	Pentamidine isethionate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	8813	n.a.	n.a.	PENTAMIDINE ISETHIONATE; 140-64-7; Pentamidine isethionate salt; Pentamidine diisethionate; 4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate); Pentamidine isetionate; Pentamidine (isethionate); Pentacarinat; Lomidine; Diamidine; UNII-V2P3K60DA2; Pneumopent; Lomidin; Pentamidine isothionate; Lomidine isoethionate; PENTAM; RP 2512; V2P3K60DA2; CHEBI:7977; 4,4'-(Pentamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulfonate); 1,5-Bis(p-amidinophenoxy)pentane bis(2-hydroxyethanesulfonate salt); USAF XR-10	C23H36N4O10S2	YBVNFKZSMZGRAD-UHFFFAOYSA-N	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid	n.a.	n.a.
PMDBD652	Perhexiline maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5284439	n.a.	n.a.	Perhexiline maleate; 6724-53-4; Perhexiline maleate salt; Pexid; 2-(2,2-Dicyclohexylethyl)piperidine maleate; Perhexiline maleate [USAN]; CCRIS 5491; C19H35N.C4H4O4; EINECS 229-775-5; MLS000028601; MLS001077289; 2-(2,2-Dicyclohexylethyl)piperidine acid maleate; 2-(2,2-Dicyclohexylethyl)piperidine maleate (1:1); 2-(2,2-Dicyclohexylethyl)piperidinium hydrogen maleate; Piperidine, 2-(2,2-dicyclohexylethyl)-, maleate (1:1); NCGC00095025-01; SMR000058713; Piperidine, 2-(2,2-dicyclohexylethyl)-, (Z)-2-butenedioate (1:1); DSSTox_CI	C23H39NO4	JDZOTSLZMQDFLG-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;2-(2,2-dicyclohexylethyl)piperidine	n.a.	n.a.
PMDBD653	Pericyazine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4747	n.a.	n.a.	periciazine; Propericiazine; PERICYAZINE; Piperocyanomazine; Neuleptil; 2622-26-6; Periciazinum; Nemactil; Neulactil; Aolept; propericyazine; Periciazina; Bayer 1409; Periciazine [INN]; Periciazinum [INN-Latin]; Periciazina [INN-Spanish]; 2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine; 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile; SKF 20,716; IC 6002; 6909 RP; WH 7508; RP 8908; 2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine; UNII-3405M6FD73; F.I. 6145; EINECS 220-071-3; Cyano-3 ((hydroxy-4 piperi	C21H23N3OS	LUALIOATIOESLM-UHFFFAOYSA-N	10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile	n.a.	n.a.
PMDBD656	Persistent organic pollutant	Environmental Chemicals	Industrial Chemicals and Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD660	Phenethicillin potassium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23675317	n.a.	n.a.	phenethicillin potassium; Pheneticillin potassium; Penicillin-152 potassium; Phenethicillin potassium salt; Synthecillin; Alfacillin; Synthecilline; Feneticilline; Synerpenin; Astracillin; Synapen; Semopen; Peniplus; Oralopen; Maxipen; Bendralan; Alticina; Priospen; Chemipen; Triospen; Syncillin; Penemve; Optipen; Brocsil; Pensig; Penova; Broxil; Darcil; alpha-Oracillin; Synthepen tabl; Penicillin mv; Dramcillin-S; K Phenethicillin; Chemipen-C; Ro-Cillin; A-Phenoxyethylpenicillinic acid potassium salt; CHEBI:31987; 132-93-4; Pheno-M-penicillin	C17H19KN2O5S	ORMNNUPLFAPCFD-DVLYDCSHSA-M	potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD663	Phenytoin sodium	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	657302	n.a.	n.a.	PHENYTOIN SODIUM; 630-93-3; Dilantin sodium; Diphenylhydantoin Sodium; 5,5-Diphenylhydantoin sodium salt; Diphantoine; Fenidantoin; Novodiphenyl; Citrullamon; Epsolin; Epdantoin; Ditomed; Fenytoin; Fenigramon; Enkefal; Derizene; Phenilep; Hidantin; Dihydan; Alepsin; Tacosal; Fenitron; Eptolin; Epileptin; Decatona; Cumatil; Aladdin; Episar; Muldis; Ditoin; Lepitoin sodium; Hidantal sodium; Fenitoin sodium; Denyl sodium; Sodium phenytoin; Diphenine sodium; Aleviatin sodium; Fenitoina Sodica; Epilantin-E; Soluble phenytoin; Diphenylan sodium; Metinal	C15H11N2NaO2	FJPYVLNWWICYDW-UHFFFAOYSA-M	sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione	n.a.	n.a.
PMDBD666	Phosphate or sulfate ester prodrugs	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD667	Physical activity	Others	Others	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD670	Pimethixene maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5702167	n.a.	n.a.	PIMETHIXENE MALEATE; 13187-06-9; UNII-U22U244M9X; EINECS 236-141-1; BP-400; 9-(N-Methyl-piperidyliden-4)thioxane maleate; U22U244M9X; 9-(1-Methyl-4-piperidylene)thioxanthene maleate; Thioxanthene, 9-(1-methyl-4-piperidylene)-, maleate; NCGC00094897-01; 1-Methyl-4-(9H-thioxanthen-9-ylidene)piperidinium hydrogen maleate; DSSTox_RID_81183; DSSTox_CID_25863; DSSTox_GSID_45863; Pimethixen maleate salt; SR-01000872656; CAS-13187-06-9; Prestwick_656; Pimethixene maleate salt; SCHEMBL301225; SPECTRUM1501114; DTXSID7045863; CHEMBL1523827	C23H23NO4S	IPANUAHQWFDVAG-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;1-methyl-4-thioxanthen-9-ylidenepiperidine	n.a.	n.a.
PMDBD672	Pinaverium bromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	40703	n.a.	n.a.	PINAVERIUM BROMIDE; 53251-94-8; Dicetel; Pinaverium bromide [INN]; Pinaverii bromidum [INN-Latin]; LAT 1717; Bromuro de pinaverio [INN-Spanish]; Bromure de pinaverium [INN-French]; EINECS 258-450-0; Pinaverium bromide (INN); Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, bromide (1:1); Pinaverii bromidum; UNII-7SCF54H12J; 4-(6-Bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium bromide	C26H41Br2NO4	IKGXLCMLVINENI-UHFFFAOYSA-M	4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium;bromide	n.a.	n.a.
PMDBD676	Piperacillin sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23666879	n.a.	n.a.	PIPERACILLIN SODIUM; 59703-84-3; Pipracil; Sodium piperacillin; PIPERACILLIN SODIUM SALT; Piperacillin (sodium); UNII-M98T69Q7HP; Pentcillin; MLS000069533; CHEBI:8233; M98T69Q7HP; Pipracil Sterile; SMR000058579; Zosyn Sterile; CCRIS 2591; T 1220; T-1220; EINECS 261-868-6; CL 227193; CL 227,193; Pentcillin (TN); Pipracil (TN); Sodium (2S,5R,6R)-6-((R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate	C23H26N5NaO7S	WCMIIGXFCMNQDS-IDYPWDAWSA-M	sodium;(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD678	Pivmecillinam hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	115162	n.a.	n.a.	pivmecillinam hydrochloride; 32887-03-9; Melysin; Pivmecillinam (hydrochloride); amdinocillin pivoxil hydrochloride; Selexid; Pivmecillinam HCl; UNII-48FX7N21H2; Pivmecilinamo clorhidrato [Spanish]; EINECS 251-278-7; pivmecilinamo clorhidrato; MLS002154128; 48FX7N21H2; FL-1039; CHEBI:51213; 4-Thia-1-azabicyclo[3.2.0]	C21H34ClN3O5S	UHPXMYLONAGUPC-WKLLBTDKSA-N	2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride	n.a.	n.a.
PMDBD679	Pizotifen malate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	168993	n.a.	n.a.	Pizotifen malate; Pizotyline malate; 5189-11-7; Pizotifen (malate); Sanomtgran; Mosegor; Pizotifen hydrogen malate; Litec malate; Sandomygran malate; Sandomigran malate; BC 105 malate; C19H21NS.C4H6O5; CHEBI:50213; EINECS 225-970-4; 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine 2-hydroxysuccinate; Pizotifen maleate; Sandomigran (TN); Q-201591; Piperidine, 4-(9,10-dihydro-4H-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-methyl-, malate (1:1); Malic acid, compound with 4-(9,10-dihydro-4H-b	C23H27NO5S	IWAWCPZVTXCFKD-UHFFFAOYSA-N	2-hydroxybutanedioic acid;1-methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidine	n.a.	n.a.
PMDBD680	Plant-derived glycosides(amygdalin)	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD681	Plantago asiatica L.	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD682	Platinum chemotherapy	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD683	Polyaromatic compounds	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD684	Polyphenols	Herbal Substance; Dietary Substance	Medicinal Herbal Compounds; Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD685	Polyphenols (caffeic acid)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD686	Polyphenols (grape and/or cranberry extract)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD687	Polyphenols (resveratrol)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD688	Polysaccharide	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD689	Polysaccharides (after cyclophosphamide administration)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD691	Polysorbate 81	Environmental Chemicals	Industrial Chemicals and Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD692	Pomegranate byproduct	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD693	Pomegranate extract	Herbal Substance; Dietary Substance	Herbal Substance; Dietary Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD694	Pomegranate peel extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD695	Potassium oxonate	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	2723920	n.a.	n.a.	Potassium oxonate; 2207-75-2; Oteracil potassium; Oxonic acid potassium salt; Allantoxanic acid potassium salt; Oxonic acid, potassium salt; Oxonate, potassium; potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate; Potassium azaorotate; Oxonate; Potassium 2,6-dihydroxytriazinecarboxylate; Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate; UNII-4R7FFA00RX; 4R7FFA00RX; CHEBI:80230; Allantoxanic acid, potassium salt; 5-Azaorotic acid, potassium salt; Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-car	C4H2KN3O4	IAPCTXZQXAVYNG-UHFFFAOYSA-M	potassium;4,6-dioxo-1H-1,3,5-triazine-2-carboxylate	n.a.	n.a.
PMDBD696	Potentilla discolor Bunge	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD697	PPIs	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD701	Prenylamine lactate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	65557	n.a.	n.a.	Prenylamine lactate; Angormin; Sedolatan; Irrorin; Incoran; Coredamin; Plactamin; Corontin; Reocorin; Crepasin; Seccidin; Roinin; Agozol; UNII-6J3J6SXI7V; 69-43-2; EINECS 200-705-5; Prenylamine lactate [JAN]; 6J3J6SXI7V; N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine lactate; Prenylamine lactate (JAN); Phenethylamine, N-(3,3-diphenylpropyl)-alpha-methyl-, lactate; 3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine;2-hydroxypropanoic acid; C24H27N.C3H6O3; Segontin (TN); Prestwick_878; MLS002153874; CHEMBL1367944; SCHEMBL10614915; HM	C27H33NO3	QPOFIDVRLWJICD-UHFFFAOYSA-N	3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine;2-hydroxypropanoic acid	n.a.	n.a.
PMDBD702	Pridinol methanesulfonate salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	165542	n.a.	n.a.	Pridinol methanesulfonate; 6856-31-1; Pridinol methanesulfonate salt; UNII-AQ4K0AJT6G; Prestwick_138; AQ4K0AJT6G; MLS000069569; SMR000058822; Loxeen; 1,1-diphenyl-3-piperidin-1-ylpropan-1-ol;methanesulfonic acid; SR-01000000125; C20H25NO.CH4O3S; EINECS 229-953-2; Pridinol (mesylate); Konlax (TN); Opera_ID_274; MLS002222172; MLS001074110; SPECTRUM1503077; SCHEMBL195084; REGID_for_CID_165542; CHEMBL1528011; HMS502E08; DTXSID40218667; HMS3370K22; HMS2233N07; Pharmakon1600-01503077; HMS1922C17; HMS3714O20; HMS2097O20; HMS1570O20; CCG-39523	C21H29NO4S	VNJHUUNVDMYCRH-UHFFFAOYSA-N	1,1-diphenyl-3-piperidin-1-ylpropan-1-ol;methanesulfonic acid	n.a.	n.a.
PMDBD703	Prilocaine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	92163	n.a.	n.a.	Prilocaine hydrochloride; 1786-81-8; Propitocaine hydrochloride; Prilocaine HCl; Xylonest; Prilocaine chloride; Citanest hydrochloride; Citanest plain; Prilocaine (hydrochloride); Astra 1512; N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride; 2-(Propylamino)-o-propionotoluidide hydrochloride; L-67; EINECS 217-244-0; MFCD00079279; MLS000069690; Propanamide, N-(2-methylphenyl)-2-(propylamino)-, hydrochloride (1:1); 2-(Propylamino)-o-propionotoluidide monohydrochloride; alpha-Propylamine-2-methyl-prop	C13H21ClN2O	BJPJNTKRKALCPP-UHFFFAOYSA-N	N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride	n.a.	n.a.
PMDBD704	Primaquine phosphate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6135	n.a.	n.a.	primaquine diphosphate; 63-45-6; PRIMAQUINE PHOSPHATE; Primaquine bisphosphate; Primaquine (Diphosphate); Primaquine bis(phosphate); 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2); CCRIS 1946; EINECS 200-560-8; NSC 149765; Primaquine phosphate;Primaquine bisphosphate; 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline diphosphate; 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline phosphate (1:2); DSSTox_RID_80773; DSSTox_CID_25248; DSSTox_GSID_45248; Primaquine diphosphate, 98%	C15H27N3O9P2	GJOHLWZHWQUKAU-UHFFFAOYSA-N	4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid	n.a.	n.a.
PMDBD705	Proadifen hydrochloride	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	65341	n.a.	n.a.	Proadifen hydrochloride; 62-68-0; Proadifen HCl; Propyladiphenin; SKF-525A hydrochloride; Proadifen (hydrochloride); SKF 525A; SK&amp;F 525-A; RP 5171; Proadifen hydrochloride [USAN]; UNII-30624AA6X2; SKF 525-A; U 5446; NSC 39690; NSC 170997; 5171 RP; 2-Diethylaminoethyl 2,2-diphenylvalerate hydrochloride; 2-(Diethylamino)ethyl-2,2-diphenylvalerate hydrochloride; AI3-22677; 2'-Diethylaminoethyl 2,2-diphenylpentanoate hydrochloride; 5171 R. P.; Diethylaminoethanol ester of diphenylpropylacetic acid hydrochloride; 30624AA6X2	C23H32ClNO2	FHIKZROVIDCMJA-UHFFFAOYSA-N	2-(diethylamino)ethyl 2,2-diphenylpentanoate;hydrochloride	n.a.	n.a.
PMDBD706	Proanthocyanidin-rich grape seed extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD708	Prochlorperazine dimaleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281032	n.a.	n.a.	Prochlorperazine dimaleate; Prochlorperazine maleate; 84-02-6; Prochlorperazine dimaleate salt; UNII-I1T8O1JTL6; Buccastem; Emetiral; Vertigon; Pasotomin; Nibromin A; Meterazin maleate; Stemetil dimaleate; I1T8O1JTL6; Proclorperazine maleate; Prochlorperazinu dimaleat; Prochlorperazine bimaleate; C20H24ClN3S.2C4H4O4; Prochlorperazine hydrogen maleate; Prochloroproazine hydrogen maleate; Prochlorperazinu dimaleat [Czech]; EINECS 201-511-3; DSSTox_RID_83206; DSSTox_CID_28941; DSSTox_GSID_49015; CHEBI:8436	C28H32ClN3O8S	DSKIOWHQLUWFLG-SPIKMXEPSA-N	(Z)-but-2-enedioic acid;2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	n.a.	n.a.
PMDBD709	Promazine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5887	n.a.	n.a.	PROMAZINE HYDROCHLORIDE; 53-60-1; Promazine Hcl; Starazin; Sparine; Talofen; Promazine (hydrochloride); Promazine monohydrochloride; UNII-U16EOR79U4; RP 4560; Chlorowodorek promazyny [Polish]; N,N-dimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride; EINECS 200-179-7; NSC 17468; Promazine hydrochloride [USP]; AI3-28022; MLS000069671; U16EOR79U4; N-(3-(Dimethylamino)propyl)phenothiazine hydrochloride; 10-(3-(Dimethylamino)propyl)phenothiazine hydrochloride; Phenothiazine, 10-(3-(dimethylamino)propyl)-, hydrochloride	C17H21ClN2S	JIVSXRLRGOICGA-UHFFFAOYSA-N	N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine;hydrochloride	n.a.	n.a.
PMDBD710	Promethazine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6014	n.a.	n.a.	PROMETHAZINE HYDROCHLORIDE; 58-33-3; Promethazine Hcl; Phenergan; N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine hydrochloride; Fenergan; Farganesse; Diprazin; Pipolphen; Fellozine; Pipolfen; Romergan; Diprasine; Ganphen; Plletia; Remsed; Atosil; Promethazine (hydrochloride); Promethazine chloride; Promethiazin; Soporil; Proneurin; Primine; Kinetosin; Allerfen; Promine; Promantine; Lergigan; Histantil; Duplamin; Phencen; Phenadoz; Hibechin; Goodnight; Frinova; Closin; Bonnox; Dorme; Prome; Prometh Plain; Prometh Fortis; Eusedon Mono; Phenerg	C17H21ClN2S	XXPDBLUZJRXNNZ-UHFFFAOYSA-N	N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride	n.a.	n.a.
PMDBD711	Prontosil	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	66895	n.a.	n.a.	prontosil; Sulfamidochrysoidine; Rubiazol; Prontosil rubrum; 103-12-8; UNII-Q64Q9N6Q6O; Q64Q9N6Q6O; CHEBI:8464; P-[(2,4-diaminophenyl)azo]benzenesulphonamide; p-((2,4-Diaminophenyl)azo)benzenesulphonamide; 4-[(2,4-diaminophenyl)diazenyl]benzenesulfonamide; p-[(2,4-diaminophenyl)azo]benzenesulphonamide;sulfamidochrysoidine; ulfamidochrysoidine; EINECS 203-081-2; Aseptil rojo (TN); AI3-09088; SCHEMBL155099; SCHEMBL155098; CHEMBL488279; CTK4A1757; DTXSID60145608; Relbazon; Streptocid	C12H13N5O2S	ABBQGOCHXSPKHJ-UHFFFAOYSA-N	4-[(2,4-diaminophenyl)diazenyl]benzenesulfonamide	n.a.	n.a.
PMDBD712	Propidium iodide	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	104981	n.a.	n.a.	propidium iodide; 25535-16-4; Propidium diiodide; 3,8-Diamino-5-(3-(diethyl(methyl)ammonio)propyl)-6-phenylphenanthridin-5-ium iodide; Propidium Iodine; Propidium (Iodide); UNII-TP416O228T; CHEBI:51240; EINECS 247-081-0; NSC 169541; 3,8-Diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide; 3,8-Diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium diiodide; TP416O228T; C27H34I2N4; 3,8-Diamino-5-(3-diethylaminopropyl)-6-phenylphenanthridinium iodide methiodide; Phenanthridinium, 3,8-dia	C27H34I2N4	XJMOSONTPMZWPB-UHFFFAOYSA-M	3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;diiodide	n.a.	n.a.
PMDBD713	Protriptyline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6603149	n.a.	n.a.	Protriptyline hydrochloride; 1225-55-4; Protriptyline HCl; Maximed; Vivactil; Concordin; Protriptyline (hydrochloride); Triptyl; Triptil hydrochloride; Normethyl EX4442; MK-240; UNII-44665V00O8; Triptil (VAN); MLS000069697; Vivactyl; MK-240 (VAN); SMR000058503; EINECS 214-956-3; 44665V00O8; 5H-Dibenzo[a,d]cycloheptene-5-propanamine, N-methyl-, hydrochloride (1:1); NSC 169912; DSSTox_RID_82027; DSSTox_CID_26951; DSSTox_GSID_46951; N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine hydrochloride; CHEBI:8598; 5-(3-Methylaminopropyl)-5H	C19H22ClN	OGQDIIKRQRZXJH-UHFFFAOYSA-N	N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine;hydrochloride	n.a.	n.a.
PMDBD716	Pyrvinium pamoate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54680693	n.a.	n.a.	Pyrvinium pamoate; 3546-41-6; Pyrvinium embonate; Viprynium embonate; Vanquin; Pyrvinium pamoate salt hydrate; NSC 223622; Vermitibier; Vanquil; NCGC00017042-01; 4-[(3-carboxylato-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylate;2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine; Vipyrvinium embonate; Dipyrivinium Pamoate; CAS-3546-41-6; Povan (TN); DSSTox_CID_3545; DSSTox_RID_77072; DSSTox_GSID_23545; SCHEMBL62130; Pyrvinium pamoate (JAN/USP); CHEBI:8688; DTXSID4023545	C75H70N6O6	OOPDAHSJBRZRPH-UHFFFAOYSA-L	3-carboxy-1-[(3-carboxy-2-oxidonaphthalen-1-yl)methyl]naphthalen-2-olate;2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine	n.a.	n.a.
PMDBD718	Quercetin-3-glucoside	Herbal Substance; Dietary Substance	Medicinal Herbal Compounds; Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	5280804	n.a.	n.a.	Isoquercitrin; Isoquercetin; 482-35-9; Quercetin 3-o-glucopyranoside; Quercetin 3-glucoside; 3-Glucosylquercetin; Glucosyl 3-quercetin; Quercetol 3-glucoside; Hirsutrin; Quercetin 3-O-glucoside; Quercetin 3-D-glucoside; Isotrifoliin; Quercetol 3-monoglucoside; Quercetin 3-monoglucoside; Quercetin 3-beta-glucoside; quercetin-3-glucoside; Quercetin-3-O-glucopyranoside; Quercetin 3-beta-O-glucoside; quercetin-3-O-glucoside; 3-beta-D-Glucosylquercetin; UNII-6HN2PC637T; NSC 115918; BRN 0100989; CHEMBL250450; 6HN2PC637T; CHEBI:68352; quer	C21H20O12	OVSQVDMCBVZWGM-QSOFNFLRSA-N	2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one	n.a.	n.a.
PMDBD719	Quetiapine hemifumarate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281025	n.a.	n.a.	Quetiapine fumarate; 111974-72-2; Quetiapine hemifumarate; Seroquel XR; Seroquel; ICI-204636; ICI 204,636; ZM 204636; UNII-2S3PL1B6UJ; Quetiapine fumarate [USAN]; ZD5077; 2S3PL1B6UJ; ZM 204,636; ICI 204636; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate; Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt); CHEBI:8708; FK949E	C46H54N6O8S2	ZTHJULTYCAQOIJ-WXXKFALUSA-N	2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol;(E)-but-2-enedioic acid	n.a.	n.a.
PMDBD720	Quinacrine dihydrochloride dihydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2725002	n.a.	n.a.	Quinacrine dihydrochloride dihydrate; 6151-30-0; Quinacrine HCl; Quinacrine hydrochloride; Mepacrine hydrochloride; Atabrine hydrochloride dihydrate; Mepacrine hydrochloride dihydrate; Quinacrine hydrochloride dihydrate; Quinacrine 2HCl 2H2O; Quinacrine hydrochloride hydrate; Mepacrine HCl; DSSTox_RID_80962; DSSTox_CID_25565; 6-Chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine dihydrochloride dihydrate; DSSTox_GSID_45565; Acridine, 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxy-, dihydrochlo	C23H36Cl3N3O3	RZFNKJVCPDLQQA-UHFFFAOYSA-N	4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine;dihydrate;dihydrochloride	n.a.	n.a.
PMDBD722	Qushi Huayu Fang	Herbal Substance	TCM Formula	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD723	R(-) Apomorphine hydrochloride hemihydrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6852399	n.a.	n.a.	MLS000069811; Apomorphine hydrochloride hemihydrate; 41372-20-7; SMR000059235; R-(-)-Apomorphine hydrochloride hemihydrate; SMR000653528; (R)-Apomorphine Hydrochloride Hemihydrate; Opera_ID_1132; MLS002153277; MLS002222153; MLS001074112; SCHEMBL5429071; C17H17NO2.ClH.H2O; CHEMBL1256708; HW2A207; 2223AH; AKOS030526144; NCGC00180984-01; SMR001307246; R(-) Apomorphine hydrochloride hemihydrate; MLS-0235817.0001; (R)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride hydrate	C17H20ClNO3	DQQCJDBYNZMPOA-FFXKMJQXSA-N	(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride	n.a.	n.a.
PMDBD724	Rabeprazole Sodium salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	14720269	n.a.	n.a.	RABEPRAZOLE SODIUM; 117976-90-6; Rebeprazole sodium; Pariet; Aciphex; Rabeprazole sodium salt; Rabeprazole (sodium); Aciphex Sprinkle; LY 307640 sodium; LY-307640; Rabeprazole sodium [USAN]; CHEBI:8769; LY307640 sodium; E 3810; E3810; Sodium rabeprazole; AK-94764; DSSTox_CID_24205; 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridyl)methyl)sulfinyl)benzimidazole sodium salt; DSSTox_RID_80118; C18H20N3NaO3S; DSSTox_GSID_44205; 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt; Q-201655; Rabici	C18H20N3NaO3S	KRCQSTCYZUOBHN-UHFFFAOYSA-N	sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide	n.a.	n.a.
PMDBD726	Racepinephrine HCl	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5924	n.a.	n.a.	329-63-5; DL-ADRENALINE HYDROCHLORIDE; (+/-)-Epinephrine hydrochloride; Racepinephrine hydrochloride; 4-(1-Hydroxy-2-(methylamino)ethyl)benzene-1,2-diol hydrochloride; DL-Epinephrine (hydrochloride); (+-)-Epinephrine hydrochloride; 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, hydrochloride; Asthmanefrin; (+-)-Adrenaline hydrochloride; (+/-)-ADRENALIN HYDROCHLORIDE; EINECS 206-346-0; Racepinephrine hydrochloride (USP); Racepinephrine hydrochloride [USP]; 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, chlorid	C9H14ClNO3	ATADHKWKHYVBTJ-UHFFFAOYSA-N	4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;hydrochloride	n.a.	n.a.
PMDBD727	Radiation sensitizer misonidazole	Therapeutic Substance	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD728	Raloxifene hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54900	n.a.	n.a.	RALOXIFENE HYDROCHLORIDE; 82640-04-8; Raloxifene Hcl; Evista; Keoxifene hydrochloride; Keoxifene; (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride; LY 156758; Raloxifene (hydrochloride); UNII-4F86W47BR6; C28H27NO4S.HCl; LY156758; CHEBI:50740; Evista (Raloxifene Hydrochloride); 4F86W47BR6; Optruma; LY-156758; 6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride; C28H28ClNO4S; DSSTox_RID_79119; DSSTox_CID_14181; DSSTox_GSI	C28H28ClNO4S	BKXVVCILCIUCLG-UHFFFAOYSA-N	[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride	n.a.	n.a.
PMDBD733	Red Ginseng	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD734	Red meat (haem)	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD735	Red wine	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD736	Red wine grape extract	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD737	Regular soy milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD743	Ribostamycin sulfate salt	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6419922	n.a.	n.a.	Ribostamycin sulfate salt; 53797-35-6; Prestwick_190; HMS1570G18	C17H36N4O14S	RTCDDYYZMGGHOE-SAQGLUNGSA-N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[(2S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid	n.a.	n.a.
PMDBD749	Riluzole hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6419992	n.a.	n.a.	Riluzole hydrochloride; 850608-87-6; 2-Amino-6-trifluoromethoxybenzothiazole hydrochloride; SMR000449311; SR-01000002997; Prestwick_644; CPD000449311; Riluzole (hydrochloride); MLS001424008; MLS000758261; SCHEMBL1394245; CHEMBL1531817; HY-B0211A; 2-Benzothiazolamine, 6-(trifluoromethoxy)-, monohydrochloride; HMS1568B15; AKOS024458639; CCG-100788; NC00038; NCGC00180988-01; CS-0020981; SR-01000002997-9; SR-01000002997-4; 2-Amino-6-(trifluoromethoxy)-benzothiazole hydrochloride; 6-(Trifluoromethoxy)benzo[d]thiazol-2-amine hydrochlor	C8H6ClF3N2OS	QEAOELIJQRYJJS-UHFFFAOYSA-N	6-(trifluoromethoxy)-1,3-benzothiazol-2-amine;hydrochloride	n.a.	n.a.
PMDBD752	Rizatriptan benzoate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	77997	n.a.	n.a.	Rizatriptan benzoate; 145202-66-0; Maxalt; Maxalt-MLT; MK-462; Rizatriptan (benzoate); MK 462; MK-0462; UNII-WR978S7QHH; MK 0462; 2-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1H-INDOL-3-YL)-N,N-DIMETHYLETHANAMINE BENZOATE; Rizatriptan benzoate [USAN:USP]; L 705126; L-705126; WR978S7QHH; L-705,126; L 705,126; Rizatriptan Benzoate (Maxalt); N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate; AK163196; 3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; 1H-Indole-3-ethanamine, N,N-dim	C22H25N5O2	JPRXYLQNJJVCMZ-UHFFFAOYSA-N	benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine	n.a.	n.a.
PMDBD753	Ronidazole	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	5094	n.a.	n.a.	ronidazole; 7681-76-7; Ronidazol; Ridzol; Ridzol P; Ridazole; Dugro; (1-Methyl-5-nitro-1H-imidazol-2-yl)methyl carbamate; (1-Methyl-5-nitroimidazol-2-yl)methyl carbamate; Ronidazolum; Ronidazol-pharmachim; Ronidazol [INN-Spanish]; Ronidazolum [INN-Latin]; UNII-E01R4M1063; 1H-Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate (ester); Ronidazol-pharmachim [Bulgarian]; EINECS 231-675-1; BRN 0886221; 1-Methyl-5-nitroimidazole-2-methanol carbamate ester; AI3-27430; MLS000028665; C6H8N4O4; E01R4M1063; 1-Methyl-5-nitro-1H-imidazole-2-m	C6H8N4O4	PQFRTXSWDXZRRS-UHFFFAOYSA-N	(1-methyl-5-nitroimidazol-2-yl)methyl carbamate	n.a.	n.a.
PMDBD754	Rosmarinus officinals	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD763	Salvia officinalis	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD764	Saquinavir mesylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	60934	n.a.	n.a.	Saquinavir mesylate; 149845-06-7; Invirase; Fortovase; Saquinavir mesilate; Saquinavir, Mesylate; Ro 31-8959/003; UNII-UHB9Z3841A; Saquinavir monomethanesulfonate salt; UHB9Z3841A; CHEBI:32121; Saquinavir mesylate (AIDS Initiative); NCGC00091469-01; DSSTox_CID_3835; DSSTox_RID_77202; DSSTox_GSID_23835; Ro 31-8959; (S)-N-((alphaS)-alpha-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide monomethanesulfonate (salt); Butanediamide, N1-[(1S,2R)-3-[(3S,4aS	C39H54N6O8S	IRHXGOXEBNJUSN-YOXDLBRISA-N	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid	n.a.	n.a.
PMDBD766	Saturated fat	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD767	Saturated fat (palmitate)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD768	Saturated fats	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD774	Semen Coicis	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD777	Sertaconazole nitrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	200103	n.a.	n.a.	Sertaconazole nitrate; 99592-39-9; Dermofix; Ertaczo; Zalain; Sertaconazole (nitrate); FI 7056; FI-7045; Ginedermofix; Dermoseptic; Sertaconazole mononitrate; 1-[2-[(7-Chloro-1-benzothien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate; 1H-Imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, mononitrate; Fisderm; Onabet; Extens; SR-05000001439; 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid; Ertaczo (TN); Zalain (TN); 1-(2-((7-Chlo	C20H16Cl3N3O4S	HAAITRDZHUANGT-UHFFFAOYSA-N	1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid	n.a.	n.a.
PMDBD781	Sildenafil citrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	135413523	n.a.	n.a.	Sildenafil citrate; 171599-83-0; Revatio; VIAGRA; Sildenafil (citrate); Caverta; Sildenafil citrate [USAN]; UNII-BW9B0ZE037; Sildenafil citrate salt; BW9B0ZE037; CHEBI:58987; 5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate; UK 92480-10; UK 92480; sildenafilcitrate; UK-92480-10; DSSTox_RID_81321; DSSTox_CID_26076; DSSTox_GSID_46076; 1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sul	C28H38N6O11S	DEIYFTQMQPDXOT-UHFFFAOYSA-N	5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid	n.a.	n.a.
PMDBD782	Silybum marianum	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD784	Sisomicin sulfate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	439243	n.a.	n.a.	Sisomicin sulfate; Extramycin; Pathomycin; 53179-09-2; Siseptin; Baymicine; Sisomin; Mensiso; Sisomycin sulfate; UNII-K14444371C; Sch 13475 sulfate; Antibiotic 66-40 sulfate; Disisomicin pentakis(sulphate); EINECS 258-414-4; K14444371C; Sisomicin (sulfate); O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-&gt;4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-&gt;6))-2-deoxy-L-streptamine sulfate (2:5) (salt); Siseptin (TN); Sisomicin sulfate [USAN:USP:JAN]	C38H84N10O34S5	CIKNYWFPGZCHDL-ZHFUJENKSA-N	(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid	n.a.	n.a.
PMDBD786	Sodium butyrate	Environmental Chemicals	Microbiota metabolite	n.a.	n.a.	n.a.	n.a.	n.a.	5222465	n.a.	n.a.	SODIUM BUTYRATE; 156-54-7; Sodium butanoate; Butyric acid sodium salt; Butanoic acid, sodium salt; Butyrate sodium; Sodium n-butyrate; Butyric acid, sodium salt; Sodium propanecarboxylate; Butanoic acid, sodium salt (1:1); Butanoic acid sodium salt; UNII-8RAS91C36W; CCRIS 7068; HSDB 5655; Sodium butyrate (USP); TPA/BA; Sodium butyrate [USP]; EINECS 205-857-6; C4H7NaO2; MFCD00002816; NSC 174280; 8RAS91C36W; CHEBI:64103; Butyric Acid, Na; Butyric acid sodium salt, 98%; CHEMBL62381; NSC174280; NSC-174280; NCGC00167555-01; Sodiumbutanoate	C4H7NaO2	MFBOGIVSZKQAPD-UHFFFAOYSA-M	sodium;butanoate	n.a.	n.a.
PMDBD787	Sodium cyclamate	Dietary Substance	Dietary Compounds; Artificial Sweetener	n.a.	n.a.	n.a.	n.a.	n.a.	23665706	n.a.	n.a.	SODIUM CYCLAMATE; 139-05-9; Sodium cyclohexylsulfamate; Sodium N-cyclohexylsulfamate; Cyclamate sodium; Sulfamic acid, cyclohexyl-, monosodium salt; Cyclamic acid sodium salt; Suestamin; Assugrin; Sugaron; Suessette; Ibiosuc; Sugarin; Natrii cyclamas; Sucaryl sodium; Sodium sucaryl; Ciclamato sodico; Hachi-Sugar; Dulzor-Etas; Natrium cyclamicum; Assurgrin feinsuss; Assurgrin vollsuss; Sodium cyclohexanesulfamate; Sucrum 7; Cyclamate de sodium; Asugryn; Natrium cyclohexylsulfamat; Cyclohexylsulfamate sodium; Natriumzyklamate [German]	C6H12NNaO3S	UDIPTWFVPPPURJ-UHFFFAOYSA-M	sodium;N-cyclohexylsulfamate	n.a.	n.a.
PMDBD791	Soy isoflavones (daidzein, genistein, glycitein)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD792	Soy milk	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD793	Soy milk (powder)	Dietary Substance	Drinks	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD794	Soy protein	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD795	Soy protein concentrate (SPC)	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD797	Soygerm powder	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD799	Spectinomycin dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64740	n.a.	n.a.	Spectinomycin dihydrochloride; 21736-83-4; Spectinomycin hydrochloride; actinospectacin; Spectinomycin 2HCl; Spectinomycin HCl; Spectinomycin (dihydrochloride); Spectinomycin dihydrochloride pentahydrate; CHEBI:9216; EN300-74585; DSSTox_RID_80873; DSSTox_CID_25429; DSSTox_GSID_45429; 22189-32-8; UNII-296JEI210Z	C14H26Cl2N2O7	FOGDPGQSHLLYIK-XYQGXRRISA-N	(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one;dihydrochloride	n.a.	n.a.
PMDBD800	Spiperone	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5265	n.a.	n.a.	spiperone; Spiropitan; Spiroperidol; 749-02-0; Spiperonum; Espiperona; [3H]spiperone; [3H]-spiperone; R 5147; Spiperonum [INN-Latin]; Espiperona [INN-Spanish]; E 525; UNII-4X6E73CJ0Q; NSC 170983; 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; MLS000028615; Spiperone [USAN:INN:BAN:JAN]; 8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one; 8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane; EINECS 212-024-0; BRN 0632204; SMR000058674; 1,3,8-Triazaspiro(4.5	C23H26FN3O2	DKGZKTPJOSAWFA-UHFFFAOYSA-N	8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one	n.a.	n.a.
PMDBD802	Stachyose	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	439531	n.a.	n.a.	Stachyose; 470-55-3; Lupeose; CHEBI:17164; stachyose hydrate; Manneotetrose; alpha-D-Galp-(1-&gt;6)-alpha-D-Galp-(1-&gt;6)-alpha-D-Glcp-(1&lt;-&gt;2)-beta-D-Fruf; 54261-98-2; O-alpha-D-galactopyranosyl-(1-&gt;6)o-alpha-D-galactopyranosyl-(1-&gt;6)O-alpha-D-galactopyranosyl-beta-D-fructofuranoside; Stachyose hydrate from Stachys tuberifera; 10094-58-3; tachyose; Stachyose n-Hydrate; MFCD00149457; Stachyose - 70%; bmse000240; Epitope ID:150068; C01613; SCHEMBL32922; CHEMBL1625803; ZINC85544384; AKOS016009597; NCGC00246978-01; AK111	C24H42O21	UQZIYBXSHAGNOE-XNSRJBNMSA-N	(2S,3R,4S,5R,6R)-2-[[(2R,3R,4S,5R,6S)-6-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	n.a.	n.a.
PMDBD805	Streptozotocin	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	29327	n.a.	n.a.	streptozocin; STREPTOZOTOCIN; 18883-66-4; streptozosin; Streptozocinium; Streptozocine; Estreptozocina; Streptozocinum; alpha-Streptozocin; streptozotocin (stz); N-D-Glucosyl-(2)-N'-nitrosomethylurea; CHEBI:9288; C8H15N3O7; N-D-Glucosyl-(2)-N'-nitrosomethylharnstoff; 2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose; UNII-8H27GUR065; 8H27GUR065; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; 2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose; DSSTox_CID_1282; DSSTox_RID_76055; DSSTox_GSID_212	C8H15N3O7	ZSJLQEPLLKMAKR-GKHCUFPYSA-N	1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea	n.a.	n.a.
PMDBD807	Sulconazole nitrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	65495	n.a.	n.a.	Sulconazole nitrate; 61318-91-0; Exelderm; 82382-23-8; Sulconazole nitrate salt; Sulconazole mononitrate; Sulconazolenitrate; 1-[2-(4-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate; RS 44872; RS-44872; MLS000028611; RS-44872-00-10-3; SMR000058734; 1-(2-[p-Chlorobenzylthio]-2-[2,4-dichlorophenyl]ethyl)-1H-imidazole; (+-)-1-(2,4-Dichloro-beta-((4-chlorobenzyl)thio)phenethyl)imidazole nitrate; DSSTox_RID_80911; DSSTox_CID_25490; (+-)-1-(2,4-Dichloro-beta-((p-chlorobenzyl)thio)phenethyl)imidazole mononitrat	C18H16Cl3N3O3S	CRKGMGQUHDNAPB-UHFFFAOYSA-N	1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid	n.a.	n.a.
PMDBD809	Sulfamonomethoxine	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	5332	n.a.	n.a.	sulfamonomethoxine; 1220-83-3; Sulfamonomethoxin; Daimeton; Sulfamonometoxina; 4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide; Sulfamonomethoxinum; 4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide; DS-36; DJ-1550; N1-(6-Methoxy-4-pyrimidinyl)sulfanilamide; ICI 32525; Ro 4-3476; UNII-U700P169W2; Sulfamonometoxina [INN-Spanish]; Sulfamonomethoxinum [INN-Latin]; 4-METHOXY-6-SULFANILAMIDOPYRIMIDINE; 4-amino-N-(6-methoxypyrimidin-4-yl)benzene-1-sulfonamide; BRN 	C11H12N4O3S	WMPXPUYPYQKQCX-UHFFFAOYSA-N	4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide	n.a.	n.a.
PMDBD814	Sulfonamide antibiotics	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD815	Sulfoxide	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	8442	n.a.	n.a.	Sulfoxide; PIPERONYL SULFOXIDE; Sulfoxyl; Sulphoxide; Sulfox-cide; Sulfocide; 120-62-7; n-Octylisosafrole sulfoxide; Isosafrole n-octylsulfoxide; Sulfoxide (synergist); n-Octylsulfoxide of isosafrole; Isosafrole octyl sulfoxide; Piperonyl sulfoxide (insecticide); Isosafrole, octyl sulfoxide; NCI-C02824; Caswell No. 615; ENT 16,634; Isofrol-n-octyl sulfoxide; UNII-WOR3CS513R; Piperonyl sulfoxide (VAN); NSC 8400; CCRIS 523; 5-[2-(Octylsulfinyl)propyl]-1,3-benzodioxole; n-Octyl sulfoxide of isosafrole; HSDB 1746; 1-Methyl-2-(3,4-methy	C18H28O3S	ATTZFSUZZUNHBP-UHFFFAOYSA-N	5-(2-octylsulfinylpropyl)-1,3-benzodioxole	n.a.	n.a.
PMDBD817	Sulindac sulfide	Environmental Chemicals	Active Metabolite of Prodrug	n.a.	n.a.	n.a.	n.a.	n.a.	5352624	n.a.	n.a.	Sulindac sulfide; 49627-27-2; (Z)-Sulindac sulfide; UNII-6UVA8S2DEY; 32004-67-4; 6UVA8S2DEY; CHEMBL18797; CHEBI:75408; (Z)-5-Fluoro-2-methyl-1-[p-(methylthio)benzylidene]indene-3-acetic acid; NCGC00161601-01; DSSTox_CID_29004; DSSTox_RID_83269; DSSTox_GSID_49078; Sulindac sulphide; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfanyl)benzylidene]-1H-inden-3-yl}acetic acid; (Z)-5-Fluoro-2-methyl-1-((4-(methylthio)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-2-(3-(4-(methylthio)benzylidene)-6-fluoro-2-methyl-3H-inden-1-yl)acetic a	C20H17FO2S	LFWHFZJPXXOYNR-MFOYZWKCSA-N	2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfanylphenyl)methylidene]inden-1-yl]acetic acid	n.a.	n.a.
PMDBD820	Sumatriptan succinate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	59772	n.a.	n.a.	SUMATRIPTAN SUCCINATE; 103628-48-4; Imitrex; Imigran; Suminat; Migratriptan; Sumadol; Sumigrene; Novelian; Migratan; Antibet; Permicran; Diletan; Sumatrin; Micralgin; Imijekt; Arcoiran; Migmax; Sumavel DosePro; 1-(3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide succinate; Alsuma; Sumatriptan (succinate); Sumatriptan succinate [USAN]; UNII-J8BDZ68989; C14H21N3O2S.C4H6O4; GR 43175C; GR 43175; sumatriptan hydrogen succinate; CHEBI:64359; J8BDZ68989; GR-43175C; Onzetra Xsail; mitrex; Zembrace SymTouch; Sumitrex; Imitrex (TN)	C18H27N3O6S	PORMUFZNYQJOEI-UHFFFAOYSA-N	butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide	n.a.	n.a.
PMDBD823	Talampicillin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	71446	n.a.	n.a.	talampicillin hydrochloride; Yamacillin; Talampicillin HCl; Talpen; BRL 8988; Talampicillin hydrochloride [USAN:JAN]; 39878-70-1; (2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with 3-hydroxyphthalide, monohydrochloride; CHEBI:34993; Aseocillin (TN)	C24H24ClN3O6S	PAZSYTCTHYSIAO-WVFSJLEKSA-N	(3-oxo-1H-2-benzofuran-1-yl) (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrochloride	n.a.	n.a.
PMDBD824	Tamoxifen citrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2733525	n.a.	n.a.	Tamoxifen citrate; 54965-24-1; Istubal; Tamoxifen (Citrate); Zitazonium; UNII-7FRV7310N6; Tamoxifen citrate salt; ICI 46474; Zynoplex; Tamoxifen Citrate (Nolvadex); Tamoplex; Noxitem; Ledertam; Ginarsan; Tamoxasta; Oncotam; Terimon; Tafoxen; Jenoxifen; Tamofen; Nourytan; Farmifeno; Nolgen; Emblon; Noltam; Zemide; Kessar; Tamax; Taxus; Genox; Tamox-Puren; Apo-Tamox; C32H37NO8; 7FRV7310N6; Z-Tamoxifen citrate; NSC180973; NCGC00024928-06; Tamoxifen citrate, 98%; CAS-54965-24-1; DSSTox_CID_1301; DSSTox_RID_76068; DSSTox_GSID_21301; CCRIS 6718; Caditam	C32H37NO8	FQZYTYWMLGAPFJ-OQKDUQJOSA-N	2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid	n.a.	n.a.
PMDBD825	Taurine conjugated bile acid	Environmental Chemicals	Human Metabolite	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD827	Tea polyphenols	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD831	Tenatoprazole	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	636411	n.a.	n.a.	Tenatoprazole; 113712-98-4; Ulsacare; Protop; TU-199; TU 199; C16H18N4O3S; NCGC00167521-01; DSSTox_CID_26687; DSSTox_RID_81821; DSSTox_GSID_46687; Tenatoprazole [INN]; CAS-113712-98-4; Benatoprazole; Tenatoprazole (JAN/INN); SCHEMBL323288; sTU-199; DTXSID1046687; CHEMBL1475252; CHEBI:94379; CTK8E8964; Tenatoprazole, &gt;=98% (HPLC); HMS3713D12; HMS2090B06; BCP09130; Tox21_112518; BDBM50402289; s4212; Tox21_112518_1; AKOS015969750; AKOS01589516	C16H18N4O3S	ZBFDAUIVDSSISP-UHFFFAOYSA-N	5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine	n.a.	n.a.
PMDBD835	Terminalia arjuna	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD837	Tetracycline hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	54704426	n.a.	n.a.	TETRACYCLINE HYDROCHLORIDE; 64-75-5; Tetracycline HCl; Achromycin hydrochloride; Tetracycline (hydrochloride); Topicycline; Tetrabid; Supramycin; Sustamycin; Telotrex; Sumycin; UNII-P6R62377KV; MFCD00078142; Triphacyclin; Tetramavan; Tetrabakat; Dumocyclin; Tetracompren; Stilciclina; Remicyclin; Hostacycline; Bristacycline; Tetralution; Quadracycline; Mephacyclin; Tetrablet; Tetrakap; Tetracaps; Actisite; Tetrosol; Tetramed; Ricycline; Piracaps; Partrex; Diacycine; Artomycin; Tefilin; Subamycin; Unicin; Teline; Qidtet; Paltet; Retet; Tetra-wedel; Neo	C22H25ClN2O8	YCIHPQHVWDULOY-FMZCEJRJSA-N	(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride	n.a.	n.a.
PMDBD839	Thiazolidinediones	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD840	Thiethylperazine dimalate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	11954258	n.a.	n.a.	Thiethylperazine malate; Norzine Ampuls; Thietylperazine malate; 52239-63-1; Thiethylperazine dimalate; EINECS 257-780-2; 2-(Ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine malate (1:2); NCGC00017115-01; CAS-52239-63-1; Thiethylperazine malate [USP]; Torecan (TN); Butanedioic acid, hydroxy-, compd. with 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazine (2:1); 10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-, 2-hydroxy-1,4-butanedioate (1:2); Malic acid, compound w	C30H41N3O10S2	GTHHLZDYRHLACN-UHFFFAOYSA-N	2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;2-hydroxybutanedioic acid	n.a.	n.a.
PMDBD842	Thioguanosine	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2724387	n.a.	n.a.	6-Thioguanosine; 85-31-4; THIOGUANOSINE; 2-Amino-6-mercaptopurin-9-ylriboside; 6-Thioguanosine (VAN); 2-Amino-6-mercaptopurine riboside; 6-Mercaptoguanosine; UNII-C558LI0K8P; Ribosylthioguanine; C10H13N5O4S; Thioguanine riboside; EINECS 201-597-2; 6-Thiodeoxyguanosine; 6-Thioguanine riboside; MLS002153781; AI3-50278; C558LI0K8P; 6-Thioguanine ribonucleoside; 2-Amino-9-(beta-D-ribofuranosyl)purine-6-thiol; 2-Amino-6-mercapto-9(beta-D-ribofuranosyl)purine; 2-Amino-9beta-D-ribofuranosyl-9H-purine-6-thiol; 2-Amin	C10H13N5O4S	OTDJAMXESTUWLO-UUOKFMHZSA-N	2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione	n.a.	n.a.
PMDBD843	Thioridazine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	66062	n.a.	n.a.	Thioridazine hydrochloride; 130-61-0; Thioridazine Hcl; Sonapax hydrochloride; Thioridazine chloride; Mellaril hydrochloride; Thioridazine.HCl; Aldazine; USAF SZ-B; Melleril (tablet); USAF SZ-3; Thioridazine (hydrochloride); EINECS 204-992-8; NSC 186060; MLS000028408; Thioridazine-d3 Hydrochloride; CHEBI:48566; Orsanil; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine hydrochloride; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine hydrochloride; SMR000058380; 10-(2-(1-Methyl-2-piperidyl)	C21H27ClN2S2	NZFNXWQNBYZDAQ-UHFFFAOYSA-N	10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochloride	n.a.	n.a.
PMDBD846	Thonzonium bromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	11102	n.a.	n.a.	THONZONIUM BROMIDE; 553-08-2; Tonzonium bromide; Thonzonium (bromide); Thonzide; UNII-JI2B19CR0R; NC 1264; JI2B19CR0R; MLS002154065; SMR001233380; Tonzonium bromide [INN]; Tonzonium bromide (INN); DSSTox_CID_25326; DSSTox_RID_80805; DSSTox_GSID_45326; Tonzonii bromidum; Hexadecyl(2-[(p-methoxybenzyl)-2-pyrimidinylamino]ethyl)dimethylammonium bromide; Hexadecyl(2-((p-methoxybenzyl)-2-pyrimidinylamino)ethyl)dimethylammonium bromide; Bromuro de tonzonio; Bromure de tonzonium; SR-01000841261; NCGC00016507-01; CAS-553-08-2; Tonzoniumb	C32H55BrN4O	WBWDWFZTSDZAIG-UHFFFAOYSA-M	hexadecyl-[2-[(4-methoxyphenyl)methyl-pyrimidin-2-ylamino]ethyl]-dimethylazanium;bromide	n.a.	n.a.
PMDBD847	Thyroxine (L)	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5819	n.a.	n.a.	L-thyroxine; levothyroxine; 51-48-9; thyroxine; thyroxin; Tetraiodothyronine; Thyrax; 3,3',5,5'-Tetraiodo-L-thyronine; Thyroxinal; Thyreoideum; Thyratabs; Thyroxine iodine; synthroid; Levothyroxin; (-)-Thyroxine; L-Thyroxin; 3,5,3',5'-Tetraiodo-L-thyronine; L-T4; Thyroxine (l); DL-Thyroxin; Levothyroxine sodium; levothroid; t4; Thyroxine (VAN); 3,5,3',5'-Tetraiodothyronine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Laevothyroxinum; T4 (Hormone); L-3,5,3',5'-Tetraiodothyronine; Levothyroxinum (acid); Laevothyroxinum (acid); Th	C15H11I4NO4	XUIIKFGFIJCVMT-LBPRGKRZSA-N	(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid	n.a.	n.a.
PMDBD848	Ticarcillin sodium	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	470375	n.a.	n.a.	TICARCILLIN DISODIUM; ticarcillin sodium; Ticarpen; Aerugipen; Ticar; Ticarcillin disodium salt; 4697-14-7; UNII-G8TVV6DSYG; G8TVV6DSYG; CHEBI:35017; 29457-07-6; NCGC00017046-01; Monapen; CAS-4697-14-7; BRL 2288; 74682-62-5; Disodium Ticarcillin; BRL-2288; N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-3-thiophenemalonamic acid disodium salt; disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxidanidyl-3-oxidanylidene-2-thiophen-3-yl-propanoyl]amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxyl	C15H14N2Na2O6S2	ZBBCUBMBMZNEME-QBGWIPKPSA-L	disodium;(2S,5R,6R)-6-[[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	n.a.	n.a.
PMDBD851	Tiratricol, 3,3',5-triiodothyroacetic acid	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5803	n.a.	n.a.	Tiratricol; 51-24-1; Triac; 3,3',5-TRIIODOTHYROACETIC ACID; Triiodothyroacetic acid; 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid; UNII-29OQ9EU4R1; Tiratricol [INN]; 3',3,5-Triiodothyroacetic acid; CHEMBL41632; 29OQ9EU4R1; Triacana; Tiratricol (INN); CAS-51-24-1; NCGC00016227-01; Teatrois; Tiratricol, 3,3',5-triiodothyroacetic acid; [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID; DSSTox_RID_80767; DSSTox_CID_25232; DSSTox_GSID_45232; Tiratr	C14H9I3O4	UOWZUVNAGUAEQC-UHFFFAOYSA-N	2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid	n.a.	n.a.
PMDBD852	TMAO	Environmental Chemicals	Human Metabolite	n.a.	n.a.	n.a.	n.a.	n.a.	1145	n.a.	n.a.	TRIMETHYLAMINE N-OXIDE; Trimethylamine oxide; 1184-78-7; Triox; N,N-dimethylmethanamine oxide; TMAO; Trimethyloxamine; Methanamine, N,N-dimethyl-, N-oxide; trimethylamine-N-oxide; Trimethylamine, N-oxide; N,N-Dimethylmethanamine N-oxide; TMANO; (CH3)3NO; Trimethylaminoxid; UNII-FLD0K1SJ1A; EINECS 214-675-6; FLD0K1SJ1A; NSC 408426; TRIMETHYLAMINE N-OXIDE HYDROCHLORIDE; AI3-60110; N(CH3)3O; Trimethylamine, N-oxide (8CI); N,N-Dimethyl-methanamine-N-oxide; N,N-dimethylmethanamine oxide (IUPAC); TMAe; trimethylaminoxide; trimethylamineox	C3H9NO	UYPYRKYUKCHHIB-UHFFFAOYSA-N	N,N-dimethylmethanamine oxide	n.a.	n.a.
PMDBD854	Tofu diet	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD858	Toltrazuril	Therapeutic Substance	Approved Drug (veterinary medicine)	n.a.	n.a.	n.a.	n.a.	n.a.	68591	n.a.	n.a.	Toltrazuril; 69004-03-1; Baycox; Toltrazurilum [Latin]; Toltrazurilo [Spanish]; UNII-QVZ3IAR3JS; Bay-i 9142; 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfanyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione; QVZ3IAR3JS; Toltrazurilum; Toltrazurilo; 1-Methyl-3-(4-(p-((trifluoromethyl)thio)phenoxy)-m-tolyl)-s-triazine-2,4,6(1H,3H,5H)-trione; C18H16F3N3O4S; bay vi 9142; 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1-methyl-3-[3	C18H14F3N3O4S	OCINXEZVIIVXFU-UHFFFAOYSA-N	1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfanyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione	n.a.	n.a.
PMDBD860	Tosufloxacin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	10433396	n.a.	n.a.	Tosufloxacin hydrochloride; A 60969; 104051-69-6; Tosufloxacin HCl; SR-01000763339; SCHEMBL3754459; CHEMBL542832; CCG-220465; SR-01000763339-4; Q27283349; 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride; 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, hydrochloride(1:1)	C19H16ClF3N4O3	CIHZSSCESOLBRQ-UHFFFAOYSA-N	7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;hydrochloride	n.a.	n.a.
PMDBD861	Tracazolate hydrochloride	Environmental Chemicals	Unclassified Substance	n.a.	n.a.	n.a.	n.a.	n.a.	24871267	n.a.	n.a.	Tracazolate hydrochloride; 1135210-68-2; DSSTox_RID_80751; DSSTox_CID_25208; DSSTox_GSID_45208; ethyl 4-(butylamino)-1-ethyl-6-methyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate hydrochloride; ICI 136753; SR-01000075239; NCGC00015985-03; 4-(Butylamino)-1-ethyl-6-methyl 1H-pyrazolo[3,4b]pyridine-5-ethylcarboxylate hydrochloride; SCHEMBL1061780; DTXSID0045208; CHEMBL2356666; HMS1571C13; Tox21_110273; Tox21_110273_1; AKOS024456664; CCG-220976; NCGC00015985-08; NCGC00180921-01; T-230; B6790; SR-01000075239-6; SR-01000075239-3; J-002976	C16H25ClN4O2	TUIXDPUEMQXVHO-UHFFFAOYSA-N	ethyl 4-(butylamino)-1-ethyl-6-methylpyrazolo[3,4-b]pyridine-5-carboxylate;hydrochloride	n.a.	n.a.
PMDBD865	Trazodone hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	62935	n.a.	n.a.	Trazodone hydrochloride; 25332-39-2; Trazodone Hcl; Desyrel; Molipaxin; Bimaran; Thombran; Trittico; Apo-Trazodone; Trazodone (hydrochloride); Pragmazone; Triticum; Tritico; Tombran; Devidon; Trialodine; Azona; AF-1161; UNII-6E8ZO8LRNM; KB-831; Oleptro; AF 1161; EINECS 246-855-5; 6E8ZO8LRNM; NSC 292811; MLS000069698; CHEBI:9655; Trazodone hydrochloride (Desyrel); NSC-292811; 2-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one monohydrochloride; 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)	C19H23Cl2N5O	OHHDIOKRWWOXMT-UHFFFAOYSA-N	2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride	n.a.	n.a.
PMDBD870	Trifluoperazine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	66064	n.a.	n.a.	Trifluoperazine dihydrochloride; 440-17-5; Trifluoperazine hydrochloride; Trifluoperazine 2HCl; Terfluzine; Stelazine; Trifluoperazine HCl; Triphthazine; Jatroneural; Eskazinyl; Eskazine; Tryptazine; Triftazin; Trazine; Fluoperazine; Trifluoroperazine hydrochloride; Tryptazine dihydrochloride; Triphthazine dihydrochloride; Calmazine; Stalazine hydrochloride; Modalina; Stelazine dihydrochloride; UNII-6P1Y2SNF5V; Fluoperazine dihydrochloride; Trifluoroperazine dihydrochloride; Trifluoperazine (dihydrochloride); SKF 5019; Trifluoperazin	C21H26Cl2F3N3S	BXDAOUXDMHXPDI-UHFFFAOYSA-N	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride	n.a.	n.a.
PMDBD871	Triflupromazine hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	66069	n.a.	n.a.	Triflupromazine hydrochloride; 1098-60-8; Fluorofen; Neoprin; Flumazin; Triflupromazine HCl; Nivoman; Psyquil; Siquil; Vesprin hydrochloride; Triflupromazine (hydrochloride); Trifluopromazine hydrochloride; Fluopromazine monohydrochloride; Triflupromazine monohydrochloride; UNII-9E75N4A5HM; MC 4703; Trifluopromazine hydrochloride (VAN); EINECS 214-149-6; NSC 14959; NSC 17473; MLS000069672; 9E75N4A5HM; NCGC00094410-02; SMR000058517; Vesprin (TN); 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine monohydrochloride; 10-(3-D	C18H20ClF3N2S	FTNWXGFYRHWUKG-UHFFFAOYSA-N	N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydrochloride	n.a.	n.a.
PMDBD874	Trimebutine maleate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5388977	n.a.	n.a.	Trimebutine maleate; 34140-59-5; Debridat; Polibutin; Trimebutine (maleate); Dromostat; Trimedat; Trimebutine maleate salt; Ibutin; Digerent polifarma; SMR000058893; MLS000028659; 2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate maleate; NCGC00096059-01; EINECS 251-845-9; TM 906; DSSTox_RID_81292; DSSTox_CID_26017; 3,4,5-Trimethoxybenzoic Acid 2-(Dimethylamino)-2-phenylbutyl Ester Maleate Salt; DSSTox_GSID_46017; Q-201885; MLS001401430; SMR000653473; CAS-34140-59-5; SMR000471622; Trimebutine maleate [JAN]; Cerekinon (TN); EIN	C26H33NO9	FSRLGULMGJGKGI-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;[2-(dimethylamino)-2-phenylbutyl] 3,4,5-trimethoxybenzoate	n.a.	n.a.
PMDBD875	Trimeprazine tartrate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441236	n.a.	n.a.	Trimeprazine tartrate; Alimemazine hemitartrate; Alimemazine tartrate; 4330-99-8; Trimeprazine tartrate [USP]; Trimeprazine tartrate (USP); (2R,3R)-2,3-dihydroxybutanedioic acid;N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine; Alimezine (TN); Alimemazine tartrate (JP17); SCHEMBL719590; s5730; CCG-270431; SC-78545; D02245; Q27256512; Trimeprazine Tartrate 1.0 mg/ml in Methanol (as free base); 10-[3-(Dimethylamino)-2-methylpropyl]phenothiazine Tartrate	C40H50N4O6S2	AJZJIYUOOJLBAU-CEAXSRTFSA-N	(2R,3R)-2,3-dihydroxybutanedioic acid;N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine	n.a.	n.a.
PMDBD876	Trimetazidine dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	83201	n.a.	n.a.	Trimetazidine dihydrochloride; 13171-25-0; 1-(2,3,4-Trimethoxybenzyl)piperazine dihydrochloride; Kyurinett; Trimetazidine HCl; Trimetazidine hydrochloride; Trimetajust; Lubomail; Yosimilon; Vastarel; Trimetazidine (dihydrochloride); 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride; Trimetazidine DiHCl; UNII-48V6723Z1P; EINECS 236-117-0; S 4004; Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, dihydrochloride; 48V6723Z1P; DSSTox_RID_80858; DSSTox_CID_25407; DSSTox_GSID_45407; W-108326; Piperazine, 1-(2,3,4-trimethoxyb	C14H24Cl2N2O3	VYFLPFGUVGMBEP-UHFFFAOYSA-N	1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride	n.a.	n.a.
PMDBD882	Unfermented soy product	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD883	Unsaturated fat	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD884	Unspecified antibiotic	Therapeutic Substance	Drug Class	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD885	Urolithin-A	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	5488186	n.a.	n.a.	urolithin A; 1143-70-0; 3,8-dihydroxy-6H-benzo[c]chromen-6-one; 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one; 3,8-Dihydroxyurolithin; 3,8-Hydroxydibenzo-alpha-pyrone; 3,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one; 3,8-dihydroxybenzo[c]chromen-6-one; 3,8-dihydroxy-urolithin; SCHEMBL803408; CHEMBL1836264; CTK4A8707; KS-00000TQI; DTXSID40150694; Urolithin A, &gt;=97% (HPLC); s5312; ZINC13484727; AKOS028108778; CCG-266776; DB15464; CS-6305; DS-19328; AK5445	C13H8O4	RIUPLDUFZCXCHM-UHFFFAOYSA-N	3,8-dihydroxybenzo[c]chromen-6-one	n.a.	n.a.
PMDBD886	Vaccinium myrtillus	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	84540227	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD889	Vancomycin hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6420023	n.a.	n.a.	Vancomycin HCL; VANCOMYCIN HYDROCHLORIDE; Vancomycin monohydrochloride; 1404-93-9; Vancomycin (hydrochloride); UNII-71WO621TJD; Vancocine hydrochloride; Vancomycin, hydrochloride; 71WO621TJD; Vancomycin hydrochloride from Streptomyces orientalis; Vancocin hydrochloride; AeroVanc; Vancomycin, monohydrochloride; SR-01000076194; Prestwick_816; Vancomycin hydrochloride [USP:JAN]; Cancocin hydrochloride; Vancocin hydrochloride in plastic container; Vancomycin HCl (Vancocin); CHEMBL3747636; CHEMBL1200628; DTXSID90891868; HMS1569D15; Va	C66H76Cl3N9O24	LCTORFDMHNKUSG-XTTLPDOESA-N	(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid;hydrochloride	n.a.	n.a.
PMDBD891	Vecuronium bromide	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	39764	n.a.	n.a.	VECURONIUM BROMIDE; 50700-72-6; Norcuron; ORG NC 45; Vecuronii bromidum; Bromuro de vecuronio; Vecuronium (bromide); Bromure de vecuronium; Org-NC-45; NC-45; UNII-7E4PHP5N1D; ORG-NC 45; Vecuronii bromidum [INN-Latin]; Bromure de vecuronium [INN-French]; Bromuro de vecuronio [INN-Spanish]; EINECS 256-723-9; 7E4PHP5N1D; acetate;bromide; CHEBI:9940; 1-(3alpha,17beta-Dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium bromide, diacetate; DSSTox_CID_3736; DSSTox_RID_77174; 5alpha-Androstan-3alpha,17beta	C34H57BrN2O4	VEPSYABRBFXYIB-PWXDFCLTSA-M	[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide	n.a.	n.a.
PMDBD901	Western high-fat diets	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD902	Wild blueberry	Dietary Substance	Foods	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD903	Wine polyphenols	Dietary Substance	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD904	Wognoside	Herbal Substance	Medicinal Herbal Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	12004622	n.a.	n.a.	Wogonoside; 51059-44-0; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid; Oprea1_259997; Wogonin 7-O-b-D-glucuronide; MLS000563432; SCHEMBL13223530; CHEMBL1508816; HMS3332D12; HMS2212B09; BCP31664; Oroxindin; Wogonin 7-O-glucuronide; SMR000232282; DB-050213; FT-0689337	C22H20O11	LNOHXHDWGCMVCO-UHFFFAOYSA-N	3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid	n.a.	n.a.
PMDBD994	AMC formula	Herbal Substance	TCM Formula	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD905	Xiao-Qing-Long Tang	Herbal Substance	TCM Formula	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD911	Zingiber officinale	Herbal Substance	Medicinal Herb	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD912	Ziprasidone  Hydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	219099	n.a.	n.a.	Ziprasidone hydrochloride; 122883-93-6; Ziprasidone HCl; Geodon; Zeldox; 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride; Ziprasidone (hydrochloride); UNII-JAL53626GG; 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; Ziprasidone hydrochloride [USAN]; 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; C21H21ClN4OS.HCl; JAL53626GG; C21H22Cl2N4OS; CP 88059; 2H-Indol-2-one, 	C21H22Cl2N4OS	NZDBKBRIBJLNNT-UHFFFAOYSA-N	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride	n.a.	n.a.
PMDBD913	Ziprasidone mesylate	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	656685	n.a.	n.a.	Ziprasidone mesylate; 199191-69-0; Ziprasidone mesylate trihydrate; Ziprasidone mesilate; Geodon; UNII-3X6SAX83JZ; Ziprasidone mesylate hydrate; 3X6SAX83JZ; Ziprasidone mesylate [USAN]; Geodon (TN); CP-88, 059-27; Ziprasidone mesylate (USAN); CP-8805927; 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monomethanesulfonate, trihydrate; 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monomethanesulfonate, trihydrate; Ziprasidone (mesylate hydrate); CH	C22H31ClN4O7S2	WLQZEFFFIUHSJB-UHFFFAOYSA-N	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;methanesulfonic acid;trihydrate	n.a.	n.a.
PMDBD914	Zn(ii)-curcumin	Environmental Chemicals	Nutrient Supplement	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD917	Zuclopenthixol dihydrochloride	Therapeutic Substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6433208	n.a.	n.a.	Zuclopenthixol dihydrochloride; Zuclopenthixol hydrochloride; Clopixol; Cisordinol; Sordenac; Ciatyl; cis-Clopenthixol hydrochloride; UNII-7042692VYN; alpha-Clopenthixol dihydrochloride; EINECS 261-080-2; 58045-23-1; Clopenthixol cis(Z)-form dihydrochloride; Chlorpenthixol dihydrochloride; N 789; FDA 0199; EINECS 211-194-3; NSC 78203; NSC 169185; 7042692VYN; Clopixol (TN); Clopenthixol dihydrochloride; W 2304; 1-Piperazineethanol, 4-(3-(2-chlorothioxanthen-9-yl)propyl)-, dihydrochloride; Thioxanthene, 2-chloro-9-(3-(4-(2-hydroxye	C22H27Cl3N2OS	LPWNZMIBFHMYMX-MHKBYHAFSA-N	2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;dihydrochloride	n.a.	n.a.
PMDBD1184	Etanercept	Therapeutic substance	Drug	185243-69-0	DB00005	PA449515	D00742	DNC000605	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1017	Adalimumab	Therapeutic substance	Drug	331731-18-1	DB00051	PA10004	D02597	DAP000392	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1239	Infliximab	Therapeutic substance	Drug	170277-31-3	DB00065	PA452639	D02598	DAP000107	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1485	Ustekinumab	Therapeutic substance	Drug	815610-63-0	DB05679	n.a.	D09214	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1437	Teicoplanin	Therapeutic substance	Antibiotics	61036-62-2	DB06149	PA164746244	D02142	n.a.	133065662	n.a.	n.a.	Targocid; Antibiotic 8327A; Teichomycin; MDL 507; Teicoplanina; Teicoplanine; Teicoplaninum; Tecoplaninum; Tecoplanina; Tecoplanine; Teicoplaninum [Latin]; Teicoplanine [French]; Teicoplanina [Spanish]; Tecoplaninum [INN-Latin]; Tecoplanine [INN-French]; Teicoplanine [INN-French]; Teicoplaninum [INN-Latin]; Tecoplanina [INN-Spanish]; Teicoplanina [INN-Spanish]; UNII-4U3D3YY81M; Teicoplanin [USAN:INN:BAN]; 4U3D3YY81M; GTPL10924; MDL-507; 61036-62-2; 8327A	C88H97Cl2N9O33	BJNLLBUOHPVGFT-CAYRISATSA-N	(1S,2R,19R,22R,34S,37R,40R,52S)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-amino-5,15-dichloro-64-[(2S,3R,4R,5S,6R)-3-(decanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,3	n.a.	n.a.
PMDBD1211	Garenoxacin	Therapeutic substance	Antibiotics	194804-75-6	DB06160	n.a.	n.a.	n.a.	124093	110579	n.a.	Garenoxacin; 194804-75-6; Ganefloxacin; T-3811; T 3811; UNII-V72H9867WB; (R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; V72H9867WB; BMS-284756; Garenfloxacin; 194804-75-6 pound not223652-90-2; NCGC00181770-01; Garenoxacin [INN:BAN]; BMS 284756 (*Mesylate salt*); garenoxacinum; garenoxacino; garenoxacine; T-3811MEa; C23H20F2N2O4; BMS-284756 (*Mesylate salt*); BMS284756	C23H20F2N2O4	NJDRXTDGYFKORP-LLVKDONJSA-N	1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD1487	Vedolizumab	Therapeutic substance	Approved Drug	943609-66-3	DB09033	n.a.	D08083	n.a.	n.a.	943609663	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1026	Amino acids	Dietary Substances	Dietary Compounds	65072-01-7	DB09393	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1492	Vitamin D	Therapeutic substance	Drug	1406-16-2	DB11094	n.a.	n.a.	n.a.	5280795	n.a.	n.a.	Vitamin D3; cholecalciferol; 67-97-0; Calciol; Colecalciferol; VITAMIN D; Oleovitamin D3; Trivitan; Arachitol; Ricketon; Vigorsan; Deparal; Activated 7-dehydrocholesterol; Colecalcipherol; Delsterol; Quintox; Ebivit; Cholecalciferolum; (+)-Vitamin D3; D3-Vigantol; D3-Vicotrat; vitamin d-3; Vi-de-3-hydrosol; NEO Dohyfral D3; Vitinc Dan-Dee-3; Rampage; Colecalciferolum; Cholecalciferol, D3; Vi-De3; Colecalciferolo [DCIT]; FeraCol; Duphafral D3 1000; 1406-16-2; Colecalciferolum [INN-Latin]; 7-Dehydrocholestrol, activated; Irradiated 7-dehydroch	C27H44O	QYSXJUFSXHHAJI-YRZJJWOYSA-N	(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol	n.a.	n.a.
PMDBD1417	Sitafloxacin	Therapeutic substance	Antibiotics	163253-35-8	DB13261	n.a.	n.a.	n.a.	461399	27471522	n.a.	Sitafloxacin; Gracevit; 127254-12-0; Sitafloxacin Sesquihydrate; UNII-3GJC60U4Q8; DU-6859a; 163253-35-8; Sitafloxacin isomer II; C19H18ClF2N3O3; DU 6859; CHEBI:4304; 3GJC60U4Q8; 7-((S)-7-AMINO-5-AZASPIRO[2.4]HEPTAN-5-YL)-8-CHLORO-6-FLUORO-1-((1R,2S)-2-FLUOROCYCLOPROPYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; STFX; DU-6859; 127254-10-8; 7-(7-Amino-5-azaspiro(2.4)heptan-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid sesquihydrate; 7-((7S)-Amino-5-azaspiro(2,4)heptan-5-yl)-8	C19H18ClF2N3O3	PNUZDKCDAWUEGK-CYZMBNFOSA-N	7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD1089	Cefpirome 	Therapeutic substance	Antibiotics	84957-29-9	DB13682	n.a.	D07649	n.a.	5479539	4586396	n.a.	CEFPIROME; 84957-29-9; Cefpiromum; Cefpiroma; Cefrom; HR 810; UNII-S72Q2F09HY; cefpirome sulfate; S72Q2F09HY; CHEBI:3503; Cefpiromum [Latin]; Cefpiroma [Spanish]; Cefpirome [INN:BAN]; HR-810; (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(6,7-dihydro-5H-cyclopenta[b]pyridinium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; cefpirome sulphate; NCGC00181339-01; Cerfpirome; C22H22N6O5S2; Broact; Keiten; Cefpirome (INN); 5H-1-Pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimin	C22H22N6O5S2	DKOQGJHPHLTOJR-WHRDSVKCSA-N	(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1278	Mercuric chloride	Environmental Chemicals	Heavy Metals	7487-94-7	DB13765	n.a.	D01905	n.a.	24085	22517	n.a.	MERCURIC CHLORIDE; Mercury(II) chloride; Dichloromercury; Sublimate; Mercury dichloride; Mercury bichloride; Corrosive sublimate; Mercury perchloride; Mercuric bichloride; 7487-94-7; Sublimat; Sulema; HgCl2; Perchloride of mercury; Corrosive mercury chloride; Chlorure mercurique; Calochlor; Fungchex; Sulem; Bichlorure de mercure; Abavit B; Mercury chloride (HgCl2); Bichloride of mercury; Chlorid rtutnaty; Mercury(2+) chloride; Quecksilber chlorid; Calocure; Sublimat [Czech]; Sulema [Russian]; Cloruro di mercurio; mercury(II)chloride; dic	Cl2Hg	LWJROJCJINYWOX-UHFFFAOYSA-L	dichloromercury	n.a.	n.a.
PMDBD1068	Cadmium	Environmental Chemicals	Heavy Metals	7440-43-9	DB14085	n.a.	n.a.	n.a.	23973	22410	n.a.	7440-43-9; Cadmium; Cd; Colloidal cadmium; Cadmium compounds; Cadmium, elemental; Kadmium; Kadmium [German]; UNII-00BH33GNGH; CCRIS 112; HSDB 282; EINECS 231-152-8; MFCD00010914; 00BH33GNGH; C I 77180; C.I. 77180; Cadmium [Cadmium and cadmium compounds]; Cadmium [Cadmium and certain cadmium compounds]; cadmio; Cadmium, Reference Standard Solution; Cadmium, mass of 135; Cadmium metal; Elemental cadmium; CD135; Cadmium, p.a.; Cadmium powder 325 mesh; 48Cd; Cadmium, &gt;=99.9%; EC 231-152-8; Cadmium powder - 100mesh; Cadmium, thermovacuum 	Cd	BDOSMKKIYDKNTQ-UHFFFAOYSA-N	cadmium	n.a.	n.a.
PMDBD1000	4-Aminosalicylic Acid	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4649	n.a.	n.a.	4-Aminosalicylic acid; 4-Amino-2-hydroxybenzoic acid; 65-49-6; Aminosalicylic acid; P-AMINOSALICYLIC ACID; Rezipas; Aminopar; Pamisyl; Parasalindon; Deapasil; Apacil; Parasal; Paser; Para-aminosalicylic acid; Paramycin; Gabbropas; Pasnodia; Parasalicil; Osacyl; Aminox; Pasolac; Pasmed; Pasdium; Pasara; Pamacyl; Propasa; Pasalon; Entepas; Pasem; Pasa; 2-Hydroxy-4-aminobenzoic acid; PASK; APAS; Para-Pas; Sanipirol-4; para-Amino salicylic acid; Hellipidyl; Pascorbic; 4-Aminosalicylate; PAS-C; PAS (acid); Kyselina p-am	C7H7NO3	WUBBRNOQWQTFEX-UHFFFAOYSA-N	4-amino-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD1001	2,2',4,4'-Tetrabromodiphenyl ether	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	95170	n.a.	n.a.	5436-43-1; 2,2',4,4'-Tetrabromodiphenyl ether; 4,4'-Oxybis(1,3-dibromobenzene); BDE-47; PBDE 47; DIBROMOPHENYL ETHER; 2,2'4,4'-Tetrabromodiphenyl ether; 2,4-dibromo-1-(2,4-dibromophenoxy)benzene; BDE 47; C12H6Br4O; PBDE-47; UNII-0N97R5X10X; 1,1'-oxybis(2,4-dibromobenzene); NSC 21724; bis(2,4-dibromophenyl) ether; CHEBI:81584; 0N97R5X10X; NSC21724; 1,1'-Oxybis[2,4-dibromobenzene]; AK121881; PBDE 47 (2,2',4,4'-Tetrabromodiphenyl ether); DSSTox_CID_10056; PBDE No. 	C12H6Br4O	XYBSIYMGXVUVGY-UHFFFAOYSA-N	2,4-dibromo-1-(2,4-dibromophenoxy)benzene	n.a.	n.a.
PMDBD1002	2,3,7,8-tetrachlorodibenzofuran	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	39929	n.a.	n.a.	2,3,7,8-TETRACHLORODIBENZOFURAN; Tcdbf; TCDF; 51207-31-9; 2,3,7,8-TCDF; UNII-XZJ41GQI5D; NCI-C56611; HSDB 4306; 2,3,7,8-Tetrapolychlorinated dibenzofuran; 2,3,7,8-Tetrachloro-dibenzofuran; XZJ41GQI5D; BRN 1430934; CHEMBL136710; CHEBI:81506; 2,3,7,8-Tetrachlorodibenzo[b,d]furan; 2,3,7,8-Tetrachlorodibenzofuran [Dioxin and dioxin-like compounds]; PCDF 83; SCHEMBL548471; ACMC-1B053; DTXSID3052147; CTK3F0526; ZINC5784249; 2,3,7,8-TCDF (and congeners); BDBM50408308; LS-162; 2,3,7,8-Tetrachlorodibenzo[b	C12H4Cl4O	KSMVNVHUTQZITP-UHFFFAOYSA-N	2,3,7,8-tetrachlorodibenzofuran	n.a.	n.a.
PMDBD1003	2,3,7,8-tetrachlorodibenzo-p-dioxin	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	15625	n.a.	n.a.	2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; TCDD; Dioxin; Tetradioxin; Tetrachlorodibenzodioxin; 1746-01-6; Dioxine; TCDBD; 2,3,7,8-Tetrachlorooxanthrene; 2,3,7,8-TCDD; 2,3,7,8-Tetrachlorodibenzodioxin; Dioksyny; Dioksyny [Polish]; Dioxin (herbicide contaminant); 2,3,7,8-Tetrachlorodibenzo-1,4-dioxin; NCI-C03714; UNII-DO80M48B6O; PCDD 48; CCRIS 576; HSDB 4151; EINECS 217-122-7; 2,3,7,8-Tetrachlorodibenzo[b,e][1,4]dioxin; 2,3,7,8-tetrachloro-dibenzo-p-dioxin; Dibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetrach	C12H4Cl4O2	HGUFODBRKLSHSI-UHFFFAOYSA-N	2,3,7,8-tetrachlorodibenzo-p-dioxin	n.a.	n.a.
PMDBD1004	5-aminosalicylic acid	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4075	n.a.	n.a.	5-Aminosalicylic acid; mesalamine; Mesalazine; 5-Amino-2-hydroxybenzoic acid; 89-57-6; Asacol; Pentasa; Claversal; Canasa; 5-ASA; Salofalk; Rowasa; m-Aminosalicylic acid; Mesasal; Lialda; Fisalamine; Lixacol; Apriso; p-Aminosalicylsaeure; sfRowasa; Mesalazinum; Asacolitin; Mesalazina; 5-amino-2-hydroxy-benzoic acid; Asacol HD; Mesalazinum [Latin]; 5-Amino Salicylic Acid; Mesalamine [USAN]; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; 2-Hydroxy-5-aminobenzoic acid; 3-carbox	C7H7NO3	KBOPZPXVLCULAV-UHFFFAOYSA-N	5-amino-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD1005	5-fluoro-2'-deoxyuridine	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5790	n.a.	n.a.	floxuridine; 50-91-9; 5-Fluorodeoxyuridine; 2'-Deoxy-5-fluorouridine; Fluorodeoxyuridine; FUDR; Floxuridin; Deoxyfluorouridine; 5-Fluoro-2'-deoxyuridine; Fluoruridine deoxyribose; 5FdU; Floxuridinum; Floxiridina; 5-Fluoro-2-desoxyuridine; FdUrd; beta-5-Fluoro-2'-deoxyuridine; 5 Fluorodeoxyuridine; Floxuridinum [INN-Latin]; 5-Fluorouracil 2'-deoxyriboside; Floxiridina [INN-Spanish]; 5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione; 5-Fluoro-2-deoxyuridine; 5-Fluorouracil deoxyribo	C9H11FN2O5	ODKNJVUHOIMIIZ-RRKCRQDMSA-N	5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	n.a.	n.a.
PMDBD1006	5-fluorocytosine	Therapeutic substance	Prodrug	n.a.	n.a.	n.a.	n.a.	n.a.	3366	n.a.	n.a.	5-Fluorocytosine; flucytosine; 2022-85-7; Ancotil; Ancobon; 5-Fluorocystosine; Fluocytosine; 5-FC; Flucytosin; 5-Fluorocytosin; Fluorcytosine; Alcobon; 4-Amino-5-fluoropyrimidin-2(1H)-one; Flucytosinum; Ro 2-9915; 4-Amino-5-fluoro-2(1H)-pyrimidinone; 5-Flurocytosine; 5-Flucytosine; 2-Hydroxy-4-amino-5-fluoropyrimidine; 5-fluoro cytosine; Ancobon (TN); Flucitosina [DCIT]; Ro 29915 E/265601; NSC 103805; Flucytosinum [INN-Latin]; 117969-88-7; Flucytosine (Ancobon); Flucytosine (5	C4H4FN3O	XRECTZIEBJDKEO-UHFFFAOYSA-N	6-amino-5-fluoro-1H-pyrimidin-2-one	n.a.	n.a.
PMDBD1007	5-fluorodeoxyuridine	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5790	n.a.	n.a.	floxuridine; 50-91-9; 5-Fluorodeoxyuridine; 2'-Deoxy-5-fluorouridine; Fluorodeoxyuridine; FUDR; Floxuridin; Deoxyfluorouridine; 5-Fluoro-2'-deoxyuridine; Fluoruridine deoxyribose; 5FdU; Floxuridinum; Floxiridina; 5-Fluoro-2-desoxyuridine; FdUrd; beta-5-Fluoro-2'-deoxyuridine; 5 Fluorodeoxyuridine; Floxuridinum [INN-Latin]; 5-Fluorouracil 2'-deoxyriboside; Floxiridina [INN-Spanish]; 5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione; 5-Fluoro-2-deoxyuridine; 5-Fluorouracil deoxyribo	C9H11FN2O5	ODKNJVUHOIMIIZ-RRKCRQDMSA-N	5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	n.a.	n.a.
PMDBD1008	6-Mercaptopurine-2′-deoxyriboside	Therapeutic substance	Investigational Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3037127	n.a.	n.a.	2'-Deoxy-6-thioinosine; NSC 90557; 6-Mercaptopurine deoxyriboside; NSC 409366; 6-Mercaptopurine-2'-deoxyribonucleoside; 2239-64-7; 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-9H-purine-6(1H)-thiol; Inosine, 2'-deoxy-6-thio- (9CI); dI6S; 6-Mercapto-9-(2'-deoxy-b-D-ribofuranosyl)purine; 6-thio-2' -deoxyinosine; SCHEMBL16216743; 6-Mercaptopurine-2-deoxyriboside; MFCD00056001; ZINC17163387; LS-127175; (2R,3S,5R)-2-(Hydroxymethyl)-5-(6-me	C10H12N4O3S	WACLJMMBCDNRJE-RRKCRQDMSA-N	9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione	n.a.	n.a.
PMDBD1009	ACE inhibitors	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1011	Acesulfame potassium	Environmental Chemicals	Artificial Sweeteners	n.a.	n.a.	n.a.	n.a.	n.a.	11074431	n.a.	n.a.	Acesulfame potassium; 55589-62-3; Acesulfame K; potassium 6-methyl-4-oxo-4H-1,2,3-oxathiazin-3-ide 2,2-dioxide; 6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide potassium salt; Acesulfame (potassium); Acesulfame potassium salt; Acesulfame-K; NCGC00090729-01; AK128967; C4H4KNO4S; DSSTox_CID_10606; DSSTox_RID_78852; DSSTox_GSID_30606; Acesulfame potassium (NF); CAS-55589-62-3; E950; E 950; potassium;6-methyl-2,2-dioxo-1-oxa-2?^{6}-thia-3-azanidacyclohex-5-en-4-one; MLS006010910; INS NO.950; CHEMBL1351474; DTXSID1030606; KS-00000JHP	C4H4KNO4S	WBZFUFAFFUEMEI-UHFFFAOYSA-M	potassium;6-methyl-2,2-dioxo-1-oxa-2lambda6-thia-3-azanidacyclohex-5-en-4-one	n.a.	n.a.
PMDBD1015	Actinomycin	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1016	Acyclovir Zovirax	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	135398513	n.a.	n.a.	acyclovir; Aciclovir; Acycloguanosine; 59277-89-3; Zovirax; Vipral; Virorax; Wellcome-248U; 9-[(2-Hydroxyethoxy)methyl]guanine; Aciclovirum; Zovir; Aciclovirum [Latin]; Sitavig; 9-HYROXYETHOXYMETHYLGUANINE; Aciclovirum [INN-Latin]; W-248-U; 9-(2-Hydroxyethoxy)methylguanine; Acyclovir-side chain-2-3H; 2-Amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-one; 9-((2-Hydroxyethoxy)methyl)guanine; BW-248U; UNII-X4HES1O11F; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; DRG-0008; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin	C8H11N5O3	MKUXAQIIEYXACX-UHFFFAOYSA-N	2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one	n.a.	n.a.
PMDBD1019	Aflatoxin B1	Environmental Chemicals	Biological Contaminants	n.a.	n.a.	n.a.	n.a.	n.a.	186907	n.a.	n.a.	AFLATOXIN B1; 1162-65-8; Aflatoxin B; NSC 529592; HSDB 3453; CCRIS 12; UNII-9N2N2Y55MH; NSC-529592; AFB1; EINECS 214-603-3; Aflatoxin B1, crystalline; BRN 1269174; CHEBI:2504; 9N2N2Y55MH; (6aR,9aS)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione; 2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione; Cyclopenta(c)furo(3'	C17H12O6	OQIQSTLJSLGHID-WNWIJWBNSA-N	(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione	n.a.	n.a.
PMDBD1020	Aldicarb	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	9570071	n.a.	n.a.	aldicarb; Temik; Aldicarbe; 116-06-3; Temik 10 G; NSC 379586; Z-isomeraldicarb; UC-21149; 2-Methyl-2-(methylthio)propionaldehyde O-(methylcarbamoyl)oxime; OMS-771; 2-Methyl-2-(methylthio)propanal, O-((methylamino)carbonyl)oxime; Propanal, 2-methyl-2-(methylthio)-, O-((methylamino)carbonyl)oxime; Carbamyl; Sulfone aldoxycarb; 2-Methyl-2-(methylthio)propanal O-[(methylamino)carbonyl]oxime; Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino)carbonyl]oxime; Aldicarb [ISO]; Aldicarbe [French]; Temik G10; TEMIK G; Caswell No. 011A	C7H14N2O2S	QGLZXHRNAYXIBU-WEVVVXLNSA-N	[(E)-(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate	n.a.	n.a.
PMDBD1023	Alpha blockers	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1029	Amoxicillin plus metronidazole	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1030	Amoxicillin/clavulanate	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1032	Anti PD-1 therapy	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1033	Antibiotics (previous month antibiotics)	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1034	Antihistamines (H1 inhibitor)	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1035	Antihistamines (H2 inhibitor)	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1036	Antihistamines (H3 inhibitor)	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1038	AQ4N	Therapeutic substance	Prodrug	n.a.	n.a.	n.a.	n.a.	n.a.	9955116	n.a.	n.a.	Banoxantrone; AQ4N; 136470-65-0; UNII-W5H7E45YT3; W5H7E45YT3; AQ 4N; Banoxantrone [INN:BAN]; AQ-4N; SCHEMBL3676563; CHEMBL117391; ZINC3776950; DB04975; 1,4-Bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-9,10-anthracenedione N,N'-dioxide; NCGC00346890-01; DS-016089; NS00069174; Q27292332; 1,4-Bis(2-(dimethylazinoyl)ethylamino)-5,8-dihydroxy-9,10-anthraquinone; 1,4-Bis[2-(dimethylamino-n-oxide)ethylamino]-5,8-dihydroxyanthracene-9,10-dione	C22H28N4O6	YZBAXVICWUUHGG-UHFFFAOYSA-N	2-[[4-[2-[dimethyl(oxido)azaniumyl]ethylamino]-5,8-dihydroxy-9,10-dioxoanthracen-1-yl]amino]-N,N-dimethylethanamine oxide	n.a.	n.a.
PMDBD1039	Ara G hydrate	Therapeutic substance	Investigational Drug	n.a.	n.a.	n.a.	n.a.	n.a.	135499520	n.a.	n.a.	38819-10-2; 9-(beta-D-Arabinofuranosyl)guanine; Arabinosylguanine; Ara-G hydrate; 9-Arabinofuranosylguanine; 9-beta-d-Arabinofuranosylguanine; Ara-G; Guanine arabinoside; 9-(b-d-arabinofuranosyl)guanine; 9-beta-Arabinosylguanine; NSC 76352; UNII-0Z99WX0GPF; 0Z99WX0GPF; CHEMBL240933; CHEBI:73141; 9-(BETA-D-ARABINOFURANOSYL)-GUANINE; C10H13N5O5; 2-amino-9-(beta-D-arabinofuranosyl)-1,9-dihydro-6H-purin-6-one; 2-Amino-9-((2R,3S,4	C10H13N5O5	NYHBQMYGNKIUIF-FJFJXFQQSA-N	2-amino-9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	n.a.	n.a.
PMDBD1040	aracytine	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	114682	n.a.	n.a.	Arabinofuranosylcytosine; Cytarabinoside; Spongocytidine; Aracytidine; Aracytine; Cytarabin; Iretin; 3083-52-1; Arabinoside C; Arabinosylcytosine; Cytosine arabinose; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinosylcytosine; Cytosine b-D-arabinofuranoside; Cyclocide; Citozar; ara-Cytosine; Cytosar U; Tarabine PFS; AC-1075; U 19920A; Spectrum_000331; Spectrum3_000373; Spectrum2_000159; U-19,920; Spectrum5_000821; Spectrum4_000307; (Arabinofuranosyl)cytosine; 4-Amino-1-arabinofuranosyl-2(1H)-pyrimidinone	C9H13N3O5	UHDGCWIWMRVCDJ-STUHELBRSA-N	4-amino-1-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	n.a.	n.a.
PMDBD1041	Arsenic and zinc	Environmental Chemicals	Heavy Metals	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1044	Aspirin	Therapeutic substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2244	n.a.	n.a.	aspirin; ACETYLSALICYLIC ACID; 50-78-2; 2-Acetoxybenzoic acid; 2-(Acetyloxy)benzoic acid; o-Acetoxybenzoic acid; Acylpyrin; O-Acetylsalicylic acid; Ecotrin; Easprin; Acetophen; Acenterine; Polopiryna; Acetosal; Acetylsalicylate; Colfarit; Salicylic acid acetate; o-Carboxyphenyl acetate; Enterosarein; Temperal; Acetylin; Aspergum; Salcetogen; Pharmacin; Acetosalin; Premaspin; Micristin; Benaspir; Aspirdrops; Acetonyl; Aceticyl; Empirin; Ecolen; Rhodine; Endydol; Saletin; Rheumintabletten; Solprin acid; Enterosarine; Bialpirinia; Globentyl; Enterici	C9H8O4	BSYNRYMUTXBXSQ-UHFFFAOYSA-N	2-acetyloxybenzoic acid	n.a.	n.a.
PMDBD1046	Atorvastatin Calcium	Therapeutic substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	60822	n.a.	n.a.	ATORVASTATIN CALCIUM; 134523-03-8; Lipitor; Sortis; Tahor; Atorvastatin Hemicalcium; CI-981; Atorvastatin hemicalcium salt; Atorvastatin calcium salt; UNII-C0GEJ5QCSO; Torvast; C0GEJ5QCSO; DRG-0321; CI 981; PD 134298-38A; CHEBI:50686; Atorvastatin calcium hydrate; Atorvastatin calcium [USAN]; Sotis; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); Lipitor (TN); 110862-48-1; DSSTox_RID_80143; DSSTox_CID_24303; DSSTox_GSID_44303; Storvas; Rotacor; CHEMBL3	C66H68CaF2N4O10	FQCKMBLVYCEXJB-MNSAWQCASA-L	calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate	n.a.	n.a.
PMDBD1048	Atrazine; estradiol; PCB126; PCB153	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1052	Benzo[a]pyrene	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	2336	n.a.	n.a.	benzo[a]pyrene; 50-32-8; benzo[pqr]tetraphene; 3,4-Benzopyrene; BENZO(A)PYRENE; 3,4-Benzpyrene; benzo[def]chrysene; Benzpyrene; 6,7-Benzopyrene; Benz[a]pyrene; 3,4-BP; 3,4-Benz[a]pyrene; 3,4-Benzopirene; 3,4-Benzpyren; Benzo[d,e,f]chrysene; Benz(a)pyrene; (B(a)P); B(a)P; BP; 3,4 Benzpyrene; RCRA waste number U022; Benzo(d,e,f)chrysene; 3,4-Benz(a)pyrene; NSC 21914; 3,4-Benzo(a)pyrene; B[a]p; 3,4-Benzpyren [German]; CCRIS 76; Benzo[A]-Pyrene; Benzo(def)chrysene; 3,4-benzylpyrene; 3,4-Benzopirene [Italian]; UNII-3417WMA06D; CHEBI:29865; HSDB 	C20H12	FMMWHPNWAFZXNH-UHFFFAOYSA-N	benzo[a]pyrene	n.a.	n.a.
PMDBD1053	Benztropine Mesylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	238053	n.a.	n.a.	BENZTROPINE MESYLATE; Cogentin mesylate; 132-17-2; Benztropine (mesylate); MLS000737056; NSC42199; SMR000394012; Cobrentin methanesulfonate; EN300-51031; 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane, methanesulfonic acid; Benzatropine methanesulfonate; Q-200693; 3-Diphenylmethoxytropane mesylate; MK 02; 3-(Benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate; 3-Diphenylmethoxytropane methanesulfonate; Tropine benzohydryl ether methanesulfonate; 102701-02-0; Cogentin methanesulfonate; SR-01000075303; Ben	C22H29NO4S	CPFJLLXFNPCTDW-UHFFFAOYSA-N	3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid	n.a.	n.a.
PMDBD1054	Berry fruits(cranberries; raspberries)	Environmental Chemicals	Food	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1055	Beta blockers	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1058	Bile acids	Dietary Substances	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	439520	n.a.	n.a.	Bile salt; Bile acid; Bile Salts; CHEBI:22868; C01558	C24H40O5	BHQCQFFYRZLCQQ-UMZBRFQRSA-N	4-[(3R,5S,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	n.a.	n.a.
PMDBD1059	Bisoprolol Fumarate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6917733	n.a.	n.a.	Bisoprolol fumarate; 104344-23-2; Bisoprolol hemifumarate; Zebeta; Bisoprolol monofumarate; Monocor; Maintate; Fondril; Emcor; Concor; Soprol; TA-4708; Euradal; SMR000471619; 105878-43-1; MFCD00792743; Bisocard; Congescor; Cardicor; SR-01000597980; Concor COR; 66722-45-0; Bisoprolol fumarate (1:x); SCHEMBL41419; MLS001401436; MLS001076669; ARONIS24282; CHEMBL1200708; C18H31NO4.C4H4O4; Pharmakon1600-01505704; HMS2233F12; HMS1569A21; BCPP000331; HMS2051I16; HMS2094O19; EMD33512; SBB080729; s1206; RW2574; NSC759181; AKOS005267174; CCG-213520; AC-5016	C22H35NO8	RZPZLFIUFMNCLY-WLHGVMLRSA-N	(E)-but-2-enedioic acid;1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol	n.a.	n.a.
PMDBD1061	bisphenol A; ethinyl estradiol	Environmental Chemicals	Others	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1063	Brompheniramine Maleate	Therapeutic substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281067	n.a.	n.a.	Brompheniramine maleate; 980-71-2; Brompheniramine hydrogen maleate; Rolabromophen; Dimotane; Veltane; Spentane; Gammistin; Drauxin; Nagemid; Ebalin; Allent; Dimetane-ten; Parabromdylamine maleate; Drixoral Syrup; Brompheniramine (maleate); Dimetapp Allergy; Dimetane Extentabs; Lodrane; Brompheniramine maleate [USP]; EINECS 213-562-9; MLS000028423; CHEBI:3184; (+/-)-Brompheniramine maleate; (+/-)-Brompheniramine maleate salt; SMR000058417; 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate; 2-(p-Bromo-alpha-(2-(dimethyl	C20H23BrN2O4	SRGKFVAASLQVBO-BTJKTKAUSA-N	3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid	n.a.	n.a.
PMDBD1066	Butorphanol-(+)-Tartrate	Therapeutic substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	24840146	n.a.	n.a.	Butorphanol tartrate; levo-BC-2627 tartrate; Torbutrol; Torate; Stadol NS; Torbutrol (Veterinary); Stadol Preservative Free; DEA No. 9720; EINECS 261-443-5; Butorphanol Tartrate Preservative Free; 58786-99-5; Butorphanol tartrate civ; (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol D-(-)-tartrate (1:1) (salt); Morphinan-3,14-diol, 17-(cyclobutylmethyl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt); Morphinan-3,14-diol, 17-(cyclobutylmethyl)-, (-)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt); SCHEMBL443889; CHEM	C25H35NO8	GMTYREVWZXJPLF-SXWPHCFWSA-N	(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol;2,3-dihydroxybutanedioic acid	n.a.	n.a.
PMDBD1074	Carbamate aldicarb	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	9570071	n.a.	n.a.	aldicarb; Temik; Aldicarbe; 116-06-3; Temik 10 G; NSC 379586; Z-isomeraldicarb; UC-21149; 2-Methyl-2-(methylthio)propionaldehyde O-(methylcarbamoyl)oxime; OMS-771; 2-Methyl-2-(methylthio)propanal, O-((methylamino)carbonyl)oxime; Propanal, 2-methyl-2-(methylthio)-, O-((methylamino)carbonyl)oxime; Carbamyl; Sulfone aldoxycarb; 2-Methyl-2-(methylthio)propanal O-[(methylamino)carbonyl]oxime; Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino)carbonyl]oxime; Aldicarb [ISO]; Aldicarbe [French]; Temik G10; TEMIK G; Caswell No. 011A	C7H14N2O2S	QGLZXHRNAYXIBU-WEVVVXLNSA-N	[(E)-(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate	n.a.	n.a.
PMDBD1078	Carbinoxamine Maleate	Therapeutic substance	Approved Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282409	n.a.	n.a.	CARBINOXAMINE MALEATE; 3505-38-2; Lergefin; Carbinoxamine maleate salt; Ciberon; Cliston; Clistin; p-Carbinoxamine maleate; Allergefon maleate; Paracarbinoxamine maleate; Hislosine; Ziriton; Histine sirup; Polistin T-caps; Polistine T-caps; Carbinoxamine hydrogen maleate; Clistin-D; EINECS 222-498-0; NSC 62362; CHEBI:31353; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine maleate; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine bimaleate; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine maleate (1:	C20H23ClN2O5	GVNWHCVWDRNXAZ-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine	n.a.	n.a.
PMDBD1079	carboxymethylcellulose or polysorbate-80	Environmental Chemicals	Food additives	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1081	Carnitine	Dietary Substances	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	288	n.a.	n.a.	DL-Carnitine; Carnitine; 406-76-8; Carnitine DL-form; Carnitine [INN]; 3-hydroxy-4-(trimethylammonio)butanoate; (+-)-Carnitine; 461-06-3; L(-)-Carnitine; D,L-carnitine; Levocarnitine;Vitamin B(T); d(+)-carnitine; 3-hydroxy-4-(trimethylazaniumyl)butanoate; EINECS 206-976-6; Carnicor; Carnitinum [INN-Latin]; Carnitina [INN-Spanish]; CHEBI:17126; MFCD00038747; AK113129; Carnitina; (S)-3-Hydroxy-4-(trimethylammonio)butanoate; (1)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; Novaine; Excitine; Vitacarn; Miotonal; Miocor; Novain	C7H15NO3	PHIQHXFUZVPYII-UHFFFAOYSA-N	3-hydroxy-4-(trimethylazaniumyl)butanoate	n.a.	n.a.
PMDBD1082	CB1954	Therapeutic substance	Drug; Prodrug	n.a.	n.a.	n.a.	n.a.	n.a.	89105	n.a.	n.a.	Tretazicar; 21919-05-1; CB 1954; CB1954; 5-(1-Aziridinyl)-2,4-dinitrobenzamide; 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE; 5-Aziridino-2,4-dinitrobenzamide; CB-1954; 5-Aziridinyl-2,4-dinitrobenzamide; Tretazicar [INN]; 2,4-Dinitroethyleneiminobenzamide; 2,4-Dinitro-5-ethyleneiminobenzamide; NSC 115829; CHEMBL23330; CCRIS 1631; UNII-7865D5D01M; NSC-115829; 7865D5D01M; BRN 5825582; CB1; C9H8N4O5; SMR000326847; 5-[aziridin-1-yl]-2,4-dinitrobenzamide; aziri	C9H8N4O5	WOCXQMCIOTUMJV-UHFFFAOYSA-N	5-(aziridin-1-yl)-2,4-dinitrobenzamide	n.a.	n.a.
PMDBD1084	Cefditoren Pivoxil	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6437877	n.a.	n.a.	cefditoren pivoxil; 117467-28-4; Spectracef; Cefditoren pivaloyloxymethyl ester; CDTR-PI; Cefditorin; Meiact; Cefditoren (pivoxil); Cefditoren PI voxil; Cefditoren Pivoxil [JAN]; UNII-78THA212DH; ME 1207; ME-1207; CCRIS 7768; CEFDITORIN PIVOXIL; C25H28N6O7S3; ME1207; 78THA212DH; CHEBI:560555; [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; [(2,2-dimethylpropanoyl)o	C25H28N6O7S3	AFZFFLVORLEPPO-UVYJNCLZSA-N	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1086	Cefetamet-pivoxil	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	5486182	n.a.	n.a.	Cefetamet pivoxil; Cefetamet pivoxyl; 65243-33-6; Globocef; UNII-F6XA85N260; F6XA85N260; Cefetamet pivaloyloxymethyl ester; 7-(2 (2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-desacetoxyceph-3-em-4-carboxylic acid pivaloyloxymethyl ester; Cefditoren impurity 3, Cefetamet Pivoxil; PubChem20563; NCGC00181788-01; SCHEMBL74256; CHEMBL4303443; DTXSID40110016; CHEBI:135812; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-o	C20H25N5O7S2	DASYMCLQENWCJG-XUKDPADISA-N	2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1090	Cefpodoxime Proxetil	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	6526396	n.a.	n.a.	cefpodoxime proxetil; Vantin; Banan; 87239-81-4; Orelox; Doxef; CS-807; U-76252; CHEBI:3505; Cefodox; Cepodem; Cefoprox; DSSTox_CID_2766; DSSTox_RID_76722; DSSTox_GSID_22766; cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester; (RS)-1-((Isopropoxycarbonyl)oxy)ethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Cephpodoxime Proxetil; Simplicef; Otreon; CS 807; Xtum-O	C21H27N5O9S2	LTINZAODLRIQIX-FBXRGJNPSA-N	1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1092	Ceftaroline	Therapeutic substance	Approved Drug; Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	9852981	n.a.	n.a.	Ceftaroline fosamil; Ceftaroline inner salt; 229016-73-3; PPI-0903; CHEBI:70718; UNII-7P6FQA5D21; 7P6FQA5D21; (6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; ceftarolina fosamilo; Ceftaroline fosamil [USAN:INN:BAN]; ceftarolinum fosamilum; SCHEMBL1464037; CHEMBL501122; DTXSID60177444; DB06590	C22H21N8O8PS4	ZCCUWMICIWSJIX-NQJJCJBVSA-N	(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1093	Ceftaroline/avibactam	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1094	Ceftazidime/avibactam	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1099	Cefuroxime axetil	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	6321416	n.a.	n.a.	cefuroxime axetil; Ceftin; Zinnat; Cefuroxime 1-acetoxyethyl ester; Elobact; Zinat; Bioracef; CXM-AX; Coliofossim; 64544-07-6; Furoxime; Cethixim; Cepazine; Cetoxil; Celocid; Nivador; Medoxm; Kalcef; Zoref; Sharox-500; CCI-15641; UNII-Z49QDT0J8Z; DRG-0157; SN 407; CCI 15641; CHEBI:3516; (E)-Cefuroxime Axetil; BRN 6854419; Z49QDT0J8Z; (RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate; C20H22N4O10S	C20H22N4O10S	KEJCWVGMRLCZQQ-YJBYXUATSA-N	1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1100	Cefuroxime axetil followed vancomycin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1101	Cefuroxime axetil than vancomycIn	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1102	Cephaloridine	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	5773	n.a.	n.a.	cephaloridine; cefaloridine; Cephaloridin; Cephaloridinum; Cefaloridin; Cepaloridin; Cefalorizin; Cephalomycine; Cepalorin; Ceflorin; Loridine; 50-59-9; Cefaloridina; Kefloridin; Cefaloridinum; Glaxoridin; Ceporin; Intrasporin; Vioviantine; Sefacin; Keflordin; Deflorin; Cilifor; Ceporan; Verolgin; Lloncefal; Kefspor; Ampligram; Sasperin; Faredina; Ceporine; Keflodin; Betaine cephaloridine; CHEBI:3537; UNII-LVZ1VC61HB; Cefaloridinum [INN-Latin]; Cefaloridina [INN-Spanish]; N-(7-(2'-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SCH 	C19H17N3O4S2	CZTQZXZIADLWOZ-CRAIPNDOSA-N	(6R,7R)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1103	Cephazolin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	33255	n.a.	n.a.	cefazolin; Cephazolin; Cephamezine; 25953-19-9; Cefazoline; Cefamezin; Cephazoline; Cephazolidin; Cefazolina; Cefazolinum; Cefazolin acid; Elzogram; Kefzol; Cefazolinum [INN-Latin]; CEZ; Cefazoline [INN-French]; Cefazolina [INN-Spanish]; Totacef; Cephazolin Sodium; UNII-IHS69L0Y4T; HSDB 3213; CHEBI:474053; EINECS 247-362-8; Cefazolin sodium salt; BRN 4169371; IHS69L0Y4T; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefazil	C14H14N8O4S3	MLYYVTUWGNIJIB-BXKDBHETSA-N	(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1104	Chemotherapy	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1105	Chenodiol	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	10133	n.a.	n.a.	chenodeoxycholic acid; Chenodiol; Chenic acid; Chenix; Cdca; Chenodeoxycholate; 474-25-9; Chenodesoxycholic acid; Gallodesoxycholic acid; Chendol; Anthropodeoxycholic acid; Anthropodesoxycholic acid; Chenofalk; Anthropododesoxycholic acid; Chenodesoxycholsaeure; Henohol; Xenbilox; Chenique Acid; Chenocholic acid; Chenodiol [USAN]; 3alpha,7alpha-Dihydroxy-5beta-cholan-24-oic acid; Sodium chenodeoxycholate; Acido chenodeoxicholico; Chenodesoxycholsaeure [German]; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Acide chenodeoxycholique	C24H40O4	RUDATBOHQWOJDD-BSWAIDMHSA-N	(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	n.a.	n.a.
PMDBD1106	Chloroquine Diphosphate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64927	n.a.	n.a.	Chloroquine diphosphate; Chloroquine phosphate; 50-63-5; Aralen phosphate; Tanakan; Delagil; Arechin; Chloroquine bis(phosphate); Chingamin phosphate; Resochin; Chingaminum; Alermine; H-Stadur; Aralen diphosphate; Quingamine; Miniquine; Tanakene; Avloclor; Khingamin; Chloroquin diphosphate; Chlorochin diphosphate; Tanakan (antimalarial); Chloroquine (phosphate); Gontochin phosphate; dl-Chloroquine diphosphate; Chloroquine diphosphate salt; NSC 14050; Ipsen 225; CCRIS 1554; EINECS 200-055-2; WR 1522; 3377 RP; Chloroquine dihydrogen phospha	C18H32ClN3O8P2	QKICWELGRMTQCR-UHFFFAOYSA-N	4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid	n.a.	n.a.
PMDBD1107	Chlorothalonil	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	15910	n.a.	n.a.	CHLOROTHALONIL; Tetrachloroisophthalonitrile; 1897-45-6; Daconil; Bravo; m-Tcpn; Nopcocide; 1,3-Dicyanotetrachlorobenzene; 2,4,5,6-Tetrachloroisophthalonitrile; meta-TCPN; Chloroalonil; Dacosoil; Exotherm; Clortosip; Termil; Repulse; Forturf; Faber; Sweep; Exotherm termil; m-Tetrachlorophthalonitrile; Daconil M; Tpn (pesticide); meta-Tetrachlorophthalodinitrile; Bravo 6F; Terraclactyl; Chlorthalonil; Daconil 2787; Clortocaf ramato; Daconil Flowable; Bravo-W-75; Bravo 500; 2,4,5,6-tetrachloro	C8Cl4N2	CRQQGFGUEAVUIL-UHFFFAOYSA-N	2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile	n.a.	n.a.
PMDBD1111	Chlorpyrifos	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	2730	n.a.	n.a.	chlorpyrifos; 2921-88-2; Chlorpyriphos; Dursban; Lorsban; Trichlorpyrphos; Brodan; Chlorpyrifos-ethyl; Piridane; Pyrinex; Coroban; Stipend; Equity; Lentrek; Lock-On; Killmaster; Danusban; Spannit; Tafaban; Bonidel; Geodinfos; Zidil; Terial; Durmet; Radar; Dowco 179; Suscon green; Suscon blue; suSCon; Dursban R; Dursban F; Chlorpyrifos ethyl; Dursban 4E; Chlorpyriphos-ethyl; Ethyl chlorpyriphos; Chloropyrifos; Dursban 10CR; Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Chlorpyrifos (Dursban); Detmol U.A.; Dhanusban; Grofo	C9H11Cl3NO3PS	SBPBAQFWLVIOKP-UHFFFAOYSA-N	diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-lambda5-phosphane	n.a.	n.a.
PMDBD1115	Chromium (VI)	Environmental Chemicals	Heavy Metals	n.a.	n.a.	n.a.	n.a.	n.a.	29131	n.a.	n.a.	Chromium(6+); Chromium(VI); Chromium hexavalent ion; Hexavalent chromium; Chromium(6+) ion; 18540-29-9; Chromium(6+)ion; Chromium(6+)ions; Chromium(VI) ions; Chromium, hexavalent; Chromium(6+) ions; CHROMIUM (VI); Chromium (cr(sup 6+)); Chromium compounds, hexavalent; Chromium ion (6+); Chromium(VI) compounds; NCI-C04273; Chromium, ion(Cr6+); Chromium, ion (Cr 6+); Chromium (hexavalent compounds); Chromium, hexavalent (Cr(VI)); Chromium, ion (Cr6+); Cr(VI); Chromium(VI) compounds, n.o.s.; Chromium (VI) ion; chromium(VI) cation; Cr6+	Cr+6	JOPOVCBBYLSVDA-UHFFFAOYSA-N	chromium(6+)	n.a.	n.a.
PMDBD1119	Ciprofloxacin plus clindamycin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1121	Clarithromycin plus metronidazole	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1125	Clomiphene Citrate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3033832	n.a.	n.a.	Clomifene citrate; CLOMIPHENE CITRATE; 50-41-9; Zuclomiphene citrate; Clomid; cis-Clomiphene citrate; Clomiphene A citrate; Zuclomid; Clomiphene citrate salt; Milophene; Serophene; Chloramiphene; Omifin; Clomifene citrate (Serophene); (Z)-Clomiphene citrate; UNII-UY5X264QZV; Clostilbegyt; RMI 16289; Ikaclomin; Genozym; Clomphid; Clomivid; Dyneric; 2-(4-(2-Chloro-1,2-diphenylvinyl)phenoxy)-N,N-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate; Zuclomiphene (citrate); NSC 35770; 7619-53-6; NSC 151466; UY5X264QZV; Fertivet; Fertyl; Cl	C32H36ClNO8	PYTMYKVIJXPNBD-OQKDUQJOSA-N	2-[4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid	n.a.	n.a.
PMDBD1127	Clopidogrel Hydrogen Sulfate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	115366	n.a.	n.a.	Clopidogrel bisulfate; 120202-66-6; Clopidogrel hydrogen sulfate; Iscover; Plavix; 135046-48-9; Clopidogrel bisulphate; (S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; Clopidogrel hemisulfate; CLOPIDOGREL SULFATE; Clopidogrel sulphate; clopidogrel hydrogen sulphate; Clopidogrel (hydrogen sulfate); UNII-08I79HTP27; 113665-84-2; Clopidogrel (Plavix); SR 25990C; (S)-(+)-Clopidogrel Sulfate; SR-25990C; 08I79HTP27; PM-103; MFCD05865229; Myogrel; SR-25990; Clopidogrel hydrogensulfate; Plavix (TN	C16H18ClNO6S2	FDEODCTUSIWGLK-RSAXXLAASA-N	methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid	n.a.	n.a.
PMDBD1129	Corticosteroids	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1131	Cromolyn	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2882	n.a.	n.a.	cromolyn; Cromoglicic acid; 16110-51-3; Cromoglycate; Cromoglycic acid; Intal; Cromoglicate; Acido cromoglicico; Acide cromoglicique; Acidum cromoglicicum; 5,5'-((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(4-oxo-4H-chromene-2-carboxylic acid); UNII-Y0TK0FS77W; Aarane; Acidum cromoglicicum [INN-Latin]; Acido cromoglicico [INN-Spanish]; Acide cromoglicique [INN-French]; Sodium Chromoglycate; Y0TK0FS77W; CHEBI:59773; Rynacrom; Lomudas; Frenasma; Nalcrom; Lomusol; Lomudal; Aararre; Nebulasma; Nasmil; Cromo asma aerosol; 1,3-Bis(2-carboxychromo	C23H16O11	IMZMKUWMOSJXDT-UHFFFAOYSA-N	5-[3-(2-carboxy-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid	n.a.	n.a.
PMDBD1132	Crude extracts of metabolites from Microcystis aeruginosa	Environmental Chemicals	Biological Contaminants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1133	Cyclamate	Environmental Chemicals	Artificial Sweeteners	n.a.	n.a.	n.a.	n.a.	n.a.	7533	n.a.	n.a.	Cyclamic acid; Cyclohexylsulfamic acid; 100-88-9; CYCLAMATE; N-Cyclohexylsulfamic acid; Cyclohexanesulfamic acid; Hexamic acid; Sucaryl; Sucaryl acid; Cyclohexylaminesulphonic acid; N-Cyclohexylsulphamic acid; Polycat 200; Cyclohexylaminesulfonic acid; Cyclohexylamidosulfuric acid; Cylamic acid; Cyclohexylsulphamic acid; Cyclohexanesulphamic acid; Zyklamat; Cyclohexylamidosulphuric acid; Cyclohexylamide sulfate; Cyclohexylamine sulfamic acid; NSC 220327; UNII-HN3OFO5036; Cyc	C6H13NO3S	HCAJEUSONLESMK-UHFFFAOYSA-N	cyclohexylsulfamic acid	n.a.	n.a.
PMDBD1134	Cyclosporine A	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5284373	n.a.	n.a.	cyclosporin A; cyclosporine; Ciclosporin; 59865-13-3; Cyclosporine A; Cyclosporin; Neoral; Ciclosporine; Sandimmun; Sang-35; Sandimmune; Ciclosporinum; Ciclosporina; Equoral; Neoplanta; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; 83HN0GTJ6D; MLS001333756; CHEBI:4031; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A); DSSTox_GSID_203	C62H111N11O12	PMATZTZNYRCHOR-CGLBZJNRSA-N	(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone	n.a.	n.a.
PMDBD1144	Delavirdine Mesylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441386	n.a.	n.a.	DELAVIRDINE MESYLATE; 147221-93-0; Delavirdine (mesylate); Delavirdine mesilate; Rescriptor; U-90152S; UNII-421105KRQE; Delavirdine monomethanesulfonate; delavirdine methanesulfonate; Delavirdine mesylate [USAN]; CHEBI:4379; 421105KRQE; Delavirdine mesylate (USAN); 1-(3-(Isopropylamino)-2-pyridyl)-4-((5-methanesulfonamidoindol-2-yl)carbonyl)piperazine monomethanesulfonate; Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1); SR-05000001471; Res	C23H32N6O6S2	MEPNHSOMXMALDZ-UHFFFAOYSA-N	methanesulfonic acid;N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide	n.a.	n.a.
PMDBD1146	Deoxynivalenol	Environmental Chemicals	Biological Contaminants	n.a.	n.a.	n.a.	n.a.	n.a.	40024	n.a.	n.a.	DEOXYNIVALENOL; 51481-10-8; Vomitoxin; Dehydronivalenol; 4-Deoxynivalenol; 4-Desoxynivalenol; Desoxynivalenol; UNII-JT37HYP23V; NSC 269144; CCRIS 7801; Rd toxin; HSDB 7245; 12,13-Epoxy-3-alpha,7-alpha,15-trihydroxy-9-trichothecen-8-one; JT37HYP23V; Deoxynivalenol 100 microg/mL in Acetonitrile; 3alpha,7alpha,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-one; SCHEMBL2694361; CHEMBL513300; (3alp	C15H20O6	LINOMUASTDIRTM-QGRHZQQGSA-N	(1R,2R,3S,7R,9R,10R,12S)-3,10-dihydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-one	n.a.	n.a.
PMDBD1147	DEP; methylparaben; triclosan	Environmental Chemicals	Phthalates	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1150	Desvenlafaxine Succinate Hydrate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6918664	n.a.	n.a.	386750-22-7; Pristiq; Desvenlafaxine succinate hydrate; Desvenlafaxine (succinate hydrate); Desvenlafaxine Succinate [USAN]; DVS-233; butanedioic acid;4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol;hydrate; Desvenlafaxine succinate (USAN); O-desmethylvenlafaxine Succinate Monohydrate; Desvenlafaxine Succinate Monohydrate (O-Desmethylvenlafaxine Succinate Monohydrate); Pristiq (TN); SCHEMBL1278407; Desvenlafaxine(succinatehydrate); Desvenlafaxinesuccinatemonohydrate; HY-B0602A; CTK8E8387; DTXSID70959511; HMS3747G15	C20H33NO7	PWPDEXVGKDEKTE-UHFFFAOYSA-N	butanedioic acid;4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol;hydrate	n.a.	n.a.
PMDBD1153	Di(2-ethylhexyl) phthlate	Environmental Chemicals	Phthalates	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1155	Diazinon 	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	3017	n.a.	n.a.	diazinon; Dimpylate; 333-41-5; Diazinone; Oleodiazinon; Neocidol; Spectracide; Diazitol; Dassitox; Ciazinon; Ektoband; Nedcidol; Nucidol; Flytrol; Exodin; Diazol; Diazide; Sarolex; Dazzel; Dacutox; Basudin; Antigal; Galesan; Bazuden; Dicid; Alfa-tox; Diazajet; Dimpylat; Garden Tox; Neocidol (oil); Terminator; Bassadinon; Kayazol; Dizinon; Meodinon; Kayazinon; Drawizon; Disonex; Compass; Nipsan; Dyzol; Diazinon ag 500; Knox-out; Neodinon; Optimizer; Dimpylatum; Delzinon; Dizictol; Dipofene; Srolex; Dizinil; Bazudin; Basudin 10 G; Geigy 24480; Basudin S; Knox Out	C12H21N2O3PS	FHIVAFMUCKRCQO-UHFFFAOYSA-N	diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane	n.a.	n.a.
PMDBD1157	Dichlorodiphenyl-dichloroethylene	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1159	Diethyl phosphate (metabolite of CPF+ others)(I)	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1164	DMP, DEP, and DBP combined	Environmental Chemicals	Phthalates	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1173	Emulsiﬁers (P80 and CMC) 	Environmental Chemicals	Other	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1175	Enalaprilat Maleate	Therapeutic substance	Approved Drug; Prodrug	n.a.	n.a.	n.a.	n.a.	n.a.	5388962	n.a.	n.a.	enalapril; 75847-73-3; Vasotec; Enalaprilum; Enalaprila; Lexxel; Enalaprilum [INN-Latin]; Enalaprila [INN-Spanish]; UNII-69PN84IO1A; Enalapril Richet; CHEMBL578; Gadopril; 69PN84IO1A; CHEBI:4784; C20H28N2O5; (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester; NCGC00021569-04; Enalapril [INN:BAN]; N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; DSSTox_CID_2982; DSSTox_RID_76817; DSSTox_GSID_22982; (S)-1-{(S)-2-[1-((S)-Ethoxycarbony	C20H28N2O5	GBXSMTUPTTWBMN-XIRDDKMYSA-N	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid	n.a.	n.a.
PMDBD1176	Epoxiconazole	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	3317081	n.a.	n.a.	Epoxiconazole; 135319-73-2; CHEBI:83758; 1-[[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole; 1-{[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole; 133855-98-8; 106325-08-0; 1-((3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl)methyl)-1H-1,2,4-triazole; Epoxyconazol; DSSTox_CID_20372; DSSTox_RID_79488; SCHEMBL21976; DSSTox_GSID_40372; Epoxiconazole (BAS 480F); cc-169; CHEMBL3184033	C17H13ClFN3O	ZMYFCFLJBGAQRS-UHFFFAOYSA-N	1-[[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole	n.a.	n.a.
PMDBD1177	Eprosartan Mesylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282474	n.a.	n.a.	EPROSARTAN MESYLATE; 144143-96-4; Teveten; Eprosartan mesilate; eprosartan methanesulfonate; Eprosartan (mesylate); UNII-8N2L1NX8S3; Eprosartan mesylate [USAN:BAN]; SK&amp;F 108566-J; 8N2L1NX8S3; CHEBI:48409; (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate; SK&amp;F-108566-J; DSSTox_CID_24217; DSSTox_RID_80124; DSSTox_GSID_44217; Eprosartan Monomethanesulfonate; 2-Thiophenepropanoic acid, alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (alphaE)-, methane	C24H28N2O7S2	DJSLTDBPKHORNY-XMMWENQYSA-N	4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid	n.a.	n.a.
PMDBD1181	Esomeprazole Potassium	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23672364	n.a.	n.a.	Esomeprazole potassium; UNII-F37S7G37O2; Esomeprazole potassium [USAN]; F37S7G37O2; Esomeprazole potassium (USAN); 161796-84-5; CHEMBL2105642; DTXSID20167240; D09339; Q27277571; Potassium 5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]benzimidazol-1-ide; 1H-Benzimidazole, 6-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, potassium salt (1:1); (-)-5-Methoxy-2-((S)-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole potassium salt	C17H18KN3O3S	FOFFPEFVSRGLOZ-JIDHJSLPSA-N	potassium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide	n.a.	n.a.
PMDBD1186	Ethinyl Estradiol	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5991	n.a.	n.a.	ethinyl estradiol; Ethynylestradiol; Ethynyl estradiol; ETHINYLESTRADIOL; 57-63-6; Ethinyloestradiol; Ginestrene; 17-Ethinylestradiol; 17alpha-Ethynylestradiol; Progynon C; Novestrol; Etistradiol; Etinoestryl; Ethinoral; Orestralyn; Etinestryl; Eticyclin; Spanestrin; Follicoral; Etinestrol; Eticyclol; Primogyn; Menolyn; Amenoron; Lynoral; Ethidol; Estorals; Oradiol; Estinyl; Estigyn; Linoral; Inestra; Estoral; Ertonyl; Dyloform; Esteed; Neo-Estrone; Primogyn M; Primogyn C; Nogest-S; Eston-E; Feminone; Palonyl; Perovex; 17-Ethynylestradiol; Diogyn E; Mi	C20H24O2	BFPYWIDHMRZLRN-SLHNCBLASA-N	(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol	n.a.	n.a.
PMDBD1191	Fenoprofen Calcium	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64746	n.a.	n.a.	Fenoprofen calcium; 34597-40-5; Calcium 2-(3-phenoxyphenyl)propionate; Fenprofen calcium; Calcium fenoprofen; Fenoprofen calcium anhydrous; 56367-29-4; 2-(3-Phenoxyphenyl)propionic acid calcium salt; EINECS 252-107-9; Calcium (1)-bis(2-(3-phenoxyphenyl)propionate); Fenoprofen Calcium Salt; dl-2-(3-Phenoxyphenyl)propionic acid calcium salt; (+-)-alpha-Methyl-3-phenoxybenzeneacetic acid calcium salt; 53746-45-5; 71720-56-4; Nalfon 200; anhydrous fenoprofen calc	C30H26CaO6	VHUXSAWXWSTUOD-UHFFFAOYSA-L	calcium;2-(3-phenoxyphenyl)propanoate	n.a.	n.a.
PMDBD1194	Fipronil	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	3352	n.a.	n.a.	fipronil; 120068-37-3; Fipronil [ISO]; C12H4Cl2F6N4OS; HSDB 7051; RM 1601; MB 46030; CHEMBL101326; 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile; 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile; M &amp; B 46030; CHEBI:83394; 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1h-pyrazole-3-carbonitrile; NCGC00094574-06; DSSTox_CID_14609; DSSTox_RID_79176; 5-Amino-3-cyano-1-(2,6-di	C12H4Cl2F6N4OS	ZOCSXAVNDGMNBV-UHFFFAOYSA-N	5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile	n.a.	n.a.
PMDBD1196	Flecainide Acetate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	41022	n.a.	n.a.	Flecainide acetate; 54143-56-5; Flecainide (acetate); Tambocor; FLECAINIDE MONOACETATE; R-818; Flecainide acetate salt; R 818; EINECS 258-997-5; N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; MLS000069675; CHEBI:5091; N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; SMR000058451; EN300-51344; n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate; 2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate; N-(2-Piperidylmethyl)-2,5-bi	C19H24F6N2O5	RKXNZRPQSOPPRN-UHFFFAOYSA-N	acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide	n.a.	n.a.
PMDBD1198	Fludarabine de phosphate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1199	Fludrocortisone Acetate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	225609	n.a.	n.a.	FLUDROCORTISONE ACETATE; 514-36-3; Scherofluron; Cortineff; Fludrocortisone 21-acetate; Florinef acetate; Alflorone acetate; F-Cortef acetate; Cortef-F; Fluohydrocortisone acetate; Fludrocortisone (acetate); UNII-V47IF0PVH4; Fluorocortisone acetate; 9alpha-Fluorohydrocortisone acetate; U 4845; 9alpha-Fluorohydrocortisone 21-acetate; V47IF0PVH4; CHEBI:5102; NSC-15186; (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate	C23H31FO6	SYWHXTATXSMDSB-GSLJADNHSA-N	[2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate	n.a.	n.a.
PMDBD1208	Fox River mixture (PCBs mixture)	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1214	Genistin	Dietary Substances	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	5281377	n.a.	n.a.	Genistin; 529-59-9; Genistine; Genistein 7-glucoside; Genistoside; Genistein glucoside; Genisteol 7-monoglucoside; Genistein 7-O-beta-D-glucoside; UNII-1POG3SCN5T; NSC 5112; Glucosyl-7-genistein; CHEBI:27514; Genistein, 7-O-beta-D-glucoside; Genistein, 7-beta-D-glucopyranoside; 1POG3SCN5T; Isoflavone, 4',5,7-trihydroxy-, 7-D-glucoside; BRN 0064479; C21H20O10; 4',5,7-Trihydroxyisoflavone 7-glucoside; genistein 7-O-glucoside; 4',5,7-trihydroxyisoflavone 7-D-glucoside; 5-hydroxy-3-(4-hydroxyph	C21H20O10	ZCOLJUOHXJRHDI-CMWLGVBASA-N	5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one	n.a.	n.a.
PMDBD1216	Glucocorticoids	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1219	Glyphosate-based herbicide	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1221	Guanabenz Acetate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5702062	n.a.	n.a.	Guanabenz acetate; 23256-50-0; Wytensin; WY-8678 acetate; Guanabenz (Acetate); Wy-8678; UNII-443O19GK1A; WY 8678 acetate; MLS000028717; Guanabenz (WY-8678) Acetate; 443O19GK1A; C8H8Cl2N4.C2H4O2; HSDB 6535; SMR000058454; EINECS 245-534-7; Guanabenz monoacetate; BR 750; ((2,6-Dichlorobenzylidene)amino)guanidine acetate; ((2,6-Dichlorobenzylidene)amino)guanidine monoacetate; Guanabenz acetate salt; SR-01000075268; [(2,6-Dichlorobenzylidene)amino]guanidine acetate; 3-((2,6-Dichlorophenyl)methylene)carbazamidine monoacetate; Wytensin 	C10H12Cl2N4O2	MCSPBPXATWBACD-GAYQJXMFSA-N	acetic acid;2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine	n.a.	n.a.
PMDBD1223	Hexachlorocyclohexane	Environmental Chemicals	Pesticides; Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1224	High-fat diet (HFD)	Dietary Substances	Diet	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1229	Hydroxychloroquine Sulfate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	12947	n.a.	n.a.	HYDROXYCHLOROQUINE SULFATE; 747-36-4; Hydroxychloroquine sulphate; Ercoquin; 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol sulfate; Plaquinol; Toremonil; TCMDC-123987; NSC 4375; Oxichlorochine Sulfate; Hydroxychloroquine sulfate [USP]; EINECS 212-019-3; AI3-52706; NSC-4375; Quensyl; AK-72909; Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt); DSSTox_CID_27788; 2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt); 2-((4-((7-Chloro-4-quinolinyl)ami	C18H28ClN3O5S	JCBIVZZPXRZKTI-UHFFFAOYSA-N	2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid	n.a.	n.a.
PMDBD1230	Hydroxyzine Dihydrochloride	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	91513	n.a.	n.a.	Hydroxyzine dihydrochloride; 2192-20-3; Hydroxyzine hydrochloride; Hydroxyzine 2HCl; 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol dihydrochloride; Orgatrax; Vistaject; Vistazine; Neurolax; Vistarex; Arcanax; Alamon; Durrax; Disron; Quiess; Marax; Atranine A; Vistaril steraject; Vistaril Parenteral; Hydroxyzine (dihydrochloride); Tran-Q dihydrochloride; Ataraxoid dihydrochloride; Tranquizine dihydrochloride; EINECS 218-586-3; AK-54930; AI3-50162; W-107513; CHEBI:5819; Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmet	C21H29Cl3N2O2	ANOMHKZSQFYSBR-UHFFFAOYSA-N	2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride	n.a.	n.a.
PMDBD1237	Indigestible polysaccharides	Dietary Substances	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1243	Ketotifen Fumarate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282408	n.a.	n.a.	KETOTIFEN FUMARATE; 34580-14-8; Zaditen; Zaditor; Ketotifen hydrogen fumarate; Alaway; Ketotifen (fumarate); UNII-HBD503WORO; HC 20,511 fumarate; Ketotifen fumarate (Zaditor); Ketotifen fumarate [USAN:JAN]; Ketotifen fumarate salt; EINECS 252-100-0; HBD503WORO; MLS000069701; SMR000058462; 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one fumarate (1:1); C23H23NO5S; 4,9-dihydro-4-(1-methylpiperidin-4-ylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophene-10-one fumarate; 4,9-Dihydro-4-(1-methy	C23H23NO5S	YNQQEYBLVYAWNX-WLHGVMLRSA-N	(E)-but-2-enedioic acid;2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one	n.a.	n.a.
PMDBD1248	Lapatinib Ditosylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	9941095	n.a.	n.a.	Lapatinib Ditosylate; 388082-77-7; Tykerb; Tyverb; Lapatinib (GW-572016) Ditosylate; Lapatinib (ditosylate); N-(3-CHLORO-4-((3-FLUOROBENZYL)OXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)FURAN-2-YL)QUINAZOLIN-4-AMINE BIS(4-METHYLBENZENESULFONATE); 388082-78-8; UNII-4WK72K94MC; 4WK72K94MC; AK-47669; bis(4-methylbenzene-1-sulfonic acid); N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine; Tykerb Ditosylate; SR-05000001472; GW-572016; Lapatinib d	C43H42ClFN4O10S3	UWYXLGUQQFPJRI-UHFFFAOYSA-N	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	n.a.	n.a.
PMDBD1250	Laxatives	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1251	Lead	Environmental Chemicals	Heavy Metals	n.a.	n.a.	n.a.	n.a.	n.a.	5352425	n.a.	n.a.	Lead; 7439-92-1; Pb; Plumbum; Blei; Lead metal; Lead cation Pb4+; Glover; Lead element; Lead flake; Lead, elemental; Omaha &amp; grant; C.I. Pigment Metal 4; Rough lead bullion; Olow [Polish]; Lead S2; CI pigment metal 4; Lead S 2; Lead ion (1 ); Lead, ion (Pb4+); Lead, inorganic; UNII-7Y62STE4M2; SSO 1; KS-4; HSDB 231; CCRIS 1581; lead(0); Pb-S 100; UNII-2P299V784P; C.I. 77575; EINECS 231-100-4; CI 77575; 7Y62STE4M2; Trimethyl Lead Ion; MFCD00134050; 2P299V784P; Lead, elemental and inorganic compounds; plomo; Lead, 99+%, powder; Lead, 99+%, gra	Pb	WABPQHHGFIMREM-UHFFFAOYSA-N	lead	n.a.	n.a.
PMDBD1252	Lemofloxacin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	45357079	n.a.	n.a.	Lemofloxacin; AKOS015960855; AS-14325; AC-12466; K763	C17H21F2N3O3	YZGAZHWDQGGMJN-UHFFFAOYSA-N	1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-2,3-dihydroquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD1254	Lenapenem	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	216262	n.a.	n.a.	Lenapenem; UNII-D6NBQ3H12U; 149951-16-6; D6NBQ3H12U; BO-2727; (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S,5S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Lenapenem [INN]; L-739428; 149882-71-3; SCHEMBL75702; CHEMBL3989459; GTPL10825; CTK4C6450; BO2727; Q27276182; L-739,4	C18H29N3O5S	PZLOCBSBEUDCPF-YJIVIRPOSA-N	(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S,5S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	n.a.	n.a.
PMDBD1256	Levocetirizine Dihydrochloride	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	9955977	n.a.	n.a.	Levocetirizine dihydrochloride; 130018-87-0; Xusal; Levocetirizine 2HCl; Xyzal; UNII-SOD6A38AGA; SOD6A38AGA; Levocetirizine dihydrochloride [USAN]; (R)-Cetirizine dihydrochloride; Levocetirizine HCl; Levocetirizine (dihydrochloride); Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride; (2-(4-((R)-(4-Chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride; Acetic acid, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2); [2-[4	C21H27Cl3N2O3	PGLIUCLTXOYQMV-GHVWMZMZSA-N	2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride	n.a.	n.a.
PMDBD1261	Losartan Potassium	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	11751549	n.a.	n.a.	LOSARTAN POTASSIUM; 124750-99-8; Cozaar; Lorzaar; Losaprex; losartan potassium salt; Hyzaar; ERYTHROPOIETIN; losartanpotassium; MK 954; Tenopres; Losacor; Lorzaan; Lortaan; Losacar; Ocsaar; Lotim; UNII-3ST302B24A; Niten; Losartan Potassium (DuP 753); Neo Lotan; Du Pont 753; 11096-26-7; MK-0954; 3ST302B24A; DuP 753; L-158086; MK0954; MK 0954; Lifezar; C22H22CIKN6OK; DuP-753; 2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium; 2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methano	C22H22ClKN6O	OXCMYAYHXIHQOA-UHFFFAOYSA-N	potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol	n.a.	n.a.
PMDBD1263	L-tyrosine	Dietary Substances	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	6057	n.a.	n.a.	L-tyrosine; tyrosine; 60-18-4; (S)-Tyrosine; p-Tyrosine; H-Tyr-OH; L-p-Tyrosine; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; 4-Hydroxy-L-phenylalanine; Tyrosinum [Latin]; Tyrosine (VAN); Tirosina [Spanish]; L-(-)-Tyrosine; (-)-alpha-Amino-p-hydroxyhydrocinnamic acid; Tyrosine [USAN:INN]; beta-(p-Hydroxyphenyl)alanine; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; 3-(4-Hydroxyphenyl)-L-alanine; L-Tyrosin; FEMA No. 3736; L-2-Amino-3-p-hydroxyphenylpropanoic acid; (S)-3-(p-Hydroxyphen	C9H11NO3	OUYCCCASQSFEME-QMMMGPOBSA-N	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid	n.a.	n.a.
PMDBD1268	MCB3837	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	44201350	n.a.	n.a.	Oxaquin; MCB-3837; UNII-1221R21ZRQ; 1221R21ZRQ; SCHEMBL2109002; GTPL10997; DNV3837; MCB3837; MCB 3837; DNV-3837; HY-100435; CS-0018921; Q27251356; 7-(4-{4-[(5S)-5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2-fluoro-phenoxymethyl}-4-phosphonooxy-piperidin-1-yl) -1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid; 7-(4-((4-((5S)-5-(Acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid; 3-Quinolinecarboxylic aci	C31H33F2N4O11P	MNABRWLVTSGIMU-FQEVSTJZSA-N	7-[4-[[4-[(5S)-5-(acetamidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy]methyl]-4-phosphonooxypiperidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid	n.a.	n.a.
PMDBD1269	Meclizine Dihydrochloride	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64713	n.a.	n.a.	Meclizine dihydrochloride; 1104-22-9; Meclozine dihydrochloride; Bonamine; Meclizine hydrochloride; 1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride; Postafen; Vertizine; Diadril; Taizer; V-Cline; Duremesin; Ancolan dihydrochloride; Postafene dihydrochloride; meclizine diHCl; Meclizine (dihydrochloride); NSC 28728; Parachloramine dihydrochloride; Meclizine hydrochloride anhydrous; EINECS 214-164-8; UNII-V5604WJ3XP; UNII-408UZ554UD; V5604WJ3XP; Meclizine 2HCl; 408UZ554UD; 1-[(4-chlorophenyl)(phenyl)met	C25H29Cl3N2	VCTHNOIYJIXQLV-UHFFFAOYSA-N	1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;dihydrochloride	n.a.	n.a.
PMDBD1270	Meclofenamate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4037	n.a.	n.a.	meclofenamic acid; meclofenamate; 644-62-2; Meclophenamic acid; Arquel; Meclomen (free acid); 2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid; Meclomen; Acido meclofenamico; Acide meclofenamique; Acidum meclofenamicum; Acidum meclofenamicum [INN-Latin]; Acido meclofenamico [INN-Spanish]; Acide meclofenamique [INN-French]; INF 4668; N-(2,6-Dichloro-m-tolyl)anthranilic acid; CI-583; N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid; 2-(2,6-dichloro-3-methylanilino)benzoic acid; N-(2,6-Dichloro-3-methylphenyl)anthranilic acid	C14H11Cl2NO2	SBDNJUWAMKYJOX-UHFFFAOYSA-N	2-(2,6-dichloro-3-methylanilino)benzoic acid	n.a.	n.a.
PMDBD1273	Melamine	Dietary Substances	Dietary Compounds; industrial compound	n.a.	n.a.	n.a.	n.a.	n.a.	7955	n.a.	n.a.	MELAMINE; 1,3,5-Triazine-2,4,6-triamine; 108-78-1; Cyanuramide; Cyanurotriamine; Cyanurotriamide; Isomelamine; Theoharn; Teoharn; Triaminotriazine; Cyanuric triamide; Hicophor PR; s-Triazinetriamine; Aero; 2,4,6-Triamino-1,3,5-triazine; Yukamelamine; Pluragard; Cymel; Virset 656-4; 2,4,6-Triamino-s-triazine; Spinflam ML 94M; 2,4,6-Triaminotriazine; Pluragard C 133; ADK Stab ZS 27; Mark ZS 27; DG 002 (amine); NCI-C50715; Cyanurtriamide; 1,3,5-Triazine-2,4,6(1H,3H,5H)-triimine; ZS 27; UNII-N3GP2YSD88; s-triamino	C3H6N6	JDSHMPZPIAZGSV-UHFFFAOYSA-N	1,3,5-triazine-2,4,6-triamine	n.a.	n.a.
PMDBD1276	Mepenzolate Bromide	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6461	n.a.	n.a.	MEPENZOLATE BROMIDE; 76-90-4; Cantil; Colibantil; Cantilaque; Gastropidil; Trancolon; Delevil; Colopiril; Tralanta; Eftoron; Cantilon; Colum; Trokonil; Mepenzolate (Bromide); JB 340; Mepenzolati bromidum [INN-Latin]; N-Methyl-3-piperidyl benzilate methobromide; Bromure de mepenzolate [INN-French]; N-Methyl-3-piperidyl benzilate methyl bromide; Bromuro de mepenzolato [INN-Spanish]; 3-(2-Hydroxy-2,2-diphenylacetoxy)-1,1-dimethylpiperidin-1-ium bromide; Cantril; N-Methyl-3-piperidyldiphenylglycolate methobromide; 3-Hydroxy-1,1-dimeth	C21H26BrNO3	JRRNZNSGDSFFIR-UHFFFAOYSA-M	(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide	n.a.	n.a.
PMDBD1279	Mercury	Environmental Chemicals	Heavy Metals	n.a.	n.a.	n.a.	n.a.	n.a.	23931	n.a.	n.a.	Mercury; Hg; 7439-97-6; Quicksilver; Hydrargyrum; Metallic mercury; Liquid silver; Quecksilber; Mercurio; Mercure; Quick silver; Colloidal mercury; Mercury, elemental; Rtec; Kwik; Mercury vapor; elemental mercury; Mercury, metallic; Mercure [French]; RCRA waste number U151; Mercurio [Italian]; RTEC [Polish]; Quecksilber [German]; KWIK [Dutch]; Caswell No. 546; UNII-FXS1BY2PGL; Mercury, vapor; NCI-C60399; CCRIS 1578; UN 2024 (liquid compounds); HSDB 1208; Mercury vapor (as Hg); FXS1BY2PGL; EINECS 231-106-7; UN2809; RCRA waste no. U151; EPA Pes	Hg	QSHDDOUJBYECFT-UHFFFAOYSA-N	mercury	n.a.	n.a.
PMDBD1280	Mesalazines	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	4075	n.a.	n.a.	5-Aminosalicylic acid; mesalamine; Mesalazine; 5-Amino-2-hydroxybenzoic acid; 89-57-6; Asacol; Pentasa; Claversal; Canasa; 5-ASA; Salofalk; Rowasa; m-Aminosalicylic acid; Mesasal; Lialda; Fisalamine; Lixacol; Apriso; p-Aminosalicylsaeure; sfRowasa; Mesalazinum; Asacolitin; Mesalazina; 5-amino-2-hydroxy-benzoic acid; Asacol HD; Mesalazinum [Latin]; 5-Amino Salicylic Acid; Mesalamine [USAN]; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; 2-Hydroxy-5-aminobenzoic acid; 3-carbox	C7H7NO3	KBOPZPXVLCULAV-UHFFFAOYSA-N	5-amino-2-hydroxybenzoic acid	n.a.	n.a.
PMDBD1282	Metaproterenol Hemisulfate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441333	n.a.	n.a.	Metaproterenol sulfate; Orciprenaline sulfate; 5874-97-5; Metaproterenol hemisulfate; Metaproterenol hemisulfate salt; Metaproterenol sulfate, orciprenaline sulfate; TH-152; EN300-50867; DSSTox_RID_80848; DSSTox_CID_25391; DSSTox_GSID_45391; 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid; Metaproterenol sulphate; Prestwick_845; Alupent (TN); MFCD00058303; NCGC00016662-01; CAS-5874-97-5; Orciprenaline (hemisulfate); Metaproterenol (hemisulfate); SCHEMBL41815; Metaproterenol sulfate (USP); Orciprenaline sulf	C22H36N2O10S	MKFFGUZYVNDHIH-UHFFFAOYSA-N	5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid	n.a.	n.a.
PMDBD1284	Methenamine Hippurate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	21945	n.a.	n.a.	Methenamine hippurate; 5714-73-8; Hiprex; Hippramine; Haiprex; Viapta; hexamine hippurate; Hexamethylenetetramine hippurate; Hexamethylenetetramine monohippurate; UNII-M329791L57; Methenamine (hippurate); R-657; EINECS 227-206-5; Hexamethylene tetramine hippurate; HIPPURIC ACID, compd. with HEXAMETHYLENETETRAMINE (1:1); M329791L57; Hexamethylenetetramine monohippurate;Hexamethylenetetramine monohippurate; N-Benzoylglycine, compound with 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1); Glycine, N-benzoyl, compd. with 1,3,5,7	C15H21N5O3	ROAIXOJGRFKICW-UHFFFAOYSA-N	2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane	n.a.	n.a.
PMDBD1287	Methylergonovine Maleate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281072	n.a.	n.a.	Methylergonovine maleate; Methylergometrine maleate; 57432-61-8; Methergine; Erezingen; Methylergobasine maleate; USAF uctl-8; UNII-IR84JPZ1RK; Maleic acid, methyl ergonovine; Methylergonovine maleate salt; EINECS 260-734-4; IR84JPZ1RK; Ergonovine, methyl-, maleate (1:1); Methylergometrine (maleate); Methylergonovine maleate [USP]; 9,10-Didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methylergoline-8beta-carboxamide maleate (1:1) (salt); Methylergonovine maleate (USP); Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)	C24H29N3O6	NOFOWWRHEPHDCY-DAUURJMHSA-N	(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid	n.a.	n.a.
PMDBD1299	Mitomycin C	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5746	n.a.	n.a.	mitomycin C; Mitomycin; 50-07-7; Mutamycin; Ametycine; Mitocin-C; Mitomycin-C; Ametycin; Mytozytrex; Mitomycinum; Mytomycin; Mitozytrex; Mitomycinum C; Mitocin C; Mitomycins; Mitamycin; MMC; Mitosol; 7-Amino-9alpha-methoxymitosane; NSC-26980; Mitomycyna C [Polish]; Mito-C; Mit-C; Mitomycinum [INN-Latin]; Mitomycine [INN-French]; Mitomicina [INN-Spanish]; NSC 26980; Mitomycyna C; NCI-C04706; C15H18N4O5; RCRA waste number U010; NSC26980; Mitomycine; CCRIS 414; UNII-50SG953SK6; HSDB 3239; EINECS 200-008-6; RCRA waste no. U010; AI3-26199; CHEBI:2750	C15H18N4O5	NWIBSHFKIJFRCO-WUDYKRTCSA-N	[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate	n.a.	n.a.
PMDBD1301	Mixture	Environmental Chemicals	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1304	Monoethylhexyl phthalate	Environmental Chemicals	Phthalates	n.a.	n.a.	n.a.	n.a.	n.a.	20393	n.a.	n.a.	4376-20-9; 2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid; Mehp; Mono(2-ethylhexyl) phthalate; Mono(2-ethylhexyl)phthalate; PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER; 2-Ethylhexyl hydrogen phthalate; Monoethylhexyl phthalate; MONO-2-ETHYLHEXYL PHTHALATE; Mono-(2-ethylhexyl)phthalate; (2-Ethylhexyl) hydrogen phthalate; 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester; mono(ethylhexyl) phthalate; BAR 1; Phthalate, mono(2-ethylhexyl); CCRIS 1742; EINECS 224-477-1; 2-(2-ethylhexoxycarbonyl)benzoic acid; Monoethylhexyl phthalic ac	C16H22O4	DJDSLBVSSOQSLW-UHFFFAOYSA-N	2-(2-ethylhexoxycarbonyl)benzoic acid	n.a.	n.a.
PMDBD1315	Nelfinavir Mesylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	64142	n.a.	n.a.	Nelfinavir mesylate; 159989-65-8; Viracept; Nelfinavir mesilate; Nelfinavir Mesylate [USAN]; UNII-98D603VP8V; Nelfinavir mesylate hydrate; HSDB 7159; C32H45N3O4S.CH4O3S; Nelfinavir Methanesulfonate; AG-1343; CHEBI:7497; AG1343; 98D603VP8V; AG 1343; Viracept (TN); NFV; DSSTox_RID_79093; DSSTox_CID_10777; DSSTox_GSID_33736; CHEMBL1205; 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2(2,S*,3S*),3-alpha,4a-beta,8a-beta))-, monomethanesulfonate 	C33H49N3O7S2	NQHXCOAXSHGTIA-SKXNDZRYSA-N	(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;methanesulfonic acid	n.a.	n.a.
PMDBD1316	Neocarzinostatin	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282473	n.a.	n.a.	ZINOSTATIN; Neocarzinostatin (JAN); Zinostatin (USAN/INN); SCHEMBL1347615; D02046; 33862-EP2311808A1; 33862-EP2298768A1; 33862-EP2295416A2; 33862-EP2298764A1; 33862-EP2298748A2; 33862-EP2295427A1; 33862-EP2295055A2; 33862-EP2272832A1; 33862-EP2311453A1; 33862-EP2298765A1; 33862-EP2295426A1; 33862-EP2311829A1; 33862-EP2305642A2; 33862-EP2275420A1; 120130-EP2298778A1; 120130-EP2272832A1	C35H35NO12	BLXZMHNVKCEIJX-PNKAXBHOSA-N	[(4S,6R,11R,12R)-11-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-[(4R)-2-oxo-1,3-dioxolan-4-yl]-5-oxatricyclo[8.3.0.04,6]tridec-1(13)-en-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate	n.a.	n.a.
PMDBD1317	Neotame 	Environmental Chemicals	Artificial Sweeteners	n.a.	n.a.	n.a.	n.a.	n.a.	9810996	n.a.	n.a.	Neotame; 165450-17-9; Neotame [NF]; (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid; UNII-VJ597D52EX; N-(N-(3,3-dimethylbutyl)-L-alpha-aspartyl)-L-phenylalanine 1-methyl ester; VJ597D52EX; Neotame-d5; L-Phenylalanine, N-(3,3-dimethylbutyl)-L-alpha-aspartyl-, 2-methyl ester; (S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic ac; (3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxob	C20H30N2O5	HLIAVLHNDJUHFG-HOTGVXAUSA-N	(3S)-3-(3,3-dimethylbutylamino)-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid	n.a.	n.a.
PMDBD1319	Nickel	Environmental Chemicals	Heavy Metals	n.a.	n.a.	n.a.	n.a.	n.a.	935	n.a.	n.a.	Ni; 7440-02-0; Nickel; Raney alloy; Fibrex; Nickel catalyst; Nickel, soluble salts; Nickel ion; Nickel particles; Fibrex P; Nickel, elemental; Nichel [Italian]; nickel(1+); Nickel 205; Nickel 270; Nickel 207; Nickel 201; Nickel 200; niquel; niccolum; Alcan 756; Metallic nickel; Nickel, ion (Ni1+); NI 0901-S (harshaw); CCRIS 427; UNII-7OV03QG267; Nickel,Raney Nickel; NP 2; EL12; Ni 4303T; Ni 270; HSDB 1096; Nickel, elemental/metal; Ni 0901-S; RCH 55/5; Nickel, soluble compounds; EINECS 231-111-4; Nickel [Nickel and nickel compounds]; 28Ni; CI 777	Ni	PXHVJJICTQNCMI-UHFFFAOYSA-N	nickel	n.a.	n.a.
PMDBD1324	NSAIDs and sulfasalazine therapy	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1326	Ochratoxin A	Environmental Chemicals	Biological Contaminants	n.a.	n.a.	n.a.	n.a.	n.a.	442530	n.a.	n.a.	OCHRATOXIN A; 303-47-9; Antibiotic 9663; Phenylalanine - ochratoxin A; NCI-C56586; (-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; NSC 201422; C20H18ClNO6; CHEBI:7719; OTA; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; UNII-1779SX6LUY; N-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-isochromen-7-yl]carbonyl}-L-phenylalanine; L-Phenylalanine, N-(	C20H18ClNO6	RWQKHEORZBHNRI-BMIGLBTASA-N	(2S)-2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid	n.a.	n.a.
PMDBD1330	Omega-3 PUFA supplementation	Dietary Substances	Dietary Compounds	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1332	Opiates (opioid)	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1334	Oseltamivir Phosphate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	78000	n.a.	n.a.	Oseltamivir phosphate; 204255-11-8; Tamiflu; Oseltamivir (phosphate); UNII-4A3O49NGEZ; Oseltamir Phosphate; GS 4104; 4A3O49NGEZ; ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate; CHEBI:7799; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1); GS4104; Ro 64-0796/002; Osteltamivir phosphate; 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1); (3R-(3alpha,4beta,5al	C16H31N2O8P	PGZUMBJQJWIWGJ-ONAKXNSWSA-N	ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid	n.a.	n.a.
PMDBD1335	Other bisphenols	Environmental Chemicals	Bisphenols	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1340	p,p'-Dichlorodiphenyldichloroethylene	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	3035	n.a.	n.a.	p,p'-DDE; 72-55-9; 4,4'-DDE; dichlorodiphenyldichloroethylene; DDT dehydrochloride; 2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene; 1,1-Dichloro-2,2-bis(4-chlorophenyl)ethene; DDE; NCI-C00555; p,p'-Dichlorodiphenyldichloroethylene; p,p'-Dichlorodiphenyl dichloroethylene; p,p'-(Dichlorodiphenyl)-2,2-dichloroethylene; 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene; DDE (VAN); NSC 1153; para,para'-DDE; 2,2-Bis(p-chlorophenyl)-1,1-dichloroethylene; CCRIS 193; Dichlorodipheny	C14H8Cl4	UCNVFOCBFJOQAL-UHFFFAOYSA-N	1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene	n.a.	n.a.
PMDBD1342	Paracetamol	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	1983	n.a.	n.a.	acetaminophen; Paracetamol; 4-Acetamidophenol; 103-90-2; N-(4-Hydroxyphenyl)acetamide; Tylenol; APAP; Panadol; Acetaminofen; Datril; N-Acetyl-p-aminophenol; p-Hydroxyacetanilide; 4'-Hydroxyacetanilide; p-Acetamidophenol; Naprinol; Lonarid; Algotropyl; Anelix; Multin; Acenol; Acamol; p-Acetaminophenol; Pyrinazine; Injectapap; Clixodyne; Liquagesic; Acetagesic; Gelocatil; Servigesic; Acetalgin; Abensanil; Valadol; Tralgon; Tabalgin; Lestemp; Alvedon; Valgesic; Tussapap; Finimal; Paracet; Homoolan; Febrolin; Febrilix; Febridol; Dymadon; Anaflon; Apamide	C8H9NO2	RZVAJINKPMORJF-UHFFFAOYSA-N	N-(4-hydroxyphenyl)acetamide	n.a.	n.a.
PMDBD1345	PCB congeners	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1346	PCB congeners (PCB153, PCB138, PCB180)	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1347	PCB mixture	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1348	PCB-126	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	56775	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1351	Penicillin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	2349	n.a.	n.a.	Penicillin; Cillin; 61-33-6; Benzopenicillin; Galofak; 7005-30-3; Compocillin G; 3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (Phenylmethyl)penicillin; NSC131815; (Phenylmethyl)penicillinic acid; NSC-193396; 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Penicilline G sodium salt; Oprea1_713794; Oprea1_861345; CHEMBL300052; SCHEMBL2109546; CTK2H5530; DTXSID20274362; NSC11964; NSC193396; NSC-11964; STL453455; AKOS030242685; MCULE-3899	C16H18N2O4S	JGSARLDLIJGVTE-UHFFFAOYSA-N	3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	n.a.	n.a.
PMDBD1352	Penicillin G; erythromycin, or both	Environmental Chemicals	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1353	Pentachlorophenol	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	992	n.a.	n.a.	pentachlorophenol; 2,3,4,5,6-Pentachlorophenol; 87-86-5; Chlorophen; Lauxtol; Permite; Pentachlorophenate; Dowicide 7; Santophen; Permasan; Sinituho; Permagard; Pentacon; Penchlorol; Fungifen; Liroprem; Permacide; Peratox; Penwar; Durotox; Glazd penta; Grundier arbezol; Penta-Kil; Term-i-trol; PENTA; Chem-Tol; Santophen 20; Pentachlorphenol; Thompson's wood fix; Preventol P; PCP (pesticide); Chlon; Pentachlorofenol; Permatox penta; Lauxtol A; Dowicide EC-7; Santobrite; Pentaclorofenolo; Penta ready; Woodtreat A; Penta wr; Chem	C6HCl5O	IZUPBVBPLAPZRR-UHFFFAOYSA-N	2,3,4,5,6-pentachlorophenol	n.a.	n.a.
PMDBD1356	Perfluorobutanesulfonic acid	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	67815	n.a.	n.a.	375-73-5; perfluorobutanesulfonic acid; Nonafluorobutanesulfonic acid; Nonafluoro-1-butanesulfonic acid; 1-Perfluorobutanesulfonic acid; 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonic acid; Nonafluorobutane-1-sulfonic acid; PFBS; 1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonic acid; perfluorobutane sulfonic acid; 1,1,2,2,3,3,4,4,4-Nonafluorobutane-1-sulphonic acid; EINECS 206-793-1; UNII-1FV02N6NVO; 1FV02N6NVO; 59933-66-3; Perfluorobutane s	C4HF9O3S	JGTNAGYHADQMCM-UHFFFAOYSA-N	1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonic acid	n.a.	n.a.
PMDBD1357	Perindopril Erbumine	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	441313	n.a.	n.a.	PERINDOPRIL ERBUMINE; 107133-36-8; ACEON; Perindopril tert-butylamine; McN-A-2833-109; Perindopril (erbumine); Perindopril erbumine [USAN]; CHEBI:8025; S-9490-3; UNII-1964X464OJ; 1964X464OJ; (2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1); Covapril; Coversyl	C23H43N3O5	IYNMDWMQHSMDDE-MHXJNQAMSA-N	(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine	n.a.	n.a.
PMDBD1359	PFAS: F-53B	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1367	Pitavastatin Calcium	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282451	n.a.	n.a.	Pitavastatin calcium; 147526-32-7; Livalo; Pitavastatin hemicalcium; NK-104; Nisvastatin; UNII-IYD54XEG3W; Pitavastatin calcium salt; NK 104; IYD54XEG3W; 2C25H23FNO4.Ca; CHEBI:71258; Itavastatin calcium; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; Pitavastatin calcium (JAN); Livazo; Flovas; Alipza; P-872441; P 872441	C50H46CaF2N2O8	RHGYHLPFVJEAOC-FFNUKLMVSA-L	calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate	n.a.	n.a.
PMDBD1369	Polychemotherapy	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1370	Polycyclic aromatic hydrocarbon	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1371	Polymyxin E 	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	5311054	n.a.	n.a.	colistin; Polymyxin E; 1066-17-7; Colobreathe; Promixin; Colistin,(S); N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide; SCHEMBL1979092; CHEMBL499783; GTPL10794; Colistin  sulfate, &gt;19000 IU/mg; AB01566924_01; SR-01000872582; 066C177; Q418946; SR-0100	C52H98N16O13	YKQOSKADJPQZHB-QNPLFGSASA-N	N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide	n.a.	n.a.
PMDBD1373	Pramipexole Dihydrochloride Monohydrate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	166589	n.a.	n.a.	Pramipexole dihydrochloride monohydrate; 191217-81-9; Mirapex; Pramipexole 2HCl Monohydrate; Pramipexole dihydrochloride hydrate; (S)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride hydrate; UNII-3D867NP06J; PRAMIPEXOLE HYDROCHLORIDE; Pramipexole hydrochloride hydrate; BI-Sifrol; SND919CL2Y; CHEBI:51147; C10H17N3S.2HCl.H2O; PNU-98528E; 3D867NP06J; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride monohydrate; 191712-81-9; Pramipexole dihydrochloride [USAN]; SND-919CL2Y; 2,6-B	C10H21Cl2N3OS	APVQOOKHDZVJEX-QTPLPEIMSA-N	(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;hydrate;dihydrochloride	n.a.	n.a.
PMDBD1387	Propamocarb	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	32490	n.a.	n.a.	PROPAMOCARB; 24579-73-5; Propamocarbe; Propyl (3-(dimethylamino)propyl)carbamate; Carbamic acid, [3-(dimethylamino)propyl]-, propyl ester; UNII-8HLL7N9UWO; Propamocarbe [ISO-French]; propyl N-[3-(dimethylamino)propyl]carbamate; Nor-AM 39744; Propamocarb [ANSI:BSI:ISO]; 8HLL7N9UWO; Propyl 3-(dimethylamino)propylcarbamate; BRN 2080745; SN 39744; CHEBI:82033; EPA Pesticide Chemical Code 119302; Propamocarb free base; propyl [3-(dimethylamino)propyl]carbamate; Carbamic acid, (3-(dimethylamino)propyl)-, propyl ester; propamocarbe 	C9H20N2O2	WZZLDXDUQPOXNW-UHFFFAOYSA-N	propyl N-[3-(dimethylamino)propyl]carbamate	n.a.	n.a.
PMDBD1390	Proton pump inhibitors	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1393	Quetiapine Fumarate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5281025	n.a.	n.a.	Quetiapine fumarate; 111974-72-2; Quetiapine hemifumarate; Seroquel XR; Seroquel; ICI-204636; ICI 204,636; ZM 204636; UNII-2S3PL1B6UJ; Quetiapine fumarate [USAN]; ZD5077; 2S3PL1B6UJ; ZM 204,636; ICI 204636; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate; Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt); CHEBI:8708; FK949E	C46H54N6O8S2	ZTHJULTYCAQOIJ-WXXKFALUSA-N	2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol;(E)-but-2-enedioic acid	n.a.	n.a.
PMDBD1396	Quinupristin/dalfopristin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1401	Rasagiline Mesylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3052775	n.a.	n.a.	Rasagiline mesylate; 161735-79-1; Rasagiline mesilate; Azilect; TVP-1012; (R)-N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate; Rasagiline (mesylate); Rasagiline methanesulfonate; Rasagiline mesylate [USAN]; UNII-LH8C2JI290; TVP 1012; LH8C2JI290; MFCD08460604; TV 1012; NCGC00168774-01; Azilect (TN); 1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (R)-, methanesulfonate; 1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-, methanesulfonate; (R)-N-2-Propynyl-1-indanamine methanesulfonate; Rasagiline mesylate (USAN)	C13H17NO3S	JDBJJCWRXSVHOQ-UTONKHPSSA-N	methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine	n.a.	n.a.
PMDBD1402	Rifampin	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	135398735	n.a.	n.a.	Rifampicin; rifampin; Rifadin; Rimactane; Rimactan; Rifamycin AMP; 13292-46-1; Rifaldazine; Rifaprodin; Tubocin; Riforal; Rifa; Rifampicinum; Archidyn; Rifoldine; Rifoldin; Rimactizid; Rimazid; Rifagen; Rifampicin SV; R/AMP; Rimactazid; Rifobac; Fenampicin; Doloresum; Sinerdol; Rifaldin; Rifadine; Rifinah; Rifamor; Benemicin; Rifaldazin; Eremfat; Arficin; Arzide; Rifcin; Rifam; L-5103 Lepetit; Dione 21-acetate; Rifampicine [French]; Rifampicina; Abrifam; Rifampicinum [INN-Latin]; Rifampicina [INN-Spanish]; Ba 41166/E; 3-(((4-Methyl-1-piperazinyl)imino	C43H58N4O12	JQXXHWHPUNPDRT-WLSIYKJHSA-N	[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate	n.a.	n.a.
PMDBD1404	Ritipenem acoxil	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	6918147	n.a.	n.a.	Ritipenem Acoxil; UNII-F975H7YQX9; F975H7YQX9; Ritipenem acetoxymethyl ester; FCE-22891; Fce 22891; Penemac; BRN 4723315; 87238-52-6; Rtipenem acoxil; Acetoxymethyl (5R,6S)-2-carbamoyloxymethyl-6-((1R)-hydroxyethyl)-2-penem-3-carboxylate; FC/TA-891; fce22891; SCHEMBL9799600; ZINC3934758; Q27277840	C13H16N2O8S	FZKGLCPKPZBGLX-ROXVQFJHSA-N	acetyloxymethyl (5R,6S)-3-(carbamoyloxymethyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate	n.a.	n.a.
PMDBD1405	Rivastigmine Tartrate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6918078	n.a.	n.a.	Rivastigmine tartrate; 129101-54-8; SDZ-ENA 713; Rivastigmine Hydrogen Tartrate; Rivastigmine (tartrate); UNII-9IY2357JPE; ENA 713; Rivastigmine tartrate (Exelon); (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate; 9IY2357JPE; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1); Rivastigmine bitartrate; Rivastigmine hydrogentartrate; Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)	C18H28N2O8	GWHQHAUAXRMMOT-MBANBULQSA-N	(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate	n.a.	n.a.
PMDBD1408	Rosuvastatin Calcium	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282455	n.a.	n.a.	Rosuvastatin calcium; Crestor; 147098-20-2; Rosuvastatin Calcium Salt; Rosuvastatin hemicalcium; ZD 4522; Rosuvastatin; ZD4522; ZD 4522, calcium salt; UNII-83MVU38M7Q; Rosuvastatin calcium [USAN]; S-4522; S 4522; 83MVU38M7Q; CHEBI:77249; calcium (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate; Crestor (TN); ZD-4522; Rovista; (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, c	C44H54CaF2N6O12S2	LALFOYNTGMUKGG-BGRFNVSISA-L	calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate	n.a.	n.a.
PMDBD1410	Rulfoxacin	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	58258	n.a.	n.a.	Rufloxacin; 101363-10-4; MF 934; RUFLOXACIN HCl; UNII-Y521XM2900; C17H18FN3O3S; CHEBI:8909; Y521XM2900; Rufloxacine; Rufloxacino; Rufloxacinum; 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid; 9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid;9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid; 8-Fluoro-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihyd	C17H18FN3O3S	NJCJBUHJQLFDSW-UHFFFAOYSA-N	7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid	n.a.	n.a.
PMDBD1411	saccharin; sucralose; aspartame	Environmental Chemicals	Artificial Sweeteners	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1416	Silver nanoparticles	Environmental Chemicals	Nanoparticles	n.a.	n.a.	n.a.	n.a.	n.a.	23954	n.a.	n.a.	Silver; Ag; 7440-22-4; Argentum; Silver metal; Silver atom; Colloidal silver; Silver, colloidal; Algaedyn; Epinall; Amalgum; Silber; Shell silver; Astroflake 5; Carey Lea silver; Silver, elemental; Silber [German]; Silpowder 130; Degussa 67; Degussa 80; Silflake 135; KS (metal); Jelcon SH 1; L-3 (element); Caswell No. 735; Metz 25B; FA 2 (metal); Dotite XA 208; Germany: C-Pigment 2; D 25 (metal); TCG 7r; G 12 (metal); Lead refinery silver bullion; Silver nanoparticles; Metz 3000-1; UNII-3M4G523W1G; HSDB 5034; EINECS 231-131-3; SR 999; LS 500; LA 	Ag	BQCADISMDOOEFD-UHFFFAOYSA-N	silver	n.a.	n.a.
PMDBD1418	Sitagliptin Phosphate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6451150	n.a.	n.a.	Sitagliptin phosphate; 654671-78-0; Januvia; Sitagliptin (phosphate); MK-0431; UNII-494P4635I6; MK 0431; CHEMBL393336; 494P4635I6; MK0431; (2R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt; 7-(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate	C16H18F6N5O5P	IQFYVLUXQXSJJN-SBSPUUFOSA-N	(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid	n.a.	n.a.
PMDBD1420	Sorafenib Tosylate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	406563	n.a.	n.a.	Sorafenib tosylate; 475207-59-1; Nexavar; BAY 43-9006; Nexavar(R); Sorafenib (Tosylate); Sorafenib tosylate [USAN]; UNII-5T62Q3B36J; CHEBI:50928; 5T62Q3B36J; BAY 54-9085; AK162385; Sorafenib (Nexavar); Sorafenib tosylate (USAN); DSSTox_CID_27817; DSSTox_RID_82581; DSSTox_GSID_47839; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfona	C28H24ClF3N4O6S	IVDHYUQIDRJSTI-UHFFFAOYSA-N	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid	n.a.	n.a.
PMDBD1422	Splenda	Environmental Chemicals	Artificial Sweeteners	n.a.	n.a.	n.a.	n.a.	n.a.	71485	n.a.	n.a.	Sucralose; 56038-13-2; Trichlorosucrose; Splenda; Aspasvit; Acucar Light; Trichlorogalacto-sucrose; 1',4,6'-Trichlorogalactosucrose; UNII-96K6UQ3ZD4; EINECS 259-952-2; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside; BRN 3654410; 96K6UQ3ZD4; Trichlorogalactosucrose; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside; CHEBI:32159; Sucralose [BAN]; 4,1',6'-Trichloro-4,1',6'-trideoxy-galacto-sucrose; DSSTox_CID_20245; 1,6-Dichloro-1,6-dideoxy-beta	C12H19Cl3O8	BAQAVOSOZGMPRM-QBMZZYIRSA-N	(2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol	n.a.	n.a.
PMDBD1423	SSRI antidepressants	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1424	Statins	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1425	Streptonegrin	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5298	n.a.	n.a.	streptonigrin; Rufocromomycin; Bruneomycin; Nigrin; Streptonigran; Valacidin; Rufocromomycine; 3930-19-6; Rufocromomicina; NSC-45383; Rufocromomycinum; Abbott Crystalline antibiotic; NSC 45383; NSC45383; Streptonigrin [USAN]; Antibiotic from Streptomyces flocculus; Rufochromomycin; A 050165L302; AO50165L302; NSC83950; SN (VAN); Rufocromomycinum [INN-Latin]; Rufocromomycine [INN-French]; Rufocromomicina [INN-Spanish]; CCRIS 1264; CHEBI:9287; MLS000028827; UNII-261Q3JB310; 5278 R. P.; EINECS 223-501-8; NSC 83950; 5-Amino-6-(7-amino-5,8-dih	C25H22N4O8	PVYJZLYGTZKPJE-UHFFFAOYSA-N	5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid	n.a.	n.a.
PMDBD1426	Sucralose 	Environmental Chemicals	Artificial Sweeteners	n.a.	n.a.	n.a.	n.a.	n.a.	71485	n.a.	n.a.	Sucralose; 56038-13-2; Trichlorosucrose; Splenda; Aspasvit; Acucar Light; Trichlorogalacto-sucrose; 1',4,6'-Trichlorogalactosucrose; UNII-96K6UQ3ZD4; EINECS 259-952-2; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside; BRN 3654410; 96K6UQ3ZD4; Trichlorogalactosucrose; 1,6-Dichloro-1,6-dideoxy-beta-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside; CHEBI:32159; Sucralose [BAN]; 4,1',6'-Trichloro-4,1',6'-trideoxy-galacto-sucrose; DSSTox_CID_20245; 1,6-Dichloro-1,6-dideoxy-beta	C12H19Cl3O8	BAQAVOSOZGMPRM-QBMZZYIRSA-N	(2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol	n.a.	n.a.
PMDBD1428	Sulphalene	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	9047	n.a.	n.a.	SULFALENE; 152-47-6; Sulfamethoxypyrazine; Sulfametopyrazine; Sulfalen; Sulfamethopyrazine; 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide; Kelfizine; Longum; Sulfapyrazinemethoxyne; Sulfapyrazinemethoxine; Kelfizina; Polycidal; Kelfizin; Dalysep; Sulfapyrazinemethoxyine; Kelfizine W; SMP2; 3-Methoxy-2-sulfapyrazine; 2-Sulfanilamido-3-methoxypyrazine; 3-Methoxy-2-sulfanilamidopyrazine; Farmitalia 204/122; 3-Methoxypyrazine sulfanilamide; 2-Methoxy-3-sulfanilamidopyrazine; Sulfalene [USAN:INN]; Sulfalenum [INN-Latin]; Solfametop	C11H12N4O3S	KXRZBTAEDBELFD-UHFFFAOYSA-N	4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide	n.a.	n.a.
PMDBD1429	Sulphasomidine	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	5343	n.a.	n.a.	SULFISOMIDINE; Sulfaisodimidine; sulfisomidin; 515-64-0; Sulphasomidine; Sulfasomidine; Sulfadimetine; 4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide; Sulfamethin; Sulfaisodimerazine; Elkosin; Domian; Sulfaisodimidinum; Solfisomidina; Sulfaisomidine; Elkosine; Elcosine; Aristogyn; Aristamid; Mefenal; Erycon; Elkosil; Isosulf; 4-Sulfa-2,6-dimethylpyrimidine; 4-Sulfanilamido-2,6-dimethylpyrimidine; 2,4-Dimethyl-6-sulfanilamidopyrimidine; 6-Sulfanilamido-2,4-dimethylpyrimidine; 2,6-Dimethyl-4-sulfanilamidopyrimidine; Solfisomid	C12H14N4O2S	YZMCKZRAOLZXAZ-UHFFFAOYSA-N	4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide	n.a.	n.a.
PMDBD1435	Tau-fluvalinate	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	91768	n.a.	n.a.	Tau-fluvalinate; 102851-06-9; CHEBI:39367; Fluwarol; Fluvarol; Mavrik EW; D-Valine, N-[2-chloro-4-(trifluoromethyl)phenyl]-,cyano(3-phenoxyphenyl)methyl ester; N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valine cyano(3-phenoxyphenyl)methyl ester; cyano(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate; Tau-fluvalinate [ISO]; (a-RS,2R)-Fluvalinate; (RS)-alpha-Cyano-3-phenoxybenzyl N-(2-chloro-alpha,alpha,alpha-trifluoro-p-tolyl)-D-valinate; [cyano-(3-phenoxyphenyl)methyl] (2R)-2-[2-chloro-4-(trifluor	C26H22ClF3N2O3	INISTDXBRIBGOC-XMMISQBUSA-N	[cyano-(3-phenoxyphenyl)methyl] (2R)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate	n.a.	n.a.
PMDBD1446	Tetrachlorodibenzo-p-dioxin	Environmental Chemicals	Persistent Organic Pollutants	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1449	Thiamethoxam	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	5821911	n.a.	n.a.	Thiamethoxam; 153719-23-4; Actara; Diacloden; Cruiser; Adage; Actara 2GR; Actara 25WG; Adage 5FS; Thiamethoxam [ISO]; (E)-thiamethoxam; CGA 293343; CCRIS 9026; UNII-747IC8B487; n-(3-((2-chlorothiazol-5-yl)methyl)-5-methyl-1,3,5-oxadiazinan-4-ylidene)nitramide; 747IC8B487; AK405352; 3-((2-Chloro-5-thiazolyl)methyl)tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine; C8H10CLN5O3S; 4H-1,3,5-Oxadiazin-4-imine, 3-[(2-chloro-5-thiazolyl)meth	C8H10ClN5O3S	NWWZPOKUUAIXIW-DHZHZOJOSA-N	(NE)-N-[3-[(2-chloro-1,3-thiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-ylidene]nitramide	n.a.	n.a.
PMDBD1450	Thioguanine	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	2723601	n.a.	n.a.	6-Thioguanine; thioguanine; 154-42-7; Tioguanine; 2-Amino-6-mercaptopurine; 6-Mercaptoguanine; Tioguanin; Tabloid; Lanvis; 2-Amino-6-purinethiol; 2-Aminopurin-6-thiol; 2-Amino 6MP; 2-Aminopurine-6-thiol; Wellcome U3B; 2-Aminopurine-6(1H)-thione; 6-Mercapto-2-aminopurine; 2-Amino-9H-purine-6-thiol; 6-TG; 2-Amino-6-merkaptopurin; Tioguaninum; Tioguanina; 2-Thioguanine; 2-Amino-1,7-dihydro-6H-purine-6-thione; BW 5071; 2-Amin	C5H5N5S	WYWHKKSPHMUBEB-UHFFFAOYSA-N	2-amino-3,7-dihydropurine-6-thione	n.a.	n.a.
PMDBD1451	Thiopurines	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1455	Ticarcillin/clavulanate	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1461	Tolmetin sodium dihydrate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	23677829	n.a.	n.a.	Tolmetin sodium dihydrate; 64490-92-2; Sodium tolmetin dihydrate; Tolumetin sodium dihydrate; Tolmetin (sodium dihydrate); UNII-02N1TZF99F; 02N1TZF99F; CHEBI:72014; Sodium 1-methyl-5-p-toluoylpyrrole-2-acetate dihydrate; NCGC00017129-01; CAS-64490-92-2; DSSTox_CID_25594; DSSTox_RID_80987; DSSTox_GSID_45594; Tolmetin sodium salt dihydrate; Sodium 2-(1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetate dihydrate; 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt, dihydrate; McN-2559-21-98; Tolectin sdoium; 1-M	C15H18NNaO5	QQILXENAYPUNEA-UHFFFAOYSA-M	sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate;dihydrate	n.a.	n.a.
PMDBD1462	Tolterodine Tartrate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	443878	n.a.	n.a.	Tolterodine tartrate; 124937-52-6; Detrol LA; Detrusitol; Detrol; PNU-200583E; UNII-5T619TQR3R; Tolterodine L-Tartrate; Tolterodine tartrate [USAN]; (R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methylphenol (2R,3R)-2,3-dihydroxysuccinate; Tolterodine (tartrate); Kabi-2234; PNU 200583E; 5T619TQR3R; Tolterodine tartrate (Detrol LA); Urotrol; (R)-2-(3-Diisopropylamino-1-phenyl-propyl)-p-cresol L-tartrate; C26H37NO7; (+)-(R)-2-(I-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate (1:1) (salt); Phenol, 2-((1R)-3-(bis(1-methyl	C26H37NO7	TWHNMSJGYKMTRB-KXYUELECSA-N	(2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol	n.a.	n.a.
PMDBD1466	Toremifene Base	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3005573	n.a.	n.a.	toremifene; Acapodene; Farestone; Z-Toremifene; 89778-26-7; Toremifeno; Toremifenum; Toremifenum [Latin]; Toremifeno [Spanish]; FC-1157a; GTx 006; Toremifene [INN:BAN]; UNII-7NFE54O27T; GTx-006; C26H28ClNO; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine; CHEBI:9635; 7NFE54O27T; (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylami	C26H28ClNO	XFCLJVABOIYOMF-QPLCGJKRSA-N	2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine	n.a.	n.a.
PMDBD1467	Torsemide	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	41781	n.a.	n.a.	Torasemide; TORSEMIDE; 56211-40-6; Demadex; Torasemidum; Torasemida; Luprac; Torasemidum [INN-Latin]; Torasemida [INN-Spanish]; Torem; Unat; JDL 464; AC 4464; AC-4464; 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea; JDL-464; BM-02015; BM 02015; N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide; UNII-W31X2H97FB; AC4464; Torsemide (Demadex); CCRIS 6736; N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide; BRN 0498515; MLS001165687; CHEBI:9637; W31X2H97FB; Torasemide, Anhydrous; NCGC000168	C16H20N4O3S	NGBFQHCMQULJNZ-UHFFFAOYSA-N	1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea	n.a.	n.a.
PMDBD1468	Traffic-related air 	Environmental Chemicals	Others	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1470	Trans-resveratrol	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	445154	n.a.	n.a.	resveratrol; 501-36-0; trans-resveratrol; 3,4',5-Trihydroxystilbene; 3,5,4'-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; (E)-resveratrol; 3,4',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Resvida; 3,4',5-Trihydroxy-trans-stilbene; SRT-501; SRT501; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 3,5,4'-Trihydroxy-trans-stilbene; Resveratol; trans-3,4',5-trihydroxystilbene; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Resveratrol, natural; UNII-Q369O8926L; CHEBI:45713; C14H12O3; tr	C14H12O3	LUKBXSAWLPMMSZ-OWOJBTEDSA-N	5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol	n.a.	n.a.
PMDBD1471	Tranylcypromine Hemisulfate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	25267092	n.a.	n.a.	Tranylcypromine hemisulfate; 13492-01-8; Tranylcypromine sulfate; TRANS-2-PHENYLCYCLOPROPYLAMINE HEMISULFATE SALT; (1R,2S)-2-phenylcyclopropan-1-amine;sulfuric acid; Cyclopropanamine, 2-phenyl-, (1R,2S)-rel-, sulfate (2:1); Tranylcypromine sulfate [USAN:USP]; s9464; API0009012; Tranylcypromine sulfate; Tranylcypromine; AS-16857; (1R,2S)-2-phenylcyclopropanamine hemisulfate; C-20989; trans-2-phenyl-cyclo-propyl-amine hemisulfate salt; UNII-7ZAT6ES870 component BKPRVQDIOGQWTG-FKXFVUDVSA-N	C18H24N2O4S	BKPRVQDIOGQWTG-FKXFVUDVSA-N	(1R,2S)-2-phenylcyclopropan-1-amine;sulfuric acid	n.a.	n.a.
PMDBD1473	Triamcinolone Acetonide	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	6436	n.a.	n.a.	TRIAMCINOLONE ACETONIDE; 76-25-5; Azmacort; Aristogel; Aristoderm; Nasacort; Vetalog; Kenalog; Nasacort AQ; Tricinolon; Triaceton; Tramacin; Zilretta; Triacort; Solodelf; Kenalone; Triacet; Rineton; Flutone; Trymex; Triderm; Oracort; Flutex; Triatex; Oralone; AllerNaze; Triam-Injekt; Aristocort A; Adcortyl A; Tri-Nasal; Omcilon A; Kenalog-H; Nasacort HFA; Volon A; Coupe-A; Kenalog in Orabase; Kenalog-10; Aristocort acetonide; Kenalog 40; Tricort-40; Triamcinolone (acetonide); Kenalog-40; Triamcinolone 16,17-acetonide; Trivaris; Triesence; Acetospan; Vo	C24H31FO6	YNDXUCZADRHECN-JNQJZLCISA-N	(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one	n.a.	n.a.
PMDBD1476	Trichlorfon	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	5853	n.a.	n.a.	Metrifonate; TRICHLORFON; Chlorophos; Trichlorphon; Metriphonate; Methyl chlorophos; 52-68-6; Chlorofos; Bilarcil; Foschlor; Dipterex; Chloroftalm; Chloroxyphos; Ricifon; Neguvon; Dylox; Trichlorophon; Khloroftalm; Agroforotox; Trichlorofon; Polfoschlor; Fliegenteller; Chlorophthalm; Hypodermacid; Wotexit; Phoschlor; Mazoten; Forotox; Masoten; Diptevur; Bovinox; Votexit; Volfartol; Sotipox; Ritsifon; Ditrifon; Cekufon; Dyvon; Briton; Tugon; Trinex; Loisol; Combot; Anthon; Danex; Soldep; Proxol; Dyrex; Briten; Trichlorphon FN; (+-)-Trichlorfon; Foschlor R; DE	C4H8Cl3O4P	NFACJZMKEDPNKN-UHFFFAOYSA-N	2,2,2-trichloro-1-dimethoxyphosphorylethanol	n.a.	n.a.
PMDBD1477	Tricyclic antidepressants	Therapeutic substance	Drug category	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1480	Trimethoprim/sulfamethoxazole	Therapeutic substance	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1481	Trimipramine Maleate	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5282318	n.a.	n.a.	Trimipramine maleate; 521-78-8; Surmontil maleate; Trimipramine maleate salt; Trimeprimine maleate; Trimipramine (maleate); Trimeprimine monomaleate; Trimipramini maleas; Trimipramine hydrogen maleate; Trimipramium maleinicum; Trimipramine acid maleate; Trimipramine Maleate, BP; C20H26N2.C4H4O4; EINECS 208-318-3; UNII-D28E1043W5; UNII-I412286V22; D28E1043W5; I412286V22; DSSTox_RID_80796; DSSTox_CID_25315; 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine maleate (1:1); DSSTox_GSID_45315; 5H-Dibenz(b,f)azep	C24H30N2O4	YDGHCKHAXOUQOS-BTJKTKAUSA-N	(Z)-but-2-enedioic acid;3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine	n.a.	n.a.
PMDBD1482	Trospium Chloride	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	5284631	n.a.	n.a.	trospium chloride; Sanctura; 10405-02-4; Spasmex; Spasmo-lyt; Uraplex; Santura; Relaspium; Trospium Cl; Sanctura XR; Trospii chloridum; Cloruro de trospio; Spasmo 3; Trospium (chloride); Chlorure de trospium; IP631; UNII-1E6682427E; Trospium chloride (Sanctura); Keptan; Azoniaspiro Compound XVII; AS Xvii; IP-631; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Regurin; CAS-10405-02-4; NCGC00167438-02; NCGC	C25H30ClNO3	RVCSYOQWLPPAOA-DHWZJIOFSA-M	[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride	n.a.	n.a.
PMDBD1484	Ursodiol	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	31401	n.a.	n.a.	URSODEOXYCHOLIC ACID; ursodiol; 128-13-2; Actigall; UDCA; Ursofalk; Ursolvan; ursodeoxycholate; Delursan; UrSO; Urso Forte; Ursodesoxycholic acid; Destolit; Ursochol; Cholit-ursan; Ursodamor; Ursobilin; Litursol; Solutrat; Deursil; Ursacol; Lyeton; Arsacol; Urso DS; Peptarom; UDCS; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid; Ursosan; Ursodexycholic Acid; Urso 250; 3-alpha,7-beta-Dioxycholanic acid; 7-beta-Hydroxylithocholic acid; 3-alpha,7-beta-Dihydroxycholanic acid; Acido ursodeossicolico [Italian]; Acido urso	C24H40O4	RUDATBOHQWOJDD-UZVSRGJWSA-N	(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	n.a.	n.a.
PMDBD1486	Valacyclovir	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	135398742	n.a.	n.a.	valacyclovir; Valaciclovir; 124832-26-4; Valtrex; Zelitrex; ValACV; Valcyclovir; Valaciclovir [INN:BAN]; Val-ACV; UNII-MZ1IW7Q79D; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; Valtrex (TN); MZ1IW7Q79D; CHEMBL1349; 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; BW256U87; CHEBI:35854; 124832-27-5; Valcivir; (S)-2-[(2-Amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl-2-amino-3-methylbutanoate; W-200980; Talavir; Virval; Vala	C13H20N6O4	HDOVUKNUBWVHOX-QMMMGPOBSA-N	2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate	n.a.	n.a.
PMDBD1494	Ziprasidone hydrochloride	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	219099	n.a.	n.a.	Ziprasidone hydrochloride; 122883-93-6; Ziprasidone HCl; Geodon; Zeldox; 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride; Ziprasidone (hydrochloride); UNII-JAL53626GG; 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; Ziprasidone hydrochloride [USAN]; 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride; C21H21ClN4OS.HCl; JAL53626GG; C21H22Cl2N4OS; CP 88059; 2H-Indol-2-one, 	C21H22Cl2N4OS	NZDBKBRIBJLNNT-UHFFFAOYSA-N	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride	n.a.	n.a.
PMDBD1496	β-Hexachlorocyclo hexane	Environmental Chemicals	Pesticides	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1497	β-lactam	Environmental Chemicals	Antibiotics	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.	n.a.
PMDBD1498	Β-Lapachone	Therapeutic substance	Drug	n.a.	n.a.	n.a.	n.a.	n.a.	3885	n.a.	n.a.	beta-Lapachone; 4707-32-8; lapachone; ARQ 501; 2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione; .beta.-Lapachone; ARQ-501; 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-B]pyran-5,6-dione; UNII-6N4FA2QQ6A; NSC 26326; 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione; SL 11001; 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione; NSC-26326; NSC 629749; BRN 0181499; 6N4FA2QQ6A; CHEBI:10429; 3,4-Dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-d	C15H14O3	QZPQTZZNNJUOLS-UHFFFAOYSA-N	2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione	n.a.	n.a.
